data_1bym_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bym _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo . . . . . 0 N--CA 1.484 0.945 0 N-CA-C 110.413 -0.649 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 pt -56.85 156.1 13.6 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 0.0 110.216 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.99 -168.2 0.4 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.059 1.558 . . . . 0.0 110.329 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -119.5 165.94 13.31 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.45 178.49 8.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -1.16 . . . . 0.0 110.231 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -151.86 46.43 0.78 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.329 -0.857 . . . . 0.0 110.25 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -102.91 29.25 5.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -0.905 . . . . 0.0 110.248 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo . . . . . 0 N--CA 1.484 0.96 0 N-CA-C 110.491 -0.619 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.533 ' CA ' ' HG3' ' A' ' 222' ' ' ARG . . . 154.11 128.52 1.23 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 151' ' ' ARG . 26.1 m -142.29 5.2 1.64 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -1.14 . . . . 0.0 110.431 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.555 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 0.0 OUTLIER 58.41 135.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.882 . . . . 0.0 110.319 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.565 ' CG1' HD13 ' A' ' 221' ' ' ILE . 4.2 p -65.84 56.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.162 -0.961 . . . . 0.0 110.391 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.598 ' CG2' ' CB ' ' A' ' 218' ' ' ALA . 5.1 pt -158.92 -37.1 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.104 -0.998 . . . . 0.0 110.156 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 150' ' ' THR . 0.3 OUTLIER -74.64 -16.25 60.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.372 -0.83 . . . . 0.0 109.736 179.637 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.518 ' O ' ' NE ' ' A' ' 161' ' ' ARG . . . -88.68 -20.12 25.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.489 -0.757 . . . . 0.0 109.971 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.513 ' HA ' ' NH1' ' A' ' 161' ' ' ARG . . . -70.01 124.86 25.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.352 -0.842 . . . . 0.0 110.166 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.55 ' CB ' ' HD2' ' A' ' 161' ' ' ARG . 77.1 m -123.21 171.78 9.09 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.17 -0.956 . . . . 0.0 110.356 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.472 ' C ' ' O ' ' A' ' 157' ' ' THR . 36.4 t -38.62 -39.62 0.5 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.344 -0.847 . . . . 0.0 109.603 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' MET . . . . . 0.463 ' O ' ' HD3' ' A' ' 161' ' ' ARG . 2.6 ptt? -104.05 146.52 32.7 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 121.496 -0.753 . . . . 0.0 109.566 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.457 ' HB2' ' OE2' ' A' ' 194' ' ' GLU . 44.1 Cg_endo -71.14 81.04 1.21 Allowed 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.898 1.472 . . . . 0.0 110.577 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.55 ' HD2' ' CB ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -63.37 -135.19 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.175 -0.953 . . . . 0.0 109.902 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.558 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 12.7 tttt -154.65 107.46 2.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.309 -0.869 . . . . 0.0 109.9 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.625 ' O ' ' O ' ' A' ' 193' ' ' VAL . 23.3 m -123.74 -150.43 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 110.845 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.664 ' HG2' ' N ' ' A' ' 165' ' ' ILE . 0.7 OUTLIER 179.48 155.41 0.52 Allowed 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.152 -0.967 . . . . 0.0 109.876 -179.201 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.788 ' HB ' ' CA ' ' A' ' 189' ' ' VAL . 0.2 OUTLIER -97.48 144.89 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.225 -0.922 . . . . 0.0 109.83 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.521 ' CG1' ' HG2' ' A' ' 224' ' ' GLU . 21.6 m -123.32 7.16 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.068 -1.02 . . . . 0.0 110.455 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -177.04 114.06 0.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.911 . . . . 0.0 110.412 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.499 ' CG2' ' HG2' ' A' ' 188' ' ' ARG . 0.7 OUTLIER -103.59 20.93 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.35 -0.844 . . . . 0.0 109.945 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' ' 168' ' ' ILE . 1.8 t-20 -44.86 172.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 110.292 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -166.68 92.04 0.44 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.176 -0.952 . . . . 0.0 110.261 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.3 pp -83.61 13.88 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.197 -0.939 . . . . 0.0 110.311 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.549 ' CD1' ' OE1' ' A' ' 175' ' ' GLU . 1.6 m-85 -62.56 135.54 57.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 110.209 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . 0.459 ' O ' ' HB ' ' A' ' 174' ' ' VAL . 11.1 mm-40 -59.67 -21.08 60.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.184 -0.948 . . . . 0.0 110.225 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.459 ' HB ' ' O ' ' A' ' 173' ' ' GLN . 4.5 p 179.76 90.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -0.937 . . . . 0.0 110.159 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.549 ' OE1' ' CD1' ' A' ' 172' ' ' PHE . 4.7 tt0 -143.52 105.18 4.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 110.252 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.523 ' O ' ' CB ' ' A' ' 177' ' ' ASP . 0.1 OUTLIER -138.07 -82.93 0.32 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 110.147 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.523 ' CB ' ' O ' ' A' ' 176' ' ' THR . 0.8 OUTLIER 70.96 -159.36 0.13 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.301 -0.875 . . . . 0.0 110.438 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -59.27 -18.9 41.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.354 -0.841 . . . . 0.0 110.583 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.598 ' HA ' ' CD1' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -53.29 -36.03 60.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.169 -0.957 . . . . 0.0 110.129 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.48 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.7 OUTLIER -40.63 -27.92 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 0.0 109.892 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 179' ' ' PHE . 19.7 tt0 -63.2 -41.55 99.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.854 . . . . 0.0 109.823 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.598 ' CD1' ' HA ' ' A' ' 179' ' ' PHE . 1.7 mt -58.25 -46.48 85.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.419 -0.801 . . . . 0.0 109.766 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.471 ' CD1' ' O ' ' A' ' 183' ' ' LEU . 0.2 OUTLIER -67.34 -32.75 73.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.551 -0.718 . . . . 0.0 110.164 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -83.15 0.62 44.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.389 -0.819 . . . . 0.0 110.278 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.466 ' O ' HG13 ' A' ' 187' ' ' ILE . . . -81.71 8.29 10.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 110.219 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 23.4 t0 59.98 49.9 7.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.254 -0.904 . . . . 0.0 110.152 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.551 ' O ' ' CB ' ' A' ' 188' ' ' ARG . 88.8 mt -138.6 -72.99 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 110.242 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.551 ' CB ' ' O ' ' A' ' 187' ' ' ILE . 3.4 ttp180 72.46 157.17 0.18 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.435 -0.791 . . . . 0.0 109.839 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.947 ' O ' ' N ' ' A' ' 191' ' ' SER . 3.7 m 33.17 36.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 O-C-N 121.352 -0.842 . . . . 0.0 110.731 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.568 ' C ' ' O ' ' A' ' 189' ' ' VAL . . . 27.74 19.26 0.0 OUTLIER Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.947 ' N ' ' O ' ' A' ' 189' ' ' VAL . 30.6 t 38.29 -144.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.233 -1.157 . . . . 0.0 109.801 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.614 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -90.74 113.2 25.25 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.256 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.625 ' O ' ' O ' ' A' ' 163' ' ' VAL . 33.6 m -159.27 -137.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.288 -0.882 . . . . 0.0 109.996 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.558 ' CB ' ' HA ' ' A' ' 162' ' ' LYS . 5.4 pt-20 -170.54 167.37 8.07 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.214 -0.929 . . . . 0.0 110.086 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.544 ' CG2' ' HG ' ' A' ' 204' ' ' LEU . 0.4 OUTLIER -124.75 173.68 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.116 -0.99 . . . . 0.0 110.401 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.439 ' CG2' ' HB3' ' A' ' 160' ' ' PRO . 46.1 t -145.25 85.74 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.318 -0.864 . . . . 0.0 110.055 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.505 ' N ' ' OD1' ' A' ' 197' ' ' ASP . 18.9 p-10 -40.65 133.81 1.93 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.0 110.436 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.443 ' O ' ' C ' ' A' ' 199' ' ' ASP . 12.9 mmt85 -123.66 67.11 1.02 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.268 -0.895 . . . . 0.0 110.184 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 198' ' ' ARG . 2.7 t0 40.72 81.67 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.395 -0.815 . . . . 0.0 110.158 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 88.27 -37.9 3.23 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.62 164.61 12.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.223 -1.163 . . . . 0.0 110.166 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.499 HD11 ' CG2' ' A' ' 153' ' ' ILE . 4.1 mt -145.83 118.29 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.921 . . . . 0.0 110.24 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.437 HG21 ' O ' ' A' ' 211' ' ' VAL . 2.1 m -104.85 163.14 12.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 109.961 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.629 ' CD2' ' CD2' ' A' ' 206' ' ' HIS . 0.5 OUTLIER -119.83 138.19 53.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.152 -0.967 . . . . 0.0 110.213 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.554 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.5 OUTLIER -119.72 117.08 27.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.36 -0.837 . . . . 0.0 109.97 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.629 ' CD2' ' CD2' ' A' ' 204' ' ' LEU . 3.9 m170 -105.46 162.13 13.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.384 -0.822 . . . . 0.0 110.14 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -59.63 77.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.312 -0.867 . . . . 0.0 110.473 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 102.86 24.68 7.97 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.56 ' O ' ' CG ' ' A' ' 206' ' ' HIS . 3.1 mtpt -174.06 124.64 0.34 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -1.226 . . . . 0.0 110.462 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.46 150.86 40.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.266 -0.896 . . . . 0.0 110.149 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.437 ' O ' HG21 ' A' ' 203' ' ' THR . 8.4 p -137.72 165.48 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.172 -0.955 . . . . 0.0 110.252 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.88 88.99 3.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 110.202 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.522 ' CD1' ' HB1' ' A' ' 218' ' ' ALA . 3.4 pp -76.93 -160.01 0.15 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.21 -0.931 . . . . 0.0 110.216 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.516 HD13 ' CD1' ' A' ' 217' ' ' LEU . 0.5 OUTLIER -130.01 132.91 46.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -0.892 . . . . 0.0 110.217 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.46 ' OD2' HG13 ' A' ' 202' ' ' ILE . 0.7 OUTLIER -51.8 -23.58 4.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 110.222 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.86 -54.29 44.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 110.242 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.516 ' CD1' HD13 ' A' ' 214' ' ' LEU . 0.1 OUTLIER -89.6 -19.1 25.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.188 -0.945 . . . . 0.0 110.345 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . 0.598 ' CB ' ' CG2' ' A' ' 153' ' ' ILE . . . -53.33 -18.36 2.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -0.877 . . . . 0.0 110.19 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.544 ' CG ' HD13 ' A' ' 153' ' ' ILE . 14.0 t-80 -103.5 49.99 0.81 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.931 . . . . 0.0 110.136 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 1.3 m -133.74 -61.59 0.8 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.327 -0.858 . . . . 0.0 110.225 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.596 ' CD1' ' N ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -60.55 145.15 12.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.419 -0.8 . . . . 0.0 110.379 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.533 ' HG3' ' CA ' ' A' ' 149' ' ' GLY . 1.0 OUTLIER -89.82 116.48 27.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 109.611 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.545 ' CG2' HG22 ' A' ' 165' ' ' ILE . 0.5 OUTLIER -124.64 170.07 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.077 -1.015 . . . . 0.0 110.636 -179.419 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.521 ' HG2' ' CG1' ' A' ' 166' ' ' VAL . 0.0 OUTLIER -150.11 -168.89 3.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.449 -0.782 . . . . 0.0 110.07 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 22.3 mt-10 -90.18 149.17 22.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.176 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.513 ' CD1' ' HB2' ' A' ' 192' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.924 -1.036 . . . . 0.0 110.199 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 N--CA 1.484 0.932 0 N-CA-C 110.472 -0.626 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.475 ' O ' ' CG2' ' A' ' 132' ' ' ILE . 7.3 tp -124.05 63.61 31.97 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 110.233 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.08 -164.52 0.2 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.059 1.557 . . . . 0.0 110.444 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -139.4 81.45 0.26 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 47.56 56.32 7.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -1.159 . . . . 0.0 110.249 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -89.62 42.25 1.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.942 . . . . 0.0 110.196 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.19 8.61 6.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.226 -0.921 . . . . 0.0 110.232 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 110.268 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo . . . . . 0 N--CA 1.483 0.911 0 N-CA-C 110.368 -0.666 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 140.19 153.17 5.97 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.494 ' N ' ' O ' ' A' ' 223' ' ' ILE . 3.7 m -131.5 2.46 4.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -1.138 . . . . 0.0 110.265 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.486 ' O ' ' HB2' ' A' ' 154' ' ' ASP . 6.1 mtm-85 61.0 118.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.266 -0.897 . . . . 0.0 110.276 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.675 ' O ' HG12 ' A' ' 153' ' ' ILE . 5.9 p -42.82 165.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.183 -0.948 . . . . 0.0 110.218 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.675 HG12 ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 72.17 -20.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.759 -0.588 . . . . 0.0 110.282 -179.439 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' A' ' 152' ' ' VAL . 0.4 OUTLIER -91.4 -18.98 23.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 0.0 108.71 178.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.429 ' HB2' HG12 ' A' ' 163' ' ' VAL . . . -108.33 -15.04 14.56 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.563 0.697 . . . . 0.0 109.45 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -67.83 152.12 46.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.437 -0.79 . . . . 0.0 110.157 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -161.94 174.59 12.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 110.227 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 157' ' ' THR . 0.2 OUTLIER -41.97 -48.32 4.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 110.166 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' MET . . . . . 0.463 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 4.0 mmm -82.32 166.66 35.39 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 110.201 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 46.5 Cg_endo -73.35 84.06 1.41 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.019 1.536 . . . . 0.0 110.437 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -70.72 111.48 6.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 0.0 110.241 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.567 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 0.2 OUTLIER -71.99 117.26 13.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.896 . . . . 0.0 110.286 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.668 ' O ' ' O ' ' A' ' 193' ' ' VAL . 0.0 OUTLIER -133.88 -165.4 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.213 -0.929 . . . . 0.0 110.431 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.552 ' CG ' ' HA ' ' A' ' 192' ' ' GLU . 20.1 ttp180 -173.54 147.61 1.46 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.847 -1.158 . . . . 0.0 109.829 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.801 ' HB ' ' C ' ' A' ' 189' ' ' VAL . 0.2 OUTLIER -95.03 143.55 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.162 -0.961 . . . . 0.0 110.181 -179.457 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.8 m -123.9 -8.21 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 110.175 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -158.66 124.04 4.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 0.0 110.188 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.459 ' CG2' ' HG2' ' A' ' 188' ' ' ARG . 5.1 tt -117.58 6.65 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.279 -0.888 . . . . 0.0 110.169 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.446 ' O ' ' CB ' ' A' ' 170' ' ' GLU . 27.1 t-20 -41.88 113.35 0.42 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.303 -0.873 . . . . 0.0 110.114 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.579 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 0.1 OUTLIER 172.68 123.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 110.321 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.591 ' O ' ' C ' ' A' ' 172' ' ' PHE . 63.2 mt -84.89 17.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 109.91 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.591 ' C ' ' O ' ' A' ' 171' ' ' ILE . 0.5 OUTLIER 25.06 -138.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.686 -0.634 . . . . 0.0 110.954 179.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.04 -145.94 0.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 0.0 110.213 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 32.8 m -114.71 6.46 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 110.355 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.71 174.09 7.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 110.245 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' A' ' 177' ' ' ASP . 12.1 p -148.29 -84.48 0.1 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -0.889 . . . . 0.0 110.165 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 176' ' ' THR . 7.0 t0 70.09 -139.16 0.06 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.345 -0.847 . . . . 0.0 110.218 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 181' ' ' GLN . 0.0 OUTLIER -64.07 -28.34 69.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.114 -0.991 . . . . 0.0 110.256 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.539 ' CZ ' HD11 ' A' ' 183' ' ' LEU . 0.3 OUTLIER -50.03 -51.8 39.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 110.076 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -49.97 -21.38 1.18 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.065 -1.022 . . . . 0.0 109.822 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.475 ' HB3' ' O ' ' A' ' 178' ' ' GLN . 20.8 tt0 -69.49 -59.95 2.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.291 -0.881 . . . . 0.0 110.422 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.546 ' C ' ' CD1' ' A' ' 182' ' ' LEU . 3.9 pp -66.62 -15.64 63.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.831 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.539 HD11 ' CZ ' ' A' ' 179' ' ' PHE . 0.3 OUTLIER -85.97 -28.81 24.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.36 -0.838 . . . . 0.0 109.668 179.619 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -81.12 6.85 12.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.346 -0.846 . . . . 0.0 109.821 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.487 ' CB ' HG23 ' A' ' 187' ' ' ILE . . . -81.05 12.46 3.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.353 -0.842 . . . . 0.0 110.232 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 185' ' ' ALA . 23.1 t70 43.48 41.15 3.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.156 -0.965 . . . . 0.0 109.326 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.497 ' O ' ' O ' ' A' ' 188' ' ' ARG . 0.4 OUTLIER -117.19 -43.63 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.451 -0.781 . . . . 0.0 110.379 -179.448 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.544 ' O ' HG21 ' A' ' 189' ' ' VAL . 3.9 ttp-105 53.22 168.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.341 -0.849 . . . . 0.0 109.882 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.956 ' O ' ' N ' ' A' ' 191' ' ' SER . 2.7 m 31.46 37.67 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 121.369 -0.832 . . . . 0.0 110.809 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.538 ' C ' ' O ' ' A' ' 189' ' ' VAL . . . 28.41 19.14 0.0 OUTLIER Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.956 ' N ' ' O ' ' A' ' 189' ' ' VAL . 18.1 t 41.52 -153.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.167 -1.196 . . . . 0.0 109.766 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.597 ' O ' ' CG1' ' A' ' 193' ' ' VAL . 1.8 pt-20 -89.11 115.81 26.91 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.582 -0.699 . . . . 0.0 109.115 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.668 ' O ' ' O ' ' A' ' 163' ' ' VAL . 35.4 m -159.8 -131.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.939 . . . . 0.0 109.942 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.575 ' HA ' HG22 ' A' ' 163' ' ' VAL . 8.1 pt-20 -176.8 169.34 2.48 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.241 -0.912 . . . . 0.0 110.387 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.543 ' CG2' ' HG ' ' A' ' 204' ' ' LEU . 0.5 OUTLIER -125.46 170.78 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.221 -0.924 . . . . 0.0 110.51 -179.552 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.462 ' O ' ' C ' ' A' ' 197' ' ' ASP . 65.7 t -148.13 80.7 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.367 -0.833 . . . . 0.0 109.892 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 197' ' ' ASP . 11.5 p30 -39.39 123.28 1.42 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.394 -0.816 . . . . 0.0 110.448 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -107.12 78.1 1.2 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.271 -0.893 . . . . 0.0 110.135 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 198' ' ' ARG . 27.7 t0 41.78 79.43 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.295 -0.878 . . . . 0.0 110.212 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 87.68 -37.27 3.25 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.497 ' O ' ' N ' ' A' ' 198' ' ' ARG . 45.0 m170 -90.99 168.37 11.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.239 -1.153 . . . . 0.0 110.202 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.554 ' CD1' ' HB ' ' A' ' 153' ' ' ILE . 7.7 mt -141.09 121.6 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.221 -0.924 . . . . 0.0 110.166 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 58.0 m -109.12 160.18 16.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.332 -0.855 . . . . 0.0 109.863 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.543 ' HG ' ' CG2' ' A' ' 195' ' ' ILE . 0.6 OUTLIER -119.74 132.46 55.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.158 -0.964 . . . . 0.0 110.217 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.557 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 1.4 m -119.82 128.12 53.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.878 . . . . 0.0 109.941 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.582 ' CD2' HG13 ' A' ' 193' ' ' VAL . 1.8 m170 -105.48 173.98 6.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.366 -0.834 . . . . 0.0 109.958 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -58.35 96.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 0.0 110.229 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 76.14 29.72 58.23 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.68 165.41 32.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.117 -1.225 . . . . 0.0 110.26 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -161.12 143.37 12.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.224 -0.922 . . . . 0.0 110.177 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.478 ' CG1' ' N ' ' A' ' 212' ' ' GLU . 1.6 p -142.74 -154.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.176 -0.952 . . . . 0.0 110.228 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.478 ' N ' ' CG1' ' A' ' 211' ' ' VAL . 1.3 tt0 -115.23 169.49 9.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 110.323 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.429 HD11 ' CD2' ' A' ' 182' ' ' LEU . 11.6 tp -168.27 89.68 0.26 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.355 -0.841 . . . . 0.0 110.149 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.579 ' N ' ' CD2' ' A' ' 214' ' ' LEU . 2.5 pt? -41.62 152.78 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 110.292 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.45 ' HA ' ' HB1' ' A' ' 218' ' ' ALA . 3.3 t0 -83.01 -22.39 33.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 110.195 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.98 -61.93 2.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.241 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.517 ' HB2' ' CD1' ' A' ' 214' ' ' LEU . 0.2 OUTLIER -75.63 -14.86 60.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -0.872 . . . . 0.0 110.197 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . 0.577 ' CB ' HG23 ' A' ' 153' ' ' ILE . . . -50.29 -51.16 47.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 110.16 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.551 ' HB2' ' CD1' ' A' ' 153' ' ' ILE . 9.6 t60 -74.02 72.98 1.67 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.211 -0.93 . . . . 0.0 110.22 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 31.5 m -156.39 -53.82 0.08 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.154 -0.967 . . . . 0.0 110.425 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.572 HD13 ' CG1' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -66.07 174.82 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.397 -0.815 . . . . 0.0 110.409 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.2 mtm180 -122.62 99.67 6.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.417 -0.802 . . . . 0.0 109.734 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 165' ' ' ILE . 0.0 OUTLIER -119.36 167.45 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.97 . . . . 0.0 110.173 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.452 ' C ' HG11 ' A' ' 163' ' ' VAL . 15.1 pt-20 -150.3 174.35 12.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.245 -0.909 . . . . 0.0 110.135 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.493 ' HA ' HG11 ' A' ' 163' ' ' VAL . 0.7 OUTLIER -43.96 143.04 1.2 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.47 -0.769 . . . . 0.0 110.23 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.427 ' OXT' ' OE1' ' A' ' 225' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.196 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo . . . . . 0 N--CA 1.483 0.877 0 N-CA-C 110.496 -0.617 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.439 ' O ' HG21 ' A' ' 132' ' ' ILE . 0.4 OUTLIER -61.96 135.56 94.71 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.234 -0.916 . . . . 0.0 110.147 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.09 -90.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.986 1.519 . . . . 0.0 110.444 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 139.53 -116.17 1.19 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.6 mm? 59.11 166.12 0.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -1.143 . . . . 0.0 110.2 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -80.96 86.05 6.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.188 -0.945 . . . . 0.0 110.274 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -142.28 57.25 1.46 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.295 -0.878 . . . . 0.0 110.239 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 0.0 110.215 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.423 ' HB2' ' OE2' ' A' ' 224' ' ' GLU . 46.8 Cg_endo . . . . . 0 N--CA 1.484 0.955 0 N-CA-C 110.435 -0.641 . . . . 0.0 110.435 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.505 ' HA3' ' HB2' ' A' ' 222' ' ' ARG . . . -133.18 159.16 23.48 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.516 ' O ' ' CB ' ' A' ' 154' ' ' ASP . 0.6 OUTLIER -158.15 17.63 0.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -1.153 . . . . 0.0 110.471 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.605 ' CB ' ' HB2' ' A' ' 154' ' ' ASP . 0.5 OUTLIER 56.11 117.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.146 -0.971 . . . . 0.0 110.375 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.643 HG11 ' CG2' ' A' ' 223' ' ' ILE . 0.0 OUTLIER -41.39 -80.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.193 -0.942 . . . . 0.0 111.247 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.609 ' CG2' ' CB ' ' A' ' 218' ' ' ALA . 0.2 OUTLIER -47.44 -18.82 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.429 -0.795 . . . . 0.0 111.631 -178.628 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.605 ' HB2' ' CB ' ' A' ' 151' ' ' ARG . 0.3 OUTLIER -71.9 -13.49 61.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.798 -1.189 . . . . 0.0 109.094 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -125.63 2.08 7.55 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.653 -0.655 . . . . 0.0 109.624 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.552 ' O ' ' CG2' ' A' ' 157' ' ' THR . . . -81.04 -177.5 6.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.42 -0.8 . . . . 0.0 110.486 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.575 ' N ' ' HB3' ' A' ' 160' ' ' PRO . 7.2 t 40.11 -168.53 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.548 -0.72 . . . . 0.0 110.55 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.53 ' C ' ' O ' ' A' ' 157' ' ' THR . 25.0 p 34.64 76.58 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.327 -0.858 . . . . 0.0 110.16 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' MET . . . . . 0.479 ' N ' ' CD ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER 58.33 54.28 5.73 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.92 . . . . 0.0 109.586 -179.445 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.575 ' HB3' ' N ' ' A' ' 157' ' ' THR . 43.8 Cg_endo -71.2 -159.09 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.091 1.574 . . . . 0.0 110.682 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.514 ' CB ' ' O ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER 168.2 -153.94 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.317 -0.865 . . . . 0.0 110.301 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -90.73 116.7 28.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -0.919 . . . . 0.0 110.539 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.577 ' O ' ' O ' ' A' ' 193' ' ' VAL . 0.0 OUTLIER -112.26 -171.44 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.271 -0.893 . . . . 0.0 110.112 179.555 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.675 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -170.61 131.43 0.89 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.888 -1.133 . . . . 0.0 110.056 -179.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.554 HG22 ' CG2' ' A' ' 223' ' ' ILE . 0.5 OUTLIER -88.97 152.03 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.333 -0.854 . . . . 0.0 110.656 -179.197 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 222' ' ' ARG . 9.2 m -133.61 -1.67 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 110.184 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.567 ' CB ' ' HD2' ' A' ' 222' ' ' ARG . 0.1 OUTLIER -171.59 125.24 0.59 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 110.169 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.523 ' CD1' HG13 ' A' ' 171' ' ' ILE . 8.5 tt -90.21 -3.12 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.854 . . . . 0.0 110.235 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 168' ' ' ILE . 0.2 OUTLIER 62.71 -141.26 0.4 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 110.243 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.87 109.0 18.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 110.306 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.523 HG13 ' CD1' ' A' ' 168' ' ' ILE . 41.9 mm -87.84 23.19 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 110.178 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -54.93 86.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.285 -0.884 . . . . 0.0 110.234 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . 0.504 ' N ' ' O ' ' A' ' 171' ' ' ILE . 0.7 OUTLIER -142.99 -172.07 3.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 110.181 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.41 -4.78 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 110.262 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.417 ' OE1' ' OD2' ' A' ' 216' ' ' ASP . 77.0 mt-10 -71.48 167.0 20.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.178 -0.951 . . . . 0.0 110.204 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -173.7 -95.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.191 -0.943 . . . . 0.0 110.229 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 176' ' ' THR . 4.2 t0 72.35 -140.21 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.283 -0.886 . . . . 0.0 110.273 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -58.42 -16.2 13.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.276 -0.89 . . . . 0.0 110.43 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.573 ' CE2' HD11 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -60.5 -22.84 64.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.081 -1.012 . . . . 0.0 110.135 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 177' ' ' ASP . 0.6 OUTLIER -54.55 -26.91 34.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.144 -0.973 . . . . 0.0 109.864 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.464 ' HB3' ' OE2' ' A' ' 212' ' ' GLU . 3.2 tt0 -69.26 -65.75 0.67 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.365 -0.834 . . . . 0.0 110.218 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 179' ' ' PHE . 4.5 pp -58.99 -15.07 11.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.884 . . . . 0.0 110.268 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.573 HD11 ' CE2' ' A' ' 179' ' ' PHE . 0.7 OUTLIER -86.45 -31.18 21.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 109.998 179.8 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.15 -8.03 35.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.359 -0.838 . . . . 0.0 110.07 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -88.86 10.06 22.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.865 . . . . 0.0 110.176 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 185' ' ' ALA . 31.8 t0 41.69 66.66 0.66 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.907 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.3 tt -121.3 -173.56 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 110.54 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.576 ' O ' ' O ' ' A' ' 189' ' ' VAL . 0.1 OUTLIER -171.81 122.53 0.5 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.661 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 1.4 m 50.27 105.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.204 -0.935 . . . . 0.0 108.947 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 191' ' ' SER . . . -45.14 -12.99 0.03 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.592 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 4.1 t 65.84 -143.26 0.19 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.012 -1.287 . . . . 0.0 109.42 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.675 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 1.9 tt0 -71.31 102.86 2.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.572 -0.705 . . . . 0.0 109.487 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.577 ' O ' ' O ' ' A' ' 163' ' ' VAL . 16.9 m -156.65 -140.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.097 -1.002 . . . . 0.0 109.967 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 162' ' ' LYS . 8.3 pt-20 -176.88 138.1 0.26 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 110.728 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.584 ' CG1' ' CG2' ' A' ' 202' ' ' ILE . 0.0 OUTLIER -132.26 161.21 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.293 -0.88 . . . . 0.0 109.99 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.563 ' N ' HG12 ' A' ' 195' ' ' ILE . 37.5 t -154.75 150.3 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.421 -0.799 . . . . 0.0 110.165 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.477 ' N ' HG11 ' A' ' 196' ' ' VAL . 4.4 t0 -58.92 119.53 7.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -0.943 . . . . 0.0 110.133 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 199' ' ' ASP . 0.0 OUTLIER -119.32 106.95 12.81 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.232 -0.917 . . . . 0.0 110.396 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 198' ' ' ARG . 15.9 m-20 40.75 79.71 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.254 -0.904 . . . . 0.0 110.372 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 44.84 25.12 0.85 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.414 ' O ' ' CB ' ' A' ' 198' ' ' ARG . 0.0 OUTLIER -150.18 106.83 3.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.214 -1.168 . . . . 0.0 110.132 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.584 ' CG2' ' CG1' ' A' ' 195' ' ' ILE . 49.8 mt -64.27 139.46 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 110.336 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 195' ' ' ILE . 3.7 m -119.16 150.32 40.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.338 -0.851 . . . . 0.0 109.935 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.545 ' HA ' ' HB ' ' A' ' 195' ' ' ILE . 0.5 OUTLIER -119.8 130.34 54.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 0.0 110.284 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.546 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 3.2 t -119.79 126.86 52.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.393 -0.817 . . . . 0.0 110.014 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.514 ' HB3' ' CG1' ' A' ' 193' ' ' VAL . 0.0 OUTLIER -114.19 106.64 14.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.451 -0.781 . . . . 0.0 109.836 180.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.487 ' HB3' ' O ' ' A' ' 206' ' ' HIS . 21.4 t30 61.01 17.4 7.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 110.243 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 114.04 -20.01 17.35 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -81.35 101.37 9.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -1.155 . . . . 0.0 110.277 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 30.5 p30 -83.93 147.84 27.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.912 . . . . 0.0 110.292 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.409 ' CG1' ' CE1' ' A' ' 206' ' ' HIS . 4.3 p -155.12 151.66 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.319 -0.863 . . . . 0.0 110.167 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.464 ' OE2' ' HB3' ' A' ' 181' ' ' GLN . 15.4 pt-20 -57.28 148.05 23.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 0.0 110.165 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.463 ' CD1' ' HB2' ' A' ' 204' ' ' LEU . 0.4 OUTLIER -113.86 -149.33 0.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 110.2 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.55 ' O ' ' CD1' ' A' ' 214' ' ' LEU . 0.4 OUTLIER -152.16 108.89 3.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 110.223 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -59.8 -38.67 82.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 110.304 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.417 ' OD2' ' OE1' ' A' ' 175' ' ' GLU . 0.2 OUTLIER -65.7 -44.71 85.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.911 . . . . 0.0 110.267 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.533 ' O ' ' CG2' ' A' ' 220' ' ' THR . 0.2 OUTLIER -85.83 -22.91 27.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.267 -0.896 . . . . 0.0 110.254 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . 0.609 ' CB ' ' CG2' ' A' ' 153' ' ' ILE . . . -40.63 -44.84 2.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.334 -0.853 . . . . 0.0 110.288 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.487 ' HA ' HD13 ' A' ' 153' ' ' ILE . 39.8 t-80 -90.69 49.73 1.71 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.155 -0.966 . . . . 0.0 110.509 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' THR . . . . . 0.54 HG21 HD11 ' A' ' 221' ' ' ILE . 3.0 t -137.52 -27.16 0.95 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.126 -0.984 . . . . 0.0 110.486 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.54 HD11 HG21 ' A' ' 220' ' ' THR . 0.1 OUTLIER -95.23 144.5 9.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 120.998 -1.064 . . . . 0.0 110.362 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.567 ' HD2' ' CB ' ' A' ' 167' ' ' GLN . 3.7 ptp85 -95.06 106.72 18.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.146 -0.971 . . . . 0.0 109.405 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.643 ' CG2' HG11 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -119.78 174.03 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.183 -0.948 . . . . 0.0 110.253 -179.132 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 163' ' ' VAL . 1.2 tt0 -124.65 171.95 9.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.096 -1.003 . . . . 0.0 110.583 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 6.8 tp10 -113.52 110.99 21.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.374 -0.829 . . . . 0.0 110.182 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 162' ' ' LYS . 7.6 mp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.984 -1.007 . . . . 0.0 110.16 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 N--CA 1.484 0.949 0 N-CA-C 110.38 -0.662 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.504 HG23 HD11 ' A' ' 132' ' ' ILE . 9.9 tt -63.79 140.63 97.86 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.25 -0.906 . . . . 0.0 110.223 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.09 -166.86 0.32 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.962 1.506 . . . . 0.0 110.384 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.12 -119.6 2.01 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.4 tp -130.44 138.36 50.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.198 -1.178 . . . . 0.0 110.187 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 138' ' ' LEU . 0.5 OUTLIER 52.93 33.27 14.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.305 -0.872 . . . . 0.0 110.158 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 59.83 -85.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.314 -0.866 . . . . 0.0 110.21 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 136' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.283 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.462 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 45.8 Cg_endo . . . . . 0 N--CA 1.484 0.927 0 N-CA-C 110.358 -0.67 . . . . 0.0 110.358 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 151' ' ' ARG . . . -114.83 35.01 4.6 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.539 ' O ' ' CG1' ' A' ' 223' ' ' ILE . 23.8 m -42.07 93.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.37 -1.076 . . . . 0.0 110.236 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.549 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 7.2 ptp85 -42.02 142.75 0.66 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.219 -0.926 . . . . 0.0 110.112 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.582 ' CG1' HD13 ' A' ' 221' ' ' ILE . 0.8 OUTLIER -57.57 -153.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.176 -0.953 . . . . 0.0 110.039 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.577 ' CG2' ' CB ' ' A' ' 218' ' ' ALA . 11.8 pt 39.29 25.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.321 -0.862 . . . . 0.0 110.436 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER -135.55 -36.35 0.78 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.312 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.431 ' CB ' HG13 ' A' ' 163' ' ' VAL . . . -88.76 -9.94 50.06 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.473 ' HB1' HD13 ' A' ' 195' ' ' ILE . . . -74.7 107.42 6.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.546 -0.721 . . . . 0.0 110.234 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 158' ' ' SER . 5.7 t -174.11 169.62 3.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.272 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 159' ' ' MET . 0.6 OUTLIER 41.77 74.17 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.327 -0.858 . . . . 0.0 110.124 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' MET . . . . . 0.496 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 0.0 OUTLIER 63.51 165.9 0.11 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.144 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 44.6 Cg_endo -72.24 88.01 0.87 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.999 1.526 . . . . 0.0 110.435 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.2 ttt85 -65.61 -140.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 110.21 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -145.29 93.15 2.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.234 -0.916 . . . . 0.0 110.254 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.675 ' O ' ' O ' ' A' ' 193' ' ' VAL . 21.5 m -111.52 -172.94 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.0 110.224 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.616 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 12.8 ptt-85 -162.39 147.17 12.3 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.725 -1.234 . . . . 0.0 110.872 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 191' ' ' SER . 1.2 mt -98.71 165.84 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.493 -0.755 . . . . 0.0 110.273 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 222' ' ' ARG . 19.1 m -142.54 -31.8 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.158 -0.964 . . . . 0.0 110.484 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 222' ' ' ARG . 0.7 OUTLIER -140.34 123.91 17.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 110.282 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 221' ' ' ILE . 7.4 tt -99.61 -5.95 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 110.117 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 168' ' ' ILE . 17.4 m120 55.05 164.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.315 -0.866 . . . . 0.0 110.204 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 169' ' ' ASN . 28.5 mt-10 -144.51 49.57 1.32 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.14 -0.975 . . . . 0.0 110.204 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.4 ' HA ' HD11 ' A' ' 171' ' ' ILE . 16.0 mm -100.23 -3.08 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.211 -0.931 . . . . 0.0 110.234 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -123.01 154.47 38.42 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.142 -0.974 . . . . 0.0 110.214 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 174' ' ' VAL . 0.0 OUTLIER -79.43 -26.99 41.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.226 -0.921 . . . . 0.0 110.187 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.555 HG11 ' CZ ' ' A' ' 179' ' ' PHE . 41.6 t 43.91 74.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 110.344 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -103.88 116.96 33.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.289 -0.882 . . . . 0.0 110.107 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.589 ' CG2' ' HB3' ' A' ' 179' ' ' PHE . 2.9 m -155.42 134.56 12.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.901 . . . . 0.0 110.18 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 179' ' ' PHE . 1.1 p-10 -48.73 -101.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.316 -0.865 . . . . 0.0 111.248 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.484 ' C ' ' O ' ' A' ' 177' ' ' ASP . 5.1 pt20 -34.04 -30.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.258 -0.901 . . . . 0.0 111.082 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.589 ' HB3' ' CG2' ' A' ' 176' ' ' THR . 7.4 t80 -60.48 -59.59 5.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.944 . . . . 0.0 110.487 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.525 ' OG1' ' O ' ' A' ' 177' ' ' ASP . 0.9 OUTLIER -37.98 -29.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.359 -0.838 . . . . 0.0 110.33 -179.706 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.504 ' N ' ' O ' ' A' ' 179' ' ' PHE . 24.4 tt0 -57.45 -56.69 18.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.202 -0.937 . . . . 0.0 110.019 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 179' ' ' PHE . 2.6 pp -70.03 -14.04 62.5 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.286 -0.884 . . . . 0.0 109.686 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.47 ' HB3' ' HA ' ' A' ' 180' ' ' THR . 0.4 OUTLIER -89.8 -32.13 17.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.393 -0.817 . . . . 0.0 109.775 179.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -69.4 -4.8 19.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.309 -0.869 . . . . 0.0 109.806 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -83.74 14.33 4.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.428 -0.795 . . . . 0.0 110.114 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 185' ' ' ALA . 0.7 OUTLIER 42.82 62.74 1.67 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.156 -0.965 . . . . 0.0 109.896 -179.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.8 tt -119.35 -173.78 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 110.52 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.575 ' O ' HG23 ' A' ' 189' ' ' VAL . 0.1 OUTLIER -174.53 115.56 0.18 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.362 -0.836 . . . . 0.0 108.748 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.649 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 1.3 m 51.57 108.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.298 -0.876 . . . . 0.0 109.073 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.496 ' O ' HG12 ' A' ' 193' ' ' VAL . . . -46.12 -13.96 0.08 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.573 ' O ' ' HB2' ' A' ' 164' ' ' ARG . 7.7 t 63.93 -146.87 0.3 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -1.148 . . . . 0.0 109.483 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.616 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.2 OUTLIER -63.4 99.63 0.21 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.618 -0.676 . . . . 0.0 109.576 179.336 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.675 ' O ' ' O ' ' A' ' 163' ' ' VAL . 26.2 m -157.28 -135.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -0.93 . . . . 0.0 109.603 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.507 ' N ' HG22 ' A' ' 193' ' ' VAL . 0.3 OUTLIER -175.04 160.47 2.78 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.124 179.297 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.564 HG12 ' CG2' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -119.97 176.62 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.074 -1.016 . . . . 0.0 110.227 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.445 ' CG2' ' C ' ' A' ' 195' ' ' ILE . 7.4 t -148.7 86.7 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.291 -0.881 . . . . 0.0 110.183 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 197' ' ' ASP . 15.8 p-10 -43.8 127.33 5.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 110.245 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.499 ' O ' ' C ' ' A' ' 199' ' ' ASP . 21.9 mtt180 -99.76 71.58 1.7 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -0.889 . . . . 0.0 110.37 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 198' ' ' ARG . 3.9 p-10 36.18 39.74 0.09 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.366 -0.833 . . . . 0.0 110.413 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 140.75 -48.77 0.81 Allowed Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.453 ' O ' ' CG1' ' A' ' 202' ' ' ILE . 0.1 OUTLIER -89.9 -158.12 0.51 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -1.11 . . . . 0.0 109.801 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.564 HD11 ' CG2' ' A' ' 153' ' ' ILE . 8.1 mt -155.63 159.53 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.073 -1.017 . . . . 0.0 110.571 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 195' ' ' ILE . 43.2 m -144.32 151.97 40.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.534 -0.729 . . . . 0.0 109.464 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.538 ' CD2' ' CD2' ' A' ' 206' ' ' HIS . 0.5 OUTLIER -119.91 129.09 54.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.166 -0.959 . . . . 0.0 110.536 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.578 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.5 OUTLIER -119.98 119.8 34.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.424 -0.797 . . . . 0.0 109.826 179.77 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.538 ' CD2' ' CD2' ' A' ' 204' ' ' LEU . 1.5 m170 -107.31 152.35 24.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.498 -0.751 . . . . 0.0 109.931 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -49.04 -20.54 0.55 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.15 -0.969 . . . . 0.0 110.059 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' A' ' 209' ' ' LYS . . . -91.2 -31.81 9.42 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 208' ' ' GLY . 10.4 pttt 174.02 -173.95 0.06 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.211 -1.17 . . . . 0.0 110.173 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 4.6 p30 -112.17 161.59 16.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.893 . . . . 0.0 110.413 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 39.1 t -147.04 147.14 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 0.0 110.127 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.0 160.74 30.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.0 110.283 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.413 HD11 HG21 ' A' ' 202' ' ' ILE . 2.9 mt -131.83 -160.11 1.02 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.203 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.478 ' N ' ' CD2' ' A' ' 214' ' ' LEU . 0.9 OUTLIER -173.15 169.18 4.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.19 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -75.81 -26.17 56.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 110.183 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.447 ' OD2' ' HA ' ' A' ' 174' ' ' VAL . 1.0 OUTLIER -63.21 -57.02 11.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 110.125 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.453 ' O ' ' C ' ' A' ' 218' ' ' ALA . 0.2 OUTLIER -78.35 -28.0 47.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 110.112 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . 0.577 ' CB ' ' CG2' ' A' ' 153' ' ' ILE . . . -40.05 -63.8 0.57 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.369 -0.832 . . . . 0.0 110.487 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.525 ' N ' HD12 ' A' ' 153' ' ' ILE . 3.5 t-160 -91.77 77.59 5.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.879 . . . . 0.0 110.306 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 219' ' ' HIS . 4.9 m -166.74 -48.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 0.0 110.44 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.601 HG12 ' CG2' ' A' ' 223' ' ' ILE . 0.1 OUTLIER -73.98 136.75 24.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.361 -0.837 . . . . 0.0 110.786 -179.66 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.539 ' O ' ' CG2' ' A' ' 166' ' ' VAL . 0.0 OUTLIER -89.39 112.91 24.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.212 -0.93 . . . . 0.0 109.256 179.275 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.601 ' CG2' HG12 ' A' ' 221' ' ' ILE . 0.7 OUTLIER -119.97 -169.48 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.158 -0.964 . . . . 0.0 110.808 -179.053 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 148' ' ' PRO . 30.8 mt-10 -150.25 156.57 41.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.449 -0.782 . . . . 0.0 110.051 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -107.48 99.2 8.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 110.254 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.233 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.489 ' O ' ' HD3' ' A' ' 133' ' ' PRO . 44.3 Cg_endo . . . . . 0 N--CA 1.486 1.034 0 N-CA-C 110.58 -0.585 . . . . 0.0 110.58 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 30.3 mt -106.12 85.96 1.83 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 110.134 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 131' ' ' PRO . 45.9 Cg_endo -72.6 -53.95 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.992 1.522 . . . . 0.0 110.453 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.43 42.48 2.01 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.4 tp -124.28 26.16 7.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.293 -1.122 . . . . 0.0 110.254 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -103.62 -88.22 0.42 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.898 . . . . 0.0 110.085 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -109.6 -17.98 13.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.284 -0.885 . . . . 0.0 110.208 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.253 -0.904 . . . . 0.0 110.189 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 N--CA 1.484 0.913 0 N-CA-C 110.344 -0.675 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.484 ' O ' ' HG2' ' A' ' 222' ' ' ARG . . . -48.21 123.41 9.62 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.584 ' HB ' ' O ' ' A' ' 223' ' ' ILE . 2.2 m -47.39 -89.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -1.142 . . . . 0.0 110.088 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.595 ' CB ' ' HB2' ' A' ' 154' ' ' ASP . 0.0 OUTLIER 169.07 135.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.89 . . . . 0.0 110.01 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.632 ' HA ' HG12 ' A' ' 223' ' ' ILE . 1.2 m -37.85 -92.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.346 -0.846 . . . . 0.0 111.302 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.544 ' CD1' ' N ' ' A' ' 154' ' ' ASP . 1.9 pp -41.04 -23.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.151 -0.968 . . . . 0.0 111.032 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.595 ' HB2' ' CB ' ' A' ' 151' ' ' ARG . 1.2 m-20 -75.12 -16.79 60.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.107 -0.996 . . . . 0.0 110.001 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -109.9 -16.21 13.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.398 -0.814 . . . . 0.0 110.178 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.467 ' HB3' ' HB ' ' A' ' 195' ' ' ILE . . . -82.7 99.72 9.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.342 -0.849 . . . . 0.0 110.303 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 156' ' ' ALA . 3.2 m -169.8 152.11 4.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.261 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 159' ' ' MET . 6.4 t 55.41 88.29 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.897 . . . . 0.0 110.27 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' MET . . . . . 0.444 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 27.4 mtm 55.83 169.5 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 110.183 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 45.9 Cg_endo -72.87 91.29 0.82 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.047 1.551 . . . . 0.0 110.417 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -82.32 129.05 34.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 0.0 110.073 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.469 ' O ' HG11 ' A' ' 163' ' ' VAL . 2.4 mmtp -68.91 125.5 26.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.898 . . . . 0.0 110.427 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.535 ' C ' ' O ' ' A' ' 193' ' ' VAL . 29.2 m -141.63 -153.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.229 -0.92 . . . . 0.0 110.234 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.626 ' HG2' ' N ' ' A' ' 165' ' ' ILE . 0.0 OUTLIER -176.21 153.94 1.32 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.901 -1.124 . . . . 0.0 110.213 -179.452 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 1.008 ' HB ' ' O ' ' A' ' 189' ' ' VAL . 20.1 mt -102.36 176.21 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.159 -0.963 . . . . 0.0 111.291 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.616 ' CA ' ' HA2' ' A' ' 190' ' ' GLY . 2.7 m -126.36 -28.2 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.664 -0.648 . . . . 0.0 109.561 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.595 ' CA ' ' CG2' ' A' ' 189' ' ' VAL . 0.5 OUTLIER 162.22 147.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.558 -0.714 . . . . 0.0 110.515 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.556 ' HA ' ' CG2' ' A' ' 221' ' ' ILE . 2.7 mt -66.0 -7.29 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.484 -0.76 . . . . 0.0 109.088 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 170' ' ' GLU . 0.1 OUTLIER 53.45 108.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.593 -0.692 . . . . 0.0 110.305 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 169' ' ' ASN . 1.0 OUTLIER 61.78 76.88 0.35 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -0.885 . . . . 0.0 110.278 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.495 HG21 ' HB ' ' A' ' 168' ' ' ILE . 1.7 pp -80.05 6.18 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.894 . . . . 0.0 110.181 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -49.06 -25.53 2.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 110.306 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -71.86 163.61 27.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.937 . . . . 0.0 110.335 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.493 ' O ' ' CG2' ' A' ' 174' ' ' VAL . 7.0 p -169.95 39.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.248 -0.908 . . . . 0.0 110.264 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.606 ' O ' ' C ' ' A' ' 176' ' ' THR . 18.6 pt-20 -72.73 -152.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.127 -0.983 . . . . 0.0 110.348 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.606 ' C ' ' O ' ' A' ' 175' ' ' GLU . 9.7 t 21.9 94.39 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.747 -0.595 . . . . 0.0 111.091 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.488 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.1 OUTLIER -60.49 -12.05 8.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.178 -0.951 . . . . 0.0 110.235 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -76.47 -6.9 53.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.118 -0.989 . . . . 0.0 110.251 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.507 ' HA ' HD13 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -87.02 -31.61 20.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.169 -0.957 . . . . 0.0 110.112 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.502 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 1.1 p -42.69 -31.62 0.49 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 109.808 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -60.6 -22.84 64.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.357 -0.839 . . . . 0.0 109.608 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.584 ' CD2' ' CG1' ' A' ' 211' ' ' VAL . 13.6 mt -83.17 -39.8 20.55 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.343 -0.848 . . . . 0.0 109.089 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.75 -29.13 61.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.61 -0.681 . . . . 0.0 109.778 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -72.73 -2.62 21.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 109.882 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.53 ' HB2' ' CG2' ' A' ' 187' ' ' ILE . . . -88.53 14.86 8.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.316 -0.865 . . . . 0.0 110.205 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 185' ' ' ALA . 0.2 OUTLIER 42.37 30.97 0.24 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 109.209 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.53 ' CG2' ' HB2' ' A' ' 185' ' ' ALA . 4.5 tt -116.29 164.34 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.602 -0.687 . . . . 0.0 110.48 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.417 ' N ' HG12 ' A' ' 187' ' ' ILE . 1.8 ttp180 -134.05 161.28 35.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.308 -0.87 . . . . 0.0 109.116 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 1.008 ' O ' ' HB ' ' A' ' 165' ' ' ILE . 14.0 m -79.53 -37.39 18.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.871 -1.143 . . . . 0.0 109.099 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.617 ' N ' HG21 ' A' ' 189' ' ' VAL . . . -56.07 50.54 0.01 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.768 ' N ' ' O ' ' A' ' 189' ' ' VAL . 1.8 t -140.66 167.36 22.35 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.372 -1.075 . . . . 0.0 109.228 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.586 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 1.4 mt-10 -65.46 122.45 17.21 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.794 -0.763 . . . . 0.0 109.036 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.667 ' HA ' ' O ' ' A' ' 205' ' ' SER . 0.4 OUTLIER -160.44 144.79 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.042 -1.036 . . . . 0.0 110.254 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 204' ' ' LEU . 1.4 pt-20 -112.18 159.84 18.17 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.346 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.52 ' CG2' ' HG ' ' A' ' 204' ' ' LEU . 1.2 mt -119.53 153.93 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.069 -1.019 . . . . 0.0 110.532 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 42.3 t -127.63 107.57 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.482 -0.761 . . . . 0.0 109.991 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -75.17 111.74 10.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.928 . . . . 0.0 110.286 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.476 ' O ' ' C ' ' A' ' 199' ' ' ASP . 0.0 OUTLIER -102.89 67.03 0.95 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.217 -0.927 . . . . 0.0 110.299 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 198' ' ' ARG . 25.4 m-20 38.97 37.55 0.22 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.349 -0.844 . . . . 0.0 110.213 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 141.1 -43.16 1.12 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.451 ' O ' ' N ' ' A' ' 198' ' ' ARG . 0.1 OUTLIER -90.12 123.55 34.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -1.122 . . . . 0.0 110.139 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.472 HG21 HG23 ' A' ' 195' ' ' ILE . 10.4 mt -126.36 99.54 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.112 -0.993 . . . . 0.0 110.348 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.495 HG22 ' HA ' ' A' ' 212' ' ' GLU . 89.9 m -106.86 157.45 17.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.318 -0.864 . . . . 0.0 109.878 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.616 ' CD1' ' CB ' ' A' ' 213' ' ' LEU . 2.0 mp -120.05 150.31 40.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.458 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.667 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 16.4 t -119.42 110.48 16.98 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.458 -0.776 . . . . 0.0 109.228 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.647 ' CD2' ' CG1' ' A' ' 193' ' ' VAL . 23.6 m80 -92.45 153.58 19.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.597 -0.689 . . . . 0.0 110.129 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.464 ' N ' ' OD1' ' A' ' 207' ' ' ASN . 26.6 p-10 -51.77 93.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 110.286 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 209' ' ' LYS . . . 136.91 -32.45 2.44 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 208' ' ' GLY . 0.0 OUTLIER 176.56 160.15 0.35 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -1.151 . . . . 0.0 110.285 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 1.9 p-10 -109.68 174.78 5.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.33 -0.856 . . . . 0.0 110.117 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.584 ' CG1' ' CD2' ' A' ' 182' ' ' LEU . 45.6 t -154.6 140.98 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.378 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.495 ' HA ' HG22 ' A' ' 203' ' ' THR . 55.6 mt-10 -73.48 74.37 1.43 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.4 -0.812 . . . . 0.0 110.219 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.616 ' CB ' ' CD1' ' A' ' 204' ' ' LEU . 30.6 tp -57.89 162.62 3.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.917 . . . . 0.0 110.273 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.496 ' N ' ' HG ' ' A' ' 213' ' ' LEU . 3.2 mm? -51.37 146.74 6.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 0.0 110.189 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.479 ' O ' ' HB1' ' A' ' 218' ' ' ALA . 2.1 m-20 -83.17 -102.39 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.942 . . . . 0.0 109.906 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.97 -24.48 1.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.0 -1.062 . . . . 0.0 109.742 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.542 ' O ' ' C ' ' A' ' 218' ' ' ALA . 0.1 OUTLIER -90.15 -14.25 33.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.319 -0.863 . . . . 0.0 110.211 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . 0.659 ' O ' ' N ' ' A' ' 220' ' ' THR . . . -29.98 -49.07 0.1 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.506 -0.746 . . . . 0.0 110.723 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.568 ' O ' ' CG ' ' A' ' 219' ' ' HIS . 7.8 p80 -51.37 78.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.364 -0.835 . . . . 0.0 110.404 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' THR . . . . . 0.659 ' N ' ' O ' ' A' ' 218' ' ' ALA . 1.2 p -136.56 -28.76 0.98 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 110.365 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.584 ' CG1' HG12 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -109.98 154.74 11.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 O-C-N 121.196 -0.94 . . . . 0.0 110.584 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.542 ' O ' ' CG2' ' A' ' 166' ' ' VAL . 0.6 OUTLIER -89.03 94.41 9.94 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 178.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.69 ' HB ' ' HA ' ' A' ' 165' ' ' ILE . 0.4 OUTLIER -119.38 149.43 21.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.322 -0.861 . . . . 0.0 110.712 -178.202 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.411 ' HA ' ' HB ' ' A' ' 150' ' ' THR . 13.9 pt-20 -132.02 178.51 6.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.417 -0.802 . . . . 0.0 110.096 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.533 ' HA ' ' CG1' ' A' ' 163' ' ' VAL . 0.0 OUTLIER -85.93 173.97 9.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 110.349 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.203 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo . . . . . 0 N--CA 1.484 0.932 0 N-CA-C 110.417 -0.647 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 17.0 mm -96.63 122.44 57.12 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 110.141 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.43 -53.66 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.917 1.483 . . . . 0.0 110.372 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -156.74 -89.55 0.07 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.2 mt -104.29 -166.51 1.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.291 -1.123 . . . . 0.0 110.162 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 136' ' ' ASP . 46.0 t0 -106.83 -20.96 13.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 110.209 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -63.97 85.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.315 -0.866 . . . . 0.0 110.208 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 0.0 110.206 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo . . . . . 0 N--CA 1.483 0.865 0 N-CA-C 110.383 -0.66 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.46 ' CA ' ' HB3' ' A' ' 222' ' ' ARG . . . -160.44 152.41 23.15 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.452 ' O ' ' CG2' ' A' ' 150' ' ' THR . 58.1 m -147.23 18.0 1.21 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -1.137 . . . . 0.0 110.242 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.569 ' CB ' HD12 ' A' ' 153' ' ' ILE . 1.9 mpp_? 63.15 127.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.964 . . . . 0.0 110.184 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.546 ' CG1' HD13 ' A' ' 221' ' ' ILE . 0.6 OUTLIER -78.6 36.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.121 -0.987 . . . . 0.0 111.155 -179.648 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.584 ' CD1' ' N ' ' A' ' 153' ' ' ILE . 0.1 OUTLIER -138.84 -32.27 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.865 -1.147 . . . . 0.0 110.226 179.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.94 -12.67 61.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.454 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.519 ' O ' ' CB ' ' A' ' 161' ' ' ARG . . . -103.64 -14.03 16.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.516 -0.74 . . . . 0.0 109.966 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.449 ' HB1' HD11 ' A' ' 195' ' ' ILE . . . -81.8 72.64 8.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 110.273 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -73.54 -171.64 1.05 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.251 -0.906 . . . . 0.0 110.111 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.487 ' OG ' ' N ' ' A' ' 159' ' ' MET . 0.9 OUTLIER -42.41 -57.65 2.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 0.0 110.132 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' MET . . . . . 0.487 ' N ' ' OG ' ' A' ' 158' ' ' SER . 3.0 mmt -75.68 165.19 55.38 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.891 . . . . 0.0 110.081 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 44.4 Cg_endo -72.14 73.21 2.64 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.976 1.514 . . . . 0.0 110.444 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 155' ' ' ALA . 1.8 tpt180 -51.64 127.38 20.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -0.951 . . . . 0.0 110.197 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.489 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -74.8 125.4 28.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.873 . . . . 0.0 110.36 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.623 ' O ' ' O ' ' A' ' 193' ' ' VAL . 0.1 OUTLIER -144.86 -166.16 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 110.112 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.638 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -169.19 136.66 1.83 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.824 -1.172 . . . . 0.0 110.101 -179.601 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' A' ' 191' ' ' SER . 0.9 OUTLIER -92.52 153.08 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.294 -0.879 . . . . 0.0 110.489 -179.434 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.476 ' CG1' ' NE ' ' A' ' 164' ' ' ARG . 11.1 m -145.43 11.22 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 110.204 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -170.91 123.92 0.63 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.229 -0.92 . . . . 0.0 110.195 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.45 HG23 HG11 ' A' ' 189' ' ' VAL . 19.2 tt -131.3 4.99 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.326 -0.858 . . . . 0.0 110.15 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.432 ' O ' ' CB ' ' A' ' 170' ' ' GLU . 4.4 p30 -52.58 169.05 0.09 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 110.163 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.432 ' CB ' ' O ' ' A' ' 169' ' ' ASN . 0.3 OUTLIER 64.86 44.8 3.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.182 -0.949 . . . . 0.0 110.134 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.43 HG22 HG12 ' A' ' 168' ' ' ILE . 1.3 pp -119.61 31.95 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.27 -0.894 . . . . 0.0 110.22 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.27 89.7 1.21 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 110.215 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . 0.435 ' OE1' ' HA ' ' A' ' 173' ' ' GLN . 8.3 mm100 -106.06 165.38 11.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.274 -0.891 . . . . 0.0 110.205 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.5 m -106.72 11.45 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.161 -0.962 . . . . 0.0 110.27 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.78 139.74 37.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.896 . . . . 0.0 110.18 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.527 HG22 ' CG2' ' A' ' 180' ' ' THR . 54.4 m -118.88 -92.81 0.53 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 110.245 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 176' ' ' THR . 0.4 OUTLIER 66.3 -165.62 0.22 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.212 -0.93 . . . . 0.0 110.28 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -55.2 -20.64 11.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.261 -0.899 . . . . 0.0 110.294 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' A' ' 180' ' ' THR . 0.0 OUTLIER -49.17 -26.29 2.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.195 -0.941 . . . . 0.0 109.983 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.577 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.2 OUTLIER -55.15 -26.42 38.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.884 . . . . 0.0 109.949 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -69.29 -63.36 1.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.321 -0.862 . . . . 0.0 110.114 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.488 ' C ' ' CD1' ' A' ' 182' ' ' LEU . 4.4 pp -61.6 -15.91 43.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.379 -0.826 . . . . 0.0 110.114 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.56 HD12 ' CZ ' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -91.1 -28.55 17.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.162 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 180' ' ' THR . 18.9 t70 -79.99 4.25 17.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 110.183 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -85.12 16.66 3.38 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.862 . . . . 0.0 110.188 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 185' ' ' ALA . 3.8 t0 41.66 43.17 2.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.248 -0.907 . . . . 0.0 109.92 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.6 tt -102.9 -178.5 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.874 . . . . 0.0 110.367 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.579 ' O ' ' O ' ' A' ' 189' ' ' VAL . 9.4 ptt180 -170.52 117.48 0.51 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.635 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 1.3 m 51.3 108.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.199 -0.938 . . . . 0.0 109.154 -178.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.477 ' O ' HG12 ' A' ' 193' ' ' VAL . . . -45.63 -13.65 0.06 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.56 ' N ' ' O ' ' A' ' 189' ' ' VAL . 3.7 t 66.05 -144.14 0.19 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.071 -1.253 . . . . 0.0 109.421 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.638 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -65.21 101.93 0.6 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.474 -0.766 . . . . 0.0 109.267 179.221 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.623 ' O ' ' O ' ' A' ' 163' ' ' VAL . 23.0 m -156.9 -138.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -0.948 . . . . 0.0 110.033 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.518 ' HA ' HG22 ' A' ' 163' ' ' VAL . 1.1 pp20? -175.48 160.85 2.61 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.293 -0.88 . . . . 0.0 110.142 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.542 ' CG2' ' HG ' ' A' ' 204' ' ' LEU . 0.4 OUTLIER -120.86 169.81 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.159 -0.963 . . . . 0.0 110.335 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.519 ' CG1' ' HB ' ' A' ' 203' ' ' THR . 4.7 p -149.67 77.38 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.883 . . . . 0.0 110.032 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 202' ' ' ILE . 11.8 t70 -40.78 142.22 0.49 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 110.336 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.475 ' O ' ' N ' ' A' ' 200' ' ' GLY . 1.9 ttp180 -139.77 -174.6 3.95 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.205 -0.935 . . . . 0.0 110.315 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -42.28 96.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.258 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 198' ' ' ARG . . . 44.01 29.48 1.51 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -150.26 113.72 4.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.252 -1.146 . . . . 0.0 110.215 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.467 ' CD1' HG21 ' A' ' 153' ' ' ILE . 70.3 mt -94.24 144.99 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 0.0 110.167 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.519 ' HB ' ' CG1' ' A' ' 196' ' ' VAL . 1.2 m -126.32 156.09 40.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.056 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.542 ' HG ' ' CG2' ' A' ' 195' ' ' ILE . 1.0 OUTLIER -119.82 131.98 55.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -0.956 . . . . 0.0 110.232 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.528 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 20.1 t -119.75 124.6 46.58 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.3 -0.875 . . . . 0.0 109.781 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.556 ' HA ' ' CB ' ' A' ' 193' ' ' VAL . 2.4 m170 -106.02 158.95 16.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.417 -0.802 . . . . 0.0 109.999 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.0 72.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 110.155 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 153.63 -21.07 0.71 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 208' ' ' GLY . 0.3 OUTLIER 169.93 149.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.161 -1.199 . . . . 0.0 110.218 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 1.2 p30 -97.08 -171.99 2.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.92 . . . . 0.0 110.13 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 8.7 p -158.69 165.36 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -0.917 . . . . 0.0 110.226 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -69.49 141.04 54.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 110.239 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.539 ' CD1' ' HB1' ' A' ' 218' ' ' ALA . 0.3 OUTLIER -148.15 145.04 28.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.932 . . . . 0.0 110.173 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.485 ' O ' ' HG ' ' A' ' 214' ' ' LEU . 0.6 OUTLIER -133.61 143.49 48.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.268 -0.895 . . . . 0.0 110.21 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.418 ' OD2' HD13 ' A' ' 202' ' ' ILE . 0.3 OUTLIER -50.2 -51.56 43.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.197 -0.94 . . . . 0.0 110.185 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 215' ' ' ASP . 0.5 OUTLIER -43.38 -49.18 7.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.932 . . . . 0.0 110.262 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.464 ' O ' ' OG1' ' A' ' 220' ' ' THR . 0.4 OUTLIER -89.12 -26.77 21.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.891 . . . . 0.0 110.14 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . 0.593 ' O ' ' CD1' ' A' ' 221' ' ' ILE . . . -64.83 -17.68 64.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.257 -0.902 . . . . 0.0 110.091 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.509 ' O ' ' CG2' ' A' ' 220' ' ' THR . 0.2 OUTLIER -89.2 56.56 3.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.135 -0.978 . . . . 0.0 110.217 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' THR . . . . . 0.509 ' CG2' ' O ' ' A' ' 219' ' ' HIS . 17.6 p -158.12 -47.22 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 0.0 110.372 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.593 ' CD1' ' O ' ' A' ' 218' ' ' ALA . 0.1 OUTLIER -63.17 130.93 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.29 -0.881 . . . . 0.0 110.52 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.46 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . 37.0 mtt85 -91.67 104.09 16.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.345 -0.847 . . . . 0.0 109.618 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.534 ' CG2' HG12 ' A' ' 221' ' ' ILE . 0.1 OUTLIER -119.51 171.53 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.144 -0.973 . . . . 0.0 110.023 -179.566 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -140.13 167.58 21.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.163 -0.961 . . . . 0.0 110.415 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 8.1 pt-20 -91.53 38.85 0.99 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.381 -0.824 . . . . 0.0 110.247 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.175 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 N--CA 1.483 0.889 0 N-CA-C 110.494 -0.618 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 5.9 pt -104.27 161.04 24.07 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.199 -0.938 . . . . 0.0 110.262 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.0 -12.4 25.94 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.0 1.526 . . . . 0.0 110.464 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 135' ' ' LEU . . . 118.51 -77.32 0.3 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.448 ' CB ' ' O ' ' A' ' 134' ' ' GLY . 0.2 OUTLIER 65.29 138.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.294 -1.121 . . . . 0.0 110.241 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 17.7 p30 -61.98 96.63 0.07 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 110.22 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.2 89.12 4.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.933 . . . . 0.0 110.232 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.297 -0.877 . . . . 0.0 110.223 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 N--CA 1.484 0.943 0 N-CA-C 110.44 -0.639 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.469 ' HA3' ' HB2' ' A' ' 222' ' ' ARG . . . 131.84 157.5 8.72 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.544 ' O ' ' CG1' ' A' ' 223' ' ' ILE . 54.2 m -123.31 143.56 50.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.308 -1.113 . . . . 0.0 110.163 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 154' ' ' ASP . 0.1 OUTLIER -50.16 127.69 17.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.123 -0.986 . . . . 0.0 110.055 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.541 ' CG1' HD13 ' A' ' 221' ' ' ILE . 2.5 p -43.88 -25.49 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.103 -0.998 . . . . 0.0 110.378 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.561 ' CG2' ' CB ' ' A' ' 218' ' ' ALA . 1.3 pt -95.22 -14.04 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 110.325 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.515 ' HB3' ' CG2' ' A' ' 150' ' ' THR . 2.0 m-20 -77.35 -19.28 56.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.994 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -97.36 -13.0 22.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.371 -0.831 . . . . 0.0 110.016 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 157' ' ' THR . . . -51.06 166.07 0.1 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.875 . . . . 0.0 110.262 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.533 ' O ' ' CB ' ' A' ' 158' ' ' SER . 14.7 m 51.93 167.37 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.315 -0.866 . . . . 0.0 110.398 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 157' ' ' THR . 0.1 OUTLIER 70.89 -52.14 0.68 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.24 -0.913 . . . . 0.0 110.309 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -100.72 139.17 20.36 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.175 -0.953 . . . . 0.0 110.147 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.552 ' O ' ' C ' ' A' ' 161' ' ' ARG . 45.4 Cg_endo -72.92 71.85 3.35 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.962 1.506 . . . . 0.0 110.426 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.59 ' HB3' ' CG2' ' A' ' 196' ' ' VAL . 7.7 ptt180 27.12 99.8 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.505 0.669 . . . . 0.0 111.282 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.469 ' O ' HG11 ' A' ' 163' ' ' VAL . 0.4 OUTLIER -170.72 56.41 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.175 -0.953 . . . . 0.0 109.995 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.669 ' O ' ' O ' ' A' ' 193' ' ' VAL . 34.9 m -141.83 -151.83 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.925 0.869 . . . . 0.0 110.503 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.64 ' CB ' ' HA ' ' A' ' 192' ' ' GLU . 16.4 ptt180 -175.46 169.03 3.21 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.86 -1.15 . . . . 0.0 110.433 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.769 ' HB ' ' C ' ' A' ' 189' ' ' VAL . 0.1 OUTLIER -99.78 162.98 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.302 -0.874 . . . . 0.0 109.848 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 222' ' ' ARG . 27.0 m -137.28 -24.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.177 -0.952 . . . . 0.0 110.759 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.528 ' HB2' ' CD ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -152.45 127.89 9.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.038 -1.039 . . . . 0.0 110.458 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.451 ' HA ' ' CB ' ' A' ' 221' ' ' ILE . 1.2 tt -96.69 -1.68 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.983 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 168' ' ' ILE . 38.1 m-80 56.6 -95.17 0.05 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 110.231 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.553 ' HG3' ' CZ ' ' A' ' 172' ' ' PHE . 4.3 pt-20 -168.2 83.1 0.18 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.066 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.6 ' O ' ' C ' ' A' ' 172' ' ' PHE . 2.4 pp -86.57 25.78 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.329 -0.857 . . . . 0.0 110.377 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.6 ' C ' ' O ' ' A' ' 171' ' ' ILE . 0.9 OUTLIER 22.83 -136.26 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.583 -0.698 . . . . 0.0 111.024 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . 0.517 ' HA ' ' CG2' ' A' ' 176' ' ' THR . 14.9 mt-30 -107.66 -90.55 0.44 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.193 -0.942 . . . . 0.0 110.258 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.555 ' O ' ' HB3' ' A' ' 175' ' ' GLU . 6.7 t 59.64 90.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.891 . . . . 0.0 110.291 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.555 ' HB3' ' O ' ' A' ' 174' ' ' VAL . 3.7 tt0 63.63 -56.69 0.2 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.489 -0.757 . . . . 0.0 110.822 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 174' ' ' VAL . 8.9 p 45.54 -91.72 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.301 -0.874 . . . . 0.0 110.215 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 178' ' ' GLN . 12.5 t0 43.72 -93.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 110.129 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.528 ' N ' ' O ' ' A' ' 176' ' ' THR . 1.4 mt-30 -48.38 -25.11 1.46 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.179 -0.951 . . . . 0.0 110.015 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.505 ' O ' ' HG ' ' A' ' 182' ' ' LEU . 3.0 t80 -82.97 -52.77 6.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.99 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 177' ' ' ASP . 0.3 OUTLIER -43.65 -25.15 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.172 -0.955 . . . . 0.0 109.889 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -69.17 -64.59 0.84 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.305 -0.872 . . . . 0.0 110.19 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 179' ' ' PHE . 3.5 pp -63.92 -13.6 46.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.357 -0.839 . . . . 0.0 109.848 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.477 ' CD1' ' CZ ' ' A' ' 179' ' ' PHE . 1.7 tp -87.81 -30.42 20.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.387 -0.821 . . . . 0.0 109.861 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -72.18 -15.04 61.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.828 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -89.44 20.03 4.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -0.829 . . . . 0.0 110.136 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 47.31 85.21 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.892 . . . . 0.0 110.093 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.556 ' O ' ' CB ' ' A' ' 188' ' ' ARG . 57.6 mt -146.04 -82.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 0.0 110.374 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.556 ' CB ' ' O ' ' A' ' 187' ' ' ILE . 0.1 OUTLIER 72.79 161.38 0.24 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.453 -0.779 . . . . 0.0 109.683 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.971 ' O ' ' N ' ' A' ' 191' ' ' SER . 3.9 m 33.87 37.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 O-C-N 121.334 -0.853 . . . . 0.0 110.613 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.559 ' C ' ' O ' ' A' ' 189' ' ' VAL . . . 25.68 19.73 0.0 OUTLIER Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.971 ' N ' ' O ' ' A' ' 189' ' ' VAL . 13.6 t 36.88 -146.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -1.149 . . . . 0.0 109.868 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.64 ' HA ' ' CB ' ' A' ' 164' ' ' ARG . 0.9 OUTLIER -89.95 115.26 27.11 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.026 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.669 ' O ' ' O ' ' A' ' 163' ' ' VAL . 34.1 m -159.69 -133.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.096 -1.003 . . . . 0.0 109.985 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.525 ' CG ' ' HB2' ' A' ' 205' ' ' SER . 1.7 pt-20 -158.47 168.82 25.92 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.266 -0.896 . . . . 0.0 110.094 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.546 ' CG2' ' HG ' ' A' ' 204' ' ' LEU . 0.0 OUTLIER -136.36 146.61 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.163 -0.96 . . . . 0.0 110.353 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.59 ' CG2' ' HB3' ' A' ' 161' ' ' ARG . 94.8 t -139.05 108.14 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.249 -0.907 . . . . 0.0 110.105 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 202' ' ' ILE . 4.6 t0 -50.77 113.73 0.98 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.211 -0.931 . . . . 0.0 110.135 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 201' ' ' HIS . 1.0 OUTLIER -110.1 93.61 4.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.224 -0.923 . . . . 0.0 110.294 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 198' ' ' ARG . 43.7 t0 41.81 53.96 3.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.222 -0.924 . . . . 0.0 110.126 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 88.89 -27.34 7.41 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 11.6 m170 -92.08 91.34 7.76 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.26 -1.141 . . . . 0.0 110.273 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 197' ' ' ASP . 2.7 mt -59.66 91.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.904 . . . . 0.0 110.18 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 85.6 m -67.95 148.38 51.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.276 -0.89 . . . . 0.0 110.153 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.546 ' HG ' ' CG2' ' A' ' 195' ' ' ILE . 0.1 OUTLIER -120.23 132.89 55.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.241 -0.912 . . . . 0.0 110.282 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.569 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.7 OUTLIER -119.79 125.93 49.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.332 -0.855 . . . . 0.0 109.898 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.595 ' CD2' HG13 ' A' ' 193' ' ' VAL . 1.9 m170 -104.55 74.08 1.14 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.385 -0.822 . . . . 0.0 110.366 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.52 ' C ' ' O ' ' A' ' 206' ' ' HIS . 3.7 p-10 32.14 51.51 0.21 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.484 -0.76 . . . . 0.0 110.793 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 135.58 -39.9 1.61 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 206' ' ' HIS . 6.7 mtmt -102.58 162.91 12.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.296 -1.12 . . . . 0.0 110.138 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.466 ' HA ' ' O ' ' A' ' 204' ' ' LEU . 14.7 t0 -150.17 144.44 25.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 110.319 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.469 ' CG1' ' HB3' ' A' ' 182' ' ' LEU . 24.5 t -134.76 159.1 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.285 -0.884 . . . . 0.0 110.032 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.436 ' N ' HG11 ' A' ' 211' ' ' VAL . 23.0 tt0 -98.67 63.49 1.44 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 0.0 110.304 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.505 HD23 ' CD1' ' A' ' 204' ' ' LEU . 12.8 tp -56.12 160.12 3.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -0.919 . . . . 0.0 110.113 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 218' ' ' ALA . 0.6 OUTLIER -122.56 144.75 48.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 0.0 110.199 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -52.67 -40.72 63.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.265 -0.897 . . . . 0.0 110.168 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.24 -56.66 13.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.894 . . . . 0.0 110.193 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.53 HD22 ' CD1' ' A' ' 171' ' ' ILE . 0.0 OUTLIER -84.55 -27.15 27.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.201 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . 0.561 ' CB ' ' CG2' ' A' ' 153' ' ' ILE . . . -74.51 -11.05 60.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.0 110.186 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.443 ' HA ' HG12 ' A' ' 153' ' ' ILE . 12.2 t-160 -100.96 77.98 1.89 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.933 . . . . 0.0 110.244 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.3 -43.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -0.943 . . . . 0.0 110.468 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.545 HD12 ' N ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -73.29 143.04 14.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.293 -0.88 . . . . 0.0 110.657 -179.738 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.533 ' O ' ' CG2' ' A' ' 166' ' ' VAL . 4.8 ptp85 -89.45 127.18 35.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.074 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.617 ' HB ' ' O ' ' A' ' 164' ' ' ARG . 0.7 OUTLIER -125.5 170.91 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.192 -0.943 . . . . 0.0 110.821 -178.84 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.405 ' CG ' ' HA2' ' A' ' 149' ' ' GLY . 38.8 mt-10 -149.95 172.64 14.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -0.872 . . . . 0.0 110.12 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.431 ' OE1' ' OXT' ' A' ' 226' ' ' LEU . 0.0 OUTLIER -81.55 169.38 17.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.9 . . . . 0.0 110.156 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' A' ' 226' ' ' LEU . 39.2 tp . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.167 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 132' ' ' ILE . 46.1 Cg_endo . . . . . 0 N--CA 1.483 0.881 0 N-CA-C 110.451 -0.634 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.441 ' C ' ' O ' ' A' ' 131' ' ' PRO . 1.7 mp 41.26 75.47 0.61 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.285 -0.884 . . . . 0.0 110.271 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.03 -28.37 13.02 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.983 1.517 . . . . 0.0 110.342 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -46.07 167.57 0.05 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.4 -154.63 0.48 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.305 -1.115 . . . . 0.0 110.229 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -102.13 52.3 0.81 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 110.23 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -124.61 55.98 1.31 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.292 -0.88 . . . . 0.0 110.252 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 110.213 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.441 ' HA ' ' OE1' ' A' ' 224' ' ' GLU . 45.9 Cg_endo . . . . . 0 N--CA 1.484 0.951 0 N-CA-C 110.456 -0.632 . . . . 0.0 110.456 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -164.35 106.18 0.27 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 223' ' ' ILE . 99.7 m -134.53 2.2 3.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -1.115 . . . . 0.0 110.256 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 153' ' ' ILE . 32.9 mtt180 59.83 123.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 110.121 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.578 HG22 HD12 ' A' ' 165' ' ' ILE . 40.5 t -66.21 60.14 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.203 -0.936 . . . . 0.0 110.339 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.548 HG23 ' CB ' ' A' ' 218' ' ' ALA . 0.8 OUTLIER -159.33 -34.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.306 -0.871 . . . . 0.0 110.145 179.802 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.33 -13.07 61.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.861 . . . . 0.0 109.44 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.525 ' CB ' HG13 ' A' ' 163' ' ' VAL . . . -88.17 -28.01 21.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.485 -0.759 . . . . 0.0 109.976 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -75.62 120.48 21.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.895 . . . . 0.0 110.238 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 14.6 m -162.6 109.0 1.23 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 110.267 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.47 ' O ' ' HB3' ' A' ' 159' ' ' MET . 1.3 t 62.59 10.36 4.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 0.0 110.256 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' MET . . . . . 0.47 ' HB3' ' O ' ' A' ' 158' ' ' SER . 0.0 OUTLIER 173.12 158.42 0.27 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.286 -0.884 . . . . 0.0 110.2 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 46.2 Cg_endo -73.12 63.81 4.22 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.049 1.552 . . . . 0.0 110.299 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.511 ' CG ' ' O ' ' A' ' 155' ' ' ALA . 7.9 mtt180 -42.18 119.22 1.31 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 0.0 110.248 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.475 ' O ' HG11 ' A' ' 163' ' ' VAL . 6.1 ttmt -58.33 124.98 21.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.291 -0.881 . . . . 0.0 110.258 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.623 ' O ' ' O ' ' A' ' 193' ' ' VAL . 30.6 m -139.67 -159.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.881 . . . . 0.0 110.122 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.614 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -175.09 139.11 0.46 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.822 -1.174 . . . . 0.0 110.486 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.592 ' HA ' ' CG2' ' A' ' 223' ' ' ILE . 2.1 mt -91.38 153.87 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.45 -0.781 . . . . 0.0 110.893 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.475 HG21 ' O ' ' A' ' 222' ' ' ARG . 3.4 m -138.85 -29.62 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.486 -0.759 . . . . 0.0 110.448 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -136.57 118.88 15.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.117 -0.989 . . . . 0.0 110.217 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.425 HD11 HG23 ' A' ' 221' ' ' ILE . 1.3 tt -116.32 -3.12 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.201 -0.937 . . . . 0.0 110.254 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 57.26 170.73 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.222 -0.924 . . . . 0.0 110.298 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 172' ' ' PHE . 7.7 pt-20 -155.66 160.75 40.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.151 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.427 ' C ' ' O ' ' A' ' 170' ' ' GLU . 23.1 mt 41.3 27.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.919 . . . . 0.0 110.248 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 170' ' ' GLU . 2.6 t80 -172.29 57.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.255 -0.903 . . . . 0.0 110.245 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -112.5 -61.23 1.76 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -0.925 . . . . 0.0 110.169 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.582 ' CG2' ' N ' ' A' ' 175' ' ' GLU . 0.5 OUTLIER -164.22 -86.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.385 -0.822 . . . . 0.0 110.185 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.582 ' N ' ' CG2' ' A' ' 174' ' ' VAL . 2.6 mt-10 -141.89 11.89 2.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.059 -1.025 . . . . 0.0 110.228 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.602 ' CG2' ' CG2' ' A' ' 180' ' ' THR . 0.2 OUTLIER 66.28 -58.44 0.35 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.286 -0.883 . . . . 0.0 110.259 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 178' ' ' GLN . 3.3 p30 36.93 -145.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.377 -0.827 . . . . 0.0 110.776 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.512 ' N ' ' OD1' ' A' ' 177' ' ' ASP . 0.2 OUTLIER -63.46 -27.47 69.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.312 -0.867 . . . . 0.0 110.567 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.57 ' HA ' ' CD1' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -44.08 -35.34 2.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.001 . . . . 0.0 109.771 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.602 ' CG2' ' CG2' ' A' ' 176' ' ' THR . 0.7 OUTLIER -42.8 -27.85 0.21 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.144 -0.973 . . . . 0.0 109.456 179.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 179' ' ' PHE . 23.5 tp60 -59.84 -36.01 75.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.542 -0.724 . . . . 0.0 109.609 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.57 ' CD1' ' HA ' ' A' ' 179' ' ' PHE . 1.2 mt -69.11 -43.62 74.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.38 -0.825 . . . . 0.0 109.433 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -37.64 88.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.613 -0.679 . . . . 0.0 109.888 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -59.16 -14.74 11.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.462 -0.774 . . . . 0.0 109.845 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 182' ' ' LEU . . . -84.69 16.93 2.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.423 -0.798 . . . . 0.0 110.189 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 185' ' ' ALA . 27.4 t70 43.6 57.56 3.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -0.921 . . . . 0.0 109.764 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.6 tt -129.93 175.24 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.322 -0.861 . . . . 0.0 110.339 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.571 ' O ' ' O ' ' A' ' 189' ' ' VAL . 0.1 OUTLIER -163.11 105.73 1.02 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.743 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.681 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 1.3 m 50.63 105.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.332 -0.855 . . . . 0.0 108.813 -178.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' A' ' 191' ' ' SER . . . -43.28 -15.74 0.03 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.604 ' N ' ' O ' ' A' ' 189' ' ' VAL . 6.1 t 65.57 -142.1 0.2 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.18 -1.188 . . . . 0.0 109.388 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.614 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -64.11 100.24 0.32 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.569 -0.707 . . . . 0.0 109.265 179.294 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.623 ' O ' ' O ' ' A' ' 163' ' ' VAL . 17.0 m -156.73 -141.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.158 -0.964 . . . . 0.0 110.222 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.534 ' HA ' ' CG2' ' A' ' 163' ' ' VAL . 4.2 pt-20 -173.26 169.08 4.59 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.345 -0.847 . . . . 0.0 110.11 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.518 ' CG2' ' HG ' ' A' ' 204' ' ' LEU . 0.6 OUTLIER -121.3 169.17 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.169 -0.957 . . . . 0.0 110.288 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.413 HG21 ' C ' ' A' ' 195' ' ' ILE . 18.8 t -128.7 98.4 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.34 -0.85 . . . . 0.0 110.178 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -49.35 117.86 2.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.9 . . . . 0.0 110.201 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.531 ' HB3' ' CB ' ' A' ' 201' ' ' HIS . 0.1 OUTLIER -109.05 146.39 34.04 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.212 -0.93 . . . . 0.0 110.213 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.45 94.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.908 . . . . 0.0 110.12 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 198' ' ' ARG . . . 75.64 14.55 81.96 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.531 ' CB ' ' HB3' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -150.25 160.92 43.34 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.249 -1.148 . . . . 0.0 110.095 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 10.6 mt -136.02 159.73 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 110.251 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.447 ' O ' HG21 ' A' ' 195' ' ' ILE . 2.1 m -151.0 163.26 39.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -0.877 . . . . 0.0 109.96 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.534 HD21 ' N ' ' A' ' 205' ' ' SER . 0.6 OUTLIER -119.8 137.28 54.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.058 -1.026 . . . . 0.0 110.345 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.542 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 1.2 t -119.73 120.47 36.67 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.404 -0.81 . . . . 0.0 109.583 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.555 ' HA ' ' CG1' ' A' ' 193' ' ' VAL . 7.4 m170 -89.24 165.86 14.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.429 -0.795 . . . . 0.0 110.205 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.503 ' C ' ' O ' ' A' ' 206' ' ' HIS . 4.6 m-20 -32.85 -34.35 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.566 -0.709 . . . . 0.0 110.952 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -153.83 32.7 0.74 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 206' ' ' HIS . 20.8 mttt -154.29 179.38 9.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -1.124 . . . . 0.0 110.51 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 204' ' ' LEU . 12.8 t0 -155.56 158.46 38.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 110.053 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.42 ' N ' ' OD1' ' A' ' 210' ' ' ASP . 7.3 p -146.49 140.81 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -0.953 . . . . 0.0 110.329 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -68.78 83.73 0.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.286 -0.884 . . . . 0.0 110.231 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.66 121.1 17.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.184 -0.948 . . . . 0.0 110.243 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.534 ' CD2' ' HB2' ' A' ' 217' ' ' LEU . 29.6 tp -57.63 158.82 5.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 0.0 110.222 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.464 ' HA ' ' HB1' ' A' ' 218' ' ' ALA . 11.2 t0 -89.57 -49.65 6.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.346 -0.846 . . . . 0.0 110.274 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.544 ' O ' ' NE2' ' A' ' 219' ' ' HIS . 0.4 OUTLIER -55.35 -48.52 74.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -0.921 . . . . 0.0 110.202 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.534 ' HB2' ' CD2' ' A' ' 214' ' ' LEU . 0.5 OUTLIER -85.85 -11.93 52.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 110.113 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . 0.548 ' CB ' HG23 ' A' ' 153' ' ' ILE . . . -35.62 -41.77 0.21 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.55 -0.718 . . . . 0.0 110.669 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.544 ' NE2' ' O ' ' A' ' 216' ' ' ASP . 24.7 p80 -93.98 73.47 4.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 110.434 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' THR . . . . . 0.466 HG22 HG22 ' A' ' 221' ' ' ILE . 8.9 t -137.25 -44.86 0.56 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.941 . . . . 0.0 110.092 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.599 ' CD1' ' H ' ' A' ' 221' ' ' ILE . 0.3 OUTLIER -73.74 146.54 10.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.326 -0.859 . . . . 0.0 110.363 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.475 ' O ' HG21 ' A' ' 166' ' ' VAL . 8.1 mtt180 -89.89 114.39 26.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 0.0 109.28 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.613 ' HB ' ' O ' ' A' ' 164' ' ' ARG . 0.8 OUTLIER -141.58 -172.6 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.131 -0.981 . . . . 0.0 110.894 -179.036 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.441 ' OE1' ' HA ' ' A' ' 148' ' ' PRO . 0.5 OUTLIER -144.18 166.81 23.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.355 -0.84 . . . . 0.0 110.178 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.526 ' HA ' ' CG1' ' A' ' 163' ' ' VAL . 0.3 OUTLIER -111.92 124.01 51.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.366 -0.834 . . . . 0.0 110.26 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.415 ' OXT' ' HB3' ' A' ' 162' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.19 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 N--CA 1.483 0.861 0 N-CA-C 110.434 -0.641 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.425 ' O ' ' CG2' ' A' ' 132' ' ' ILE . 10.8 tt -62.57 114.63 12.63 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.194 -0.941 . . . . 0.0 110.233 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.36 -166.05 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.959 1.505 . . . . 0.0 110.458 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 136' ' ' ASP . . . -173.0 -116.71 0.42 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 134' ' ' GLY . 6.8 mp 56.25 -83.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -1.151 . . . . 0.0 110.319 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 134' ' ' GLY . 6.7 t70 -41.79 -27.04 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.306 -0.871 . . . . 0.0 110.278 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 135' ' ' LEU . 0.5 OUTLIER 42.37 35.23 0.6 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 110.319 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 53.9 tp . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.235 -0.916 . . . . 0.0 110.167 -179.963 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 149' ' ' GLY . 46.5 Cg_endo . . . . . 0 N--CA 1.483 0.882 0 N-CA-C 110.54 -0.6 . . . . 0.0 110.54 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 148' ' ' PRO . . . 55.88 162.14 0.02 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 223' ' ' ILE . 1.6 m -73.75 -177.01 2.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.219 -1.165 . . . . 0.0 109.969 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.504 ' O ' ' O ' ' A' ' 152' ' ' VAL . 96.7 mtt180 -141.58 143.8 33.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.281 -0.887 . . . . 0.0 109.944 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.648 ' O ' ' CG1' ' A' ' 153' ' ' ILE . 69.6 t -50.05 -177.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 109.413 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.648 ' CG1' ' O ' ' A' ' 152' ' ' VAL . 8.2 pt 43.94 25.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.004 -1.06 . . . . 0.0 110.011 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.8 OUTLIER -147.47 -35.47 0.23 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.483 -0.761 . . . . 0.0 109.673 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -96.12 -15.64 22.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.492 -0.755 . . . . 0.0 109.812 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.22 172.98 0.26 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.293 -0.879 . . . . 0.0 110.268 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.523 ' CG2' ' CG ' ' A' ' 161' ' ' ARG . 7.2 t -174.36 167.44 4.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.192 -0.943 . . . . 0.0 110.104 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 157' ' ' THR . 96.9 p -42.7 -49.81 5.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.33 -0.856 . . . . 0.0 110.166 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.67 161.07 75.5 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.214 -0.929 . . . . 0.0 110.119 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.73 68.73 3.71 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.959 1.505 . . . . 0.0 110.481 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.523 ' CG ' ' CG2' ' A' ' 157' ' ' THR . 3.0 mmt85 -60.89 107.66 0.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.195 -0.941 . . . . 0.0 110.167 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.518 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -65.46 96.71 0.26 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.909 . . . . 0.0 110.311 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.622 ' O ' ' O ' ' A' ' 193' ' ' VAL . 8.5 m -104.7 -164.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.967 . . . . 0.0 110.254 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.655 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -179.67 149.03 0.35 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.843 -1.161 . . . . 0.0 110.169 -179.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.778 ' HB ' ' C ' ' A' ' 189' ' ' VAL . 0.3 OUTLIER -89.82 150.03 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.302 -0.874 . . . . 0.0 110.233 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.512 HG21 ' N ' ' A' ' 167' ' ' GLN . 21.4 m -124.07 -20.3 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.151 -0.968 . . . . 0.0 110.289 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.512 ' N ' HG21 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -160.87 120.61 2.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.18 -0.95 . . . . 0.0 110.251 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.456 ' O ' HG12 ' A' ' 168' ' ' ILE . 5.3 tt -122.33 7.05 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.198 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.463 ' O ' ' HB3' ' A' ' 170' ' ' GLU . 52.9 t30 -62.32 89.28 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.2 -0.937 . . . . 0.0 110.214 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 169' ' ' ASN . 10.3 pt-20 177.2 47.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.927 . . . . 0.0 110.253 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.8 mt -82.28 44.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.893 . . . . 0.0 110.336 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.429 ' O ' ' C ' ' A' ' 173' ' ' GLN . 2.9 m-85 -46.6 -64.09 0.85 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 110.188 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . 0.429 ' C ' ' O ' ' A' ' 172' ' ' PHE . 0.4 OUTLIER -42.42 159.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.357 -0.839 . . . . 0.0 110.197 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 55.6 t -111.01 -5.81 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.885 . . . . 0.0 110.237 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.72 104.78 16.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.869 . . . . 0.0 110.267 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -165.74 33.24 0.05 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.145 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.415 ' O ' ' OG1' ' A' ' 180' ' ' THR . 28.8 t70 -52.83 -44.48 66.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.927 . . . . 0.0 110.215 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -68.21 -31.31 70.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.298 -0.876 . . . . 0.0 110.241 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.54 ' CD1' ' C ' ' A' ' 179' ' ' PHE . 0.1 OUTLIER -70.15 -39.75 75.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.367 -0.833 . . . . 0.0 109.995 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.506 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -55.58 -18.79 8.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.148 -0.97 . . . . 0.0 109.912 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -72.17 -58.02 3.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.35 -0.843 . . . . 0.0 110.234 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.496 ' C ' ' CD1' ' A' ' 182' ' ' LEU . 4.5 pp -69.54 -7.68 40.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 0.0 109.983 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.524 HD11 ' CZ ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -97.57 -27.13 14.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.359 -0.838 . . . . 0.0 109.924 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 180' ' ' THR . 4.6 t70 -81.37 -3.16 51.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.349 -0.844 . . . . 0.0 109.957 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -87.24 26.88 1.13 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.332 -0.855 . . . . 0.0 110.151 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 11.5 t0 56.01 63.06 2.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 0.0 110.137 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.56 ' O ' ' CB ' ' A' ' 188' ' ' ARG . 34.8 mt -130.86 -82.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.213 -0.929 . . . . 0.0 110.42 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.56 ' CB ' ' O ' ' A' ' 187' ' ' ILE . 0.1 OUTLIER 73.89 151.74 0.12 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.515 -0.741 . . . . 0.0 109.681 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.939 ' O ' ' N ' ' A' ' 191' ' ' SER . 4.4 m 33.86 38.52 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 O-C-N 121.315 -0.866 . . . . 0.0 110.443 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.556 ' C ' ' O ' ' A' ' 189' ' ' VAL . . . 28.16 19.81 0.0 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.939 ' N ' ' O ' ' A' ' 189' ' ' VAL . 21.2 t 39.5 -145.12 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.346 -1.091 . . . . 0.0 109.608 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.655 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 1.8 tt0 -96.26 117.62 31.16 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.622 ' O ' ' O ' ' A' ' 163' ' ' VAL . 33.0 m -157.71 -137.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.209 -0.932 . . . . 0.0 110.097 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.571 ' HA ' ' CG2' ' A' ' 163' ' ' VAL . 1.9 pt-20 -173.75 159.51 3.49 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 110.091 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.543 ' CG2' ' HG ' ' A' ' 204' ' ' LEU . 1.0 OUTLIER -120.46 165.13 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.07 -1.019 . . . . 0.0 110.452 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 197' ' ' ASP . 40.2 t -138.64 86.09 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.329 -0.857 . . . . 0.0 110.128 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 196' ' ' VAL . 48.5 t0 -42.31 129.92 3.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -0.893 . . . . 0.0 110.369 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.543 ' CB ' ' O ' ' A' ' 201' ' ' HIS . 8.7 ttp180 -115.16 72.66 0.8 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.223 -0.923 . . . . 0.0 110.161 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 198' ' ' ARG . 1.3 m-20 41.27 58.32 2.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 0.0 110.395 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 109.81 -44.82 1.42 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.543 ' O ' ' CB ' ' A' ' 198' ' ' ARG . 0.3 OUTLIER -93.74 114.86 27.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.187 -1.184 . . . . 0.0 110.266 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.565 ' CD1' ' HA ' ' A' ' 153' ' ' ILE . 11.9 mt -95.45 127.72 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.925 . . . . 0.0 110.411 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.416 ' O ' HG21 ' A' ' 195' ' ' ILE . 40.4 m -110.83 163.67 13.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 0.0 109.97 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.543 ' HG ' ' CG2' ' A' ' 195' ' ' ILE . 0.7 OUTLIER -119.64 133.76 55.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 110.293 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.537 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 1.4 t -119.84 120.02 35.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.342 -0.849 . . . . 0.0 109.865 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.517 ' HA ' ' CG1' ' A' ' 193' ' ' VAL . 2.8 m170 -106.53 -163.83 0.95 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.341 -0.849 . . . . 0.0 110.111 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -52.69 91.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 110.063 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 59.83 20.95 54.4 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -130.53 168.7 16.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -1.141 . . . . 0.0 110.181 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 204' ' ' LEU . 0.2 OUTLIER -157.84 152.18 24.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.218 -0.926 . . . . 0.0 110.235 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.508 HG11 ' N ' ' A' ' 212' ' ' GLU . 40.5 t -146.87 167.55 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.891 . . . . 0.0 110.145 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.508 ' N ' HG11 ' A' ' 211' ' ' VAL . 2.7 tt0 -98.62 69.92 1.9 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.29 -0.881 . . . . 0.0 110.333 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.502 ' HG ' ' N ' ' A' ' 214' ' ' LEU . 6.5 tp -63.25 155.28 28.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.289 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.565 ' O ' ' CB ' ' A' ' 218' ' ' ALA . 27.8 mt -59.37 150.82 25.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.22 -0.925 . . . . 0.0 109.94 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' A' ' 218' ' ' ALA . 2.9 p-10 -90.91 -109.18 0.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.028 -1.045 . . . . 0.0 110.238 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 215' ' ' ASP . 0.3 OUTLIER -42.87 -25.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.029 -1.044 . . . . 0.0 109.911 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 215' ' ' ASP . 1.1 mp -81.46 -21.6 38.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.299 -0.876 . . . . 0.0 110.488 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . 0.565 ' CB ' ' O ' ' A' ' 214' ' ' LEU . . . -75.67 48.12 0.44 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.076 -1.015 . . . . 0.0 110.461 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -118.76 29.05 7.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.137 -0.977 . . . . 0.0 110.173 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' THR . . . . . 0.407 ' O ' ' CD ' ' A' ' 170' ' ' GLU . 0.2 OUTLIER -113.69 -34.23 5.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 110.165 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.647 HG12 HG22 ' A' ' 223' ' ' ILE . 0.1 OUTLIER -70.52 134.01 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.307 -0.87 . . . . 0.0 110.347 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.451 ' O ' HG21 ' A' ' 166' ' ' VAL . 4.4 mtt180 -89.87 101.39 14.09 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.216 -0.927 . . . . 0.0 109.642 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.671 ' CG2' ' CG2' ' A' ' 165' ' ' ILE . 1.0 OUTLIER -119.56 -176.78 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 110.659 -179.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.429 ' HA ' ' HB ' ' A' ' 150' ' ' THR . 11.5 pt-20 -150.6 178.48 9.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.468 -0.77 . . . . 0.0 110.204 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 3.8 tm-20 -106.48 120.15 41.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.303 -0.873 . . . . 0.0 110.068 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 39.1 tp . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.222 -179.954 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 N--CA 1.484 0.916 0 N-CA-C 110.468 -0.628 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 24.6 mm -71.19 117.95 61.29 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 0.0 110.226 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.85 90.07 0.85 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.985 1.519 . . . . 0.0 110.373 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -84.3 99.67 2.28 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 137' ' ' GLU . 1.2 tp -69.79 -16.7 63.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -1.13 . . . . 0.0 110.14 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 137' ' ' GLU . 0.5 OUTLIER 60.76 -81.31 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.266 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 135' ' ' LEU . 7.5 mt-10 57.64 29.21 16.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.378 -0.826 . . . . 0.0 110.165 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 110.271 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.484 0.953 0 N-CA-C 110.631 -0.565 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -154.24 -172.48 22.23 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.492 ' O ' ' CB ' ' A' ' 154' ' ' ASP . 53.7 m -147.28 10.76 1.0 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.296 -1.12 . . . . 0.0 110.375 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 13.5 mmt180 59.7 136.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -0.9 . . . . 0.0 110.226 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.54 ' O ' ' CD1' ' A' ' 195' ' ' ILE . 1.4 t -64.97 -0.58 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.219 -0.926 . . . . 0.0 110.966 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.551 HG22 ' CB ' ' A' ' 218' ' ' ALA . 1.0 OUTLIER -115.53 -4.62 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.911 -1.118 . . . . 0.0 110.652 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.509 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 0.7 OUTLIER -103.19 -28.6 11.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.125 -0.985 . . . . 0.0 109.949 179.673 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.468 ' HB1' HG23 ' A' ' 150' ' ' THR . . . -84.09 -15.4 47.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 110.05 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.494 ' O ' HG21 ' A' ' 157' ' ' THR . . . -71.97 -161.8 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.326 -0.859 . . . . 0.0 110.197 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.494 HG21 ' O ' ' A' ' 156' ' ' ALA . 0.4 OUTLIER 55.88 160.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.33 -0.856 . . . . 0.0 110.12 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 157' ' ' THR . 5.6 p 42.86 30.84 0.27 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 110.212 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.73 134.15 1.74 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.323 -0.86 . . . . 0.0 110.065 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.608 ' O ' ' O ' ' A' ' 161' ' ' ARG . 45.9 Cg_endo -73.36 74.61 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.935 1.492 . . . . 0.0 110.542 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.608 ' O ' ' O ' ' A' ' 160' ' ' PRO . 2.1 ptt85 27.44 104.32 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.492 0.663 . . . . 0.0 111.393 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.409 ' C ' ' CG1' ' A' ' 163' ' ' VAL . 0.0 OUTLIER -168.76 68.75 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.99 -1.069 . . . . 0.0 110.287 179.534 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.655 ' O ' ' O ' ' A' ' 193' ' ' VAL . 16.6 m -150.62 -155.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.886 . . . . 0.0 110.329 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.644 ' CB ' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -177.56 167.72 2.22 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.783 -1.198 . . . . 0.0 110.518 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.781 ' HB ' ' C ' ' A' ' 189' ' ' VAL . 0.3 OUTLIER -98.83 159.52 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.224 -0.922 . . . . 0.0 110.268 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.514 HG21 ' N ' ' A' ' 167' ' ' GLN . 31.5 m -131.13 -28.62 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.892 . . . . 0.0 110.222 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.514 ' N ' HG21 ' A' ' 166' ' ' VAL . 4.6 tt0 -144.92 93.59 2.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.197 -0.939 . . . . 0.0 110.124 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.46 HG21 ' N ' ' A' ' 169' ' ' ASN . 0.3 OUTLIER -54.07 -32.23 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.219 -0.925 . . . . 0.0 110.124 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.46 ' N ' HG21 ' A' ' 168' ' ' ILE . 0.2 OUTLIER 42.56 71.25 0.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 0.0 110.252 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 170' ' ' GLU . 33.6 tt0 -151.28 72.29 1.04 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.259 -0.9 . . . . 0.0 110.211 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.462 HG21 HD11 ' A' ' 171' ' ' ILE . 32.4 mm -84.2 -6.63 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 110.281 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -75.32 166.37 23.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.427 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -115.66 -17.38 11.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -0.918 . . . . 0.0 110.2 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 86.6 t -69.66 -21.33 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.19 -0.944 . . . . 0.0 110.224 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -89.82 90.27 8.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.252 -0.905 . . . . 0.0 110.177 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.588 ' CG2' ' CG2' ' A' ' 180' ' ' THR . 21.2 m -124.36 -90.06 0.57 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.885 . . . . 0.0 110.197 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 176' ' ' THR . 3.0 t0 68.37 -158.0 0.19 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.214 -0.929 . . . . 0.0 110.319 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.443 ' OE1' ' OE1' ' A' ' 212' ' ' GLU . 1.2 mt-30 -59.14 -23.33 62.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.895 . . . . 0.0 110.411 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.568 ' CE2' HD11 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -47.96 -23.51 0.8 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.181 -0.949 . . . . 0.0 110.133 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.588 ' CG2' ' CG2' ' A' ' 176' ' ' THR . 0.5 OUTLIER -58.58 -25.75 62.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 109.949 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -71.46 -62.85 1.26 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.301 -0.874 . . . . 0.0 110.167 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 179' ' ' PHE . 3.3 pp -61.06 -13.89 19.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.341 -0.85 . . . . 0.0 110.101 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.568 HD11 ' CE2' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -85.22 -30.14 24.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.903 . . . . 0.0 110.058 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -69.59 -14.28 62.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.416 -0.802 . . . . 0.0 110.039 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.453 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -91.45 24.82 2.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -0.858 . . . . 0.0 110.174 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 185' ' ' ALA . 30.5 t0 40.84 83.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 110.171 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.548 ' O ' ' CB ' ' A' ' 188' ' ' ARG . 87.7 mt -133.85 -75.78 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.0 110.448 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.548 ' CB ' ' O ' ' A' ' 187' ' ' ILE . 5.6 ttp85 71.48 154.65 0.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.374 -0.829 . . . . 0.0 109.716 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.956 ' O ' ' N ' ' A' ' 191' ' ' SER . 4.2 m 32.9 38.35 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 121.235 -0.916 . . . . 0.0 110.558 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.583 ' N ' ' CD1' ' A' ' 165' ' ' ILE . . . 26.83 19.58 0.0 OUTLIER Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.956 ' N ' ' O ' ' A' ' 189' ' ' VAL . 39.5 t 37.06 -146.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.322 -1.105 . . . . 0.0 109.868 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.644 ' HA ' ' CB ' ' A' ' 164' ' ' ARG . 18.9 mt-10 -92.12 115.99 28.55 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.655 ' O ' ' O ' ' A' ' 163' ' ' VAL . 34.3 m -159.25 -132.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.098 -1.001 . . . . 0.0 109.59 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 205' ' ' SER . 1.5 pm0 -167.29 159.0 12.29 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.544 -0.862 . . . . 0.0 110.239 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.54 ' CD1' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER -119.98 163.95 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.28 -0.887 . . . . 0.0 110.154 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.527 ' CG2' ' HD3' ' A' ' 161' ' ' ARG . 54.8 t -140.83 90.01 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.208 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.48 ' OD1' ' CB ' ' A' ' 156' ' ' ALA . 15.4 m-20 -52.66 118.74 3.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.883 . . . . 0.0 110.332 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.459 ' CB ' ' O ' ' A' ' 201' ' ' HIS . 0.6 OUTLIER -105.02 73.13 1.04 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.224 -0.922 . . . . 0.0 110.246 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 198' ' ' ARG . 1.6 m-20 42.55 53.87 4.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 110.21 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 110.62 -41.36 2.26 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.459 ' O ' ' CB ' ' A' ' 198' ' ' ARG . 0.1 OUTLIER -89.79 95.29 10.18 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.279 -1.13 . . . . 0.0 110.162 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.526 HD11 HG22 ' A' ' 202' ' ' ILE . 20.4 mt -80.71 114.45 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 110.322 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.473 HG21 ' N ' ' A' ' 204' ' ' LEU . 3.9 m -102.56 163.33 12.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 0.0 109.916 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.567 HD21 ' CD2' ' A' ' 206' ' ' HIS . 0.7 OUTLIER -119.81 136.84 54.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.097 -1.002 . . . . 0.0 110.308 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.613 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.4 OUTLIER -119.88 123.31 43.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 0.0 109.92 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.567 ' CD2' HD21 ' A' ' 204' ' ' LEU . 2.7 m80 -112.08 -171.59 1.88 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.296 -0.877 . . . . 0.0 110.07 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -48.94 91.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.215 -0.928 . . . . 0.0 110.175 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 54.98 23.84 32.71 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.511 ' O ' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -138.5 94.81 2.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -1.144 . . . . 0.0 110.259 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -100.44 148.44 24.75 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.254 -0.904 . . . . 0.0 110.246 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.41 ' O ' HG22 ' A' ' 203' ' ' THR . 14.3 t -141.18 171.56 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.932 . . . . 0.0 110.225 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 213' ' ' LEU . 2.7 tt0 -95.72 84.89 4.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 110.181 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.486 ' O ' ' CD2' ' A' ' 214' ' ' LEU . 6.8 tp -60.03 -138.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -0.926 . . . . 0.0 110.296 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.559 ' O ' ' CB ' ' A' ' 218' ' ' ALA . 14.8 mt -139.62 157.71 45.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.248 -0.907 . . . . 0.0 110.087 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 216' ' ' ASP . 4.6 p30 -90.52 -106.76 0.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.207 -0.933 . . . . 0.0 110.263 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 215' ' ' ASP . 0.1 OUTLIER -41.73 -25.38 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.092 -1.005 . . . . 0.0 110.121 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 215' ' ' ASP . 0.3 OUTLIER -80.79 -26.76 36.97 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.259 -0.901 . . . . 0.0 110.329 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . 0.559 ' CB ' ' O ' ' A' ' 214' ' ' LEU . . . -71.94 -3.88 25.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.053 -1.03 . . . . 0.0 110.018 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.499 ' O ' ' NH1' ' A' ' 151' ' ' ARG . 11.2 t-80 -83.56 55.34 3.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 110.143 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.1 -49.72 0.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -0.913 . . . . 0.0 110.322 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.621 HG12 ' CG2' ' A' ' 223' ' ' ILE . 0.1 OUTLIER -67.22 137.46 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.291 -0.881 . . . . 0.0 110.352 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.463 ' O ' ' CG2' ' A' ' 166' ' ' VAL . 0.6 OUTLIER -89.53 110.73 21.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 109.333 179.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.621 ' CG2' HG12 ' A' ' 221' ' ' ILE . 0.5 OUTLIER -119.82 175.46 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.165 -0.959 . . . . 0.0 110.636 -179.111 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.454 ' O ' ' HB ' ' A' ' 163' ' ' VAL . 5.9 mt-10 -143.61 167.32 22.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.336 -0.852 . . . . 0.0 110.12 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.45 ' HA ' HG11 ' A' ' 163' ' ' VAL . 4.7 pt-20 -101.57 48.51 0.88 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.312 -0.867 . . . . 0.0 110.253 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.426 HD11 ' CZ ' ' A' ' 164' ' ' ARG . 2.4 tp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.118 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.416 ' O ' HG13 ' A' ' 132' ' ' ILE . 45.6 Cg_endo . . . . . 0 N--CA 1.484 0.939 0 N-CA-C 110.41 -0.65 . . . . 0.0 110.41 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 131' ' ' PRO . 1.8 mp -141.7 129.09 11.64 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.231 -0.918 . . . . 0.0 110.177 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.98 -19.61 22.97 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.955 1.503 . . . . 0.0 110.47 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.83 -97.41 1.85 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.414 ' O ' ' HG3' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -125.37 -6.34 7.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -1.12 . . . . 0.0 110.21 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.4 t70 52.11 54.13 11.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.27 -0.894 . . . . 0.0 110.216 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 135' ' ' LEU . 43.2 mt-10 -135.55 27.61 3.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 110.292 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 110.223 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo . . . . . 0 N--CA 1.483 0.889 0 N-CA-C 110.415 -0.648 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.483 ' HA3' ' HB3' ' A' ' 222' ' ' ARG . . . 113.61 126.18 4.38 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.538 ' CG2' ' HB3' ' A' ' 154' ' ' ASP . 98.0 m -141.39 151.97 43.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -1.101 . . . . 0.0 110.1 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 154' ' ' ASP . 0.0 OUTLIER -43.15 125.06 3.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.142 -0.974 . . . . 0.0 110.259 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.567 ' HA ' ' CD1' ' A' ' 223' ' ' ILE . 5.9 p -44.75 -26.8 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.239 -0.913 . . . . 0.0 110.174 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.516 HG22 ' CB ' ' A' ' 218' ' ' ALA . 9.9 pt -92.33 -15.7 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.204 -0.935 . . . . 0.0 110.248 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.538 ' HB3' ' CG2' ' A' ' 150' ' ' THR . 0.8 OUTLIER -77.35 -21.97 52.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.396 179.558 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -106.9 -9.78 16.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.562 -0.711 . . . . 0.0 109.756 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 157' ' ' THR . . . -66.13 -174.11 0.23 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 110.216 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.549 ' OG1' ' CB ' ' A' ' 197' ' ' ASP . 4.0 m 43.64 -170.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 110.182 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.521 ' O ' ' CB ' ' A' ' 159' ' ' MET . 2.2 t 50.45 30.35 4.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.173 -0.954 . . . . 0.0 110.058 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' MET . . . . . 0.521 ' CB ' ' O ' ' A' ' 158' ' ' SER . 0.5 OUTLIER 69.88 64.8 0.49 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 110.135 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.588 ' O ' ' CG ' ' A' ' 161' ' ' ARG . 45.9 Cg_endo -74.11 -61.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.0 1.526 . . . . 0.0 110.22 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.59 ' CD ' ' N ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER 74.07 179.63 0.2 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.455 -0.778 . . . . 0.0 110.238 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.59 ' N ' ' CD ' ' A' ' 161' ' ' ARG . 14.0 tptt -40.03 126.3 2.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.834 . . . . 0.0 110.84 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.582 ' O ' ' O ' ' A' ' 193' ' ' VAL . 0.1 OUTLIER -134.11 -160.88 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.411 -0.805 . . . . 0.0 109.436 179.175 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.616 ' HA ' ' O ' ' A' ' 191' ' ' SER . 0.1 OUTLIER -177.21 144.4 0.42 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.831 -1.168 . . . . 0.0 110.39 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 191' ' ' SER . 1.1 mt -103.66 151.03 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.39 -0.819 . . . . 0.0 110.442 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.444 HG12 ' C ' ' A' ' 165' ' ' ILE . 22.9 m -150.72 17.87 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.165 -0.959 . . . . 0.0 110.295 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -155.03 119.86 4.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.213 -0.929 . . . . 0.0 110.196 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 168' ' ' ILE . 0.9 OUTLIER -111.31 11.18 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.187 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 168' ' ' ILE . 5.4 m-20 -42.06 122.29 2.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.21 -0.932 . . . . 0.0 110.086 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 171' ' ' ILE . 5.1 pt-20 -144.79 55.88 1.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 110.189 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 170' ' ' GLU . 28.1 mt -41.91 -33.32 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.291 -0.881 . . . . 0.0 110.022 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -98.93 158.71 15.46 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.349 -0.845 . . . . 0.0 110.191 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . 0.45 ' O ' ' HB ' ' A' ' 174' ' ' VAL . 0.0 OUTLIER -178.0 152.54 0.74 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 110.187 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 173' ' ' GLN . 2.5 p 178.33 -30.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 110.134 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.433 ' OE2' ' OD2' ' A' ' 216' ' ' ASP . 35.0 tt0 -85.29 151.39 24.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -0.891 . . . . 0.0 110.123 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.518 HG21 ' N ' ' A' ' 177' ' ' ASP . 36.4 m -164.68 -96.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 110.037 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.518 ' N ' HG21 ' A' ' 176' ' ' THR . 2.6 m-20 69.17 -136.7 0.08 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.148 -0.97 . . . . 0.0 110.307 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -56.55 -28.94 61.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.207 -0.933 . . . . 0.0 110.52 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.566 ' HA ' ' CD1' ' A' ' 182' ' ' LEU . 0.1 OUTLIER -42.95 -39.82 2.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 110.263 -179.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.488 ' C ' ' O ' ' A' ' 179' ' ' PHE . 0.7 OUTLIER -39.26 -28.3 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.905 . . . . 0.0 110.089 -179.781 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 179' ' ' PHE . 5.9 tt0 -60.2 -36.02 76.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.268 -0.895 . . . . 0.0 109.576 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.566 ' CD1' ' HA ' ' A' ' 179' ' ' PHE . 1.0 OUTLIER -69.77 -41.32 75.31 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.389 -0.82 . . . . 0.0 109.431 179.345 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.87 -39.17 87.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.41 -0.806 . . . . 0.0 109.812 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -61.73 -17.78 57.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.429 -0.794 . . . . 0.0 109.703 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -90.66 18.87 5.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.385 -0.822 . . . . 0.0 110.033 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 185' ' ' ALA . 2.8 m-20 42.48 68.02 0.53 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 109.669 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.484 ' CG2' ' N ' ' A' ' 188' ' ' ARG . 10.6 mm -115.24 167.47 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.302 -0.874 . . . . 0.0 110.882 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.636 ' O ' ' O ' ' A' ' 189' ' ' VAL . 0.2 OUTLIER -173.31 113.26 0.22 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.691 ' CG2' ' O ' ' A' ' 189' ' ' VAL . 0.6 OUTLIER 43.74 101.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.272 -0.893 . . . . 0.0 108.693 -178.149 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.548 ' O ' ' CG1' ' A' ' 193' ' ' VAL . . . -39.02 -19.05 0.01 OUTLIER Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.641 ' N ' ' O ' ' A' ' 189' ' ' VAL . 3.7 t 67.04 -145.18 0.15 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.969 -1.312 . . . . 0.0 108.979 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.527 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 7.8 mt-10 -62.68 98.33 0.12 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 109.25 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.582 ' O ' ' O ' ' A' ' 163' ' ' VAL . 10.0 m -154.1 -142.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.062 -1.024 . . . . 0.0 110.356 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.556 ' HA ' HG22 ' A' ' 163' ' ' VAL . 24.3 tt0 -169.64 157.71 7.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.88 . . . . 0.0 110.394 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.55 ' CG2' ' HG ' ' A' ' 204' ' ' LEU . 0.1 OUTLIER -131.54 161.92 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.147 -0.97 . . . . 0.0 110.215 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.45 ' O ' ' HG2' ' A' ' 198' ' ' ARG . 97.1 t -144.97 86.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.266 -0.897 . . . . 0.0 110.067 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.549 ' CB ' ' OG1' ' A' ' 157' ' ' THR . 53.1 t0 -55.7 124.29 16.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.305 -0.872 . . . . 0.0 110.404 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.503 ' NH2' ' HB3' ' A' ' 198' ' ' ARG . 6.5 mmm180 -107.12 80.98 1.48 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.351 -0.843 . . . . 0.0 110.19 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.489 ' C ' ' O ' ' A' ' 198' ' ' ARG . 2.7 p30 36.23 38.19 0.06 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.452 -0.78 . . . . 0.0 110.565 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 137.57 -50.47 0.82 Allowed Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.49 ' O ' ' HB2' ' A' ' 198' ' ' ARG . 1.6 t-160 -90.04 114.75 26.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.344 -1.092 . . . . 0.0 110.42 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 197' ' ' ASP . 35.6 mt -100.98 116.93 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 110.171 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 195' ' ' ILE . 6.9 m -97.1 152.57 18.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 110.364 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.586 HD21 ' CD2' ' A' ' 206' ' ' HIS . 0.7 OUTLIER -119.84 131.95 55.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.361 -0.837 . . . . 0.0 110.086 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.557 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 5.0 t -119.72 115.69 24.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.276 -0.89 . . . . 0.0 110.137 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.586 ' CD2' HD21 ' A' ' 204' ' ' LEU . 1.9 m80 -103.45 153.59 20.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.605 -0.684 . . . . 0.0 109.832 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -51.02 -19.2 0.98 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.214 -0.929 . . . . 0.0 110.094 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.498 ' O ' ' HB3' ' A' ' 209' ' ' LYS . . . -95.86 -27.42 10.36 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.498 ' HB3' ' O ' ' A' ' 208' ' ' GLY . 1.4 ptmt 171.63 -179.36 0.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.261 -1.141 . . . . 0.0 110.281 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.444 ' OD2' ' O ' ' A' ' 204' ' ' LEU . 0.8 OUTLIER -124.36 149.71 46.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -0.848 . . . . 0.0 110.131 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 6.1 p -129.68 164.7 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.244 -0.91 . . . . 0.0 110.075 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -86.97 70.34 10.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.374 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 1.8 tp -63.08 163.37 10.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.975 . . . . 0.0 110.099 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.509 ' CG ' ' HB2' ' A' ' 217' ' ' LEU . 0.6 OUTLIER -130.2 145.43 51.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.911 . . . . 0.0 110.307 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.465 ' HA ' HG23 ' A' ' 153' ' ' ILE . 3.5 p30 -55.08 -37.1 66.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 110.271 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.433 ' OD2' ' OE2' ' A' ' 175' ' ' GLU . 0.6 OUTLIER -55.79 -50.37 70.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.193 -0.942 . . . . 0.0 110.245 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.556 ' HG ' ' CD1' ' A' ' 179' ' ' PHE . 2.2 mm? -89.41 -28.18 19.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 110.218 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . 0.516 ' CB ' HG22 ' A' ' 153' ' ' ILE . . . -67.1 -9.28 37.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 109.969 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.479 ' CD2' ' HD3' ' A' ' 151' ' ' ARG . 3.0 t-160 -91.09 69.24 6.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.169 -0.957 . . . . 0.0 110.181 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' THR . . . . . 0.438 ' CG2' ' O ' ' A' ' 219' ' ' HIS . 0.6 OUTLIER -166.54 -58.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.177 -0.952 . . . . 0.0 110.4 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.577 ' CD1' ' N ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -65.53 136.43 26.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.304 -0.872 . . . . 0.0 110.319 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.483 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 47.1 mtt180 -95.67 116.59 29.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 110.058 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.567 ' CD1' ' HA ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER -119.78 177.37 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 110.168 -179.759 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.523 ' HB2' ' NH2' ' A' ' 164' ' ' ARG . 2.3 mt-10 -150.04 179.69 7.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.933 . . . . 0.0 110.295 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 1.5 mt-10 -90.15 69.89 7.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.384 -0.822 . . . . 0.0 110.214 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.463 ' OXT' ' O ' ' A' ' 225' ' ' GLU . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.214 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo . . . . . 0 N--CA 1.483 0.876 0 N-CA-C 110.413 -0.649 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.3 mp -113.91 112.08 47.82 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.312 -0.868 . . . . 0.0 110.149 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.65 159.42 48.77 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.035 1.545 . . . . 0.0 110.567 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 149.51 -43.57 0.76 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.59 -21.18 62.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.284 -1.127 . . . . 0.0 110.188 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.0 t70 50.97 89.48 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.282 -0.886 . . . . 0.0 110.252 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -138.38 21.42 2.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 110.194 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.51 HD22 ' N ' ' A' ' 138' ' ' LEU . 2.7 pt? . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.195 -0.941 . . . . 0.0 110.171 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 N--CA 1.482 0.817 0 N-CA-C 110.439 -0.639 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -178.95 153.17 12.03 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.522 ' HB ' ' O ' ' A' ' 223' ' ' ILE . 7.7 m -123.46 -1.82 8.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.159 -1.201 . . . . 0.0 110.216 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.497 ' CB ' ' HB2' ' A' ' 154' ' ' ASP . 2.5 mpt_? 57.21 110.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.879 . . . . 0.0 109.851 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.576 ' N ' HG12 ' A' ' 223' ' ' ILE . 4.9 t -40.46 -68.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.358 -0.839 . . . . 0.0 110.278 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.591 HG13 ' CD2' ' A' ' 219' ' ' HIS . 0.2 OUTLIER -43.8 -28.13 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.21 -0.932 . . . . 0.0 110.594 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 150' ' ' THR . 0.5 OUTLIER -81.05 -19.78 43.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.11 -0.994 . . . . 0.0 110.209 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 152' ' ' VAL . . . -100.44 -6.01 26.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.169 -0.957 . . . . 0.0 110.181 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.488 ' O ' HG21 ' A' ' 157' ' ' THR . . . -75.78 166.98 22.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.93 . . . . 0.0 110.174 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 158' ' ' SER . 0.4 OUTLIER 45.71 -175.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.165 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 157' ' ' THR . 1.7 t 69.85 -54.59 0.61 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 109.987 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' MET . . . . . 0.487 ' CB ' ' O ' ' A' ' 158' ' ' SER . 0.0 OUTLIER 169.65 59.59 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.362 -0.836 . . . . 0.0 110.129 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.545 ' O ' ' CB ' ' A' ' 161' ' ' ARG . 44.6 Cg_endo -73.2 -72.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.019 1.536 . . . . 0.0 110.414 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.545 ' CB ' ' O ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER 71.45 -66.44 0.3 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.28 -0.888 . . . . 0.0 110.255 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.583 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 4.9 tttp -162.24 120.08 2.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 0.0 110.755 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.61 ' CG2' ' HA ' ' A' ' 194' ' ' GLU . 31.3 m -139.89 -151.53 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.889 . . . . 0.0 110.016 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.649 ' HG3' ' HA ' ' A' ' 192' ' ' GLU . 11.1 ttp180 -179.89 155.5 0.62 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.676 -1.265 . . . . 0.0 110.556 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.802 ' HB ' ' C ' ' A' ' 189' ' ' VAL . 0.3 OUTLIER -89.66 151.28 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.163 -0.961 . . . . 0.0 109.896 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 222' ' ' ARG . 20.0 m -122.48 -18.46 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.176 -0.952 . . . . 0.0 110.588 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.459 ' N ' HG21 ' A' ' 166' ' ' VAL . 46.4 tt0 -167.88 123.94 1.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.165 -0.96 . . . . 0.0 110.519 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.481 ' O ' ' ND2' ' A' ' 169' ' ' ASN . 6.5 mt -99.83 -13.38 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.359 -0.838 . . . . 0.0 109.894 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' A' ' 168' ' ' ILE . 9.8 p30 38.83 -161.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.521 -0.737 . . . . 0.0 110.39 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 170' ' ' GLU . 8.5 tt0 179.1 45.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.886 . . . . 0.0 110.278 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.428 ' C ' ' O ' ' A' ' 170' ' ' GLU . 5.3 mt -42.36 -42.32 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.144 -0.973 . . . . 0.0 110.049 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -85.16 151.32 24.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 110.041 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . 0.532 ' O ' ' CG1' ' A' ' 174' ' ' VAL . 0.2 OUTLIER -127.18 -169.03 1.97 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.217 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 173' ' ' GLN . 9.7 p 37.42 35.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.404 -0.81 . . . . 0.0 110.514 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' A' ' 177' ' ' ASP . 1.9 tm-20 -107.71 -68.06 0.92 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.892 . . . . 0.0 110.168 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.539 ' CG2' ' CG2' ' A' ' 180' ' ' THR . 0.0 OUTLIER 45.17 -89.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.467 -0.77 . . . . 0.0 110.475 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 175' ' ' GLU . 0.6 OUTLIER 68.01 -170.29 0.19 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 0.0 110.101 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 11.3 tm0? -44.63 -24.01 0.16 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.217 -0.927 . . . . 0.0 110.482 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.55 ' HA ' ' CD1' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -58.69 -34.01 70.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.185 -0.947 . . . . 0.0 110.328 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.544 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.8 OUTLIER -40.31 -29.02 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 110.046 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 179' ' ' PHE . 5.9 tt0 -62.6 -34.13 76.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.385 -0.822 . . . . 0.0 110.038 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.55 ' CD1' ' HA ' ' A' ' 179' ' ' PHE . 1.6 mt -69.53 -45.41 68.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.346 -0.847 . . . . 0.0 109.738 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 2.0 tt -63.3 -29.32 70.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.448 -0.783 . . . . 0.0 110.051 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.58 -1.68 17.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 110.058 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.405 ' O ' HG13 ' A' ' 187' ' ' ILE . . . -103.04 11.11 37.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.888 . . . . 0.0 110.266 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 185' ' ' ALA . 0.4 OUTLIER 44.69 86.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 109.912 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.643 ' O ' ' CB ' ' A' ' 188' ' ' ARG . 16.1 mt -147.58 -79.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.216 -0.928 . . . . 0.0 110.631 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.643 ' CB ' ' O ' ' A' ' 187' ' ' ILE . 34.1 ttt-85 81.02 149.84 0.1 Allowed 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.92 ' O ' ' N ' ' A' ' 191' ' ' SER . 2.7 m 33.28 35.95 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.37 -0.831 . . . . 0.0 110.329 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.57 ' O ' ' CG1' ' A' ' 193' ' ' VAL . . . 30.28 17.41 0.0 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.92 ' N ' ' O ' ' A' ' 189' ' ' VAL . 9.5 t 43.37 -147.19 0.06 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.117 -1.225 . . . . 0.0 109.343 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.649 ' HA ' ' HG3' ' A' ' 164' ' ' ARG . 3.4 mt-10 -77.82 116.16 18.13 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.593 ' O ' ' O ' ' A' ' 163' ' ' VAL . 0.2 OUTLIER -161.66 162.98 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.117 -0.99 . . . . 0.0 109.886 -179.485 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.61 ' HA ' ' CG2' ' A' ' 163' ' ' VAL . 4.0 pt-20 -119.87 169.01 10.54 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 119.225 -0.99 . . . . 0.0 110.27 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.557 ' CD1' HG11 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -123.31 142.25 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.931 . . . . 0.0 110.463 -179.483 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.474 ' O ' ' C ' ' A' ' 197' ' ' ASP . 56.5 t -133.9 98.97 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.442 -0.786 . . . . 0.0 109.878 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' A' ' 196' ' ' VAL . 1.1 t0 -38.58 106.58 0.05 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.262 -0.899 . . . . 0.0 110.484 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 200' ' ' GLY . 0.0 OUTLIER -90.55 -172.48 3.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.234 -0.916 . . . . 0.0 110.349 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -53.02 86.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 110.286 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 198' ' ' ARG . . . 65.59 18.37 65.76 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.449 ' O ' ' N ' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -139.64 -176.13 4.45 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.284 -1.127 . . . . 0.0 110.123 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.478 ' CG2' HG23 ' A' ' 195' ' ' ILE . 47.6 mt -137.76 100.8 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 110.336 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.478 ' OG1' ' HG3' ' A' ' 198' ' ' ARG . 6.0 m -86.68 143.51 27.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.147 -0.971 . . . . 0.0 110.121 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.491 ' HB3' HG22 ' A' ' 193' ' ' VAL . 2.7 mp -120.89 146.23 46.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 0.0 110.148 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 210' ' ' ASP . 45.1 m -129.85 130.98 45.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.295 -0.878 . . . . 0.0 110.447 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 209' ' ' LYS . 0.0 OUTLIER -116.13 -157.21 0.64 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.297 -0.877 . . . . 0.0 109.996 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -44.72 91.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.209 -0.932 . . . . 0.0 110.349 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 45.34 31.64 3.42 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.555 ' O ' ' CE1' ' A' ' 206' ' ' HIS . 0.4 OUTLIER -140.89 118.17 11.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -1.173 . . . . 0.0 110.328 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.508 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 2.3 p-10 -104.72 150.59 24.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 110.341 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.404 ' CG2' ' CE1' ' A' ' 206' ' ' HIS . 32.6 t -142.12 149.84 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.89 . . . . 0.0 110.18 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -82.5 67.25 8.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.284 -0.885 . . . . 0.0 110.297 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.49 ' HB3' ' CD1' ' A' ' 204' ' ' LEU . 3.4 tm? -51.54 125.56 14.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 0.0 110.056 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.499 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 22.1 tp -65.33 106.65 1.41 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 110.251 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.485 ' HA ' ' HB3' ' A' ' 218' ' ' ALA . 4.4 p30 -59.74 -41.57 91.25 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.306 -0.871 . . . . 0.0 110.358 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.481 ' HB2' ' CD1' ' A' ' 214' ' ' LEU . 0.3 OUTLIER -41.65 -69.66 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.316 -179.798 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 219' ' ' HIS . 0.2 OUTLIER -79.58 -13.62 59.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -0.904 . . . . 0.0 110.501 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . 0.589 ' CB ' ' CG2' ' A' ' 153' ' ' ILE . . . -40.44 -27.69 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.272 -0.893 . . . . 0.0 110.269 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.636 ' N ' ' CD2' ' A' ' 219' ' ' HIS . 6.3 m170 -72.09 67.56 0.66 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.893 . . . . 0.0 110.09 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 7.1 t -158.41 -42.31 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.973 . . . . 0.0 110.702 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.572 HG12 ' CG2' ' A' ' 223' ' ' ILE . 0.1 OUTLIER -74.53 132.61 33.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.2 -0.938 . . . . 0.0 110.566 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.531 ' O ' ' CG2' ' A' ' 166' ' ' VAL . 19.3 mtm180 -89.48 110.68 21.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.23 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.618 HG23 HG22 ' A' ' 165' ' ' ILE . 0.8 OUTLIER -119.89 171.78 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 110.806 -179.092 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.468 ' O ' ' HB ' ' A' ' 163' ' ' VAL . 0.8 OUTLIER -150.2 -165.73 2.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.402 -0.811 . . . . 0.0 109.936 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -99.61 155.58 17.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 110.33 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.241 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 N--CA 1.483 0.902 0 N-CA-C 110.574 -0.587 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.1 mt -100.83 118.57 60.37 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 110.359 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.28 155.48 46.46 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.917 1.483 . . . . 0.0 110.362 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -82.96 -107.34 0.48 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.499 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 28.7 tp -108.4 -36.22 6.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.118 -1.225 . . . . 0.0 110.203 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 10.2 t70 175.18 -93.98 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.408 -0.807 . . . . 0.0 110.093 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.448 ' N ' ' OD2' ' A' ' 136' ' ' ASP . 0.7 OUTLIER -73.0 62.69 0.63 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.183 -0.948 . . . . 0.0 110.26 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 25.7 tp . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.2 -0.938 . . . . 0.0 110.232 -180.0 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo . . . . . 0 N--CA 1.484 0.919 0 N-CA-C 110.415 -0.648 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -178.22 117.5 0.58 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.493 ' O ' HD12 ' A' ' 223' ' ' ILE . 8.3 m -159.82 146.15 16.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -1.155 . . . . 0.0 110.275 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.522 ' O ' ' CD1' ' A' ' 223' ' ' ILE . 11.4 ptp180 -53.61 171.09 0.09 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.282 -0.886 . . . . 0.0 110.178 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.547 ' HB ' HG23 ' A' ' 221' ' ' ILE . 12.5 p -104.1 36.82 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.209 -0.932 . . . . 0.0 110.612 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.604 ' CG2' ' CB ' ' A' ' 218' ' ' ALA . 9.0 pt -135.82 -34.29 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.946 . . . . 0.0 110.078 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.403 ' HB2' ' HD2' ' A' ' 151' ' ' ARG . 0.1 OUTLIER -72.92 -14.11 61.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.286 -0.884 . . . . 0.0 109.457 179.446 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -97.52 -21.15 17.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.578 -0.701 . . . . 0.0 109.896 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -73.5 90.58 1.74 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 110.17 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 5.2 t -91.77 179.12 5.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.929 . . . . 0.0 110.252 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.4 t -44.77 -46.68 10.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.267 -0.895 . . . . 0.0 110.027 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' MET . . . . . 0.488 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 5.5 mmt -75.56 164.81 58.32 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 110.116 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 45.1 Cg_endo -71.94 73.86 2.44 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.947 1.498 . . . . 0.0 110.327 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.431 ' O ' HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -63.31 110.19 1.82 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.855 . . . . 0.0 110.234 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.471 ' C ' HG21 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.78 138.09 48.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.407 -0.808 . . . . 0.0 110.26 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.576 ' O ' ' O ' ' A' ' 193' ' ' VAL . 0.1 OUTLIER -149.98 -174.13 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.348 -0.845 . . . . 0.0 110.071 179.932 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.674 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -163.22 134.93 5.01 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.856 -1.153 . . . . 0.0 110.244 -179.619 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.718 HD11 ' N ' ' A' ' 165' ' ' ILE . 0.5 OUTLIER -76.05 151.34 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.171 -0.955 . . . . 0.0 110.145 -179.415 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.519 HG11 ' NE ' ' A' ' 164' ' ' ARG . 28.9 m -149.26 15.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.305 -0.872 . . . . 0.0 109.993 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -179.12 110.37 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.354 -0.841 . . . . 0.0 110.065 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.509 ' HB ' HG11 ' A' ' 189' ' ' VAL . 0.6 OUTLIER -95.9 24.27 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 110.121 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 170' ' ' GLU . 2.2 t-20 -42.43 165.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 110.041 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 169' ' ' ASN . 0.7 OUTLIER 57.84 72.66 0.51 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.143 -0.973 . . . . 0.0 110.009 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.479 HD13 HG22 ' A' ' 171' ' ' ILE . 25.8 mm -88.03 -13.35 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 0.0 110.349 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.558 ' O ' ' CG ' ' A' ' 172' ' ' PHE . 1.5 p90 -47.6 123.53 5.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.217 -0.927 . . . . 0.0 110.158 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.24 177.28 6.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.167 -0.958 . . . . 0.0 110.388 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 8.7 p -160.28 39.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 110.127 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.539 ' O ' ' CB ' ' A' ' 176' ' ' THR . 0.2 OUTLIER -127.27 -73.6 0.61 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -0.891 . . . . 0.0 110.166 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.593 ' HA ' ' CD1' ' A' ' 179' ' ' PHE . 0.3 OUTLIER 72.0 -147.39 0.06 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.474 -0.766 . . . . 0.0 110.299 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 176' ' ' THR . 0.8 OUTLIER 65.52 -150.1 0.24 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.38 -0.825 . . . . 0.0 110.413 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 177' ' ' ASP . 1.6 tp60 -38.98 -37.1 0.33 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.279 -0.888 . . . . 0.0 110.738 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.593 ' CD1' ' HA ' ' A' ' 176' ' ' THR . 0.0 OUTLIER -48.0 -33.96 8.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.941 . . . . 0.0 110.057 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.543 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 1.3 p -39.33 -31.15 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.43 -0.793 . . . . 0.0 110.193 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 179' ' ' PHE . 23.5 tt0 -59.38 -36.35 75.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.309 -0.87 . . . . 0.0 109.824 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.572 ' CD1' ' HA ' ' A' ' 179' ' ' PHE . 1.2 mt -68.99 -46.61 67.62 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.371 -0.831 . . . . 0.0 109.733 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.487 ' CD1' ' O ' ' A' ' 183' ' ' LEU . 0.2 OUTLIER -68.52 -32.62 72.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.489 -0.757 . . . . 0.0 110.11 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.05 -4.51 32.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.84 . . . . 0.0 109.957 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.444 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -89.17 9.48 25.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.369 -0.832 . . . . 0.0 110.165 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 185' ' ' ALA . 23.1 t0 41.98 82.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.176 -0.953 . . . . 0.0 109.766 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.7 tt -141.22 173.3 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 110.49 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.52 ' O ' ' O ' ' A' ' 189' ' ' VAL . 0.0 OUTLIER -167.13 114.29 0.79 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.747 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.743 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 1.7 m 49.92 96.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 120.986 -1.071 . . . . 0.0 108.188 -178.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.534 ' N ' HG13 ' A' ' 165' ' ' ILE . . . -42.0 -16.26 0.02 OUTLIER Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 189' ' ' VAL . 9.2 t 62.82 -143.35 0.38 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.128 -1.219 . . . . 0.0 109.825 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.674 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 1.0 OUTLIER -59.54 104.36 0.27 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.512 -0.743 . . . . 0.0 109.751 179.626 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.576 ' O ' ' O ' ' A' ' 163' ' ' VAL . 11.0 m -154.78 -139.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.072 -1.018 . . . . 0.0 110.182 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.522 ' HA ' HG22 ' A' ' 163' ' ' VAL . 54.7 tt0 -176.32 167.17 2.84 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 109.926 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.552 ' CG1' HG23 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -129.45 167.46 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.114 -0.992 . . . . 0.0 110.342 -179.831 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.446 ' O ' ' C ' ' A' ' 197' ' ' ASP . 71.5 t -151.36 88.62 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.364 -0.835 . . . . 0.0 110.007 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 196' ' ' VAL . 17.8 t0 -41.24 110.23 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.319 -0.863 . . . . 0.0 110.104 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.453 ' O ' ' C ' ' A' ' 199' ' ' ASP . 0.0 OUTLIER -109.01 88.18 2.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.24 -0.913 . . . . 0.0 110.364 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 198' ' ' ARG . 0.5 OUTLIER 40.93 58.2 2.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 110.213 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 89.17 -28.04 7.05 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.45 ' O ' ' HB2' ' A' ' 198' ' ' ARG . 1.4 t60 -90.64 87.42 6.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -1.154 . . . . 0.0 110.182 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.56 ' CD1' ' CG2' ' A' ' 153' ' ' ILE . 66.2 mt -70.48 87.72 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.347 -0.846 . . . . 0.0 110.299 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.7 m -71.79 157.46 37.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.948 . . . . 0.0 110.007 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.503 ' CD2' ' CD2' ' A' ' 206' ' ' HIS . 0.9 OUTLIER -119.64 141.26 49.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -0.937 . . . . 0.0 110.204 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.494 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 1.6 t -119.77 115.48 23.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.869 . . . . 0.0 109.99 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.55 ' HA ' ' CB ' ' A' ' 193' ' ' VAL . 3.2 m80 -105.42 -165.78 1.15 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.314 -0.866 . . . . 0.0 109.942 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.457 ' O ' ' OD1' ' A' ' 207' ' ' ASN . 11.5 p30 -46.45 91.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.863 . . . . 0.0 110.142 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 49.43 24.92 5.74 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.518 ' O ' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -136.89 102.59 4.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.237 -1.155 . . . . 0.0 110.283 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.452 ' O ' HG21 ' A' ' 211' ' ' VAL . 18.4 p30 -99.77 153.81 18.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 110.241 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.452 HG21 ' O ' ' A' ' 210' ' ' ASP . 52.7 t -140.98 147.66 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.179 -0.95 . . . . 0.0 110.208 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -74.97 77.58 2.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 110.176 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 19.6 tp -74.6 169.51 17.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -0.951 . . . . 0.0 110.238 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.505 ' CD1' ' HB2' ' A' ' 217' ' ' LEU . 0.5 OUTLIER -123.53 142.96 50.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.252 -0.905 . . . . 0.0 110.21 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.46 ' OD1' HD11 ' A' ' 153' ' ' ILE . 38.8 t0 -56.7 -44.95 82.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 110.198 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.42 -49.61 13.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 110.204 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.505 ' HB2' ' CD1' ' A' ' 214' ' ' LEU . 1.9 mp -87.21 -17.6 32.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.0 110.225 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . 0.604 ' CB ' ' CG2' ' A' ' 153' ' ' ILE . . . -55.01 -19.03 5.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 110.152 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.415 ' O ' ' C ' ' A' ' 220' ' ' THR . 61.4 t60 -68.96 -52.85 24.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.209 -0.932 . . . . 0.0 110.146 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' THR . . . . . 0.495 ' O ' ' C ' ' A' ' 221' ' ' ILE . 68.9 p -43.0 -78.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.197 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.633 ' CG2' ' CG2' ' A' ' 223' ' ' ILE . 1.6 mp -31.54 117.71 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.55 -0.719 . . . . 0.0 111.935 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 2.4 ttm-85 -100.77 103.7 14.93 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.655 ' CG2' ' CD1' ' A' ' 165' ' ' ILE . 0.1 OUTLIER -119.47 -179.8 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.145 -0.972 . . . . 0.0 111.262 -178.351 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.498 ' N ' HG12 ' A' ' 223' ' ' ILE . 2.5 mm-40 -150.74 168.42 24.45 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.472 ' HA ' HG11 ' A' ' 163' ' ' VAL . 1.3 mp0 -71.97 140.91 49.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.904 . . . . 0.0 110.251 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.412 HD12 ' HG3' ' A' ' 192' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.187 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 N--CA 1.483 0.905 0 N-CA-C 110.426 -0.644 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 80.7 mt -119.06 122.6 29.49 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.237 -0.914 . . . . 0.0 110.204 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.48 -87.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.024 1.539 . . . . 0.0 110.419 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 135' ' ' LEU . . . 137.29 -6.52 3.64 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 134' ' ' GLY . 13.5 mt 57.66 47.15 16.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -1.19 . . . . 0.0 110.184 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 137' ' ' GLU . 9.5 t70 179.48 -85.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.255 -0.903 . . . . 0.0 110.231 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER 59.89 48.79 8.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.313 -0.867 . . . . 0.0 110.224 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.314 -0.866 . . . . 0.0 110.208 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 N--CA 1.483 0.898 0 N-CA-C 110.403 -0.653 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.527 ' CA ' ' HG2' ' A' ' 222' ' ' ARG . . . 167.34 132.31 1.38 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 151' ' ' ARG . 56.6 m -136.85 4.5 2.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -1.166 . . . . 0.0 110.197 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.498 ' HB2' ' HB2' ' A' ' 154' ' ' ASP . 0.3 OUTLIER 59.53 127.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 0.0 110.049 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.539 ' N ' HG12 ' A' ' 223' ' ' ILE . 2.1 p -77.72 12.52 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.252 -0.905 . . . . 0.0 110.79 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.611 ' CG2' ' CB ' ' A' ' 218' ' ' ALA . 18.2 pt -124.58 -24.6 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.011 -1.055 . . . . 0.0 110.421 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 0.6 OUTLIER -71.53 -21.59 61.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.131 -0.981 . . . . 0.0 109.259 179.414 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.81 -16.85 29.3 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.605 -0.684 . . . . 0.0 109.805 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.533 ' HB1' ' CD1' ' A' ' 195' ' ' ILE . . . -64.03 92.55 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.836 . . . . 0.0 110.203 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 156' ' ' ALA . 6.4 t -177.36 171.7 1.95 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.937 . . . . 0.0 110.343 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.515 ' OG ' ' NH1' ' A' ' 161' ' ' ARG . 3.7 p 42.35 73.1 0.14 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.345 -0.847 . . . . 0.0 110.118 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' MET . . . . . 0.505 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 1.6 mtp 68.62 167.45 0.12 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.281 -0.887 . . . . 0.0 110.117 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 45.7 Cg_endo -72.51 101.81 1.32 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.014 1.534 . . . . 0.0 110.381 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.515 ' NH1' ' OG ' ' A' ' 158' ' ' SER . 0.4 OUTLIER -85.41 120.14 26.54 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.291 -0.881 . . . . 0.0 110.207 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.54 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 13.7 mtmt -62.24 87.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 110.205 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.619 ' O ' ' O ' ' A' ' 193' ' ' VAL . 33.8 m -91.96 -166.36 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 110.352 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.64 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -172.61 136.74 0.76 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.841 -1.162 . . . . 0.0 110.41 -179.744 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.601 ' HA ' ' CB ' ' A' ' 223' ' ' ILE . 1.1 mt -93.6 162.36 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.374 -0.829 . . . . 0.0 110.544 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' A' ' 222' ' ' ARG . 6.6 m -136.74 -32.62 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 110.736 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.552 ' CG ' ' HB2' ' A' ' 222' ' ' ARG . 6.3 pt20 -147.04 119.46 8.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.073 -1.017 . . . . 0.0 110.652 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.533 HG13 ' CG2' ' A' ' 221' ' ' ILE . 11.6 tt -110.76 17.82 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 0.0 109.869 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 168' ' ' ILE . 67.0 m-20 -37.84 105.52 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.466 -0.771 . . . . 0.0 110.606 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.424 ' CD ' ' HB2' ' A' ' 172' ' ' PHE . 0.4 OUTLIER -131.02 107.33 9.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 109.954 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 2.0 pp -81.49 11.33 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -0.889 . . . . 0.0 110.525 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.424 ' HB2' ' CD ' ' A' ' 170' ' ' GLU . 1.1 m-85 -64.7 176.37 1.18 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 0.0 110.18 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -77.29 -165.35 0.57 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.276 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.0 p -117.92 32.37 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -0.89 . . . . 0.0 110.212 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' A' ' 176' ' ' THR . 4.6 tp10 -64.13 -143.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.293 -0.88 . . . . 0.0 110.301 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.566 ' OG1' ' CD1' ' A' ' 179' ' ' PHE . 75.2 p 42.64 92.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.281 -0.887 . . . . 0.0 110.139 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.53 -31.25 71.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 110.209 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -72.32 -25.21 61.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.862 . . . . 0.0 110.289 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.578 ' CZ ' HD12 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -85.49 -29.1 24.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.237 -0.914 . . . . 0.0 110.072 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.551 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -58.81 -16.99 19.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.179 -0.951 . . . . 0.0 109.73 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.21 -60.19 2.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.346 -0.846 . . . . 0.0 110.254 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 179' ' ' PHE . 4.4 pp -64.59 -10.53 26.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.88 . . . . 0.0 110.133 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.578 HD12 ' CZ ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -92.57 -32.4 14.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 109.916 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -67.93 -7.27 27.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 0.0 109.883 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -83.54 13.79 4.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.343 -0.848 . . . . 0.0 110.23 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 185' ' ' ALA . 8.9 m-20 42.98 62.98 1.62 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.211 -0.931 . . . . 0.0 110.007 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.3 tt -118.5 -174.57 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.331 -0.856 . . . . 0.0 110.348 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.589 ' O ' ' O ' ' A' ' 189' ' ' VAL . 0.4 OUTLIER -171.41 112.08 0.34 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.346 -0.846 . . . . 0.0 108.908 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.634 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 1.1 m 51.35 109.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.381 -0.824 . . . . 0.0 109.202 -178.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 191' ' ' SER . . . -44.19 -15.68 0.05 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.574 ' N ' ' O ' ' A' ' 189' ' ' VAL . 3.3 t 68.3 -145.06 0.12 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.179 -1.189 . . . . 0.0 109.534 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.64 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 3.8 mm-40 -66.39 102.93 0.93 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.496 -0.752 . . . . 0.0 109.331 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.619 ' O ' ' O ' ' A' ' 163' ' ' VAL . 20.6 m -156.46 -140.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 110.323 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.54 ' CB ' ' HA ' ' A' ' 162' ' ' LYS . 3.1 pt-20 -177.3 139.77 0.27 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.334 -0.854 . . . . 0.0 110.029 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.553 ' HB ' ' HG ' ' A' ' 204' ' ' LEU . 0.0 OUTLIER -130.39 161.19 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.104 -0.998 . . . . 0.0 110.452 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.551 ' N ' HG12 ' A' ' 195' ' ' ILE . 18.2 t -129.71 130.66 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.46 -0.775 . . . . 0.0 110.012 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.479 ' HA ' HG12 ' A' ' 202' ' ' ILE . 7.1 t70 -83.5 137.62 33.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -0.941 . . . . 0.0 110.321 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -130.23 71.34 1.45 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.28 -0.888 . . . . 0.0 110.201 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 198' ' ' ARG . 47.5 t0 42.73 71.39 0.23 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 110.149 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 88.84 -35.81 3.58 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.501 ' O ' ' N ' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -89.87 108.29 19.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.263 -1.139 . . . . 0.0 110.195 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.479 HG12 ' HA ' ' A' ' 197' ' ' ASP . 7.8 mt -112.82 138.63 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 110.296 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.541 ' O ' HG12 ' A' ' 195' ' ' ILE . 31.4 m -126.74 146.06 50.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.346 -0.846 . . . . 0.0 109.832 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.581 HD23 ' CG2' ' A' ' 193' ' ' VAL . 0.2 OUTLIER -119.48 133.16 55.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.086 -1.008 . . . . 0.0 110.387 -179.796 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.582 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 1.2 m -119.96 124.12 45.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.412 -0.805 . . . . 0.0 109.768 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.585 ' CG ' ' O ' ' A' ' 209' ' ' LYS . 2.5 m170 -107.83 100.1 9.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.413 -0.805 . . . . 0.0 110.207 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 207' ' ' ASN . 1.2 p-10 39.02 29.77 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.352 -0.843 . . . . 0.0 110.78 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 123.6 -33.3 3.99 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.585 ' O ' ' CG ' ' A' ' 206' ' ' HIS . 3.6 mmtt -91.86 110.69 22.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.225 -1.162 . . . . 0.0 109.972 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 204' ' ' LEU . 4.1 p30 -109.23 169.7 8.52 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.118 -0.989 . . . . 0.0 110.484 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.418 HG11 ' N ' ' A' ' 212' ' ' GLU . 37.8 t -151.41 146.24 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.326 -0.859 . . . . 0.0 110.128 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 213' ' ' LEU . 2.3 tt0 -75.25 72.61 2.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.285 -0.884 . . . . 0.0 110.221 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 212' ' ' GLU . 1.1 mp -55.19 -165.86 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.891 . . . . 0.0 110.23 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.482 ' O ' ' HB1' ' A' ' 218' ' ' ALA . 0.5 OUTLIER -157.93 136.95 11.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 110.188 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 214' ' ' LEU . 21.7 t0 -41.88 -48.14 4.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -0.901 . . . . 0.0 110.428 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.458 ' HB3' HD13 ' A' ' 214' ' ' LEU . 7.4 t0 -47.84 -52.05 20.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.181 -0.95 . . . . 0.0 110.336 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.475 ' O ' HG22 ' A' ' 221' ' ' ILE . 0.4 OUTLIER -88.46 -32.29 18.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.272 -0.892 . . . . 0.0 110.297 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . 0.611 ' CB ' ' CG2' ' A' ' 153' ' ' ILE . . . -62.99 -26.75 69.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.03 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.565 ' CG ' HD13 ' A' ' 153' ' ' ILE . 1.1 t60 -99.1 29.88 3.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.935 . . . . 0.0 110.11 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 50.6 m -138.41 -33.47 0.67 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.257 -0.902 . . . . 0.0 110.451 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.576 HG12 ' CG2' ' A' ' 223' ' ' ILE . 0.2 OUTLIER -67.35 140.21 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 110.445 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.552 ' HB2' ' CG ' ' A' ' 167' ' ' GLN . 1.4 mtt180 -91.94 113.5 25.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 109.383 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.601 ' CB ' ' HA ' ' A' ' 165' ' ' ILE . 0.7 OUTLIER -127.12 -169.26 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.126 -0.983 . . . . 0.0 110.954 -179.126 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.443 ' HG3' ' N ' ' A' ' 225' ' ' GLU . 3.0 tp10 -148.85 156.92 43.0 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.468 -0.77 . . . . 0.0 109.98 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 1.1 tt0 -104.95 122.68 46.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.296 -0.878 . . . . 0.0 110.221 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.1 tp . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.222 179.935 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo . . . . . 0 N--CA 1.484 0.918 0 N-CA-C 110.473 -0.626 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.1 mt -136.54 106.52 9.18 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.889 . . . . 0.0 110.255 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.23 -0.98 9.91 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.999 1.526 . . . . 0.0 110.461 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -85.43 -170.91 47.67 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.448 HD21 ' O ' ' A' ' 135' ' ' LEU . 0.4 OUTLIER -149.25 -35.03 0.18 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -1.117 . . . . 0.0 110.305 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.45 124.98 36.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 110.312 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -138.2 49.66 1.92 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -0.905 . . . . 0.0 110.197 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 26.6 tp . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 110.322 -179.903 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo . . . . . 0 N--CA 1.483 0.898 0 N-CA-C 110.464 -0.629 . . . . 0.0 110.464 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 145.52 92.68 0.13 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.487 ' O ' ' O ' ' A' ' 151' ' ' ARG . 91.0 m -81.22 -20.91 40.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -1.152 . . . . 0.0 110.202 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.512 ' O ' ' O ' ' A' ' 152' ' ' VAL . 11.4 mtt85 59.92 132.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.34 -0.85 . . . . 0.0 110.043 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.697 ' O ' ' CG1' ' A' ' 153' ' ' ILE . 37.6 t -51.35 -174.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.239 -0.913 . . . . 0.0 109.369 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.697 ' CG1' ' O ' ' A' ' 152' ' ' VAL . 1.0 OUTLIER 52.44 15.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.143 -0.973 . . . . 0.0 110.209 -179.589 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.464 ' HB3' HG21 ' A' ' 150' ' ' THR . 1.2 t0 -130.4 -31.21 1.85 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.357 -0.839 . . . . 0.0 109.419 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.533 ' CB ' HG13 ' A' ' 163' ' ' VAL . . . -84.64 -18.85 34.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.514 -0.741 . . . . 0.0 109.814 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.34 136.02 56.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.343 -0.848 . . . . 0.0 110.039 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.515 ' O ' ' CB ' ' A' ' 158' ' ' SER . 7.9 m -160.88 87.16 0.73 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.112 -0.992 . . . . 0.0 110.359 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 157' ' ' THR . 2.1 t 70.11 -53.17 0.63 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.305 -0.872 . . . . 0.0 110.058 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' MET . . . . . 0.472 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 59.0 mtp -108.98 168.01 8.33 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 121.327 -0.858 . . . . 0.0 110.056 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.472 ' HB2' ' OE2' ' A' ' 194' ' ' GLU . 46.2 Cg_endo -72.63 65.86 3.83 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.952 1.501 . . . . 0.0 110.427 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -44.0 109.66 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 110.234 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.496 ' HA ' ' CG ' ' A' ' 194' ' ' GLU . 5.6 tttm -58.1 132.15 52.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.905 . . . . 0.0 110.255 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.546 ' O ' ' O ' ' A' ' 193' ' ' VAL . 16.0 m -150.24 -159.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 110.498 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.604 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.1 OUTLIER -173.81 150.86 1.73 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.936 -1.103 . . . . 0.0 110.347 -179.633 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.64 ' CD1' HG23 ' A' ' 223' ' ' ILE . 2.0 mm -88.92 148.42 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.34 -0.85 . . . . 0.0 110.297 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 222' ' ' ARG . 22.6 m -136.47 5.34 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.888 . . . . 0.0 109.814 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.46 ' HB3' ' HB3' ' A' ' 222' ' ' ARG . 1.7 tm0? -171.77 121.17 0.48 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.898 . . . . 0.0 109.867 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.539 ' HB ' ' CG1' ' A' ' 189' ' ' VAL . 0.3 OUTLIER -93.74 -2.31 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.0 110.33 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 49.78 -137.07 1.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.168 -0.958 . . . . 0.0 110.022 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -117.87 108.23 15.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.956 . . . . 0.0 110.198 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 172' ' ' PHE . 1.0 OUTLIER -60.49 -13.84 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.164 -0.96 . . . . 0.0 110.105 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.443 ' N ' HG13 ' A' ' 171' ' ' ILE . 0.5 OUTLIER -75.69 82.93 2.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 110.127 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -110.58 -89.63 0.49 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 110.198 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.469 ' CG1' ' N ' ' A' ' 175' ' ' GLU . 37.5 t -128.47 -91.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.906 . . . . 0.0 110.233 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.469 ' N ' ' CG1' ' A' ' 174' ' ' VAL . 2.8 mt-10 -94.1 -172.14 2.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 0.0 110.198 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.556 HG22 ' CD2' ' A' ' 179' ' ' PHE . 20.0 m -136.04 -65.36 0.58 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.287 -0.883 . . . . 0.0 110.217 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.516 ' HB2' ' O ' ' A' ' 176' ' ' THR . 5.6 m-20 70.57 -153.43 0.11 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.455 -0.778 . . . . 0.0 110.359 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' A' ' 181' ' ' GLN . 18.6 tt0 -45.42 -25.68 0.45 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.278 -0.889 . . . . 0.0 110.607 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.599 ' CE1' ' HB2' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -42.39 -54.64 3.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.208 -0.932 . . . . 0.0 110.026 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.535 HG21 ' CG2' ' A' ' 176' ' ' THR . 0.0 OUTLIER -47.84 -23.42 0.74 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.054 -1.029 . . . . 0.0 109.836 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 178' ' ' GLN . 34.5 tt0 -71.98 -62.0 1.58 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 110.199 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 179' ' ' PHE . 4.6 pp -65.33 -9.3 23.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.346 -0.846 . . . . 0.0 109.892 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.599 ' HB2' ' CE1' ' A' ' 179' ' ' PHE . 3.4 tm? -92.25 -31.67 15.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.876 . . . . 0.0 109.851 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -70.25 -5.81 30.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.42 -0.8 . . . . 0.0 110.008 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -88.11 29.35 0.95 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -0.906 . . . . 0.0 110.235 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 186' ' ' ASP . 1.8 m-20 52.48 36.23 19.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.214 -0.929 . . . . 0.0 110.208 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 16.3 mm -93.47 156.6 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 110.185 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.589 ' O ' ' C ' ' A' ' 189' ' ' VAL . 2.5 ptm180 -170.83 130.32 0.81 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.863 ' O ' ' N ' ' A' ' 191' ' ' SER . 34.3 m 33.75 69.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.212 -0.93 . . . . 0.0 109.008 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 189' ' ' VAL . . . -20.93 -32.2 0.0 OUTLIER Glycine 0 N--CA 1.498 2.785 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.863 ' N ' ' O ' ' A' ' 189' ' ' VAL . 3.4 t 70.86 -143.54 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -1.142 . . . . 0.0 109.831 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.604 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.8 OUTLIER -61.36 102.48 0.23 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.416 -0.803 . . . . 0.0 109.796 179.741 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.546 ' O ' ' O ' ' A' ' 163' ' ' VAL . 20.3 m -156.32 -142.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.126 -0.984 . . . . 0.0 110.246 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.496 ' CG ' ' HA ' ' A' ' 162' ' ' LYS . 21.6 tt0 -175.95 161.21 2.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 110.218 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.547 ' CG2' ' HG ' ' A' ' 204' ' ' LEU . 0.7 OUTLIER -123.48 172.15 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.128 -0.983 . . . . 0.0 110.279 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.519 ' CG1' ' HB ' ' A' ' 203' ' ' THR . 14.8 p -146.59 102.13 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 110.158 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 197' ' ' ASP . 5.1 p-10 -42.35 113.94 0.51 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.266 -0.896 . . . . 0.0 110.193 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.463 ' N ' ' O ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -100.55 160.6 14.22 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.252 -0.905 . . . . 0.0 110.304 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -55.73 91.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.253 -0.904 . . . . 0.0 110.064 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 198' ' ' ARG . . . 76.76 12.4 84.53 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.463 ' O ' ' N ' ' A' ' 198' ' ' ARG . 0.0 OUTLIER -150.13 179.88 7.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.169 -1.195 . . . . 0.0 110.179 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' ' 153' ' ' ILE . 42.5 mt -144.79 133.68 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.921 . . . . 0.0 110.308 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.519 ' HB ' ' CG1' ' A' ' 196' ' ' VAL . 0.2 OUTLIER -113.83 152.86 30.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 110.026 179.794 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.547 ' HG ' ' CG2' ' A' ' 195' ' ' ILE . 1.1 tt -119.72 137.25 54.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 110.294 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.531 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 3.0 t -119.78 128.14 53.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.356 -0.84 . . . . 0.0 109.865 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.53 ' O ' ' N ' ' A' ' 208' ' ' GLY . 1.3 m80 -112.72 125.68 54.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.387 -0.82 . . . . 0.0 110.013 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 206' ' ' HIS . 2.0 t-20 42.82 -93.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.216 -0.927 . . . . 0.0 110.224 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -126.28 19.1 6.42 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.13 129.27 39.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -1.138 . . . . 0.0 110.258 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 7.9 t70 -117.94 156.78 27.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.296 -0.878 . . . . 0.0 110.22 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.421 ' N ' ' OD1' ' A' ' 210' ' ' ASP . 5.5 p -149.43 162.23 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.251 -0.905 . . . . 0.0 110.201 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -65.01 156.4 31.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 110.126 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.507 HD22 ' CB ' ' A' ' 218' ' ' ALA . 0.7 OUTLIER -156.48 88.76 1.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.232 -0.917 . . . . 0.0 110.202 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.494 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 14.5 tp -41.34 113.74 0.43 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.235 -0.916 . . . . 0.0 110.244 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.498 ' O ' ' HB1' ' A' ' 218' ' ' ALA . 8.2 t0 -60.18 -43.17 96.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.325 -0.859 . . . . 0.0 110.428 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 215' ' ' ASP . 55.9 t0 -43.07 -67.37 0.28 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.131 -0.981 . . . . 0.0 110.177 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.28 -13.54 56.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.259 -0.901 . . . . 0.0 110.531 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . 0.539 ' HB2' ' CG2' ' A' ' 153' ' ' ILE . . . -45.01 -26.43 0.43 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.148 -0.97 . . . . 0.0 110.1 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.599 ' CG ' HD13 ' A' ' 153' ' ' ILE . 0.7 OUTLIER -78.95 64.63 3.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.268 -0.895 . . . . 0.0 110.182 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' THR . . . . . 0.481 HG22 HD11 ' A' ' 221' ' ' ILE . 0.5 OUTLIER -129.25 -22.89 3.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -0.973 . . . . 0.0 110.467 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.556 ' CG1' HG22 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -99.78 145.95 9.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.09 -1.006 . . . . 0.0 110.57 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.527 ' O ' ' CG2' ' A' ' 166' ' ' VAL . 0.3 OUTLIER -88.81 96.35 10.65 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.323 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.64 HG23 ' CD1' ' A' ' 165' ' ' ILE . 0.5 OUTLIER -119.64 173.16 5.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.304 -0.873 . . . . 0.0 111.419 -177.492 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.481 ' HA ' ' HB ' ' A' ' 150' ' ' THR . 0.6 OUTLIER -145.9 -172.87 4.01 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.5 -0.75 . . . . 0.0 110.181 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 8.4 tt0 -112.08 127.14 55.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.377 -0.827 . . . . 0.0 110.201 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.418 HD21 ' OXT' ' A' ' 226' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.231 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 N--CA 1.483 0.904 0 N-CA-C 110.465 -0.629 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 28.2 mm -72.96 124.07 90.3 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 110.218 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.11 96.02 0.86 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.917 1.483 . . . . 0.0 110.431 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -178.31 85.72 0.07 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -166.66 95.97 0.54 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.326 -1.102 . . . . 0.0 110.144 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -88.88 60.21 5.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 0.0 110.21 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 40.4 mt-10 63.08 -71.17 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.0 110.4 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 136' ' ' ASP . 14.8 tp . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.319 -0.863 . . . . 0.0 110.238 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo . . . . . 0 N--CA 1.484 0.915 0 N-CA-C 110.694 -0.541 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.578 ' O ' ' HB ' ' A' ' 150' ' ' THR . . . 95.23 -74.26 0.91 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.578 ' HB ' ' O ' ' A' ' 149' ' ' GLY . 22.2 m 65.89 -121.54 0.34 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.345 -1.091 . . . . 0.0 109.889 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.529 ' CD ' ' O ' ' A' ' 150' ' ' THR . 1.5 mmt180 -143.41 157.62 44.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.961 -1.087 . . . . 0.0 109.989 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.542 ' CG2' HD11 ' A' ' 195' ' ' ILE . 0.6 OUTLIER -69.3 -3.94 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.157 -0.964 . . . . 0.0 110.479 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.607 ' CG2' ' CB ' ' A' ' 218' ' ' ALA . 1.6 pp -117.65 -30.9 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.098 -1.001 . . . . 0.0 110.335 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.513 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -74.88 -13.25 60.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -0.967 . . . . 0.0 109.214 179.346 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -113.04 -7.34 13.68 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.562 -0.711 . . . . 0.0 109.72 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.529 ' CB ' HD13 ' A' ' 195' ' ' ILE . . . -85.0 177.21 8.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.335 -0.853 . . . . 0.0 110.194 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.527 ' O ' ' CB ' ' A' ' 158' ' ' SER . 0.4 OUTLIER 56.88 153.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.347 -0.846 . . . . 0.0 110.185 179.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 157' ' ' THR . 0.7 OUTLIER 70.69 -51.5 0.67 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.181 -0.95 . . . . 0.0 110.157 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' MET . . . . . 0.454 ' N ' ' CD ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER -161.86 55.3 0.57 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.851 . . . . 0.0 109.883 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.526 ' HB3' ' HA ' ' A' ' 156' ' ' ALA . 43.6 Cg_endo -72.66 -67.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.092 1.575 . . . . 0.0 110.565 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.415 ' CB ' ' O ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER 64.23 -153.97 0.3 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.908 . . . . 0.0 110.228 179.833 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.433 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -86.92 90.37 8.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.21 -0.931 . . . . 0.0 110.553 -179.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.593 ' O ' ' O ' ' A' ' 193' ' ' VAL . 0.1 OUTLIER -92.46 -169.44 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.226 -0.921 . . . . 0.0 109.909 179.542 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.587 ' C ' ' HB ' ' A' ' 223' ' ' ILE . 0.3 OUTLIER -167.07 137.96 3.13 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.712 -1.243 . . . . 0.0 110.286 -179.578 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.562 ' CG2' ' HB ' ' A' ' 221' ' ' ILE . 0.2 OUTLIER -85.37 133.46 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.318 -0.864 . . . . 0.0 110.284 -179.59 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.497 HG21 ' O ' ' A' ' 222' ' ' ARG . 15.5 m -119.92 -23.09 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.235 -0.916 . . . . 0.0 110.7 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -148.97 125.6 11.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.032 -1.043 . . . . 0.0 110.531 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 221' ' ' ILE . 5.1 tt -108.62 6.78 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.348 -0.845 . . . . 0.0 110.03 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 168' ' ' ILE . 3.0 t-20 -43.35 98.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.348 -0.845 . . . . 0.0 110.347 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.485 ' CG ' ' HB2' ' A' ' 172' ' ' PHE . 1.0 OUTLIER -157.9 116.06 3.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -0.929 . . . . 0.0 110.185 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 172' ' ' PHE . 1.6 pp -83.26 10.33 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.341 -0.85 . . . . 0.0 110.196 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.485 ' HB2' ' CG ' ' A' ' 170' ' ' GLU . 0.1 OUTLIER -60.09 -148.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.285 -0.885 . . . . 0.0 110.147 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . 0.457 ' O ' ' HB ' ' A' ' 174' ' ' VAL . 11.7 tt0 53.86 174.37 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 110.07 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 173' ' ' GLN . 1.6 p 175.44 -26.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 110.249 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.467 ' O ' ' HB ' ' A' ' 176' ' ' THR . 0.0 OUTLIER -172.58 129.54 0.54 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.908 . . . . 0.0 110.329 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 175' ' ' GLU . 1.7 t 177.36 99.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.337 -0.852 . . . . 0.0 110.172 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.55 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.5 OUTLIER -75.8 -28.25 58.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.291 -0.88 . . . . 0.0 110.307 -179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -17.51 64.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.105 -0.997 . . . . 0.0 109.972 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.653 ' HA ' HD13 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -90.28 -39.39 12.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 110.683 -179.827 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.55 ' OG1' ' O ' ' A' ' 177' ' ' ASP . 0.2 OUTLIER -41.19 -26.09 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.13 -0.981 . . . . 0.0 110.05 -179.568 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.5 ' NE2' ' OE2' ' A' ' 212' ' ' GLU . 0.6 OUTLIER -53.4 -45.09 69.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.183 -0.948 . . . . 0.0 109.515 179.303 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.653 HD13 ' HA ' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -69.84 -34.76 74.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.403 -0.811 . . . . 0.0 108.973 179.083 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.432 HD11 ' C ' ' A' ' 183' ' ' LEU . 0.2 OUTLIER -66.05 -33.73 76.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.592 -0.692 . . . . 0.0 109.786 179.609 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -57.87 -16.16 10.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.409 -0.807 . . . . 0.0 109.87 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -92.83 12.61 23.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.438 -0.789 . . . . 0.0 110.252 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 185' ' ' ALA . 22.0 t70 43.8 85.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.732 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.2 tt -135.56 177.1 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 110.824 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.581 ' O ' ' O ' ' A' ' 189' ' ' VAL . 4.2 ttp180 -174.64 114.41 0.17 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.719 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 1.1 m 46.66 98.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.174 -0.954 . . . . 0.0 108.546 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.517 ' O ' ' CG1' ' A' ' 193' ' ' VAL . . . -40.44 -18.19 0.01 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.627 ' N ' ' O ' ' A' ' 189' ' ' VAL . 5.7 t 64.65 -141.95 0.25 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.037 -1.272 . . . . 0.0 109.213 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.576 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 4.9 pm0 -61.57 99.69 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.507 -0.746 . . . . 0.0 109.3 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.593 ' O ' ' O ' ' A' ' 163' ' ' VAL . 13.1 m -155.07 -139.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.083 -1.01 . . . . 0.0 109.98 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.475 ' HA ' HG22 ' A' ' 163' ' ' VAL . 3.4 pt-20 -173.26 158.69 3.65 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.3 -0.875 . . . . 0.0 110.564 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.542 HD11 ' CG2' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -131.09 162.97 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.28 -0.888 . . . . 0.0 110.275 -179.719 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' A' ' 195' ' ' ILE . 77.7 t -157.28 100.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.249 -0.907 . . . . 0.0 110.12 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.524 ' CB ' ' OG1' ' A' ' 157' ' ' THR . 16.1 t0 -42.91 109.64 0.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.903 . . . . 0.0 110.258 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.521 ' CB ' ' O ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -97.11 81.17 3.02 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.307 -0.871 . . . . 0.0 110.129 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 49.3 57.73 6.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 110.101 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 89.26 -25.96 9.66 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.521 ' O ' ' CB ' ' A' ' 198' ' ' ARG . 2.7 t60 -98.72 95.0 6.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -1.143 . . . . 0.0 110.163 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.517 HD12 ' CG2' ' A' ' 153' ' ' ILE . 83.8 mt -64.56 115.85 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.341 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 195' ' ' ILE . 28.8 m -94.48 147.19 23.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.151 -0.968 . . . . 0.0 110.065 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.593 HD21 ' CD2' ' A' ' 206' ' ' HIS . 1.2 tt -119.71 129.34 54.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.227 -0.92 . . . . 0.0 110.128 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.55 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.0 OUTLIER -120.02 122.84 42.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.296 -0.877 . . . . 0.0 110.015 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.593 ' CD2' HD21 ' A' ' 204' ' ' LEU . 0.1 OUTLIER -106.91 154.5 20.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.534 -0.729 . . . . 0.0 109.89 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -50.66 -19.83 1.04 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.947 . . . . 0.0 109.955 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.47 ' O ' ' HD3' ' A' ' 209' ' ' LYS . . . -87.38 -32.76 12.88 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.47 ' HD3' ' O ' ' A' ' 208' ' ' GLY . 0.0 OUTLIER 176.77 -152.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.159 -1.2 . . . . 0.0 110.29 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 204' ' ' LEU . 36.7 t70 -137.73 156.29 48.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.324 -0.86 . . . . 0.0 110.174 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.92 173.39 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.218 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.5 ' OE2' ' NE2' ' A' ' 181' ' ' GLN . 13.2 pt-20 -91.33 162.32 14.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 110.337 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.514 HD13 ' CD1' ' A' ' 204' ' ' LEU . 0.3 OUTLIER -147.88 153.21 38.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 110.177 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.472 ' N ' ' CD2' ' A' ' 214' ' ' LEU . 0.4 OUTLIER -120.08 129.52 54.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.263 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 214' ' ' LEU . 1.5 m-20 -43.31 -29.33 0.4 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 110.195 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -56.06 -59.17 5.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 110.119 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.62 ' CD2' ' CD1' ' A' ' 179' ' ' PHE . 1.0 OUTLIER -90.12 -24.68 21.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 110.314 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . 0.607 ' CB ' ' CG2' ' A' ' 153' ' ' ILE . . . -52.19 -42.47 63.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.194 -0.941 . . . . 0.0 110.158 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.565 ' O ' ' CG ' ' A' ' 219' ' ' HIS . 69.2 t60 -84.03 58.84 4.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.893 . . . . 0.0 110.194 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 217' ' ' LEU . 30.6 p -145.02 -31.63 0.41 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 110.621 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.562 ' HB ' ' CG2' ' A' ' 165' ' ' ILE . 0.1 OUTLIER -90.97 141.05 14.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.175 -0.953 . . . . 0.0 110.456 -179.799 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.497 ' O ' HG21 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -92.6 111.33 22.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.379 -0.826 . . . . 0.0 109.793 179.778 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.587 ' HB ' ' C ' ' A' ' 164' ' ' ARG . 0.1 OUTLIER -121.23 166.22 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.167 -0.958 . . . . 0.0 110.108 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.428 ' C ' HG13 ' A' ' 163' ' ' VAL . 1.2 tt0 -137.08 161.38 36.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.121 -0.987 . . . . 0.0 110.553 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 22.1 mm-40 -72.26 137.18 46.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.422 -0.799 . . . . 0.0 110.222 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.213 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 N--CA 1.483 0.89 0 N-CA-C 110.31 -0.688 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.47 ' CG2' ' O ' ' A' ' 132' ' ' ILE . 16.9 tt -163.51 107.34 0.97 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.29 -0.881 . . . . 0.0 110.124 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.44 -26.62 16.82 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.009 1.531 . . . . 0.0 110.423 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.28 58.1 1.53 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.45 -76.71 0.55 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -1.153 . . . . 0.0 110.271 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 40.0 p-10 -87.06 33.98 0.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.347 -0.846 . . . . 0.0 110.323 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 136' ' ' ASP . 0.0 OUTLIER 42.87 54.03 4.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.912 . . . . 0.0 110.131 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.469 ' CD2' ' O ' ' A' ' 138' ' ' LEU . 1.6 tt . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 0.0 110.237 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 N--CA 1.484 0.964 0 N-CA-C 110.441 -0.638 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -170.91 167.79 40.94 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.544 ' O ' ' CD1' ' A' ' 223' ' ' ILE . 8.1 m -144.72 100.59 3.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -1.158 . . . . 0.0 109.978 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.694 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -37.09 150.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.873 . . . . 0.0 110.555 -179.8 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.774 ' HA ' HD13 ' A' ' 223' ' ' ILE . 17.7 m -54.88 -150.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.229 -0.919 . . . . 0.0 110.379 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.607 ' CG2' ' CB ' ' A' ' 218' ' ' ALA . 11.2 pt 40.22 27.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.23 -0.919 . . . . 0.0 110.042 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -144.0 -37.32 0.33 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.522 -0.736 . . . . 0.0 109.383 179.639 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -98.27 -9.67 25.16 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.541 -0.724 . . . . 0.0 109.741 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.408 ' O ' ' HB ' ' A' ' 157' ' ' THR . . . -74.05 175.37 7.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.328 -0.857 . . . . 0.0 110.201 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.509 HG23 ' CG ' ' A' ' 161' ' ' ARG . 5.7 t -177.09 178.41 1.13 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.258 -0.901 . . . . 0.0 110.127 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 157' ' ' THR . 21.1 t -42.83 -61.1 1.35 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.901 . . . . 0.0 110.131 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' MET . . . . . 0.48 ' HB2' ' HD2' ' A' ' 160' ' ' PRO . 0.0 OUTLIER -71.01 165.01 51.69 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.898 . . . . 0.0 110.034 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 159' ' ' MET . 45.7 Cg_endo -72.6 66.99 3.78 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.944 1.497 . . . . 0.0 110.353 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.509 ' CG ' HG23 ' A' ' 157' ' ' THR . 0.0 OUTLIER -47.86 125.64 9.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.254 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.458 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 1.2 tttp -77.3 100.37 5.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -0.909 . . . . 0.0 110.274 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.521 HG22 ' HA ' ' A' ' 194' ' ' GLU . 0.1 OUTLIER -117.41 -164.01 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 0.0 110.301 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.658 ' O ' ' HB ' ' A' ' 223' ' ' ILE . 23.7 ttt180 -172.33 157.82 4.22 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.911 -1.118 . . . . 0.0 110.265 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.689 ' HB ' HG21 ' A' ' 189' ' ' VAL . 0.8 OUTLIER -110.49 151.36 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.651 -179.359 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.0 m -133.04 -5.05 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.299 -0.876 . . . . 0.0 110.775 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -174.06 131.13 0.4 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.914 -1.116 . . . . 0.0 110.96 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.575 ' CG2' HG12 ' A' ' 189' ' ' VAL . 9.0 tt -126.23 10.03 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.451 -0.781 . . . . 0.0 109.598 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.472 ' O ' ' HB3' ' A' ' 170' ' ' GLU . 1.5 t-20 -56.09 83.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.373 -0.829 . . . . 0.0 110.356 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.519 ' O ' ' C ' ' A' ' 171' ' ' ILE . 0.7 OUTLIER -179.98 -173.76 0.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.363 -0.836 . . . . 0.0 109.934 179.84 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.519 ' C ' ' O ' ' A' ' 170' ' ' GLU . 2.1 mm 33.15 36.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.409 -0.807 . . . . 0.0 110.408 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' A' ' 170' ' ' GLU . 0.2 OUTLIER -67.09 -38.9 86.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.914 . . . . 0.0 110.41 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . 0.578 ' O ' ' CB ' ' A' ' 174' ' ' VAL . 0.0 OUTLIER -78.76 -156.62 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.878 . . . . 0.0 110.353 -179.741 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.578 ' CB ' ' O ' ' A' ' 173' ' ' GLN . 2.9 t 76.58 -29.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.601 -0.687 . . . . 0.0 110.876 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.481 ' O ' ' O ' ' A' ' 174' ' ' VAL . 46.2 tt0 55.19 161.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.041 -1.037 . . . . 0.0 110.278 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.569 ' CG2' ' HB3' ' A' ' 179' ' ' PHE . 1.9 m -166.37 113.43 0.86 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.193 -0.942 . . . . 0.0 110.257 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.541 ' O ' ' OG1' ' A' ' 180' ' ' THR . 12.3 m-20 -76.86 -30.39 56.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.124 -0.985 . . . . 0.0 110.443 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.81 -17.53 55.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.097 -1.002 . . . . 0.0 110.449 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.6 ' C ' ' CD1' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -90.29 -15.23 31.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.14 -0.975 . . . . 0.0 110.392 -179.667 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.541 ' OG1' ' O ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -61.73 -20.63 63.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.002 -1.061 . . . . 0.0 109.891 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -71.41 -63.05 1.19 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.857 . . . . 0.0 109.899 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 179' ' ' PHE . 0.7 OUTLIER -61.71 -14.31 30.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.659 179.643 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.565 HD11 ' CZ ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -83.13 -29.94 28.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.868 . . . . 0.0 109.878 179.653 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.97 -12.06 34.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 110.018 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.54 ' CB ' HG23 ' A' ' 187' ' ' ILE . . . -85.88 19.09 2.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 0.0 110.199 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 185' ' ' ALA . 0.2 OUTLIER 41.69 29.6 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.0 109.516 -179.61 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.693 ' O ' ' HB3' ' A' ' 188' ' ' ARG . 1.5 tt -116.4 149.33 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.505 -0.747 . . . . 0.0 110.409 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.757 ' O ' ' O ' ' A' ' 189' ' ' VAL . 0.0 OUTLIER 164.91 108.91 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.757 ' O ' ' O ' ' A' ' 188' ' ' ARG . 6.1 p 38.45 175.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 121.589 0.709 . . . . 0.0 110.93 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.512 ' N ' ' CG2' ' A' ' 189' ' ' VAL . . . 107.41 -7.06 36.66 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.3 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.562 ' O ' ' HG3' ' A' ' 164' ' ' ARG . 0.5 OUTLIER -159.62 -177.35 6.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.859 -1.377 . . . . 0.0 111.74 -179.515 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.612 ' HA ' ' HG3' ' A' ' 164' ' ' ARG . 38.8 tt0 -67.39 137.87 56.28 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.753 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.632 ' CG1' ' CD2' ' A' ' 206' ' ' HIS . 2.0 m -161.16 134.62 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.291 -0.881 . . . . 0.0 109.467 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 204' ' ' LEU . 0.1 OUTLIER -102.68 156.84 17.36 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.309 179.51 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' A' ' 203' ' ' THR . 1.2 mt -118.74 153.1 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.936 -1.102 . . . . 0.0 110.683 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.406 ' O ' ' C ' ' A' ' 197' ' ' ASP . 55.8 t -132.16 91.47 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.513 -0.742 . . . . 0.0 110.31 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.467 ' HA ' HG12 ' A' ' 202' ' ' ILE . 33.3 m-20 -43.45 137.07 2.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.22 -0.925 . . . . 0.0 110.125 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.444 ' HB2' ' HB3' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -128.25 71.87 1.4 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.261 -0.899 . . . . 0.0 110.265 -180.0 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 198' ' ' ARG . 0.3 OUTLIER 42.07 75.05 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.251 -0.905 . . . . 0.0 110.223 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 87.92 -36.81 3.32 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -90.55 165.58 13.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.178 -1.19 . . . . 0.0 110.17 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.467 HG12 ' HA ' ' A' ' 197' ' ' ASP . 9.1 mt -153.77 149.61 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.205 -0.935 . . . . 0.0 110.395 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 195' ' ' ILE . 85.8 m -146.2 159.44 43.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.398 -0.813 . . . . 0.0 109.541 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.562 ' HA ' ' O ' ' A' ' 194' ' ' GLU . 0.7 OUTLIER -119.37 157.33 28.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.934 . . . . 0.0 110.602 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.549 ' N ' ' O ' ' A' ' 194' ' ' GLU . 0.1 OUTLIER -124.54 95.07 4.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.528 -0.732 . . . . 0.0 109.429 179.429 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.632 ' CD2' ' CG1' ' A' ' 193' ' ' VAL . 40.6 m80 -76.36 74.11 3.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.448 -0.782 . . . . 0.0 110.382 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 206' ' ' HIS . 7.1 t-20 42.54 67.52 0.59 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -0.95 . . . . 0.0 110.278 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 99.17 -38.5 3.07 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.491 ' O ' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -95.71 97.11 9.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.287 -1.125 . . . . 0.0 110.23 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 204' ' ' LEU . 0.5 OUTLIER -102.07 153.62 19.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 110.295 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.514 ' CG2' HG22 ' A' ' 187' ' ' ILE . 1.0 OUTLIER -143.52 149.98 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.309 -0.869 . . . . 0.0 109.881 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.402 ' HA ' HG22 ' A' ' 203' ' ' THR . 2.5 tt0 -58.44 -174.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 110.199 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.583 ' O ' ' HG ' ' A' ' 214' ' ' LEU . 0.3 OUTLIER -174.47 -28.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.253 -0.905 . . . . 0.0 110.271 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 213' ' ' LEU . 0.5 OUTLIER 33.04 -151.05 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.477 -0.764 . . . . 0.0 110.728 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.485 ' HA ' ' HB1' ' A' ' 218' ' ' ALA . 3.1 m-20 -90.49 -61.28 1.71 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.362 -0.836 . . . . 0.0 110.497 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 215' ' ' ASP . 0.1 OUTLIER -41.48 -52.65 3.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 110.505 -179.686 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.556 ' CD1' ' HB2' ' A' ' 179' ' ' PHE . 0.5 OUTLIER -79.36 -27.76 41.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.18 -0.95 . . . . 0.0 110.261 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . 0.607 ' CB ' ' CG2' ' A' ' 153' ' ' ILE . . . -43.36 -77.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 110.498 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.512 ' HB2' ' CD1' ' A' ' 153' ' ' ILE . 47.4 t-80 -65.88 89.7 0.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.347 -0.846 . . . . 0.0 110.386 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' THR . . . . . 0.453 ' O ' ' OE2' ' A' ' 170' ' ' GLU . 8.1 m -161.23 -63.85 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.825 . . . . 0.0 110.096 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.694 ' O ' ' HA ' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -76.18 139.66 18.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.513 -0.742 . . . . 0.0 110.781 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -90.03 106.55 18.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.385 -0.822 . . . . 0.0 109.29 179.202 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.774 HD13 ' HA ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER -121.48 173.35 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.135 -0.978 . . . . 0.0 110.698 -178.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.517 ' O ' ' CG1' ' A' ' 163' ' ' VAL . 3.5 mt-10 -150.28 -170.25 3.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.355 -0.841 . . . . 0.0 110.165 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.469 ' HA ' HG11 ' A' ' 163' ' ' VAL . 10.0 tm-20 -104.98 112.27 25.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.261 -0.899 . . . . 0.0 110.18 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 19.9 tp . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.209 179.961 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 132' ' ' ILE . 45.3 Cg_endo . . . . . 0 N--CA 1.483 0.896 0 N-CA-C 110.529 -0.604 . . . . 0.0 110.529 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' A' ' 131' ' ' PRO . 14.7 mt 41.31 94.64 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.337 -0.852 . . . . 0.0 110.388 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.61 -21.88 21.57 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.074 1.565 . . . . 0.0 110.466 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 135.47 -103.22 0.45 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.8 mm? 49.02 -163.52 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -1.136 . . . . 0.0 110.29 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -118.67 76.5 1.1 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 110.236 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 137' ' ' GLU . 2.8 pt-20 -126.49 90.03 3.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.919 . . . . 0.0 110.199 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mt . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.2 -0.938 . . . . 0.0 110.165 179.998 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 149' ' ' GLY . 46.2 Cg_endo . . . . . 0 N--CA 1.483 0.896 0 N-CA-C 110.608 -0.574 . . . . 0.0 110.608 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 148' ' ' PRO . . . 58.57 149.26 0.01 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.574 ' N ' ' O ' ' A' ' 223' ' ' ILE . 58.6 m -97.97 140.0 32.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.252 -1.146 . . . . 0.0 109.95 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 0.7 OUTLIER -76.53 131.57 39.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.902 -1.123 . . . . 0.0 110.058 179.84 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.665 ' O ' HG12 ' A' ' 153' ' ' ILE . 32.8 t -40.87 161.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.271 -0.893 . . . . 0.0 109.974 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.665 HG12 ' O ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER 75.01 -15.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.583 -0.698 . . . . 0.0 110.292 -179.025 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 151' ' ' ARG . 0.3 OUTLIER -103.44 -15.0 16.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.104 -0.998 . . . . 0.0 109.265 179.24 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.425 ' HB2' HG13 ' A' ' 163' ' ' VAL . . . -111.99 -11.98 13.79 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.522 -0.736 . . . . 0.0 109.879 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -76.27 128.51 35.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 110.259 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.484 HG22 ' NH1' ' A' ' 161' ' ' ARG . 0.2 OUTLIER -102.32 176.81 5.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.15 -0.969 . . . . 0.0 110.259 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.54 -59.82 2.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.925 . . . . 0.0 110.21 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' MET . . . . . 0.412 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 1.8 mpt? -75.11 166.3 46.62 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.898 . . . . 0.0 110.193 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 161' ' ' ARG . 45.8 Cg_endo -72.78 78.6 2.07 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.055 1.555 . . . . 0.0 110.437 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.484 ' NH1' HG22 ' A' ' 157' ' ' THR . 0.4 OUTLIER -60.35 -141.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 110.202 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.86 87.45 1.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.21 -0.931 . . . . 0.0 110.322 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.623 ' O ' ' O ' ' A' ' 193' ' ' VAL . 12.3 m -112.7 -162.43 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.311 -0.868 . . . . 0.0 110.221 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.641 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -169.79 151.81 4.32 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.808 -1.183 . . . . 0.0 110.985 -179.315 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.586 ' CG2' ' CG2' ' A' ' 223' ' ' ILE . 2.1 mt -100.65 154.0 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.361 -0.837 . . . . 0.0 109.97 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.53 ' CG1' ' HD2' ' A' ' 164' ' ' ARG . 31.4 m -133.91 -30.1 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.048 -1.033 . . . . 0.0 111.12 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.531 ' N ' HG13 ' A' ' 189' ' ' VAL . 2.0 mt-30 -149.45 128.91 13.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.09 -1.006 . . . . 0.0 110.704 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 221' ' ' ILE . 10.5 mt -83.36 -10.05 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.384 -0.822 . . . . 0.0 109.686 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.551 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 1.6 t30 70.36 2.38 4.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.375 -0.828 . . . . 0.0 110.342 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 44.09 62.53 1.94 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 110.394 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.551 ' CG1' ' HB3' ' A' ' 169' ' ' ASN . 13.9 mm -102.15 17.9 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 0.0 110.075 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.435 ' C ' ' O ' ' A' ' 171' ' ' ILE . 56.7 t80 -41.76 113.31 0.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.345 -0.847 . . . . 0.0 110.29 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -141.82 -32.58 0.52 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.312 -0.867 . . . . 0.0 110.378 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.457 ' O ' ' C ' ' A' ' 175' ' ' GLU . 48.7 t -127.6 75.73 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 110.101 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 174' ' ' VAL . 43.3 tt0 -39.3 157.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.429 -0.795 . . . . 0.0 110.429 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.641 ' OG1' ' CD1' ' A' ' 179' ' ' PHE . 1.0 OUTLIER -136.36 135.91 39.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.313 -0.867 . . . . 0.0 110.145 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.591 ' O ' ' OG1' ' A' ' 180' ' ' THR . 11.5 t70 -72.13 -45.91 58.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.234 -0.917 . . . . 0.0 110.871 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -21.38 63.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.056 -1.027 . . . . 0.0 110.42 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.641 ' CD1' ' OG1' ' A' ' 176' ' ' THR . 0.0 OUTLIER -90.78 -31.42 16.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 110.667 -179.782 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.599 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.5 OUTLIER -43.88 -25.97 0.23 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.953 -1.092 . . . . 0.0 109.683 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 179' ' ' PHE . 35.5 tt0 -61.62 -35.04 76.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.85 . . . . 0.0 109.578 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.527 ' CD1' ' HA ' ' A' ' 179' ' ' PHE . 0.8 OUTLIER -72.12 -39.85 68.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.398 -0.813 . . . . 0.0 109.546 179.454 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.61 -33.7 75.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.517 -0.739 . . . . 0.0 109.928 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -63.19 -14.75 52.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 0.0 109.735 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -86.89 16.66 4.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.375 -0.828 . . . . 0.0 110.034 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 186' ' ' ASP . 5.8 m-20 42.26 48.64 4.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 109.368 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.3 tt -128.96 169.56 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.517 -0.739 . . . . 0.0 110.554 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.483 ' O ' ' C ' ' A' ' 189' ' ' VAL . 0.0 OUTLIER -150.87 -133.29 0.05 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.365 -0.835 . . . . 0.0 108.784 179.506 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.579 ' CB ' HG23 ' A' ' 165' ' ' ILE . 4.3 m -42.47 120.37 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 120.965 -1.084 . . . . 0.0 109.076 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.527 ' O ' HG12 ' A' ' 193' ' ' VAL . . . -50.31 -7.7 0.14 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.608 ' O ' ' HB2' ' A' ' 164' ' ' ARG . 28.3 t 58.77 -150.53 0.44 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.163 -1.198 . . . . 0.0 109.675 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.641 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 95.5 mt-10 -64.35 101.86 0.47 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.693 -0.63 . . . . 0.0 109.826 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.623 ' O ' ' O ' ' A' ' 163' ' ' VAL . 30.8 m -158.16 -135.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.913 . . . . 0.0 109.742 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.464 ' OE2' ' HB2' ' A' ' 205' ' ' SER . 0.0 OUTLIER -169.05 158.74 8.73 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.293 -0.879 . . . . 0.0 110.117 179.407 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.595 ' CG2' ' CD1' ' A' ' 204' ' ' LEU . 0.0 OUTLIER -120.04 156.81 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 0.0 110.088 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.449 ' N ' ' O ' ' A' ' 203' ' ' THR . 11.4 t -125.24 92.38 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 110.165 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.459 ' HA ' HG12 ' A' ' 202' ' ' ILE . 8.5 t0 -41.73 134.1 2.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.292 -0.88 . . . . 0.0 110.205 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.523 ' CB ' ' O ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -132.92 154.98 49.89 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.233 -0.917 . . . . 0.0 110.137 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -59.26 90.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.237 -0.914 . . . . 0.0 110.362 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 89.88 1.56 76.49 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.523 ' O ' ' CB ' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -150.14 170.79 18.1 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -1.182 . . . . 0.0 110.326 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.459 HG12 ' HA ' ' A' ' 197' ' ' ASP . 7.5 mt -146.62 99.96 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.0 110.202 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 196' ' ' VAL . 55.1 m -72.61 150.78 42.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -0.909 . . . . 0.0 110.004 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.595 ' CD1' ' CG2' ' A' ' 195' ' ' ILE . 0.0 OUTLIER -119.9 137.9 53.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.129 -0.982 . . . . 0.0 110.288 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.549 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.6 OUTLIER -119.66 124.05 45.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.36 -0.837 . . . . 0.0 109.964 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.544 ' HA ' ' CB ' ' A' ' 193' ' ' VAL . 3.0 m80 -110.09 -171.95 1.94 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.458 -0.776 . . . . 0.0 110.188 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -56.68 98.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 110.244 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 61.09 26.11 65.32 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 206' ' ' HIS . 2.5 mtpt -143.16 158.97 43.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -1.156 . . . . 0.0 110.286 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -156.6 139.27 15.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.917 . . . . 0.0 110.153 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.2 p -134.27 172.63 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.318 -0.863 . . . . 0.0 110.205 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -110.87 103.46 11.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.255 -0.903 . . . . 0.0 110.234 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.404 HD21 HD11 ' A' ' 204' ' ' LEU . 13.2 tp -95.22 171.69 8.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 110.087 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.531 ' O ' ' CB ' ' A' ' 218' ' ' ALA . 5.6 mt -91.12 166.17 13.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 110.141 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.437 ' HB2' ' HA ' ' A' ' 201' ' ' HIS . 6.0 t0 -89.9 -75.0 0.46 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 110.094 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.19 -22.34 60.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.929 . . . . 0.0 110.092 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.487 ' CB ' ' HB2' ' A' ' 214' ' ' LEU . 0.2 OUTLIER -90.04 -24.94 21.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.897 . . . . 0.0 110.272 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 214' ' ' LEU . . . -62.79 -33.03 74.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.204 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.625 ' CG ' ' CD1' ' A' ' 153' ' ' ILE . 0.3 OUTLIER -64.18 84.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 110.183 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 3.3 m -165.2 -46.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 110.577 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.584 ' CD1' ' H ' ' A' ' 221' ' ' ILE . 0.3 OUTLIER -74.36 144.81 11.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.259 -0.9 . . . . 0.0 110.841 -179.566 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 148' ' ' PRO . 0.0 OUTLIER -89.31 107.36 19.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.42 -0.8 . . . . 0.0 109.19 179.352 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.586 ' CG2' ' CG2' ' A' ' 165' ' ' ILE . 0.6 OUTLIER -119.87 163.98 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.316 -0.865 . . . . 0.0 110.84 -178.855 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.44 ' HG2' ' HA2' ' A' ' 149' ' ' GLY . 27.1 mt-10 -139.43 -177.77 5.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 0.0 110.27 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 3.6 mt-10 -95.02 70.18 3.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.878 . . . . 0.0 110.339 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 23.3 mt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.284 179.982 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo . . . . . 0 N--CA 1.483 0.903 0 N-CA-C 110.443 -0.637 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.426 ' HB ' ' HD2' ' A' ' 133' ' ' PRO . 10.0 pt -73.56 163.42 68.54 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 110.189 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.426 ' HD2' ' HB ' ' A' ' 132' ' ' ILE . 46.2 Cg_endo -73.24 -17.01 24.75 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.973 1.512 . . . . 0.0 110.425 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 135' ' ' LEU . . . 107.46 -135.89 13.07 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.453 ' CB ' ' O ' ' A' ' 134' ' ' GLY . 0.3 OUTLIER 66.22 29.8 9.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -1.114 . . . . 0.0 110.259 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -151.96 87.99 1.37 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 110.298 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -71.83 61.68 0.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.935 . . . . 0.0 110.137 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.252 -0.905 . . . . 0.0 110.254 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.493 ' HA ' ' HG2' ' A' ' 222' ' ' ARG . 46.9 Cg_endo . . . . . 0 N--CA 1.483 0.857 0 N-CA-C 110.548 -0.597 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 148' ' ' PRO . . . 43.69 -111.46 0.43 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 151' ' ' ARG . 87.0 m -131.47 0.49 4.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -1.147 . . . . 0.0 110.288 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' A' ' 153' ' ' ILE . 1.8 mtm-85 61.03 131.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 110.138 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.546 ' CG1' HD13 ' A' ' 221' ' ' ILE . 4.7 p -65.69 55.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.264 -0.897 . . . . 0.0 110.683 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.634 ' CD1' ' CD2' ' A' ' 219' ' ' HIS . 3.1 pt -156.23 -35.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.085 -1.009 . . . . 0.0 110.019 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 150' ' ' THR . 0.2 OUTLIER -69.81 -13.99 62.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 0.0 109.083 179.224 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 156' ' ' ALA . . . -96.31 1.76 52.23 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.582 -0.699 . . . . 0.0 109.899 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 155' ' ' ALA . . . -57.69 -152.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 110.399 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 159' ' ' MET . 12.6 t -41.02 -34.53 0.43 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.38 -0.825 . . . . 0.0 110.269 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 157' ' ' THR . 10.1 t -43.39 -26.12 0.18 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.917 . . . . 0.0 109.688 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' MET . . . . . 0.486 ' HB3' ' HD2' ' A' ' 161' ' ' ARG . 0.1 OUTLIER -160.37 103.84 1.36 Allowed Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.434 -0.791 . . . . 0.0 109.602 179.702 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.23 106.35 1.73 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.938 1.494 . . . . 0.0 110.476 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.496 ' O ' ' HG3' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -171.42 175.27 4.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.358 -0.839 . . . . 0.0 110.28 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.589 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 1.0 OUTLIER -88.98 150.54 22.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.275 -0.891 . . . . 0.0 110.326 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.555 ' O ' ' O ' ' A' ' 193' ' ' VAL . 2.8 m -147.34 -155.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.168 -0.957 . . . . 0.0 110.851 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.624 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 4.8 ttt-85 178.71 150.99 0.28 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.026 -1.046 . . . . 0.0 110.107 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.753 ' HB ' ' C ' ' A' ' 189' ' ' VAL . 0.0 OUTLIER -93.71 149.39 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.217 -0.927 . . . . 0.0 109.864 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.483 ' O ' ' NE2' ' A' ' 167' ' ' GLN . 18.2 m -130.8 0.98 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.096 -1.003 . . . . 0.0 110.472 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.483 ' NE2' ' O ' ' A' ' 166' ' ' VAL . 0.9 OUTLIER -167.02 123.37 1.17 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.115 -0.991 . . . . 0.0 110.253 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.503 ' CG2' HG11 ' A' ' 189' ' ' VAL . 1.3 tt -130.32 9.04 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 0.0 110.138 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 168' ' ' ILE . 15.0 m-20 -41.49 101.37 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -0.887 . . . . 0.0 110.181 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.41 ' O ' ' CD1' ' A' ' 172' ' ' PHE . 2.3 tp10 -146.86 116.32 7.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.207 -0.933 . . . . 0.0 110.329 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.454 ' O ' ' C ' ' A' ' 172' ' ' PHE . 1.2 pp -84.25 20.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 110.17 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.454 ' C ' ' O ' ' A' ' 171' ' ' ILE . 55.8 p90 -39.96 145.11 0.16 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 0.0 110.437 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -149.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.915 . . . . 0.0 110.267 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 176' ' ' THR . 37.0 t -119.32 -15.58 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.216 -0.927 . . . . 0.0 110.294 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.32 88.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 0.0 110.128 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.545 ' CG2' ' HB3' ' A' ' 179' ' ' PHE . 0.3 OUTLIER -155.09 -36.83 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 0.0 110.356 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.483 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.4 OUTLIER 53.48 -85.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.414 -0.804 . . . . 0.0 110.465 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 176' ' ' THR . 13.5 tm0? -41.64 -26.74 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.264 -0.898 . . . . 0.0 110.433 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.585 ' CZ ' ' HG ' ' A' ' 183' ' ' LEU . 0.1 OUTLIER -89.14 -44.36 10.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.236 -0.915 . . . . 0.0 110.219 -179.91 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.519 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -44.37 -24.35 0.17 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.085 -1.009 . . . . 0.0 109.799 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -66.7 -67.68 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.37 -0.831 . . . . 0.0 110.155 179.799 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.497 ' C ' ' CD1' ' A' ' 182' ' ' LEU . 4.3 pp -60.97 -16.57 44.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.88 . . . . 0.0 109.747 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.585 ' HG ' ' CZ ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -81.79 -32.71 31.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 109.663 179.549 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.74 -18.62 60.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.432 -0.793 . . . . 0.0 109.851 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -87.16 16.81 4.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.371 -0.831 . . . . 0.0 110.206 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 51.38 68.32 0.81 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.12 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.437 HG22 HD11 ' A' ' 187' ' ' ILE . 16.2 mm -107.14 88.63 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 110.389 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 190' ' ' GLY . 1.5 ptp180 -100.49 142.39 32.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.364 -0.835 . . . . 0.0 109.636 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 1.0 ' O ' ' N ' ' A' ' 191' ' ' SER . 5.9 m 33.77 34.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 121.288 -0.883 . . . . 0.0 110.628 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.576 ' C ' ' O ' ' A' ' 189' ' ' VAL . . . 22.93 21.86 0.0 OUTLIER Glycine 0 N--CA 1.496 2.683 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 1.0 ' N ' ' O ' ' A' ' 189' ' ' VAL . 1.3 t 36.48 -148.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -1.148 . . . . 0.0 109.842 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.624 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 22.3 tt0 -83.46 118.3 23.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.614 -0.679 . . . . 0.0 109.383 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.589 ' CG1' ' O ' ' A' ' 192' ' ' GLU . 34.2 m -158.67 -137.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.091 -1.005 . . . . 0.0 110.097 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 162' ' ' LYS . 42.9 tt0 -174.3 158.77 3.0 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.207 -0.933 . . . . 0.0 110.54 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.528 ' CG2' ' HG ' ' A' ' 204' ' ' LEU . 0.4 OUTLIER -120.84 145.62 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.311 -0.868 . . . . 0.0 109.973 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.482 ' O ' ' O ' ' A' ' 197' ' ' ASP . 6.5 t -135.37 35.76 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.154 -0.966 . . . . 0.0 110.298 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 196' ' ' VAL . 0.4 OUTLIER 54.64 162.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.345 -0.847 . . . . 0.0 110.451 179.8 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.536 ' HB2' ' N ' ' A' ' 203' ' ' THR . 30.0 ttt-85 -143.54 160.04 41.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.219 -0.926 . . . . 0.0 110.172 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 198' ' ' ARG . 0.1 OUTLIER -43.97 103.92 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.403 -179.877 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 61.58 11.83 30.69 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.404 ' C ' ' HB3' ' A' ' 198' ' ' ARG . 1.2 t60 -150.17 -156.19 0.7 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.138 -1.213 . . . . 0.0 110.194 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.43 ' C ' ' HB2' ' A' ' 198' ' ' ARG . 92.5 mt -129.16 134.28 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.208 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.536 ' N ' ' HB2' ' A' ' 198' ' ' ARG . 4.3 m -109.27 148.2 31.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 110.149 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.528 ' HG ' ' CG2' ' A' ' 195' ' ' ILE . 1.1 tt -119.71 135.2 54.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 110.161 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.513 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.5 OUTLIER -119.86 124.93 47.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.355 -0.84 . . . . 0.0 109.895 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.532 ' CD2' HG13 ' A' ' 193' ' ' VAL . 2.2 m170 -106.06 -162.69 0.88 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.378 -0.826 . . . . 0.0 110.105 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -52.83 90.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 110.175 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 59.93 26.58 63.31 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 54.5 mttt -132.54 169.9 15.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.25 -1.147 . . . . 0.0 110.328 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.47 ' O ' ' CG2' ' A' ' 211' ' ' VAL . 7.9 t70 -156.02 145.61 21.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.354 -0.842 . . . . 0.0 110.068 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 210' ' ' ASP . 55.5 t -156.22 144.12 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.92 . . . . 0.0 110.252 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.451 ' OE1' ' NE2' ' A' ' 178' ' ' GLN . 6.4 tt0 -56.56 161.56 2.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 110.14 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.482 ' CD1' ' C ' ' A' ' 213' ' ' LEU . 1.5 tm? -142.57 92.63 2.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 110.216 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.496 HD12 ' HB2' ' A' ' 217' ' ' LEU . 1.4 pt? -46.83 174.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.333 -0.854 . . . . 0.0 110.148 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -90.17 -30.91 17.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.353 -0.842 . . . . 0.0 110.27 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.494 ' CB ' HD13 ' A' ' 214' ' ' LEU . 0.5 OUTLIER -60.33 -44.89 95.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.939 . . . . 0.0 110.364 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.496 ' HB2' HD12 ' A' ' 214' ' ' LEU . 0.1 OUTLIER -84.24 -18.92 34.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.172 -0.955 . . . . 0.0 110.18 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . 0.572 ' CB ' ' CG2' ' A' ' 153' ' ' ILE . . . -67.18 -58.68 4.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 110.412 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.634 ' CD2' ' CD1' ' A' ' 153' ' ' ILE . 13.0 t-80 -85.87 79.32 9.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.189 -0.944 . . . . 0.0 110.471 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' THR . . . . . 0.453 HG23 ' HA ' ' A' ' 217' ' ' LEU . 2.8 t -176.5 -48.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 110.294 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.562 HG12 ' CG2' ' A' ' 223' ' ' ILE . 0.2 OUTLIER -70.4 142.58 15.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.215 -0.928 . . . . 0.0 110.294 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.493 ' HG2' ' HA ' ' A' ' 148' ' ' PRO . 10.0 mtt180 -89.51 114.7 26.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.237 -0.914 . . . . 0.0 109.497 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.562 ' CG2' HG12 ' A' ' 221' ' ' ILE . 0.7 OUTLIER -120.83 -176.53 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 110.725 -179.224 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 223' ' ' ILE . 46.0 mm-40 -149.57 174.52 12.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.484 -0.76 . . . . 0.0 110.03 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.465 ' HG3' HG11 ' A' ' 163' ' ' VAL . 0.4 OUTLIER -100.01 144.03 29.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 110.176 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.459 HD22 ' CG ' ' A' ' 192' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.221 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo . . . . . 0 N--CA 1.485 0.971 0 N-CA-C 110.531 -0.603 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 63.0 mt -115.28 106.56 50.84 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.187 -0.946 . . . . 0.0 110.253 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.477 ' CG ' HD22 ' A' ' 135' ' ' LEU . 46.7 Cg_endo -73.02 -49.11 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.016 1.535 . . . . 0.0 110.513 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 128.71 1.91 5.86 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.477 HD22 ' CG ' ' A' ' 133' ' ' PRO . 1.3 pp -94.22 141.39 28.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -1.13 . . . . 0.0 110.286 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -109.12 27.82 9.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.328 -0.857 . . . . 0.0 110.152 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.63 69.91 0.85 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 0.0 110.179 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.243 -0.911 . . . . 0.0 110.222 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo . . . . . 0 N--CA 1.484 0.934 0 N-CA-C 110.392 -0.657 . . . . 0.0 110.392 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.462 ' HA3' ' HD3' ' A' ' 222' ' ' ARG . . . 164.26 83.92 0.05 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.538 ' O ' ' CG1' ' A' ' 223' ' ' ILE . 30.0 m -97.26 136.48 37.69 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -1.153 . . . . 0.0 110.276 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 154' ' ' ASP . 26.1 mtt-85 -64.87 128.77 37.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.096 -1.002 . . . . 0.0 109.888 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.545 ' CG1' HG23 ' A' ' 195' ' ' ILE . 1.3 t -43.6 -32.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.168 -0.957 . . . . 0.0 110.232 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.58 ' CG2' ' CB ' ' A' ' 218' ' ' ALA . 1.1 pp -83.55 -13.33 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.209 -0.932 . . . . 0.0 110.451 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 151' ' ' ARG . 0.3 OUTLIER -79.52 -14.71 58.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 109.794 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -116.56 -5.38 11.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.332 -0.855 . . . . 0.0 109.998 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.48 135.2 40.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.299 -0.875 . . . . 0.0 110.296 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 158' ' ' SER . 0.2 OUTLIER -139.67 171.82 13.69 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.204 -0.935 . . . . 0.0 110.192 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 157' ' ' THR . 0.1 OUTLIER -42.9 -60.84 1.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 110.053 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 2.2 mtt -78.54 162.98 63.8 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.179 -0.95 . . . . 0.0 110.068 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.21 73.29 3.26 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.946 1.498 . . . . 0.0 110.467 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.13 130.8 23.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.326 -0.859 . . . . 0.0 110.197 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.28 103.13 4.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 110.203 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.638 ' O ' ' O ' ' A' ' 193' ' ' VAL . 17.6 m -128.72 -169.12 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.168 -0.957 . . . . 0.0 110.273 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.605 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 9.2 ptt-85 -166.25 147.32 6.52 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.711 -1.243 . . . . 0.0 110.836 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.605 HG22 HG23 ' A' ' 223' ' ' ILE . 0.8 OUTLIER -90.42 152.23 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.394 -0.816 . . . . 0.0 110.117 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.498 HG21 ' N ' ' A' ' 167' ' ' GLN . 17.9 m -138.59 -29.71 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.208 -0.933 . . . . 0.0 110.762 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.498 ' N ' HG21 ' A' ' 166' ' ' VAL . 35.3 mt-30 -131.87 118.01 19.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.169 -0.957 . . . . 0.0 110.34 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 170' ' ' GLU . 1.0 OUTLIER -84.44 -4.71 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.336 -0.853 . . . . 0.0 110.134 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.9 m120 51.16 -89.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.231 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 168' ' ' ILE . 77.6 tt0 -173.75 88.62 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 110.207 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.456 HG21 HD22 ' A' ' 217' ' ' LEU . 5.8 mt -76.98 2.83 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.278 -0.889 . . . . 0.0 110.21 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -58.54 108.0 0.58 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.244 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -130.45 -172.38 2.79 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.307 -0.871 . . . . 0.0 110.177 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.4 ' O ' ' CG1' ' A' ' 174' ' ' VAL . 61.2 t -109.59 20.1 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.203 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 177' ' ' ASP . 20.7 mm-40 -114.54 -32.95 5.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 110.21 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.536 ' O ' ' CB ' ' A' ' 177' ' ' ASP . 69.0 p 42.26 -92.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.387 -0.821 . . . . 0.0 110.288 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 176' ' ' THR . 0.7 OUTLIER 72.41 -154.68 0.08 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.262 -0.898 . . . . 0.0 110.172 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.45 ' O ' ' HB2' ' A' ' 181' ' ' GLN . 4.4 mm-40 -57.7 -23.68 52.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 110.507 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.56 ' CE1' HD21 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -47.48 -40.91 19.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.133 -0.98 . . . . 0.0 110.259 -179.851 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.51 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -46.93 -24.88 0.67 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.994 -1.066 . . . . 0.0 109.634 179.662 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' A' ' 178' ' ' GLN . 11.7 tp60 -63.24 -66.18 0.58 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.43 -0.794 . . . . 0.0 110.42 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 179' ' ' PHE . 4.6 pp -63.91 -12.69 39.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.0 110.11 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.56 HD21 ' CE1' ' A' ' 179' ' ' PHE . 0.8 OUTLIER -93.14 -30.64 15.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.314 -0.866 . . . . 0.0 109.731 179.631 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 180' ' ' THR . 9.8 t70 -73.41 -7.02 49.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.293 -0.879 . . . . 0.0 109.855 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.468 ' O ' HG12 ' A' ' 187' ' ' ILE . . . -87.58 32.32 0.72 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.323 -0.861 . . . . 0.0 110.175 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 185' ' ' ALA . 7.6 t70 43.41 55.84 4.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.194 -0.941 . . . . 0.0 109.976 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 185' ' ' ALA . 9.3 mm -110.64 163.94 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.873 . . . . 0.0 110.511 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.559 ' O ' ' O ' ' A' ' 189' ' ' VAL . 0.1 OUTLIER -166.15 104.54 0.65 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.692 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 1.5 m 50.86 103.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.523 ' O ' ' CG1' ' A' ' 193' ' ' VAL . . . -42.69 -16.95 0.03 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 189' ' ' VAL . 6.3 t 64.98 -145.59 0.24 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.191 -1.182 . . . . 0.0 109.13 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.605 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 21.7 tt0 -61.02 100.64 0.12 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.215 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.638 ' O ' ' O ' ' A' ' 163' ' ' VAL . 17.7 m -156.28 -136.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.165 -0.959 . . . . 0.0 109.77 -179.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.444 ' N ' HG22 ' A' ' 193' ' ' VAL . 11.5 pt-20 -173.19 164.43 4.78 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.35 -0.844 . . . . 0.0 110.007 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.557 HG12 ' CG2' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -122.81 173.32 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.201 -0.937 . . . . 0.0 110.394 -179.764 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 197' ' ' ASP . 99.4 t -141.49 83.86 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 0.0 110.096 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 196' ' ' VAL . 8.4 t70 -42.46 121.94 2.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.927 . . . . 0.0 110.205 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.404 ' N ' ' O ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -119.02 171.36 8.31 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.178 -0.951 . . . . 0.0 110.307 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -56.0 99.98 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 110.331 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 62.87 22.75 64.84 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.404 ' O ' ' N ' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -148.08 158.01 43.83 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.281 -1.129 . . . . 0.0 110.083 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.493 HD11 ' CB ' ' A' ' 215' ' ' ASP . 57.8 mt -142.33 95.2 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 110.225 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 92.0 m -84.83 157.27 20.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 0.0 109.998 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.623 HD21 ' CD2' ' A' ' 206' ' ' HIS . 0.6 OUTLIER -119.91 141.57 49.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.206 -0.934 . . . . 0.0 110.367 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.598 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.0 OUTLIER -119.58 122.71 42.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.353 -0.842 . . . . 0.0 109.966 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.623 ' CD2' HD21 ' A' ' 204' ' ' LEU . 5.3 m170 -98.97 167.86 10.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.45 -0.781 . . . . 0.0 110.309 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -44.07 106.95 0.08 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.338 -0.851 . . . . 0.0 110.24 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 57.57 24.34 52.37 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 206' ' ' HIS . 3.8 mtmt -150.76 175.46 11.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -1.13 . . . . 0.0 110.226 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 211' ' ' VAL . 5.6 t70 -171.18 161.9 6.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.216 -0.928 . . . . 0.0 110.148 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.479 ' N ' ' OD1' ' A' ' 210' ' ' ASP . 10.0 p -151.72 150.66 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.185 -0.947 . . . . 0.0 110.336 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.74 168.47 9.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 0.0 110.08 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.417 HD22 ' HB3' ' A' ' 218' ' ' ALA . 26.3 tp -172.75 149.65 2.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -0.886 . . . . 0.0 110.239 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.421 HD13 ' HB2' ' A' ' 216' ' ' ASP . 0.3 OUTLIER -114.46 124.32 51.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.267 -0.895 . . . . 0.0 110.171 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.493 ' CB ' HD11 ' A' ' 202' ' ' ILE . 13.5 p-10 -47.28 -22.65 0.43 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 110.23 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.555 ' O ' ' CE1' ' A' ' 219' ' ' HIS . 1.4 m-20 -51.42 -66.3 0.41 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 0.0 110.328 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.456 HD22 HG21 ' A' ' 171' ' ' ILE . 0.3 OUTLIER -89.84 -18.02 27.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 110.348 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . 0.58 ' CB ' ' CG2' ' A' ' 153' ' ' ILE . . . -47.44 -22.78 0.49 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.337 -0.852 . . . . 0.0 110.286 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 216' ' ' ASP . 0.0 OUTLIER -89.16 58.14 4.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 110.409 -179.882 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' THR . . . . . 0.472 HG21 ' O ' ' A' ' 219' ' ' HIS . 18.0 p -142.83 -41.72 0.32 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -0.918 . . . . 0.0 110.262 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.55 ' CD1' ' N ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -69.41 137.27 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.39 -0.819 . . . . 0.0 110.305 -179.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.469 ' HB2' ' HB2' ' A' ' 167' ' ' GLN . 30.3 mtt180 -89.99 115.45 27.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.53 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.605 HG23 HG22 ' A' ' 165' ' ' ILE . 1.0 OUTLIER -129.37 -178.07 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 110.816 -179.125 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.42 -179.65 7.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.349 -0.844 . . . . 0.0 110.208 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -99.7 100.82 11.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.222 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.495 ' O ' ' NH1' ' A' ' 164' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.206 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 20.7 p30 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.794 0.331 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.05 -49.37 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.992 1.522 . . . . 0.0 110.413 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 pt -56.85 156.1 13.6 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 0.0 110.216 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.99 -168.2 0.4 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.059 1.558 . . . . 0.0 110.329 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -119.5 165.94 13.31 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.45 178.49 8.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -1.16 . . . . 0.0 110.231 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -151.86 46.43 0.78 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.329 -0.857 . . . . 0.0 110.25 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -102.91 29.25 5.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -0.905 . . . . 0.0 110.248 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.44 138.1 32.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.453 ' O ' ' HB ' ' A' ' 140' ' ' VAL . . . -124.84 154.92 18.32 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 139' ' ' GLY . 41.2 t 55.12 100.92 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -1.125 . . . . 0.0 110.219 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -114.82 -51.41 0.45 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.6 m120 51.33 -169.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.158 -1.201 . . . . 0.0 110.246 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.6 t -120.27 123.79 44.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.0 110.187 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 58.38 -167.74 0.14 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.211 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 45.0 84.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 110.199 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -118.32 -2.57 11.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.283 -0.886 . . . . 0.0 110.132 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -167.73 149.58 5.19 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 110.154 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.1 81.04 1.75 Allowed 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.07 1.563 . . . . 0.0 110.491 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.533 ' CA ' ' HG3' ' A' ' 222' ' ' ARG . . . 154.11 128.52 1.23 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 151' ' ' ARG . 26.1 m -142.29 5.2 1.64 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -1.14 . . . . 0.0 110.431 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.555 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 0.0 OUTLIER 58.41 135.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.882 . . . . 0.0 110.319 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.565 ' CG1' HD13 ' A' ' 221' ' ' ILE . 4.2 p -65.84 56.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.162 -0.961 . . . . 0.0 110.391 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.598 ' CG2' ' CB ' ' A' ' 218' ' ' ALA . 5.1 pt -158.92 -37.1 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.104 -0.998 . . . . 0.0 110.156 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 150' ' ' THR . 0.3 OUTLIER -74.64 -16.25 60.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.372 -0.83 . . . . 0.0 109.736 179.637 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.518 ' O ' ' NE ' ' A' ' 161' ' ' ARG . . . -88.68 -20.12 25.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.489 -0.757 . . . . 0.0 109.971 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.513 ' HA ' ' NH1' ' A' ' 161' ' ' ARG . . . -70.01 124.86 25.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.352 -0.842 . . . . 0.0 110.166 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.55 ' CB ' ' HD2' ' A' ' 161' ' ' ARG . 77.1 m -123.21 171.78 9.09 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.17 -0.956 . . . . 0.0 110.356 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.472 ' C ' ' O ' ' A' ' 157' ' ' THR . 36.4 t -38.62 -39.62 0.5 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.344 -0.847 . . . . 0.0 109.603 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' MET . . . . . 0.463 ' O ' ' HD3' ' A' ' 161' ' ' ARG . 2.6 ptt? -104.05 146.52 32.7 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 121.496 -0.753 . . . . 0.0 109.566 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.457 ' HB2' ' OE2' ' A' ' 194' ' ' GLU . 44.1 Cg_endo -71.14 81.04 1.21 Allowed 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.898 1.472 . . . . 0.0 110.577 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.55 ' HD2' ' CB ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -63.37 -135.19 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.175 -0.953 . . . . 0.0 109.902 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.558 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 12.7 tttt -154.65 107.46 2.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.309 -0.869 . . . . 0.0 109.9 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.625 ' O ' ' O ' ' A' ' 193' ' ' VAL . 23.3 m -123.74 -150.43 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 110.845 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.664 ' HG2' ' N ' ' A' ' 165' ' ' ILE . 0.7 OUTLIER 179.48 155.41 0.52 Allowed 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.152 -0.967 . . . . 0.0 109.876 -179.201 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.788 ' HB ' ' CA ' ' A' ' 189' ' ' VAL . 0.2 OUTLIER -97.48 144.89 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.225 -0.922 . . . . 0.0 109.83 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.521 ' CG1' ' HG2' ' A' ' 224' ' ' GLU . 21.6 m -123.32 7.16 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.068 -1.02 . . . . 0.0 110.455 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -177.04 114.06 0.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.911 . . . . 0.0 110.412 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.499 ' CG2' ' HG2' ' A' ' 188' ' ' ARG . 0.7 OUTLIER -103.59 20.93 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.35 -0.844 . . . . 0.0 109.945 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' ' 168' ' ' ILE . 1.8 t-20 -44.86 172.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 110.292 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -166.68 92.04 0.44 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.176 -0.952 . . . . 0.0 110.261 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.3 pp -83.61 13.88 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.197 -0.939 . . . . 0.0 110.311 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.549 ' CD1' ' OE1' ' A' ' 175' ' ' GLU . 1.6 m-85 -62.56 135.54 57.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 110.209 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.459 ' O ' ' HB ' ' A' ' 174' ' ' VAL . 11.1 mm-40 -59.67 -21.08 60.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.184 -0.948 . . . . 0.0 110.225 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.459 ' HB ' ' O ' ' A' ' 173' ' ' GLN . 4.5 p 179.76 90.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -0.937 . . . . 0.0 110.159 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.549 ' OE1' ' CD1' ' A' ' 172' ' ' PHE . 4.7 tt0 -143.52 105.18 4.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 110.252 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.523 ' O ' ' CB ' ' A' ' 177' ' ' ASP . 0.1 OUTLIER -138.07 -82.93 0.32 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 110.147 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.523 ' CB ' ' O ' ' A' ' 176' ' ' THR . 0.8 OUTLIER 70.96 -159.36 0.13 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.301 -0.875 . . . . 0.0 110.438 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -59.27 -18.9 41.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.354 -0.841 . . . . 0.0 110.583 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.598 ' HA ' ' CD1' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -53.29 -36.03 60.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.169 -0.957 . . . . 0.0 110.129 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.48 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.7 OUTLIER -40.63 -27.92 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 0.0 109.892 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 179' ' ' PHE . 19.7 tt0 -63.2 -41.55 99.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.854 . . . . 0.0 109.823 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.598 ' CD1' ' HA ' ' A' ' 179' ' ' PHE . 1.7 mt -58.25 -46.48 85.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.419 -0.801 . . . . 0.0 109.766 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.471 ' CD1' ' O ' ' A' ' 183' ' ' LEU . 0.2 OUTLIER -67.34 -32.75 73.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.551 -0.718 . . . . 0.0 110.164 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -83.15 0.62 44.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.389 -0.819 . . . . 0.0 110.278 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.466 ' O ' HG13 ' A' ' 187' ' ' ILE . . . -81.71 8.29 10.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 110.219 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 23.4 t0 59.98 49.9 7.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.254 -0.904 . . . . 0.0 110.152 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.551 ' O ' ' CB ' ' A' ' 188' ' ' ARG . 88.8 mt -138.6 -72.99 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 110.242 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.551 ' CB ' ' O ' ' A' ' 187' ' ' ILE . 3.4 ttp180 72.46 157.17 0.18 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.435 -0.791 . . . . 0.0 109.839 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.947 ' O ' ' N ' ' A' ' 191' ' ' SER . 3.7 m 33.17 36.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 O-C-N 121.352 -0.842 . . . . 0.0 110.731 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.568 ' C ' ' O ' ' A' ' 189' ' ' VAL . . . 27.74 19.26 0.0 OUTLIER Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.947 ' N ' ' O ' ' A' ' 189' ' ' VAL . 30.6 t 38.29 -144.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.233 -1.157 . . . . 0.0 109.801 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.614 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -90.74 113.2 25.25 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.256 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.625 ' O ' ' O ' ' A' ' 163' ' ' VAL . 33.6 m -159.27 -137.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.288 -0.882 . . . . 0.0 109.996 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.558 ' CB ' ' HA ' ' A' ' 162' ' ' LYS . 5.4 pt-20 -170.54 167.37 8.07 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.214 -0.929 . . . . 0.0 110.086 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.544 ' CG2' ' HG ' ' A' ' 204' ' ' LEU . 0.4 OUTLIER -124.75 173.68 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.116 -0.99 . . . . 0.0 110.401 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.439 ' CG2' ' HB3' ' A' ' 160' ' ' PRO . 46.1 t -145.25 85.74 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.318 -0.864 . . . . 0.0 110.055 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.505 ' N ' ' OD1' ' A' ' 197' ' ' ASP . 18.9 p-10 -40.65 133.81 1.93 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.0 110.436 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.443 ' O ' ' C ' ' A' ' 199' ' ' ASP . 12.9 mmt85 -123.66 67.11 1.02 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.268 -0.895 . . . . 0.0 110.184 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 198' ' ' ARG . 2.7 t0 40.72 81.67 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.395 -0.815 . . . . 0.0 110.158 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 88.27 -37.9 3.23 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.62 164.61 12.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.223 -1.163 . . . . 0.0 110.166 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.499 HD11 ' CG2' ' A' ' 153' ' ' ILE . 4.1 mt -145.83 118.29 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.921 . . . . 0.0 110.24 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.437 HG21 ' O ' ' A' ' 211' ' ' VAL . 2.1 m -104.85 163.14 12.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 109.961 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.629 ' CD2' ' CD2' ' A' ' 206' ' ' HIS . 0.5 OUTLIER -119.83 138.19 53.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.152 -0.967 . . . . 0.0 110.213 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.554 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.5 OUTLIER -119.72 117.08 27.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.36 -0.837 . . . . 0.0 109.97 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.629 ' CD2' ' CD2' ' A' ' 204' ' ' LEU . 3.9 m170 -105.46 162.13 13.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.384 -0.822 . . . . 0.0 110.14 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -59.63 77.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.312 -0.867 . . . . 0.0 110.473 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 102.86 24.68 7.97 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.56 ' O ' ' CG ' ' A' ' 206' ' ' HIS . 3.1 mtpt -174.06 124.64 0.34 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -1.226 . . . . 0.0 110.462 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.46 150.86 40.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.266 -0.896 . . . . 0.0 110.149 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.437 ' O ' HG21 ' A' ' 203' ' ' THR . 8.4 p -137.72 165.48 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.172 -0.955 . . . . 0.0 110.252 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.88 88.99 3.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 110.202 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.522 ' CD1' ' HB1' ' A' ' 218' ' ' ALA . 3.4 pp -76.93 -160.01 0.15 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.21 -0.931 . . . . 0.0 110.216 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.516 HD13 ' CD1' ' A' ' 217' ' ' LEU . 0.5 OUTLIER -130.01 132.91 46.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -0.892 . . . . 0.0 110.217 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.46 ' OD2' HG13 ' A' ' 202' ' ' ILE . 0.7 OUTLIER -51.8 -23.58 4.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 110.222 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.86 -54.29 44.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 110.242 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.516 ' CD1' HD13 ' A' ' 214' ' ' LEU . 0.1 OUTLIER -89.6 -19.1 25.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.188 -0.945 . . . . 0.0 110.345 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.598 ' CB ' ' CG2' ' A' ' 153' ' ' ILE . . . -53.33 -18.36 2.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -0.877 . . . . 0.0 110.19 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.544 ' CG ' HD13 ' A' ' 153' ' ' ILE . 14.0 t-80 -103.5 49.99 0.81 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.931 . . . . 0.0 110.136 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 1.3 m -133.74 -61.59 0.8 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.327 -0.858 . . . . 0.0 110.225 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.596 ' CD1' ' N ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -60.55 145.15 12.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.419 -0.8 . . . . 0.0 110.379 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.533 ' HG3' ' CA ' ' A' ' 149' ' ' GLY . 1.0 OUTLIER -89.82 116.48 27.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 109.611 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.545 ' CG2' HG22 ' A' ' 165' ' ' ILE . 0.5 OUTLIER -124.64 170.07 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.077 -1.015 . . . . 0.0 110.636 -179.419 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.521 ' HG2' ' CG1' ' A' ' 166' ' ' VAL . 0.0 OUTLIER -150.11 -168.89 3.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.449 -0.782 . . . . 0.0 110.07 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 22.3 mt-10 -90.18 149.17 22.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.176 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.513 ' CD1' ' HB2' ' A' ' 192' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.924 -1.036 . . . . 0.0 110.199 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.423 ' OD1' HG23 ' A' ' 132' ' ' ILE . 14.1 p30 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 120.747 0.308 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.11 62.97 4.18 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.061 1.559 . . . . 0.0 110.472 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.475 ' O ' ' CG2' ' A' ' 132' ' ' ILE . 7.3 tp -124.05 63.61 31.97 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 110.233 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.08 -164.52 0.2 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.059 1.557 . . . . 0.0 110.444 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -139.4 81.45 0.26 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 47.56 56.32 7.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -1.159 . . . . 0.0 110.249 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -89.62 42.25 1.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.942 . . . . 0.0 110.196 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.19 8.61 6.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.226 -0.921 . . . . 0.0 110.232 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.07 75.49 1.62 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 110.268 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 173.17 -177.9 45.39 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 141' ' ' GLY . 1.4 p -117.96 -156.63 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -1.141 . . . . 0.0 110.095 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.468 ' N ' ' CG1' ' A' ' 140' ' ' VAL . . . -47.7 -96.25 0.01 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.06 116.31 4.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -1.12 . . . . 0.0 110.235 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.481 ' OG ' ' N ' ' A' ' 144' ' ' ASP . 30.5 t -166.25 -142.3 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.255 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.481 ' N ' ' OG ' ' A' ' 143' ' ' SER . 5.7 m-20 54.16 -163.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 110.217 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.81 114.65 12.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 110.204 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 147' ' ' ALA . . . -126.83 84.09 2.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.228 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 146' ' ' ALA . . . 62.76 158.35 0.12 Allowed Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.259 -0.901 . . . . 0.0 110.093 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.75 65.86 3.92 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.051 1.553 . . . . 0.0 110.368 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 140.19 153.17 5.97 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.494 ' N ' ' O ' ' A' ' 223' ' ' ILE . 3.7 m -131.5 2.46 4.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -1.138 . . . . 0.0 110.265 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.486 ' O ' ' HB2' ' A' ' 154' ' ' ASP . 6.1 mtm-85 61.0 118.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.266 -0.897 . . . . 0.0 110.276 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.675 ' O ' HG12 ' A' ' 153' ' ' ILE . 5.9 p -42.82 165.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.183 -0.948 . . . . 0.0 110.218 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.675 HG12 ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 72.17 -20.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.759 -0.588 . . . . 0.0 110.282 -179.439 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' A' ' 152' ' ' VAL . 0.4 OUTLIER -91.4 -18.98 23.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 0.0 108.71 178.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.429 ' HB2' HG12 ' A' ' 163' ' ' VAL . . . -108.33 -15.04 14.56 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.563 0.697 . . . . 0.0 109.45 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -67.83 152.12 46.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.437 -0.79 . . . . 0.0 110.157 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -161.94 174.59 12.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 110.227 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 157' ' ' THR . 0.2 OUTLIER -41.97 -48.32 4.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 110.166 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' MET . . . . . 0.463 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 4.0 mmm -82.32 166.66 35.39 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 110.201 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 46.5 Cg_endo -73.35 84.06 1.41 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.019 1.536 . . . . 0.0 110.437 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -70.72 111.48 6.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 0.0 110.241 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.567 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 0.2 OUTLIER -71.99 117.26 13.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.896 . . . . 0.0 110.286 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.668 ' O ' ' O ' ' A' ' 193' ' ' VAL . 0.0 OUTLIER -133.88 -165.4 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.213 -0.929 . . . . 0.0 110.431 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.552 ' CG ' ' HA ' ' A' ' 192' ' ' GLU . 20.1 ttp180 -173.54 147.61 1.46 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.847 -1.158 . . . . 0.0 109.829 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.801 ' HB ' ' C ' ' A' ' 189' ' ' VAL . 0.2 OUTLIER -95.03 143.55 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.162 -0.961 . . . . 0.0 110.181 -179.457 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.8 m -123.9 -8.21 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 110.175 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -158.66 124.04 4.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 0.0 110.188 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.459 ' CG2' ' HG2' ' A' ' 188' ' ' ARG . 5.1 tt -117.58 6.65 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.279 -0.888 . . . . 0.0 110.169 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.446 ' O ' ' CB ' ' A' ' 170' ' ' GLU . 27.1 t-20 -41.88 113.35 0.42 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.303 -0.873 . . . . 0.0 110.114 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.579 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 0.1 OUTLIER 172.68 123.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 110.321 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.591 ' O ' ' C ' ' A' ' 172' ' ' PHE . 63.2 mt -84.89 17.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 109.91 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.591 ' C ' ' O ' ' A' ' 171' ' ' ILE . 0.5 OUTLIER 25.06 -138.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.686 -0.634 . . . . 0.0 110.954 179.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.04 -145.94 0.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 0.0 110.213 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 32.8 m -114.71 6.46 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 110.355 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.71 174.09 7.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 110.245 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' A' ' 177' ' ' ASP . 12.1 p -148.29 -84.48 0.1 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -0.889 . . . . 0.0 110.165 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 176' ' ' THR . 7.0 t0 70.09 -139.16 0.06 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.345 -0.847 . . . . 0.0 110.218 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 181' ' ' GLN . 0.0 OUTLIER -64.07 -28.34 69.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.114 -0.991 . . . . 0.0 110.256 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.539 ' CZ ' HD11 ' A' ' 183' ' ' LEU . 0.3 OUTLIER -50.03 -51.8 39.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 110.076 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -49.97 -21.38 1.18 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.065 -1.022 . . . . 0.0 109.822 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.475 ' HB3' ' O ' ' A' ' 178' ' ' GLN . 20.8 tt0 -69.49 -59.95 2.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.291 -0.881 . . . . 0.0 110.422 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.546 ' C ' ' CD1' ' A' ' 182' ' ' LEU . 3.9 pp -66.62 -15.64 63.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.831 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.539 HD11 ' CZ ' ' A' ' 179' ' ' PHE . 0.3 OUTLIER -85.97 -28.81 24.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.36 -0.838 . . . . 0.0 109.668 179.619 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -81.12 6.85 12.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.346 -0.846 . . . . 0.0 109.821 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.487 ' CB ' HG23 ' A' ' 187' ' ' ILE . . . -81.05 12.46 3.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.353 -0.842 . . . . 0.0 110.232 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 185' ' ' ALA . 23.1 t70 43.48 41.15 3.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.156 -0.965 . . . . 0.0 109.326 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.497 ' O ' ' O ' ' A' ' 188' ' ' ARG . 0.4 OUTLIER -117.19 -43.63 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.451 -0.781 . . . . 0.0 110.379 -179.448 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.544 ' O ' HG21 ' A' ' 189' ' ' VAL . 3.9 ttp-105 53.22 168.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.341 -0.849 . . . . 0.0 109.882 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.956 ' O ' ' N ' ' A' ' 191' ' ' SER . 2.7 m 31.46 37.67 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 121.369 -0.832 . . . . 0.0 110.809 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.538 ' C ' ' O ' ' A' ' 189' ' ' VAL . . . 28.41 19.14 0.0 OUTLIER Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.956 ' N ' ' O ' ' A' ' 189' ' ' VAL . 18.1 t 41.52 -153.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.167 -1.196 . . . . 0.0 109.766 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.597 ' O ' ' CG1' ' A' ' 193' ' ' VAL . 1.8 pt-20 -89.11 115.81 26.91 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.582 -0.699 . . . . 0.0 109.115 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.668 ' O ' ' O ' ' A' ' 163' ' ' VAL . 35.4 m -159.8 -131.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.939 . . . . 0.0 109.942 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.575 ' HA ' HG22 ' A' ' 163' ' ' VAL . 8.1 pt-20 -176.8 169.34 2.48 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.241 -0.912 . . . . 0.0 110.387 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.543 ' CG2' ' HG ' ' A' ' 204' ' ' LEU . 0.5 OUTLIER -125.46 170.78 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.221 -0.924 . . . . 0.0 110.51 -179.552 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.462 ' O ' ' C ' ' A' ' 197' ' ' ASP . 65.7 t -148.13 80.7 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.367 -0.833 . . . . 0.0 109.892 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 197' ' ' ASP . 11.5 p30 -39.39 123.28 1.42 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.394 -0.816 . . . . 0.0 110.448 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -107.12 78.1 1.2 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.271 -0.893 . . . . 0.0 110.135 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 198' ' ' ARG . 27.7 t0 41.78 79.43 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.295 -0.878 . . . . 0.0 110.212 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 87.68 -37.27 3.25 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.497 ' O ' ' N ' ' A' ' 198' ' ' ARG . 45.0 m170 -90.99 168.37 11.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.239 -1.153 . . . . 0.0 110.202 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.554 ' CD1' ' HB ' ' A' ' 153' ' ' ILE . 7.7 mt -141.09 121.6 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.221 -0.924 . . . . 0.0 110.166 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 58.0 m -109.12 160.18 16.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.332 -0.855 . . . . 0.0 109.863 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.543 ' HG ' ' CG2' ' A' ' 195' ' ' ILE . 0.6 OUTLIER -119.74 132.46 55.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.158 -0.964 . . . . 0.0 110.217 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.557 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 1.4 m -119.82 128.12 53.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.878 . . . . 0.0 109.941 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.582 ' CD2' HG13 ' A' ' 193' ' ' VAL . 1.8 m170 -105.48 173.98 6.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.366 -0.834 . . . . 0.0 109.958 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -58.35 96.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 0.0 110.229 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 76.14 29.72 58.23 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.68 165.41 32.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.117 -1.225 . . . . 0.0 110.26 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -161.12 143.37 12.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.224 -0.922 . . . . 0.0 110.177 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.478 ' CG1' ' N ' ' A' ' 212' ' ' GLU . 1.6 p -142.74 -154.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.176 -0.952 . . . . 0.0 110.228 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.478 ' N ' ' CG1' ' A' ' 211' ' ' VAL . 1.3 tt0 -115.23 169.49 9.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 110.323 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.429 HD11 ' CD2' ' A' ' 182' ' ' LEU . 11.6 tp -168.27 89.68 0.26 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.355 -0.841 . . . . 0.0 110.149 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.579 ' N ' ' CD2' ' A' ' 214' ' ' LEU . 2.5 pt? -41.62 152.78 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 110.292 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.45 ' HA ' ' HB1' ' A' ' 218' ' ' ALA . 3.3 t0 -83.01 -22.39 33.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 110.195 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.98 -61.93 2.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.241 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.517 ' HB2' ' CD1' ' A' ' 214' ' ' LEU . 0.2 OUTLIER -75.63 -14.86 60.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -0.872 . . . . 0.0 110.197 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.577 ' CB ' HG23 ' A' ' 153' ' ' ILE . . . -50.29 -51.16 47.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 110.16 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.551 ' HB2' ' CD1' ' A' ' 153' ' ' ILE . 9.6 t60 -74.02 72.98 1.67 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.211 -0.93 . . . . 0.0 110.22 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 31.5 m -156.39 -53.82 0.08 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.154 -0.967 . . . . 0.0 110.425 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.572 HD13 ' CG1' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -66.07 174.82 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.397 -0.815 . . . . 0.0 110.409 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.2 mtm180 -122.62 99.67 6.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.417 -0.802 . . . . 0.0 109.734 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 165' ' ' ILE . 0.0 OUTLIER -119.36 167.45 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.97 . . . . 0.0 110.173 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.452 ' C ' HG11 ' A' ' 163' ' ' VAL . 15.1 pt-20 -150.3 174.35 12.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.245 -0.909 . . . . 0.0 110.135 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.493 ' HA ' HG11 ' A' ' 163' ' ' VAL . 0.7 OUTLIER -43.96 143.04 1.2 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.47 -0.769 . . . . 0.0 110.23 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.427 ' OXT' ' OE1' ' A' ' 225' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.196 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.441 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 24.5 p30 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 120.784 0.326 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 130' ' ' ASN . 46.1 Cg_endo -72.98 -89.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.95 1.5 . . . . 0.0 110.496 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.439 ' O ' HG21 ' A' ' 132' ' ' ILE . 0.4 OUTLIER -61.96 135.56 94.71 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.234 -0.916 . . . . 0.0 110.147 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.09 -90.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.986 1.519 . . . . 0.0 110.444 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 139.53 -116.17 1.19 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.6 mm? 59.11 166.12 0.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -1.143 . . . . 0.0 110.2 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -80.96 86.05 6.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.188 -0.945 . . . . 0.0 110.274 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -142.28 57.25 1.46 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.295 -0.878 . . . . 0.0 110.239 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.38 142.6 32.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 0.0 110.215 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 122.81 -82.25 0.35 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.429 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 7.1 p -83.72 48.68 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.236 -1.155 . . . . 0.0 110.258 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -157.97 90.43 0.11 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -70.68 78.1 0.6 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -1.174 . . . . 0.0 110.186 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.2 t -164.6 -169.38 1.73 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 110.223 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 144' ' ' ASP . 1.2 p30 -139.7 117.88 11.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.887 . . . . 0.0 110.208 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.452 ' O ' ' CB ' ' A' ' 146' ' ' ALA . . . -78.82 74.49 5.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.203 -0.936 . . . . 0.0 110.167 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 145' ' ' ALA . . . 172.97 -160.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.251 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 146' ' ' ALA . . . 65.71 137.66 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 110.23 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.423 ' HB2' ' OE2' ' A' ' 224' ' ' GLU . 46.8 Cg_endo -72.99 57.59 3.26 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.041 1.548 . . . . 0.0 110.435 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.505 ' HA3' ' HB2' ' A' ' 222' ' ' ARG . . . -133.18 159.16 23.48 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.516 ' O ' ' CB ' ' A' ' 154' ' ' ASP . 0.6 OUTLIER -158.15 17.63 0.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -1.153 . . . . 0.0 110.471 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.605 ' CB ' ' HB2' ' A' ' 154' ' ' ASP . 0.5 OUTLIER 56.11 117.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.146 -0.971 . . . . 0.0 110.375 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.643 HG11 ' CG2' ' A' ' 223' ' ' ILE . 0.0 OUTLIER -41.39 -80.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.193 -0.942 . . . . 0.0 111.247 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.609 ' CG2' ' CB ' ' A' ' 218' ' ' ALA . 0.2 OUTLIER -47.44 -18.82 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.429 -0.795 . . . . 0.0 111.631 -178.628 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.605 ' HB2' ' CB ' ' A' ' 151' ' ' ARG . 0.3 OUTLIER -71.9 -13.49 61.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.798 -1.189 . . . . 0.0 109.094 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -125.63 2.08 7.55 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.653 -0.655 . . . . 0.0 109.624 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.552 ' O ' ' CG2' ' A' ' 157' ' ' THR . . . -81.04 -177.5 6.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.42 -0.8 . . . . 0.0 110.486 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.575 ' N ' ' HB3' ' A' ' 160' ' ' PRO . 7.2 t 40.11 -168.53 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.548 -0.72 . . . . 0.0 110.55 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.53 ' C ' ' O ' ' A' ' 157' ' ' THR . 25.0 p 34.64 76.58 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.327 -0.858 . . . . 0.0 110.16 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' MET . . . . . 0.479 ' N ' ' CD ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER 58.33 54.28 5.73 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.92 . . . . 0.0 109.586 -179.445 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.575 ' HB3' ' N ' ' A' ' 157' ' ' THR . 43.8 Cg_endo -71.2 -159.09 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.091 1.574 . . . . 0.0 110.682 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.514 ' CB ' ' O ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER 168.2 -153.94 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.317 -0.865 . . . . 0.0 110.301 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -90.73 116.7 28.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -0.919 . . . . 0.0 110.539 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.577 ' O ' ' O ' ' A' ' 193' ' ' VAL . 0.0 OUTLIER -112.26 -171.44 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.271 -0.893 . . . . 0.0 110.112 179.555 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.675 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -170.61 131.43 0.89 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.888 -1.133 . . . . 0.0 110.056 -179.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.554 HG22 ' CG2' ' A' ' 223' ' ' ILE . 0.5 OUTLIER -88.97 152.03 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.333 -0.854 . . . . 0.0 110.656 -179.197 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 222' ' ' ARG . 9.2 m -133.61 -1.67 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 110.184 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.567 ' CB ' ' HD2' ' A' ' 222' ' ' ARG . 0.1 OUTLIER -171.59 125.24 0.59 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 110.169 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.523 ' CD1' HG13 ' A' ' 171' ' ' ILE . 8.5 tt -90.21 -3.12 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.854 . . . . 0.0 110.235 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 168' ' ' ILE . 0.2 OUTLIER 62.71 -141.26 0.4 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 110.243 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.87 109.0 18.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 110.306 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.523 HG13 ' CD1' ' A' ' 168' ' ' ILE . 41.9 mm -87.84 23.19 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 110.178 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -54.93 86.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.285 -0.884 . . . . 0.0 110.234 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.504 ' N ' ' O ' ' A' ' 171' ' ' ILE . 0.7 OUTLIER -142.99 -172.07 3.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 110.181 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.41 -4.78 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 110.262 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.417 ' OE1' ' OD2' ' A' ' 216' ' ' ASP . 77.0 mt-10 -71.48 167.0 20.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.178 -0.951 . . . . 0.0 110.204 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -173.7 -95.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.191 -0.943 . . . . 0.0 110.229 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 176' ' ' THR . 4.2 t0 72.35 -140.21 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.283 -0.886 . . . . 0.0 110.273 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -58.42 -16.2 13.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.276 -0.89 . . . . 0.0 110.43 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.573 ' CE2' HD11 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -60.5 -22.84 64.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.081 -1.012 . . . . 0.0 110.135 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 177' ' ' ASP . 0.6 OUTLIER -54.55 -26.91 34.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.144 -0.973 . . . . 0.0 109.864 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.464 ' HB3' ' OE2' ' A' ' 212' ' ' GLU . 3.2 tt0 -69.26 -65.75 0.67 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.365 -0.834 . . . . 0.0 110.218 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 179' ' ' PHE . 4.5 pp -58.99 -15.07 11.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.884 . . . . 0.0 110.268 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.573 HD11 ' CE2' ' A' ' 179' ' ' PHE . 0.7 OUTLIER -86.45 -31.18 21.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 109.998 179.8 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.15 -8.03 35.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.359 -0.838 . . . . 0.0 110.07 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -88.86 10.06 22.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.865 . . . . 0.0 110.176 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 185' ' ' ALA . 31.8 t0 41.69 66.66 0.66 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.907 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.3 tt -121.3 -173.56 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 110.54 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.576 ' O ' ' O ' ' A' ' 189' ' ' VAL . 0.1 OUTLIER -171.81 122.53 0.5 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.661 ' CG2' ' O ' ' A' ' 189' ' ' VAL . 1.4 m 50.27 105.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.204 -0.935 . . . . 0.0 108.947 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 191' ' ' SER . . . -45.14 -12.99 0.03 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.592 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 4.1 t 65.84 -143.26 0.19 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.012 -1.287 . . . . 0.0 109.42 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.675 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 1.9 tt0 -71.31 102.86 2.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.572 -0.705 . . . . 0.0 109.487 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.577 ' O ' ' O ' ' A' ' 163' ' ' VAL . 16.9 m -156.65 -140.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.097 -1.002 . . . . 0.0 109.967 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 162' ' ' LYS . 8.3 pt-20 -176.88 138.1 0.26 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 110.728 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.584 ' CG1' ' CG2' ' A' ' 202' ' ' ILE . 0.0 OUTLIER -132.26 161.21 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.293 -0.88 . . . . 0.0 109.99 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.563 ' N ' HG12 ' A' ' 195' ' ' ILE . 37.5 t -154.75 150.3 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.421 -0.799 . . . . 0.0 110.165 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.477 ' N ' HG11 ' A' ' 196' ' ' VAL . 4.4 t0 -58.92 119.53 7.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -0.943 . . . . 0.0 110.133 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 199' ' ' ASP . 0.0 OUTLIER -119.32 106.95 12.81 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.232 -0.917 . . . . 0.0 110.396 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 198' ' ' ARG . 15.9 m-20 40.75 79.71 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.254 -0.904 . . . . 0.0 110.372 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 44.84 25.12 0.85 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.414 ' O ' ' CB ' ' A' ' 198' ' ' ARG . 0.0 OUTLIER -150.18 106.83 3.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.214 -1.168 . . . . 0.0 110.132 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.584 ' CG2' ' CG1' ' A' ' 195' ' ' ILE . 49.8 mt -64.27 139.46 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 110.336 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 195' ' ' ILE . 3.7 m -119.16 150.32 40.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.338 -0.851 . . . . 0.0 109.935 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.545 ' HA ' ' HB ' ' A' ' 195' ' ' ILE . 0.5 OUTLIER -119.8 130.34 54.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 0.0 110.284 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.546 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 3.2 t -119.79 126.86 52.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.393 -0.817 . . . . 0.0 110.014 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.514 ' HB3' ' CG1' ' A' ' 193' ' ' VAL . 0.0 OUTLIER -114.19 106.64 14.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.451 -0.781 . . . . 0.0 109.836 180.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.487 ' HB3' ' O ' ' A' ' 206' ' ' HIS . 21.4 t30 61.01 17.4 7.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 110.243 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 114.04 -20.01 17.35 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -81.35 101.37 9.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -1.155 . . . . 0.0 110.277 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 30.5 p30 -83.93 147.84 27.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.912 . . . . 0.0 110.292 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.409 ' CG1' ' CE1' ' A' ' 206' ' ' HIS . 4.3 p -155.12 151.66 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.319 -0.863 . . . . 0.0 110.167 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.464 ' OE2' ' HB3' ' A' ' 181' ' ' GLN . 15.4 pt-20 -57.28 148.05 23.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 0.0 110.165 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.463 ' CD1' ' HB2' ' A' ' 204' ' ' LEU . 0.4 OUTLIER -113.86 -149.33 0.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 110.2 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.55 ' CD1' ' O ' ' A' ' 214' ' ' LEU . 0.4 OUTLIER -152.16 108.89 3.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 110.223 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -59.8 -38.67 82.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 110.304 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.417 ' OD2' ' OE1' ' A' ' 175' ' ' GLU . 0.2 OUTLIER -65.7 -44.71 85.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.911 . . . . 0.0 110.267 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.533 ' O ' ' CG2' ' A' ' 220' ' ' THR . 0.2 OUTLIER -85.83 -22.91 27.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.267 -0.896 . . . . 0.0 110.254 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.609 ' CB ' ' CG2' ' A' ' 153' ' ' ILE . . . -40.63 -44.84 2.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.334 -0.853 . . . . 0.0 110.288 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.487 ' HA ' HD13 ' A' ' 153' ' ' ILE . 39.8 t-80 -90.69 49.73 1.71 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.155 -0.966 . . . . 0.0 110.509 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' THR . . . . . 0.54 HG21 HD11 ' A' ' 221' ' ' ILE . 3.0 t -137.52 -27.16 0.95 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.126 -0.984 . . . . 0.0 110.486 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.54 HD11 HG21 ' A' ' 220' ' ' THR . 0.1 OUTLIER -95.23 144.5 9.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 120.998 -1.064 . . . . 0.0 110.362 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.567 ' HD2' ' CB ' ' A' ' 167' ' ' GLN . 3.7 ptp85 -95.06 106.72 18.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.146 -0.971 . . . . 0.0 109.405 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.643 ' CG2' HG11 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -119.78 174.03 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.183 -0.948 . . . . 0.0 110.253 -179.132 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 163' ' ' VAL . 1.2 tt0 -124.65 171.95 9.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.096 -1.003 . . . . 0.0 110.583 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 6.8 tp10 -113.52 110.99 21.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.374 -0.829 . . . . 0.0 110.182 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 162' ' ' LYS . 7.6 mp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.984 -1.007 . . . . 0.0 110.16 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.733 0.302 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.16 -45.66 0.43 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.023 1.539 . . . . 0.0 110.38 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.504 HG23 HD11 ' A' ' 132' ' ' ILE . 9.9 tt -63.79 140.63 97.86 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.25 -0.906 . . . . 0.0 110.223 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.09 -166.86 0.32 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.962 1.506 . . . . 0.0 110.384 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.12 -119.6 2.01 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.4 tp -130.44 138.36 50.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.198 -1.178 . . . . 0.0 110.187 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 138' ' ' LEU . 0.5 OUTLIER 52.93 33.27 14.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.305 -0.872 . . . . 0.0 110.158 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 59.83 -85.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.314 -0.866 . . . . 0.0 110.21 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -63.04 127.73 32.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.283 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.14 -40.68 95.08 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.1 t -76.48 120.21 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -1.145 . . . . 0.0 110.224 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -68.14 -35.01 82.48 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -80.79 85.64 6.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.274 -1.133 . . . . 0.0 110.26 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 36.4 t -173.8 -46.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.259 -0.901 . . . . 0.0 110.244 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.26 -157.09 0.4 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 0.0 110.211 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.67 146.97 53.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.271 -0.893 . . . . 0.0 110.252 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.459 ' O ' ' CB ' ' A' ' 147' ' ' ALA . . . -173.47 161.38 4.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.882 . . . . 0.0 110.207 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.459 ' CB ' ' O ' ' A' ' 146' ' ' ALA . . . 66.17 169.5 0.11 Allowed Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.21 -0.931 . . . . 0.0 110.173 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.462 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 45.8 Cg_endo -72.98 76.35 2.55 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.122 1.59 . . . . 0.0 110.358 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 151' ' ' ARG . . . -114.83 35.01 4.6 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.539 ' O ' ' CG1' ' A' ' 223' ' ' ILE . 23.8 m -42.07 93.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.37 -1.076 . . . . 0.0 110.236 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.549 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 7.2 ptp85 -42.02 142.75 0.66 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.219 -0.926 . . . . 0.0 110.112 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.582 ' CG1' HD13 ' A' ' 221' ' ' ILE . 0.8 OUTLIER -57.57 -153.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.176 -0.953 . . . . 0.0 110.039 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.577 ' CG2' ' CB ' ' A' ' 218' ' ' ALA . 11.8 pt 39.29 25.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.321 -0.862 . . . . 0.0 110.436 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER -135.55 -36.35 0.78 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.312 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.431 ' CB ' HG13 ' A' ' 163' ' ' VAL . . . -88.76 -9.94 50.06 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.473 ' HB1' HD13 ' A' ' 195' ' ' ILE . . . -74.7 107.42 6.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.546 -0.721 . . . . 0.0 110.234 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 158' ' ' SER . 5.7 t -174.11 169.62 3.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.272 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 159' ' ' MET . 0.6 OUTLIER 41.77 74.17 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.327 -0.858 . . . . 0.0 110.124 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' MET . . . . . 0.496 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 0.0 OUTLIER 63.51 165.9 0.11 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.144 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 44.6 Cg_endo -72.24 88.01 0.87 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.999 1.526 . . . . 0.0 110.435 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.2 ttt85 -65.61 -140.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 110.21 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -145.29 93.15 2.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.234 -0.916 . . . . 0.0 110.254 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.675 ' O ' ' O ' ' A' ' 193' ' ' VAL . 21.5 m -111.52 -172.94 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.0 110.224 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.616 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 12.8 ptt-85 -162.39 147.17 12.3 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.725 -1.234 . . . . 0.0 110.872 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 191' ' ' SER . 1.2 mt -98.71 165.84 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.493 -0.755 . . . . 0.0 110.273 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 222' ' ' ARG . 19.1 m -142.54 -31.8 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.158 -0.964 . . . . 0.0 110.484 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 222' ' ' ARG . 0.7 OUTLIER -140.34 123.91 17.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 110.282 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 221' ' ' ILE . 7.4 tt -99.61 -5.95 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 110.117 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 168' ' ' ILE . 17.4 m120 55.05 164.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.315 -0.866 . . . . 0.0 110.204 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 169' ' ' ASN . 28.5 mt-10 -144.51 49.57 1.32 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.14 -0.975 . . . . 0.0 110.204 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.4 ' HA ' HD11 ' A' ' 171' ' ' ILE . 16.0 mm -100.23 -3.08 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.211 -0.931 . . . . 0.0 110.234 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -123.01 154.47 38.42 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.142 -0.974 . . . . 0.0 110.214 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 174' ' ' VAL . 0.0 OUTLIER -79.43 -26.99 41.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.226 -0.921 . . . . 0.0 110.187 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.555 HG11 ' CZ ' ' A' ' 179' ' ' PHE . 41.6 t 43.91 74.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 110.344 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -103.88 116.96 33.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.289 -0.882 . . . . 0.0 110.107 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.589 ' CG2' ' HB3' ' A' ' 179' ' ' PHE . 2.9 m -155.42 134.56 12.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.901 . . . . 0.0 110.18 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 179' ' ' PHE . 1.1 p-10 -48.73 -101.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.316 -0.865 . . . . 0.0 111.248 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.484 ' C ' ' O ' ' A' ' 177' ' ' ASP . 5.1 pt20 -34.04 -30.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.258 -0.901 . . . . 0.0 111.082 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.589 ' HB3' ' CG2' ' A' ' 176' ' ' THR . 7.4 t80 -60.48 -59.59 5.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.944 . . . . 0.0 110.487 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.525 ' OG1' ' O ' ' A' ' 177' ' ' ASP . 0.9 OUTLIER -37.98 -29.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.359 -0.838 . . . . 0.0 110.33 -179.706 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.504 ' N ' ' O ' ' A' ' 179' ' ' PHE . 24.4 tt0 -57.45 -56.69 18.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.202 -0.937 . . . . 0.0 110.019 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 179' ' ' PHE . 2.6 pp -70.03 -14.04 62.5 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.286 -0.884 . . . . 0.0 109.686 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.47 ' HB3' ' HA ' ' A' ' 180' ' ' THR . 0.4 OUTLIER -89.8 -32.13 17.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.393 -0.817 . . . . 0.0 109.775 179.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -69.4 -4.8 19.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.309 -0.869 . . . . 0.0 109.806 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -83.74 14.33 4.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.428 -0.795 . . . . 0.0 110.114 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 185' ' ' ALA . 0.7 OUTLIER 42.82 62.74 1.67 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.156 -0.965 . . . . 0.0 109.896 -179.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.8 tt -119.35 -173.78 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 110.52 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.575 ' O ' HG23 ' A' ' 189' ' ' VAL . 0.1 OUTLIER -174.53 115.56 0.18 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.362 -0.836 . . . . 0.0 108.748 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.649 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 1.3 m 51.57 108.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.298 -0.876 . . . . 0.0 109.073 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.496 ' O ' HG12 ' A' ' 193' ' ' VAL . . . -46.12 -13.96 0.08 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.573 ' O ' ' HB2' ' A' ' 164' ' ' ARG . 7.7 t 63.93 -146.87 0.3 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -1.148 . . . . 0.0 109.483 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.616 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.2 OUTLIER -63.4 99.63 0.21 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.618 -0.676 . . . . 0.0 109.576 179.336 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.675 ' O ' ' O ' ' A' ' 163' ' ' VAL . 26.2 m -157.28 -135.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -0.93 . . . . 0.0 109.603 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.507 ' N ' HG22 ' A' ' 193' ' ' VAL . 0.3 OUTLIER -175.04 160.47 2.78 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.124 179.297 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.564 HG12 ' CG2' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -119.97 176.62 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.074 -1.016 . . . . 0.0 110.227 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.445 ' CG2' ' C ' ' A' ' 195' ' ' ILE . 7.4 t -148.7 86.7 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.291 -0.881 . . . . 0.0 110.183 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 197' ' ' ASP . 15.8 p-10 -43.8 127.33 5.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 110.245 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.499 ' O ' ' C ' ' A' ' 199' ' ' ASP . 21.9 mtt180 -99.76 71.58 1.7 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -0.889 . . . . 0.0 110.37 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 198' ' ' ARG . 3.9 p-10 36.18 39.74 0.09 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.366 -0.833 . . . . 0.0 110.413 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 140.75 -48.77 0.81 Allowed Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.453 ' O ' ' CG1' ' A' ' 202' ' ' ILE . 0.1 OUTLIER -89.9 -158.12 0.51 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -1.11 . . . . 0.0 109.801 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.564 HD11 ' CG2' ' A' ' 153' ' ' ILE . 8.1 mt -155.63 159.53 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.073 -1.017 . . . . 0.0 110.571 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 195' ' ' ILE . 43.2 m -144.32 151.97 40.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.534 -0.729 . . . . 0.0 109.464 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.538 ' CD2' ' CD2' ' A' ' 206' ' ' HIS . 0.5 OUTLIER -119.91 129.09 54.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.166 -0.959 . . . . 0.0 110.536 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.578 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.5 OUTLIER -119.98 119.8 34.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.424 -0.797 . . . . 0.0 109.826 179.77 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.538 ' CD2' ' CD2' ' A' ' 204' ' ' LEU . 1.5 m170 -107.31 152.35 24.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.498 -0.751 . . . . 0.0 109.931 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -49.04 -20.54 0.55 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.15 -0.969 . . . . 0.0 110.059 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' A' ' 209' ' ' LYS . . . -91.2 -31.81 9.42 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 208' ' ' GLY . 10.4 pttt 174.02 -173.95 0.06 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.211 -1.17 . . . . 0.0 110.173 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 4.6 p30 -112.17 161.59 16.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.893 . . . . 0.0 110.413 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 39.1 t -147.04 147.14 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 0.0 110.127 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.0 160.74 30.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.0 110.283 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.413 HD11 HG21 ' A' ' 202' ' ' ILE . 2.9 mt -131.83 -160.11 1.02 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.203 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.478 ' N ' ' CD2' ' A' ' 214' ' ' LEU . 0.9 OUTLIER -173.15 169.18 4.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.19 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -75.81 -26.17 56.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 110.183 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.447 ' OD2' ' HA ' ' A' ' 174' ' ' VAL . 1.0 OUTLIER -63.21 -57.02 11.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 110.125 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.453 ' O ' ' C ' ' A' ' 218' ' ' ALA . 0.2 OUTLIER -78.35 -28.0 47.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 110.112 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.577 ' CB ' ' CG2' ' A' ' 153' ' ' ILE . . . -40.05 -63.8 0.57 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.369 -0.832 . . . . 0.0 110.487 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.525 ' N ' HD12 ' A' ' 153' ' ' ILE . 3.5 t-160 -91.77 77.59 5.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.879 . . . . 0.0 110.306 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 219' ' ' HIS . 4.9 m -166.74 -48.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 0.0 110.44 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.601 HG12 ' CG2' ' A' ' 223' ' ' ILE . 0.1 OUTLIER -73.98 136.75 24.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.361 -0.837 . . . . 0.0 110.786 -179.66 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.539 ' O ' ' CG2' ' A' ' 166' ' ' VAL . 0.0 OUTLIER -89.39 112.91 24.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.212 -0.93 . . . . 0.0 109.256 179.275 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.601 ' CG2' HG12 ' A' ' 221' ' ' ILE . 0.7 OUTLIER -119.97 -169.48 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.158 -0.964 . . . . 0.0 110.808 -179.053 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 148' ' ' PRO . 30.8 mt-10 -150.25 156.57 41.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.449 -0.782 . . . . 0.0 110.051 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -107.48 99.2 8.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 110.254 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.233 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.468 ' ND2' ' HB3' ' A' ' 133' ' ' PRO . 6.9 t30 . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.489 ' O ' ' HD3' ' A' ' 133' ' ' PRO . 44.3 Cg_endo -72.59 -85.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.05 1.553 . . . . 0.0 110.58 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 30.3 mt -106.12 85.96 1.83 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 110.134 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 131' ' ' PRO . 45.9 Cg_endo -72.6 -53.95 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.992 1.522 . . . . 0.0 110.453 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.43 42.48 2.01 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.438 HD13 ' CG2' ' A' ' 140' ' ' VAL . 1.4 tp -124.28 26.16 7.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.293 -1.122 . . . . 0.0 110.254 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -103.62 -88.22 0.42 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.898 . . . . 0.0 110.085 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -109.6 -17.98 13.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.284 -0.885 . . . . 0.0 110.208 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.72 -43.72 92.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.253 -0.904 . . . . 0.0 110.189 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 99.48 165.47 29.61 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.438 ' CG2' HD13 ' A' ' 135' ' ' LEU . 25.5 t -115.23 -19.04 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.247 -1.149 . . . . 0.0 110.16 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 140' ' ' VAL . . . 44.08 -151.08 0.63 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 47.02 30.37 1.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -1.135 . . . . 0.0 110.223 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.54 -60.22 2.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 110.216 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -123.12 66.53 0.98 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.288 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -137.93 -166.95 2.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 110.113 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -124.91 -90.6 0.55 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.153 -0.967 . . . . 0.0 110.394 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -83.95 134.62 43.64 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.917 . . . . 0.0 110.394 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.8 89.12 1.01 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.989 1.521 . . . . 0.0 110.344 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.484 ' O ' ' HG2' ' A' ' 222' ' ' ARG . . . -48.21 123.41 9.62 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.584 ' HB ' ' O ' ' A' ' 223' ' ' ILE . 2.2 m -47.39 -89.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -1.142 . . . . 0.0 110.088 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.595 ' CB ' ' HB2' ' A' ' 154' ' ' ASP . 0.0 OUTLIER 169.07 135.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.89 . . . . 0.0 110.01 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.632 ' HA ' HG12 ' A' ' 223' ' ' ILE . 1.2 m -37.85 -92.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.346 -0.846 . . . . 0.0 111.302 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.544 ' CD1' ' N ' ' A' ' 154' ' ' ASP . 1.9 pp -41.04 -23.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.151 -0.968 . . . . 0.0 111.032 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.595 ' HB2' ' CB ' ' A' ' 151' ' ' ARG . 1.2 m-20 -75.12 -16.79 60.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.107 -0.996 . . . . 0.0 110.001 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -109.9 -16.21 13.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.398 -0.814 . . . . 0.0 110.178 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.467 ' HB3' ' HB ' ' A' ' 195' ' ' ILE . . . -82.7 99.72 9.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.342 -0.849 . . . . 0.0 110.303 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 156' ' ' ALA . 3.2 m -169.8 152.11 4.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.261 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 159' ' ' MET . 6.4 t 55.41 88.29 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.897 . . . . 0.0 110.27 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' MET . . . . . 0.444 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 27.4 mtm 55.83 169.5 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 110.183 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 45.9 Cg_endo -72.87 91.29 0.82 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.047 1.551 . . . . 0.0 110.417 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -82.32 129.05 34.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 0.0 110.073 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.469 ' O ' HG11 ' A' ' 163' ' ' VAL . 2.4 mmtp -68.91 125.5 26.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.898 . . . . 0.0 110.427 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.535 ' C ' ' O ' ' A' ' 193' ' ' VAL . 29.2 m -141.63 -153.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.229 -0.92 . . . . 0.0 110.234 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.626 ' HG2' ' N ' ' A' ' 165' ' ' ILE . 0.0 OUTLIER -176.21 153.94 1.32 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.901 -1.124 . . . . 0.0 110.213 -179.452 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 1.008 ' HB ' ' O ' ' A' ' 189' ' ' VAL . 20.1 mt -102.36 176.21 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.159 -0.963 . . . . 0.0 111.291 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.616 ' CA ' ' HA2' ' A' ' 190' ' ' GLY . 2.7 m -126.36 -28.2 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.664 -0.648 . . . . 0.0 109.561 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.595 ' CA ' ' CG2' ' A' ' 189' ' ' VAL . 0.5 OUTLIER 162.22 147.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.558 -0.714 . . . . 0.0 110.515 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.556 ' HA ' ' CG2' ' A' ' 221' ' ' ILE . 2.7 mt -66.0 -7.29 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.484 -0.76 . . . . 0.0 109.088 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 170' ' ' GLU . 0.1 OUTLIER 53.45 108.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.593 -0.692 . . . . 0.0 110.305 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 169' ' ' ASN . 1.0 OUTLIER 61.78 76.88 0.35 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -0.885 . . . . 0.0 110.278 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.495 HG21 ' HB ' ' A' ' 168' ' ' ILE . 1.7 pp -80.05 6.18 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.894 . . . . 0.0 110.181 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -49.06 -25.53 2.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 110.306 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -71.86 163.61 27.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.937 . . . . 0.0 110.335 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.493 ' O ' ' CG2' ' A' ' 174' ' ' VAL . 7.0 p -169.95 39.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.248 -0.908 . . . . 0.0 110.264 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.606 ' O ' ' C ' ' A' ' 176' ' ' THR . 18.6 pt-20 -72.73 -152.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.127 -0.983 . . . . 0.0 110.348 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.606 ' C ' ' O ' ' A' ' 175' ' ' GLU . 9.7 t 21.9 94.39 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.747 -0.595 . . . . 0.0 111.091 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.488 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.1 OUTLIER -60.49 -12.05 8.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.178 -0.951 . . . . 0.0 110.235 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -76.47 -6.9 53.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.118 -0.989 . . . . 0.0 110.251 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.507 ' HA ' HD13 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -87.02 -31.61 20.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.169 -0.957 . . . . 0.0 110.112 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.502 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 1.1 p -42.69 -31.62 0.49 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 109.808 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -60.6 -22.84 64.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.357 -0.839 . . . . 0.0 109.608 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.584 ' CD2' ' CG1' ' A' ' 211' ' ' VAL . 13.6 mt -83.17 -39.8 20.55 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.343 -0.848 . . . . 0.0 109.089 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.75 -29.13 61.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.61 -0.681 . . . . 0.0 109.778 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -72.73 -2.62 21.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 109.882 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.53 ' HB2' ' CG2' ' A' ' 187' ' ' ILE . . . -88.53 14.86 8.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.316 -0.865 . . . . 0.0 110.205 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 185' ' ' ALA . 0.2 OUTLIER 42.37 30.97 0.24 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 109.209 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.53 ' CG2' ' HB2' ' A' ' 185' ' ' ALA . 4.5 tt -116.29 164.34 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.602 -0.687 . . . . 0.0 110.48 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.417 ' N ' HG12 ' A' ' 187' ' ' ILE . 1.8 ttp180 -134.05 161.28 35.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.308 -0.87 . . . . 0.0 109.116 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 1.008 ' O ' ' HB ' ' A' ' 165' ' ' ILE . 14.0 m -79.53 -37.39 18.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.871 -1.143 . . . . 0.0 109.099 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.617 ' N ' HG21 ' A' ' 189' ' ' VAL . . . -56.07 50.54 0.01 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.768 ' N ' ' O ' ' A' ' 189' ' ' VAL . 1.8 t -140.66 167.36 22.35 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.372 -1.075 . . . . 0.0 109.228 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.586 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 1.4 mt-10 -65.46 122.45 17.21 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.794 -0.763 . . . . 0.0 109.036 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.667 ' HA ' ' O ' ' A' ' 205' ' ' SER . 0.4 OUTLIER -160.44 144.79 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.042 -1.036 . . . . 0.0 110.254 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 204' ' ' LEU . 1.4 pt-20 -112.18 159.84 18.17 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.346 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.52 ' CG2' ' HG ' ' A' ' 204' ' ' LEU . 1.2 mt -119.53 153.93 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.069 -1.019 . . . . 0.0 110.532 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 42.3 t -127.63 107.57 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.482 -0.761 . . . . 0.0 109.991 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -75.17 111.74 10.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.928 . . . . 0.0 110.286 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.476 ' O ' ' C ' ' A' ' 199' ' ' ASP . 0.0 OUTLIER -102.89 67.03 0.95 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.217 -0.927 . . . . 0.0 110.299 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 198' ' ' ARG . 25.4 m-20 38.97 37.55 0.22 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.349 -0.844 . . . . 0.0 110.213 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 141.1 -43.16 1.12 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.451 ' O ' ' N ' ' A' ' 198' ' ' ARG . 0.1 OUTLIER -90.12 123.55 34.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -1.122 . . . . 0.0 110.139 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.472 HG21 HG23 ' A' ' 195' ' ' ILE . 10.4 mt -126.36 99.54 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.112 -0.993 . . . . 0.0 110.348 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.495 HG22 ' HA ' ' A' ' 212' ' ' GLU . 89.9 m -106.86 157.45 17.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.318 -0.864 . . . . 0.0 109.878 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.616 ' CD1' ' CB ' ' A' ' 213' ' ' LEU . 2.0 mp -120.05 150.31 40.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.458 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.667 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 16.4 t -119.42 110.48 16.98 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.458 -0.776 . . . . 0.0 109.228 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.647 ' CD2' ' CG1' ' A' ' 193' ' ' VAL . 23.6 m80 -92.45 153.58 19.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.597 -0.689 . . . . 0.0 110.129 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.464 ' N ' ' OD1' ' A' ' 207' ' ' ASN . 26.6 p-10 -51.77 93.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 110.286 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 209' ' ' LYS . . . 136.91 -32.45 2.44 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 208' ' ' GLY . 0.0 OUTLIER 176.56 160.15 0.35 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -1.151 . . . . 0.0 110.285 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 1.9 p-10 -109.68 174.78 5.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.33 -0.856 . . . . 0.0 110.117 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.584 ' CG1' ' CD2' ' A' ' 182' ' ' LEU . 45.6 t -154.6 140.98 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.378 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.495 ' HA ' HG22 ' A' ' 203' ' ' THR . 55.6 mt-10 -73.48 74.37 1.43 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.4 -0.812 . . . . 0.0 110.219 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.616 ' CB ' ' CD1' ' A' ' 204' ' ' LEU . 30.6 tp -57.89 162.62 3.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.917 . . . . 0.0 110.273 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.496 ' N ' ' HG ' ' A' ' 213' ' ' LEU . 3.2 mm? -51.37 146.74 6.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 0.0 110.189 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.479 ' O ' ' HB1' ' A' ' 218' ' ' ALA . 2.1 m-20 -83.17 -102.39 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.942 . . . . 0.0 109.906 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.97 -24.48 1.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.0 -1.062 . . . . 0.0 109.742 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.542 ' O ' ' C ' ' A' ' 218' ' ' ALA . 0.1 OUTLIER -90.15 -14.25 33.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.319 -0.863 . . . . 0.0 110.211 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.659 ' O ' ' N ' ' A' ' 220' ' ' THR . . . -29.98 -49.07 0.1 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.506 -0.746 . . . . 0.0 110.723 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.568 ' O ' ' CG ' ' A' ' 219' ' ' HIS . 7.8 p80 -51.37 78.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.364 -0.835 . . . . 0.0 110.404 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' THR . . . . . 0.659 ' N ' ' O ' ' A' ' 218' ' ' ALA . 1.2 p -136.56 -28.76 0.98 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 110.365 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.584 ' CG1' HG12 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -109.98 154.74 11.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 O-C-N 121.196 -0.94 . . . . 0.0 110.584 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.542 ' O ' ' CG2' ' A' ' 166' ' ' VAL . 0.6 OUTLIER -89.03 94.41 9.94 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 178.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.69 ' HB ' ' HA ' ' A' ' 165' ' ' ILE . 0.4 OUTLIER -119.38 149.43 21.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.322 -0.861 . . . . 0.0 110.712 -178.202 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.411 ' HA ' ' HB ' ' A' ' 150' ' ' THR . 13.9 pt-20 -132.02 178.51 6.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.417 -0.802 . . . . 0.0 110.096 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.533 ' HA ' ' CG1' ' A' ' 163' ' ' VAL . 0.0 OUTLIER -85.93 173.97 9.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 110.349 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.203 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 120.823 0.344 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.25 -90.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.006 1.529 . . . . 0.0 110.417 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 17.0 mm -96.63 122.44 57.12 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 110.141 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.43 -53.66 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.917 1.483 . . . . 0.0 110.372 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -156.74 -89.55 0.07 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.2 mt -104.29 -166.51 1.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.291 -1.123 . . . . 0.0 110.162 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 136' ' ' ASP . 46.0 t0 -106.83 -20.96 13.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 110.209 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -63.97 85.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.315 -0.866 . . . . 0.0 110.208 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.12 -61.76 1.95 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 0.0 110.206 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -85.92 -139.77 5.33 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.3 p -170.02 69.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -1.17 . . . . 0.0 110.214 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.52 25.03 40.51 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 9.3 m120 52.05 89.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -1.114 . . . . 0.0 110.227 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.4 m -92.47 170.43 9.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 0.0 110.17 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.71 154.06 23.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.294 -0.879 . . . . 0.0 110.172 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.16 178.81 7.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.302 -0.874 . . . . 0.0 110.225 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -161.58 84.03 0.62 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.928 . . . . 0.0 110.201 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 60.96 156.89 0.11 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.899 . . . . 0.0 110.309 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.43 57.97 3.64 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.968 1.51 . . . . 0.0 110.383 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.46 ' CA ' ' HB3' ' A' ' 222' ' ' ARG . . . -160.44 152.41 23.15 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.452 ' O ' ' CG2' ' A' ' 150' ' ' THR . 58.1 m -147.23 18.0 1.21 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -1.137 . . . . 0.0 110.242 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.569 ' CB ' HD12 ' A' ' 153' ' ' ILE . 1.9 mpp_? 63.15 127.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.964 . . . . 0.0 110.184 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.546 ' CG1' HD13 ' A' ' 221' ' ' ILE . 0.6 OUTLIER -78.6 36.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.121 -0.987 . . . . 0.0 111.155 -179.648 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.584 ' CD1' ' N ' ' A' ' 153' ' ' ILE . 0.1 OUTLIER -138.84 -32.27 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.865 -1.147 . . . . 0.0 110.226 179.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.94 -12.67 61.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.454 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.519 ' O ' ' CB ' ' A' ' 161' ' ' ARG . . . -103.64 -14.03 16.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.516 -0.74 . . . . 0.0 109.966 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.449 ' HB1' HD11 ' A' ' 195' ' ' ILE . . . -81.8 72.64 8.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 110.273 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -73.54 -171.64 1.05 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.251 -0.906 . . . . 0.0 110.111 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.487 ' OG ' ' N ' ' A' ' 159' ' ' MET . 0.9 OUTLIER -42.41 -57.65 2.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 0.0 110.132 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' MET . . . . . 0.487 ' N ' ' OG ' ' A' ' 158' ' ' SER . 3.0 mmt -75.68 165.19 55.38 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.891 . . . . 0.0 110.081 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 44.4 Cg_endo -72.14 73.21 2.64 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.976 1.514 . . . . 0.0 110.444 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 155' ' ' ALA . 1.8 tpt180 -51.64 127.38 20.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -0.951 . . . . 0.0 110.197 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.489 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -74.8 125.4 28.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.873 . . . . 0.0 110.36 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.623 ' O ' ' O ' ' A' ' 193' ' ' VAL . 0.1 OUTLIER -144.86 -166.16 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 110.112 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.638 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -169.19 136.66 1.83 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.824 -1.172 . . . . 0.0 110.101 -179.601 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' A' ' 191' ' ' SER . 0.9 OUTLIER -92.52 153.08 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.294 -0.879 . . . . 0.0 110.489 -179.434 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.476 ' CG1' ' NE ' ' A' ' 164' ' ' ARG . 11.1 m -145.43 11.22 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 110.204 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -170.91 123.92 0.63 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.229 -0.92 . . . . 0.0 110.195 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.45 HG23 HG11 ' A' ' 189' ' ' VAL . 19.2 tt -131.3 4.99 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.326 -0.858 . . . . 0.0 110.15 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.432 ' O ' ' CB ' ' A' ' 170' ' ' GLU . 4.4 p30 -52.58 169.05 0.09 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 110.163 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.432 ' CB ' ' O ' ' A' ' 169' ' ' ASN . 0.3 OUTLIER 64.86 44.8 3.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.182 -0.949 . . . . 0.0 110.134 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.43 HG22 HG12 ' A' ' 168' ' ' ILE . 1.3 pp -119.61 31.95 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.27 -0.894 . . . . 0.0 110.22 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.27 89.7 1.21 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 110.215 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.435 ' OE1' ' HA ' ' A' ' 173' ' ' GLN . 8.3 mm100 -106.06 165.38 11.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.274 -0.891 . . . . 0.0 110.205 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.5 m -106.72 11.45 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.161 -0.962 . . . . 0.0 110.27 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.78 139.74 37.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.896 . . . . 0.0 110.18 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.527 HG22 ' CG2' ' A' ' 180' ' ' THR . 54.4 m -118.88 -92.81 0.53 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 110.245 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 176' ' ' THR . 0.4 OUTLIER 66.3 -165.62 0.22 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.212 -0.93 . . . . 0.0 110.28 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -55.2 -20.64 11.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.261 -0.899 . . . . 0.0 110.294 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' A' ' 180' ' ' THR . 0.0 OUTLIER -49.17 -26.29 2.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.195 -0.941 . . . . 0.0 109.983 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.577 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.2 OUTLIER -55.15 -26.42 38.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.884 . . . . 0.0 109.949 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -69.29 -63.36 1.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.321 -0.862 . . . . 0.0 110.114 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.488 ' C ' ' CD1' ' A' ' 182' ' ' LEU . 4.4 pp -61.6 -15.91 43.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.379 -0.826 . . . . 0.0 110.114 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.56 HD12 ' CZ ' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -91.1 -28.55 17.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.162 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 180' ' ' THR . 18.9 t70 -79.99 4.25 17.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 110.183 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -85.12 16.66 3.38 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.862 . . . . 0.0 110.188 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 185' ' ' ALA . 3.8 t0 41.66 43.17 2.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.248 -0.907 . . . . 0.0 109.92 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.6 tt -102.9 -178.5 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.874 . . . . 0.0 110.367 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.579 ' O ' ' O ' ' A' ' 189' ' ' VAL . 9.4 ptt180 -170.52 117.48 0.51 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.635 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 1.3 m 51.3 108.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.199 -0.938 . . . . 0.0 109.154 -178.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.477 ' O ' HG12 ' A' ' 193' ' ' VAL . . . -45.63 -13.65 0.06 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.56 ' N ' ' O ' ' A' ' 189' ' ' VAL . 3.7 t 66.05 -144.14 0.19 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.071 -1.253 . . . . 0.0 109.421 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.638 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -65.21 101.93 0.6 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.474 -0.766 . . . . 0.0 109.267 179.221 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.623 ' O ' ' O ' ' A' ' 163' ' ' VAL . 23.0 m -156.9 -138.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -0.948 . . . . 0.0 110.033 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.518 ' HA ' HG22 ' A' ' 163' ' ' VAL . 1.1 pp20? -175.48 160.85 2.61 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.293 -0.88 . . . . 0.0 110.142 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.542 ' CG2' ' HG ' ' A' ' 204' ' ' LEU . 0.4 OUTLIER -120.86 169.81 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.159 -0.963 . . . . 0.0 110.335 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.519 ' CG1' ' HB ' ' A' ' 203' ' ' THR . 4.7 p -149.67 77.38 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.883 . . . . 0.0 110.032 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 202' ' ' ILE . 11.8 t70 -40.78 142.22 0.49 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 110.336 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.475 ' O ' ' N ' ' A' ' 200' ' ' GLY . 1.9 ttp180 -139.77 -174.6 3.95 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.205 -0.935 . . . . 0.0 110.315 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -42.28 96.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.258 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 198' ' ' ARG . . . 44.01 29.48 1.51 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -150.26 113.72 4.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.252 -1.146 . . . . 0.0 110.215 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.467 ' CD1' HG21 ' A' ' 153' ' ' ILE . 70.3 mt -94.24 144.99 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 0.0 110.167 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.519 ' HB ' ' CG1' ' A' ' 196' ' ' VAL . 1.2 m -126.32 156.09 40.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.056 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.542 ' HG ' ' CG2' ' A' ' 195' ' ' ILE . 1.0 OUTLIER -119.82 131.98 55.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -0.956 . . . . 0.0 110.232 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.528 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 20.1 t -119.75 124.6 46.58 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.3 -0.875 . . . . 0.0 109.781 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.556 ' HA ' ' CB ' ' A' ' 193' ' ' VAL . 2.4 m170 -106.02 158.95 16.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.417 -0.802 . . . . 0.0 109.999 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.0 72.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 110.155 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 153.63 -21.07 0.71 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 208' ' ' GLY . 0.3 OUTLIER 169.93 149.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.161 -1.199 . . . . 0.0 110.218 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 1.2 p30 -97.08 -171.99 2.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.92 . . . . 0.0 110.13 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 8.7 p -158.69 165.36 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -0.917 . . . . 0.0 110.226 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -69.49 141.04 54.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 110.239 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.539 ' CD1' ' HB1' ' A' ' 218' ' ' ALA . 0.3 OUTLIER -148.15 145.04 28.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.932 . . . . 0.0 110.173 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.485 ' O ' ' HG ' ' A' ' 214' ' ' LEU . 0.6 OUTLIER -133.61 143.49 48.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.268 -0.895 . . . . 0.0 110.21 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.418 ' OD2' HD13 ' A' ' 202' ' ' ILE . 0.3 OUTLIER -50.2 -51.56 43.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.197 -0.94 . . . . 0.0 110.185 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 215' ' ' ASP . 0.5 OUTLIER -43.38 -49.18 7.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.932 . . . . 0.0 110.262 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.464 ' O ' ' OG1' ' A' ' 220' ' ' THR . 0.4 OUTLIER -89.12 -26.77 21.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.891 . . . . 0.0 110.14 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.593 ' O ' ' CD1' ' A' ' 221' ' ' ILE . . . -64.83 -17.68 64.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.257 -0.902 . . . . 0.0 110.091 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.509 ' O ' ' CG2' ' A' ' 220' ' ' THR . 0.2 OUTLIER -89.2 56.56 3.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.135 -0.978 . . . . 0.0 110.217 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' THR . . . . . 0.509 ' CG2' ' O ' ' A' ' 219' ' ' HIS . 17.6 p -158.12 -47.22 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 0.0 110.372 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.593 ' CD1' ' O ' ' A' ' 218' ' ' ALA . 0.1 OUTLIER -63.17 130.93 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.29 -0.881 . . . . 0.0 110.52 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.46 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . 37.0 mtt85 -91.67 104.09 16.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.345 -0.847 . . . . 0.0 109.618 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.534 ' CG2' HG12 ' A' ' 221' ' ' ILE . 0.1 OUTLIER -119.51 171.53 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.144 -0.973 . . . . 0.0 110.023 -179.566 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -140.13 167.58 21.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.163 -0.961 . . . . 0.0 110.415 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 8.1 pt-20 -91.53 38.85 0.99 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.381 -0.824 . . . . 0.0 110.247 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.175 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.559 ' CB ' ' CD ' ' A' ' 131' ' ' PRO . 1.5 m-80 . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.559 ' CD ' ' CB ' ' A' ' 130' ' ' ASN . 46.9 Cg_endo -73.01 53.67 2.49 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.975 1.513 . . . . 0.0 110.494 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 5.9 pt -104.27 161.04 24.07 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.199 -0.938 . . . . 0.0 110.262 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.0 -12.4 25.94 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.0 1.526 . . . . 0.0 110.464 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 135' ' ' LEU . . . 118.51 -77.32 0.3 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.448 ' CB ' ' O ' ' A' ' 134' ' ' GLY . 0.2 OUTLIER 65.29 138.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.294 -1.121 . . . . 0.0 110.241 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 17.7 p30 -61.98 96.63 0.07 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 110.22 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.2 89.12 4.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.933 . . . . 0.0 110.232 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -48.95 168.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.297 -0.877 . . . . 0.0 110.223 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -164.22 68.53 0.21 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.472 ' O ' ' CG1' ' A' ' 140' ' ' VAL . 8.2 p -171.32 91.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.279 -1.13 . . . . 0.0 110.228 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.13 -172.83 54.86 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.452 ' O ' ' O ' ' A' ' 143' ' ' SER . 8.9 t30 -137.62 -59.94 0.66 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -1.132 . . . . 0.0 110.16 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.452 ' O ' ' O ' ' A' ' 142' ' ' ASN . 1.5 p -50.01 -178.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 110.226 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 15.9 t0 60.57 104.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.213 -0.929 . . . . 0.0 110.2 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -110.22 -16.58 13.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.316 -0.865 . . . . 0.0 110.176 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 147' ' ' ALA . . . -161.08 129.28 4.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.186 -0.946 . . . . 0.0 110.11 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 146' ' ' ALA . . . 58.71 156.12 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.342 -0.849 . . . . 0.0 110.161 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.51 52.67 2.48 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.967 1.509 . . . . 0.0 110.44 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.469 ' HA3' ' HB2' ' A' ' 222' ' ' ARG . . . 131.84 157.5 8.72 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.544 ' O ' ' CG1' ' A' ' 223' ' ' ILE . 54.2 m -123.31 143.56 50.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.308 -1.113 . . . . 0.0 110.163 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 154' ' ' ASP . 0.1 OUTLIER -50.16 127.69 17.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.123 -0.986 . . . . 0.0 110.055 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.541 ' CG1' HD13 ' A' ' 221' ' ' ILE . 2.5 p -43.88 -25.49 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.103 -0.998 . . . . 0.0 110.378 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.561 ' CG2' ' CB ' ' A' ' 218' ' ' ALA . 1.3 pt -95.22 -14.04 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 110.325 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.515 ' HB3' ' CG2' ' A' ' 150' ' ' THR . 2.0 m-20 -77.35 -19.28 56.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.994 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -97.36 -13.0 22.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.371 -0.831 . . . . 0.0 110.016 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 157' ' ' THR . . . -51.06 166.07 0.1 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.875 . . . . 0.0 110.262 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.533 ' O ' ' CB ' ' A' ' 158' ' ' SER . 14.7 m 51.93 167.37 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.315 -0.866 . . . . 0.0 110.398 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 157' ' ' THR . 0.1 OUTLIER 70.89 -52.14 0.68 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.24 -0.913 . . . . 0.0 110.309 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -100.72 139.17 20.36 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.175 -0.953 . . . . 0.0 110.147 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.552 ' O ' ' C ' ' A' ' 161' ' ' ARG . 45.4 Cg_endo -72.92 71.85 3.35 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.962 1.506 . . . . 0.0 110.426 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.59 ' HB3' ' CG2' ' A' ' 196' ' ' VAL . 7.7 ptt180 27.12 99.8 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.505 0.669 . . . . 0.0 111.282 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.469 ' O ' HG11 ' A' ' 163' ' ' VAL . 0.4 OUTLIER -170.72 56.41 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.175 -0.953 . . . . 0.0 109.995 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.669 ' O ' ' O ' ' A' ' 193' ' ' VAL . 34.9 m -141.83 -151.83 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.925 0.869 . . . . 0.0 110.503 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.64 ' CB ' ' HA ' ' A' ' 192' ' ' GLU . 16.4 ptt180 -175.46 169.03 3.21 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.86 -1.15 . . . . 0.0 110.433 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.769 ' HB ' ' C ' ' A' ' 189' ' ' VAL . 0.1 OUTLIER -99.78 162.98 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.302 -0.874 . . . . 0.0 109.848 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 222' ' ' ARG . 27.0 m -137.28 -24.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.177 -0.952 . . . . 0.0 110.759 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.528 ' HB2' ' CD ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -152.45 127.89 9.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.038 -1.039 . . . . 0.0 110.458 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.451 ' HA ' ' CB ' ' A' ' 221' ' ' ILE . 1.2 tt -96.69 -1.68 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.983 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 168' ' ' ILE . 38.1 m-80 56.6 -95.17 0.05 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 110.231 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.553 ' HG3' ' CZ ' ' A' ' 172' ' ' PHE . 4.3 pt-20 -168.2 83.1 0.18 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.066 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.6 ' O ' ' C ' ' A' ' 172' ' ' PHE . 2.4 pp -86.57 25.78 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.329 -0.857 . . . . 0.0 110.377 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.6 ' C ' ' O ' ' A' ' 171' ' ' ILE . 0.9 OUTLIER 22.83 -136.26 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.583 -0.698 . . . . 0.0 111.024 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.517 ' HA ' ' CG2' ' A' ' 176' ' ' THR . 14.9 mt-30 -107.66 -90.55 0.44 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.193 -0.942 . . . . 0.0 110.258 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.555 ' O ' ' HB3' ' A' ' 175' ' ' GLU . 6.7 t 59.64 90.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.891 . . . . 0.0 110.291 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.555 ' HB3' ' O ' ' A' ' 174' ' ' VAL . 3.7 tt0 63.63 -56.69 0.2 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.489 -0.757 . . . . 0.0 110.822 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 174' ' ' VAL . 8.9 p 45.54 -91.72 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.301 -0.874 . . . . 0.0 110.215 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 178' ' ' GLN . 12.5 t0 43.72 -93.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 110.129 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.528 ' N ' ' O ' ' A' ' 176' ' ' THR . 1.4 mt-30 -48.38 -25.11 1.46 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.179 -0.951 . . . . 0.0 110.015 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.505 ' O ' ' HG ' ' A' ' 182' ' ' LEU . 3.0 t80 -82.97 -52.77 6.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.99 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 177' ' ' ASP . 0.3 OUTLIER -43.65 -25.15 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.172 -0.955 . . . . 0.0 109.889 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -69.17 -64.59 0.84 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.305 -0.872 . . . . 0.0 110.19 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 179' ' ' PHE . 3.5 pp -63.92 -13.6 46.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.357 -0.839 . . . . 0.0 109.848 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.477 ' CD1' ' CZ ' ' A' ' 179' ' ' PHE . 1.7 tp -87.81 -30.42 20.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.387 -0.821 . . . . 0.0 109.861 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -72.18 -15.04 61.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.828 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -89.44 20.03 4.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -0.829 . . . . 0.0 110.136 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 47.31 85.21 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.892 . . . . 0.0 110.093 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.556 ' O ' ' CB ' ' A' ' 188' ' ' ARG . 57.6 mt -146.04 -82.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 0.0 110.374 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.556 ' CB ' ' O ' ' A' ' 187' ' ' ILE . 0.1 OUTLIER 72.79 161.38 0.24 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.453 -0.779 . . . . 0.0 109.683 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.971 ' O ' ' N ' ' A' ' 191' ' ' SER . 3.9 m 33.87 37.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 O-C-N 121.334 -0.853 . . . . 0.0 110.613 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.559 ' C ' ' O ' ' A' ' 189' ' ' VAL . . . 25.68 19.73 0.0 OUTLIER Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.971 ' N ' ' O ' ' A' ' 189' ' ' VAL . 13.6 t 36.88 -146.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -1.149 . . . . 0.0 109.868 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.64 ' HA ' ' CB ' ' A' ' 164' ' ' ARG . 0.9 OUTLIER -89.95 115.26 27.11 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.026 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.669 ' O ' ' O ' ' A' ' 163' ' ' VAL . 34.1 m -159.69 -133.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.096 -1.003 . . . . 0.0 109.985 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.525 ' CG ' ' HB2' ' A' ' 205' ' ' SER . 1.7 pt-20 -158.47 168.82 25.92 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.266 -0.896 . . . . 0.0 110.094 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.546 ' CG2' ' HG ' ' A' ' 204' ' ' LEU . 0.0 OUTLIER -136.36 146.61 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.163 -0.96 . . . . 0.0 110.353 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.59 ' CG2' ' HB3' ' A' ' 161' ' ' ARG . 94.8 t -139.05 108.14 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.249 -0.907 . . . . 0.0 110.105 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 202' ' ' ILE . 4.6 t0 -50.77 113.73 0.98 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.211 -0.931 . . . . 0.0 110.135 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 201' ' ' HIS . 1.0 OUTLIER -110.1 93.61 4.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.224 -0.923 . . . . 0.0 110.294 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 198' ' ' ARG . 43.7 t0 41.81 53.96 3.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.222 -0.924 . . . . 0.0 110.126 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 88.89 -27.34 7.41 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 11.6 m170 -92.08 91.34 7.76 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.26 -1.141 . . . . 0.0 110.273 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 197' ' ' ASP . 2.7 mt -59.66 91.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.904 . . . . 0.0 110.18 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 85.6 m -67.95 148.38 51.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.276 -0.89 . . . . 0.0 110.153 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.546 ' HG ' ' CG2' ' A' ' 195' ' ' ILE . 0.1 OUTLIER -120.23 132.89 55.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.241 -0.912 . . . . 0.0 110.282 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.569 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.7 OUTLIER -119.79 125.93 49.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.332 -0.855 . . . . 0.0 109.898 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.595 ' CD2' HG13 ' A' ' 193' ' ' VAL . 1.9 m170 -104.55 74.08 1.14 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.385 -0.822 . . . . 0.0 110.366 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.52 ' C ' ' O ' ' A' ' 206' ' ' HIS . 3.7 p-10 32.14 51.51 0.21 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.484 -0.76 . . . . 0.0 110.793 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 135.58 -39.9 1.61 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 206' ' ' HIS . 6.7 mtmt -102.58 162.91 12.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.296 -1.12 . . . . 0.0 110.138 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.466 ' HA ' ' O ' ' A' ' 204' ' ' LEU . 14.7 t0 -150.17 144.44 25.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 110.319 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.469 ' CG1' ' HB3' ' A' ' 182' ' ' LEU . 24.5 t -134.76 159.1 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.285 -0.884 . . . . 0.0 110.032 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.436 ' N ' HG11 ' A' ' 211' ' ' VAL . 23.0 tt0 -98.67 63.49 1.44 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 0.0 110.304 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.505 HD23 ' CD1' ' A' ' 204' ' ' LEU . 12.8 tp -56.12 160.12 3.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -0.919 . . . . 0.0 110.113 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 218' ' ' ALA . 0.6 OUTLIER -122.56 144.75 48.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 0.0 110.199 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -52.67 -40.72 63.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.265 -0.897 . . . . 0.0 110.168 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.24 -56.66 13.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.894 . . . . 0.0 110.193 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.53 HD22 ' CD1' ' A' ' 171' ' ' ILE . 0.0 OUTLIER -84.55 -27.15 27.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.201 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.561 ' CB ' ' CG2' ' A' ' 153' ' ' ILE . . . -74.51 -11.05 60.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.0 110.186 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.443 ' HA ' HG12 ' A' ' 153' ' ' ILE . 12.2 t-160 -100.96 77.98 1.89 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.933 . . . . 0.0 110.244 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.3 -43.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -0.943 . . . . 0.0 110.468 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.545 HD12 ' N ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -73.29 143.04 14.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.293 -0.88 . . . . 0.0 110.657 -179.738 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.533 ' O ' ' CG2' ' A' ' 166' ' ' VAL . 4.8 ptp85 -89.45 127.18 35.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.074 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.617 ' HB ' ' O ' ' A' ' 164' ' ' ARG . 0.7 OUTLIER -125.5 170.91 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.192 -0.943 . . . . 0.0 110.821 -178.84 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.405 ' CG ' ' HA2' ' A' ' 149' ' ' GLY . 38.8 mt-10 -149.95 172.64 14.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -0.872 . . . . 0.0 110.12 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.431 ' OE1' ' OXT' ' A' ' 226' ' ' LEU . 0.0 OUTLIER -81.55 169.38 17.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.9 . . . . 0.0 110.156 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' A' ' 226' ' ' LEU . 39.2 tp . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.167 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.455 ' N ' ' OD1' ' A' ' 130' ' ' ASN . 8.8 p-10 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.75 0.31 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 132' ' ' ILE . 46.1 Cg_endo -72.76 -57.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.036 1.545 . . . . 0.0 110.451 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.441 ' C ' ' O ' ' A' ' 131' ' ' PRO . 1.7 mp 41.26 75.47 0.61 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.285 -0.884 . . . . 0.0 110.271 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.03 -28.37 13.02 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.983 1.517 . . . . 0.0 110.342 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -46.07 167.57 0.05 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.4 -154.63 0.48 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.305 -1.115 . . . . 0.0 110.229 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -102.13 52.3 0.81 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 110.23 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -124.61 55.98 1.31 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.292 -0.88 . . . . 0.0 110.252 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.28 -41.92 2.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 110.213 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 163.35 -25.98 0.21 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.439 HG11 ' N ' ' A' ' 141' ' ' GLY . 70.8 t -45.41 -89.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -1.129 . . . . 0.0 110.255 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.439 ' N ' HG11 ' A' ' 140' ' ' VAL . . . 159.05 -152.48 23.53 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.14 -67.46 0.54 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.306 -1.114 . . . . 0.0 110.233 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 54.95 35.98 25.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.911 . . . . 0.0 110.221 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -89.33 79.57 7.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.316 -0.865 . . . . 0.0 110.237 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.35 167.37 11.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 0.0 110.284 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.413 ' O ' ' CB ' ' A' ' 147' ' ' ALA . . . -165.81 167.7 16.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.208 -0.932 . . . . 0.0 110.251 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 146' ' ' ALA . . . 63.0 152.32 0.11 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.137 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.441 ' HA ' ' OE1' ' A' ' 224' ' ' GLU . 45.9 Cg_endo -73.14 80.77 1.81 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.052 1.553 . . . . 0.0 110.456 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -164.35 106.18 0.27 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 223' ' ' ILE . 99.7 m -134.53 2.2 3.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -1.115 . . . . 0.0 110.256 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 153' ' ' ILE . 32.9 mtt180 59.83 123.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 110.121 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.578 HG22 HD12 ' A' ' 165' ' ' ILE . 40.5 t -66.21 60.14 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.203 -0.936 . . . . 0.0 110.339 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.548 HG23 ' CB ' ' A' ' 218' ' ' ALA . 0.8 OUTLIER -159.33 -34.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.306 -0.871 . . . . 0.0 110.145 179.802 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.33 -13.07 61.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.861 . . . . 0.0 109.44 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.525 ' CB ' HG13 ' A' ' 163' ' ' VAL . . . -88.17 -28.01 21.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.485 -0.759 . . . . 0.0 109.976 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -75.62 120.48 21.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.895 . . . . 0.0 110.238 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 14.6 m -162.6 109.0 1.23 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 110.267 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.47 ' O ' ' HB3' ' A' ' 159' ' ' MET . 1.3 t 62.59 10.36 4.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 0.0 110.256 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' MET . . . . . 0.47 ' HB3' ' O ' ' A' ' 158' ' ' SER . 0.0 OUTLIER 173.12 158.42 0.27 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.286 -0.884 . . . . 0.0 110.2 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 46.2 Cg_endo -73.12 63.81 4.22 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.049 1.552 . . . . 0.0 110.299 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.511 ' CG ' ' O ' ' A' ' 155' ' ' ALA . 7.9 mtt180 -42.18 119.22 1.31 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 0.0 110.248 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.475 ' O ' HG11 ' A' ' 163' ' ' VAL . 6.1 ttmt -58.33 124.98 21.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.291 -0.881 . . . . 0.0 110.258 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.623 ' O ' ' O ' ' A' ' 193' ' ' VAL . 30.6 m -139.67 -159.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.881 . . . . 0.0 110.122 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.614 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -175.09 139.11 0.46 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.822 -1.174 . . . . 0.0 110.486 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.592 ' HA ' ' CG2' ' A' ' 223' ' ' ILE . 2.1 mt -91.38 153.87 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.45 -0.781 . . . . 0.0 110.893 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.475 HG21 ' O ' ' A' ' 222' ' ' ARG . 3.4 m -138.85 -29.62 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.486 -0.759 . . . . 0.0 110.448 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -136.57 118.88 15.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.117 -0.989 . . . . 0.0 110.217 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.425 HD11 HG23 ' A' ' 221' ' ' ILE . 1.3 tt -116.32 -3.12 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.201 -0.937 . . . . 0.0 110.254 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 57.26 170.73 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.222 -0.924 . . . . 0.0 110.298 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 172' ' ' PHE . 7.7 pt-20 -155.66 160.75 40.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.151 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.427 ' C ' ' O ' ' A' ' 170' ' ' GLU . 23.1 mt 41.3 27.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.919 . . . . 0.0 110.248 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 170' ' ' GLU . 2.6 t80 -172.29 57.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.255 -0.903 . . . . 0.0 110.245 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -112.5 -61.23 1.76 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -0.925 . . . . 0.0 110.169 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.582 ' CG2' ' N ' ' A' ' 175' ' ' GLU . 0.5 OUTLIER -164.22 -86.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.385 -0.822 . . . . 0.0 110.185 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.582 ' N ' ' CG2' ' A' ' 174' ' ' VAL . 2.6 mt-10 -141.89 11.89 2.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.059 -1.025 . . . . 0.0 110.228 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.602 ' CG2' ' CG2' ' A' ' 180' ' ' THR . 0.2 OUTLIER 66.28 -58.44 0.35 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.286 -0.883 . . . . 0.0 110.259 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 178' ' ' GLN . 3.3 p30 36.93 -145.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.377 -0.827 . . . . 0.0 110.776 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.512 ' N ' ' OD1' ' A' ' 177' ' ' ASP . 0.2 OUTLIER -63.46 -27.47 69.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.312 -0.867 . . . . 0.0 110.567 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.57 ' HA ' ' CD1' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -44.08 -35.34 2.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.001 . . . . 0.0 109.771 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.602 ' CG2' ' CG2' ' A' ' 176' ' ' THR . 0.7 OUTLIER -42.8 -27.85 0.21 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.144 -0.973 . . . . 0.0 109.456 179.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 179' ' ' PHE . 23.5 tp60 -59.84 -36.01 75.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.542 -0.724 . . . . 0.0 109.609 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.57 ' CD1' ' HA ' ' A' ' 179' ' ' PHE . 1.2 mt -69.11 -43.62 74.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.38 -0.825 . . . . 0.0 109.433 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -37.64 88.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.613 -0.679 . . . . 0.0 109.888 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -59.16 -14.74 11.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.462 -0.774 . . . . 0.0 109.845 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 182' ' ' LEU . . . -84.69 16.93 2.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.423 -0.798 . . . . 0.0 110.189 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 185' ' ' ALA . 27.4 t70 43.6 57.56 3.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -0.921 . . . . 0.0 109.764 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.6 tt -129.93 175.24 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.322 -0.861 . . . . 0.0 110.339 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.571 ' O ' ' O ' ' A' ' 189' ' ' VAL . 0.1 OUTLIER -163.11 105.73 1.02 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.743 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.681 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 1.3 m 50.63 105.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.332 -0.855 . . . . 0.0 108.813 -178.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' A' ' 191' ' ' SER . . . -43.28 -15.74 0.03 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.604 ' N ' ' O ' ' A' ' 189' ' ' VAL . 6.1 t 65.57 -142.1 0.2 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.18 -1.188 . . . . 0.0 109.388 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.614 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -64.11 100.24 0.32 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.569 -0.707 . . . . 0.0 109.265 179.294 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.623 ' O ' ' O ' ' A' ' 163' ' ' VAL . 17.0 m -156.73 -141.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.158 -0.964 . . . . 0.0 110.222 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.534 ' HA ' ' CG2' ' A' ' 163' ' ' VAL . 4.2 pt-20 -173.26 169.08 4.59 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.345 -0.847 . . . . 0.0 110.11 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.518 ' CG2' ' HG ' ' A' ' 204' ' ' LEU . 0.6 OUTLIER -121.3 169.17 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.169 -0.957 . . . . 0.0 110.288 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.413 HG21 ' C ' ' A' ' 195' ' ' ILE . 18.8 t -128.7 98.4 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.34 -0.85 . . . . 0.0 110.178 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -49.35 117.86 2.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.9 . . . . 0.0 110.201 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.531 ' HB3' ' CB ' ' A' ' 201' ' ' HIS . 0.1 OUTLIER -109.05 146.39 34.04 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.212 -0.93 . . . . 0.0 110.213 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.45 94.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.908 . . . . 0.0 110.12 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 198' ' ' ARG . . . 75.64 14.55 81.96 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.531 ' CB ' ' HB3' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -150.25 160.92 43.34 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.249 -1.148 . . . . 0.0 110.095 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 10.6 mt -136.02 159.73 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 110.251 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.447 ' O ' HG21 ' A' ' 195' ' ' ILE . 2.1 m -151.0 163.26 39.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -0.877 . . . . 0.0 109.96 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.534 HD21 ' N ' ' A' ' 205' ' ' SER . 0.6 OUTLIER -119.8 137.28 54.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.058 -1.026 . . . . 0.0 110.345 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.542 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 1.2 t -119.73 120.47 36.67 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.404 -0.81 . . . . 0.0 109.583 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.555 ' HA ' ' CG1' ' A' ' 193' ' ' VAL . 7.4 m170 -89.24 165.86 14.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.429 -0.795 . . . . 0.0 110.205 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.503 ' C ' ' O ' ' A' ' 206' ' ' HIS . 4.6 m-20 -32.85 -34.35 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.566 -0.709 . . . . 0.0 110.952 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -153.83 32.7 0.74 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 206' ' ' HIS . 20.8 mttt -154.29 179.38 9.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -1.124 . . . . 0.0 110.51 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 204' ' ' LEU . 12.8 t0 -155.56 158.46 38.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 110.053 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.42 ' N ' ' OD1' ' A' ' 210' ' ' ASP . 7.3 p -146.49 140.81 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -0.953 . . . . 0.0 110.329 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -68.78 83.73 0.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.286 -0.884 . . . . 0.0 110.231 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.66 121.1 17.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.184 -0.948 . . . . 0.0 110.243 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.534 ' CD2' ' HB2' ' A' ' 217' ' ' LEU . 29.6 tp -57.63 158.82 5.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 0.0 110.222 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.464 ' HA ' ' HB1' ' A' ' 218' ' ' ALA . 11.2 t0 -89.57 -49.65 6.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.346 -0.846 . . . . 0.0 110.274 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.544 ' O ' ' NE2' ' A' ' 219' ' ' HIS . 0.4 OUTLIER -55.35 -48.52 74.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -0.921 . . . . 0.0 110.202 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.534 ' HB2' ' CD2' ' A' ' 214' ' ' LEU . 0.5 OUTLIER -85.85 -11.93 52.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 110.113 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.548 ' CB ' HG23 ' A' ' 153' ' ' ILE . . . -35.62 -41.77 0.21 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.55 -0.718 . . . . 0.0 110.669 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.544 ' NE2' ' O ' ' A' ' 216' ' ' ASP . 24.7 p80 -93.98 73.47 4.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 110.434 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' THR . . . . . 0.466 HG22 HG22 ' A' ' 221' ' ' ILE . 8.9 t -137.25 -44.86 0.56 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.941 . . . . 0.0 110.092 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.599 ' CD1' ' H ' ' A' ' 221' ' ' ILE . 0.3 OUTLIER -73.74 146.54 10.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.326 -0.859 . . . . 0.0 110.363 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.475 ' O ' HG21 ' A' ' 166' ' ' VAL . 8.1 mtt180 -89.89 114.39 26.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 0.0 109.28 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.613 ' HB ' ' O ' ' A' ' 164' ' ' ARG . 0.8 OUTLIER -141.58 -172.6 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.131 -0.981 . . . . 0.0 110.894 -179.036 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.441 ' OE1' ' HA ' ' A' ' 148' ' ' PRO . 0.5 OUTLIER -144.18 166.81 23.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.355 -0.84 . . . . 0.0 110.178 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.526 ' HA ' ' CG1' ' A' ' 163' ' ' VAL . 0.3 OUTLIER -111.92 124.01 51.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.366 -0.834 . . . . 0.0 110.26 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.415 ' OXT' ' HB3' ' A' ' 162' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.19 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.511 ' N ' ' HD2' ' A' ' 131' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 130' ' ' ASN . 47.5 Cg_endo -73.95 57.31 3.84 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.962 1.506 . . . . 0.0 110.434 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.425 ' O ' ' CG2' ' A' ' 132' ' ' ILE . 10.8 tt -62.57 114.63 12.63 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.194 -0.941 . . . . 0.0 110.233 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.36 -166.05 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.959 1.505 . . . . 0.0 110.458 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 136' ' ' ASP . . . -173.0 -116.71 0.42 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 134' ' ' GLY . 6.8 mp 56.25 -83.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -1.151 . . . . 0.0 110.319 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 134' ' ' GLY . 6.7 t70 -41.79 -27.04 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.306 -0.871 . . . . 0.0 110.278 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 135' ' ' LEU . 0.5 OUTLIER 42.37 35.23 0.6 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 110.319 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 53.9 tp -45.36 112.54 0.46 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.235 -0.916 . . . . 0.0 110.167 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 174.7 -38.96 0.12 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.3 t -48.55 -23.15 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -1.158 . . . . 0.0 110.204 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 100.26 28.13 7.37 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -78.9 126.0 30.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -1.164 . . . . 0.0 110.314 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 144' ' ' ASP . 2.7 p -156.65 -76.62 0.09 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.885 . . . . 0.0 110.22 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 143' ' ' SER . 0.2 OUTLIER 66.64 121.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.241 -0.912 . . . . 0.0 110.153 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 144' ' ' ASP . . . 174.26 -94.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.159 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.488 ' O ' ' HB1' ' A' ' 147' ' ' ALA . . . -125.01 85.59 2.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.141 -0.974 . . . . 0.0 110.172 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.488 ' HB1' ' O ' ' A' ' 146' ' ' ALA . . . 57.71 154.69 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.284 -0.885 . . . . 0.0 110.198 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 149' ' ' GLY . 46.5 Cg_endo -73.73 50.73 2.13 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.954 1.502 . . . . 0.0 110.54 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 148' ' ' PRO . . . 55.88 162.14 0.02 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 223' ' ' ILE . 1.6 m -73.75 -177.01 2.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.219 -1.165 . . . . 0.0 109.969 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.504 ' O ' ' O ' ' A' ' 152' ' ' VAL . 96.7 mtt180 -141.58 143.8 33.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.281 -0.887 . . . . 0.0 109.944 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.648 ' O ' ' CG1' ' A' ' 153' ' ' ILE . 69.6 t -50.05 -177.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 109.413 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.648 ' CG1' ' O ' ' A' ' 152' ' ' VAL . 8.2 pt 43.94 25.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.004 -1.06 . . . . 0.0 110.011 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.8 OUTLIER -147.47 -35.47 0.23 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.483 -0.761 . . . . 0.0 109.673 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -96.12 -15.64 22.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.492 -0.755 . . . . 0.0 109.812 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.22 172.98 0.26 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.293 -0.879 . . . . 0.0 110.268 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.523 ' CG2' ' CG ' ' A' ' 161' ' ' ARG . 7.2 t -174.36 167.44 4.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.192 -0.943 . . . . 0.0 110.104 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 157' ' ' THR . 96.9 p -42.7 -49.81 5.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.33 -0.856 . . . . 0.0 110.166 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.67 161.07 75.5 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.214 -0.929 . . . . 0.0 110.119 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.73 68.73 3.71 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.959 1.505 . . . . 0.0 110.481 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.523 ' CG ' ' CG2' ' A' ' 157' ' ' THR . 3.0 mmt85 -60.89 107.66 0.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.195 -0.941 . . . . 0.0 110.167 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.518 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -65.46 96.71 0.26 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.909 . . . . 0.0 110.311 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.622 ' O ' ' O ' ' A' ' 193' ' ' VAL . 8.5 m -104.7 -164.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.967 . . . . 0.0 110.254 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.655 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -179.67 149.03 0.35 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.843 -1.161 . . . . 0.0 110.169 -179.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.778 ' HB ' ' C ' ' A' ' 189' ' ' VAL . 0.3 OUTLIER -89.82 150.03 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.302 -0.874 . . . . 0.0 110.233 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.512 HG21 ' N ' ' A' ' 167' ' ' GLN . 21.4 m -124.07 -20.3 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.151 -0.968 . . . . 0.0 110.289 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.512 ' N ' HG21 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -160.87 120.61 2.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.18 -0.95 . . . . 0.0 110.251 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.456 ' O ' HG12 ' A' ' 168' ' ' ILE . 5.3 tt -122.33 7.05 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.198 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.463 ' O ' ' HB3' ' A' ' 170' ' ' GLU . 52.9 t30 -62.32 89.28 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.2 -0.937 . . . . 0.0 110.214 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 169' ' ' ASN . 10.3 pt-20 177.2 47.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.927 . . . . 0.0 110.253 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.8 mt -82.28 44.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.893 . . . . 0.0 110.336 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.429 ' O ' ' C ' ' A' ' 173' ' ' GLN . 2.9 m-85 -46.6 -64.09 0.85 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 110.188 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.429 ' C ' ' O ' ' A' ' 172' ' ' PHE . 0.4 OUTLIER -42.42 159.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.357 -0.839 . . . . 0.0 110.197 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 55.6 t -111.01 -5.81 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.885 . . . . 0.0 110.237 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.72 104.78 16.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.869 . . . . 0.0 110.267 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -165.74 33.24 0.05 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.145 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.415 ' O ' ' OG1' ' A' ' 180' ' ' THR . 28.8 t70 -52.83 -44.48 66.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.927 . . . . 0.0 110.215 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -68.21 -31.31 70.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.298 -0.876 . . . . 0.0 110.241 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.54 ' CD1' ' C ' ' A' ' 179' ' ' PHE . 0.1 OUTLIER -70.15 -39.75 75.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.367 -0.833 . . . . 0.0 109.995 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.506 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -55.58 -18.79 8.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.148 -0.97 . . . . 0.0 109.912 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -72.17 -58.02 3.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.35 -0.843 . . . . 0.0 110.234 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.496 ' C ' ' CD1' ' A' ' 182' ' ' LEU . 4.5 pp -69.54 -7.68 40.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 0.0 109.983 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.524 HD11 ' CZ ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -97.57 -27.13 14.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.359 -0.838 . . . . 0.0 109.924 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 180' ' ' THR . 4.6 t70 -81.37 -3.16 51.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.349 -0.844 . . . . 0.0 109.957 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -87.24 26.88 1.13 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.332 -0.855 . . . . 0.0 110.151 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 11.5 t0 56.01 63.06 2.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 0.0 110.137 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.56 ' O ' ' CB ' ' A' ' 188' ' ' ARG . 34.8 mt -130.86 -82.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.213 -0.929 . . . . 0.0 110.42 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.56 ' CB ' ' O ' ' A' ' 187' ' ' ILE . 0.1 OUTLIER 73.89 151.74 0.12 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.515 -0.741 . . . . 0.0 109.681 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.939 ' O ' ' N ' ' A' ' 191' ' ' SER . 4.4 m 33.86 38.52 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 O-C-N 121.315 -0.866 . . . . 0.0 110.443 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.556 ' C ' ' O ' ' A' ' 189' ' ' VAL . . . 28.16 19.81 0.0 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.939 ' N ' ' O ' ' A' ' 189' ' ' VAL . 21.2 t 39.5 -145.12 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.346 -1.091 . . . . 0.0 109.608 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.655 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 1.8 tt0 -96.26 117.62 31.16 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.622 ' O ' ' O ' ' A' ' 163' ' ' VAL . 33.0 m -157.71 -137.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.209 -0.932 . . . . 0.0 110.097 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.571 ' HA ' ' CG2' ' A' ' 163' ' ' VAL . 1.9 pt-20 -173.75 159.51 3.49 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 110.091 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.543 ' CG2' ' HG ' ' A' ' 204' ' ' LEU . 1.0 OUTLIER -120.46 165.13 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.07 -1.019 . . . . 0.0 110.452 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 197' ' ' ASP . 40.2 t -138.64 86.09 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.329 -0.857 . . . . 0.0 110.128 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 196' ' ' VAL . 48.5 t0 -42.31 129.92 3.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -0.893 . . . . 0.0 110.369 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.543 ' CB ' ' O ' ' A' ' 201' ' ' HIS . 8.7 ttp180 -115.16 72.66 0.8 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.223 -0.923 . . . . 0.0 110.161 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 198' ' ' ARG . 1.3 m-20 41.27 58.32 2.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 0.0 110.395 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 109.81 -44.82 1.42 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.543 ' O ' ' CB ' ' A' ' 198' ' ' ARG . 0.3 OUTLIER -93.74 114.86 27.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.187 -1.184 . . . . 0.0 110.266 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.565 ' CD1' ' HA ' ' A' ' 153' ' ' ILE . 11.9 mt -95.45 127.72 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.925 . . . . 0.0 110.411 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.416 ' O ' HG21 ' A' ' 195' ' ' ILE . 40.4 m -110.83 163.67 13.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 0.0 109.97 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.543 ' HG ' ' CG2' ' A' ' 195' ' ' ILE . 0.7 OUTLIER -119.64 133.76 55.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 110.293 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.537 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 1.4 t -119.84 120.02 35.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.342 -0.849 . . . . 0.0 109.865 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.517 ' HA ' ' CG1' ' A' ' 193' ' ' VAL . 2.8 m170 -106.53 -163.83 0.95 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.341 -0.849 . . . . 0.0 110.111 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -52.69 91.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 110.063 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 59.83 20.95 54.4 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -130.53 168.7 16.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -1.141 . . . . 0.0 110.181 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 204' ' ' LEU . 0.2 OUTLIER -157.84 152.18 24.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.218 -0.926 . . . . 0.0 110.235 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.508 HG11 ' N ' ' A' ' 212' ' ' GLU . 40.5 t -146.87 167.55 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.891 . . . . 0.0 110.145 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.508 ' N ' HG11 ' A' ' 211' ' ' VAL . 2.7 tt0 -98.62 69.92 1.9 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.29 -0.881 . . . . 0.0 110.333 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.502 ' HG ' ' N ' ' A' ' 214' ' ' LEU . 6.5 tp -63.25 155.28 28.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.289 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.565 ' O ' ' CB ' ' A' ' 218' ' ' ALA . 27.8 mt -59.37 150.82 25.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.22 -0.925 . . . . 0.0 109.94 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' A' ' 218' ' ' ALA . 2.9 p-10 -90.91 -109.18 0.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.028 -1.045 . . . . 0.0 110.238 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 215' ' ' ASP . 0.3 OUTLIER -42.87 -25.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.029 -1.044 . . . . 0.0 109.911 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 215' ' ' ASP . 1.1 mp -81.46 -21.6 38.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.299 -0.876 . . . . 0.0 110.488 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.565 ' CB ' ' O ' ' A' ' 214' ' ' LEU . . . -75.67 48.12 0.44 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.076 -1.015 . . . . 0.0 110.461 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -118.76 29.05 7.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.137 -0.977 . . . . 0.0 110.173 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' THR . . . . . 0.407 ' O ' ' CD ' ' A' ' 170' ' ' GLU . 0.2 OUTLIER -113.69 -34.23 5.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 110.165 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.647 HG12 HG22 ' A' ' 223' ' ' ILE . 0.1 OUTLIER -70.52 134.01 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.307 -0.87 . . . . 0.0 110.347 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.451 ' O ' HG21 ' A' ' 166' ' ' VAL . 4.4 mtt180 -89.87 101.39 14.09 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.216 -0.927 . . . . 0.0 109.642 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.671 ' CG2' ' CG2' ' A' ' 165' ' ' ILE . 1.0 OUTLIER -119.56 -176.78 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 110.659 -179.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.429 ' HA ' ' HB ' ' A' ' 150' ' ' THR . 11.5 pt-20 -150.6 178.48 9.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.468 -0.77 . . . . 0.0 110.204 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 3.8 tm-20 -106.48 120.15 41.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.303 -0.873 . . . . 0.0 110.068 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 39.1 tp . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.222 -179.954 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.533 ' CB ' ' CD ' ' A' ' 131' ' ' PRO . 2.0 m120 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 120.734 0.302 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 130' ' ' ASN . 45.7 Cg_endo -72.92 60.53 3.71 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.976 1.514 . . . . 0.0 110.468 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 24.6 mm -71.19 117.95 61.29 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 0.0 110.226 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.85 90.07 0.85 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.985 1.519 . . . . 0.0 110.373 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -84.3 99.67 2.28 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 137' ' ' GLU . 1.2 tp -69.79 -16.7 63.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -1.13 . . . . 0.0 110.14 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 137' ' ' GLU . 0.5 OUTLIER 60.76 -81.31 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.266 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 135' ' ' LEU . 7.5 mt-10 57.64 29.21 16.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.378 -0.826 . . . . 0.0 110.165 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.93 171.09 8.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 110.271 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -139.71 -93.46 0.25 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.3 m -123.33 -176.83 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.307 -1.114 . . . . 0.0 110.219 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -127.1 -95.01 0.89 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 47.11 62.62 2.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.259 -1.142 . . . . 0.0 110.276 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 144' ' ' ASP . 7.4 p -130.58 128.69 41.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.229 -0.92 . . . . 0.0 110.221 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 143' ' ' SER . 25.4 t0 43.19 55.62 4.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.235 -0.915 . . . . 0.0 110.213 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -170.83 -142.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 0.0 110.304 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -168.71 26.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.234 -0.916 . . . . 0.0 109.933 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.608 ' N ' ' CD ' ' A' ' 148' ' ' PRO . . . 61.5 45.86 0.92 Allowed Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.331 -0.856 . . . . 0.0 110.32 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 147' ' ' ALA . 49.9 Cg_endo -73.89 35.48 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.915 1.482 . . . . 0.0 110.631 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 147' ' ' ALA . . . -154.24 -172.48 22.23 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.492 ' O ' ' CB ' ' A' ' 154' ' ' ASP . 53.7 m -147.28 10.76 1.0 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.296 -1.12 . . . . 0.0 110.375 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 13.5 mmt180 59.7 136.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -0.9 . . . . 0.0 110.226 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.54 ' O ' ' CD1' ' A' ' 195' ' ' ILE . 1.4 t -64.97 -0.58 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.219 -0.926 . . . . 0.0 110.966 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.551 HG22 ' CB ' ' A' ' 218' ' ' ALA . 1.0 OUTLIER -115.53 -4.62 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.911 -1.118 . . . . 0.0 110.652 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.509 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 0.7 OUTLIER -103.19 -28.6 11.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.125 -0.985 . . . . 0.0 109.949 179.673 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.468 ' HB1' HG23 ' A' ' 150' ' ' THR . . . -84.09 -15.4 47.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 110.05 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.494 ' O ' HG21 ' A' ' 157' ' ' THR . . . -71.97 -161.8 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.326 -0.859 . . . . 0.0 110.197 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.494 HG21 ' O ' ' A' ' 156' ' ' ALA . 0.4 OUTLIER 55.88 160.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.33 -0.856 . . . . 0.0 110.12 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 157' ' ' THR . 5.6 p 42.86 30.84 0.27 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 110.212 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.73 134.15 1.74 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.323 -0.86 . . . . 0.0 110.065 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.608 ' O ' ' O ' ' A' ' 161' ' ' ARG . 45.9 Cg_endo -73.36 74.61 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.935 1.492 . . . . 0.0 110.542 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.608 ' O ' ' O ' ' A' ' 160' ' ' PRO . 2.1 ptt85 27.44 104.32 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.492 0.663 . . . . 0.0 111.393 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.409 ' C ' ' CG1' ' A' ' 163' ' ' VAL . 0.0 OUTLIER -168.76 68.75 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.99 -1.069 . . . . 0.0 110.287 179.534 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.655 ' O ' ' O ' ' A' ' 193' ' ' VAL . 16.6 m -150.62 -155.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.886 . . . . 0.0 110.329 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.644 ' CB ' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -177.56 167.72 2.22 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.783 -1.198 . . . . 0.0 110.518 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.781 ' HB ' ' C ' ' A' ' 189' ' ' VAL . 0.3 OUTLIER -98.83 159.52 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.224 -0.922 . . . . 0.0 110.268 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.514 HG21 ' N ' ' A' ' 167' ' ' GLN . 31.5 m -131.13 -28.62 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.892 . . . . 0.0 110.222 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.514 ' N ' HG21 ' A' ' 166' ' ' VAL . 4.6 tt0 -144.92 93.59 2.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.197 -0.939 . . . . 0.0 110.124 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.46 HG21 ' N ' ' A' ' 169' ' ' ASN . 0.3 OUTLIER -54.07 -32.23 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.219 -0.925 . . . . 0.0 110.124 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.46 ' N ' HG21 ' A' ' 168' ' ' ILE . 0.2 OUTLIER 42.56 71.25 0.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 0.0 110.252 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 170' ' ' GLU . 33.6 tt0 -151.28 72.29 1.04 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.259 -0.9 . . . . 0.0 110.211 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.462 HG21 HD11 ' A' ' 171' ' ' ILE . 32.4 mm -84.2 -6.63 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 110.281 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -75.32 166.37 23.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.427 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -115.66 -17.38 11.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -0.918 . . . . 0.0 110.2 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 86.6 t -69.66 -21.33 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.19 -0.944 . . . . 0.0 110.224 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -89.82 90.27 8.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.252 -0.905 . . . . 0.0 110.177 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.588 ' CG2' ' CG2' ' A' ' 180' ' ' THR . 21.2 m -124.36 -90.06 0.57 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.885 . . . . 0.0 110.197 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 176' ' ' THR . 3.0 t0 68.37 -158.0 0.19 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.214 -0.929 . . . . 0.0 110.319 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.443 ' OE1' ' OE1' ' A' ' 212' ' ' GLU . 1.2 mt-30 -59.14 -23.33 62.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.895 . . . . 0.0 110.411 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.568 ' CE2' HD11 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -47.96 -23.51 0.8 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.181 -0.949 . . . . 0.0 110.133 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.588 ' CG2' ' CG2' ' A' ' 176' ' ' THR . 0.5 OUTLIER -58.58 -25.75 62.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 109.949 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -71.46 -62.85 1.26 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.301 -0.874 . . . . 0.0 110.167 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 179' ' ' PHE . 3.3 pp -61.06 -13.89 19.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.341 -0.85 . . . . 0.0 110.101 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.568 HD11 ' CE2' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -85.22 -30.14 24.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.903 . . . . 0.0 110.058 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -69.59 -14.28 62.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.416 -0.802 . . . . 0.0 110.039 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.453 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -91.45 24.82 2.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -0.858 . . . . 0.0 110.174 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 185' ' ' ALA . 30.5 t0 40.84 83.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 110.171 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.548 ' O ' ' CB ' ' A' ' 188' ' ' ARG . 87.7 mt -133.85 -75.78 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.0 110.448 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.548 ' CB ' ' O ' ' A' ' 187' ' ' ILE . 5.6 ttp85 71.48 154.65 0.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.374 -0.829 . . . . 0.0 109.716 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.956 ' O ' ' N ' ' A' ' 191' ' ' SER . 4.2 m 32.9 38.35 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 121.235 -0.916 . . . . 0.0 110.558 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.583 ' N ' ' CD1' ' A' ' 165' ' ' ILE . . . 26.83 19.58 0.0 OUTLIER Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.956 ' N ' ' O ' ' A' ' 189' ' ' VAL . 39.5 t 37.06 -146.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.322 -1.105 . . . . 0.0 109.868 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.644 ' HA ' ' CB ' ' A' ' 164' ' ' ARG . 18.9 mt-10 -92.12 115.99 28.55 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.655 ' O ' ' O ' ' A' ' 163' ' ' VAL . 34.3 m -159.25 -132.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.098 -1.001 . . . . 0.0 109.59 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 205' ' ' SER . 1.5 pm0 -167.29 159.0 12.29 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.544 -0.862 . . . . 0.0 110.239 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.54 ' CD1' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER -119.98 163.95 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.28 -0.887 . . . . 0.0 110.154 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.527 ' CG2' ' HD3' ' A' ' 161' ' ' ARG . 54.8 t -140.83 90.01 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.208 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.48 ' OD1' ' CB ' ' A' ' 156' ' ' ALA . 15.4 m-20 -52.66 118.74 3.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.883 . . . . 0.0 110.332 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.459 ' CB ' ' O ' ' A' ' 201' ' ' HIS . 0.6 OUTLIER -105.02 73.13 1.04 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.224 -0.922 . . . . 0.0 110.246 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 198' ' ' ARG . 1.6 m-20 42.55 53.87 4.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 110.21 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 110.62 -41.36 2.26 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.459 ' O ' ' CB ' ' A' ' 198' ' ' ARG . 0.1 OUTLIER -89.79 95.29 10.18 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.279 -1.13 . . . . 0.0 110.162 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.526 HD11 HG22 ' A' ' 202' ' ' ILE . 20.4 mt -80.71 114.45 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 110.322 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.473 HG21 ' N ' ' A' ' 204' ' ' LEU . 3.9 m -102.56 163.33 12.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 0.0 109.916 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.567 HD21 ' CD2' ' A' ' 206' ' ' HIS . 0.7 OUTLIER -119.81 136.84 54.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.097 -1.002 . . . . 0.0 110.308 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.613 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.4 OUTLIER -119.88 123.31 43.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 0.0 109.92 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.567 ' CD2' HD21 ' A' ' 204' ' ' LEU . 2.7 m80 -112.08 -171.59 1.88 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.296 -0.877 . . . . 0.0 110.07 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -48.94 91.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.215 -0.928 . . . . 0.0 110.175 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 54.98 23.84 32.71 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.511 ' O ' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -138.5 94.81 2.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -1.144 . . . . 0.0 110.259 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -100.44 148.44 24.75 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.254 -0.904 . . . . 0.0 110.246 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.41 ' O ' HG22 ' A' ' 203' ' ' THR . 14.3 t -141.18 171.56 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.932 . . . . 0.0 110.225 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 213' ' ' LEU . 2.7 tt0 -95.72 84.89 4.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 110.181 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.486 ' O ' ' CD2' ' A' ' 214' ' ' LEU . 6.8 tp -60.03 -138.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -0.926 . . . . 0.0 110.296 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.559 ' O ' ' CB ' ' A' ' 218' ' ' ALA . 14.8 mt -139.62 157.71 45.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.248 -0.907 . . . . 0.0 110.087 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 216' ' ' ASP . 4.6 p30 -90.52 -106.76 0.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.207 -0.933 . . . . 0.0 110.263 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 215' ' ' ASP . 0.1 OUTLIER -41.73 -25.38 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.092 -1.005 . . . . 0.0 110.121 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 215' ' ' ASP . 0.3 OUTLIER -80.79 -26.76 36.97 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.259 -0.901 . . . . 0.0 110.329 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.559 ' CB ' ' O ' ' A' ' 214' ' ' LEU . . . -71.94 -3.88 25.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.053 -1.03 . . . . 0.0 110.018 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.499 ' O ' ' NH1' ' A' ' 151' ' ' ARG . 11.2 t-80 -83.56 55.34 3.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 110.143 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.1 -49.72 0.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -0.913 . . . . 0.0 110.322 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.621 HG12 ' CG2' ' A' ' 223' ' ' ILE . 0.1 OUTLIER -67.22 137.46 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.291 -0.881 . . . . 0.0 110.352 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.463 ' O ' ' CG2' ' A' ' 166' ' ' VAL . 0.6 OUTLIER -89.53 110.73 21.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 109.333 179.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.621 ' CG2' HG12 ' A' ' 221' ' ' ILE . 0.5 OUTLIER -119.82 175.46 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.165 -0.959 . . . . 0.0 110.636 -179.111 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.454 ' O ' ' HB ' ' A' ' 163' ' ' VAL . 5.9 mt-10 -143.61 167.32 22.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.336 -0.852 . . . . 0.0 110.12 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.45 ' HA ' HG11 ' A' ' 163' ' ' VAL . 4.7 pt-20 -101.57 48.51 0.88 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.312 -0.867 . . . . 0.0 110.253 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.426 HD11 ' CZ ' ' A' ' 164' ' ' ARG . 2.4 tp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.118 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.5 m120 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 120.804 0.335 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.416 ' O ' HG13 ' A' ' 132' ' ' ILE . 45.6 Cg_endo -72.28 -38.34 3.74 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.049 1.552 . . . . 0.0 110.41 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 131' ' ' PRO . 1.8 mp -141.7 129.09 11.64 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.231 -0.918 . . . . 0.0 110.177 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.98 -19.61 22.97 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.955 1.503 . . . . 0.0 110.47 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.83 -97.41 1.85 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.414 ' O ' ' HG3' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -125.37 -6.34 7.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -1.12 . . . . 0.0 110.21 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.4 t70 52.11 54.13 11.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.27 -0.894 . . . . 0.0 110.216 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 135' ' ' LEU . 43.2 mt-10 -135.55 27.61 3.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 110.292 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.6 -28.04 58.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 110.223 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 115.73 -173.68 14.87 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 38.1 t -68.0 -20.78 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.229 -1.159 . . . . 0.0 110.203 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 99.71 -129.66 9.97 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -127.34 -163.18 1.23 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -1.133 . . . . 0.0 110.231 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.8 t -80.86 -27.92 36.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 110.236 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 145' ' ' ALA . 27.3 p-10 -46.6 -28.32 1.41 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.196 -0.94 . . . . 0.0 110.214 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.449 ' N ' ' OD1' ' A' ' 144' ' ' ASP . . . 47.19 26.75 0.72 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 110.211 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.459 ' O ' ' HB1' ' A' ' 147' ' ' ALA . . . -139.07 47.57 1.91 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.298 -0.876 . . . . 0.0 110.259 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 146' ' ' ALA . . . 60.8 145.92 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 110.235 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.1 64.55 4.23 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.005 1.529 . . . . 0.0 110.415 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.483 ' HA3' ' HB3' ' A' ' 222' ' ' ARG . . . 113.61 126.18 4.38 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.538 ' CG2' ' HB3' ' A' ' 154' ' ' ASP . 98.0 m -141.39 151.97 43.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -1.101 . . . . 0.0 110.1 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 154' ' ' ASP . 0.0 OUTLIER -43.15 125.06 3.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.142 -0.974 . . . . 0.0 110.259 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.567 ' HA ' ' CD1' ' A' ' 223' ' ' ILE . 5.9 p -44.75 -26.8 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.239 -0.913 . . . . 0.0 110.174 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.516 HG22 ' CB ' ' A' ' 218' ' ' ALA . 9.9 pt -92.33 -15.7 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.204 -0.935 . . . . 0.0 110.248 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.538 ' HB3' ' CG2' ' A' ' 150' ' ' THR . 0.8 OUTLIER -77.35 -21.97 52.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.396 179.558 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -106.9 -9.78 16.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.562 -0.711 . . . . 0.0 109.756 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 157' ' ' THR . . . -66.13 -174.11 0.23 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 110.216 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.549 ' OG1' ' CB ' ' A' ' 197' ' ' ASP . 4.0 m 43.64 -170.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 110.182 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.521 ' O ' ' CB ' ' A' ' 159' ' ' MET . 2.2 t 50.45 30.35 4.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.173 -0.954 . . . . 0.0 110.058 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' MET . . . . . 0.521 ' CB ' ' O ' ' A' ' 158' ' ' SER . 0.5 OUTLIER 69.88 64.8 0.49 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 110.135 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.588 ' O ' ' CG ' ' A' ' 161' ' ' ARG . 45.9 Cg_endo -74.11 -61.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.0 1.526 . . . . 0.0 110.22 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.59 ' CD ' ' N ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER 74.07 179.63 0.2 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.455 -0.778 . . . . 0.0 110.238 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.59 ' N ' ' CD ' ' A' ' 161' ' ' ARG . 14.0 tptt -40.03 126.3 2.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.834 . . . . 0.0 110.84 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.582 ' O ' ' O ' ' A' ' 193' ' ' VAL . 0.1 OUTLIER -134.11 -160.88 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.411 -0.805 . . . . 0.0 109.436 179.175 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.616 ' HA ' ' O ' ' A' ' 191' ' ' SER . 0.1 OUTLIER -177.21 144.4 0.42 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.831 -1.168 . . . . 0.0 110.39 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 191' ' ' SER . 1.1 mt -103.66 151.03 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.39 -0.819 . . . . 0.0 110.442 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.444 HG12 ' C ' ' A' ' 165' ' ' ILE . 22.9 m -150.72 17.87 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.165 -0.959 . . . . 0.0 110.295 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -155.03 119.86 4.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.213 -0.929 . . . . 0.0 110.196 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 168' ' ' ILE . 0.9 OUTLIER -111.31 11.18 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.187 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 168' ' ' ILE . 5.4 m-20 -42.06 122.29 2.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.21 -0.932 . . . . 0.0 110.086 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 171' ' ' ILE . 5.1 pt-20 -144.79 55.88 1.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 110.189 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 170' ' ' GLU . 28.1 mt -41.91 -33.32 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.291 -0.881 . . . . 0.0 110.022 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -98.93 158.71 15.46 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.349 -0.845 . . . . 0.0 110.191 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.45 ' O ' ' HB ' ' A' ' 174' ' ' VAL . 0.0 OUTLIER -178.0 152.54 0.74 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 110.187 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 173' ' ' GLN . 2.5 p 178.33 -30.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 110.134 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.433 ' OE2' ' OD2' ' A' ' 216' ' ' ASP . 35.0 tt0 -85.29 151.39 24.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -0.891 . . . . 0.0 110.123 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.518 HG21 ' N ' ' A' ' 177' ' ' ASP . 36.4 m -164.68 -96.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 110.037 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.518 ' N ' HG21 ' A' ' 176' ' ' THR . 2.6 m-20 69.17 -136.7 0.08 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.148 -0.97 . . . . 0.0 110.307 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -56.55 -28.94 61.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.207 -0.933 . . . . 0.0 110.52 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.566 ' HA ' ' CD1' ' A' ' 182' ' ' LEU . 0.1 OUTLIER -42.95 -39.82 2.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 110.263 -179.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.488 ' C ' ' O ' ' A' ' 179' ' ' PHE . 0.7 OUTLIER -39.26 -28.3 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.905 . . . . 0.0 110.089 -179.781 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 179' ' ' PHE . 5.9 tt0 -60.2 -36.02 76.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.268 -0.895 . . . . 0.0 109.576 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.566 ' CD1' ' HA ' ' A' ' 179' ' ' PHE . 1.0 OUTLIER -69.77 -41.32 75.31 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.389 -0.82 . . . . 0.0 109.431 179.345 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.87 -39.17 87.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.41 -0.806 . . . . 0.0 109.812 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -61.73 -17.78 57.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.429 -0.794 . . . . 0.0 109.703 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -90.66 18.87 5.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.385 -0.822 . . . . 0.0 110.033 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 185' ' ' ALA . 2.8 m-20 42.48 68.02 0.53 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 109.669 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.484 ' CG2' ' N ' ' A' ' 188' ' ' ARG . 10.6 mm -115.24 167.47 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.302 -0.874 . . . . 0.0 110.882 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.636 ' O ' ' O ' ' A' ' 189' ' ' VAL . 0.2 OUTLIER -173.31 113.26 0.22 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.691 ' CG2' ' O ' ' A' ' 189' ' ' VAL . 0.6 OUTLIER 43.74 101.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.272 -0.893 . . . . 0.0 108.693 -178.149 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.548 ' O ' ' CG1' ' A' ' 193' ' ' VAL . . . -39.02 -19.05 0.01 OUTLIER Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.641 ' N ' ' O ' ' A' ' 189' ' ' VAL . 3.7 t 67.04 -145.18 0.15 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.969 -1.312 . . . . 0.0 108.979 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.527 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 7.8 mt-10 -62.68 98.33 0.12 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 109.25 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.582 ' O ' ' O ' ' A' ' 163' ' ' VAL . 10.0 m -154.1 -142.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.062 -1.024 . . . . 0.0 110.356 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.556 ' HA ' HG22 ' A' ' 163' ' ' VAL . 24.3 tt0 -169.64 157.71 7.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.88 . . . . 0.0 110.394 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.55 ' CG2' ' HG ' ' A' ' 204' ' ' LEU . 0.1 OUTLIER -131.54 161.92 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.147 -0.97 . . . . 0.0 110.215 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.45 ' O ' ' HG2' ' A' ' 198' ' ' ARG . 97.1 t -144.97 86.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.266 -0.897 . . . . 0.0 110.067 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.549 ' CB ' ' OG1' ' A' ' 157' ' ' THR . 53.1 t0 -55.7 124.29 16.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.305 -0.872 . . . . 0.0 110.404 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.503 ' NH2' ' HB3' ' A' ' 198' ' ' ARG . 6.5 mmm180 -107.12 80.98 1.48 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.351 -0.843 . . . . 0.0 110.19 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.489 ' C ' ' O ' ' A' ' 198' ' ' ARG . 2.7 p30 36.23 38.19 0.06 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.452 -0.78 . . . . 0.0 110.565 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 137.57 -50.47 0.82 Allowed Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.49 ' O ' ' HB2' ' A' ' 198' ' ' ARG . 1.6 t-160 -90.04 114.75 26.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.344 -1.092 . . . . 0.0 110.42 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 197' ' ' ASP . 35.6 mt -100.98 116.93 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 110.171 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 195' ' ' ILE . 6.9 m -97.1 152.57 18.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 110.364 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.586 HD21 ' CD2' ' A' ' 206' ' ' HIS . 0.7 OUTLIER -119.84 131.95 55.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.361 -0.837 . . . . 0.0 110.086 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.557 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 5.0 t -119.72 115.69 24.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.276 -0.89 . . . . 0.0 110.137 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.586 ' CD2' HD21 ' A' ' 204' ' ' LEU . 1.9 m80 -103.45 153.59 20.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.605 -0.684 . . . . 0.0 109.832 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -51.02 -19.2 0.98 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.214 -0.929 . . . . 0.0 110.094 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.498 ' O ' ' HB3' ' A' ' 209' ' ' LYS . . . -95.86 -27.42 10.36 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.498 ' HB3' ' O ' ' A' ' 208' ' ' GLY . 1.4 ptmt 171.63 -179.36 0.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.261 -1.141 . . . . 0.0 110.281 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.444 ' OD2' ' O ' ' A' ' 204' ' ' LEU . 0.8 OUTLIER -124.36 149.71 46.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -0.848 . . . . 0.0 110.131 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 6.1 p -129.68 164.7 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.244 -0.91 . . . . 0.0 110.075 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -86.97 70.34 10.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.374 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 1.8 tp -63.08 163.37 10.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.975 . . . . 0.0 110.099 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.509 ' CG ' ' HB2' ' A' ' 217' ' ' LEU . 0.6 OUTLIER -130.2 145.43 51.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.911 . . . . 0.0 110.307 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.465 ' HA ' HG23 ' A' ' 153' ' ' ILE . 3.5 p30 -55.08 -37.1 66.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 110.271 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.433 ' OD2' ' OE2' ' A' ' 175' ' ' GLU . 0.6 OUTLIER -55.79 -50.37 70.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.193 -0.942 . . . . 0.0 110.245 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.556 ' HG ' ' CD1' ' A' ' 179' ' ' PHE . 2.2 mm? -89.41 -28.18 19.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 110.218 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.516 ' CB ' HG22 ' A' ' 153' ' ' ILE . . . -67.1 -9.28 37.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 109.969 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.479 ' CD2' ' HD3' ' A' ' 151' ' ' ARG . 3.0 t-160 -91.09 69.24 6.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.169 -0.957 . . . . 0.0 110.181 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' THR . . . . . 0.438 ' CG2' ' O ' ' A' ' 219' ' ' HIS . 0.6 OUTLIER -166.54 -58.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.177 -0.952 . . . . 0.0 110.4 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.577 ' CD1' ' N ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -65.53 136.43 26.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.304 -0.872 . . . . 0.0 110.319 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.483 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 47.1 mtt180 -95.67 116.59 29.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 110.058 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.567 ' CD1' ' HA ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER -119.78 177.37 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 110.168 -179.759 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.523 ' HB2' ' NH2' ' A' ' 164' ' ' ARG . 2.3 mt-10 -150.04 179.69 7.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.933 . . . . 0.0 110.295 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 1.5 mt-10 -90.15 69.89 7.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.384 -0.822 . . . . 0.0 110.214 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.463 ' OXT' ' O ' ' A' ' 225' ' ' GLU . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.214 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.572 ' CB ' ' CD ' ' A' ' 131' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 120.677 0.275 . . . . 0.0 110.274 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.572 ' CD ' ' CB ' ' A' ' 130' ' ' ASN . 46.2 Cg_endo -72.94 -9.34 23.52 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.93 1.49 . . . . 0.0 110.413 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.3 mp -113.91 112.08 47.82 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.312 -0.868 . . . . 0.0 110.149 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.65 159.42 48.77 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.035 1.545 . . . . 0.0 110.567 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 149.51 -43.57 0.76 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.59 -21.18 62.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.284 -1.127 . . . . 0.0 110.188 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.0 t70 50.97 89.48 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.282 -0.886 . . . . 0.0 110.252 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -138.38 21.42 2.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 110.194 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.51 HD22 ' N ' ' A' ' 138' ' ' LEU . 2.7 pt? -49.55 -21.94 1.12 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.195 -0.941 . . . . 0.0 110.171 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 141' ' ' GLY . . . -94.48 65.08 1.54 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.518 HG11 ' N ' ' A' ' 141' ' ' GLY . 97.7 t 46.53 -97.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.216 -1.167 . . . . 0.0 110.249 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.518 ' N ' HG11 ' A' ' 140' ' ' VAL . . . 152.94 -87.75 0.13 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 143' ' ' SER . 1.6 t-20 -80.79 140.25 35.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.28 -1.129 . . . . 0.0 110.284 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 142' ' ' ASN . 34.7 t -178.94 109.6 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.184 -0.947 . . . . 0.0 110.278 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.402 ' CB ' ' O ' ' A' ' 143' ' ' SER . 0.3 OUTLIER 63.69 32.24 13.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.227 -0.921 . . . . 0.0 110.296 179.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.77 -145.3 0.11 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.161 -0.962 . . . . 0.0 110.228 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -157.95 -36.55 0.07 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 110.287 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.02 147.66 48.73 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.356 -0.84 . . . . 0.0 110.175 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.69 86.74 1.02 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.976 1.514 . . . . 0.0 110.439 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -178.95 153.17 12.03 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.522 ' HB ' ' O ' ' A' ' 223' ' ' ILE . 7.7 m -123.46 -1.82 8.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.159 -1.201 . . . . 0.0 110.216 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.497 ' CB ' ' HB2' ' A' ' 154' ' ' ASP . 2.5 mpt_? 57.21 110.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.879 . . . . 0.0 109.851 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.576 ' N ' HG12 ' A' ' 223' ' ' ILE . 4.9 t -40.46 -68.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.358 -0.839 . . . . 0.0 110.278 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.591 HG13 ' CD2' ' A' ' 219' ' ' HIS . 0.2 OUTLIER -43.8 -28.13 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.21 -0.932 . . . . 0.0 110.594 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 150' ' ' THR . 0.5 OUTLIER -81.05 -19.78 43.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.11 -0.994 . . . . 0.0 110.209 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 152' ' ' VAL . . . -100.44 -6.01 26.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.169 -0.957 . . . . 0.0 110.181 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.488 ' O ' HG21 ' A' ' 157' ' ' THR . . . -75.78 166.98 22.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.93 . . . . 0.0 110.174 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 158' ' ' SER . 0.4 OUTLIER 45.71 -175.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.165 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 157' ' ' THR . 1.7 t 69.85 -54.59 0.61 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 109.987 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' MET . . . . . 0.487 ' CB ' ' O ' ' A' ' 158' ' ' SER . 0.0 OUTLIER 169.65 59.59 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.362 -0.836 . . . . 0.0 110.129 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.545 ' O ' ' CB ' ' A' ' 161' ' ' ARG . 44.6 Cg_endo -73.2 -72.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.019 1.536 . . . . 0.0 110.414 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.545 ' CB ' ' O ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER 71.45 -66.44 0.3 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.28 -0.888 . . . . 0.0 110.255 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.583 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 4.9 tttp -162.24 120.08 2.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 0.0 110.755 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.61 ' CG2' ' HA ' ' A' ' 194' ' ' GLU . 31.3 m -139.89 -151.53 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.889 . . . . 0.0 110.016 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.649 ' HG3' ' HA ' ' A' ' 192' ' ' GLU . 11.1 ttp180 -179.89 155.5 0.62 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.676 -1.265 . . . . 0.0 110.556 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.802 ' HB ' ' C ' ' A' ' 189' ' ' VAL . 0.3 OUTLIER -89.66 151.28 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.163 -0.961 . . . . 0.0 109.896 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 222' ' ' ARG . 20.0 m -122.48 -18.46 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.176 -0.952 . . . . 0.0 110.588 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.459 ' N ' HG21 ' A' ' 166' ' ' VAL . 46.4 tt0 -167.88 123.94 1.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.165 -0.96 . . . . 0.0 110.519 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.481 ' O ' ' ND2' ' A' ' 169' ' ' ASN . 6.5 mt -99.83 -13.38 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.359 -0.838 . . . . 0.0 109.894 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' A' ' 168' ' ' ILE . 9.8 p30 38.83 -161.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.521 -0.737 . . . . 0.0 110.39 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.529 ' O ' ' CG ' ' A' ' 170' ' ' GLU . 8.5 tt0 179.1 45.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.886 . . . . 0.0 110.278 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.428 ' C ' ' O ' ' A' ' 170' ' ' GLU . 5.3 mt -42.36 -42.32 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.144 -0.973 . . . . 0.0 110.049 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -85.16 151.32 24.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 110.041 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.532 ' O ' ' CG1' ' A' ' 174' ' ' VAL . 0.2 OUTLIER -127.18 -169.03 1.97 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.217 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 173' ' ' GLN . 9.7 p 37.42 35.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.404 -0.81 . . . . 0.0 110.514 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' A' ' 177' ' ' ASP . 1.9 tm-20 -107.71 -68.06 0.92 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.892 . . . . 0.0 110.168 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.539 ' CG2' ' CG2' ' A' ' 180' ' ' THR . 0.0 OUTLIER 45.17 -89.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.467 -0.77 . . . . 0.0 110.475 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 175' ' ' GLU . 0.6 OUTLIER 68.01 -170.29 0.19 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 0.0 110.101 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 11.3 tm0? -44.63 -24.01 0.16 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.217 -0.927 . . . . 0.0 110.482 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.55 ' HA ' ' CD1' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -58.69 -34.01 70.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.185 -0.947 . . . . 0.0 110.328 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.544 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.8 OUTLIER -40.31 -29.02 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 110.046 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 179' ' ' PHE . 5.9 tt0 -62.6 -34.13 76.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.385 -0.822 . . . . 0.0 110.038 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.55 ' CD1' ' HA ' ' A' ' 179' ' ' PHE . 1.6 mt -69.53 -45.41 68.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.346 -0.847 . . . . 0.0 109.738 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 2.0 tt -63.3 -29.32 70.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.448 -0.783 . . . . 0.0 110.051 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.58 -1.68 17.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 110.058 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.405 ' O ' HG13 ' A' ' 187' ' ' ILE . . . -103.04 11.11 37.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.888 . . . . 0.0 110.266 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 185' ' ' ALA . 0.4 OUTLIER 44.69 86.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 109.912 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.643 ' O ' ' CB ' ' A' ' 188' ' ' ARG . 16.1 mt -147.58 -79.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.216 -0.928 . . . . 0.0 110.631 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.643 ' CB ' ' O ' ' A' ' 187' ' ' ILE . 34.1 ttt-85 81.02 149.84 0.1 Allowed 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.92 ' O ' ' N ' ' A' ' 191' ' ' SER . 2.7 m 33.28 35.95 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.37 -0.831 . . . . 0.0 110.329 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.57 ' O ' ' CG1' ' A' ' 193' ' ' VAL . . . 30.28 17.41 0.0 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.92 ' N ' ' O ' ' A' ' 189' ' ' VAL . 9.5 t 43.37 -147.19 0.06 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.117 -1.225 . . . . 0.0 109.343 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.649 ' HA ' ' HG3' ' A' ' 164' ' ' ARG . 3.4 mt-10 -77.82 116.16 18.13 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.593 ' O ' ' O ' ' A' ' 163' ' ' VAL . 0.2 OUTLIER -161.66 162.98 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.117 -0.99 . . . . 0.0 109.886 -179.485 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.61 ' HA ' ' CG2' ' A' ' 163' ' ' VAL . 4.0 pt-20 -119.87 169.01 10.54 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 119.225 -0.99 . . . . 0.0 110.27 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.557 ' CD1' HG11 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -123.31 142.25 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.931 . . . . 0.0 110.463 -179.483 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.474 ' O ' ' C ' ' A' ' 197' ' ' ASP . 56.5 t -133.9 98.97 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.442 -0.786 . . . . 0.0 109.878 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' A' ' 196' ' ' VAL . 1.1 t0 -38.58 106.58 0.05 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.262 -0.899 . . . . 0.0 110.484 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 200' ' ' GLY . 0.0 OUTLIER -90.55 -172.48 3.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.234 -0.916 . . . . 0.0 110.349 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -53.02 86.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 110.286 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 198' ' ' ARG . . . 65.59 18.37 65.76 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.449 ' O ' ' N ' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -139.64 -176.13 4.45 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.284 -1.127 . . . . 0.0 110.123 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.478 ' CG2' HG23 ' A' ' 195' ' ' ILE . 47.6 mt -137.76 100.8 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 110.336 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.478 ' OG1' ' HG3' ' A' ' 198' ' ' ARG . 6.0 m -86.68 143.51 27.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.147 -0.971 . . . . 0.0 110.121 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.491 ' HB3' HG22 ' A' ' 193' ' ' VAL . 2.7 mp -120.89 146.23 46.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 0.0 110.148 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 210' ' ' ASP . 45.1 m -129.85 130.98 45.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.295 -0.878 . . . . 0.0 110.447 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 209' ' ' LYS . 0.0 OUTLIER -116.13 -157.21 0.64 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.297 -0.877 . . . . 0.0 109.996 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -44.72 91.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.209 -0.932 . . . . 0.0 110.349 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 45.34 31.64 3.42 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.555 ' O ' ' CE1' ' A' ' 206' ' ' HIS . 0.4 OUTLIER -140.89 118.17 11.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -1.173 . . . . 0.0 110.328 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.508 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 2.3 p-10 -104.72 150.59 24.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 110.341 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.404 ' CG2' ' CE1' ' A' ' 206' ' ' HIS . 32.6 t -142.12 149.84 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.89 . . . . 0.0 110.18 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -82.5 67.25 8.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.284 -0.885 . . . . 0.0 110.297 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.49 ' HB3' ' CD1' ' A' ' 204' ' ' LEU . 3.4 tm? -51.54 125.56 14.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 0.0 110.056 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.499 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 22.1 tp -65.33 106.65 1.41 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 110.251 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.485 ' HA ' ' HB3' ' A' ' 218' ' ' ALA . 4.4 p30 -59.74 -41.57 91.25 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.306 -0.871 . . . . 0.0 110.358 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.481 ' HB2' ' CD1' ' A' ' 214' ' ' LEU . 0.3 OUTLIER -41.65 -69.66 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.316 -179.798 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 219' ' ' HIS . 0.2 OUTLIER -79.58 -13.62 59.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -0.904 . . . . 0.0 110.501 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.589 ' CB ' ' CG2' ' A' ' 153' ' ' ILE . . . -40.44 -27.69 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.272 -0.893 . . . . 0.0 110.269 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.636 ' N ' ' CD2' ' A' ' 219' ' ' HIS . 6.3 m170 -72.09 67.56 0.66 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.893 . . . . 0.0 110.09 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 7.1 t -158.41 -42.31 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.973 . . . . 0.0 110.702 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.572 HG12 ' CG2' ' A' ' 223' ' ' ILE . 0.1 OUTLIER -74.53 132.61 33.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.2 -0.938 . . . . 0.0 110.566 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.531 ' O ' ' CG2' ' A' ' 166' ' ' VAL . 19.3 mtm180 -89.48 110.68 21.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.23 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.618 HG23 HG22 ' A' ' 165' ' ' ILE . 0.8 OUTLIER -119.89 171.78 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 110.806 -179.092 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.468 ' O ' ' HB ' ' A' ' 163' ' ' VAL . 0.8 OUTLIER -150.2 -165.73 2.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.402 -0.811 . . . . 0.0 109.936 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -99.61 155.58 17.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 110.33 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.241 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.4 m120 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 120.796 0.331 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.37 -47.35 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.039 1.547 . . . . 0.0 110.574 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.1 mt -100.83 118.57 60.37 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 110.359 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.28 155.48 46.46 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.917 1.483 . . . . 0.0 110.362 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -82.96 -107.34 0.48 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.499 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 28.7 tp -108.4 -36.22 6.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.118 -1.225 . . . . 0.0 110.203 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 10.2 t70 175.18 -93.98 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.408 -0.807 . . . . 0.0 110.093 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.448 ' N ' ' OD2' ' A' ' 136' ' ' ASP . 0.7 OUTLIER -73.0 62.69 0.63 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.183 -0.948 . . . . 0.0 110.26 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 25.7 tp -104.09 67.5 0.86 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.2 -0.938 . . . . 0.0 110.232 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -71.55 164.62 53.95 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 44.5 t 51.51 89.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.23 -1.159 . . . . 0.0 110.182 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.68 67.26 0.4 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -130.0 68.02 1.45 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -1.14 . . . . 0.0 110.19 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 37.8 m -160.61 56.11 0.32 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.204 -0.935 . . . . 0.0 110.167 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 14.2 t0 51.99 38.84 24.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 110.268 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' A' ' 147' ' ' ALA . . . -74.3 55.87 0.62 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.0 110.123 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.412 ' O ' ' CB ' ' A' ' 147' ' ' ALA . . . -63.96 76.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.333 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 145' ' ' ALA . . . 63.09 164.77 0.11 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.214 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.45 77.15 2.59 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.02 1.537 . . . . 0.0 110.415 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -178.22 117.5 0.58 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.493 ' O ' HD12 ' A' ' 223' ' ' ILE . 8.3 m -159.82 146.15 16.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -1.155 . . . . 0.0 110.275 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.522 ' O ' ' CD1' ' A' ' 223' ' ' ILE . 11.4 ptp180 -53.61 171.09 0.09 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.282 -0.886 . . . . 0.0 110.178 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.547 ' HB ' HG23 ' A' ' 221' ' ' ILE . 12.5 p -104.1 36.82 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.209 -0.932 . . . . 0.0 110.612 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.604 ' CG2' ' CB ' ' A' ' 218' ' ' ALA . 9.0 pt -135.82 -34.29 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.946 . . . . 0.0 110.078 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.403 ' HB2' ' HD2' ' A' ' 151' ' ' ARG . 0.1 OUTLIER -72.92 -14.11 61.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.286 -0.884 . . . . 0.0 109.457 179.446 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -97.52 -21.15 17.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.578 -0.701 . . . . 0.0 109.896 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -73.5 90.58 1.74 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 110.17 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 5.2 t -91.77 179.12 5.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.929 . . . . 0.0 110.252 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.4 t -44.77 -46.68 10.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.267 -0.895 . . . . 0.0 110.027 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' MET . . . . . 0.488 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 5.5 mmt -75.56 164.81 58.32 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 110.116 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 45.1 Cg_endo -71.94 73.86 2.44 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.947 1.498 . . . . 0.0 110.327 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.431 ' O ' HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -63.31 110.19 1.82 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.855 . . . . 0.0 110.234 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.471 ' C ' HG21 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.78 138.09 48.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.407 -0.808 . . . . 0.0 110.26 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.576 ' O ' ' O ' ' A' ' 193' ' ' VAL . 0.1 OUTLIER -149.98 -174.13 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.348 -0.845 . . . . 0.0 110.071 179.932 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.674 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -163.22 134.93 5.01 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.856 -1.153 . . . . 0.0 110.244 -179.619 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.718 HD11 ' N ' ' A' ' 165' ' ' ILE . 0.5 OUTLIER -76.05 151.34 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.171 -0.955 . . . . 0.0 110.145 -179.415 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.519 HG11 ' NE ' ' A' ' 164' ' ' ARG . 28.9 m -149.26 15.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.305 -0.872 . . . . 0.0 109.993 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -179.12 110.37 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.354 -0.841 . . . . 0.0 110.065 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.509 ' HB ' HG11 ' A' ' 189' ' ' VAL . 0.6 OUTLIER -95.9 24.27 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 110.121 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 170' ' ' GLU . 2.2 t-20 -42.43 165.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 110.041 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 169' ' ' ASN . 0.7 OUTLIER 57.84 72.66 0.51 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.143 -0.973 . . . . 0.0 110.009 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.479 HD13 HG22 ' A' ' 171' ' ' ILE . 25.8 mm -88.03 -13.35 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 0.0 110.349 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.558 ' O ' ' CG ' ' A' ' 172' ' ' PHE . 1.5 p90 -47.6 123.53 5.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.217 -0.927 . . . . 0.0 110.158 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.24 177.28 6.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.167 -0.958 . . . . 0.0 110.388 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 8.7 p -160.28 39.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 110.127 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.539 ' O ' ' CB ' ' A' ' 176' ' ' THR . 0.2 OUTLIER -127.27 -73.6 0.61 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -0.891 . . . . 0.0 110.166 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.593 ' HA ' ' CD1' ' A' ' 179' ' ' PHE . 0.3 OUTLIER 72.0 -147.39 0.06 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.474 -0.766 . . . . 0.0 110.299 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 176' ' ' THR . 0.8 OUTLIER 65.52 -150.1 0.24 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.38 -0.825 . . . . 0.0 110.413 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 177' ' ' ASP . 1.6 tp60 -38.98 -37.1 0.33 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.279 -0.888 . . . . 0.0 110.738 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.593 ' CD1' ' HA ' ' A' ' 176' ' ' THR . 0.0 OUTLIER -48.0 -33.96 8.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.941 . . . . 0.0 110.057 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.543 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 1.3 p -39.33 -31.15 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.43 -0.793 . . . . 0.0 110.193 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 179' ' ' PHE . 23.5 tt0 -59.38 -36.35 75.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.309 -0.87 . . . . 0.0 109.824 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.572 ' CD1' ' HA ' ' A' ' 179' ' ' PHE . 1.2 mt -68.99 -46.61 67.62 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.371 -0.831 . . . . 0.0 109.733 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.487 ' CD1' ' O ' ' A' ' 183' ' ' LEU . 0.2 OUTLIER -68.52 -32.62 72.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.489 -0.757 . . . . 0.0 110.11 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.05 -4.51 32.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.84 . . . . 0.0 109.957 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.444 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -89.17 9.48 25.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.369 -0.832 . . . . 0.0 110.165 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 185' ' ' ALA . 23.1 t0 41.98 82.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.176 -0.953 . . . . 0.0 109.766 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.7 tt -141.22 173.3 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 110.49 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.52 ' O ' ' O ' ' A' ' 189' ' ' VAL . 0.0 OUTLIER -167.13 114.29 0.79 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.747 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.743 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 1.7 m 49.92 96.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 120.986 -1.071 . . . . 0.0 108.188 -178.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.534 ' N ' HG13 ' A' ' 165' ' ' ILE . . . -42.0 -16.26 0.02 OUTLIER Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 189' ' ' VAL . 9.2 t 62.82 -143.35 0.38 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.128 -1.219 . . . . 0.0 109.825 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.674 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 1.0 OUTLIER -59.54 104.36 0.27 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.512 -0.743 . . . . 0.0 109.751 179.626 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.576 ' O ' ' O ' ' A' ' 163' ' ' VAL . 11.0 m -154.78 -139.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.072 -1.018 . . . . 0.0 110.182 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.522 ' HA ' HG22 ' A' ' 163' ' ' VAL . 54.7 tt0 -176.32 167.17 2.84 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 109.926 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.552 ' CG1' HG23 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -129.45 167.46 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.114 -0.992 . . . . 0.0 110.342 -179.831 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.446 ' O ' ' C ' ' A' ' 197' ' ' ASP . 71.5 t -151.36 88.62 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.364 -0.835 . . . . 0.0 110.007 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 196' ' ' VAL . 17.8 t0 -41.24 110.23 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.319 -0.863 . . . . 0.0 110.104 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.453 ' O ' ' C ' ' A' ' 199' ' ' ASP . 0.0 OUTLIER -109.01 88.18 2.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.24 -0.913 . . . . 0.0 110.364 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 198' ' ' ARG . 0.5 OUTLIER 40.93 58.2 2.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 110.213 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 89.17 -28.04 7.05 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.45 ' O ' ' HB2' ' A' ' 198' ' ' ARG . 1.4 t60 -90.64 87.42 6.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -1.154 . . . . 0.0 110.182 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.56 ' CD1' ' CG2' ' A' ' 153' ' ' ILE . 66.2 mt -70.48 87.72 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.347 -0.846 . . . . 0.0 110.299 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.7 m -71.79 157.46 37.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.948 . . . . 0.0 110.007 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.503 ' CD2' ' CD2' ' A' ' 206' ' ' HIS . 0.9 OUTLIER -119.64 141.26 49.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -0.937 . . . . 0.0 110.204 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.494 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 1.6 t -119.77 115.48 23.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.869 . . . . 0.0 109.99 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.55 ' HA ' ' CB ' ' A' ' 193' ' ' VAL . 3.2 m80 -105.42 -165.78 1.15 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.314 -0.866 . . . . 0.0 109.942 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.457 ' O ' ' OD1' ' A' ' 207' ' ' ASN . 11.5 p30 -46.45 91.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.863 . . . . 0.0 110.142 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 49.43 24.92 5.74 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.518 ' O ' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -136.89 102.59 4.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.237 -1.155 . . . . 0.0 110.283 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.452 ' O ' HG21 ' A' ' 211' ' ' VAL . 18.4 p30 -99.77 153.81 18.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 110.241 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.452 HG21 ' O ' ' A' ' 210' ' ' ASP . 52.7 t -140.98 147.66 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.179 -0.95 . . . . 0.0 110.208 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -74.97 77.58 2.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 110.176 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 19.6 tp -74.6 169.51 17.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -0.951 . . . . 0.0 110.238 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.505 ' CD1' ' HB2' ' A' ' 217' ' ' LEU . 0.5 OUTLIER -123.53 142.96 50.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.252 -0.905 . . . . 0.0 110.21 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.46 ' OD1' HD11 ' A' ' 153' ' ' ILE . 38.8 t0 -56.7 -44.95 82.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 110.198 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.42 -49.61 13.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 110.204 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.505 ' HB2' ' CD1' ' A' ' 214' ' ' LEU . 1.9 mp -87.21 -17.6 32.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.0 110.225 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.604 ' CB ' ' CG2' ' A' ' 153' ' ' ILE . . . -55.01 -19.03 5.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 110.152 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.415 ' O ' ' C ' ' A' ' 220' ' ' THR . 61.4 t60 -68.96 -52.85 24.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.209 -0.932 . . . . 0.0 110.146 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' THR . . . . . 0.495 ' O ' ' C ' ' A' ' 221' ' ' ILE . 68.9 p -43.0 -78.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.197 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.633 ' CG2' ' CG2' ' A' ' 223' ' ' ILE . 1.6 mp -31.54 117.71 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.55 -0.719 . . . . 0.0 111.935 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 2.4 ttm-85 -100.77 103.7 14.93 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.655 ' CG2' ' CD1' ' A' ' 165' ' ' ILE . 0.1 OUTLIER -119.47 -179.8 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.145 -0.972 . . . . 0.0 111.262 -178.351 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.498 ' N ' HG12 ' A' ' 223' ' ' ILE . 2.5 mm-40 -150.74 168.42 24.45 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.472 ' HA ' HG11 ' A' ' 163' ' ' VAL . 1.3 mp0 -71.97 140.91 49.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.904 . . . . 0.0 110.251 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.412 HD12 ' HG3' ' A' ' 192' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.187 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.743 0.306 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.0 -28.2 13.26 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.06 1.558 . . . . 0.0 110.426 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 80.7 mt -119.06 122.6 29.49 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.237 -0.914 . . . . 0.0 110.204 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.48 -87.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.024 1.539 . . . . 0.0 110.419 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 135' ' ' LEU . . . 137.29 -6.52 3.64 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 134' ' ' GLY . 13.5 mt 57.66 47.15 16.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -1.19 . . . . 0.0 110.184 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 137' ' ' GLU . 9.5 t70 179.48 -85.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.255 -0.903 . . . . 0.0 110.231 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER 59.89 48.79 8.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.313 -0.867 . . . . 0.0 110.224 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.9 -26.08 53.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.314 -0.866 . . . . 0.0 110.208 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 168.63 -98.44 0.14 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 98.0 t -133.59 152.1 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -1.149 . . . . 0.0 110.15 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -80.5 -31.82 36.02 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -140.31 106.59 5.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.262 -1.14 . . . . 0.0 110.212 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.5 t -130.95 177.07 7.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.911 . . . . 0.0 110.15 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 144' ' ' ASP . 40.9 p-10 -119.4 76.44 1.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 110.256 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.33 35.23 3.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.258 -0.901 . . . . 0.0 110.203 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 147' ' ' ALA . . . -152.63 111.6 3.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.902 . . . . 0.0 110.212 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 146' ' ' ALA . . . 62.03 144.22 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.333 -0.855 . . . . 0.0 110.176 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.14 115.47 4.36 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.017 1.535 . . . . 0.0 110.403 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.527 ' CA ' ' HG2' ' A' ' 222' ' ' ARG . . . 167.34 132.31 1.38 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 151' ' ' ARG . 56.6 m -136.85 4.5 2.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -1.166 . . . . 0.0 110.197 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.498 ' HB2' ' HB2' ' A' ' 154' ' ' ASP . 0.3 OUTLIER 59.53 127.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 0.0 110.049 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.539 ' N ' HG12 ' A' ' 223' ' ' ILE . 2.1 p -77.72 12.52 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.252 -0.905 . . . . 0.0 110.79 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.611 ' CG2' ' CB ' ' A' ' 218' ' ' ALA . 18.2 pt -124.58 -24.6 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.011 -1.055 . . . . 0.0 110.421 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 0.6 OUTLIER -71.53 -21.59 61.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.131 -0.981 . . . . 0.0 109.259 179.414 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.81 -16.85 29.3 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.605 -0.684 . . . . 0.0 109.805 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.533 ' HB1' ' CD1' ' A' ' 195' ' ' ILE . . . -64.03 92.55 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.836 . . . . 0.0 110.203 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 156' ' ' ALA . 6.4 t -177.36 171.7 1.95 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.937 . . . . 0.0 110.343 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.515 ' OG ' ' NH1' ' A' ' 161' ' ' ARG . 3.7 p 42.35 73.1 0.14 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.345 -0.847 . . . . 0.0 110.118 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' MET . . . . . 0.505 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 1.6 mtp 68.62 167.45 0.12 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.281 -0.887 . . . . 0.0 110.117 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 45.7 Cg_endo -72.51 101.81 1.32 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.014 1.534 . . . . 0.0 110.381 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.515 ' NH1' ' OG ' ' A' ' 158' ' ' SER . 0.4 OUTLIER -85.41 120.14 26.54 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.291 -0.881 . . . . 0.0 110.207 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.54 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 13.7 mtmt -62.24 87.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 110.205 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.619 ' O ' ' O ' ' A' ' 193' ' ' VAL . 33.8 m -91.96 -166.36 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 110.352 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.64 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -172.61 136.74 0.76 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.841 -1.162 . . . . 0.0 110.41 -179.744 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.601 ' HA ' ' CB ' ' A' ' 223' ' ' ILE . 1.1 mt -93.6 162.36 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.374 -0.829 . . . . 0.0 110.544 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' A' ' 222' ' ' ARG . 6.6 m -136.74 -32.62 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 110.736 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.552 ' CG ' ' HB2' ' A' ' 222' ' ' ARG . 6.3 pt20 -147.04 119.46 8.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.073 -1.017 . . . . 0.0 110.652 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.533 HG13 ' CG2' ' A' ' 221' ' ' ILE . 11.6 tt -110.76 17.82 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 0.0 109.869 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 168' ' ' ILE . 67.0 m-20 -37.84 105.52 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.466 -0.771 . . . . 0.0 110.606 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.424 ' CD ' ' HB2' ' A' ' 172' ' ' PHE . 0.4 OUTLIER -131.02 107.33 9.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 109.954 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 2.0 pp -81.49 11.33 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -0.889 . . . . 0.0 110.525 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.424 ' HB2' ' CD ' ' A' ' 170' ' ' GLU . 1.1 m-85 -64.7 176.37 1.18 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 0.0 110.18 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -77.29 -165.35 0.57 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.276 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.0 p -117.92 32.37 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -0.89 . . . . 0.0 110.212 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' A' ' 176' ' ' THR . 4.6 tp10 -64.13 -143.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.293 -0.88 . . . . 0.0 110.301 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.566 ' OG1' ' CD1' ' A' ' 179' ' ' PHE . 75.2 p 42.64 92.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.281 -0.887 . . . . 0.0 110.139 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.53 -31.25 71.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 110.209 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -72.32 -25.21 61.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.862 . . . . 0.0 110.289 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.578 ' CZ ' HD12 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -85.49 -29.1 24.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.237 -0.914 . . . . 0.0 110.072 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.551 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -58.81 -16.99 19.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.179 -0.951 . . . . 0.0 109.73 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.21 -60.19 2.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.346 -0.846 . . . . 0.0 110.254 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 179' ' ' PHE . 4.4 pp -64.59 -10.53 26.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.88 . . . . 0.0 110.133 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.578 HD12 ' CZ ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -92.57 -32.4 14.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 109.916 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -67.93 -7.27 27.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 0.0 109.883 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -83.54 13.79 4.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.343 -0.848 . . . . 0.0 110.23 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 185' ' ' ALA . 8.9 m-20 42.98 62.98 1.62 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.211 -0.931 . . . . 0.0 110.007 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.3 tt -118.5 -174.57 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.331 -0.856 . . . . 0.0 110.348 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.589 ' O ' ' O ' ' A' ' 189' ' ' VAL . 0.4 OUTLIER -171.41 112.08 0.34 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.346 -0.846 . . . . 0.0 108.908 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.634 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 1.1 m 51.35 109.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.381 -0.824 . . . . 0.0 109.202 -178.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 191' ' ' SER . . . -44.19 -15.68 0.05 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.574 ' N ' ' O ' ' A' ' 189' ' ' VAL . 3.3 t 68.3 -145.06 0.12 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.179 -1.189 . . . . 0.0 109.534 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.64 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 3.8 mm-40 -66.39 102.93 0.93 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.496 -0.752 . . . . 0.0 109.331 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.619 ' O ' ' O ' ' A' ' 163' ' ' VAL . 20.6 m -156.46 -140.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 110.323 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.54 ' CB ' ' HA ' ' A' ' 162' ' ' LYS . 3.1 pt-20 -177.3 139.77 0.27 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.334 -0.854 . . . . 0.0 110.029 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.553 ' HB ' ' HG ' ' A' ' 204' ' ' LEU . 0.0 OUTLIER -130.39 161.19 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.104 -0.998 . . . . 0.0 110.452 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.551 ' N ' HG12 ' A' ' 195' ' ' ILE . 18.2 t -129.71 130.66 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.46 -0.775 . . . . 0.0 110.012 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.479 ' HA ' HG12 ' A' ' 202' ' ' ILE . 7.1 t70 -83.5 137.62 33.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -0.941 . . . . 0.0 110.321 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -130.23 71.34 1.45 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.28 -0.888 . . . . 0.0 110.201 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 198' ' ' ARG . 47.5 t0 42.73 71.39 0.23 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 110.149 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 88.84 -35.81 3.58 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.501 ' O ' ' N ' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -89.87 108.29 19.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.263 -1.139 . . . . 0.0 110.195 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.479 HG12 ' HA ' ' A' ' 197' ' ' ASP . 7.8 mt -112.82 138.63 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 110.296 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.541 ' O ' HG12 ' A' ' 195' ' ' ILE . 31.4 m -126.74 146.06 50.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.346 -0.846 . . . . 0.0 109.832 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.581 HD23 ' CG2' ' A' ' 193' ' ' VAL . 0.2 OUTLIER -119.48 133.16 55.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.086 -1.008 . . . . 0.0 110.387 -179.796 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.582 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 1.2 m -119.96 124.12 45.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.412 -0.805 . . . . 0.0 109.768 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.585 ' CG ' ' O ' ' A' ' 209' ' ' LYS . 2.5 m170 -107.83 100.1 9.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.413 -0.805 . . . . 0.0 110.207 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 207' ' ' ASN . 1.2 p-10 39.02 29.77 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.352 -0.843 . . . . 0.0 110.78 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 123.6 -33.3 3.99 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.585 ' O ' ' CG ' ' A' ' 206' ' ' HIS . 3.6 mmtt -91.86 110.69 22.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.225 -1.162 . . . . 0.0 109.972 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 204' ' ' LEU . 4.1 p30 -109.23 169.7 8.52 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.118 -0.989 . . . . 0.0 110.484 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.418 HG11 ' N ' ' A' ' 212' ' ' GLU . 37.8 t -151.41 146.24 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.326 -0.859 . . . . 0.0 110.128 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 213' ' ' LEU . 2.3 tt0 -75.25 72.61 2.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.285 -0.884 . . . . 0.0 110.221 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 212' ' ' GLU . 1.1 mp -55.19 -165.86 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.891 . . . . 0.0 110.23 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.482 ' O ' ' HB1' ' A' ' 218' ' ' ALA . 0.5 OUTLIER -157.93 136.95 11.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 110.188 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 214' ' ' LEU . 21.7 t0 -41.88 -48.14 4.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -0.901 . . . . 0.0 110.428 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.458 ' HB3' HD13 ' A' ' 214' ' ' LEU . 7.4 t0 -47.84 -52.05 20.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.181 -0.95 . . . . 0.0 110.336 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.475 ' O ' HG22 ' A' ' 221' ' ' ILE . 0.4 OUTLIER -88.46 -32.29 18.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.272 -0.892 . . . . 0.0 110.297 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.611 ' CB ' ' CG2' ' A' ' 153' ' ' ILE . . . -62.99 -26.75 69.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.03 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.565 ' CG ' HD13 ' A' ' 153' ' ' ILE . 1.1 t60 -99.1 29.88 3.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.935 . . . . 0.0 110.11 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 50.6 m -138.41 -33.47 0.67 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.257 -0.902 . . . . 0.0 110.451 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.576 HG12 ' CG2' ' A' ' 223' ' ' ILE . 0.2 OUTLIER -67.35 140.21 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 110.445 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.552 ' HB2' ' CG ' ' A' ' 167' ' ' GLN . 1.4 mtt180 -91.94 113.5 25.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 109.383 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.601 ' CB ' ' HA ' ' A' ' 165' ' ' ILE . 0.7 OUTLIER -127.12 -169.26 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.126 -0.983 . . . . 0.0 110.954 -179.126 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.443 ' HG3' ' N ' ' A' ' 225' ' ' GLU . 3.0 tp10 -148.85 156.92 43.0 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.468 -0.77 . . . . 0.0 109.98 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 1.1 tt0 -104.95 122.68 46.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.296 -0.878 . . . . 0.0 110.221 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.1 tp . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.222 179.935 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.54 ' CB ' ' CD ' ' A' ' 131' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 120.698 0.285 . . . . 0.0 110.271 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.54 ' CD ' ' CB ' ' A' ' 130' ' ' ASN . 46.6 Cg_endo -73.37 -51.18 0.17 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.049 1.552 . . . . 0.0 110.473 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.1 mt -136.54 106.52 9.18 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.889 . . . . 0.0 110.255 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.23 -0.98 9.91 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.999 1.526 . . . . 0.0 110.461 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -85.43 -170.91 47.67 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.448 HD21 ' O ' ' A' ' 135' ' ' LEU . 0.4 OUTLIER -149.25 -35.03 0.18 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -1.117 . . . . 0.0 110.305 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.45 124.98 36.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 110.312 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -138.2 49.66 1.92 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -0.905 . . . . 0.0 110.197 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.401 ' HG ' ' N ' ' A' ' 139' ' ' GLY . 26.6 tp -100.14 -85.44 0.4 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 110.322 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.401 ' N ' ' HG ' ' A' ' 138' ' ' LEU . . . -75.1 66.91 2.15 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.7 t -71.99 -8.98 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -1.141 . . . . 0.0 110.14 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 142' ' ' ASN . . . -103.64 -31.81 4.73 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 141' ' ' GLY . 0.4 OUTLIER 43.05 45.97 4.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -1.133 . . . . 0.0 110.246 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.3 m -148.07 -164.44 2.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 110.2 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 144' ' ' ASP . 1.8 m-20 -53.38 -65.61 0.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.311 -0.868 . . . . 0.0 110.156 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.57 -175.68 2.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 110.176 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 147' ' ' ALA . . . -151.34 80.54 1.3 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.181 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 146' ' ' ALA . . . 63.1 158.29 0.12 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.953 . . . . 0.0 110.17 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.54 123.11 8.83 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.073 1.565 . . . . 0.0 110.464 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 145.52 92.68 0.13 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.487 ' O ' ' O ' ' A' ' 151' ' ' ARG . 91.0 m -81.22 -20.91 40.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -1.152 . . . . 0.0 110.202 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.512 ' O ' ' O ' ' A' ' 152' ' ' VAL . 11.4 mtt85 59.92 132.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.34 -0.85 . . . . 0.0 110.043 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.697 ' O ' ' CG1' ' A' ' 153' ' ' ILE . 37.6 t -51.35 -174.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.239 -0.913 . . . . 0.0 109.369 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.697 ' CG1' ' O ' ' A' ' 152' ' ' VAL . 1.0 OUTLIER 52.44 15.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.143 -0.973 . . . . 0.0 110.209 -179.589 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.464 ' HB3' HG21 ' A' ' 150' ' ' THR . 1.2 t0 -130.4 -31.21 1.85 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.357 -0.839 . . . . 0.0 109.419 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.533 ' CB ' HG13 ' A' ' 163' ' ' VAL . . . -84.64 -18.85 34.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.514 -0.741 . . . . 0.0 109.814 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.34 136.02 56.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.343 -0.848 . . . . 0.0 110.039 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.515 ' O ' ' CB ' ' A' ' 158' ' ' SER . 7.9 m -160.88 87.16 0.73 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.112 -0.992 . . . . 0.0 110.359 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 157' ' ' THR . 2.1 t 70.11 -53.17 0.63 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.305 -0.872 . . . . 0.0 110.058 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' MET . . . . . 0.472 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 59.0 mtp -108.98 168.01 8.33 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 121.327 -0.858 . . . . 0.0 110.056 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.472 ' HB2' ' OE2' ' A' ' 194' ' ' GLU . 46.2 Cg_endo -72.63 65.86 3.83 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.952 1.501 . . . . 0.0 110.427 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -44.0 109.66 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 110.234 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.496 ' HA ' ' CG ' ' A' ' 194' ' ' GLU . 5.6 tttm -58.1 132.15 52.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.905 . . . . 0.0 110.255 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.546 ' O ' ' O ' ' A' ' 193' ' ' VAL . 16.0 m -150.24 -159.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 110.498 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.604 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.1 OUTLIER -173.81 150.86 1.73 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.936 -1.103 . . . . 0.0 110.347 -179.633 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.64 ' CD1' HG23 ' A' ' 223' ' ' ILE . 2.0 mm -88.92 148.42 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.34 -0.85 . . . . 0.0 110.297 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 222' ' ' ARG . 22.6 m -136.47 5.34 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.888 . . . . 0.0 109.814 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.46 ' HB3' ' HB3' ' A' ' 222' ' ' ARG . 1.7 tm0? -171.77 121.17 0.48 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.898 . . . . 0.0 109.867 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.539 ' HB ' ' CG1' ' A' ' 189' ' ' VAL . 0.3 OUTLIER -93.74 -2.31 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.0 110.33 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 49.78 -137.07 1.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.168 -0.958 . . . . 0.0 110.022 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -117.87 108.23 15.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.956 . . . . 0.0 110.198 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 172' ' ' PHE . 1.0 OUTLIER -60.49 -13.84 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.164 -0.96 . . . . 0.0 110.105 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.443 ' N ' HG13 ' A' ' 171' ' ' ILE . 0.5 OUTLIER -75.69 82.93 2.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 110.127 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -110.58 -89.63 0.49 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 110.198 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.469 ' CG1' ' N ' ' A' ' 175' ' ' GLU . 37.5 t -128.47 -91.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.906 . . . . 0.0 110.233 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.469 ' N ' ' CG1' ' A' ' 174' ' ' VAL . 2.8 mt-10 -94.1 -172.14 2.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 0.0 110.198 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.556 HG22 ' CD2' ' A' ' 179' ' ' PHE . 20.0 m -136.04 -65.36 0.58 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.287 -0.883 . . . . 0.0 110.217 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.516 ' HB2' ' O ' ' A' ' 176' ' ' THR . 5.6 m-20 70.57 -153.43 0.11 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.455 -0.778 . . . . 0.0 110.359 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' A' ' 181' ' ' GLN . 18.6 tt0 -45.42 -25.68 0.45 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.278 -0.889 . . . . 0.0 110.607 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.599 ' CE1' ' HB2' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -42.39 -54.64 3.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.208 -0.932 . . . . 0.0 110.026 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.535 HG21 ' CG2' ' A' ' 176' ' ' THR . 0.0 OUTLIER -47.84 -23.42 0.74 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.054 -1.029 . . . . 0.0 109.836 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 178' ' ' GLN . 34.5 tt0 -71.98 -62.0 1.58 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 110.199 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 179' ' ' PHE . 4.6 pp -65.33 -9.3 23.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.346 -0.846 . . . . 0.0 109.892 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.599 ' HB2' ' CE1' ' A' ' 179' ' ' PHE . 3.4 tm? -92.25 -31.67 15.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.876 . . . . 0.0 109.851 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -70.25 -5.81 30.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.42 -0.8 . . . . 0.0 110.008 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -88.11 29.35 0.95 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -0.906 . . . . 0.0 110.235 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 186' ' ' ASP . 1.8 m-20 52.48 36.23 19.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.214 -0.929 . . . . 0.0 110.208 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 16.3 mm -93.47 156.6 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 110.185 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.589 ' O ' ' C ' ' A' ' 189' ' ' VAL . 2.5 ptm180 -170.83 130.32 0.81 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.863 ' O ' ' N ' ' A' ' 191' ' ' SER . 34.3 m 33.75 69.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.212 -0.93 . . . . 0.0 109.008 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 189' ' ' VAL . . . -20.93 -32.2 0.0 OUTLIER Glycine 0 N--CA 1.498 2.785 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.863 ' N ' ' O ' ' A' ' 189' ' ' VAL . 3.4 t 70.86 -143.54 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -1.142 . . . . 0.0 109.831 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.604 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.8 OUTLIER -61.36 102.48 0.23 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.416 -0.803 . . . . 0.0 109.796 179.741 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.546 ' O ' ' O ' ' A' ' 163' ' ' VAL . 20.3 m -156.32 -142.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.126 -0.984 . . . . 0.0 110.246 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.496 ' CG ' ' HA ' ' A' ' 162' ' ' LYS . 21.6 tt0 -175.95 161.21 2.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 110.218 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.547 ' CG2' ' HG ' ' A' ' 204' ' ' LEU . 0.7 OUTLIER -123.48 172.15 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.128 -0.983 . . . . 0.0 110.279 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.519 ' CG1' ' HB ' ' A' ' 203' ' ' THR . 14.8 p -146.59 102.13 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 110.158 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 197' ' ' ASP . 5.1 p-10 -42.35 113.94 0.51 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.266 -0.896 . . . . 0.0 110.193 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.463 ' N ' ' O ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -100.55 160.6 14.22 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.252 -0.905 . . . . 0.0 110.304 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -55.73 91.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.253 -0.904 . . . . 0.0 110.064 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 198' ' ' ARG . . . 76.76 12.4 84.53 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.463 ' O ' ' N ' ' A' ' 198' ' ' ARG . 0.0 OUTLIER -150.13 179.88 7.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.169 -1.195 . . . . 0.0 110.179 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' ' 153' ' ' ILE . 42.5 mt -144.79 133.68 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.921 . . . . 0.0 110.308 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.519 ' HB ' ' CG1' ' A' ' 196' ' ' VAL . 0.2 OUTLIER -113.83 152.86 30.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 110.026 179.794 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.547 ' HG ' ' CG2' ' A' ' 195' ' ' ILE . 1.1 tt -119.72 137.25 54.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 110.294 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.531 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 3.0 t -119.78 128.14 53.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.356 -0.84 . . . . 0.0 109.865 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.53 ' O ' ' N ' ' A' ' 208' ' ' GLY . 1.3 m80 -112.72 125.68 54.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.387 -0.82 . . . . 0.0 110.013 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 206' ' ' HIS . 2.0 t-20 42.82 -93.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.216 -0.927 . . . . 0.0 110.224 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -126.28 19.1 6.42 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.13 129.27 39.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -1.138 . . . . 0.0 110.258 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 7.9 t70 -117.94 156.78 27.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.296 -0.878 . . . . 0.0 110.22 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.421 ' N ' ' OD1' ' A' ' 210' ' ' ASP . 5.5 p -149.43 162.23 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.251 -0.905 . . . . 0.0 110.201 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -65.01 156.4 31.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 110.126 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.507 HD22 ' CB ' ' A' ' 218' ' ' ALA . 0.7 OUTLIER -156.48 88.76 1.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.232 -0.917 . . . . 0.0 110.202 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.494 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 14.5 tp -41.34 113.74 0.43 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.235 -0.916 . . . . 0.0 110.244 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.498 ' O ' ' HB1' ' A' ' 218' ' ' ALA . 8.2 t0 -60.18 -43.17 96.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.325 -0.859 . . . . 0.0 110.428 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 215' ' ' ASP . 55.9 t0 -43.07 -67.37 0.28 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.131 -0.981 . . . . 0.0 110.177 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.28 -13.54 56.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.259 -0.901 . . . . 0.0 110.531 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.539 ' HB2' ' CG2' ' A' ' 153' ' ' ILE . . . -45.01 -26.43 0.43 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.148 -0.97 . . . . 0.0 110.1 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.599 ' CG ' HD13 ' A' ' 153' ' ' ILE . 0.7 OUTLIER -78.95 64.63 3.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.268 -0.895 . . . . 0.0 110.182 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' THR . . . . . 0.481 HG22 HD11 ' A' ' 221' ' ' ILE . 0.5 OUTLIER -129.25 -22.89 3.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -0.973 . . . . 0.0 110.467 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.556 ' CG1' HG22 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -99.78 145.95 9.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.09 -1.006 . . . . 0.0 110.57 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.527 ' O ' ' CG2' ' A' ' 166' ' ' VAL . 0.3 OUTLIER -88.81 96.35 10.65 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.323 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.64 HG23 ' CD1' ' A' ' 165' ' ' ILE . 0.5 OUTLIER -119.64 173.16 5.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.304 -0.873 . . . . 0.0 111.419 -177.492 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.481 ' HA ' ' HB ' ' A' ' 150' ' ' THR . 0.6 OUTLIER -145.9 -172.87 4.01 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.5 -0.75 . . . . 0.0 110.181 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 8.4 tt0 -112.08 127.14 55.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.377 -0.827 . . . . 0.0 110.201 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.418 HD21 ' OXT' ' A' ' 226' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.231 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.2 t30 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 120.796 0.331 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.54 -15.84 24.45 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.977 1.514 . . . . 0.0 110.465 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 28.2 mm -72.96 124.07 90.3 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 110.218 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.11 96.02 0.86 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.917 1.483 . . . . 0.0 110.431 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -178.31 85.72 0.07 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -166.66 95.97 0.54 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.326 -1.102 . . . . 0.0 110.144 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -88.88 60.21 5.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 0.0 110.21 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 40.4 mt-10 63.08 -71.17 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.0 110.4 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 136' ' ' ASP . 14.8 tp -95.05 100.52 12.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.319 -0.863 . . . . 0.0 110.238 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 136.1 166.09 10.82 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 28.2 m -139.47 8.22 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -1.124 . . . . 0.0 110.242 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -165.72 163.7 36.86 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -129.7 150.49 50.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -1.136 . . . . 0.0 110.221 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 144' ' ' ASP . 1.0 OUTLIER 50.48 -164.16 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.922 . . . . 0.0 110.159 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 143' ' ' SER . 7.7 t0 59.85 145.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -0.893 . . . . 0.0 110.219 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 44.96 -141.79 0.26 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.349 -0.844 . . . . 0.0 110.261 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 147' ' ' ALA . . . -154.99 82.21 1.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 110.237 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.539 ' CB ' ' OG1' ' A' ' 150' ' ' THR . . . 59.68 121.37 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.204 -0.935 . . . . 0.0 110.11 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.5 90.98 0.89 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.989 1.52 . . . . 0.0 110.694 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.578 ' O ' ' HB ' ' A' ' 150' ' ' THR . . . 95.23 -74.26 0.91 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.578 ' HB ' ' O ' ' A' ' 149' ' ' GLY . 22.2 m 65.89 -121.54 0.34 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.345 -1.091 . . . . 0.0 109.889 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.529 ' CD ' ' O ' ' A' ' 150' ' ' THR . 1.5 mmt180 -143.41 157.62 44.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.961 -1.087 . . . . 0.0 109.989 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.542 ' CG2' HD11 ' A' ' 195' ' ' ILE . 0.6 OUTLIER -69.3 -3.94 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.157 -0.964 . . . . 0.0 110.479 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.607 ' CG2' ' CB ' ' A' ' 218' ' ' ALA . 1.6 pp -117.65 -30.9 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.098 -1.001 . . . . 0.0 110.335 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.513 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -74.88 -13.25 60.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -0.967 . . . . 0.0 109.214 179.346 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -113.04 -7.34 13.68 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.562 -0.711 . . . . 0.0 109.72 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.529 ' CB ' HD13 ' A' ' 195' ' ' ILE . . . -85.0 177.21 8.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.335 -0.853 . . . . 0.0 110.194 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.527 ' O ' ' CB ' ' A' ' 158' ' ' SER . 0.4 OUTLIER 56.88 153.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.347 -0.846 . . . . 0.0 110.185 179.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 157' ' ' THR . 0.7 OUTLIER 70.69 -51.5 0.67 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.181 -0.95 . . . . 0.0 110.157 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' MET . . . . . 0.454 ' N ' ' CD ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER -161.86 55.3 0.57 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.851 . . . . 0.0 109.883 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.526 ' HB3' ' HA ' ' A' ' 156' ' ' ALA . 43.6 Cg_endo -72.66 -67.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.092 1.575 . . . . 0.0 110.565 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.415 ' CB ' ' O ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER 64.23 -153.97 0.3 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.908 . . . . 0.0 110.228 179.833 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.433 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -86.92 90.37 8.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.21 -0.931 . . . . 0.0 110.553 -179.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.593 ' O ' ' O ' ' A' ' 193' ' ' VAL . 0.1 OUTLIER -92.46 -169.44 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.226 -0.921 . . . . 0.0 109.909 179.542 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.587 ' C ' ' HB ' ' A' ' 223' ' ' ILE . 0.3 OUTLIER -167.07 137.96 3.13 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.712 -1.243 . . . . 0.0 110.286 -179.578 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.562 ' CG2' ' HB ' ' A' ' 221' ' ' ILE . 0.2 OUTLIER -85.37 133.46 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.318 -0.864 . . . . 0.0 110.284 -179.59 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.497 HG21 ' O ' ' A' ' 222' ' ' ARG . 15.5 m -119.92 -23.09 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.235 -0.916 . . . . 0.0 110.7 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -148.97 125.6 11.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.032 -1.043 . . . . 0.0 110.531 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 221' ' ' ILE . 5.1 tt -108.62 6.78 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.348 -0.845 . . . . 0.0 110.03 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 168' ' ' ILE . 3.0 t-20 -43.35 98.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.348 -0.845 . . . . 0.0 110.347 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.485 ' CG ' ' HB2' ' A' ' 172' ' ' PHE . 1.0 OUTLIER -157.9 116.06 3.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -0.929 . . . . 0.0 110.185 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 172' ' ' PHE . 1.6 pp -83.26 10.33 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.341 -0.85 . . . . 0.0 110.196 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.485 ' HB2' ' CG ' ' A' ' 170' ' ' GLU . 0.1 OUTLIER -60.09 -148.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.285 -0.885 . . . . 0.0 110.147 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.457 ' O ' ' HB ' ' A' ' 174' ' ' VAL . 11.7 tt0 53.86 174.37 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 110.07 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 173' ' ' GLN . 1.6 p 175.44 -26.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 110.249 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.467 ' O ' ' HB ' ' A' ' 176' ' ' THR . 0.0 OUTLIER -172.58 129.54 0.54 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.908 . . . . 0.0 110.329 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 175' ' ' GLU . 1.7 t 177.36 99.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.337 -0.852 . . . . 0.0 110.172 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.55 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.5 OUTLIER -75.8 -28.25 58.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.291 -0.88 . . . . 0.0 110.307 -179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -17.51 64.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.105 -0.997 . . . . 0.0 109.972 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.653 ' HA ' HD13 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -90.28 -39.39 12.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 110.683 -179.827 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.55 ' OG1' ' O ' ' A' ' 177' ' ' ASP . 0.2 OUTLIER -41.19 -26.09 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.13 -0.981 . . . . 0.0 110.05 -179.568 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.5 ' NE2' ' OE2' ' A' ' 212' ' ' GLU . 0.6 OUTLIER -53.4 -45.09 69.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.183 -0.948 . . . . 0.0 109.515 179.303 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.653 HD13 ' HA ' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -69.84 -34.76 74.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.403 -0.811 . . . . 0.0 108.973 179.083 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.432 HD11 ' C ' ' A' ' 183' ' ' LEU . 0.2 OUTLIER -66.05 -33.73 76.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.592 -0.692 . . . . 0.0 109.786 179.609 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -57.87 -16.16 10.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.409 -0.807 . . . . 0.0 109.87 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -92.83 12.61 23.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.438 -0.789 . . . . 0.0 110.252 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 185' ' ' ALA . 22.0 t70 43.8 85.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.732 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.2 tt -135.56 177.1 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 110.824 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.581 ' O ' ' O ' ' A' ' 189' ' ' VAL . 4.2 ttp180 -174.64 114.41 0.17 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.719 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 1.1 m 46.66 98.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.174 -0.954 . . . . 0.0 108.546 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.517 ' O ' ' CG1' ' A' ' 193' ' ' VAL . . . -40.44 -18.19 0.01 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.627 ' N ' ' O ' ' A' ' 189' ' ' VAL . 5.7 t 64.65 -141.95 0.25 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.037 -1.272 . . . . 0.0 109.213 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.576 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 4.9 pm0 -61.57 99.69 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.507 -0.746 . . . . 0.0 109.3 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.593 ' O ' ' O ' ' A' ' 163' ' ' VAL . 13.1 m -155.07 -139.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.083 -1.01 . . . . 0.0 109.98 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.475 ' HA ' HG22 ' A' ' 163' ' ' VAL . 3.4 pt-20 -173.26 158.69 3.65 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.3 -0.875 . . . . 0.0 110.564 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.542 HD11 ' CG2' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -131.09 162.97 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.28 -0.888 . . . . 0.0 110.275 -179.719 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' A' ' 195' ' ' ILE . 77.7 t -157.28 100.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.249 -0.907 . . . . 0.0 110.12 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.524 ' CB ' ' OG1' ' A' ' 157' ' ' THR . 16.1 t0 -42.91 109.64 0.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.903 . . . . 0.0 110.258 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.521 ' CB ' ' O ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -97.11 81.17 3.02 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.307 -0.871 . . . . 0.0 110.129 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 49.3 57.73 6.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 110.101 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 89.26 -25.96 9.66 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.521 ' O ' ' CB ' ' A' ' 198' ' ' ARG . 2.7 t60 -98.72 95.0 6.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -1.143 . . . . 0.0 110.163 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.517 HD12 ' CG2' ' A' ' 153' ' ' ILE . 83.8 mt -64.56 115.85 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.341 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 195' ' ' ILE . 28.8 m -94.48 147.19 23.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.151 -0.968 . . . . 0.0 110.065 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.593 HD21 ' CD2' ' A' ' 206' ' ' HIS . 1.2 tt -119.71 129.34 54.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.227 -0.92 . . . . 0.0 110.128 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.55 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.0 OUTLIER -120.02 122.84 42.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.296 -0.877 . . . . 0.0 110.015 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.593 ' CD2' HD21 ' A' ' 204' ' ' LEU . 0.1 OUTLIER -106.91 154.5 20.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.534 -0.729 . . . . 0.0 109.89 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -50.66 -19.83 1.04 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.947 . . . . 0.0 109.955 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.47 ' O ' ' HD3' ' A' ' 209' ' ' LYS . . . -87.38 -32.76 12.88 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.47 ' HD3' ' O ' ' A' ' 208' ' ' GLY . 0.0 OUTLIER 176.77 -152.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.159 -1.2 . . . . 0.0 110.29 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 204' ' ' LEU . 36.7 t70 -137.73 156.29 48.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.324 -0.86 . . . . 0.0 110.174 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.92 173.39 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.218 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.5 ' OE2' ' NE2' ' A' ' 181' ' ' GLN . 13.2 pt-20 -91.33 162.32 14.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 110.337 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.514 HD13 ' CD1' ' A' ' 204' ' ' LEU . 0.3 OUTLIER -147.88 153.21 38.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 110.177 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.472 ' N ' ' CD2' ' A' ' 214' ' ' LEU . 0.4 OUTLIER -120.08 129.52 54.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.263 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 214' ' ' LEU . 1.5 m-20 -43.31 -29.33 0.4 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 110.195 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -56.06 -59.17 5.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 110.119 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.62 ' CD2' ' CD1' ' A' ' 179' ' ' PHE . 1.0 OUTLIER -90.12 -24.68 21.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 110.314 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.607 ' CB ' ' CG2' ' A' ' 153' ' ' ILE . . . -52.19 -42.47 63.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.194 -0.941 . . . . 0.0 110.158 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.565 ' O ' ' CG ' ' A' ' 219' ' ' HIS . 69.2 t60 -84.03 58.84 4.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.893 . . . . 0.0 110.194 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 217' ' ' LEU . 30.6 p -145.02 -31.63 0.41 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 110.621 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.562 ' HB ' ' CG2' ' A' ' 165' ' ' ILE . 0.1 OUTLIER -90.97 141.05 14.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.175 -0.953 . . . . 0.0 110.456 -179.799 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.497 ' O ' HG21 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -92.6 111.33 22.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.379 -0.826 . . . . 0.0 109.793 179.778 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.587 ' HB ' ' C ' ' A' ' 164' ' ' ARG . 0.1 OUTLIER -121.23 166.22 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.167 -0.958 . . . . 0.0 110.108 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.428 ' C ' HG13 ' A' ' 163' ' ' VAL . 1.2 tt0 -137.08 161.38 36.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.121 -0.987 . . . . 0.0 110.553 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 22.1 mm-40 -72.26 137.18 46.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.422 -0.799 . . . . 0.0 110.222 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.213 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.535 ' CB ' ' CD ' ' A' ' 131' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 120.768 0.318 . . . . 0.0 110.226 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.535 ' CD ' ' CB ' ' A' ' 130' ' ' ASN . 47.2 Cg_endo -73.69 -39.45 1.89 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.982 1.517 . . . . 0.0 110.31 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.47 ' CG2' ' O ' ' A' ' 132' ' ' ILE . 16.9 tt -163.51 107.34 0.97 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.29 -0.881 . . . . 0.0 110.124 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.44 -26.62 16.82 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.009 1.531 . . . . 0.0 110.423 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.28 58.1 1.53 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.45 -76.71 0.55 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -1.153 . . . . 0.0 110.271 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 40.0 p-10 -87.06 33.98 0.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.347 -0.846 . . . . 0.0 110.323 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 136' ' ' ASP . 0.0 OUTLIER 42.87 54.03 4.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.912 . . . . 0.0 110.131 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.469 ' CD2' ' O ' ' A' ' 138' ' ' LEU . 1.6 tt -95.7 30.87 2.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 0.0 110.237 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 129.57 151.12 7.21 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.79 -25.66 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -1.152 . . . . 0.0 110.224 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.33 157.26 31.44 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.454 ' O ' ' OD1' ' A' ' 142' ' ' ASN . 8.7 p30 -120.79 46.19 2.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.324 -1.104 . . . . 0.0 110.2 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -134.05 165.81 24.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.0 110.253 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 144' ' ' ASP . 19.4 p30 -61.84 168.06 3.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.267 -0.896 . . . . 0.0 110.231 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 53.88 49.64 18.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 110.245 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.401 ' O ' ' CB ' ' A' ' 147' ' ' ALA . . . -163.08 26.87 0.09 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.287 -0.883 . . . . 0.0 110.149 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 146' ' ' ALA . . . 174.56 122.5 0.11 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 110.179 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.58 54.19 2.87 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.001 1.527 . . . . 0.0 110.441 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -170.91 167.79 40.94 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.544 ' O ' ' CD1' ' A' ' 223' ' ' ILE . 8.1 m -144.72 100.59 3.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -1.158 . . . . 0.0 109.978 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.694 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -37.09 150.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.873 . . . . 0.0 110.555 -179.8 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.774 ' HA ' HD13 ' A' ' 223' ' ' ILE . 17.7 m -54.88 -150.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.229 -0.919 . . . . 0.0 110.379 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.607 ' CG2' ' CB ' ' A' ' 218' ' ' ALA . 11.2 pt 40.22 27.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.23 -0.919 . . . . 0.0 110.042 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -144.0 -37.32 0.33 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.522 -0.736 . . . . 0.0 109.383 179.639 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -98.27 -9.67 25.16 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.541 -0.724 . . . . 0.0 109.741 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.408 ' O ' ' HB ' ' A' ' 157' ' ' THR . . . -74.05 175.37 7.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.328 -0.857 . . . . 0.0 110.201 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.509 HG23 ' CG ' ' A' ' 161' ' ' ARG . 5.7 t -177.09 178.41 1.13 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.258 -0.901 . . . . 0.0 110.127 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 157' ' ' THR . 21.1 t -42.83 -61.1 1.35 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.901 . . . . 0.0 110.131 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' MET . . . . . 0.48 ' HB2' ' HD2' ' A' ' 160' ' ' PRO . 0.0 OUTLIER -71.01 165.01 51.69 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.898 . . . . 0.0 110.034 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 159' ' ' MET . 45.7 Cg_endo -72.6 66.99 3.78 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.944 1.497 . . . . 0.0 110.353 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.509 ' CG ' HG23 ' A' ' 157' ' ' THR . 0.0 OUTLIER -47.86 125.64 9.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.254 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.458 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 1.2 tttp -77.3 100.37 5.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -0.909 . . . . 0.0 110.274 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.521 HG22 ' HA ' ' A' ' 194' ' ' GLU . 0.1 OUTLIER -117.41 -164.01 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 0.0 110.301 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.658 ' O ' ' HB ' ' A' ' 223' ' ' ILE . 23.7 ttt180 -172.33 157.82 4.22 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.911 -1.118 . . . . 0.0 110.265 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.689 ' HB ' HG21 ' A' ' 189' ' ' VAL . 0.8 OUTLIER -110.49 151.36 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.651 -179.359 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.0 m -133.04 -5.05 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.299 -0.876 . . . . 0.0 110.775 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -174.06 131.13 0.4 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.914 -1.116 . . . . 0.0 110.96 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.575 ' CG2' HG12 ' A' ' 189' ' ' VAL . 9.0 tt -126.23 10.03 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.451 -0.781 . . . . 0.0 109.598 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.472 ' O ' ' HB3' ' A' ' 170' ' ' GLU . 1.5 t-20 -56.09 83.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.373 -0.829 . . . . 0.0 110.356 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.519 ' O ' ' C ' ' A' ' 171' ' ' ILE . 0.7 OUTLIER -179.98 -173.76 0.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.363 -0.836 . . . . 0.0 109.934 179.84 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.519 ' C ' ' O ' ' A' ' 170' ' ' GLU . 2.1 mm 33.15 36.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.409 -0.807 . . . . 0.0 110.408 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' A' ' 170' ' ' GLU . 0.2 OUTLIER -67.09 -38.9 86.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.914 . . . . 0.0 110.41 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.578 ' O ' ' CB ' ' A' ' 174' ' ' VAL . 0.0 OUTLIER -78.76 -156.62 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.878 . . . . 0.0 110.353 -179.741 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.578 ' CB ' ' O ' ' A' ' 173' ' ' GLN . 2.9 t 76.58 -29.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.601 -0.687 . . . . 0.0 110.876 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.481 ' O ' ' O ' ' A' ' 174' ' ' VAL . 46.2 tt0 55.19 161.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.041 -1.037 . . . . 0.0 110.278 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.569 ' CG2' ' HB3' ' A' ' 179' ' ' PHE . 1.9 m -166.37 113.43 0.86 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.193 -0.942 . . . . 0.0 110.257 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.541 ' O ' ' OG1' ' A' ' 180' ' ' THR . 12.3 m-20 -76.86 -30.39 56.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.124 -0.985 . . . . 0.0 110.443 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.81 -17.53 55.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.097 -1.002 . . . . 0.0 110.449 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.6 ' C ' ' CD1' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -90.29 -15.23 31.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.14 -0.975 . . . . 0.0 110.392 -179.667 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.541 ' OG1' ' O ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -61.73 -20.63 63.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.002 -1.061 . . . . 0.0 109.891 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -71.41 -63.05 1.19 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.857 . . . . 0.0 109.899 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 179' ' ' PHE . 0.7 OUTLIER -61.71 -14.31 30.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.659 179.643 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.565 HD11 ' CZ ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -83.13 -29.94 28.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.868 . . . . 0.0 109.878 179.653 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.97 -12.06 34.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 110.018 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.54 ' CB ' HG23 ' A' ' 187' ' ' ILE . . . -85.88 19.09 2.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 0.0 110.199 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 185' ' ' ALA . 0.2 OUTLIER 41.69 29.6 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.0 109.516 -179.61 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.693 ' O ' ' HB3' ' A' ' 188' ' ' ARG . 1.5 tt -116.4 149.33 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.505 -0.747 . . . . 0.0 110.409 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.757 ' O ' ' O ' ' A' ' 189' ' ' VAL . 0.0 OUTLIER 164.91 108.91 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.757 ' O ' ' O ' ' A' ' 188' ' ' ARG . 6.1 p 38.45 175.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 121.589 0.709 . . . . 0.0 110.93 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.512 ' N ' ' CG2' ' A' ' 189' ' ' VAL . . . 107.41 -7.06 36.66 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.3 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.562 ' O ' ' HG3' ' A' ' 164' ' ' ARG . 0.5 OUTLIER -159.62 -177.35 6.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.859 -1.377 . . . . 0.0 111.74 -179.515 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.612 ' HA ' ' HG3' ' A' ' 164' ' ' ARG . 38.8 tt0 -67.39 137.87 56.28 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.753 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.632 ' CG1' ' CD2' ' A' ' 206' ' ' HIS . 2.0 m -161.16 134.62 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.291 -0.881 . . . . 0.0 109.467 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 204' ' ' LEU . 0.1 OUTLIER -102.68 156.84 17.36 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.309 179.51 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' A' ' 203' ' ' THR . 1.2 mt -118.74 153.1 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.936 -1.102 . . . . 0.0 110.683 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.406 ' O ' ' C ' ' A' ' 197' ' ' ASP . 55.8 t -132.16 91.47 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.513 -0.742 . . . . 0.0 110.31 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.467 ' HA ' HG12 ' A' ' 202' ' ' ILE . 33.3 m-20 -43.45 137.07 2.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.22 -0.925 . . . . 0.0 110.125 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.444 ' HB2' ' HB3' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -128.25 71.87 1.4 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.261 -0.899 . . . . 0.0 110.265 -180.0 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 198' ' ' ARG . 0.3 OUTLIER 42.07 75.05 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.251 -0.905 . . . . 0.0 110.223 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 87.92 -36.81 3.32 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -90.55 165.58 13.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.178 -1.19 . . . . 0.0 110.17 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.467 HG12 ' HA ' ' A' ' 197' ' ' ASP . 9.1 mt -153.77 149.61 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.205 -0.935 . . . . 0.0 110.395 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 195' ' ' ILE . 85.8 m -146.2 159.44 43.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.398 -0.813 . . . . 0.0 109.541 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.562 ' HA ' ' O ' ' A' ' 194' ' ' GLU . 0.7 OUTLIER -119.37 157.33 28.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.934 . . . . 0.0 110.602 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.549 ' N ' ' O ' ' A' ' 194' ' ' GLU . 0.1 OUTLIER -124.54 95.07 4.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.528 -0.732 . . . . 0.0 109.429 179.429 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.632 ' CD2' ' CG1' ' A' ' 193' ' ' VAL . 40.6 m80 -76.36 74.11 3.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.448 -0.782 . . . . 0.0 110.382 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 206' ' ' HIS . 7.1 t-20 42.54 67.52 0.59 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -0.95 . . . . 0.0 110.278 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 99.17 -38.5 3.07 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.491 ' O ' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -95.71 97.11 9.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.287 -1.125 . . . . 0.0 110.23 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 204' ' ' LEU . 0.5 OUTLIER -102.07 153.62 19.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 110.295 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.514 ' CG2' HG22 ' A' ' 187' ' ' ILE . 1.0 OUTLIER -143.52 149.98 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.309 -0.869 . . . . 0.0 109.881 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.402 ' HA ' HG22 ' A' ' 203' ' ' THR . 2.5 tt0 -58.44 -174.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 110.199 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.583 ' O ' ' HG ' ' A' ' 214' ' ' LEU . 0.3 OUTLIER -174.47 -28.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.253 -0.905 . . . . 0.0 110.271 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 213' ' ' LEU . 0.5 OUTLIER 33.04 -151.05 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.477 -0.764 . . . . 0.0 110.728 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.485 ' HA ' ' HB1' ' A' ' 218' ' ' ALA . 3.1 m-20 -90.49 -61.28 1.71 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.362 -0.836 . . . . 0.0 110.497 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 215' ' ' ASP . 0.1 OUTLIER -41.48 -52.65 3.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 110.505 -179.686 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.556 ' CD1' ' HB2' ' A' ' 179' ' ' PHE . 0.5 OUTLIER -79.36 -27.76 41.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.18 -0.95 . . . . 0.0 110.261 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.607 ' CB ' ' CG2' ' A' ' 153' ' ' ILE . . . -43.36 -77.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 110.498 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.512 ' HB2' ' CD1' ' A' ' 153' ' ' ILE . 47.4 t-80 -65.88 89.7 0.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.347 -0.846 . . . . 0.0 110.386 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' THR . . . . . 0.453 ' O ' ' OE2' ' A' ' 170' ' ' GLU . 8.1 m -161.23 -63.85 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.825 . . . . 0.0 110.096 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.694 ' O ' ' HA ' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -76.18 139.66 18.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.513 -0.742 . . . . 0.0 110.781 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -90.03 106.55 18.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.385 -0.822 . . . . 0.0 109.29 179.202 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.774 HD13 ' HA ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER -121.48 173.35 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.135 -0.978 . . . . 0.0 110.698 -178.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.517 ' O ' ' CG1' ' A' ' 163' ' ' VAL . 3.5 mt-10 -150.28 -170.25 3.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.355 -0.841 . . . . 0.0 110.165 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.469 ' HA ' HG11 ' A' ' 163' ' ' VAL . 10.0 tm-20 -104.98 112.27 25.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.261 -0.899 . . . . 0.0 110.18 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 19.9 tp . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.209 179.961 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 27.9 t30 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 120.777 0.322 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 132' ' ' ILE . 45.3 Cg_endo -72.04 60.94 3.14 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.046 1.551 . . . . 0.0 110.529 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' A' ' 131' ' ' PRO . 14.7 mt 41.31 94.64 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.337 -0.852 . . . . 0.0 110.388 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.61 -21.88 21.57 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.074 1.565 . . . . 0.0 110.466 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 135.47 -103.22 0.45 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.8 mm? 49.02 -163.52 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -1.136 . . . . 0.0 110.29 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -118.67 76.5 1.1 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 110.236 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 137' ' ' GLU . 2.8 pt-20 -126.49 90.03 3.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.919 . . . . 0.0 110.199 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mt -65.28 128.49 36.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.2 -0.938 . . . . 0.0 110.165 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -178.73 99.67 0.13 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.8 p -66.84 98.0 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -1.097 . . . . 0.0 110.224 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 112.22 -158.3 14.4 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.469 ' N ' ' OD1' ' A' ' 142' ' ' ASN . 30.9 p-10 -176.16 111.23 0.1 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -1.112 . . . . 0.0 110.229 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -118.38 113.55 21.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 110.24 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -48.1 100.24 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 110.161 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.34 -89.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.893 . . . . 0.0 110.227 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -129.39 -90.72 0.48 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.268 -0.895 . . . . 0.0 110.209 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -108.19 166.07 11.58 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.947 . . . . 0.0 110.249 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 149' ' ' GLY . 46.2 Cg_endo -73.14 98.94 1.05 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.019 1.536 . . . . 0.0 110.608 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 148' ' ' PRO . . . 58.57 149.26 0.01 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.574 ' N ' ' O ' ' A' ' 223' ' ' ILE . 58.6 m -97.97 140.0 32.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.252 -1.146 . . . . 0.0 109.95 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 0.7 OUTLIER -76.53 131.57 39.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.902 -1.123 . . . . 0.0 110.058 179.84 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.665 ' O ' HG12 ' A' ' 153' ' ' ILE . 32.8 t -40.87 161.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.271 -0.893 . . . . 0.0 109.974 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.665 HG12 ' O ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER 75.01 -15.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.583 -0.698 . . . . 0.0 110.292 -179.025 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 151' ' ' ARG . 0.3 OUTLIER -103.44 -15.0 16.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.104 -0.998 . . . . 0.0 109.265 179.24 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.425 ' HB2' HG13 ' A' ' 163' ' ' VAL . . . -111.99 -11.98 13.79 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.522 -0.736 . . . . 0.0 109.879 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -76.27 128.51 35.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 110.259 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.484 HG22 ' NH1' ' A' ' 161' ' ' ARG . 0.2 OUTLIER -102.32 176.81 5.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.15 -0.969 . . . . 0.0 110.259 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.54 -59.82 2.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.925 . . . . 0.0 110.21 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' MET . . . . . 0.412 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 1.8 mpt? -75.11 166.3 46.62 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.898 . . . . 0.0 110.193 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 161' ' ' ARG . 45.8 Cg_endo -72.78 78.6 2.07 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.055 1.555 . . . . 0.0 110.437 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.484 ' NH1' HG22 ' A' ' 157' ' ' THR . 0.4 OUTLIER -60.35 -141.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 110.202 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.86 87.45 1.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.21 -0.931 . . . . 0.0 110.322 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.623 ' O ' ' O ' ' A' ' 193' ' ' VAL . 12.3 m -112.7 -162.43 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.311 -0.868 . . . . 0.0 110.221 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.641 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -169.79 151.81 4.32 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.808 -1.183 . . . . 0.0 110.985 -179.315 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.586 ' CG2' ' CG2' ' A' ' 223' ' ' ILE . 2.1 mt -100.65 154.0 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.361 -0.837 . . . . 0.0 109.97 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.53 ' CG1' ' HD2' ' A' ' 164' ' ' ARG . 31.4 m -133.91 -30.1 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.048 -1.033 . . . . 0.0 111.12 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.531 ' N ' HG13 ' A' ' 189' ' ' VAL . 2.0 mt-30 -149.45 128.91 13.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.09 -1.006 . . . . 0.0 110.704 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 221' ' ' ILE . 10.5 mt -83.36 -10.05 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.384 -0.822 . . . . 0.0 109.686 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.551 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 1.6 t30 70.36 2.38 4.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.375 -0.828 . . . . 0.0 110.342 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 44.09 62.53 1.94 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 110.394 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.551 ' CG1' ' HB3' ' A' ' 169' ' ' ASN . 13.9 mm -102.15 17.9 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 0.0 110.075 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.435 ' C ' ' O ' ' A' ' 171' ' ' ILE . 56.7 t80 -41.76 113.31 0.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.345 -0.847 . . . . 0.0 110.29 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -141.82 -32.58 0.52 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.312 -0.867 . . . . 0.0 110.378 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.457 ' O ' ' C ' ' A' ' 175' ' ' GLU . 48.7 t -127.6 75.73 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 110.101 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 174' ' ' VAL . 43.3 tt0 -39.3 157.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.429 -0.795 . . . . 0.0 110.429 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.641 ' OG1' ' CD1' ' A' ' 179' ' ' PHE . 1.0 OUTLIER -136.36 135.91 39.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.313 -0.867 . . . . 0.0 110.145 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.591 ' O ' ' OG1' ' A' ' 180' ' ' THR . 11.5 t70 -72.13 -45.91 58.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.234 -0.917 . . . . 0.0 110.871 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -21.38 63.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.056 -1.027 . . . . 0.0 110.42 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.641 ' CD1' ' OG1' ' A' ' 176' ' ' THR . 0.0 OUTLIER -90.78 -31.42 16.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 110.667 -179.782 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.599 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.5 OUTLIER -43.88 -25.97 0.23 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.953 -1.092 . . . . 0.0 109.683 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 179' ' ' PHE . 35.5 tt0 -61.62 -35.04 76.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.85 . . . . 0.0 109.578 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.527 ' CD1' ' HA ' ' A' ' 179' ' ' PHE . 0.8 OUTLIER -72.12 -39.85 68.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.398 -0.813 . . . . 0.0 109.546 179.454 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.61 -33.7 75.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.517 -0.739 . . . . 0.0 109.928 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -63.19 -14.75 52.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 0.0 109.735 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -86.89 16.66 4.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.375 -0.828 . . . . 0.0 110.034 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 186' ' ' ASP . 5.8 m-20 42.26 48.64 4.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 109.368 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.3 tt -128.96 169.56 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.517 -0.739 . . . . 0.0 110.554 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.483 ' O ' ' C ' ' A' ' 189' ' ' VAL . 0.0 OUTLIER -150.87 -133.29 0.05 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.365 -0.835 . . . . 0.0 108.784 179.506 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.579 ' CB ' HG23 ' A' ' 165' ' ' ILE . 4.3 m -42.47 120.37 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 120.965 -1.084 . . . . 0.0 109.076 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.527 ' O ' HG12 ' A' ' 193' ' ' VAL . . . -50.31 -7.7 0.14 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.608 ' O ' ' HB2' ' A' ' 164' ' ' ARG . 28.3 t 58.77 -150.53 0.44 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.163 -1.198 . . . . 0.0 109.675 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.641 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 95.5 mt-10 -64.35 101.86 0.47 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.693 -0.63 . . . . 0.0 109.826 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.623 ' O ' ' O ' ' A' ' 163' ' ' VAL . 30.8 m -158.16 -135.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.913 . . . . 0.0 109.742 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.464 ' OE2' ' HB2' ' A' ' 205' ' ' SER . 0.0 OUTLIER -169.05 158.74 8.73 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.293 -0.879 . . . . 0.0 110.117 179.407 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.595 ' CG2' ' CD1' ' A' ' 204' ' ' LEU . 0.0 OUTLIER -120.04 156.81 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 0.0 110.088 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.449 ' N ' ' O ' ' A' ' 203' ' ' THR . 11.4 t -125.24 92.38 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 110.165 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.459 ' HA ' HG12 ' A' ' 202' ' ' ILE . 8.5 t0 -41.73 134.1 2.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.292 -0.88 . . . . 0.0 110.205 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.523 ' CB ' ' O ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -132.92 154.98 49.89 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.233 -0.917 . . . . 0.0 110.137 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -59.26 90.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.237 -0.914 . . . . 0.0 110.362 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 89.88 1.56 76.49 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.523 ' O ' ' CB ' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -150.14 170.79 18.1 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -1.182 . . . . 0.0 110.326 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.459 HG12 ' HA ' ' A' ' 197' ' ' ASP . 7.5 mt -146.62 99.96 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.0 110.202 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 196' ' ' VAL . 55.1 m -72.61 150.78 42.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -0.909 . . . . 0.0 110.004 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.595 ' CD1' ' CG2' ' A' ' 195' ' ' ILE . 0.0 OUTLIER -119.9 137.9 53.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.129 -0.982 . . . . 0.0 110.288 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.549 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.6 OUTLIER -119.66 124.05 45.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.36 -0.837 . . . . 0.0 109.964 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.544 ' HA ' ' CB ' ' A' ' 193' ' ' VAL . 3.0 m80 -110.09 -171.95 1.94 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.458 -0.776 . . . . 0.0 110.188 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -56.68 98.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 110.244 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 61.09 26.11 65.32 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 206' ' ' HIS . 2.5 mtpt -143.16 158.97 43.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -1.156 . . . . 0.0 110.286 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -156.6 139.27 15.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.917 . . . . 0.0 110.153 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.2 p -134.27 172.63 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.318 -0.863 . . . . 0.0 110.205 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -110.87 103.46 11.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.255 -0.903 . . . . 0.0 110.234 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.404 HD21 HD11 ' A' ' 204' ' ' LEU . 13.2 tp -95.22 171.69 8.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 110.087 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.531 ' O ' ' CB ' ' A' ' 218' ' ' ALA . 5.6 mt -91.12 166.17 13.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 110.141 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.437 ' HB2' ' HA ' ' A' ' 201' ' ' HIS . 6.0 t0 -89.9 -75.0 0.46 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 110.094 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.19 -22.34 60.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.929 . . . . 0.0 110.092 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.487 ' CB ' ' HB2' ' A' ' 214' ' ' LEU . 0.2 OUTLIER -90.04 -24.94 21.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.897 . . . . 0.0 110.272 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 214' ' ' LEU . . . -62.79 -33.03 74.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.204 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.625 ' CG ' ' CD1' ' A' ' 153' ' ' ILE . 0.3 OUTLIER -64.18 84.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 110.183 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 3.3 m -165.2 -46.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 110.577 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.584 ' CD1' ' H ' ' A' ' 221' ' ' ILE . 0.3 OUTLIER -74.36 144.81 11.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.259 -0.9 . . . . 0.0 110.841 -179.566 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 148' ' ' PRO . 0.0 OUTLIER -89.31 107.36 19.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.42 -0.8 . . . . 0.0 109.19 179.352 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.586 ' CG2' ' CG2' ' A' ' 165' ' ' ILE . 0.6 OUTLIER -119.87 163.98 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.316 -0.865 . . . . 0.0 110.84 -178.855 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.44 ' HG2' ' HA2' ' A' ' 149' ' ' GLY . 27.1 mt-10 -139.43 -177.77 5.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 0.0 110.27 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 3.6 mt-10 -95.02 70.18 3.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.878 . . . . 0.0 110.339 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 23.3 mt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.284 179.982 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 9.1 t30 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 120.832 0.349 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.07 -45.22 0.47 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.058 1.557 . . . . 0.0 110.443 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.426 ' HB ' ' HD2' ' A' ' 133' ' ' PRO . 10.0 pt -73.56 163.42 68.54 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 110.189 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.426 ' HD2' ' HB ' ' A' ' 132' ' ' ILE . 46.2 Cg_endo -73.24 -17.01 24.75 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.973 1.512 . . . . 0.0 110.425 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 135' ' ' LEU . . . 107.46 -135.89 13.07 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.453 ' CB ' ' O ' ' A' ' 134' ' ' GLY . 0.3 OUTLIER 66.22 29.8 9.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -1.114 . . . . 0.0 110.259 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -151.96 87.99 1.37 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 110.298 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -71.83 61.68 0.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.935 . . . . 0.0 110.137 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.34 152.29 20.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.252 -0.905 . . . . 0.0 110.254 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.35 -168.07 13.41 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 58.9 t -80.09 96.42 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -1.156 . . . . 0.0 110.236 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -88.43 8.7 78.11 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -130.01 171.1 13.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.269 -1.136 . . . . 0.0 110.209 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 31.1 t -119.44 124.6 46.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.332 -0.855 . . . . 0.0 110.156 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -140.48 155.88 46.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 110.189 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 62.73 178.91 0.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.237 -0.914 . . . . 0.0 110.232 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -122.91 -27.02 4.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.203 -0.936 . . . . 0.0 110.228 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -166.54 142.93 3.96 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 110.198 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.493 ' HA ' ' HG2' ' A' ' 222' ' ' ARG . 46.9 Cg_endo -73.89 60.51 4.52 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.968 1.51 . . . . 0.0 110.548 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 148' ' ' PRO . . . 43.69 -111.46 0.43 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 151' ' ' ARG . 87.0 m -131.47 0.49 4.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -1.147 . . . . 0.0 110.288 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' A' ' 153' ' ' ILE . 1.8 mtm-85 61.03 131.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 110.138 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.546 ' CG1' HD13 ' A' ' 221' ' ' ILE . 4.7 p -65.69 55.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.264 -0.897 . . . . 0.0 110.683 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.634 ' CD1' ' CD2' ' A' ' 219' ' ' HIS . 3.1 pt -156.23 -35.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.085 -1.009 . . . . 0.0 110.019 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 150' ' ' THR . 0.2 OUTLIER -69.81 -13.99 62.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 0.0 109.083 179.224 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 156' ' ' ALA . . . -96.31 1.76 52.23 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.582 -0.699 . . . . 0.0 109.899 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 155' ' ' ALA . . . -57.69 -152.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 110.399 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 159' ' ' MET . 12.6 t -41.02 -34.53 0.43 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.38 -0.825 . . . . 0.0 110.269 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 157' ' ' THR . 10.1 t -43.39 -26.12 0.18 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.917 . . . . 0.0 109.688 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' MET . . . . . 0.486 ' HB3' ' HD2' ' A' ' 161' ' ' ARG . 0.1 OUTLIER -160.37 103.84 1.36 Allowed Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.434 -0.791 . . . . 0.0 109.602 179.702 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.23 106.35 1.73 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.938 1.494 . . . . 0.0 110.476 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.496 ' O ' ' HG3' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -171.42 175.27 4.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.358 -0.839 . . . . 0.0 110.28 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.589 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 1.0 OUTLIER -88.98 150.54 22.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.275 -0.891 . . . . 0.0 110.326 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.555 ' O ' ' O ' ' A' ' 193' ' ' VAL . 2.8 m -147.34 -155.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.168 -0.957 . . . . 0.0 110.851 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.624 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 4.8 ttt-85 178.71 150.99 0.28 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.026 -1.046 . . . . 0.0 110.107 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.753 ' HB ' ' C ' ' A' ' 189' ' ' VAL . 0.0 OUTLIER -93.71 149.39 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.217 -0.927 . . . . 0.0 109.864 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.483 ' O ' ' NE2' ' A' ' 167' ' ' GLN . 18.2 m -130.8 0.98 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.096 -1.003 . . . . 0.0 110.472 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.483 ' NE2' ' O ' ' A' ' 166' ' ' VAL . 0.9 OUTLIER -167.02 123.37 1.17 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.115 -0.991 . . . . 0.0 110.253 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.503 ' CG2' HG11 ' A' ' 189' ' ' VAL . 1.3 tt -130.32 9.04 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 0.0 110.138 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 168' ' ' ILE . 15.0 m-20 -41.49 101.37 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -0.887 . . . . 0.0 110.181 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.41 ' O ' ' CD1' ' A' ' 172' ' ' PHE . 2.3 tp10 -146.86 116.32 7.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.207 -0.933 . . . . 0.0 110.329 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.454 ' O ' ' C ' ' A' ' 172' ' ' PHE . 1.2 pp -84.25 20.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 110.17 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.454 ' C ' ' O ' ' A' ' 171' ' ' ILE . 55.8 p90 -39.96 145.11 0.16 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 0.0 110.437 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -149.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.915 . . . . 0.0 110.267 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 176' ' ' THR . 37.0 t -119.32 -15.58 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.216 -0.927 . . . . 0.0 110.294 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.32 88.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 0.0 110.128 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.545 ' CG2' ' HB3' ' A' ' 179' ' ' PHE . 0.3 OUTLIER -155.09 -36.83 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 0.0 110.356 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.483 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.4 OUTLIER 53.48 -85.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.414 -0.804 . . . . 0.0 110.465 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 176' ' ' THR . 13.5 tm0? -41.64 -26.74 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.264 -0.898 . . . . 0.0 110.433 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.585 ' CZ ' ' HG ' ' A' ' 183' ' ' LEU . 0.1 OUTLIER -89.14 -44.36 10.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.236 -0.915 . . . . 0.0 110.219 -179.91 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.519 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -44.37 -24.35 0.17 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.085 -1.009 . . . . 0.0 109.799 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -66.7 -67.68 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.37 -0.831 . . . . 0.0 110.155 179.799 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.497 ' C ' ' CD1' ' A' ' 182' ' ' LEU . 4.3 pp -60.97 -16.57 44.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.88 . . . . 0.0 109.747 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.585 ' HG ' ' CZ ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -81.79 -32.71 31.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 109.663 179.549 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.74 -18.62 60.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.432 -0.793 . . . . 0.0 109.851 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -87.16 16.81 4.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.371 -0.831 . . . . 0.0 110.206 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 51.38 68.32 0.81 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.12 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.437 HG22 HD11 ' A' ' 187' ' ' ILE . 16.2 mm -107.14 88.63 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 110.389 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 190' ' ' GLY . 1.5 ptp180 -100.49 142.39 32.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.364 -0.835 . . . . 0.0 109.636 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 1.0 ' O ' ' N ' ' A' ' 191' ' ' SER . 5.9 m 33.77 34.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 121.288 -0.883 . . . . 0.0 110.628 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.576 ' C ' ' O ' ' A' ' 189' ' ' VAL . . . 22.93 21.86 0.0 OUTLIER Glycine 0 N--CA 1.496 2.683 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 1.0 ' N ' ' O ' ' A' ' 189' ' ' VAL . 1.3 t 36.48 -148.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -1.148 . . . . 0.0 109.842 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.624 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 22.3 tt0 -83.46 118.3 23.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.614 -0.679 . . . . 0.0 109.383 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.589 ' CG1' ' O ' ' A' ' 192' ' ' GLU . 34.2 m -158.67 -137.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.091 -1.005 . . . . 0.0 110.097 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 162' ' ' LYS . 42.9 tt0 -174.3 158.77 3.0 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.207 -0.933 . . . . 0.0 110.54 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.528 ' CG2' ' HG ' ' A' ' 204' ' ' LEU . 0.4 OUTLIER -120.84 145.62 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.311 -0.868 . . . . 0.0 109.973 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.482 ' O ' ' O ' ' A' ' 197' ' ' ASP . 6.5 t -135.37 35.76 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.154 -0.966 . . . . 0.0 110.298 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 196' ' ' VAL . 0.4 OUTLIER 54.64 162.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.345 -0.847 . . . . 0.0 110.451 179.8 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.536 ' HB2' ' N ' ' A' ' 203' ' ' THR . 30.0 ttt-85 -143.54 160.04 41.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.219 -0.926 . . . . 0.0 110.172 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 198' ' ' ARG . 0.1 OUTLIER -43.97 103.92 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.403 -179.877 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 61.58 11.83 30.69 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.404 ' C ' ' HB3' ' A' ' 198' ' ' ARG . 1.2 t60 -150.17 -156.19 0.7 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.138 -1.213 . . . . 0.0 110.194 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.43 ' C ' ' HB2' ' A' ' 198' ' ' ARG . 92.5 mt -129.16 134.28 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.208 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.536 ' N ' ' HB2' ' A' ' 198' ' ' ARG . 4.3 m -109.27 148.2 31.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 110.149 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.528 ' HG ' ' CG2' ' A' ' 195' ' ' ILE . 1.1 tt -119.71 135.2 54.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 110.161 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.513 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.5 OUTLIER -119.86 124.93 47.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.355 -0.84 . . . . 0.0 109.895 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.532 ' CD2' HG13 ' A' ' 193' ' ' VAL . 2.2 m170 -106.06 -162.69 0.88 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.378 -0.826 . . . . 0.0 110.105 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -52.83 90.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 110.175 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 59.93 26.58 63.31 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 54.5 mttt -132.54 169.9 15.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.25 -1.147 . . . . 0.0 110.328 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.47 ' O ' ' CG2' ' A' ' 211' ' ' VAL . 7.9 t70 -156.02 145.61 21.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.354 -0.842 . . . . 0.0 110.068 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 210' ' ' ASP . 55.5 t -156.22 144.12 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.92 . . . . 0.0 110.252 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.451 ' OE1' ' NE2' ' A' ' 178' ' ' GLN . 6.4 tt0 -56.56 161.56 2.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 110.14 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.482 ' CD1' ' C ' ' A' ' 213' ' ' LEU . 1.5 tm? -142.57 92.63 2.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 110.216 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.496 HD12 ' HB2' ' A' ' 217' ' ' LEU . 1.4 pt? -46.83 174.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.333 -0.854 . . . . 0.0 110.148 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -90.17 -30.91 17.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.353 -0.842 . . . . 0.0 110.27 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.494 ' CB ' HD13 ' A' ' 214' ' ' LEU . 0.5 OUTLIER -60.33 -44.89 95.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.939 . . . . 0.0 110.364 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.496 ' HB2' HD12 ' A' ' 214' ' ' LEU . 0.1 OUTLIER -84.24 -18.92 34.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.172 -0.955 . . . . 0.0 110.18 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.572 ' CB ' ' CG2' ' A' ' 153' ' ' ILE . . . -67.18 -58.68 4.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 110.412 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.634 ' CD2' ' CD1' ' A' ' 153' ' ' ILE . 13.0 t-80 -85.87 79.32 9.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.189 -0.944 . . . . 0.0 110.471 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' THR . . . . . 0.453 HG23 ' HA ' ' A' ' 217' ' ' LEU . 2.8 t -176.5 -48.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 110.294 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.562 HG12 ' CG2' ' A' ' 223' ' ' ILE . 0.2 OUTLIER -70.4 142.58 15.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.215 -0.928 . . . . 0.0 110.294 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.493 ' HG2' ' HA ' ' A' ' 148' ' ' PRO . 10.0 mtt180 -89.51 114.7 26.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.237 -0.914 . . . . 0.0 109.497 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.562 ' CG2' HG12 ' A' ' 221' ' ' ILE . 0.7 OUTLIER -120.83 -176.53 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 110.725 -179.224 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 223' ' ' ILE . 46.0 mm-40 -149.57 174.52 12.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.484 -0.76 . . . . 0.0 110.03 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.465 ' HG3' HG11 ' A' ' 163' ' ' VAL . 0.4 OUTLIER -100.01 144.03 29.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 110.176 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.459 HD22 ' CG ' ' A' ' 192' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.221 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 120.738 0.304 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.72 -27.38 15.08 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.008 1.53 . . . . 0.0 110.531 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 63.0 mt -115.28 106.56 50.84 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.187 -0.946 . . . . 0.0 110.253 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.477 ' CG ' HD22 ' A' ' 135' ' ' LEU . 46.7 Cg_endo -73.02 -49.11 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.016 1.535 . . . . 0.0 110.513 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 128.71 1.91 5.86 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.477 HD22 ' CG ' ' A' ' 133' ' ' PRO . 1.3 pp -94.22 141.39 28.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -1.13 . . . . 0.0 110.286 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -109.12 27.82 9.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.328 -0.857 . . . . 0.0 110.152 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.63 69.91 0.85 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 0.0 110.179 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.23 71.57 1.7 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.243 -0.911 . . . . 0.0 110.222 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.89 57.29 6.96 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.9 m -73.43 -146.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -1.166 . . . . 0.0 110.165 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 113.44 -10.84 23.95 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -112.35 135.56 52.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -1.158 . . . . 0.0 110.203 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.1 t 47.51 77.58 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 110.149 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.8 -4.28 16.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 110.296 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.451 ' O ' ' HB1' ' A' ' 146' ' ' ALA . . . -62.92 -148.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 110.209 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 145' ' ' ALA . . . 60.1 54.34 4.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.276 -0.89 . . . . 0.0 110.217 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -177.77 169.71 0.97 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.283 -0.886 . . . . 0.0 110.197 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.1 53.77 2.55 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.977 1.514 . . . . 0.0 110.392 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.462 ' HA3' ' HD3' ' A' ' 222' ' ' ARG . . . 164.26 83.92 0.05 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.538 ' O ' ' CG1' ' A' ' 223' ' ' ILE . 30.0 m -97.26 136.48 37.69 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -1.153 . . . . 0.0 110.276 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 154' ' ' ASP . 26.1 mtt-85 -64.87 128.77 37.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.096 -1.002 . . . . 0.0 109.888 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.545 ' CG1' HG23 ' A' ' 195' ' ' ILE . 1.3 t -43.6 -32.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.168 -0.957 . . . . 0.0 110.232 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.58 ' CG2' ' CB ' ' A' ' 218' ' ' ALA . 1.1 pp -83.55 -13.33 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.209 -0.932 . . . . 0.0 110.451 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 151' ' ' ARG . 0.3 OUTLIER -79.52 -14.71 58.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 109.794 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -116.56 -5.38 11.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.332 -0.855 . . . . 0.0 109.998 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.48 135.2 40.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.299 -0.875 . . . . 0.0 110.296 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 158' ' ' SER . 0.2 OUTLIER -139.67 171.82 13.69 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.204 -0.935 . . . . 0.0 110.192 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 157' ' ' THR . 0.1 OUTLIER -42.9 -60.84 1.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 110.053 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 2.2 mtt -78.54 162.98 63.8 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.179 -0.95 . . . . 0.0 110.068 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.21 73.29 3.26 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.946 1.498 . . . . 0.0 110.467 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.13 130.8 23.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.326 -0.859 . . . . 0.0 110.197 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.28 103.13 4.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 110.203 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.638 ' O ' ' O ' ' A' ' 193' ' ' VAL . 17.6 m -128.72 -169.12 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.168 -0.957 . . . . 0.0 110.273 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.605 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 9.2 ptt-85 -166.25 147.32 6.52 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.711 -1.243 . . . . 0.0 110.836 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.605 HG22 HG23 ' A' ' 223' ' ' ILE . 0.8 OUTLIER -90.42 152.23 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.394 -0.816 . . . . 0.0 110.117 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.498 HG21 ' N ' ' A' ' 167' ' ' GLN . 17.9 m -138.59 -29.71 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.208 -0.933 . . . . 0.0 110.762 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.498 ' N ' HG21 ' A' ' 166' ' ' VAL . 35.3 mt-30 -131.87 118.01 19.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.169 -0.957 . . . . 0.0 110.34 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 170' ' ' GLU . 1.0 OUTLIER -84.44 -4.71 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.336 -0.853 . . . . 0.0 110.134 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.9 m120 51.16 -89.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.231 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 168' ' ' ILE . 77.6 tt0 -173.75 88.62 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 110.207 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.456 HG21 HD22 ' A' ' 217' ' ' LEU . 5.8 mt -76.98 2.83 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.278 -0.889 . . . . 0.0 110.21 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -58.54 108.0 0.58 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.244 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -130.45 -172.38 2.79 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.307 -0.871 . . . . 0.0 110.177 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.4 ' O ' ' CG1' ' A' ' 174' ' ' VAL . 61.2 t -109.59 20.1 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.203 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 177' ' ' ASP . 20.7 mm-40 -114.54 -32.95 5.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 110.21 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.536 ' O ' ' CB ' ' A' ' 177' ' ' ASP . 69.0 p 42.26 -92.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.387 -0.821 . . . . 0.0 110.288 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 176' ' ' THR . 0.7 OUTLIER 72.41 -154.68 0.08 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.262 -0.898 . . . . 0.0 110.172 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.45 ' O ' ' HB2' ' A' ' 181' ' ' GLN . 4.4 mm-40 -57.7 -23.68 52.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 110.507 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.56 ' CE1' HD21 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -47.48 -40.91 19.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.133 -0.98 . . . . 0.0 110.259 -179.851 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.51 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -46.93 -24.88 0.67 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.994 -1.066 . . . . 0.0 109.634 179.662 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' A' ' 178' ' ' GLN . 11.7 tp60 -63.24 -66.18 0.58 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.43 -0.794 . . . . 0.0 110.42 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 179' ' ' PHE . 4.6 pp -63.91 -12.69 39.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.0 110.11 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.56 HD21 ' CE1' ' A' ' 179' ' ' PHE . 0.8 OUTLIER -93.14 -30.64 15.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.314 -0.866 . . . . 0.0 109.731 179.631 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 180' ' ' THR . 9.8 t70 -73.41 -7.02 49.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.293 -0.879 . . . . 0.0 109.855 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.468 ' O ' HG12 ' A' ' 187' ' ' ILE . . . -87.58 32.32 0.72 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.323 -0.861 . . . . 0.0 110.175 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 185' ' ' ALA . 7.6 t70 43.41 55.84 4.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.194 -0.941 . . . . 0.0 109.976 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 185' ' ' ALA . 9.3 mm -110.64 163.94 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.873 . . . . 0.0 110.511 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.559 ' O ' ' O ' ' A' ' 189' ' ' VAL . 0.1 OUTLIER -166.15 104.54 0.65 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.692 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 1.5 m 50.86 103.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.523 ' O ' ' CG1' ' A' ' 193' ' ' VAL . . . -42.69 -16.95 0.03 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 189' ' ' VAL . 6.3 t 64.98 -145.59 0.24 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.191 -1.182 . . . . 0.0 109.13 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.605 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 21.7 tt0 -61.02 100.64 0.12 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.215 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.638 ' O ' ' O ' ' A' ' 163' ' ' VAL . 17.7 m -156.28 -136.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.165 -0.959 . . . . 0.0 109.77 -179.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.444 ' N ' HG22 ' A' ' 193' ' ' VAL . 11.5 pt-20 -173.19 164.43 4.78 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.35 -0.844 . . . . 0.0 110.007 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.557 HG12 ' CG2' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -122.81 173.32 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.201 -0.937 . . . . 0.0 110.394 -179.764 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 197' ' ' ASP . 99.4 t -141.49 83.86 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 0.0 110.096 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 196' ' ' VAL . 8.4 t70 -42.46 121.94 2.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.927 . . . . 0.0 110.205 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.404 ' N ' ' O ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -119.02 171.36 8.31 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.178 -0.951 . . . . 0.0 110.307 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -56.0 99.98 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 110.331 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 62.87 22.75 64.84 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.404 ' O ' ' N ' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -148.08 158.01 43.83 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.281 -1.129 . . . . 0.0 110.083 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.493 HD11 ' CB ' ' A' ' 215' ' ' ASP . 57.8 mt -142.33 95.2 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 110.225 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 92.0 m -84.83 157.27 20.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 0.0 109.998 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.623 HD21 ' CD2' ' A' ' 206' ' ' HIS . 0.6 OUTLIER -119.91 141.57 49.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.206 -0.934 . . . . 0.0 110.367 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.598 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.0 OUTLIER -119.58 122.71 42.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.353 -0.842 . . . . 0.0 109.966 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.623 ' CD2' HD21 ' A' ' 204' ' ' LEU . 5.3 m170 -98.97 167.86 10.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.45 -0.781 . . . . 0.0 110.309 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -44.07 106.95 0.08 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.338 -0.851 . . . . 0.0 110.24 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 57.57 24.34 52.37 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 206' ' ' HIS . 3.8 mtmt -150.76 175.46 11.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -1.13 . . . . 0.0 110.226 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 211' ' ' VAL . 5.6 t70 -171.18 161.9 6.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.216 -0.928 . . . . 0.0 110.148 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.479 ' N ' ' OD1' ' A' ' 210' ' ' ASP . 10.0 p -151.72 150.66 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.185 -0.947 . . . . 0.0 110.336 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.74 168.47 9.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 0.0 110.08 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.417 HD22 ' HB3' ' A' ' 218' ' ' ALA . 26.3 tp -172.75 149.65 2.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -0.886 . . . . 0.0 110.239 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.421 HD13 ' HB2' ' A' ' 216' ' ' ASP . 0.3 OUTLIER -114.46 124.32 51.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.267 -0.895 . . . . 0.0 110.171 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.493 ' CB ' HD11 ' A' ' 202' ' ' ILE . 13.5 p-10 -47.28 -22.65 0.43 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 110.23 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.555 ' O ' ' CE1' ' A' ' 219' ' ' HIS . 1.4 m-20 -51.42 -66.3 0.41 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 0.0 110.328 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.456 HD22 HG21 ' A' ' 171' ' ' ILE . 0.3 OUTLIER -89.84 -18.02 27.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 110.348 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.58 ' CB ' ' CG2' ' A' ' 153' ' ' ILE . . . -47.44 -22.78 0.49 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.337 -0.852 . . . . 0.0 110.286 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 216' ' ' ASP . 0.0 OUTLIER -89.16 58.14 4.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 110.409 -179.882 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' THR . . . . . 0.472 HG21 ' O ' ' A' ' 219' ' ' HIS . 18.0 p -142.83 -41.72 0.32 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -0.918 . . . . 0.0 110.262 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.55 ' CD1' ' N ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -69.41 137.27 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.39 -0.819 . . . . 0.0 110.305 -179.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.469 ' HB2' ' HB2' ' A' ' 167' ' ' GLN . 30.3 mtt180 -89.99 115.45 27.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.53 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.605 HG23 HG22 ' A' ' 165' ' ' ILE . 1.0 OUTLIER -129.37 -178.07 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 110.816 -179.125 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.42 -179.65 7.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.349 -0.844 . . . . 0.0 110.208 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -99.7 100.82 11.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.222 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.495 ' O ' ' NH1' ' A' ' 164' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.206 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo . . . . . 0 N--CA 1.484 0.945 0 N-CA-C 110.413 -0.649 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 pt -56.85 156.1 13.6 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 0.0 110.216 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.99 -168.2 0.4 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.059 1.558 . . . . 0.0 110.329 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -119.5 165.94 13.31 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.503 HD23 ' H ' ' A' ' 135' ' ' LEU . 0.6 OUTLIER -79.45 178.49 8.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -1.16 . . . . 0.0 110.231 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -151.86 46.43 0.78 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.329 -0.857 . . . . 0.0 110.25 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -102.91 29.25 5.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -0.905 . . . . 0.0 110.248 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo . . . . . 0 N--CA 1.484 0.96 0 N-CA-C 110.491 -0.619 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.563 ' CA ' ' HG3' ' A' ' 222' ' ' ARG . . . 154.11 128.52 1.23 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 151' ' ' ARG . 26.1 m -142.29 5.2 1.64 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -1.14 . . . . 0.0 110.431 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 0.0 OUTLIER 58.41 135.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.882 . . . . 0.0 110.319 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.841 HG13 ' O ' ' A' ' 152' ' ' VAL . 4.2 p -65.84 56.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.162 -0.961 . . . . 0.0 110.391 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.891 ' CG2' ' HB1' ' A' ' 218' ' ' ALA . 5.1 pt -158.92 -37.1 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.104 -0.998 . . . . 0.0 110.156 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.494 ' HB3' HG22 ' A' ' 150' ' ' THR . 0.3 OUTLIER -74.64 -16.25 60.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.372 -0.83 . . . . 0.0 109.736 179.637 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 1.043 ' HB1' HG11 ' A' ' 163' ' ' VAL . . . -88.68 -20.12 25.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.489 -0.757 . . . . 0.0 109.971 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.569 ' HB1' ' H ' ' A' ' 197' ' ' ASP . . . -70.01 124.86 25.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.352 -0.842 . . . . 0.0 110.166 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.576 ' CB ' ' HD2' ' A' ' 161' ' ' ARG . 77.1 m -123.21 171.78 9.09 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.17 -0.956 . . . . 0.0 110.356 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.557 ' N ' HG22 ' A' ' 157' ' ' THR . 36.4 t -38.62 -39.62 0.5 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.344 -0.847 . . . . 0.0 109.603 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' MET . . . . . 0.465 ' O ' ' HD3' ' A' ' 161' ' ' ARG . 2.6 ptt? -104.05 146.52 32.7 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 121.496 -0.753 . . . . 0.0 109.566 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.718 ' HB3' HG22 ' A' ' 196' ' ' VAL . 44.1 Cg_endo -71.14 81.04 1.21 Allowed 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.898 1.472 . . . . 0.0 110.577 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.888 HH21 HG13 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -63.37 -135.19 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.175 -0.953 . . . . 0.0 109.902 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.58 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 12.7 tttt -154.65 107.46 2.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.309 -0.869 . . . . 0.0 109.9 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 1.043 HG11 ' HB1' ' A' ' 155' ' ' ALA . 23.3 m -123.74 -150.43 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 110.845 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.666 ' HG2' ' N ' ' A' ' 165' ' ' ILE . 0.7 OUTLIER 179.48 155.41 0.52 Allowed 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.152 -0.967 . . . . 0.0 109.876 -179.201 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 1.019 HG23 HG22 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -97.48 144.89 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.225 -0.922 . . . . 0.0 109.83 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 222' ' ' ARG . 21.6 m -123.32 7.16 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.068 -1.02 . . . . 0.0 110.455 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.423 ' O ' ' N ' ' A' ' 222' ' ' ARG . 2.4 mt-30 -177.04 114.06 0.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.911 . . . . 0.0 110.412 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.997 HG21 ' HG2' ' A' ' 188' ' ' ARG . 0.7 OUTLIER -103.59 20.93 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.35 -0.844 . . . . 0.0 109.945 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' ' 168' ' ' ILE . 1.8 t-20 -44.86 172.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 110.292 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.411 ' OE2' ' HB3' ' A' ' 175' ' ' GLU . 0.4 OUTLIER -166.68 92.04 0.44 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.176 -0.952 . . . . 0.0 110.261 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.3 pp -83.61 13.88 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.197 -0.939 . . . . 0.0 110.311 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.549 ' CD1' ' OE1' ' A' ' 175' ' ' GLU . 1.6 m-85 -62.56 135.54 57.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 110.209 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.463 ' O ' ' HB ' ' A' ' 174' ' ' VAL . 11.1 mm-40 -59.67 -21.08 60.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.184 -0.948 . . . . 0.0 110.225 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 174' ' ' VAL . 4.5 p 179.76 90.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -0.937 . . . . 0.0 110.159 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.549 ' OE1' ' CD1' ' A' ' 172' ' ' PHE . 4.7 tt0 -143.52 105.18 4.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 110.252 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.523 ' O ' ' CB ' ' A' ' 177' ' ' ASP . 0.1 OUTLIER -138.07 -82.93 0.32 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 110.147 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.523 ' CB ' ' O ' ' A' ' 176' ' ' THR . 0.8 OUTLIER 70.96 -159.36 0.13 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.301 -0.875 . . . . 0.0 110.438 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -59.27 -18.9 41.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.354 -0.841 . . . . 0.0 110.583 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.819 ' HA ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -53.29 -36.03 60.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.169 -0.957 . . . . 0.0 110.129 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.48 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.7 OUTLIER -40.63 -27.92 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 0.0 109.892 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 179' ' ' PHE . 19.7 tt0 -63.2 -41.55 99.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.854 . . . . 0.0 109.823 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.819 HD12 ' HA ' ' A' ' 179' ' ' PHE . 1.7 mt -58.25 -46.48 85.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.419 -0.801 . . . . 0.0 109.766 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.62 ' O ' HD13 ' A' ' 183' ' ' LEU . 0.2 OUTLIER -67.34 -32.75 73.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.551 -0.718 . . . . 0.0 110.164 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -83.15 0.62 44.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.389 -0.819 . . . . 0.0 110.278 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.472 ' O ' HG13 ' A' ' 187' ' ' ILE . . . -81.71 8.29 10.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 110.219 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 23.4 t0 59.98 49.9 7.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.254 -0.904 . . . . 0.0 110.152 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.551 ' O ' ' CB ' ' A' ' 188' ' ' ARG . 88.8 mt -138.6 -72.99 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 110.242 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.997 ' HG2' HG21 ' A' ' 168' ' ' ILE . 3.4 ttp180 72.46 157.17 0.18 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.435 -0.791 . . . . 0.0 109.839 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.947 ' O ' ' N ' ' A' ' 191' ' ' SER . 3.7 m 33.17 36.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 O-C-N 121.352 -0.842 . . . . 0.0 110.731 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.743 ' N ' HD12 ' A' ' 165' ' ' ILE . . . 27.74 19.26 0.0 OUTLIER Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.947 ' N ' ' O ' ' A' ' 189' ' ' VAL . 30.6 t 38.29 -144.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.233 -1.157 . . . . 0.0 109.801 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.644 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -90.74 113.2 25.25 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.256 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.64 HG13 ' C ' ' A' ' 192' ' ' GLU . 33.6 m -159.27 -137.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.288 -0.882 . . . . 0.0 109.996 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.934 ' HA ' HG22 ' A' ' 163' ' ' VAL . 5.4 pt-20 -170.54 167.37 8.07 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.214 -0.929 . . . . 0.0 110.086 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.687 HG21 HG22 ' A' ' 152' ' ' VAL . 0.4 OUTLIER -124.75 173.68 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.116 -0.99 . . . . 0.0 110.401 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.718 HG22 ' HB3' ' A' ' 160' ' ' PRO . 46.1 t -145.25 85.74 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.318 -0.864 . . . . 0.0 110.055 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.569 ' H ' ' HB1' ' A' ' 156' ' ' ALA . 18.9 p-10 -40.65 133.81 1.93 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.0 110.436 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.443 ' O ' ' C ' ' A' ' 199' ' ' ASP . 12.9 mmt85 -123.66 67.11 1.02 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.268 -0.895 . . . . 0.0 110.184 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 198' ' ' ARG . 2.7 t0 40.72 81.67 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.395 -0.815 . . . . 0.0 110.158 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 88.27 -37.9 3.23 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 198' ' ' ARG . 0.0 OUTLIER -94.62 164.61 12.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.223 -1.163 . . . . 0.0 110.166 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.881 ' CD1' HG22 ' A' ' 153' ' ' ILE . 4.1 mt -145.83 118.29 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.921 . . . . 0.0 110.24 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.1 m -104.85 163.14 12.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 109.961 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 1.001 HD22 ' NE2' ' A' ' 206' ' ' HIS . 0.5 OUTLIER -119.83 138.19 53.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.152 -0.967 . . . . 0.0 110.213 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.565 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.5 OUTLIER -119.72 117.08 27.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.36 -0.837 . . . . 0.0 109.97 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 1.001 ' NE2' HD22 ' A' ' 204' ' ' LEU . 3.9 m170 -105.46 162.13 13.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.384 -0.822 . . . . 0.0 110.14 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -59.63 77.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.312 -0.867 . . . . 0.0 110.473 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 102.86 24.68 7.97 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.56 ' O ' ' CG ' ' A' ' 206' ' ' HIS . 3.1 mtpt -174.06 124.64 0.34 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -1.226 . . . . 0.0 110.462 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.46 150.86 40.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.266 -0.896 . . . . 0.0 110.149 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.76 HG12 ' HB3' ' A' ' 204' ' ' LEU . 8.4 p -137.72 165.48 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.172 -0.955 . . . . 0.0 110.252 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.88 88.99 3.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 110.202 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.816 HD12 ' N ' ' A' ' 214' ' ' LEU . 3.4 pp -76.93 -160.01 0.15 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.21 -0.931 . . . . 0.0 110.216 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.816 ' N ' HD12 ' A' ' 213' ' ' LEU . 0.5 OUTLIER -130.01 132.91 46.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -0.892 . . . . 0.0 110.217 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.453 ' OD2' HG13 ' A' ' 202' ' ' ILE . 0.7 OUTLIER -51.8 -23.58 4.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 110.222 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.86 -54.29 44.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 110.242 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.512 HD22 ' CD2' ' A' ' 179' ' ' PHE . 0.1 OUTLIER -89.6 -19.1 25.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.188 -0.945 . . . . 0.0 110.345 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.891 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -53.33 -18.36 2.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -0.877 . . . . 0.0 110.19 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.587 ' HA ' HD11 ' A' ' 153' ' ' ILE . 14.0 t-80 -103.5 49.99 0.81 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.931 . . . . 0.0 110.136 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 1.3 m -133.74 -61.59 0.8 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.327 -0.858 . . . . 0.0 110.225 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.718 HD11 HG12 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -60.55 145.15 12.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.419 -0.8 . . . . 0.0 110.379 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.709 ' O ' HG22 ' A' ' 166' ' ' VAL . 1.0 OUTLIER -89.82 116.48 27.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 109.611 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 1.019 HG22 HG23 ' A' ' 165' ' ' ILE . 0.5 OUTLIER -124.64 170.07 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.077 -1.015 . . . . 0.0 110.636 -179.419 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.657 ' HG2' HG11 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -150.11 -168.89 3.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.449 -0.782 . . . . 0.0 110.07 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 22.3 mt-10 -90.18 149.17 22.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.176 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.532 ' CD1' ' HB2' ' A' ' 192' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.924 -1.036 . . . . 0.0 110.199 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 N--CA 1.484 0.932 0 N-CA-C 110.472 -0.626 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.729 HG23 ' O ' ' A' ' 132' ' ' ILE . 7.3 tp -124.05 63.61 31.97 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 110.233 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.08 -164.52 0.2 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.059 1.557 . . . . 0.0 110.444 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -139.4 81.45 0.26 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 47.56 56.32 7.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -1.159 . . . . 0.0 110.249 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -89.62 42.25 1.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.942 . . . . 0.0 110.196 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.19 8.61 6.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.226 -0.921 . . . . 0.0 110.232 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 110.268 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo . . . . . 0 N--CA 1.483 0.911 0 N-CA-C 110.368 -0.666 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 140.19 153.17 5.97 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.576 HG22 ' HB3' ' A' ' 154' ' ' ASP . 3.7 m -131.5 2.46 4.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -1.138 . . . . 0.0 110.265 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.506 ' O ' ' HB2' ' A' ' 154' ' ' ASP . 6.1 mtm-85 61.0 118.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.266 -0.897 . . . . 0.0 110.276 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 1.077 HG13 HG23 ' A' ' 153' ' ' ILE . 5.9 p -42.82 165.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.183 -0.948 . . . . 0.0 110.218 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 1.077 HG23 HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER 72.17 -20.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.759 -0.588 . . . . 0.0 110.282 -179.439 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.576 ' HB3' HG22 ' A' ' 150' ' ' THR . 0.4 OUTLIER -91.4 -18.98 23.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 0.0 108.71 178.948 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.422 ' O ' ' HG3' ' A' ' 161' ' ' ARG . . . -108.33 -15.04 14.56 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.563 0.697 . . . . 0.0 109.45 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.611 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -67.83 152.12 46.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.437 -0.79 . . . . 0.0 110.157 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -161.94 174.59 12.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 110.227 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 157' ' ' THR . 0.2 OUTLIER -41.97 -48.32 4.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 110.166 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 159' ' ' MET . . . . . 0.448 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 4.0 mmm -82.32 166.66 35.39 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 110.201 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 46.5 Cg_endo -73.35 84.06 1.41 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.019 1.536 . . . . 0.0 110.437 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -70.72 111.48 6.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 0.0 110.241 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.597 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 0.2 OUTLIER -71.99 117.26 13.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.896 . . . . 0.0 110.286 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.819 HG12 ' C ' ' A' ' 224' ' ' GLU . 0.0 OUTLIER -133.88 -165.4 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.213 -0.929 . . . . 0.0 110.431 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.566 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 20.1 ttp180 -173.54 147.61 1.46 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.847 -1.158 . . . . 0.0 109.829 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.92 HG23 HG22 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -95.03 143.55 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.162 -0.961 . . . . 0.0 110.181 -179.457 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 222' ' ' ARG . 28.8 m -123.9 -8.21 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 110.175 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -158.66 124.04 4.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 0.0 110.188 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.776 HG21 ' HG2' ' A' ' 188' ' ' ARG . 5.1 tt -117.58 6.65 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.279 -0.888 . . . . 0.0 110.169 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.446 ' O ' ' CB ' ' A' ' 170' ' ' GLU . 27.1 t-20 -41.88 113.35 0.42 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.303 -0.873 . . . . 0.0 110.114 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.604 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 0.1 OUTLIER 172.68 123.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 110.321 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.6 ' O ' HG22 ' A' ' 171' ' ' ILE . 63.2 mt -84.89 17.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 109.91 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.604 ' CE1' ' HB3' ' A' ' 170' ' ' GLU . 0.5 OUTLIER 25.06 -138.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.686 -0.634 . . . . 0.0 110.954 179.736 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.04 -145.94 0.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 0.0 110.213 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 32.8 m -114.71 6.46 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 110.355 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.71 174.09 7.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 110.245 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' A' ' 177' ' ' ASP . 12.1 p -148.29 -84.48 0.1 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -0.889 . . . . 0.0 110.165 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 176' ' ' THR . 7.0 t0 70.09 -139.16 0.06 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.345 -0.847 . . . . 0.0 110.218 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.496 ' O ' ' HB3' ' A' ' 181' ' ' GLN . 0.0 OUTLIER -64.07 -28.34 69.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.114 -0.991 . . . . 0.0 110.256 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.639 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.3 OUTLIER -50.03 -51.8 39.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 110.076 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -49.97 -21.38 1.18 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.065 -1.022 . . . . 0.0 109.822 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.496 ' HB3' ' O ' ' A' ' 178' ' ' GLN . 20.8 tt0 -69.49 -59.95 2.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.291 -0.881 . . . . 0.0 110.422 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.877 HD12 ' N ' ' A' ' 183' ' ' LEU . 3.9 pp -66.62 -15.64 63.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.831 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.877 ' N ' HD12 ' A' ' 182' ' ' LEU . 0.3 OUTLIER -85.97 -28.81 24.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.36 -0.838 . . . . 0.0 109.668 179.619 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -81.12 6.85 12.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.346 -0.846 . . . . 0.0 109.821 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.755 ' HB3' HG22 ' A' ' 187' ' ' ILE . . . -81.05 12.46 3.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.353 -0.842 . . . . 0.0 110.232 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 185' ' ' ALA . 23.1 t70 43.48 41.15 3.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.156 -0.965 . . . . 0.0 109.326 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.755 HG22 ' HB3' ' A' ' 185' ' ' ALA . 0.4 OUTLIER -117.19 -43.63 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.451 -0.781 . . . . 0.0 110.379 -179.448 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.776 ' HG2' HG21 ' A' ' 168' ' ' ILE . 3.9 ttp-105 53.22 168.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.341 -0.849 . . . . 0.0 109.882 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.956 ' O ' ' N ' ' A' ' 191' ' ' SER . 2.7 m 31.46 37.67 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 121.369 -0.832 . . . . 0.0 110.809 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.741 ' N ' HD12 ' A' ' 165' ' ' ILE . . . 28.41 19.14 0.0 OUTLIER Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.956 ' N ' ' O ' ' A' ' 189' ' ' VAL . 18.1 t 41.52 -153.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.167 -1.196 . . . . 0.0 109.766 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.647 ' C ' HG13 ' A' ' 193' ' ' VAL . 1.8 pt-20 -89.11 115.81 26.91 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.582 -0.699 . . . . 0.0 109.115 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.668 ' O ' ' O ' ' A' ' 163' ' ' VAL . 35.4 m -159.8 -131.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.939 . . . . 0.0 109.942 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.68 ' O ' HD23 ' A' ' 204' ' ' LEU . 8.1 pt-20 -176.8 169.34 2.48 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.241 -0.912 . . . . 0.0 110.387 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 1.035 HD13 HG23 ' A' ' 152' ' ' VAL . 0.5 OUTLIER -125.46 170.78 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.221 -0.924 . . . . 0.0 110.51 -179.552 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.462 ' O ' ' C ' ' A' ' 197' ' ' ASP . 65.7 t -148.13 80.7 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.367 -0.833 . . . . 0.0 109.892 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 197' ' ' ASP . 11.5 p30 -39.39 123.28 1.42 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.394 -0.816 . . . . 0.0 110.448 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.511 ' HB3' ' HB2' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -107.12 78.1 1.2 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.271 -0.893 . . . . 0.0 110.135 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 198' ' ' ARG . 27.7 t0 41.78 79.43 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.295 -0.878 . . . . 0.0 110.212 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 87.68 -37.27 3.25 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 198' ' ' ARG . 45.0 m170 -90.99 168.37 11.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.239 -1.153 . . . . 0.0 110.202 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.559 ' CD1' ' HB ' ' A' ' 153' ' ' ILE . 7.7 mt -141.09 121.6 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.221 -0.924 . . . . 0.0 110.166 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 195' ' ' ILE . 58.0 m -109.12 160.18 16.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.332 -0.855 . . . . 0.0 109.863 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 1.05 HD12 HD22 ' A' ' 213' ' ' LEU . 0.6 OUTLIER -119.74 132.46 55.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.158 -0.964 . . . . 0.0 110.217 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.568 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 1.4 m -119.82 128.12 53.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.878 . . . . 0.0 109.941 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.653 ' HB3' HG12 ' A' ' 193' ' ' VAL . 2.4 m-70 -105.48 173.98 6.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.366 -0.834 . . . . 0.0 109.958 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -58.35 96.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 0.0 110.229 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 76.14 29.72 58.23 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.68 165.41 32.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.117 -1.225 . . . . 0.0 110.26 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -161.12 143.37 12.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.224 -0.922 . . . . 0.0 110.177 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.746 HG13 ' N ' ' A' ' 212' ' ' GLU . 1.6 p -142.74 -154.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.176 -0.952 . . . . 0.0 110.228 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.746 ' N ' HG13 ' A' ' 211' ' ' VAL . 1.3 tt0 -115.23 169.49 9.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 110.323 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 1.05 HD22 HD12 ' A' ' 204' ' ' LEU . 11.6 tp -168.27 89.68 0.26 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.355 -0.841 . . . . 0.0 110.149 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.934 HD11 ' HB2' ' A' ' 217' ' ' LEU . 2.5 pt? -41.62 152.78 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 110.292 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -83.01 -22.39 33.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 110.195 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.98 -61.93 2.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.241 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.934 ' HB2' HD11 ' A' ' 214' ' ' LEU . 0.2 OUTLIER -75.63 -14.86 60.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -0.872 . . . . 0.0 110.197 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.799 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -50.29 -51.16 47.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 110.16 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.538 ' HB2' ' CD1' ' A' ' 153' ' ' ILE . 9.6 t60 -74.02 72.98 1.67 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.211 -0.93 . . . . 0.0 110.22 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' THR . . . . . 0.413 HG21 ' HD1' ' A' ' 172' ' ' PHE . 31.5 m -156.39 -53.82 0.08 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.154 -0.967 . . . . 0.0 110.425 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.668 HD11 HG12 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -66.07 174.82 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.397 -0.815 . . . . 0.0 110.409 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.446 ' O ' HG22 ' A' ' 166' ' ' VAL . 1.2 mtm180 -122.62 99.67 6.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.417 -0.802 . . . . 0.0 109.734 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.92 HG22 HG23 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -119.36 167.45 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.97 . . . . 0.0 110.173 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.819 ' C ' HG12 ' A' ' 163' ' ' VAL . 15.1 pt-20 -150.3 174.35 12.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.245 -0.909 . . . . 0.0 110.135 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.427 ' OE1' ' OXT' ' A' ' 226' ' ' LEU . 0.7 OUTLIER -43.96 143.04 1.2 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.47 -0.769 . . . . 0.0 110.23 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.427 ' OXT' ' OE1' ' A' ' 225' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.196 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo . . . . . 0 N--CA 1.483 0.877 0 N-CA-C 110.496 -0.617 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.96 135.56 94.71 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.234 -0.916 . . . . 0.0 110.147 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.09 -90.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.986 1.519 . . . . 0.0 110.444 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 139.53 -116.17 1.19 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.6 mm? 59.11 166.12 0.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -1.143 . . . . 0.0 110.2 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -80.96 86.05 6.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.188 -0.945 . . . . 0.0 110.274 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -142.28 57.25 1.46 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.295 -0.878 . . . . 0.0 110.239 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 0.0 110.215 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.442 ' HB2' ' OE2' ' A' ' 224' ' ' GLU . 46.8 Cg_endo . . . . . 0 N--CA 1.484 0.955 0 N-CA-C 110.435 -0.641 . . . . 0.0 110.435 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.552 ' HA3' ' HB2' ' A' ' 222' ' ' ARG . . . -133.18 159.16 23.48 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.538 ' O ' ' HB3' ' A' ' 154' ' ' ASP . 0.6 OUTLIER -158.15 17.63 0.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -1.153 . . . . 0.0 110.471 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.634 ' C ' HD12 ' A' ' 223' ' ' ILE . 0.5 OUTLIER 56.11 117.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.146 -0.971 . . . . 0.0 110.375 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 1.031 HG13 HG21 ' A' ' 223' ' ' ILE . 0.0 OUTLIER -41.39 -80.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.193 -0.942 . . . . 0.0 111.247 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 1.108 ' CG2' ' HB1' ' A' ' 218' ' ' ALA . 0.2 OUTLIER -47.44 -18.82 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.429 -0.795 . . . . 0.0 111.631 -178.628 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.616 ' HB2' ' CB ' ' A' ' 151' ' ' ARG . 0.3 OUTLIER -71.9 -13.49 61.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.798 -1.189 . . . . 0.0 109.094 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -125.63 2.08 7.55 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.653 -0.655 . . . . 0.0 109.624 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.74 ' O ' HG22 ' A' ' 157' ' ' THR . . . -81.04 -177.5 6.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.42 -0.8 . . . . 0.0 110.486 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.74 HG22 ' O ' ' A' ' 156' ' ' ALA . 7.2 t 40.11 -168.53 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.548 -0.72 . . . . 0.0 110.55 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.53 ' C ' ' O ' ' A' ' 157' ' ' THR . 25.0 p 34.64 76.58 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.327 -0.858 . . . . 0.0 110.16 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' MET . . . . . 0.479 ' N ' ' CD ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER 58.33 54.28 5.73 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.92 . . . . 0.0 109.586 -179.445 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.575 ' HB3' ' N ' ' A' ' 157' ' ' THR . 43.8 Cg_endo -71.2 -159.09 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.091 1.574 . . . . 0.0 110.682 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.514 ' CB ' ' O ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER 168.2 -153.94 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.317 -0.865 . . . . 0.0 110.301 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.533 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 0.1 OUTLIER -90.73 116.7 28.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -0.919 . . . . 0.0 110.539 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.69 HG12 ' O ' ' A' ' 224' ' ' GLU . 0.0 OUTLIER -112.26 -171.44 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.271 -0.893 . . . . 0.0 110.112 179.555 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.7 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -170.61 131.43 0.89 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.888 -1.133 . . . . 0.0 110.056 -179.592 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.949 HG23 HG22 ' A' ' 223' ' ' ILE . 0.5 OUTLIER -88.97 152.03 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.333 -0.854 . . . . 0.0 110.656 -179.197 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 222' ' ' ARG . 9.2 m -133.61 -1.67 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 110.184 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.573 ' CB ' ' HD2' ' A' ' 222' ' ' ARG . 0.1 OUTLIER -171.59 125.24 0.59 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 110.169 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.85 HD11 HG13 ' A' ' 171' ' ' ILE . 8.5 tt -90.21 -3.12 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.854 . . . . 0.0 110.235 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 168' ' ' ILE . 5.3 t-20 62.71 -141.26 0.4 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 110.243 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.87 109.0 18.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 110.306 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.85 HG13 HD11 ' A' ' 168' ' ' ILE . 41.9 mm -87.84 23.19 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 110.178 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -54.93 86.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.285 -0.884 . . . . 0.0 110.234 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.504 ' N ' ' O ' ' A' ' 171' ' ' ILE . 0.7 OUTLIER -142.99 -172.07 3.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 110.181 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.415 ' O ' HG22 ' A' ' 174' ' ' VAL . 9.2 p -122.41 -4.78 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 110.262 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.426 ' C ' HG22 ' A' ' 176' ' ' THR . 77.0 mt-10 -71.48 167.0 20.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.178 -0.951 . . . . 0.0 110.204 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -173.7 -95.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.191 -0.943 . . . . 0.0 110.229 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 176' ' ' THR . 4.2 t0 72.35 -140.21 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.283 -0.886 . . . . 0.0 110.273 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -58.42 -16.2 13.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.276 -0.89 . . . . 0.0 110.43 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 1.0 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -60.5 -22.84 64.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.081 -1.012 . . . . 0.0 110.135 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.503 HG23 ' OG1' ' A' ' 176' ' ' THR . 0.6 OUTLIER -54.55 -26.91 34.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.144 -0.973 . . . . 0.0 109.864 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.489 ' HB3' ' OE2' ' A' ' 212' ' ' GLU . 3.2 tt0 -69.26 -65.75 0.67 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.365 -0.834 . . . . 0.0 110.218 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.651 ' C ' HD12 ' A' ' 182' ' ' LEU . 4.5 pp -58.99 -15.07 11.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.884 . . . . 0.0 110.268 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 1.0 HD13 ' CZ ' ' A' ' 179' ' ' PHE . 0.7 OUTLIER -86.45 -31.18 21.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 109.998 179.8 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.15 -8.03 35.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.359 -0.838 . . . . 0.0 110.07 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -88.86 10.06 22.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.865 . . . . 0.0 110.176 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 185' ' ' ALA . 31.8 t0 41.69 66.66 0.66 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.907 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.3 tt -121.3 -173.56 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 110.54 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.701 ' C ' HG13 ' A' ' 189' ' ' VAL . 0.1 OUTLIER -171.81 122.53 0.5 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.701 HG13 ' C ' ' A' ' 188' ' ' ARG . 1.4 m 50.27 105.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.204 -0.935 . . . . 0.0 108.947 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.74 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -45.14 -12.99 0.03 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.631 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 4.1 t 65.84 -143.26 0.19 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.012 -1.287 . . . . 0.0 109.42 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.7 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 1.9 tt0 -71.31 102.86 2.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.572 -0.705 . . . . 0.0 109.487 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.607 HG13 ' C ' ' A' ' 192' ' ' GLU . 16.9 m -156.65 -140.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.097 -1.002 . . . . 0.0 109.967 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.645 ' HA ' HG23 ' A' ' 163' ' ' VAL . 8.3 pt-20 -176.88 138.1 0.26 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 110.728 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.692 ' C ' HD13 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -132.26 161.21 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.293 -0.88 . . . . 0.0 109.99 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.553 ' N ' HG12 ' A' ' 195' ' ' ILE . 37.5 t -154.75 150.3 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.421 -0.799 . . . . 0.0 110.165 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -58.92 119.53 7.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -0.943 . . . . 0.0 110.133 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 199' ' ' ASP . 0.0 OUTLIER -119.32 106.95 12.81 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.232 -0.917 . . . . 0.0 110.396 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 198' ' ' ARG . 15.9 m-20 40.75 79.71 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.254 -0.904 . . . . 0.0 110.372 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 44.84 25.12 0.85 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.414 ' O ' ' CB ' ' A' ' 198' ' ' ARG . 0.0 OUTLIER -150.18 106.83 3.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.214 -1.168 . . . . 0.0 110.132 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.728 HD13 HG22 ' A' ' 153' ' ' ILE . 49.8 mt -64.27 139.46 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 110.336 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 195' ' ' ILE . 3.7 m -119.16 150.32 40.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.338 -0.851 . . . . 0.0 109.935 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.56 ' HG ' ' HB ' ' A' ' 195' ' ' ILE . 0.5 OUTLIER -119.8 130.34 54.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 0.0 110.284 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.556 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 3.2 t -119.79 126.86 52.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.393 -0.817 . . . . 0.0 110.014 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.514 ' HB3' HG12 ' A' ' 193' ' ' VAL . 0.0 OUTLIER -114.19 106.64 14.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.451 -0.781 . . . . 0.0 109.836 180.0 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.493 ' HB3' ' O ' ' A' ' 206' ' ' HIS . 21.4 t30 61.01 17.4 7.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 110.243 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 114.04 -20.01 17.35 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -81.35 101.37 9.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -1.155 . . . . 0.0 110.277 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 210' ' ' ASP . 30.5 p30 -83.93 147.84 27.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.912 . . . . 0.0 110.292 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.409 ' CG1' ' CE1' ' A' ' 206' ' ' HIS . 4.3 p -155.12 151.66 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.319 -0.863 . . . . 0.0 110.167 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.489 ' OE2' ' HB3' ' A' ' 181' ' ' GLN . 15.4 pt-20 -57.28 148.05 23.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 0.0 110.165 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.48 ' HG ' ' HB2' ' A' ' 204' ' ' LEU . 0.4 OUTLIER -113.86 -149.33 0.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 110.2 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.723 HD13 ' CB ' ' A' ' 217' ' ' LEU . 0.4 OUTLIER -152.16 108.89 3.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 110.223 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -59.8 -38.67 82.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 110.304 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.417 ' OD2' ' OE1' ' A' ' 175' ' ' GLU . 0.2 OUTLIER -65.7 -44.71 85.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.911 . . . . 0.0 110.267 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.848 ' O ' HG22 ' A' ' 220' ' ' THR . 0.2 OUTLIER -85.83 -22.91 27.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.267 -0.896 . . . . 0.0 110.254 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 1.108 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -40.63 -44.84 2.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.334 -0.853 . . . . 0.0 110.288 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.455 ' CD2' ' HG2' ' A' ' 151' ' ' ARG . 39.8 t-80 -90.69 49.73 1.71 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.155 -0.966 . . . . 0.0 110.509 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' THR . . . . . 0.848 HG22 ' O ' ' A' ' 217' ' ' LEU . 3.0 t -137.52 -27.16 0.95 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.126 -0.984 . . . . 0.0 110.486 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.762 HG13 HD13 ' A' ' 165' ' ' ILE . 0.1 OUTLIER -95.23 144.5 9.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 120.998 -1.064 . . . . 0.0 110.362 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.573 ' HD2' ' CB ' ' A' ' 167' ' ' GLN . 3.7 ptp85 -95.06 106.72 18.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.146 -0.971 . . . . 0.0 109.405 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 1.031 HG21 HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -119.78 174.03 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.183 -0.948 . . . . 0.0 110.253 -179.132 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.69 ' O ' HG12 ' A' ' 163' ' ' VAL . 1.2 tt0 -124.65 171.95 9.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.096 -1.003 . . . . 0.0 110.583 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 6.8 tp10 -113.52 110.99 21.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.374 -0.829 . . . . 0.0 110.182 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 162' ' ' LYS . 7.6 mp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.984 -1.007 . . . . 0.0 110.16 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 N--CA 1.484 0.949 0 N-CA-C 110.38 -0.662 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 9.9 tt -63.79 140.63 97.86 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.25 -0.906 . . . . 0.0 110.223 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.09 -166.86 0.32 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.962 1.506 . . . . 0.0 110.384 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.12 -119.6 2.01 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.4 tp -130.44 138.36 50.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.198 -1.178 . . . . 0.0 110.187 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 138' ' ' LEU . 0.5 OUTLIER 52.93 33.27 14.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.305 -0.872 . . . . 0.0 110.158 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 59.83 -85.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.314 -0.866 . . . . 0.0 110.21 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 136' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.283 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.473 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 45.8 Cg_endo . . . . . 0 N--CA 1.484 0.927 0 N-CA-C 110.358 -0.67 . . . . 0.0 110.358 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 151' ' ' ARG . . . -114.83 35.01 4.6 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.539 ' O ' ' CG1' ' A' ' 223' ' ' ILE . 23.8 m -42.07 93.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.37 -1.076 . . . . 0.0 110.236 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.568 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 7.2 ptp85 -42.02 142.75 0.66 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.219 -0.926 . . . . 0.0 110.112 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 1.01 ' CG1' HG23 ' A' ' 153' ' ' ILE . 0.8 OUTLIER -57.57 -153.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.176 -0.953 . . . . 0.0 110.039 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 1.096 HG21 ' CB ' ' A' ' 218' ' ' ALA . 11.8 pt 39.29 25.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.321 -0.862 . . . . 0.0 110.436 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER -135.55 -36.35 0.78 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.312 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -88.76 -9.94 50.06 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.667 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -74.7 107.42 6.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.546 -0.721 . . . . 0.0 110.234 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 158' ' ' SER . 5.7 t -174.11 169.62 3.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.272 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 159' ' ' MET . 0.6 OUTLIER 41.77 74.17 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.327 -0.858 . . . . 0.0 110.124 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 159' ' ' MET . . . . . 0.513 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 0.0 OUTLIER 63.51 165.9 0.11 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.144 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 44.6 Cg_endo -72.24 88.01 0.87 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.999 1.526 . . . . 0.0 110.435 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.2 ttt85 -65.61 -140.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 110.21 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -145.29 93.15 2.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.234 -0.916 . . . . 0.0 110.254 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.675 ' O ' ' O ' ' A' ' 193' ' ' VAL . 21.5 m -111.52 -172.94 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.0 110.224 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.643 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 12.8 ptt-85 -162.39 147.17 12.3 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.725 -1.234 . . . . 0.0 110.872 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 1.042 HG23 ' CG2' ' A' ' 223' ' ' ILE . 1.2 mt -98.71 165.84 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.493 -0.755 . . . . 0.0 110.273 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 222' ' ' ARG . 19.1 m -142.54 -31.8 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.158 -0.964 . . . . 0.0 110.484 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 222' ' ' ARG . 0.7 OUTLIER -140.34 123.91 17.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 110.282 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.67 HG13 HG22 ' A' ' 221' ' ' ILE . 7.4 tt -99.61 -5.95 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 110.117 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 168' ' ' ILE . 17.4 m120 55.05 164.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.315 -0.866 . . . . 0.0 110.204 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 169' ' ' ASN . 28.5 mt-10 -144.51 49.57 1.32 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.14 -0.975 . . . . 0.0 110.204 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.0 mm -100.23 -3.08 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.211 -0.931 . . . . 0.0 110.234 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -123.01 154.47 38.42 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.142 -0.974 . . . . 0.0 110.214 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 174' ' ' VAL . 0.0 OUTLIER -79.43 -26.99 41.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.226 -0.921 . . . . 0.0 110.187 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.661 HG11 HD12 ' A' ' 217' ' ' LEU . 41.6 t 43.91 74.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 110.344 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -103.88 116.96 33.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.289 -0.882 . . . . 0.0 110.107 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.638 HG22 ' HB3' ' A' ' 179' ' ' PHE . 2.9 m -155.42 134.56 12.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.901 . . . . 0.0 110.18 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 179' ' ' PHE . 1.1 p-10 -48.73 -101.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.316 -0.865 . . . . 0.0 111.248 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.484 ' C ' ' O ' ' A' ' 177' ' ' ASP . 5.1 pt20 -34.04 -30.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.258 -0.901 . . . . 0.0 111.082 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.638 ' HB3' HG22 ' A' ' 176' ' ' THR . 7.4 t80 -60.48 -59.59 5.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.944 . . . . 0.0 110.487 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.547 ' HA ' ' HB3' ' A' ' 183' ' ' LEU . 0.9 OUTLIER -37.98 -29.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.359 -0.838 . . . . 0.0 110.33 -179.706 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.504 ' N ' ' O ' ' A' ' 179' ' ' PHE . 24.4 tt0 -57.45 -56.69 18.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.202 -0.937 . . . . 0.0 110.019 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.573 ' C ' HD12 ' A' ' 182' ' ' LEU . 2.6 pp -70.03 -14.04 62.5 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.286 -0.884 . . . . 0.0 109.686 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.547 ' HB3' ' HA ' ' A' ' 180' ' ' THR . 0.4 OUTLIER -89.8 -32.13 17.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.393 -0.817 . . . . 0.0 109.775 179.676 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -69.4 -4.8 19.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.309 -0.869 . . . . 0.0 109.806 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -83.74 14.33 4.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.428 -0.795 . . . . 0.0 110.114 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 185' ' ' ALA . 0.7 OUTLIER 42.82 62.74 1.67 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.156 -0.965 . . . . 0.0 109.896 -179.793 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.8 tt -119.35 -173.78 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 110.52 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.719 ' C ' HG13 ' A' ' 189' ' ' VAL . 0.1 OUTLIER -174.53 115.56 0.18 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.362 -0.836 . . . . 0.0 108.748 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.719 HG13 ' C ' ' A' ' 188' ' ' ARG . 1.3 m 51.57 108.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.298 -0.876 . . . . 0.0 109.073 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.794 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -46.12 -13.96 0.08 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.568 ' O ' ' HB2' ' A' ' 164' ' ' ARG . 7.7 t 63.93 -146.87 0.3 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -1.148 . . . . 0.0 109.483 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.643 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.2 OUTLIER -63.4 99.63 0.21 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.618 -0.676 . . . . 0.0 109.576 179.336 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.675 ' O ' ' O ' ' A' ' 163' ' ' VAL . 26.2 m -157.28 -135.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -0.93 . . . . 0.0 109.603 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.599 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.3 OUTLIER -175.04 160.47 2.78 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.124 179.297 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.797 HD13 ' CG2' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -119.97 176.62 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.074 -1.016 . . . . 0.0 110.227 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.463 HG23 ' C ' ' A' ' 195' ' ' ILE . 7.4 t -148.7 86.7 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.291 -0.881 . . . . 0.0 110.183 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 197' ' ' ASP . 15.8 p-10 -43.8 127.33 5.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 110.245 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.499 ' O ' ' C ' ' A' ' 199' ' ' ASP . 21.9 mtt180 -99.76 71.58 1.7 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -0.889 . . . . 0.0 110.37 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 198' ' ' ARG . 3.9 p-10 36.18 39.74 0.09 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.366 -0.833 . . . . 0.0 110.413 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 140.75 -48.77 0.81 Allowed Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.453 ' O ' ' CG1' ' A' ' 202' ' ' ILE . 0.1 OUTLIER -89.9 -158.12 0.51 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -1.11 . . . . 0.0 109.801 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.906 ' CD1' HG22 ' A' ' 153' ' ' ILE . 8.1 mt -155.63 159.53 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.073 -1.017 . . . . 0.0 110.571 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.613 ' O ' HG22 ' A' ' 195' ' ' ILE . 43.2 m -144.32 151.97 40.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.534 -0.729 . . . . 0.0 109.464 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 1.093 HD22 ' CE1' ' A' ' 206' ' ' HIS . 0.5 OUTLIER -119.91 129.09 54.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.166 -0.959 . . . . 0.0 110.536 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.59 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.5 OUTLIER -119.98 119.8 34.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.424 -0.797 . . . . 0.0 109.826 179.77 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 1.093 ' CE1' HD22 ' A' ' 204' ' ' LEU . 2.1 m-70 -107.31 152.35 24.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.498 -0.751 . . . . 0.0 109.931 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -49.04 -20.54 0.55 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.15 -0.969 . . . . 0.0 110.059 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 209' ' ' LYS . . . -91.2 -31.81 9.42 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 208' ' ' GLY . 10.4 pttt 174.02 -173.95 0.06 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.211 -1.17 . . . . 0.0 110.173 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 4.6 p30 -112.17 161.59 16.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.893 . . . . 0.0 110.413 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 39.1 t -147.04 147.14 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 0.0 110.127 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.0 160.74 30.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.0 110.283 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.704 ' C ' HD23 ' A' ' 214' ' ' LEU . 2.9 mt -131.83 -160.11 1.02 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.203 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.711 HD23 ' N ' ' A' ' 214' ' ' LEU . 0.9 OUTLIER -173.15 169.18 4.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.19 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -75.81 -26.17 56.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 110.183 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.537 ' CB ' HD12 ' A' ' 214' ' ' LEU . 1.0 OUTLIER -63.21 -57.02 11.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 110.125 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.661 HD12 HG11 ' A' ' 174' ' ' VAL . 0.2 OUTLIER -78.35 -28.0 47.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 110.112 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 1.096 ' CB ' HG21 ' A' ' 153' ' ' ILE . . . -40.05 -63.8 0.57 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.369 -0.832 . . . . 0.0 110.487 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.415 ' HB2' HD11 ' A' ' 153' ' ' ILE . 3.5 t-160 -91.77 77.59 5.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.879 . . . . 0.0 110.306 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 4.9 m -166.74 -48.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 0.0 110.44 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.67 HG22 HG13 ' A' ' 168' ' ' ILE . 0.1 OUTLIER -73.98 136.75 24.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.361 -0.837 . . . . 0.0 110.786 -179.66 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.718 ' O ' HG22 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -89.39 112.91 24.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.212 -0.93 . . . . 0.0 109.256 179.275 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 1.042 ' CG2' HG23 ' A' ' 165' ' ' ILE . 0.7 OUTLIER -119.97 -169.48 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.158 -0.964 . . . . 0.0 110.808 -179.053 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 148' ' ' PRO . 30.8 mt-10 -150.25 156.57 41.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.449 -0.782 . . . . 0.0 110.051 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -107.48 99.2 8.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 110.254 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.233 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.522 ' O ' ' HD3' ' A' ' 133' ' ' PRO . 44.3 Cg_endo . . . . . 0 N--CA 1.486 1.034 0 N-CA-C 110.58 -0.585 . . . . 0.0 110.58 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 30.3 mt -106.12 85.96 1.83 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 110.134 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 131' ' ' PRO . 45.9 Cg_endo -72.6 -53.95 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.992 1.522 . . . . 0.0 110.453 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.43 42.48 2.01 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.4 tp -124.28 26.16 7.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.293 -1.122 . . . . 0.0 110.254 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -103.62 -88.22 0.42 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.898 . . . . 0.0 110.085 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -109.6 -17.98 13.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.284 -0.885 . . . . 0.0 110.208 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.253 -0.904 . . . . 0.0 110.189 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 N--CA 1.484 0.913 0 N-CA-C 110.344 -0.675 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.476 ' O ' ' HG2' ' A' ' 222' ' ' ARG . . . -48.21 123.41 9.62 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.821 HG22 ' N ' ' A' ' 151' ' ' ARG . 2.2 m -47.39 -89.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -1.142 . . . . 0.0 110.088 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.821 ' N ' HG22 ' A' ' 150' ' ' THR . 0.0 OUTLIER 169.07 135.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.89 . . . . 0.0 110.01 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.918 HG11 HD11 ' A' ' 221' ' ' ILE . 1.2 m -37.85 -92.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.346 -0.846 . . . . 0.0 111.302 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 1.02 HD12 ' N ' ' A' ' 154' ' ' ASP . 1.9 pp -41.04 -23.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.151 -0.968 . . . . 0.0 111.032 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 1.02 ' N ' HD12 ' A' ' 153' ' ' ILE . 1.2 m-20 -75.12 -16.79 60.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.107 -0.996 . . . . 0.0 110.001 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -109.9 -16.21 13.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.398 -0.814 . . . . 0.0 110.178 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.425 ' O ' ' OG1' ' A' ' 157' ' ' THR . . . -82.7 99.72 9.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.342 -0.849 . . . . 0.0 110.303 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 156' ' ' ALA . 3.2 m -169.8 152.11 4.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.261 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 159' ' ' MET . 6.4 t 55.41 88.29 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.897 . . . . 0.0 110.27 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' MET . . . . . 0.426 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 27.4 mtm 55.83 169.5 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 110.183 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.459 ' HB3' HG22 ' A' ' 196' ' ' VAL . 45.9 Cg_endo -72.87 91.29 0.82 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.047 1.551 . . . . 0.0 110.417 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -82.32 129.05 34.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 0.0 110.073 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.487 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 2.4 mmtp -68.91 125.5 26.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.898 . . . . 0.0 110.427 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.738 HG12 ' HA ' ' A' ' 225' ' ' GLU . 29.2 m -141.63 -153.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.229 -0.92 . . . . 0.0 110.234 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.618 ' HG2' ' N ' ' A' ' 165' ' ' ILE . 0.0 OUTLIER -176.21 153.94 1.32 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.901 -1.124 . . . . 0.0 110.213 -179.452 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 1.073 HG21 ' HB ' ' A' ' 189' ' ' VAL . 20.1 mt -102.36 176.21 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.159 -0.963 . . . . 0.0 111.291 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.91 HG22 ' O ' ' A' ' 222' ' ' ARG . 2.7 m -126.36 -28.2 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.664 -0.648 . . . . 0.0 109.561 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.622 ' HA ' ' CG2' ' A' ' 189' ' ' VAL . 0.5 OUTLIER 162.22 147.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.558 -0.714 . . . . 0.0 110.515 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.855 ' HA ' HG22 ' A' ' 221' ' ' ILE . 2.7 mt -66.0 -7.29 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.484 -0.76 . . . . 0.0 109.088 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.484 ' O ' ' HB2' ' A' ' 170' ' ' GLU . 0.1 OUTLIER 53.45 108.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.593 -0.692 . . . . 0.0 110.305 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 169' ' ' ASN . 1.0 OUTLIER 61.78 76.88 0.35 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -0.885 . . . . 0.0 110.278 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.505 HG22 ' HB ' ' A' ' 168' ' ' ILE . 1.7 pp -80.05 6.18 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.894 . . . . 0.0 110.181 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -49.06 -25.53 2.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 110.306 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -71.86 163.61 27.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.937 . . . . 0.0 110.335 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.774 ' O ' HG22 ' A' ' 174' ' ' VAL . 7.0 p -169.95 39.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.248 -0.908 . . . . 0.0 110.264 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.606 ' O ' ' C ' ' A' ' 176' ' ' THR . 18.6 pt-20 -72.73 -152.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.127 -0.983 . . . . 0.0 110.348 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.764 HG23 ' O ' ' A' ' 176' ' ' THR . 9.7 t 21.9 94.39 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.747 -0.595 . . . . 0.0 111.091 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.486 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.1 OUTLIER -60.49 -12.05 8.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.178 -0.951 . . . . 0.0 110.235 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -76.47 -6.9 53.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.118 -0.989 . . . . 0.0 110.251 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.757 ' HB3' HG23 ' A' ' 176' ' ' THR . 0.0 OUTLIER -87.02 -31.61 20.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.169 -0.957 . . . . 0.0 110.112 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.502 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 1.1 p -42.69 -31.62 0.49 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 109.808 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -60.6 -22.84 64.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.357 -0.839 . . . . 0.0 109.608 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.69 HD22 ' CG1' ' A' ' 211' ' ' VAL . 13.6 mt -83.17 -39.8 20.55 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.343 -0.848 . . . . 0.0 109.089 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.422 HD13 ' HZ ' ' A' ' 179' ' ' PHE . 0.5 OUTLIER -74.75 -29.13 61.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.61 -0.681 . . . . 0.0 109.778 179.633 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -72.73 -2.62 21.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 109.882 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.581 ' HB3' HG22 ' A' ' 187' ' ' ILE . . . -88.53 14.86 8.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.316 -0.865 . . . . 0.0 110.205 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 185' ' ' ALA . 0.2 OUTLIER 42.37 30.97 0.24 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 109.209 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.581 HG22 ' HB3' ' A' ' 185' ' ' ALA . 4.5 tt -116.29 164.34 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.602 -0.687 . . . . 0.0 110.48 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.424 ' N ' HG12 ' A' ' 187' ' ' ILE . 1.8 ttp180 -134.05 161.28 35.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.308 -0.87 . . . . 0.0 109.116 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 1.1 HG11 HG21 ' A' ' 221' ' ' ILE . 14.0 m -79.53 -37.39 18.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.871 -1.143 . . . . 0.0 109.099 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.642 ' HA2' ' CA ' ' A' ' 166' ' ' VAL . . . -56.07 50.54 0.01 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.768 ' N ' ' O ' ' A' ' 189' ' ' VAL . 1.8 t -140.66 167.36 22.35 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.372 -1.075 . . . . 0.0 109.228 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.61 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 1.4 mt-10 -65.46 122.45 17.21 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.794 -0.763 . . . . 0.0 109.036 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.683 ' HA ' ' O ' ' A' ' 205' ' ' SER . 0.4 OUTLIER -160.44 144.79 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.042 -1.036 . . . . 0.0 110.254 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.673 ' HA ' HG22 ' A' ' 163' ' ' VAL . 1.4 pt-20 -112.18 159.84 18.17 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.346 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 1.07 HG23 ' HG ' ' A' ' 204' ' ' LEU . 1.2 mt -119.53 153.93 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.069 -1.019 . . . . 0.0 110.532 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.459 HG22 ' HB3' ' A' ' 160' ' ' PRO . 42.3 t -127.63 107.57 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.482 -0.761 . . . . 0.0 109.991 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -75.17 111.74 10.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.928 . . . . 0.0 110.286 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.476 ' O ' ' C ' ' A' ' 199' ' ' ASP . 0.0 OUTLIER -102.89 67.03 0.95 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.217 -0.927 . . . . 0.0 110.299 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 198' ' ' ARG . 25.4 m-20 38.97 37.55 0.22 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.349 -0.844 . . . . 0.0 110.213 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 141.1 -43.16 1.12 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.451 ' O ' ' N ' ' A' ' 198' ' ' ARG . 0.1 OUTLIER -90.12 123.55 34.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -1.122 . . . . 0.0 110.139 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.946 HD13 HG22 ' A' ' 153' ' ' ILE . 10.4 mt -126.36 99.54 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.112 -0.993 . . . . 0.0 110.348 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.663 HG23 ' O ' ' A' ' 211' ' ' VAL . 89.9 m -106.86 157.45 17.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.318 -0.864 . . . . 0.0 109.878 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 1.07 ' HG ' HG23 ' A' ' 195' ' ' ILE . 2.0 mp -120.05 150.31 40.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.458 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.683 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 16.4 t -119.42 110.48 16.98 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.458 -0.776 . . . . 0.0 109.228 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.681 ' ND1' HG11 ' A' ' 193' ' ' VAL . 22.5 m-70 -92.45 153.58 19.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.597 -0.689 . . . . 0.0 110.129 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.464 ' N ' ' OD1' ' A' ' 207' ' ' ASN . 26.6 p-10 -51.77 93.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 110.286 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 136.91 -32.45 2.44 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 208' ' ' GLY . 0.0 OUTLIER 176.56 160.15 0.35 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -1.151 . . . . 0.0 110.285 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.537 ' O ' HG23 ' A' ' 211' ' ' VAL . 1.9 p-10 -109.68 174.78 5.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.33 -0.856 . . . . 0.0 110.117 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.69 ' CG1' HD22 ' A' ' 182' ' ' LEU . 45.6 t -154.6 140.98 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.378 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -73.48 74.37 1.43 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.4 -0.812 . . . . 0.0 110.219 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.616 ' CB ' ' CD1' ' A' ' 204' ' ' LEU . 30.6 tp -57.89 162.62 3.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.917 . . . . 0.0 110.273 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.574 ' O ' ' HB2' ' A' ' 218' ' ' ALA . 3.2 mm? -51.37 146.74 6.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 0.0 110.189 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 218' ' ' ALA . 2.1 m-20 -83.17 -102.39 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.942 . . . . 0.0 109.906 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.97 -24.48 1.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.0 -1.062 . . . . 0.0 109.742 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.671 ' HA ' ' CE1' ' A' ' 219' ' ' HIS . 0.1 OUTLIER -90.15 -14.25 33.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.319 -0.863 . . . . 0.0 110.211 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.73 ' CB ' HG23 ' A' ' 153' ' ' ILE . . . -29.98 -49.07 0.1 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.506 -0.746 . . . . 0.0 110.723 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.671 ' CE1' ' HA ' ' A' ' 217' ' ' LEU . 38.5 p-80 -51.37 78.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.364 -0.835 . . . . 0.0 110.404 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' THR . . . . . 0.659 ' N ' ' O ' ' A' ' 218' ' ' ALA . 1.2 p -136.56 -28.76 0.98 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 110.365 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 1.1 HG21 HG11 ' A' ' 189' ' ' VAL . 0.1 OUTLIER -109.98 154.74 11.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 O-C-N 121.196 -0.94 . . . . 0.0 110.584 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.91 ' O ' HG22 ' A' ' 166' ' ' VAL . 0.6 OUTLIER -89.03 94.41 9.94 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 178.958 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 1.029 ' CG2' HG23 ' A' ' 165' ' ' ILE . 0.4 OUTLIER -119.38 149.43 21.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.322 -0.861 . . . . 0.0 110.712 -178.202 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.83 ' N ' HD12 ' A' ' 223' ' ' ILE . 13.9 pt-20 -132.02 178.51 6.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.417 -0.802 . . . . 0.0 110.096 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.738 ' HA ' HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -85.93 173.97 9.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 110.349 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.411 ' HA ' HD22 ' A' ' 226' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.203 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo . . . . . 0 N--CA 1.484 0.932 0 N-CA-C 110.417 -0.647 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 17.0 mm -96.63 122.44 57.12 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 110.141 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.43 -53.66 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.917 1.483 . . . . 0.0 110.372 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -156.74 -89.55 0.07 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.2 mt -104.29 -166.51 1.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.291 -1.123 . . . . 0.0 110.162 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 46.0 t0 -106.83 -20.96 13.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 110.209 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -63.97 85.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.315 -0.866 . . . . 0.0 110.208 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.534 ' HA ' HD13 ' A' ' 138' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 0.0 110.206 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo . . . . . 0 N--CA 1.483 0.865 0 N-CA-C 110.383 -0.66 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.453 ' CA ' ' HB3' ' A' ' 222' ' ' ARG . . . -160.44 152.41 23.15 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.672 ' O ' HG22 ' A' ' 150' ' ' THR . 58.1 m -147.23 18.0 1.21 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -1.137 . . . . 0.0 110.242 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.968 ' HG3' HD11 ' A' ' 153' ' ' ILE . 1.9 mpp_? 63.15 127.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.964 . . . . 0.0 110.184 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.795 HG13 ' O ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER -78.6 36.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.121 -0.987 . . . . 0.0 111.155 -179.648 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.968 HD11 ' HG3' ' A' ' 151' ' ' ARG . 0.1 OUTLIER -138.84 -32.27 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.865 -1.147 . . . . 0.0 110.226 179.45 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.94 -12.67 61.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.454 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.519 ' O ' ' CB ' ' A' ' 161' ' ' ARG . . . -103.64 -14.03 16.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.516 -0.74 . . . . 0.0 109.966 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.913 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -81.8 72.64 8.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 110.273 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.451 ' OG1' ' HD3' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -73.54 -171.64 1.05 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.251 -0.906 . . . . 0.0 110.111 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.487 ' OG ' ' N ' ' A' ' 159' ' ' MET . 0.9 OUTLIER -42.41 -57.65 2.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 0.0 110.132 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 159' ' ' MET . . . . . 0.487 ' N ' ' OG ' ' A' ' 158' ' ' SER . 3.0 mmt -75.68 165.19 55.38 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.891 . . . . 0.0 110.081 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 44.4 Cg_endo -72.14 73.21 2.64 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.976 1.514 . . . . 0.0 110.444 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 155' ' ' ALA . 1.8 tpt180 -51.64 127.38 20.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -0.951 . . . . 0.0 110.197 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -74.8 125.4 28.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.873 . . . . 0.0 110.36 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.669 HG23 ' HA ' ' A' ' 194' ' ' GLU . 0.1 OUTLIER -144.86 -166.16 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 110.112 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.667 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -169.19 136.66 1.83 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.824 -1.172 . . . . 0.0 110.101 -179.601 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.945 HG23 HG22 ' A' ' 223' ' ' ILE . 0.9 OUTLIER -92.52 153.08 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.294 -0.879 . . . . 0.0 110.489 -179.434 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.476 ' CG1' ' NE ' ' A' ' 164' ' ' ARG . 11.1 m -145.43 11.22 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 110.204 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -170.91 123.92 0.63 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.229 -0.92 . . . . 0.0 110.195 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.52 HG13 HG22 ' A' ' 221' ' ' ILE . 19.2 tt -131.3 4.99 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.326 -0.858 . . . . 0.0 110.15 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.432 ' O ' ' CB ' ' A' ' 170' ' ' GLU . 4.4 p30 -52.58 169.05 0.09 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 110.163 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.432 ' CB ' ' O ' ' A' ' 169' ' ' ASN . 0.3 OUTLIER 64.86 44.8 3.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.182 -0.949 . . . . 0.0 110.134 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.512 HD12 ' C ' ' A' ' 171' ' ' ILE . 1.3 pp -119.61 31.95 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.27 -0.894 . . . . 0.0 110.22 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.27 89.7 1.21 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 110.215 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -106.06 165.38 11.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.274 -0.891 . . . . 0.0 110.205 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.5 m -106.72 11.45 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.161 -0.962 . . . . 0.0 110.27 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.78 139.74 37.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.896 . . . . 0.0 110.18 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.957 HG23 HG23 ' A' ' 180' ' ' THR . 54.4 m -118.88 -92.81 0.53 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 110.245 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.526 ' N ' HG22 ' A' ' 176' ' ' THR . 0.4 OUTLIER 66.3 -165.62 0.22 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.212 -0.93 . . . . 0.0 110.28 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -55.2 -20.64 11.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.261 -0.899 . . . . 0.0 110.294 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.98 ' CE2' HD13 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -49.17 -26.29 2.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.195 -0.941 . . . . 0.0 109.983 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.957 HG23 HG23 ' A' ' 176' ' ' THR . 0.2 OUTLIER -55.15 -26.42 38.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.884 . . . . 0.0 109.949 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -69.29 -63.36 1.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.321 -0.862 . . . . 0.0 110.114 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.8 HD12 ' N ' ' A' ' 183' ' ' LEU . 4.4 pp -61.6 -15.91 43.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.379 -0.826 . . . . 0.0 110.114 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.98 HD13 ' CE2' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -91.1 -28.55 17.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.162 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 180' ' ' THR . 18.9 t70 -79.99 4.25 17.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 110.183 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -85.12 16.66 3.38 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.862 . . . . 0.0 110.188 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 185' ' ' ALA . 3.8 t0 41.66 43.17 2.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.248 -0.907 . . . . 0.0 109.92 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.6 tt -102.9 -178.5 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.874 . . . . 0.0 110.367 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.717 ' C ' HG13 ' A' ' 189' ' ' VAL . 9.4 ptt180 -170.52 117.48 0.51 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.717 HG13 ' C ' ' A' ' 188' ' ' ARG . 1.3 m 51.3 108.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.199 -0.938 . . . . 0.0 109.154 -178.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.816 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -45.63 -13.65 0.06 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 3.7 t 66.05 -144.14 0.19 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.071 -1.253 . . . . 0.0 109.421 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.667 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -65.21 101.93 0.6 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.474 -0.766 . . . . 0.0 109.267 179.221 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.623 ' O ' ' O ' ' A' ' 163' ' ' VAL . 23.0 m -156.9 -138.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -0.948 . . . . 0.0 110.033 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.669 ' HA ' HG23 ' A' ' 163' ' ' VAL . 1.1 pp20? -175.48 160.85 2.61 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.293 -0.88 . . . . 0.0 110.142 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.913 HD12 ' HB2' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -120.86 169.81 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.159 -0.963 . . . . 0.0 110.335 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 196' ' ' VAL . 4.7 p -149.67 77.38 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.883 . . . . 0.0 110.032 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 202' ' ' ILE . 11.8 t70 -40.78 142.22 0.49 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 110.336 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.475 ' O ' ' N ' ' A' ' 200' ' ' GLY . 1.9 ttp180 -139.77 -174.6 3.95 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.205 -0.935 . . . . 0.0 110.315 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -42.28 96.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.258 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 198' ' ' ARG . . . 44.01 29.48 1.51 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -150.26 113.72 4.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.252 -1.146 . . . . 0.0 110.215 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.619 HD13 HG22 ' A' ' 153' ' ' ILE . 70.3 mt -94.24 144.99 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 0.0 110.167 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.529 ' HB ' ' CG1' ' A' ' 196' ' ' VAL . 1.2 m -126.32 156.09 40.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.056 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.949 HD22 ' CE1' ' A' ' 206' ' ' HIS . 1.0 OUTLIER -119.82 131.98 55.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -0.956 . . . . 0.0 110.232 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.538 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 20.1 t -119.75 124.6 46.58 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.3 -0.875 . . . . 0.0 109.781 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.949 ' CE1' HD22 ' A' ' 204' ' ' LEU . 3.1 m-70 -106.02 158.95 16.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.417 -0.802 . . . . 0.0 109.999 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -62.0 72.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 110.155 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 153.63 -21.07 0.71 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 208' ' ' GLY . 0.3 OUTLIER 169.93 149.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.161 -1.199 . . . . 0.0 110.218 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 1.2 p30 -97.08 -171.99 2.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.92 . . . . 0.0 110.13 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 8.7 p -158.69 165.36 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -0.917 . . . . 0.0 110.226 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -69.49 141.04 54.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 110.239 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.798 HD13 ' N ' ' A' ' 214' ' ' LEU . 0.3 OUTLIER -148.15 145.04 28.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.932 . . . . 0.0 110.173 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.798 ' N ' HD13 ' A' ' 213' ' ' LEU . 0.6 OUTLIER -133.61 143.49 48.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.268 -0.895 . . . . 0.0 110.21 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.617 ' HA ' ' HB3' ' A' ' 218' ' ' ALA . 0.3 OUTLIER -50.2 -51.56 43.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.197 -0.94 . . . . 0.0 110.185 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.771 ' HB2' HD12 ' A' ' 214' ' ' LEU . 0.5 OUTLIER -43.38 -49.18 7.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.932 . . . . 0.0 110.262 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.59 ' HB2' HD11 ' A' ' 214' ' ' LEU . 0.4 OUTLIER -89.12 -26.77 21.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.891 . . . . 0.0 110.14 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.758 ' HB2' ' CD1' ' A' ' 213' ' ' LEU . . . -64.83 -17.68 64.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.257 -0.902 . . . . 0.0 110.091 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.658 ' O ' HG23 ' A' ' 220' ' ' THR . 0.2 OUTLIER -89.2 56.56 3.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.135 -0.978 . . . . 0.0 110.217 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 220' ' ' THR . . . . . 0.658 HG23 ' O ' ' A' ' 219' ' ' HIS . 17.6 p -158.12 -47.22 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 0.0 110.372 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.7 HD13 ' N ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -63.17 130.93 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.29 -0.881 . . . . 0.0 110.52 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.453 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . 37.0 mtt85 -91.67 104.09 16.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.345 -0.847 . . . . 0.0 109.618 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.945 HG22 HG23 ' A' ' 165' ' ' ILE . 0.1 OUTLIER -119.51 171.53 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.144 -0.973 . . . . 0.0 110.023 -179.566 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.589 ' C ' HG12 ' A' ' 163' ' ' VAL . 6.6 mm-40 -140.13 167.58 21.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.163 -0.961 . . . . 0.0 110.415 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 8.1 pt-20 -91.53 38.85 0.99 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.381 -0.824 . . . . 0.0 110.247 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.175 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 N--CA 1.483 0.889 0 N-CA-C 110.494 -0.618 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 5.9 pt -104.27 161.04 24.07 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.199 -0.938 . . . . 0.0 110.262 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.0 -12.4 25.94 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.0 1.526 . . . . 0.0 110.464 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 135' ' ' LEU . . . 118.51 -77.32 0.3 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.448 ' CB ' ' O ' ' A' ' 134' ' ' GLY . 0.2 OUTLIER 65.29 138.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.294 -1.121 . . . . 0.0 110.241 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 17.7 p30 -61.98 96.63 0.07 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 110.22 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.2 89.12 4.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.933 . . . . 0.0 110.232 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.538 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.297 -0.877 . . . . 0.0 110.223 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 N--CA 1.484 0.943 0 N-CA-C 110.44 -0.639 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 222' ' ' ARG . . . 131.84 157.5 8.72 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.544 ' O ' ' CG1' ' A' ' 223' ' ' ILE . 54.2 m -123.31 143.56 50.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.308 -1.113 . . . . 0.0 110.163 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 154' ' ' ASP . 0.1 OUTLIER -50.16 127.69 17.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.123 -0.986 . . . . 0.0 110.055 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.795 HG12 ' O ' ' A' ' 218' ' ' ALA . 2.5 p -43.88 -25.49 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.103 -0.998 . . . . 0.0 110.378 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.71 HG22 HD13 ' A' ' 202' ' ' ILE . 1.3 pt -95.22 -14.04 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 110.325 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.539 ' HB3' ' CG2' ' A' ' 150' ' ' THR . 2.0 m-20 -77.35 -19.28 56.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.994 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -97.36 -13.0 22.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.371 -0.831 . . . . 0.0 110.016 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 157' ' ' THR . . . -51.06 166.07 0.1 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.875 . . . . 0.0 110.262 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.533 ' O ' ' CB ' ' A' ' 158' ' ' SER . 14.7 m 51.93 167.37 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.315 -0.866 . . . . 0.0 110.398 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 157' ' ' THR . 0.1 OUTLIER 70.89 -52.14 0.68 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.24 -0.913 . . . . 0.0 110.309 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -100.72 139.17 20.36 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.175 -0.953 . . . . 0.0 110.147 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.552 ' O ' ' C ' ' A' ' 161' ' ' ARG . 45.4 Cg_endo -72.92 71.85 3.35 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.962 1.506 . . . . 0.0 110.426 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.781 ' HB3' HG22 ' A' ' 196' ' ' VAL . 7.7 ptt180 27.12 99.8 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.505 0.669 . . . . 0.0 111.282 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -170.72 56.41 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.175 -0.953 . . . . 0.0 109.995 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.669 ' O ' ' O ' ' A' ' 193' ' ' VAL . 34.9 m -141.83 -151.83 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.925 0.869 . . . . 0.0 110.503 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.671 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 16.4 ptt180 -175.46 169.03 3.21 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.86 -1.15 . . . . 0.0 110.433 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 1.068 HG23 HG22 ' A' ' 223' ' ' ILE . 0.1 OUTLIER -99.78 162.98 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.302 -0.874 . . . . 0.0 109.848 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.817 HG22 ' O ' ' A' ' 222' ' ' ARG . 27.0 m -137.28 -24.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.177 -0.952 . . . . 0.0 110.759 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.551 ' HB2' ' CD ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -152.45 127.89 9.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.038 -1.039 . . . . 0.0 110.458 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.771 HG13 HG22 ' A' ' 221' ' ' ILE . 1.2 tt -96.69 -1.68 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.983 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 168' ' ' ILE . 38.1 m-80 56.6 -95.17 0.05 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 110.231 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.554 ' HG3' ' CZ ' ' A' ' 172' ' ' PHE . 4.3 pt-20 -168.2 83.1 0.18 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.066 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.911 HD13 ' CD2' ' A' ' 217' ' ' LEU . 2.4 pp -86.57 25.78 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.329 -0.857 . . . . 0.0 110.377 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.6 ' C ' ' O ' ' A' ' 171' ' ' ILE . 0.9 OUTLIER 22.83 -136.26 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.583 -0.698 . . . . 0.0 111.024 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.659 ' C ' HG23 ' A' ' 176' ' ' THR . 60.8 mt-30 -107.66 -90.55 0.44 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.193 -0.942 . . . . 0.0 110.258 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.581 ' O ' ' N ' ' A' ' 176' ' ' THR . 6.7 t 59.64 90.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.891 . . . . 0.0 110.291 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.565 ' HB3' ' O ' ' A' ' 174' ' ' VAL . 3.7 tt0 63.63 -56.69 0.2 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.489 -0.757 . . . . 0.0 110.822 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.659 HG23 ' C ' ' A' ' 173' ' ' GLN . 8.9 p 45.54 -91.72 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.301 -0.874 . . . . 0.0 110.215 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 178' ' ' GLN . 12.5 t0 43.72 -93.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 110.129 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.528 ' N ' ' O ' ' A' ' 176' ' ' THR . 1.4 mt-30 -48.38 -25.11 1.46 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.179 -0.951 . . . . 0.0 110.015 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.985 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 3.0 t80 -82.97 -52.77 6.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.99 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 177' ' ' ASP . 0.3 OUTLIER -43.65 -25.15 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.172 -0.955 . . . . 0.0 109.889 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -69.17 -64.59 0.84 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.305 -0.872 . . . . 0.0 110.19 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.576 ' HB3' HG11 ' A' ' 211' ' ' VAL . 3.5 pp -63.92 -13.6 46.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.357 -0.839 . . . . 0.0 109.848 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.985 HD13 ' CZ ' ' A' ' 179' ' ' PHE . 1.7 tp -87.81 -30.42 20.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.387 -0.821 . . . . 0.0 109.861 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -72.18 -15.04 61.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.828 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -89.44 20.03 4.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -0.829 . . . . 0.0 110.136 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 47.31 85.21 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.892 . . . . 0.0 110.093 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.556 ' O ' ' CB ' ' A' ' 188' ' ' ARG . 57.6 mt -146.04 -82.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 0.0 110.374 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.556 ' CB ' ' O ' ' A' ' 187' ' ' ILE . 0.1 OUTLIER 72.79 161.38 0.24 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.453 -0.779 . . . . 0.0 109.683 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.971 ' O ' ' N ' ' A' ' 191' ' ' SER . 3.9 m 33.87 37.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 O-C-N 121.334 -0.853 . . . . 0.0 110.613 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.763 ' N ' HD12 ' A' ' 165' ' ' ILE . . . 25.68 19.73 0.0 OUTLIER Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.971 ' N ' ' O ' ' A' ' 189' ' ' VAL . 13.6 t 36.88 -146.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -1.149 . . . . 0.0 109.868 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.671 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.9 OUTLIER -89.95 115.26 27.11 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.026 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.669 ' O ' ' O ' ' A' ' 163' ' ' VAL . 34.1 m -159.69 -133.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.096 -1.003 . . . . 0.0 109.985 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.552 ' CG ' ' HB2' ' A' ' 205' ' ' SER . 1.7 pt-20 -158.47 168.82 25.92 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.266 -0.896 . . . . 0.0 110.094 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.919 HG23 ' HG ' ' A' ' 204' ' ' LEU . 0.0 OUTLIER -136.36 146.61 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.163 -0.96 . . . . 0.0 110.353 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.781 HG22 ' HB3' ' A' ' 161' ' ' ARG . 94.8 t -139.05 108.14 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.249 -0.907 . . . . 0.0 110.105 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 202' ' ' ILE . 4.6 t0 -50.77 113.73 0.98 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.211 -0.931 . . . . 0.0 110.135 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 201' ' ' HIS . 1.0 OUTLIER -110.1 93.61 4.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.224 -0.923 . . . . 0.0 110.294 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 198' ' ' ARG . 43.7 t0 41.81 53.96 3.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.222 -0.924 . . . . 0.0 110.126 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 88.89 -27.34 7.41 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.465 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 11.6 m170 -92.08 91.34 7.76 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.26 -1.141 . . . . 0.0 110.273 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.71 HD13 HG22 ' A' ' 153' ' ' ILE . 2.7 mt -59.66 91.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.904 . . . . 0.0 110.18 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 85.6 m -67.95 148.38 51.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.276 -0.89 . . . . 0.0 110.153 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.919 ' HG ' HG23 ' A' ' 195' ' ' ILE . 0.1 OUTLIER -120.23 132.89 55.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.241 -0.912 . . . . 0.0 110.282 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.582 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.7 OUTLIER -119.79 125.93 49.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.332 -0.855 . . . . 0.0 109.898 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.528 ' HA ' HG12 ' A' ' 193' ' ' VAL . 2.6 m-70 -104.55 74.08 1.14 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.385 -0.822 . . . . 0.0 110.366 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.52 ' C ' ' O ' ' A' ' 206' ' ' HIS . 3.7 p-10 32.14 51.51 0.21 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.484 -0.76 . . . . 0.0 110.793 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 135.58 -39.9 1.61 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.515 ' HB2' ' HB2' ' A' ' 206' ' ' HIS . 6.7 mtmt -102.58 162.91 12.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.296 -1.12 . . . . 0.0 110.138 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 204' ' ' LEU . 14.7 t0 -150.17 144.44 25.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 110.319 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.576 HG11 ' HB3' ' A' ' 182' ' ' LEU . 24.5 t -134.76 159.1 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.285 -0.884 . . . . 0.0 110.032 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -98.67 63.49 1.44 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 0.0 110.304 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.617 HD22 ' CD1' ' A' ' 204' ' ' LEU . 12.8 tp -56.12 160.12 3.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -0.919 . . . . 0.0 110.113 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.538 HD23 ' N ' ' A' ' 214' ' ' LEU . 0.6 OUTLIER -122.56 144.75 48.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 0.0 110.199 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -52.67 -40.72 63.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.265 -0.897 . . . . 0.0 110.168 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.518 ' CB ' HD12 ' A' ' 214' ' ' LEU . 0.2 OUTLIER -52.24 -56.66 13.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.894 . . . . 0.0 110.193 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.911 ' CD2' HD13 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -84.55 -27.15 27.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.201 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.795 ' O ' HG12 ' A' ' 152' ' ' VAL . . . -74.51 -11.05 60.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.0 110.186 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.686 ' O ' HG23 ' A' ' 220' ' ' THR . 0.3 OUTLIER -100.96 77.98 1.89 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.933 . . . . 0.0 110.244 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 220' ' ' THR . . . . . 0.686 HG23 ' O ' ' A' ' 219' ' ' HIS . 0.0 OUTLIER -178.3 -43.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -0.943 . . . . 0.0 110.468 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.771 HG22 HG13 ' A' ' 168' ' ' ILE . 0.1 OUTLIER -73.29 143.04 14.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.293 -0.88 . . . . 0.0 110.657 -179.738 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.817 ' O ' HG22 ' A' ' 166' ' ' VAL . 4.8 ptp85 -89.45 127.18 35.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.074 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 1.068 HG22 HG23 ' A' ' 165' ' ' ILE . 0.7 OUTLIER -125.5 170.91 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.192 -0.943 . . . . 0.0 110.821 -178.84 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.422 ' CG ' ' HA2' ' A' ' 149' ' ' GLY . 38.8 mt-10 -149.95 172.64 14.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -0.872 . . . . 0.0 110.12 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.431 ' OE1' ' OXT' ' A' ' 226' ' ' LEU . 0.0 OUTLIER -81.55 169.38 17.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.9 . . . . 0.0 110.156 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.441 ' O ' ' HG ' ' A' ' 226' ' ' LEU . 39.2 tp . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.167 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 132' ' ' ILE . 46.1 Cg_endo . . . . . 0 N--CA 1.483 0.881 0 N-CA-C 110.451 -0.634 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.441 ' C ' ' O ' ' A' ' 131' ' ' PRO . 1.7 mp 41.26 75.47 0.61 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.285 -0.884 . . . . 0.0 110.271 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.03 -28.37 13.02 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.983 1.517 . . . . 0.0 110.342 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -46.07 167.57 0.05 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.4 -154.63 0.48 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.305 -1.115 . . . . 0.0 110.229 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -102.13 52.3 0.81 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 110.23 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -124.61 55.98 1.31 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.292 -0.88 . . . . 0.0 110.252 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 110.213 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.486 ' HA ' ' OE1' ' A' ' 224' ' ' GLU . 45.9 Cg_endo . . . . . 0 N--CA 1.484 0.951 0 N-CA-C 110.456 -0.632 . . . . 0.0 110.456 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -164.35 106.18 0.27 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.513 ' O ' HG22 ' A' ' 150' ' ' THR . 99.7 m -134.53 2.2 3.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -1.115 . . . . 0.0 110.256 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 153' ' ' ILE . 32.9 mtt180 59.83 123.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 110.121 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.885 ' CG2' HG21 ' A' ' 223' ' ' ILE . 40.5 t -66.21 60.14 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.203 -0.936 . . . . 0.0 110.339 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.721 HG23 ' O ' ' A' ' 152' ' ' VAL . 0.8 OUTLIER -159.33 -34.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.306 -0.871 . . . . 0.0 110.145 179.802 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.33 -13.07 61.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.861 . . . . 0.0 109.44 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.712 ' CB ' HG11 ' A' ' 163' ' ' VAL . . . -88.17 -28.01 21.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.485 -0.759 . . . . 0.0 109.976 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -75.62 120.48 21.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.895 . . . . 0.0 110.238 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 14.6 m -162.6 109.0 1.23 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 110.267 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' A' ' 159' ' ' MET . 1.3 t 62.59 10.36 4.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 0.0 110.256 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' MET . . . . . 0.45 ' HB3' ' O ' ' A' ' 158' ' ' SER . 0.0 OUTLIER 173.12 158.42 0.27 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.286 -0.884 . . . . 0.0 110.2 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 46.2 Cg_endo -73.12 63.81 4.22 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.049 1.552 . . . . 0.0 110.299 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.585 ' O ' HG13 ' A' ' 163' ' ' VAL . 7.9 mtt180 -42.18 119.22 1.31 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 0.0 110.248 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.492 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 6.1 ttmt -58.33 124.98 21.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.291 -0.881 . . . . 0.0 110.258 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.856 HG22 ' HA ' ' A' ' 194' ' ' GLU . 30.6 m -139.67 -159.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.881 . . . . 0.0 110.122 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.645 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -175.09 139.11 0.46 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.822 -1.174 . . . . 0.0 110.486 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 1.033 HG23 HG22 ' A' ' 223' ' ' ILE . 2.1 mt -91.38 153.87 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.45 -0.781 . . . . 0.0 110.893 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.478 ' CG1' ' HD3' ' A' ' 164' ' ' ARG . 3.4 m -138.85 -29.62 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.486 -0.759 . . . . 0.0 110.448 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -136.57 118.88 15.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.117 -0.989 . . . . 0.0 110.217 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.585 ' HB ' HG12 ' A' ' 189' ' ' VAL . 1.3 tt -116.32 -3.12 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.201 -0.937 . . . . 0.0 110.254 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 57.26 170.73 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.222 -0.924 . . . . 0.0 110.298 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 172' ' ' PHE . 7.7 pt-20 -155.66 160.75 40.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.151 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.427 ' C ' ' O ' ' A' ' 170' ' ' GLU . 23.1 mt 41.3 27.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.919 . . . . 0.0 110.248 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 170' ' ' GLU . 2.6 t80 -172.29 57.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.255 -0.903 . . . . 0.0 110.245 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.512 ' HB3' HG12 ' A' ' 174' ' ' VAL . 1.9 mt-30 -112.5 -61.23 1.76 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -0.925 . . . . 0.0 110.169 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.846 HG22 ' N ' ' A' ' 175' ' ' GLU . 0.5 OUTLIER -164.22 -86.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.385 -0.822 . . . . 0.0 110.185 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.846 ' N ' HG22 ' A' ' 174' ' ' VAL . 2.6 mt-10 -141.89 11.89 2.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.059 -1.025 . . . . 0.0 110.228 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.984 HG22 HG23 ' A' ' 180' ' ' THR . 0.2 OUTLIER 66.28 -58.44 0.35 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.286 -0.883 . . . . 0.0 110.259 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 178' ' ' GLN . 3.3 p30 36.93 -145.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.377 -0.827 . . . . 0.0 110.776 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.512 ' N ' ' OD1' ' A' ' 177' ' ' ASP . 0.2 OUTLIER -63.46 -27.47 69.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.312 -0.867 . . . . 0.0 110.567 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.819 ' HA ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -44.08 -35.34 2.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.001 . . . . 0.0 109.771 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.984 HG23 HG22 ' A' ' 176' ' ' THR . 0.7 OUTLIER -42.8 -27.85 0.21 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.144 -0.973 . . . . 0.0 109.456 179.693 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 179' ' ' PHE . 23.5 tp60 -59.84 -36.01 75.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.542 -0.724 . . . . 0.0 109.609 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.819 HD12 ' HA ' ' A' ' 179' ' ' PHE . 1.2 mt -69.11 -43.62 74.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.38 -0.825 . . . . 0.0 109.433 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -37.64 88.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.613 -0.679 . . . . 0.0 109.888 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -59.16 -14.74 11.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.462 -0.774 . . . . 0.0 109.845 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -84.69 16.93 2.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.423 -0.798 . . . . 0.0 110.189 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 185' ' ' ALA . 27.4 t70 43.6 57.56 3.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -0.921 . . . . 0.0 109.764 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.6 tt -129.93 175.24 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.322 -0.861 . . . . 0.0 110.339 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.694 ' C ' HG13 ' A' ' 189' ' ' VAL . 0.1 OUTLIER -163.11 105.73 1.02 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.743 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.694 HG13 ' C ' ' A' ' 188' ' ' ARG . 1.3 m 50.63 105.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.332 -0.855 . . . . 0.0 108.813 -178.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.921 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -43.28 -15.74 0.03 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.604 ' N ' ' O ' ' A' ' 189' ' ' VAL . 6.1 t 65.57 -142.1 0.2 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.18 -1.188 . . . . 0.0 109.388 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.645 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -64.11 100.24 0.32 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.569 -0.707 . . . . 0.0 109.265 179.294 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.623 ' O ' ' O ' ' A' ' 163' ' ' VAL . 17.0 m -156.73 -141.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.158 -0.964 . . . . 0.0 110.222 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.856 ' HA ' HG22 ' A' ' 163' ' ' VAL . 4.2 pt-20 -173.26 169.08 4.59 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.345 -0.847 . . . . 0.0 110.11 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.872 HG21 HG12 ' A' ' 152' ' ' VAL . 0.6 OUTLIER -121.3 169.17 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.169 -0.957 . . . . 0.0 110.288 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 18.8 t -128.7 98.4 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.34 -0.85 . . . . 0.0 110.178 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -49.35 117.86 2.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.9 . . . . 0.0 110.201 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.546 ' HB3' ' CB ' ' A' ' 201' ' ' HIS . 0.1 OUTLIER -109.05 146.39 34.04 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.212 -0.93 . . . . 0.0 110.213 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.45 94.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.908 . . . . 0.0 110.12 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 198' ' ' ARG . . . 75.64 14.55 81.96 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.546 ' CB ' ' HB3' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -150.25 160.92 43.34 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.249 -1.148 . . . . 0.0 110.095 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 10.6 mt -136.02 159.73 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 110.251 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.545 ' O ' HG22 ' A' ' 195' ' ' ILE . 2.1 m -151.0 163.26 39.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -0.877 . . . . 0.0 109.96 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.854 HD11 HD11 ' A' ' 165' ' ' ILE . 0.6 OUTLIER -119.8 137.28 54.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.058 -1.026 . . . . 0.0 110.345 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.554 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 1.2 t -119.73 120.47 36.67 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.404 -0.81 . . . . 0.0 109.583 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.561 ' HA ' ' CG1' ' A' ' 193' ' ' VAL . 7.4 m170 -89.24 165.86 14.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.429 -0.795 . . . . 0.0 110.205 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.503 ' C ' ' O ' ' A' ' 206' ' ' HIS . 4.6 m-20 -32.85 -34.35 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.566 -0.709 . . . . 0.0 110.952 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -153.83 32.7 0.74 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 206' ' ' HIS . 20.8 mttt -154.29 179.38 9.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -1.124 . . . . 0.0 110.51 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 204' ' ' LEU . 12.8 t0 -155.56 158.46 38.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 110.053 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.487 HG12 ' HB3' ' A' ' 204' ' ' LEU . 7.3 p -146.49 140.81 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -0.953 . . . . 0.0 110.329 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -68.78 83.73 0.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.286 -0.884 . . . . 0.0 110.231 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.66 121.1 17.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.184 -0.948 . . . . 0.0 110.243 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 1.019 HD23 ' HB2' ' A' ' 217' ' ' LEU . 29.6 tp -57.63 158.82 5.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 0.0 110.222 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.596 ' H ' HD12 ' A' ' 214' ' ' LEU . 11.2 t0 -89.57 -49.65 6.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.346 -0.846 . . . . 0.0 110.274 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.544 ' O ' ' NE2' ' A' ' 219' ' ' HIS . 0.4 OUTLIER -55.35 -48.52 74.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -0.921 . . . . 0.0 110.202 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 1.019 ' HB2' HD23 ' A' ' 214' ' ' LEU . 0.5 OUTLIER -85.85 -11.93 52.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 110.113 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.699 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -35.62 -41.77 0.21 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.55 -0.718 . . . . 0.0 110.669 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.563 ' HB3' ' CD1' ' A' ' 153' ' ' ILE . 24.7 p80 -93.98 73.47 4.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 110.434 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' THR . . . . . 0.771 HG23 HG23 ' A' ' 221' ' ' ILE . 8.9 t -137.25 -44.86 0.56 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.941 . . . . 0.0 110.092 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.895 HD13 ' H ' ' A' ' 221' ' ' ILE . 0.3 OUTLIER -73.74 146.54 10.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.326 -0.859 . . . . 0.0 110.363 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.459 ' O ' HG22 ' A' ' 166' ' ' VAL . 8.1 mtt180 -89.89 114.39 26.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 0.0 109.28 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 1.033 HG22 HG23 ' A' ' 165' ' ' ILE . 0.8 OUTLIER -141.58 -172.6 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.131 -0.981 . . . . 0.0 110.894 -179.036 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.486 ' OE1' ' HA ' ' A' ' 148' ' ' PRO . 0.5 OUTLIER -144.18 166.81 23.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.355 -0.84 . . . . 0.0 110.178 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.829 ' HA ' HG12 ' A' ' 163' ' ' VAL . 0.3 OUTLIER -111.92 124.01 51.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.366 -0.834 . . . . 0.0 110.26 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.419 ' OXT' ' HB3' ' A' ' 162' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.19 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 N--CA 1.483 0.861 0 N-CA-C 110.434 -0.641 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.642 HG23 ' O ' ' A' ' 132' ' ' ILE . 10.8 tt -62.57 114.63 12.63 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.194 -0.941 . . . . 0.0 110.233 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.36 -166.05 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.959 1.505 . . . . 0.0 110.458 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 136' ' ' ASP . . . -173.0 -116.71 0.42 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.54 HD12 ' N ' ' A' ' 135' ' ' LEU . 6.8 mp 56.25 -83.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -1.151 . . . . 0.0 110.319 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 134' ' ' GLY . 6.7 t70 -41.79 -27.04 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.306 -0.871 . . . . 0.0 110.278 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 135' ' ' LEU . 0.5 OUTLIER 42.37 35.23 0.6 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 110.319 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 53.9 tp . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.235 -0.916 . . . . 0.0 110.167 -179.963 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 149' ' ' GLY . 46.5 Cg_endo . . . . . 0 N--CA 1.483 0.882 0 N-CA-C 110.54 -0.6 . . . . 0.0 110.54 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 148' ' ' PRO . . . 55.88 162.14 0.02 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.564 HG22 ' H ' ' A' ' 151' ' ' ARG . 1.6 m -73.75 -177.01 2.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.219 -1.165 . . . . 0.0 109.969 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.564 ' H ' HG22 ' A' ' 150' ' ' THR . 96.7 mtt180 -141.58 143.8 33.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.281 -0.887 . . . . 0.0 109.944 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.842 HG12 HG23 ' A' ' 153' ' ' ILE . 69.6 t -50.05 -177.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 109.413 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.977 HG21 ' HB3' ' A' ' 218' ' ' ALA . 8.2 pt 43.94 25.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.004 -1.06 . . . . 0.0 110.011 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.8 OUTLIER -147.47 -35.47 0.23 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.483 -0.761 . . . . 0.0 109.673 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -96.12 -15.64 22.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.492 -0.755 . . . . 0.0 109.812 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.691 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -57.22 172.98 0.26 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.293 -0.879 . . . . 0.0 110.268 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.535 ' CG2' ' HG2' ' A' ' 161' ' ' ARG . 7.2 t -174.36 167.44 4.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.192 -0.943 . . . . 0.0 110.104 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 157' ' ' THR . 96.9 p -42.7 -49.81 5.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.33 -0.856 . . . . 0.0 110.166 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.67 161.07 75.5 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.214 -0.929 . . . . 0.0 110.119 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.73 68.73 3.71 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.959 1.505 . . . . 0.0 110.481 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.665 ' O ' HG13 ' A' ' 163' ' ' VAL . 3.0 mmt85 -60.89 107.66 0.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.195 -0.941 . . . . 0.0 110.167 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.552 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -65.46 96.71 0.26 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.909 . . . . 0.0 110.311 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 1.091 HG22 ' HA ' ' A' ' 194' ' ' GLU . 8.5 m -104.7 -164.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.967 . . . . 0.0 110.254 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.672 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -179.67 149.03 0.35 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.843 -1.161 . . . . 0.0 110.169 -179.394 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 1.173 HG23 ' CG2' ' A' ' 223' ' ' ILE . 0.3 OUTLIER -89.82 150.03 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.302 -0.874 . . . . 0.0 110.233 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 222' ' ' ARG . 21.4 m -124.07 -20.3 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.151 -0.968 . . . . 0.0 110.289 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.87 120.61 2.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.18 -0.95 . . . . 0.0 110.251 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.761 HG13 HG22 ' A' ' 221' ' ' ILE . 5.3 tt -122.33 7.05 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.198 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.448 ' O ' ' HB3' ' A' ' 170' ' ' GLU . 52.9 t30 -62.32 89.28 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.2 -0.937 . . . . 0.0 110.214 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' A' ' 169' ' ' ASN . 10.3 pt-20 177.2 47.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.927 . . . . 0.0 110.253 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' ' 171' ' ' ILE . 9.8 mt -82.28 44.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.893 . . . . 0.0 110.336 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.429 ' O ' ' C ' ' A' ' 173' ' ' GLN . 2.9 m-85 -46.6 -64.09 0.85 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 110.188 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.429 ' C ' ' O ' ' A' ' 172' ' ' PHE . 0.4 OUTLIER -42.42 159.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.357 -0.839 . . . . 0.0 110.197 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.453 ' O ' HG12 ' A' ' 174' ' ' VAL . 55.6 t -111.01 -5.81 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.885 . . . . 0.0 110.237 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.634 ' O ' HG23 ' A' ' 176' ' ' THR . 0.2 OUTLIER -96.72 104.78 16.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.869 . . . . 0.0 110.267 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 175' ' ' GLU . 0.1 OUTLIER -165.74 33.24 0.05 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.145 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -52.83 -44.48 66.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.927 . . . . 0.0 110.215 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -68.21 -31.31 70.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.298 -0.876 . . . . 0.0 110.241 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 1.007 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -70.15 -39.75 75.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.367 -0.833 . . . . 0.0 109.995 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.506 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -55.58 -18.79 8.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.148 -0.97 . . . . 0.0 109.912 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -72.17 -58.02 3.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.35 -0.843 . . . . 0.0 110.234 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.782 ' C ' HD12 ' A' ' 182' ' ' LEU . 4.5 pp -69.54 -7.68 40.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 0.0 109.983 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 1.007 HD13 ' CZ ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -97.57 -27.13 14.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.359 -0.838 . . . . 0.0 109.924 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 180' ' ' THR . 4.6 t70 -81.37 -3.16 51.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.349 -0.844 . . . . 0.0 109.957 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -87.24 26.88 1.13 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.332 -0.855 . . . . 0.0 110.151 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 11.5 t0 56.01 63.06 2.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 0.0 110.137 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.56 ' O ' ' CB ' ' A' ' 188' ' ' ARG . 34.8 mt -130.86 -82.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.213 -0.929 . . . . 0.0 110.42 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.56 ' CB ' ' O ' ' A' ' 187' ' ' ILE . 0.1 OUTLIER 73.89 151.74 0.12 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.515 -0.741 . . . . 0.0 109.681 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.939 ' O ' ' N ' ' A' ' 191' ' ' SER . 4.4 m 33.86 38.52 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 O-C-N 121.315 -0.866 . . . . 0.0 110.443 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.829 ' N ' HD12 ' A' ' 165' ' ' ILE . . . 28.16 19.81 0.0 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.939 ' N ' ' O ' ' A' ' 189' ' ' VAL . 21.2 t 39.5 -145.12 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.346 -1.091 . . . . 0.0 109.608 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.672 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 1.8 tt0 -96.26 117.62 31.16 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.63 HG13 ' C ' ' A' ' 192' ' ' GLU . 33.0 m -157.71 -137.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.209 -0.932 . . . . 0.0 110.097 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 1.091 ' HA ' HG22 ' A' ' 163' ' ' VAL . 1.9 pt-20 -173.75 159.51 3.49 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 110.091 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.834 HD13 HG13 ' A' ' 152' ' ' VAL . 1.0 OUTLIER -120.46 165.13 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.07 -1.019 . . . . 0.0 110.452 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 197' ' ' ASP . 40.2 t -138.64 86.09 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.329 -0.857 . . . . 0.0 110.128 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 196' ' ' VAL . 48.5 t0 -42.31 129.92 3.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -0.893 . . . . 0.0 110.369 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.543 ' CB ' ' O ' ' A' ' 201' ' ' HIS . 8.7 ttp180 -115.16 72.66 0.8 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.223 -0.923 . . . . 0.0 110.161 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 198' ' ' ARG . 1.3 m-20 41.27 58.32 2.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 0.0 110.395 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 109.81 -44.82 1.42 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.543 ' O ' ' CB ' ' A' ' 198' ' ' ARG . 0.3 OUTLIER -93.74 114.86 27.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.187 -1.184 . . . . 0.0 110.266 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.688 HD13 ' HA ' ' A' ' 153' ' ' ILE . 11.9 mt -95.45 127.72 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.925 . . . . 0.0 110.411 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.424 ' O ' HG22 ' A' ' 195' ' ' ILE . 40.4 m -110.83 163.67 13.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 0.0 109.97 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 1.04 HD22 ' CD2' ' A' ' 206' ' ' HIS . 0.7 OUTLIER -119.64 133.76 55.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 110.293 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.548 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 1.4 t -119.84 120.02 35.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.342 -0.849 . . . . 0.0 109.865 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 1.04 ' CD2' HD22 ' A' ' 204' ' ' LEU . 2.8 m170 -106.53 -163.83 0.95 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.341 -0.849 . . . . 0.0 110.111 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -52.69 91.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 110.063 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 59.83 20.95 54.4 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -130.53 168.7 16.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -1.141 . . . . 0.0 110.181 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' A' ' 204' ' ' LEU . 0.2 OUTLIER -157.84 152.18 24.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.218 -0.926 . . . . 0.0 110.235 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 212' ' ' GLU . 40.5 t -146.87 167.55 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.891 . . . . 0.0 110.145 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.508 ' N ' HG12 ' A' ' 211' ' ' VAL . 2.7 tt0 -98.62 69.92 1.9 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.29 -0.881 . . . . 0.0 110.333 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.51 ' HG ' ' N ' ' A' ' 214' ' ' LEU . 6.5 tp -63.25 155.28 28.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.289 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.86 ' O ' ' HB2' ' A' ' 218' ' ' ALA . 27.8 mt -59.37 150.82 25.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.22 -0.925 . . . . 0.0 109.94 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' A' ' 218' ' ' ALA . 2.9 p-10 -90.91 -109.18 0.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.028 -1.045 . . . . 0.0 110.238 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 215' ' ' ASP . 0.3 OUTLIER -42.87 -25.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.029 -1.044 . . . . 0.0 109.911 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 215' ' ' ASP . 1.1 mp -81.46 -21.6 38.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.299 -0.876 . . . . 0.0 110.488 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.977 ' HB3' HG21 ' A' ' 153' ' ' ILE . . . -75.67 48.12 0.44 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.076 -1.015 . . . . 0.0 110.461 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.712 ' CB ' HD11 ' A' ' 153' ' ' ILE . 4.3 t60 -118.76 29.05 7.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.137 -0.977 . . . . 0.0 110.173 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' THR . . . . . 0.407 ' O ' ' CD ' ' A' ' 170' ' ' GLU . 0.2 OUTLIER -113.69 -34.23 5.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 110.165 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.777 HG12 HG23 ' A' ' 223' ' ' ILE . 0.1 OUTLIER -70.52 134.01 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.307 -0.87 . . . . 0.0 110.347 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.867 ' O ' HG22 ' A' ' 166' ' ' VAL . 4.4 mtt180 -89.87 101.39 14.09 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.216 -0.927 . . . . 0.0 109.642 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 1.173 ' CG2' HG23 ' A' ' 165' ' ' ILE . 1.0 OUTLIER -119.56 -176.78 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 110.659 -179.484 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.474 ' OE1' HG11 ' A' ' 166' ' ' VAL . 11.5 pt-20 -150.6 178.48 9.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.468 -0.77 . . . . 0.0 110.204 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 3.8 tm-20 -106.48 120.15 41.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.303 -0.873 . . . . 0.0 110.068 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.421 HD23 ' HD2' ' A' ' 162' ' ' LYS . 39.1 tp . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.222 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 N--CA 1.484 0.916 0 N-CA-C 110.468 -0.628 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 24.6 mm -71.19 117.95 61.29 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 0.0 110.226 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.85 90.07 0.85 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.985 1.519 . . . . 0.0 110.373 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -84.3 99.67 2.28 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 137' ' ' GLU . 1.2 tp -69.79 -16.7 63.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -1.13 . . . . 0.0 110.14 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 137' ' ' GLU . 0.5 OUTLIER 60.76 -81.31 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.266 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 135' ' ' LEU . 7.5 mt-10 57.64 29.21 16.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.378 -0.826 . . . . 0.0 110.165 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 110.271 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.484 0.953 0 N-CA-C 110.631 -0.565 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -154.24 -172.48 22.23 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.631 ' O ' HG22 ' A' ' 150' ' ' THR . 53.7 m -147.28 10.76 1.0 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.296 -1.12 . . . . 0.0 110.375 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.533 ' HB2' ' HB2' ' A' ' 154' ' ' ASP . 13.5 mmt180 59.7 136.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -0.9 . . . . 0.0 110.226 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.992 HG13 HG21 ' A' ' 195' ' ' ILE . 1.4 t -64.97 -0.58 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.219 -0.926 . . . . 0.0 110.966 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.828 HG21 ' HB3' ' A' ' 218' ' ' ALA . 1.0 OUTLIER -115.53 -4.62 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.911 -1.118 . . . . 0.0 110.652 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.533 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 0.7 OUTLIER -103.19 -28.6 11.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.125 -0.985 . . . . 0.0 109.949 179.673 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.492 ' HB2' ' CG2' ' A' ' 150' ' ' THR . . . -84.09 -15.4 47.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 110.05 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.726 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -71.97 -161.8 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.326 -0.859 . . . . 0.0 110.197 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 156' ' ' ALA . 0.4 OUTLIER 55.88 160.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.33 -0.856 . . . . 0.0 110.12 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 157' ' ' THR . 5.6 p 42.86 30.84 0.27 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 110.212 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.73 134.15 1.74 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.323 -0.86 . . . . 0.0 110.065 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.608 ' O ' ' O ' ' A' ' 161' ' ' ARG . 45.9 Cg_endo -73.36 74.61 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.935 1.492 . . . . 0.0 110.542 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.667 ' HB3' HG22 ' A' ' 196' ' ' VAL . 2.1 ptt85 27.44 104.32 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.492 0.663 . . . . 0.0 111.393 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.51 ' C ' HG13 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -168.76 68.75 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.99 -1.069 . . . . 0.0 110.287 179.534 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.655 ' O ' ' O ' ' A' ' 193' ' ' VAL . 16.6 m -150.62 -155.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.886 . . . . 0.0 110.329 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.669 ' CB ' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -177.56 167.72 2.22 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.783 -1.198 . . . . 0.0 110.518 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 1.088 HG23 ' CG2' ' A' ' 223' ' ' ILE . 0.3 OUTLIER -98.83 159.52 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.224 -0.922 . . . . 0.0 110.268 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 222' ' ' ARG . 31.5 m -131.13 -28.62 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.892 . . . . 0.0 110.222 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -144.92 93.59 2.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.197 -0.939 . . . . 0.0 110.124 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.762 ' H ' HG12 ' A' ' 189' ' ' VAL . 0.3 OUTLIER -54.07 -32.23 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.219 -0.925 . . . . 0.0 110.124 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 168' ' ' ILE . 0.2 OUTLIER 42.56 71.25 0.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 0.0 110.252 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 170' ' ' GLU . 33.6 tt0 -151.28 72.29 1.04 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.259 -0.9 . . . . 0.0 110.211 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 32.4 mm -84.2 -6.63 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 110.281 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -75.32 166.37 23.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.427 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -115.66 -17.38 11.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -0.918 . . . . 0.0 110.2 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 86.6 t -69.66 -21.33 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.19 -0.944 . . . . 0.0 110.224 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -89.82 90.27 8.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.252 -0.905 . . . . 0.0 110.177 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' THR . . . . . 1.055 HG23 HG23 ' A' ' 180' ' ' THR . 21.2 m -124.36 -90.06 0.57 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.885 . . . . 0.0 110.197 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.589 ' N ' HG22 ' A' ' 176' ' ' THR . 3.0 t0 68.37 -158.0 0.19 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.214 -0.929 . . . . 0.0 110.319 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.443 ' OE1' ' OE1' ' A' ' 212' ' ' GLU . 1.2 mt-30 -59.14 -23.33 62.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.895 . . . . 0.0 110.411 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 1.025 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -47.96 -23.51 0.8 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.181 -0.949 . . . . 0.0 110.133 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 180' ' ' THR . . . . . 1.055 HG23 HG23 ' A' ' 176' ' ' THR . 0.5 OUTLIER -58.58 -25.75 62.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 109.949 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -71.46 -62.85 1.26 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.301 -0.874 . . . . 0.0 110.167 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.837 HD22 HD12 ' A' ' 213' ' ' LEU . 3.3 pp -61.06 -13.89 19.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.341 -0.85 . . . . 0.0 110.101 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 1.025 HD13 ' CZ ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -85.22 -30.14 24.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.903 . . . . 0.0 110.058 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -69.59 -14.28 62.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.416 -0.802 . . . . 0.0 110.039 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.453 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -91.45 24.82 2.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -0.858 . . . . 0.0 110.174 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 185' ' ' ALA . 30.5 t0 40.84 83.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 110.171 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.647 HD12 ' O ' ' A' ' 182' ' ' LEU . 87.7 mt -133.85 -75.78 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.0 110.448 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.548 ' CB ' ' O ' ' A' ' 187' ' ' ILE . 5.6 ttp85 71.48 154.65 0.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.374 -0.829 . . . . 0.0 109.716 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.956 ' O ' ' N ' ' A' ' 191' ' ' SER . 4.2 m 32.9 38.35 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 121.235 -0.916 . . . . 0.0 110.558 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.872 ' N ' HD12 ' A' ' 165' ' ' ILE . . . 26.83 19.58 0.0 OUTLIER Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.956 ' N ' ' O ' ' A' ' 189' ' ' VAL . 39.5 t 37.06 -146.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.322 -1.105 . . . . 0.0 109.868 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.669 ' HA ' ' CB ' ' A' ' 164' ' ' ARG . 18.9 mt-10 -92.12 115.99 28.55 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.655 ' O ' ' O ' ' A' ' 163' ' ' VAL . 34.3 m -159.25 -132.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.098 -1.001 . . . . 0.0 109.59 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.604 ' O ' HD23 ' A' ' 204' ' ' LEU . 1.5 pm0 -167.29 159.0 12.29 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.544 -0.862 . . . . 0.0 110.239 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.992 HG21 HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -119.98 163.95 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.28 -0.887 . . . . 0.0 110.154 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.667 HG22 ' HB3' ' A' ' 161' ' ' ARG . 54.8 t -140.83 90.01 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.208 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.48 ' OD1' ' CB ' ' A' ' 156' ' ' ALA . 15.4 m-20 -52.66 118.74 3.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.883 . . . . 0.0 110.332 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.474 ' HB3' ' HB3' ' A' ' 201' ' ' HIS . 0.6 OUTLIER -105.02 73.13 1.04 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.224 -0.922 . . . . 0.0 110.246 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 198' ' ' ARG . 1.6 m-20 42.55 53.87 4.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 110.21 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 110.62 -41.36 2.26 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 198' ' ' ARG . 0.1 OUTLIER -89.79 95.29 10.18 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.279 -1.13 . . . . 0.0 110.162 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.502 HD13 ' HA ' ' A' ' 153' ' ' ILE . 20.4 mt -80.71 114.45 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 110.322 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 211' ' ' VAL . 3.9 m -102.56 163.33 12.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 0.0 109.916 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.923 HD22 ' CD2' ' A' ' 206' ' ' HIS . 0.7 OUTLIER -119.81 136.84 54.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.097 -1.002 . . . . 0.0 110.308 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.626 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.4 OUTLIER -119.88 123.31 43.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 0.0 109.92 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.923 ' CD2' HD22 ' A' ' 204' ' ' LEU . 2.7 m80 -112.08 -171.59 1.88 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.296 -0.877 . . . . 0.0 110.07 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -48.94 91.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.215 -0.928 . . . . 0.0 110.175 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 54.98 23.84 32.71 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.511 ' O ' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -138.5 94.81 2.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -1.144 . . . . 0.0 110.259 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -100.44 148.44 24.75 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.254 -0.904 . . . . 0.0 110.246 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 212' ' ' GLU . 14.3 t -141.18 171.56 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.932 . . . . 0.0 110.225 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 213' ' ' LEU . 2.7 tt0 -95.72 84.89 4.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 110.181 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.904 ' O ' HD23 ' A' ' 214' ' ' LEU . 6.8 tp -60.03 -138.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -0.926 . . . . 0.0 110.296 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.904 HD23 ' O ' ' A' ' 213' ' ' LEU . 14.8 mt -139.62 157.71 45.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.248 -0.907 . . . . 0.0 110.087 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 216' ' ' ASP . 4.6 p30 -90.52 -106.76 0.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.207 -0.933 . . . . 0.0 110.263 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 215' ' ' ASP . 0.1 OUTLIER -41.73 -25.38 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.092 -1.005 . . . . 0.0 110.121 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 215' ' ' ASP . 0.3 OUTLIER -80.79 -26.76 36.97 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.259 -0.901 . . . . 0.0 110.329 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.842 ' HB2' ' O ' ' A' ' 214' ' ' LEU . . . -71.94 -3.88 25.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.053 -1.03 . . . . 0.0 110.018 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.499 ' O ' ' NH1' ' A' ' 151' ' ' ARG . 32.7 t60 -83.56 55.34 3.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 110.143 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.1 -49.72 0.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -0.913 . . . . 0.0 110.322 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.661 HD13 ' N ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -67.22 137.46 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.291 -0.881 . . . . 0.0 110.352 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.708 ' O ' HG22 ' A' ' 166' ' ' VAL . 0.6 OUTLIER -89.53 110.73 21.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 109.333 179.52 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 1.088 ' CG2' HG23 ' A' ' 165' ' ' ILE . 0.5 OUTLIER -119.82 175.46 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.165 -0.959 . . . . 0.0 110.636 -179.111 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.465 ' O ' ' HB ' ' A' ' 163' ' ' VAL . 5.9 mt-10 -143.61 167.32 22.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.336 -0.852 . . . . 0.0 110.12 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.51 ' HA ' HG12 ' A' ' 163' ' ' VAL . 4.7 pt-20 -101.57 48.51 0.88 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.312 -0.867 . . . . 0.0 110.253 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.519 HD13 ' NH2' ' A' ' 164' ' ' ARG . 2.4 tp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.118 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.475 ' HB2' HD12 ' A' ' 132' ' ' ILE . 45.6 Cg_endo . . . . . 0 N--CA 1.484 0.939 0 N-CA-C 110.41 -0.65 . . . . 0.0 110.41 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.475 HD12 ' HB2' ' A' ' 131' ' ' PRO . 1.8 mp -141.7 129.09 11.64 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.231 -0.918 . . . . 0.0 110.177 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.98 -19.61 22.97 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.955 1.503 . . . . 0.0 110.47 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.83 -97.41 1.85 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.43 ' O ' ' HG3' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -125.37 -6.34 7.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -1.12 . . . . 0.0 110.21 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.4 t70 52.11 54.13 11.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.27 -0.894 . . . . 0.0 110.216 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 135' ' ' LEU . 43.2 mt-10 -135.55 27.61 3.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 110.292 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 138' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 110.223 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo . . . . . 0 N--CA 1.483 0.889 0 N-CA-C 110.415 -0.648 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.502 ' HA3' ' HB3' ' A' ' 222' ' ' ARG . . . 113.61 126.18 4.38 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.58 HG22 ' CB ' ' A' ' 154' ' ' ASP . 98.0 m -141.39 151.97 43.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -1.101 . . . . 0.0 110.1 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.5 ' HG2' ' HA ' ' A' ' 219' ' ' HIS . 0.0 OUTLIER -43.15 125.06 3.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.142 -0.974 . . . . 0.0 110.259 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 1.096 HG22 HD13 ' A' ' 195' ' ' ILE . 5.9 p -44.75 -26.8 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.239 -0.913 . . . . 0.0 110.174 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.92 HG22 HD13 ' A' ' 202' ' ' ILE . 9.9 pt -92.33 -15.7 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.204 -0.935 . . . . 0.0 110.248 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.58 ' CB ' HG22 ' A' ' 150' ' ' THR . 0.8 OUTLIER -77.35 -21.97 52.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.396 179.558 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.411 ' HB3' HD11 ' A' ' 223' ' ' ILE . . . -106.9 -9.78 16.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.562 -0.711 . . . . 0.0 109.756 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.53 ' HA ' ' HB3' ' A' ' 160' ' ' PRO . . . -66.13 -174.11 0.23 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 110.216 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.766 HG22 ' H ' ' A' ' 158' ' ' SER . 4.0 m 43.64 -170.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 110.182 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.766 ' H ' HG22 ' A' ' 157' ' ' THR . 2.2 t 50.45 30.35 4.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.173 -0.954 . . . . 0.0 110.058 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' MET . . . . . 0.521 ' CB ' ' O ' ' A' ' 158' ' ' SER . 0.5 OUTLIER 69.88 64.8 0.49 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 110.135 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.588 ' O ' ' CG ' ' A' ' 161' ' ' ARG . 45.9 Cg_endo -74.11 -61.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.0 1.526 . . . . 0.0 110.22 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.764 ' O ' HG22 ' A' ' 163' ' ' VAL . 0.0 OUTLIER 74.07 179.63 0.2 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.455 -0.778 . . . . 0.0 110.238 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.59 ' N ' ' CD ' ' A' ' 161' ' ' ARG . 14.0 tptt -40.03 126.3 2.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.834 . . . . 0.0 110.84 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 1.063 HG23 ' HA ' ' A' ' 194' ' ' GLU . 0.1 OUTLIER -134.11 -160.88 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.411 -0.805 . . . . 0.0 109.436 179.175 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.654 ' HA ' ' O ' ' A' ' 191' ' ' SER . 0.1 OUTLIER -177.21 144.4 0.42 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.831 -1.168 . . . . 0.0 110.39 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.927 HG23 HG22 ' A' ' 223' ' ' ILE . 1.1 mt -103.66 151.03 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.39 -0.819 . . . . 0.0 110.442 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.508 HG13 ' C ' ' A' ' 165' ' ' ILE . 22.9 m -150.72 17.87 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.165 -0.959 . . . . 0.0 110.295 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.432 ' OE1' HG23 ' A' ' 166' ' ' VAL . 0.1 OUTLIER -155.03 119.86 4.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.213 -0.929 . . . . 0.0 110.196 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 168' ' ' ILE . 0.9 OUTLIER -111.31 11.18 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.187 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 168' ' ' ILE . 5.4 m-20 -42.06 122.29 2.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.21 -0.932 . . . . 0.0 110.086 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 171' ' ' ILE . 5.1 pt-20 -144.79 55.88 1.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 110.189 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 170' ' ' GLU . 28.1 mt -41.91 -33.32 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.291 -0.881 . . . . 0.0 110.022 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.58 ' HE1' HG22 ' A' ' 220' ' ' THR . 3.4 p90 -98.93 158.71 15.46 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.349 -0.845 . . . . 0.0 110.191 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.453 ' O ' ' HB ' ' A' ' 174' ' ' VAL . 0.0 OUTLIER -178.0 152.54 0.74 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 110.187 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 173' ' ' GLN . 2.5 p 178.33 -30.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 110.134 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.433 ' OE2' ' OD2' ' A' ' 216' ' ' ASP . 35.0 tt0 -85.29 151.39 24.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -0.891 . . . . 0.0 110.123 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.74 HG23 ' HD2' ' A' ' 179' ' ' PHE . 36.4 m -164.68 -96.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 110.037 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.62 ' N ' HG22 ' A' ' 176' ' ' THR . 2.6 m-20 69.17 -136.7 0.08 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.148 -0.97 . . . . 0.0 110.307 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -56.55 -28.94 61.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.207 -0.933 . . . . 0.0 110.52 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.74 ' HD2' HG23 ' A' ' 176' ' ' THR . 0.1 OUTLIER -42.95 -39.82 2.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 110.263 -179.812 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.694 HG23 ' CG2' ' A' ' 176' ' ' THR . 0.7 OUTLIER -39.26 -28.3 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.905 . . . . 0.0 110.089 -179.781 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 179' ' ' PHE . 28.0 tt0 -60.2 -36.02 76.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.268 -0.895 . . . . 0.0 109.576 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.607 HD12 ' HA ' ' A' ' 179' ' ' PHE . 1.0 OUTLIER -69.77 -41.32 75.31 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.389 -0.82 . . . . 0.0 109.431 179.345 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.57 HD23 ' CZ ' ' A' ' 179' ' ' PHE . 0.1 OUTLIER -66.87 -39.17 87.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.41 -0.806 . . . . 0.0 109.812 179.641 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -61.73 -17.78 57.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.429 -0.794 . . . . 0.0 109.703 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -90.66 18.87 5.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.385 -0.822 . . . . 0.0 110.033 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 185' ' ' ALA . 2.8 m-20 42.48 68.02 0.53 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 109.669 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.522 HG22 ' N ' ' A' ' 188' ' ' ARG . 10.6 mm -115.24 167.47 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.302 -0.874 . . . . 0.0 110.882 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.636 ' O ' ' O ' ' A' ' 189' ' ' VAL . 0.2 OUTLIER -173.31 113.26 0.22 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.691 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 0.6 OUTLIER 43.74 101.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.272 -0.893 . . . . 0.0 108.693 -178.149 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.894 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -39.02 -19.05 0.01 OUTLIER Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.654 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 3.7 t 67.04 -145.18 0.15 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.969 -1.312 . . . . 0.0 108.979 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.581 ' C ' HG13 ' A' ' 193' ' ' VAL . 7.8 mt-10 -62.68 98.33 0.12 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 109.25 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.612 HG23 ' N ' ' A' ' 194' ' ' GLU . 10.0 m -154.1 -142.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.062 -1.024 . . . . 0.0 110.356 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 1.063 ' HA ' HG23 ' A' ' 163' ' ' VAL . 24.3 tt0 -169.64 157.71 7.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.88 . . . . 0.0 110.394 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 1.096 HD13 HG22 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -131.54 161.92 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.147 -0.97 . . . . 0.0 110.215 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.465 ' O ' ' HG2' ' A' ' 198' ' ' ARG . 97.1 t -144.97 86.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.266 -0.897 . . . . 0.0 110.067 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.549 ' CB ' ' OG1' ' A' ' 157' ' ' THR . 53.1 t0 -55.7 124.29 16.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.305 -0.872 . . . . 0.0 110.404 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.515 ' NH2' ' HB3' ' A' ' 198' ' ' ARG . 6.5 mmm180 -107.12 80.98 1.48 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.351 -0.843 . . . . 0.0 110.19 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.489 ' C ' ' O ' ' A' ' 198' ' ' ARG . 2.7 p30 36.23 38.19 0.06 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.452 -0.78 . . . . 0.0 110.565 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 137.57 -50.47 0.82 Allowed Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 198' ' ' ARG . 1.6 t-160 -90.04 114.75 26.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.344 -1.092 . . . . 0.0 110.42 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.92 HD13 HG22 ' A' ' 153' ' ' ILE . 35.6 mt -100.98 116.93 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 110.171 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.469 HG22 ' OD2' ' A' ' 210' ' ' ASP . 6.9 m -97.1 152.57 18.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 110.364 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 1.086 HD22 ' CD2' ' A' ' 206' ' ' HIS . 0.7 OUTLIER -119.84 131.95 55.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.361 -0.837 . . . . 0.0 110.086 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.568 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 5.0 t -119.72 115.69 24.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.276 -0.89 . . . . 0.0 110.137 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 1.086 ' CD2' HD22 ' A' ' 204' ' ' LEU . 1.9 m80 -103.45 153.59 20.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.605 -0.684 . . . . 0.0 109.832 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -51.02 -19.2 0.98 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.214 -0.929 . . . . 0.0 110.094 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' A' ' 209' ' ' LYS . . . -95.86 -27.42 10.36 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 208' ' ' GLY . 1.4 ptmt 171.63 -179.36 0.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.261 -1.141 . . . . 0.0 110.281 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.469 ' OD2' HG22 ' A' ' 203' ' ' THR . 0.8 OUTLIER -124.36 149.71 46.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -0.848 . . . . 0.0 110.131 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 6.1 p -129.68 164.7 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.244 -0.91 . . . . 0.0 110.075 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -86.97 70.34 10.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.374 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.996 HD22 HD12 ' A' ' 204' ' ' LEU . 1.8 tp -63.08 163.37 10.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.975 . . . . 0.0 110.099 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.614 HD11 HD23 ' A' ' 217' ' ' LEU . 0.6 OUTLIER -130.2 145.43 51.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.911 . . . . 0.0 110.307 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.454 ' HA ' HG21 ' A' ' 153' ' ' ILE . 3.5 p30 -55.08 -37.1 66.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 110.271 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.575 ' HB2' HD12 ' A' ' 214' ' ' LEU . 0.6 OUTLIER -55.79 -50.37 70.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.193 -0.942 . . . . 0.0 110.245 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.614 HD23 HD11 ' A' ' 214' ' ' LEU . 2.2 mm? -89.41 -28.18 19.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 110.218 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.651 ' HB1' HG23 ' A' ' 153' ' ' ILE . . . -67.1 -9.28 37.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 109.969 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.8 ' O ' HG23 ' A' ' 220' ' ' THR . 2.4 t-80 -91.09 69.24 6.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.169 -0.957 . . . . 0.0 110.181 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' THR . . . . . 0.8 HG23 ' O ' ' A' ' 219' ' ' HIS . 0.6 OUTLIER -166.54 -58.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.177 -0.952 . . . . 0.0 110.4 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.675 ' N ' HD13 ' A' ' 221' ' ' ILE . 0.1 OUTLIER -65.53 136.43 26.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.304 -0.872 . . . . 0.0 110.319 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.502 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 47.1 mtt180 -95.67 116.59 29.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 110.058 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.927 HG22 HG23 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -119.78 177.37 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 110.168 -179.759 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.546 ' HB2' ' NH2' ' A' ' 164' ' ' ARG . 2.3 mt-10 -150.04 179.69 7.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.933 . . . . 0.0 110.295 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 1.5 mt-10 -90.15 69.89 7.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.384 -0.822 . . . . 0.0 110.214 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.463 ' OXT' ' O ' ' A' ' 225' ' ' GLU . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.214 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo . . . . . 0 N--CA 1.483 0.876 0 N-CA-C 110.413 -0.649 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.3 mp -113.91 112.08 47.82 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.312 -0.868 . . . . 0.0 110.149 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.65 159.42 48.77 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.035 1.545 . . . . 0.0 110.567 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 149.51 -43.57 0.76 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.59 -21.18 62.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.284 -1.127 . . . . 0.0 110.188 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.0 t70 50.97 89.48 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.282 -0.886 . . . . 0.0 110.252 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -138.38 21.42 2.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 110.194 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.692 ' N ' HD23 ' A' ' 138' ' ' LEU . 2.7 pt? . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.195 -0.941 . . . . 0.0 110.171 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 N--CA 1.482 0.817 0 N-CA-C 110.439 -0.639 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -178.95 153.17 12.03 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.53 ' HB ' ' O ' ' A' ' 223' ' ' ILE . 7.7 m -123.46 -1.82 8.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.159 -1.201 . . . . 0.0 110.216 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.507 ' CB ' ' HB2' ' A' ' 154' ' ' ASP . 2.5 mpt_? 57.21 110.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.879 . . . . 0.0 109.851 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 1.025 HG13 HD13 ' A' ' 195' ' ' ILE . 4.9 t -40.46 -68.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.358 -0.839 . . . . 0.0 110.278 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.782 HD13 ' N ' ' A' ' 153' ' ' ILE . 0.2 OUTLIER -43.8 -28.13 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.21 -0.932 . . . . 0.0 110.594 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 150' ' ' THR . 0.5 OUTLIER -81.05 -19.78 43.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.11 -0.994 . . . . 0.0 110.209 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 152' ' ' VAL . . . -100.44 -6.01 26.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.169 -0.957 . . . . 0.0 110.181 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.498 ' O ' HG22 ' A' ' 157' ' ' THR . . . -75.78 166.98 22.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.93 . . . . 0.0 110.174 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.697 HG23 ' N ' ' A' ' 158' ' ' SER . 0.4 OUTLIER 45.71 -175.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.165 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.697 ' N ' HG23 ' A' ' 157' ' ' THR . 1.7 t 69.85 -54.59 0.61 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 109.987 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' MET . . . . . 0.487 ' CB ' ' O ' ' A' ' 158' ' ' SER . 0.0 OUTLIER 169.65 59.59 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.362 -0.836 . . . . 0.0 110.129 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.545 ' O ' ' CB ' ' A' ' 161' ' ' ARG . 44.6 Cg_endo -73.2 -72.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.019 1.536 . . . . 0.0 110.414 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.545 ' CB ' ' O ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER 71.45 -66.44 0.3 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.28 -0.888 . . . . 0.0 110.255 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.609 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 4.9 tttp -162.24 120.08 2.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 0.0 110.755 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.815 HG22 ' HA ' ' A' ' 194' ' ' GLU . 31.3 m -139.89 -151.53 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.889 . . . . 0.0 110.016 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.616 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 11.1 ttp180 -179.89 155.5 0.62 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.676 -1.265 . . . . 0.0 110.556 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 1.102 HG23 ' CG2' ' A' ' 223' ' ' ILE . 0.3 OUTLIER -89.66 151.28 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.163 -0.961 . . . . 0.0 109.896 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.953 HG22 ' O ' ' A' ' 222' ' ' ARG . 20.0 m -122.48 -18.46 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.176 -0.952 . . . . 0.0 110.588 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -167.88 123.94 1.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.165 -0.96 . . . . 0.0 110.519 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.492 HG12 ' HB ' ' A' ' 221' ' ' ILE . 6.5 mt -99.83 -13.38 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.359 -0.838 . . . . 0.0 109.894 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 170' ' ' GLU . 9.8 p30 38.83 -161.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.521 -0.737 . . . . 0.0 110.39 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.529 ' O ' ' CG ' ' A' ' 170' ' ' GLU . 8.5 tt0 179.1 45.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.886 . . . . 0.0 110.278 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.428 ' C ' ' O ' ' A' ' 170' ' ' GLU . 5.3 mt -42.36 -42.32 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.144 -0.973 . . . . 0.0 110.049 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -85.16 151.32 24.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 110.041 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.661 ' O ' HG12 ' A' ' 174' ' ' VAL . 0.2 OUTLIER -127.18 -169.03 1.97 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.217 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.661 HG12 ' O ' ' A' ' 173' ' ' GLN . 9.7 p 37.42 35.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.404 -0.81 . . . . 0.0 110.514 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' A' ' 177' ' ' ASP . 1.9 tm-20 -107.71 -68.06 0.92 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.892 . . . . 0.0 110.168 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.582 HG22 ' CG2' ' A' ' 180' ' ' THR . 0.0 OUTLIER 45.17 -89.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.467 -0.77 . . . . 0.0 110.475 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 175' ' ' GLU . 0.6 OUTLIER 68.01 -170.29 0.19 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 0.0 110.101 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 11.3 tm0? -44.63 -24.01 0.16 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.217 -0.927 . . . . 0.0 110.482 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.597 ' CA ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -58.69 -34.01 70.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.185 -0.947 . . . . 0.0 110.328 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.582 ' CG2' HG22 ' A' ' 176' ' ' THR . 0.8 OUTLIER -40.31 -29.02 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 110.046 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 179' ' ' PHE . 5.9 tt0 -62.6 -34.13 76.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.385 -0.822 . . . . 0.0 110.038 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.597 HD12 ' CA ' ' A' ' 179' ' ' PHE . 1.6 mt -69.53 -45.41 68.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.346 -0.847 . . . . 0.0 109.738 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 2.0 tt -63.3 -29.32 70.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.448 -0.783 . . . . 0.0 110.051 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.58 -1.68 17.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 110.058 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.421 ' O ' HG13 ' A' ' 187' ' ' ILE . . . -103.04 11.11 37.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.888 . . . . 0.0 110.266 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 185' ' ' ALA . 0.4 OUTLIER 44.69 86.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 109.912 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.643 ' O ' ' CB ' ' A' ' 188' ' ' ARG . 16.1 mt -147.58 -79.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.216 -0.928 . . . . 0.0 110.631 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.643 ' CB ' ' O ' ' A' ' 187' ' ' ILE . 34.1 ttt-85 81.02 149.84 0.1 Allowed 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.92 ' O ' ' N ' ' A' ' 191' ' ' SER . 2.7 m 33.28 35.95 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.37 -0.831 . . . . 0.0 110.329 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.749 ' N ' HD12 ' A' ' 165' ' ' ILE . . . 30.28 17.41 0.0 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.92 ' N ' ' O ' ' A' ' 189' ' ' VAL . 9.5 t 43.37 -147.19 0.06 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.117 -1.225 . . . . 0.0 109.343 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.699 ' HG2' HD21 ' A' ' 226' ' ' LEU . 3.4 mt-10 -77.82 116.16 18.13 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.593 ' O ' ' O ' ' A' ' 163' ' ' VAL . 0.2 OUTLIER -161.66 162.98 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.117 -0.99 . . . . 0.0 109.886 -179.485 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.815 ' HA ' HG22 ' A' ' 163' ' ' VAL . 4.0 pt-20 -119.87 169.01 10.54 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 119.225 -0.99 . . . . 0.0 110.27 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 1.025 HD13 HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -123.31 142.25 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.931 . . . . 0.0 110.463 -179.483 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.474 ' O ' ' C ' ' A' ' 197' ' ' ASP . 56.5 t -133.9 98.97 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.442 -0.786 . . . . 0.0 109.878 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' A' ' 196' ' ' VAL . 1.1 t0 -38.58 106.58 0.05 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.262 -0.899 . . . . 0.0 110.484 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 200' ' ' GLY . 0.0 OUTLIER -90.55 -172.48 3.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.234 -0.916 . . . . 0.0 110.349 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -53.02 86.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 110.286 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 198' ' ' ARG . . . 65.59 18.37 65.76 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.449 ' O ' ' N ' ' A' ' 198' ' ' ARG . 0.3 OUTLIER -139.64 -176.13 4.45 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.284 -1.127 . . . . 0.0 110.123 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.706 ' CG2' HG22 ' A' ' 195' ' ' ILE . 47.6 mt -137.76 100.8 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 110.336 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.477 ' OG1' ' HG3' ' A' ' 198' ' ' ARG . 6.0 m -86.68 143.51 27.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.147 -0.971 . . . . 0.0 110.121 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.869 ' HG ' HG23 ' A' ' 195' ' ' ILE . 2.7 mp -120.89 146.23 46.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 0.0 110.148 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.518 ' O ' HG23 ' A' ' 193' ' ' VAL . 45.1 m -129.85 130.98 45.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.295 -0.878 . . . . 0.0 110.447 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.663 ' CE1' HG23 ' A' ' 211' ' ' VAL . 0.0 OUTLIER -116.13 -157.21 0.64 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.297 -0.877 . . . . 0.0 109.996 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -44.72 91.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.209 -0.932 . . . . 0.0 110.349 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 45.34 31.64 3.42 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.555 ' O ' ' CE1' ' A' ' 206' ' ' HIS . 0.4 OUTLIER -140.89 118.17 11.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -1.173 . . . . 0.0 110.328 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 2.3 p-10 -104.72 150.59 24.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 110.341 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.663 HG23 ' CE1' ' A' ' 206' ' ' HIS . 32.6 t -142.12 149.84 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.89 . . . . 0.0 110.18 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -82.5 67.25 8.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.284 -0.885 . . . . 0.0 110.297 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.863 ' CB ' HD13 ' A' ' 204' ' ' LEU . 3.4 tm? -51.54 125.56 14.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 0.0 110.056 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.786 HD11 ' HB2' ' A' ' 216' ' ' ASP . 22.1 tp -65.33 106.65 1.41 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 110.251 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.666 ' HB2' HD12 ' A' ' 202' ' ' ILE . 4.4 p30 -59.74 -41.57 91.25 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.306 -0.871 . . . . 0.0 110.358 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.786 ' HB2' HD11 ' A' ' 214' ' ' LEU . 0.3 OUTLIER -41.65 -69.66 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.316 -179.798 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.518 ' HA ' HD13 ' A' ' 217' ' ' LEU . 0.2 OUTLIER -79.58 -13.62 59.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -0.904 . . . . 0.0 110.501 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.643 ' HB3' HG21 ' A' ' 153' ' ' ILE . . . -40.44 -27.69 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.272 -0.893 . . . . 0.0 110.269 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.552 ' ND1' HG21 ' A' ' 153' ' ' ILE . 0.6 OUTLIER -72.09 67.56 0.66 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.893 . . . . 0.0 110.09 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 220' ' ' THR . . . . . 0.629 HG23 HG23 ' A' ' 221' ' ' ILE . 7.1 t -158.41 -42.31 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.973 . . . . 0.0 110.702 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.629 HG23 HG23 ' A' ' 220' ' ' THR . 0.1 OUTLIER -74.53 132.61 33.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.2 -0.938 . . . . 0.0 110.566 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.953 ' O ' HG22 ' A' ' 166' ' ' VAL . 19.3 mtm180 -89.48 110.68 21.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.23 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 1.102 ' CG2' HG23 ' A' ' 165' ' ' ILE . 0.8 OUTLIER -119.89 171.78 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 110.806 -179.092 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.477 ' O ' ' HB ' ' A' ' 163' ' ' VAL . 0.8 OUTLIER -150.2 -165.73 2.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.402 -0.811 . . . . 0.0 109.936 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.482 ' CG ' HG12 ' A' ' 163' ' ' VAL . 17.3 mt-10 -99.61 155.58 17.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 110.33 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.699 HD21 ' HG2' ' A' ' 192' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.241 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 N--CA 1.483 0.902 0 N-CA-C 110.574 -0.587 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.1 mt -100.83 118.57 60.37 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 110.359 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.28 155.48 46.46 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.917 1.483 . . . . 0.0 110.362 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -82.96 -107.34 0.48 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 28.7 tp -108.4 -36.22 6.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.118 -1.225 . . . . 0.0 110.203 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 10.2 t70 175.18 -93.98 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.408 -0.807 . . . . 0.0 110.093 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.448 ' N ' ' OD2' ' A' ' 136' ' ' ASP . 0.7 OUTLIER -73.0 62.69 0.63 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.183 -0.948 . . . . 0.0 110.26 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.413 ' HA ' HD12 ' A' ' 138' ' ' LEU . 25.7 tp . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.2 -0.938 . . . . 0.0 110.232 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo . . . . . 0 N--CA 1.484 0.919 0 N-CA-C 110.415 -0.648 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -178.22 117.5 0.58 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.624 ' O ' HD13 ' A' ' 223' ' ' ILE . 8.3 m -159.82 146.15 16.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -1.155 . . . . 0.0 110.275 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.522 ' O ' ' CD1' ' A' ' 223' ' ' ILE . 11.4 ptp180 -53.61 171.09 0.09 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.282 -0.886 . . . . 0.0 110.178 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.934 HG22 HG21 ' A' ' 195' ' ' ILE . 12.5 p -104.1 36.82 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.209 -0.932 . . . . 0.0 110.612 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.873 HG22 HD13 ' A' ' 202' ' ' ILE . 9.0 pt -135.82 -34.29 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.946 . . . . 0.0 110.078 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.92 -14.11 61.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.286 -0.884 . . . . 0.0 109.457 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -97.52 -21.15 17.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.578 -0.701 . . . . 0.0 109.896 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.511 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -73.5 90.58 1.74 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 110.17 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 157' ' ' THR . 5.2 t -91.77 179.12 5.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.929 . . . . 0.0 110.252 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.4 t -44.77 -46.68 10.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.267 -0.895 . . . . 0.0 110.027 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' MET . . . . . 0.493 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 5.5 mmt -75.56 164.81 58.32 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 110.116 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 45.1 Cg_endo -71.94 73.86 2.44 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.947 1.498 . . . . 0.0 110.327 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.403 ' O ' HG22 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -63.31 110.19 1.82 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.855 . . . . 0.0 110.234 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.403 ' C ' HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.78 138.09 48.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.407 -0.808 . . . . 0.0 110.26 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.658 HG12 ' C ' ' A' ' 224' ' ' GLU . 0.1 OUTLIER -149.98 -174.13 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.348 -0.845 . . . . 0.0 110.071 179.932 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.723 ' NH2' HG12 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -163.22 134.93 5.01 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.856 -1.153 . . . . 0.0 110.244 -179.619 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 1.049 HG23 HG23 ' A' ' 221' ' ' ILE . 0.5 OUTLIER -76.05 151.34 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.171 -0.955 . . . . 0.0 110.145 -179.415 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.723 HG12 ' NH2' ' A' ' 164' ' ' ARG . 28.9 m -149.26 15.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.305 -0.872 . . . . 0.0 109.993 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -179.12 110.37 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.354 -0.841 . . . . 0.0 110.065 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.856 HG21 ' HD3' ' A' ' 188' ' ' ARG . 0.6 OUTLIER -95.9 24.27 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 110.121 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 170' ' ' GLU . 2.2 t-20 -42.43 165.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 110.041 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 169' ' ' ASN . 0.7 OUTLIER 57.84 72.66 0.51 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.143 -0.973 . . . . 0.0 110.009 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.485 ' CD1' HG12 ' A' ' 168' ' ' ILE . 25.8 mm -88.03 -13.35 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 0.0 110.349 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.558 ' CG ' ' O ' ' A' ' 172' ' ' PHE . 1.5 p90 -47.6 123.53 5.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.217 -0.927 . . . . 0.0 110.158 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.24 177.28 6.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.167 -0.958 . . . . 0.0 110.388 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.49 ' O ' HG22 ' A' ' 174' ' ' VAL . 8.7 p -160.28 39.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 110.127 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.539 ' O ' ' CB ' ' A' ' 176' ' ' THR . 0.2 OUTLIER -127.27 -73.6 0.61 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -0.891 . . . . 0.0 110.166 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.634 ' HA ' ' CD1' ' A' ' 179' ' ' PHE . 0.3 OUTLIER 72.0 -147.39 0.06 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.474 -0.766 . . . . 0.0 110.299 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 176' ' ' THR . 0.8 OUTLIER 65.52 -150.1 0.24 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.38 -0.825 . . . . 0.0 110.413 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 177' ' ' ASP . 1.6 tp60 -38.98 -37.1 0.33 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.279 -0.888 . . . . 0.0 110.738 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.811 ' HA ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -48.0 -33.96 8.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.941 . . . . 0.0 110.057 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.543 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 1.3 p -39.33 -31.15 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.43 -0.793 . . . . 0.0 110.193 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 179' ' ' PHE . 23.5 tt0 -59.38 -36.35 75.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.309 -0.87 . . . . 0.0 109.824 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.811 HD12 ' HA ' ' A' ' 179' ' ' PHE . 1.2 mt -68.99 -46.61 67.62 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.371 -0.831 . . . . 0.0 109.733 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.615 ' O ' HD13 ' A' ' 183' ' ' LEU . 0.2 OUTLIER -68.52 -32.62 72.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.489 -0.757 . . . . 0.0 110.11 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 180' ' ' THR . 0.9 OUTLIER -73.05 -4.51 32.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.84 . . . . 0.0 109.957 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.444 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -89.17 9.48 25.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.369 -0.832 . . . . 0.0 110.165 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 185' ' ' ALA . 23.1 t0 41.98 82.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.176 -0.953 . . . . 0.0 109.766 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.7 tt -141.22 173.3 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 110.49 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.856 ' HD3' HG21 ' A' ' 168' ' ' ILE . 0.0 OUTLIER -167.13 114.29 0.79 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.747 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.743 ' CG2' ' O ' ' A' ' 189' ' ' VAL . 1.7 m 49.92 96.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 120.986 -1.071 . . . . 0.0 108.188 -178.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.563 ' N ' HG13 ' A' ' 165' ' ' ILE . . . -42.0 -16.26 0.02 OUTLIER Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 189' ' ' VAL . 9.2 t 62.82 -143.35 0.38 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.128 -1.219 . . . . 0.0 109.825 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.701 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 1.0 OUTLIER -59.54 104.36 0.27 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.512 -0.743 . . . . 0.0 109.751 179.626 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.636 HG23 ' N ' ' A' ' 194' ' ' GLU . 11.0 m -154.78 -139.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.072 -1.018 . . . . 0.0 110.182 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.7 ' O ' HD23 ' A' ' 204' ' ' LEU . 54.7 tt0 -176.32 167.17 2.84 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 109.926 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.934 HG21 HG22 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -129.45 167.46 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.114 -0.992 . . . . 0.0 110.342 -179.831 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.465 HG23 ' C ' ' A' ' 195' ' ' ILE . 71.5 t -151.36 88.62 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.364 -0.835 . . . . 0.0 110.007 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 196' ' ' VAL . 17.8 t0 -41.24 110.23 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.319 -0.863 . . . . 0.0 110.104 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.479 ' HB3' ' HB3' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -109.01 88.18 2.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.24 -0.913 . . . . 0.0 110.364 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 198' ' ' ARG . 0.5 OUTLIER 40.93 58.2 2.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 110.213 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 89.17 -28.04 7.05 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 198' ' ' ARG . 1.4 t60 -90.64 87.42 6.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -1.154 . . . . 0.0 110.182 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.873 HD13 HG22 ' A' ' 153' ' ' ILE . 66.2 mt -70.48 87.72 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.347 -0.846 . . . . 0.0 110.299 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.7 m -71.79 157.46 37.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.948 . . . . 0.0 110.007 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 1.007 HD22 ' CD2' ' A' ' 206' ' ' HIS . 0.9 OUTLIER -119.64 141.26 49.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -0.937 . . . . 0.0 110.204 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.503 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 1.6 t -119.77 115.48 23.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.869 . . . . 0.0 109.99 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 1.007 ' CD2' HD22 ' A' ' 204' ' ' LEU . 3.2 m80 -105.42 -165.78 1.15 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.314 -0.866 . . . . 0.0 109.942 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.457 ' O ' ' OD1' ' A' ' 207' ' ' ASN . 11.5 p30 -46.45 91.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.863 . . . . 0.0 110.142 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 49.43 24.92 5.74 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.518 ' O ' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -136.89 102.59 4.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.237 -1.155 . . . . 0.0 110.283 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 18.4 p30 -99.77 153.81 18.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 110.241 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 52.7 t -140.98 147.66 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.179 -0.95 . . . . 0.0 110.208 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -74.97 77.58 2.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 110.176 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.627 ' CD2' HD12 ' A' ' 204' ' ' LEU . 19.6 tp -74.6 169.51 17.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -0.951 . . . . 0.0 110.238 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.647 HD23 ' N ' ' A' ' 214' ' ' LEU . 0.5 OUTLIER -123.53 142.96 50.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.252 -0.905 . . . . 0.0 110.21 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.401 ' HA ' ' CB ' ' A' ' 218' ' ' ALA . 38.8 t0 -56.7 -44.95 82.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 110.198 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.42 -49.61 13.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 110.204 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.507 ' HB2' ' CD1' ' A' ' 214' ' ' LEU . 1.9 mp -87.21 -17.6 32.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.0 110.225 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.825 ' O ' HG12 ' A' ' 152' ' ' VAL . . . -55.01 -19.03 5.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 110.152 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.415 ' O ' ' C ' ' A' ' 220' ' ' THR . 61.4 t60 -68.96 -52.85 24.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.209 -0.932 . . . . 0.0 110.146 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' THR . . . . . 0.495 ' O ' ' C ' ' A' ' 221' ' ' ILE . 68.9 p -43.0 -78.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.197 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 1.049 HG23 HG23 ' A' ' 165' ' ' ILE . 1.6 mp -31.54 117.71 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.55 -0.719 . . . . 0.0 111.935 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 2.4 ttm-85 -100.77 103.7 14.93 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 1.0 HG22 HG23 ' A' ' 165' ' ' ILE . 0.1 OUTLIER -119.47 -179.8 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.145 -0.972 . . . . 0.0 111.262 -178.351 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.658 ' C ' HG12 ' A' ' 163' ' ' VAL . 2.5 mm-40 -150.74 168.42 24.45 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -71.97 140.91 49.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.904 . . . . 0.0 110.251 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.588 HD11 ' HG3' ' A' ' 192' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.187 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 N--CA 1.483 0.905 0 N-CA-C 110.426 -0.644 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 80.7 mt -119.06 122.6 29.49 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.237 -0.914 . . . . 0.0 110.204 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.48 -87.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.024 1.539 . . . . 0.0 110.419 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 135' ' ' LEU . . . 137.29 -6.52 3.64 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 13.5 mt 57.66 47.15 16.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -1.19 . . . . 0.0 110.184 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 137' ' ' GLU . 9.5 t70 179.48 -85.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.255 -0.903 . . . . 0.0 110.231 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER 59.89 48.79 8.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.313 -0.867 . . . . 0.0 110.224 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.314 -0.866 . . . . 0.0 110.208 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 N--CA 1.483 0.898 0 N-CA-C 110.403 -0.653 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.549 ' CA ' ' HG2' ' A' ' 222' ' ' ARG . . . 167.34 132.31 1.38 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.569 ' O ' HG22 ' A' ' 150' ' ' THR . 56.6 m -136.85 4.5 2.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -1.166 . . . . 0.0 110.197 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.536 ' HB2' ' HB2' ' A' ' 154' ' ' ASP . 0.3 OUTLIER 59.53 127.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 0.0 110.049 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.969 ' HB ' HG21 ' A' ' 223' ' ' ILE . 2.1 p -77.72 12.52 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.252 -0.905 . . . . 0.0 110.79 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 1.054 ' CG2' ' HB1' ' A' ' 218' ' ' ALA . 18.2 pt -124.58 -24.6 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.011 -1.055 . . . . 0.0 110.421 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.536 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 0.6 OUTLIER -71.53 -21.59 61.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.131 -0.981 . . . . 0.0 109.259 179.414 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.81 -16.85 29.3 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.605 -0.684 . . . . 0.0 109.805 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.813 ' HB2' ' CD1' ' A' ' 195' ' ' ILE . . . -64.03 92.55 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.836 . . . . 0.0 110.203 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.581 HG23 ' OG ' ' A' ' 158' ' ' SER . 6.4 t -177.36 171.7 1.95 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.937 . . . . 0.0 110.343 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.581 ' OG ' HG23 ' A' ' 157' ' ' THR . 3.7 p 42.35 73.1 0.14 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.345 -0.847 . . . . 0.0 110.118 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' MET . . . . . 0.523 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 1.6 mtp 68.62 167.45 0.12 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.281 -0.887 . . . . 0.0 110.117 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.523 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 45.7 Cg_endo -72.51 101.81 1.32 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.014 1.534 . . . . 0.0 110.381 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.594 ' O ' HG13 ' A' ' 163' ' ' VAL . 0.4 OUTLIER -85.41 120.14 26.54 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.291 -0.881 . . . . 0.0 110.207 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.566 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 13.7 mtmt -62.24 87.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 110.205 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.87 HG22 ' HA ' ' A' ' 194' ' ' GLU . 33.8 m -91.96 -166.36 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 110.352 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.669 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -172.61 136.74 0.76 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.841 -1.162 . . . . 0.0 110.41 -179.744 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 1.065 HG23 ' CG2' ' A' ' 223' ' ' ILE . 1.1 mt -93.6 162.36 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.374 -0.829 . . . . 0.0 110.544 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 222' ' ' ARG . 6.6 m -136.74 -32.62 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 110.736 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.576 ' CG ' ' HB2' ' A' ' 222' ' ' ARG . 6.3 pt20 -147.04 119.46 8.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.073 -1.017 . . . . 0.0 110.652 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.938 HG13 HG22 ' A' ' 221' ' ' ILE . 11.6 tt -110.76 17.82 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 0.0 109.869 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 168' ' ' ILE . 67.0 m-20 -37.84 105.52 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.466 -0.771 . . . . 0.0 110.606 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.441 ' CD ' ' HB2' ' A' ' 172' ' ' PHE . 0.4 OUTLIER -131.02 107.33 9.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 109.954 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 2.0 pp -81.49 11.33 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -0.889 . . . . 0.0 110.525 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.441 ' HB2' ' CD ' ' A' ' 170' ' ' GLU . 1.1 m-85 -64.7 176.37 1.18 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 0.0 110.18 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -77.29 -165.35 0.57 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.276 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.442 ' O ' HG22 ' A' ' 174' ' ' VAL . 10.0 p -117.92 32.37 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -0.89 . . . . 0.0 110.212 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' A' ' 176' ' ' THR . 4.6 tp10 -64.13 -143.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.293 -0.88 . . . . 0.0 110.301 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.566 ' OG1' ' CD1' ' A' ' 179' ' ' PHE . 75.2 p 42.64 92.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.281 -0.887 . . . . 0.0 110.139 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.408 ' HA ' ' OG1' ' A' ' 180' ' ' THR . 0.8 OUTLIER -62.53 -31.25 71.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 110.209 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -72.32 -25.21 61.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.862 . . . . 0.0 110.289 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.998 ' CE2' HD13 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -85.49 -29.1 24.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.237 -0.914 . . . . 0.0 110.072 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.551 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -58.81 -16.99 19.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.179 -0.951 . . . . 0.0 109.73 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.21 -60.19 2.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.346 -0.846 . . . . 0.0 110.254 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.76 ' C ' HD12 ' A' ' 182' ' ' LEU . 4.4 pp -64.59 -10.53 26.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.88 . . . . 0.0 110.133 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.998 HD13 ' CE2' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -92.57 -32.4 14.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 109.916 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -67.93 -7.27 27.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 0.0 109.883 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -83.54 13.79 4.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.343 -0.848 . . . . 0.0 110.23 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 185' ' ' ALA . 8.9 m-20 42.98 62.98 1.62 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.211 -0.931 . . . . 0.0 110.007 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.3 tt -118.5 -174.57 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.331 -0.856 . . . . 0.0 110.348 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.706 ' C ' HG13 ' A' ' 189' ' ' VAL . 0.4 OUTLIER -171.41 112.08 0.34 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.346 -0.846 . . . . 0.0 108.908 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.706 HG13 ' C ' ' A' ' 188' ' ' ARG . 1.1 m 51.35 109.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.381 -0.824 . . . . 0.0 109.202 -178.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.856 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -44.19 -15.68 0.05 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.594 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 3.3 t 68.3 -145.06 0.12 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.179 -1.189 . . . . 0.0 109.534 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.669 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 3.8 mm-40 -66.39 102.93 0.93 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.496 -0.752 . . . . 0.0 109.331 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.619 ' O ' ' O ' ' A' ' 163' ' ' VAL . 20.6 m -156.46 -140.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 110.323 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.87 ' HA ' HG22 ' A' ' 163' ' ' VAL . 3.1 pt-20 -177.3 139.77 0.27 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.334 -0.854 . . . . 0.0 110.029 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.958 HG21 HG22 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -130.39 161.19 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.104 -0.998 . . . . 0.0 110.452 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.543 ' N ' HG12 ' A' ' 195' ' ' ILE . 18.2 t -129.71 130.66 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.46 -0.775 . . . . 0.0 110.012 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.479 ' HA ' HG12 ' A' ' 202' ' ' ILE . 7.1 t70 -83.5 137.62 33.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -0.941 . . . . 0.0 110.321 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -130.23 71.34 1.45 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.28 -0.888 . . . . 0.0 110.201 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 198' ' ' ARG . 47.5 t0 42.73 71.39 0.23 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 110.149 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 88.84 -35.81 3.58 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.501 ' O ' ' N ' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -89.87 108.29 19.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.263 -1.139 . . . . 0.0 110.195 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.479 HG12 ' HA ' ' A' ' 197' ' ' ASP . 7.8 mt -112.82 138.63 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 110.296 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.549 ' O ' HG12 ' A' ' 195' ' ' ILE . 31.4 m -126.74 146.06 50.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.346 -0.846 . . . . 0.0 109.832 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.756 HD22 ' CD2' ' A' ' 206' ' ' HIS . 0.2 OUTLIER -119.48 133.16 55.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.086 -1.008 . . . . 0.0 110.387 -179.796 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.592 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 1.2 m -119.96 124.12 45.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.412 -0.805 . . . . 0.0 109.768 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.756 ' CD2' HD22 ' A' ' 204' ' ' LEU . 2.5 m170 -107.83 100.1 9.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.413 -0.805 . . . . 0.0 110.207 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 207' ' ' ASN . 1.2 p-10 39.02 29.77 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.352 -0.843 . . . . 0.0 110.78 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 123.6 -33.3 3.99 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.585 ' O ' ' CG ' ' A' ' 206' ' ' HIS . 3.6 mmtt -91.86 110.69 22.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.225 -1.162 . . . . 0.0 109.972 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.532 ' HA ' ' O ' ' A' ' 204' ' ' LEU . 4.1 p30 -109.23 169.7 8.52 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.118 -0.989 . . . . 0.0 110.484 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 210' ' ' ASP . 37.8 t -151.41 146.24 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.326 -0.859 . . . . 0.0 110.128 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 213' ' ' LEU . 2.3 tt0 -75.25 72.61 2.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.285 -0.884 . . . . 0.0 110.221 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.449 HD22 HD12 ' A' ' 204' ' ' LEU . 1.1 mp -55.19 -165.86 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.891 . . . . 0.0 110.23 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.714 HD12 ' HB3' ' A' ' 216' ' ' ASP . 0.5 OUTLIER -157.93 136.95 11.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 110.188 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 214' ' ' LEU . 21.7 t0 -41.88 -48.14 4.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -0.901 . . . . 0.0 110.428 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.714 ' HB3' HD12 ' A' ' 214' ' ' LEU . 7.4 t0 -47.84 -52.05 20.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.181 -0.95 . . . . 0.0 110.336 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.734 ' O ' HG23 ' A' ' 221' ' ' ILE . 0.4 OUTLIER -88.46 -32.29 18.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.272 -0.892 . . . . 0.0 110.297 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 1.054 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -62.99 -26.75 69.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.03 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.628 ' CG ' HD11 ' A' ' 153' ' ' ILE . 1.1 t60 -99.1 29.88 3.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.935 . . . . 0.0 110.11 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 50.6 m -138.41 -33.47 0.67 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.257 -0.902 . . . . 0.0 110.451 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.938 HG22 HG13 ' A' ' 168' ' ' ILE . 0.2 OUTLIER -67.35 140.21 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 110.445 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.576 ' HB2' ' CG ' ' A' ' 167' ' ' GLN . 1.4 mtt180 -91.94 113.5 25.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 109.383 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 1.065 ' CG2' HG23 ' A' ' 165' ' ' ILE . 0.7 OUTLIER -127.12 -169.26 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.126 -0.983 . . . . 0.0 110.954 -179.126 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.443 ' HG3' ' N ' ' A' ' 225' ' ' GLU . 3.0 tp10 -148.85 156.92 43.0 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.468 -0.77 . . . . 0.0 109.98 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 1.1 tt0 -104.95 122.68 46.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.296 -0.878 . . . . 0.0 110.221 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.1 tp . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.222 179.935 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo . . . . . 0 N--CA 1.484 0.918 0 N-CA-C 110.473 -0.626 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.401 ' HA ' ' HD2' ' A' ' 133' ' ' PRO . 2.1 mt -136.54 106.52 9.18 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.889 . . . . 0.0 110.255 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 132' ' ' ILE . 46.4 Cg_endo -73.23 -0.98 9.91 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.999 1.526 . . . . 0.0 110.461 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -85.43 -170.91 47.67 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.25 -35.03 0.18 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -1.117 . . . . 0.0 110.305 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.45 124.98 36.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 110.312 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -138.2 49.66 1.92 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -0.905 . . . . 0.0 110.197 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 26.6 tp . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 110.322 -179.903 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo . . . . . 0 N--CA 1.483 0.898 0 N-CA-C 110.464 -0.629 . . . . 0.0 110.464 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 145.52 92.68 0.13 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.487 ' O ' ' O ' ' A' ' 151' ' ' ARG . 91.0 m -81.22 -20.91 40.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -1.152 . . . . 0.0 110.202 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.512 ' O ' ' O ' ' A' ' 152' ' ' VAL . 11.4 mtt85 59.92 132.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.34 -0.85 . . . . 0.0 110.043 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.775 HG12 ' H ' ' A' ' 153' ' ' ILE . 37.6 t -51.35 -174.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.239 -0.913 . . . . 0.0 109.369 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.799 HG21 ' HB3' ' A' ' 218' ' ' ALA . 1.0 OUTLIER 52.44 15.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.143 -0.973 . . . . 0.0 110.209 -179.589 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 151' ' ' ARG . 1.2 t0 -130.4 -31.21 1.85 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.357 -0.839 . . . . 0.0 109.419 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.67 ' CB ' HG11 ' A' ' 163' ' ' VAL . . . -84.64 -18.85 34.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.514 -0.741 . . . . 0.0 109.814 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.34 136.02 56.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.343 -0.848 . . . . 0.0 110.039 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 157' ' ' THR . 7.9 m -160.88 87.16 0.73 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.112 -0.992 . . . . 0.0 110.359 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 157' ' ' THR . 2.1 t 70.11 -53.17 0.63 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.305 -0.872 . . . . 0.0 110.058 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' MET . . . . . 0.455 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 59.0 mtp -108.98 168.01 8.33 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 121.327 -0.858 . . . . 0.0 110.056 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.488 ' HB2' ' OE2' ' A' ' 194' ' ' GLU . 46.2 Cg_endo -72.63 65.86 3.83 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.952 1.501 . . . . 0.0 110.427 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -44.0 109.66 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 110.234 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.496 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 5.6 tttm -58.1 132.15 52.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.905 . . . . 0.0 110.255 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.67 HG11 ' CB ' ' A' ' 155' ' ' ALA . 16.0 m -150.24 -159.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 110.498 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.64 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.1 OUTLIER -173.81 150.86 1.73 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.936 -1.103 . . . . 0.0 110.347 -179.633 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.993 HG23 HG22 ' A' ' 223' ' ' ILE . 2.0 mm -88.92 148.42 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.34 -0.85 . . . . 0.0 110.297 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.757 HG22 ' O ' ' A' ' 222' ' ' ARG . 22.6 m -136.47 5.34 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.888 . . . . 0.0 109.814 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.513 ' HB3' ' HB3' ' A' ' 222' ' ' ARG . 1.7 tm0? -171.77 121.17 0.48 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.898 . . . . 0.0 109.867 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.539 ' HB ' ' CG1' ' A' ' 189' ' ' VAL . 0.3 OUTLIER -93.74 -2.31 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.0 110.33 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 49.78 -137.07 1.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.168 -0.958 . . . . 0.0 110.022 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -117.87 108.23 15.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.956 . . . . 0.0 110.198 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 172' ' ' PHE . 1.0 OUTLIER -60.49 -13.84 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.164 -0.96 . . . . 0.0 110.105 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.439 ' N ' HG13 ' A' ' 171' ' ' ILE . 0.5 OUTLIER -75.69 82.93 2.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 110.127 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -110.58 -89.63 0.49 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 110.198 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.737 HG12 ' N ' ' A' ' 175' ' ' GLU . 37.5 t -128.47 -91.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.906 . . . . 0.0 110.233 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.737 ' N ' HG12 ' A' ' 174' ' ' VAL . 2.8 mt-10 -94.1 -172.14 2.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 0.0 110.198 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' THR . . . . . 1.058 HG23 ' CD2' ' A' ' 179' ' ' PHE . 20.0 m -136.04 -65.36 0.58 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.287 -0.883 . . . . 0.0 110.217 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 176' ' ' THR . 5.6 m-20 70.57 -153.43 0.11 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.455 -0.778 . . . . 0.0 110.359 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' A' ' 181' ' ' GLN . 18.6 tt0 -45.42 -25.68 0.45 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.278 -0.889 . . . . 0.0 110.607 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 1.058 ' CD2' HG23 ' A' ' 176' ' ' THR . 0.3 OUTLIER -42.39 -54.64 3.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.208 -0.932 . . . . 0.0 110.026 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 180' ' ' THR . . . . . 1.034 HG23 HG21 ' A' ' 176' ' ' THR . 0.0 OUTLIER -47.84 -23.42 0.74 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.054 -1.029 . . . . 0.0 109.836 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 178' ' ' GLN . 34.5 tt0 -71.98 -62.0 1.58 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 110.199 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.656 ' C ' HD12 ' A' ' 182' ' ' LEU . 4.6 pp -65.33 -9.3 23.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.346 -0.846 . . . . 0.0 109.892 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.903 ' O ' HD13 ' A' ' 183' ' ' LEU . 3.4 tm? -92.25 -31.67 15.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.876 . . . . 0.0 109.851 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -70.25 -5.81 30.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.42 -0.8 . . . . 0.0 110.008 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -88.11 29.35 0.95 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -0.906 . . . . 0.0 110.235 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 186' ' ' ASP . 1.8 m-20 52.48 36.23 19.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.214 -0.929 . . . . 0.0 110.208 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 16.3 mm -93.47 156.6 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 110.185 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.609 ' C ' HG22 ' A' ' 189' ' ' VAL . 2.5 ptm180 -170.83 130.32 0.81 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.863 ' O ' ' N ' ' A' ' 191' ' ' SER . 34.3 m 33.75 69.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.212 -0.93 . . . . 0.0 109.008 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 189' ' ' VAL . . . -20.93 -32.2 0.0 OUTLIER Glycine 0 N--CA 1.498 2.785 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.863 ' N ' ' O ' ' A' ' 189' ' ' VAL . 3.4 t 70.86 -143.54 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -1.142 . . . . 0.0 109.831 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.64 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.8 OUTLIER -61.36 102.48 0.23 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.416 -0.803 . . . . 0.0 109.796 179.741 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.74 ' CG2' HD21 ' A' ' 204' ' ' LEU . 20.3 m -156.32 -142.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.126 -0.984 . . . . 0.0 110.246 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.626 ' HA ' HG22 ' A' ' 163' ' ' VAL . 21.6 tt0 -175.95 161.21 2.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 110.218 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.753 HD13 HG13 ' A' ' 152' ' ' VAL . 0.7 OUTLIER -123.48 172.15 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.128 -0.983 . . . . 0.0 110.279 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.759 HG13 ' O ' ' A' ' 196' ' ' VAL . 14.8 p -146.59 102.13 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 110.158 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 197' ' ' ASP . 5.1 p-10 -42.35 113.94 0.51 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.266 -0.896 . . . . 0.0 110.193 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -100.55 160.6 14.22 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.252 -0.905 . . . . 0.0 110.304 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -55.73 91.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.253 -0.904 . . . . 0.0 110.064 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 198' ' ' ARG . . . 76.76 12.4 84.53 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.462 ' O ' ' N ' ' A' ' 198' ' ' ARG . 0.0 OUTLIER -150.13 179.88 7.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.169 -1.195 . . . . 0.0 110.179 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.542 HD12 ' CG ' ' A' ' 215' ' ' ASP . 42.5 mt -144.79 133.68 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.921 . . . . 0.0 110.308 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.53 ' HB ' HG12 ' A' ' 196' ' ' VAL . 0.2 OUTLIER -113.83 152.86 30.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 110.026 179.794 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.778 HD22 ' CE1' ' A' ' 206' ' ' HIS . 1.1 tt -119.72 137.25 54.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 110.294 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.539 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 3.0 t -119.78 128.14 53.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.356 -0.84 . . . . 0.0 109.865 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.778 ' CE1' HD22 ' A' ' 204' ' ' LEU . 3.1 m-70 -112.72 125.68 54.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.387 -0.82 . . . . 0.0 110.013 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 206' ' ' HIS . 14.1 t30 42.82 -93.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.216 -0.927 . . . . 0.0 110.224 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -126.28 19.1 6.42 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.13 129.27 39.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -1.138 . . . . 0.0 110.258 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 7.9 t70 -117.94 156.78 27.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.296 -0.878 . . . . 0.0 110.22 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.421 ' N ' ' OD1' ' A' ' 210' ' ' ASP . 5.5 p -149.43 162.23 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.251 -0.905 . . . . 0.0 110.201 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -65.01 156.4 31.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 110.126 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.574 HD13 HD12 ' A' ' 204' ' ' LEU . 0.7 OUTLIER -156.48 88.76 1.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.232 -0.917 . . . . 0.0 110.202 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.713 ' O ' ' HB2' ' A' ' 218' ' ' ALA . 14.5 tp -41.34 113.74 0.43 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.235 -0.916 . . . . 0.0 110.244 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.542 ' CG ' HD12 ' A' ' 202' ' ' ILE . 8.2 t0 -60.18 -43.17 96.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.325 -0.859 . . . . 0.0 110.428 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 215' ' ' ASP . 55.9 t0 -43.07 -67.37 0.28 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.131 -0.981 . . . . 0.0 110.177 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.527 ' HB2' HD23 ' A' ' 214' ' ' LEU . 0.5 OUTLIER -82.28 -13.54 56.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.259 -0.901 . . . . 0.0 110.531 -179.831 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.799 ' HB3' HG21 ' A' ' 153' ' ' ILE . . . -45.01 -26.43 0.43 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.148 -0.97 . . . . 0.0 110.1 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.767 ' CG ' HD11 ' A' ' 153' ' ' ILE . 0.7 OUTLIER -78.95 64.63 3.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.268 -0.895 . . . . 0.0 110.182 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 220' ' ' THR . . . . . 0.472 HG23 HG23 ' A' ' 221' ' ' ILE . 0.5 OUTLIER -129.25 -22.89 3.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -0.973 . . . . 0.0 110.467 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.75 HD13 ' H ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -99.78 145.95 9.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.09 -1.006 . . . . 0.0 110.57 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.757 ' O ' HG22 ' A' ' 166' ' ' VAL . 0.3 OUTLIER -88.81 96.35 10.65 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.323 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.993 HG22 HG23 ' A' ' 165' ' ' ILE . 0.5 OUTLIER -119.64 173.16 5.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.304 -0.873 . . . . 0.0 111.419 -177.492 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.485 ' HG3' ' OG1' ' A' ' 150' ' ' THR . 0.6 OUTLIER -145.9 -172.87 4.01 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.5 -0.75 . . . . 0.0 110.181 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 8.4 tt0 -112.08 127.14 55.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.377 -0.827 . . . . 0.0 110.201 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.231 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 N--CA 1.483 0.904 0 N-CA-C 110.465 -0.629 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 28.2 mm -72.96 124.07 90.3 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 110.218 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.11 96.02 0.86 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.917 1.483 . . . . 0.0 110.431 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -178.31 85.72 0.07 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -166.66 95.97 0.54 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.326 -1.102 . . . . 0.0 110.144 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -88.88 60.21 5.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 0.0 110.21 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 40.4 mt-10 63.08 -71.17 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.0 110.4 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 136' ' ' ASP . 14.8 tp . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.319 -0.863 . . . . 0.0 110.238 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo . . . . . 0 N--CA 1.484 0.915 0 N-CA-C 110.694 -0.541 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.58 ' O ' ' HB ' ' A' ' 150' ' ' THR . . . 95.23 -74.26 0.91 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.58 ' HB ' ' O ' ' A' ' 149' ' ' GLY . 22.2 m 65.89 -121.54 0.34 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.345 -1.091 . . . . 0.0 109.889 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.529 ' CD ' ' O ' ' A' ' 150' ' ' THR . 1.5 mmt180 -143.41 157.62 44.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.961 -1.087 . . . . 0.0 109.989 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.877 HG22 HD13 ' A' ' 195' ' ' ILE . 0.6 OUTLIER -69.3 -3.94 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.157 -0.964 . . . . 0.0 110.479 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.884 ' CG2' ' HB1' ' A' ' 218' ' ' ALA . 1.6 pp -117.65 -30.9 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.098 -1.001 . . . . 0.0 110.335 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.52 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -74.88 -13.25 60.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -0.967 . . . . 0.0 109.214 179.346 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -113.04 -7.34 13.68 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.562 -0.711 . . . . 0.0 109.72 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 1.023 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -85.0 177.21 8.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.335 -0.853 . . . . 0.0 110.194 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.527 ' O ' ' CB ' ' A' ' 158' ' ' SER . 0.4 OUTLIER 56.88 153.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.347 -0.846 . . . . 0.0 110.185 179.839 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 157' ' ' THR . 0.7 OUTLIER 70.69 -51.5 0.67 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.181 -0.95 . . . . 0.0 110.157 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 159' ' ' MET . . . . . 0.454 ' N ' ' CD ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER -161.86 55.3 0.57 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.851 . . . . 0.0 109.883 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.582 ' HB3' ' HA ' ' A' ' 156' ' ' ALA . 43.6 Cg_endo -72.66 -67.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.092 1.575 . . . . 0.0 110.565 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.415 ' CB ' ' O ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER 64.23 -153.97 0.3 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.908 . . . . 0.0 110.228 179.833 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.467 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -86.92 90.37 8.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.21 -0.931 . . . . 0.0 110.553 -179.775 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.598 HG23 ' HA ' ' A' ' 194' ' ' GLU . 0.1 OUTLIER -92.46 -169.44 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.226 -0.921 . . . . 0.0 109.909 179.542 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.716 ' HD3' HG12 ' A' ' 166' ' ' VAL . 0.3 OUTLIER -167.07 137.96 3.13 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.712 -1.243 . . . . 0.0 110.286 -179.578 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 1.018 HG23 HG22 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -85.37 133.46 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.318 -0.864 . . . . 0.0 110.284 -179.59 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.716 HG12 ' HD3' ' A' ' 164' ' ' ARG . 15.5 m -119.92 -23.09 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.235 -0.916 . . . . 0.0 110.7 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -148.97 125.6 11.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.032 -1.043 . . . . 0.0 110.531 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 221' ' ' ILE . 5.1 tt -108.62 6.78 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.348 -0.845 . . . . 0.0 110.03 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 168' ' ' ILE . 3.0 t-20 -43.35 98.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.348 -0.845 . . . . 0.0 110.347 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.502 ' CG ' ' HB2' ' A' ' 172' ' ' PHE . 1.0 OUTLIER -157.9 116.06 3.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -0.929 . . . . 0.0 110.185 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 172' ' ' PHE . 1.6 pp -83.26 10.33 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.341 -0.85 . . . . 0.0 110.196 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.502 ' HB2' ' CG ' ' A' ' 170' ' ' GLU . 0.1 OUTLIER -60.09 -148.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.285 -0.885 . . . . 0.0 110.147 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.461 ' OE1' HD21 ' A' ' 217' ' ' LEU . 11.7 tt0 53.86 174.37 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 110.07 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 173' ' ' GLN . 1.6 p 175.44 -26.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 110.249 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' A' ' 176' ' ' THR . 0.0 OUTLIER -172.58 129.54 0.54 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.908 . . . . 0.0 110.329 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 176' ' ' THR . 1.7 t 177.36 99.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.337 -0.852 . . . . 0.0 110.172 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.55 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.5 OUTLIER -75.8 -28.25 58.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.291 -0.88 . . . . 0.0 110.307 -179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -17.51 64.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.105 -0.997 . . . . 0.0 109.972 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 1.052 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -90.28 -39.39 12.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 110.683 -179.827 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.55 ' OG1' ' O ' ' A' ' 177' ' ' ASP . 0.2 OUTLIER -41.19 -26.09 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.13 -0.981 . . . . 0.0 110.05 -179.568 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.499 ' N ' ' O ' ' A' ' 179' ' ' PHE . 6.6 tm0? -53.4 -45.09 69.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.183 -0.948 . . . . 0.0 109.515 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 1.052 HD12 ' O ' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -69.84 -34.76 74.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.403 -0.811 . . . . 0.0 108.973 179.083 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.672 ' O ' HD13 ' A' ' 183' ' ' LEU . 0.2 OUTLIER -66.05 -33.73 76.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.592 -0.692 . . . . 0.0 109.786 179.609 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -57.87 -16.16 10.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.409 -0.807 . . . . 0.0 109.87 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -92.83 12.61 23.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.438 -0.789 . . . . 0.0 110.252 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 185' ' ' ALA . 22.0 t70 43.8 85.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.732 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.2 tt -135.56 177.1 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 110.824 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.606 ' C ' HG13 ' A' ' 189' ' ' VAL . 4.2 ttp180 -174.64 114.41 0.17 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.719 ' CG2' ' O ' ' A' ' 189' ' ' VAL . 1.1 m 46.66 98.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.174 -0.954 . . . . 0.0 108.546 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.684 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -40.44 -18.19 0.01 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.627 ' N ' ' O ' ' A' ' 189' ' ' VAL . 5.7 t 64.65 -141.95 0.25 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.037 -1.272 . . . . 0.0 109.213 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.604 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 4.9 pm0 -61.57 99.69 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.507 -0.746 . . . . 0.0 109.3 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.661 HG21 HD21 ' A' ' 204' ' ' LEU . 13.1 m -155.07 -139.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.083 -1.01 . . . . 0.0 109.98 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.622 ' N ' HG23 ' A' ' 193' ' ' VAL . 3.4 pt-20 -173.26 158.69 3.65 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.3 -0.875 . . . . 0.0 110.564 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 1.023 HD12 ' HB2' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -131.09 162.97 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.28 -0.888 . . . . 0.0 110.275 -179.719 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 195' ' ' ILE . 77.7 t -157.28 100.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.249 -0.907 . . . . 0.0 110.12 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.524 ' CB ' ' OG1' ' A' ' 157' ' ' THR . 16.1 t0 -42.91 109.64 0.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.903 . . . . 0.0 110.258 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.521 ' CB ' ' O ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -97.11 81.17 3.02 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.307 -0.871 . . . . 0.0 110.129 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 49.3 57.73 6.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 110.101 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 89.26 -25.96 9.66 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.521 ' O ' ' CB ' ' A' ' 198' ' ' ARG . 2.7 t60 -98.72 95.0 6.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -1.143 . . . . 0.0 110.163 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.873 HD13 HG22 ' A' ' 153' ' ' ILE . 83.8 mt -64.56 115.85 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.341 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 195' ' ' ILE . 28.8 m -94.48 147.19 23.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.151 -0.968 . . . . 0.0 110.065 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.968 ' HB2' HD12 ' A' ' 213' ' ' LEU . 1.2 tt -119.71 129.34 54.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.227 -0.92 . . . . 0.0 110.128 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.561 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.0 OUTLIER -120.02 122.84 42.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.296 -0.877 . . . . 0.0 110.015 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.75 ' ND1' HD22 ' A' ' 204' ' ' LEU . 1.6 m-70 -106.91 154.5 20.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.534 -0.729 . . . . 0.0 109.89 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -50.66 -19.83 1.04 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.947 . . . . 0.0 109.955 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.457 ' O ' ' HD3' ' A' ' 209' ' ' LYS . . . -87.38 -32.76 12.88 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' A' ' 208' ' ' GLY . 0.0 OUTLIER 176.77 -152.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.159 -1.2 . . . . 0.0 110.29 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 204' ' ' LEU . 36.7 t70 -137.73 156.29 48.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.324 -0.86 . . . . 0.0 110.174 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.511 HG22 ' N ' ' A' ' 212' ' ' GLU . 7.6 p -149.92 173.39 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.218 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.511 ' N ' HG22 ' A' ' 211' ' ' VAL . 13.2 pt-20 -91.33 162.32 14.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 110.337 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.968 HD12 ' HB2' ' A' ' 204' ' ' LEU . 0.3 OUTLIER -147.88 153.21 38.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 110.177 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.726 HD12 ' HB3' ' A' ' 216' ' ' ASP . 0.4 OUTLIER -120.08 129.52 54.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.263 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.527 ' HA ' ' HB3' ' A' ' 218' ' ' ALA . 1.5 m-20 -43.31 -29.33 0.4 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 110.195 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.726 ' HB3' HD12 ' A' ' 214' ' ' LEU . 5.9 t0 -56.06 -59.17 5.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 110.119 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.62 ' CD2' ' CD1' ' A' ' 179' ' ' PHE . 1.0 OUTLIER -90.12 -24.68 21.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 110.314 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.884 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -52.19 -42.47 63.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.194 -0.941 . . . . 0.0 110.158 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.565 ' CG ' ' O ' ' A' ' 219' ' ' HIS . 69.2 t60 -84.03 58.84 4.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.893 . . . . 0.0 110.194 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 217' ' ' LEU . 30.6 p -145.02 -31.63 0.41 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 110.621 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.798 HG13 HD13 ' A' ' 165' ' ' ILE . 0.1 OUTLIER -90.97 141.05 14.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.175 -0.953 . . . . 0.0 110.456 -179.799 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.485 ' HG2' ' HA3' ' A' ' 149' ' ' GLY . 0.0 OUTLIER -92.6 111.33 22.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.379 -0.826 . . . . 0.0 109.793 179.778 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 1.018 HG22 HG23 ' A' ' 165' ' ' ILE . 0.1 OUTLIER -121.23 166.22 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.167 -0.958 . . . . 0.0 110.108 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.554 ' C ' HG12 ' A' ' 163' ' ' VAL . 1.2 tt0 -137.08 161.38 36.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.121 -0.987 . . . . 0.0 110.553 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 22.1 mm-40 -72.26 137.18 46.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.422 -0.799 . . . . 0.0 110.222 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.213 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 N--CA 1.483 0.89 0 N-CA-C 110.31 -0.688 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.711 HG23 ' O ' ' A' ' 132' ' ' ILE . 16.9 tt -163.51 107.34 0.97 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.29 -0.881 . . . . 0.0 110.124 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.44 -26.62 16.82 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.009 1.531 . . . . 0.0 110.423 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.28 58.1 1.53 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.45 -76.71 0.55 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -1.153 . . . . 0.0 110.271 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.48 ' OD2' HD12 ' A' ' 138' ' ' LEU . 40.0 p-10 -87.06 33.98 0.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.347 -0.846 . . . . 0.0 110.323 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 136' ' ' ASP . 0.0 OUTLIER 42.87 54.03 4.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.912 . . . . 0.0 110.131 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.65 HD23 ' O ' ' A' ' 138' ' ' LEU . 1.6 tt . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 0.0 110.237 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 N--CA 1.484 0.964 0 N-CA-C 110.441 -0.638 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -170.91 167.79 40.94 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.743 ' O ' HD13 ' A' ' 223' ' ' ILE . 8.1 m -144.72 100.59 3.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -1.158 . . . . 0.0 109.978 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.721 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -37.09 150.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.873 . . . . 0.0 110.555 -179.8 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 1.064 HG23 HG23 ' A' ' 153' ' ' ILE . 17.7 m -54.88 -150.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.229 -0.919 . . . . 0.0 110.379 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 1.134 ' CG2' ' HB1' ' A' ' 218' ' ' ALA . 11.2 pt 40.22 27.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.23 -0.919 . . . . 0.0 110.042 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -144.0 -37.32 0.33 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.522 -0.736 . . . . 0.0 109.383 179.639 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.524 ' HB3' HG11 ' A' ' 163' ' ' VAL . . . -98.27 -9.67 25.16 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.541 -0.724 . . . . 0.0 109.741 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.414 ' O ' ' HB ' ' A' ' 157' ' ' THR . . . -74.05 175.37 7.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.328 -0.857 . . . . 0.0 110.201 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.617 HG22 ' HB2' ' A' ' 161' ' ' ARG . 5.7 t -177.09 178.41 1.13 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.258 -0.901 . . . . 0.0 110.127 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 157' ' ' THR . 21.1 t -42.83 -61.1 1.35 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.901 . . . . 0.0 110.131 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' MET . . . . . 0.547 ' HG2' HG23 ' A' ' 157' ' ' THR . 0.0 OUTLIER -71.01 165.01 51.69 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.898 . . . . 0.0 110.034 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.49 ' HB2' ' OE2' ' A' ' 194' ' ' GLU . 45.7 Cg_endo -72.6 66.99 3.78 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.944 1.497 . . . . 0.0 110.353 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.617 ' HB2' HG22 ' A' ' 157' ' ' THR . 0.0 OUTLIER -47.86 125.64 9.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.254 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.48 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 1.2 tttp -77.3 100.37 5.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -0.909 . . . . 0.0 110.274 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.958 HG12 ' O ' ' A' ' 224' ' ' GLU . 0.1 OUTLIER -117.41 -164.01 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 0.0 110.301 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.69 ' O ' ' HB ' ' A' ' 223' ' ' ILE . 23.7 ttt180 -172.33 157.82 4.22 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.911 -1.118 . . . . 0.0 110.265 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.946 HG23 HG22 ' A' ' 223' ' ' ILE . 0.8 OUTLIER -110.49 151.36 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.651 -179.359 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.0 m -133.04 -5.05 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.299 -0.876 . . . . 0.0 110.775 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -174.06 131.13 0.4 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.914 -1.116 . . . . 0.0 110.96 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.881 ' CD1' HG22 ' A' ' 221' ' ' ILE . 9.0 tt -126.23 10.03 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.451 -0.781 . . . . 0.0 109.598 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.459 ' O ' ' HB3' ' A' ' 170' ' ' GLU . 1.5 t-20 -56.09 83.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.373 -0.829 . . . . 0.0 110.356 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.519 ' O ' ' C ' ' A' ' 171' ' ' ILE . 0.7 OUTLIER -179.98 -173.76 0.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.363 -0.836 . . . . 0.0 109.934 179.84 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.554 HG22 ' O ' ' A' ' 171' ' ' ILE . 2.1 mm 33.15 36.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.409 -0.807 . . . . 0.0 110.408 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' A' ' 170' ' ' GLU . 0.2 OUTLIER -67.09 -38.9 86.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.914 . . . . 0.0 110.41 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.712 ' C ' HG23 ' A' ' 174' ' ' VAL . 0.0 OUTLIER -78.76 -156.62 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.878 . . . . 0.0 110.353 -179.741 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.712 HG23 ' C ' ' A' ' 173' ' ' GLN . 2.9 t 76.58 -29.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.601 -0.687 . . . . 0.0 110.876 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.481 ' O ' ' O ' ' A' ' 174' ' ' VAL . 46.2 tt0 55.19 161.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.041 -1.037 . . . . 0.0 110.278 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.587 ' CG2' ' HB3' ' A' ' 179' ' ' PHE . 1.9 m -166.37 113.43 0.86 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.193 -0.942 . . . . 0.0 110.257 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.541 ' O ' ' OG1' ' A' ' 180' ' ' THR . 12.3 m-20 -76.86 -30.39 56.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.124 -0.985 . . . . 0.0 110.443 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.81 -17.53 55.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.097 -1.002 . . . . 0.0 110.449 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 1.035 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -90.29 -15.23 31.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.14 -0.975 . . . . 0.0 110.392 -179.667 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.541 ' OG1' ' O ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -61.73 -20.63 63.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.002 -1.061 . . . . 0.0 109.891 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -71.41 -63.05 1.19 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.857 . . . . 0.0 109.899 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.696 HD21 ' HA ' ' A' ' 179' ' ' PHE . 0.7 OUTLIER -61.71 -14.31 30.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.659 179.643 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 1.035 HD13 ' CZ ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -83.13 -29.94 28.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.868 . . . . 0.0 109.878 179.653 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.97 -12.06 34.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 110.018 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.816 ' HB3' HG22 ' A' ' 187' ' ' ILE . . . -85.88 19.09 2.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 0.0 110.199 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 185' ' ' ALA . 0.2 OUTLIER 41.69 29.6 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.0 109.516 -179.61 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.816 HG22 ' HB3' ' A' ' 185' ' ' ALA . 1.5 tt -116.4 149.33 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.505 -0.747 . . . . 0.0 110.409 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.757 ' O ' ' O ' ' A' ' 189' ' ' VAL . 0.0 OUTLIER 164.91 108.91 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.757 ' O ' ' O ' ' A' ' 188' ' ' ARG . 6.1 p 38.45 175.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 121.589 0.709 . . . . 0.0 110.93 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.662 ' N ' HG22 ' A' ' 189' ' ' VAL . . . 107.41 -7.06 36.66 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.3 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.586 ' O ' ' HG3' ' A' ' 164' ' ' ARG . 0.5 OUTLIER -159.62 -177.35 6.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.859 -1.377 . . . . 0.0 111.74 -179.515 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.625 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 38.8 tt0 -67.39 137.87 56.28 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.753 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.709 HG11 ' CD2' ' A' ' 206' ' ' HIS . 2.0 m -161.16 134.62 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.291 -0.881 . . . . 0.0 109.467 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.641 ' HA ' HG23 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -102.68 156.84 17.36 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.309 179.51 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.677 HG12 HD23 ' A' ' 204' ' ' LEU . 1.2 mt -118.74 153.1 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.936 -1.102 . . . . 0.0 110.683 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 196' ' ' VAL . 55.8 t -132.16 91.47 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.513 -0.742 . . . . 0.0 110.31 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.476 ' HA ' HG12 ' A' ' 202' ' ' ILE . 33.3 m-20 -43.45 137.07 2.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.22 -0.925 . . . . 0.0 110.125 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.481 ' HB2' ' HB3' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -128.25 71.87 1.4 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.261 -0.899 . . . . 0.0 110.265 -180.0 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 198' ' ' ARG . 0.3 OUTLIER 42.07 75.05 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.251 -0.905 . . . . 0.0 110.223 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 87.92 -36.81 3.32 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -90.55 165.58 13.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.178 -1.19 . . . . 0.0 110.17 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.758 HD12 HG22 ' A' ' 153' ' ' ILE . 9.1 mt -153.77 149.61 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.205 -0.935 . . . . 0.0 110.395 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.821 HG23 ' O ' ' A' ' 211' ' ' VAL . 85.8 m -146.2 159.44 43.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.398 -0.813 . . . . 0.0 109.541 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.958 HD11 ' CD1' ' A' ' 213' ' ' LEU . 0.7 OUTLIER -119.37 157.33 28.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.934 . . . . 0.0 110.602 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.577 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 0.1 OUTLIER -124.54 95.07 4.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.528 -0.732 . . . . 0.0 109.429 179.429 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.709 ' CD2' HG11 ' A' ' 193' ' ' VAL . 40.6 m80 -76.36 74.11 3.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.448 -0.782 . . . . 0.0 110.382 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 206' ' ' HIS . 7.1 t-20 42.54 67.52 0.59 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -0.95 . . . . 0.0 110.278 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 99.17 -38.5 3.07 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.491 ' O ' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -95.71 97.11 9.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.287 -1.125 . . . . 0.0 110.23 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 204' ' ' LEU . 0.5 OUTLIER -102.07 153.62 19.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 110.295 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.821 ' O ' HG23 ' A' ' 203' ' ' THR . 1.0 OUTLIER -143.52 149.98 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.309 -0.869 . . . . 0.0 109.881 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -58.44 -174.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 110.199 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.958 ' CD1' HD11 ' A' ' 204' ' ' LEU . 0.3 OUTLIER -174.47 -28.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.253 -0.905 . . . . 0.0 110.271 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 1.061 ' O ' ' HB2' ' A' ' 218' ' ' ALA . 0.5 OUTLIER 33.04 -151.05 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.477 -0.764 . . . . 0.0 110.728 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 3.1 m-20 -90.49 -61.28 1.71 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.362 -0.836 . . . . 0.0 110.497 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.561 ' HB2' HD11 ' A' ' 214' ' ' LEU . 0.1 OUTLIER -41.48 -52.65 3.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 110.505 -179.686 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.823 ' HB3' HD23 ' A' ' 213' ' ' LEU . 0.5 OUTLIER -79.36 -27.76 41.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.18 -0.95 . . . . 0.0 110.261 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 1.134 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -43.36 -77.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 110.498 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.545 ' HB2' HD13 ' A' ' 153' ' ' ILE . 47.4 t-80 -65.88 89.7 0.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.347 -0.846 . . . . 0.0 110.386 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' THR . . . . . 0.453 ' O ' ' OE2' ' A' ' 170' ' ' GLU . 8.1 m -161.23 -63.85 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.825 . . . . 0.0 110.096 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.881 HG22 ' CD1' ' A' ' 168' ' ' ILE . 0.2 OUTLIER -76.18 139.66 18.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.513 -0.742 . . . . 0.0 110.781 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.514 ' HA ' ' HA ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -90.03 106.55 18.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.385 -0.822 . . . . 0.0 109.29 179.202 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.946 HG22 HG23 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -121.48 173.35 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.135 -0.978 . . . . 0.0 110.698 -178.894 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.958 ' O ' HG12 ' A' ' 163' ' ' VAL . 3.5 mt-10 -150.28 -170.25 3.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.355 -0.841 . . . . 0.0 110.165 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 10.0 tm-20 -104.98 112.27 25.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.261 -0.899 . . . . 0.0 110.18 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 19.9 tp . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.209 179.961 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 132' ' ' ILE . 45.3 Cg_endo . . . . . 0 N--CA 1.483 0.896 0 N-CA-C 110.529 -0.604 . . . . 0.0 110.529 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' A' ' 131' ' ' PRO . 14.7 mt 41.31 94.64 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.337 -0.852 . . . . 0.0 110.388 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.61 -21.88 21.57 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.074 1.565 . . . . 0.0 110.466 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 135.47 -103.22 0.45 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 135' ' ' LEU . 1.8 mm? 49.02 -163.52 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -1.136 . . . . 0.0 110.29 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -118.67 76.5 1.1 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 110.236 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.422 ' OE2' HG23 ' A' ' 132' ' ' ILE . 2.8 pt-20 -126.49 90.03 3.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.919 . . . . 0.0 110.199 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mt . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.2 -0.938 . . . . 0.0 110.165 179.998 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 149' ' ' GLY . 46.2 Cg_endo . . . . . 0 N--CA 1.483 0.896 0 N-CA-C 110.608 -0.574 . . . . 0.0 110.608 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 148' ' ' PRO . . . 58.57 149.26 0.01 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.572 ' N ' ' O ' ' A' ' 223' ' ' ILE . 58.6 m -97.97 140.0 32.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.252 -1.146 . . . . 0.0 109.95 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 0.7 OUTLIER -76.53 131.57 39.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.902 -1.123 . . . . 0.0 110.058 179.84 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 1.026 ' CG2' HG21 ' A' ' 223' ' ' ILE . 32.8 t -40.87 161.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.271 -0.893 . . . . 0.0 109.974 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.97 HD11 ' CG ' ' A' ' 219' ' ' HIS . 0.1 OUTLIER 75.01 -15.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.583 -0.698 . . . . 0.0 110.292 -179.025 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 151' ' ' ARG . 0.3 OUTLIER -103.44 -15.0 16.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.104 -0.998 . . . . 0.0 109.265 179.24 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -111.99 -11.98 13.79 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.522 -0.736 . . . . 0.0 109.879 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.776 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -76.27 128.51 35.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 110.259 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.492 HG21 ' NH1' ' A' ' 161' ' ' ARG . 0.2 OUTLIER -102.32 176.81 5.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.15 -0.969 . . . . 0.0 110.259 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.54 -59.82 2.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.925 . . . . 0.0 110.21 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -75.11 166.3 46.62 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.898 . . . . 0.0 110.193 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 161' ' ' ARG . 45.8 Cg_endo -72.78 78.6 2.07 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.055 1.555 . . . . 0.0 110.437 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.492 ' NH1' HG21 ' A' ' 157' ' ' THR . 0.4 OUTLIER -60.35 -141.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 110.202 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.86 87.45 1.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.21 -0.931 . . . . 0.0 110.322 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.623 ' O ' ' O ' ' A' ' 193' ' ' VAL . 12.3 m -112.7 -162.43 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.311 -0.868 . . . . 0.0 110.221 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.861 HH11 HG12 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -169.79 151.81 4.32 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.808 -1.183 . . . . 0.0 110.985 -179.315 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 1.099 HG23 ' CG2' ' A' ' 223' ' ' ILE . 2.1 mt -100.65 154.0 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.361 -0.837 . . . . 0.0 109.97 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.861 HG12 HH11 ' A' ' 164' ' ' ARG . 31.4 m -133.91 -30.1 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.048 -1.033 . . . . 0.0 111.12 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' A' ' 222' ' ' ARG . 2.0 mt-30 -149.45 128.91 13.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.09 -1.006 . . . . 0.0 110.704 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.69 HG23 HG22 ' A' ' 221' ' ' ILE . 10.5 mt -83.36 -10.05 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.384 -0.822 . . . . 0.0 109.686 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.563 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 0.2 OUTLIER 70.36 2.38 4.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.375 -0.828 . . . . 0.0 110.342 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 44.09 62.53 1.94 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 110.394 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.563 ' CG1' ' HB3' ' A' ' 169' ' ' ASN . 13.9 mm -102.15 17.9 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 0.0 110.075 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.435 ' C ' ' O ' ' A' ' 171' ' ' ILE . 56.7 t80 -41.76 113.31 0.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.345 -0.847 . . . . 0.0 110.29 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -141.82 -32.58 0.52 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.312 -0.867 . . . . 0.0 110.378 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.457 ' O ' ' C ' ' A' ' 175' ' ' GLU . 48.7 t -127.6 75.73 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 110.101 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 174' ' ' VAL . 43.3 tt0 -39.3 157.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.429 -0.795 . . . . 0.0 110.429 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.637 ' OG1' ' CD1' ' A' ' 179' ' ' PHE . 1.0 OUTLIER -136.36 135.91 39.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.313 -0.867 . . . . 0.0 110.145 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.591 ' O ' ' OG1' ' A' ' 180' ' ' THR . 11.5 t70 -72.13 -45.91 58.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.234 -0.917 . . . . 0.0 110.871 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -21.38 63.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.056 -1.027 . . . . 0.0 110.42 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.669 ' HB2' HD11 ' A' ' 214' ' ' LEU . 0.0 OUTLIER -90.78 -31.42 16.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 110.667 -179.782 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.599 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.5 OUTLIER -43.88 -25.97 0.23 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.953 -1.092 . . . . 0.0 109.683 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 179' ' ' PHE . 35.5 tt0 -61.62 -35.04 76.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.85 . . . . 0.0 109.578 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.578 HD21 ' O ' ' A' ' 212' ' ' GLU . 0.8 OUTLIER -72.12 -39.85 68.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.398 -0.813 . . . . 0.0 109.546 179.454 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.61 -33.7 75.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.517 -0.739 . . . . 0.0 109.928 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -63.19 -14.75 52.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 0.0 109.735 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -86.89 16.66 4.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.375 -0.828 . . . . 0.0 110.034 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 186' ' ' ASP . 5.8 m-20 42.26 48.64 4.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 109.368 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.3 tt -128.96 169.56 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.517 -0.739 . . . . 0.0 110.554 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.483 ' O ' ' C ' ' A' ' 189' ' ' VAL . 0.0 OUTLIER -150.87 -133.29 0.05 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.365 -0.835 . . . . 0.0 108.784 179.506 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 189' ' ' VAL . 4.3 m -42.47 120.37 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 120.965 -1.084 . . . . 0.0 109.076 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.84 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -50.31 -7.7 0.14 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.607 ' O ' ' HB2' ' A' ' 164' ' ' ARG . 28.3 t 58.77 -150.53 0.44 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.163 -1.198 . . . . 0.0 109.675 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.682 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 95.5 mt-10 -64.35 101.86 0.47 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.693 -0.63 . . . . 0.0 109.826 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.623 ' O ' ' O ' ' A' ' 163' ' ' VAL . 30.8 m -158.16 -135.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.913 . . . . 0.0 109.742 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.537 ' N ' HG23 ' A' ' 193' ' ' VAL . 0.0 OUTLIER -169.05 158.74 8.73 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.293 -0.879 . . . . 0.0 110.117 179.407 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.776 HD12 ' HB2' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -120.04 156.81 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 0.0 110.088 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.449 ' N ' ' O ' ' A' ' 203' ' ' THR . 11.4 t -125.24 92.38 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 110.165 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.498 ' HA ' HG12 ' A' ' 202' ' ' ILE . 8.5 t0 -41.73 134.1 2.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.292 -0.88 . . . . 0.0 110.205 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.523 ' CB ' ' O ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -132.92 154.98 49.89 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.233 -0.917 . . . . 0.0 110.137 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -59.26 90.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.237 -0.914 . . . . 0.0 110.362 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 89.88 1.56 76.49 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.523 ' O ' ' CB ' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -150.14 170.79 18.1 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -1.182 . . . . 0.0 110.326 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.498 HG12 ' HA ' ' A' ' 197' ' ' ASP . 7.5 mt -146.62 99.96 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.0 110.202 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 196' ' ' VAL . 55.1 m -72.61 150.78 42.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -0.909 . . . . 0.0 110.004 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.718 ' HG ' HG23 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -119.9 137.9 53.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.129 -0.982 . . . . 0.0 110.288 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.56 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.6 OUTLIER -119.66 124.05 45.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.36 -0.837 . . . . 0.0 109.964 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.519 ' HA ' ' CB ' ' A' ' 193' ' ' VAL . 3.0 m80 -110.09 -171.95 1.94 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.458 -0.776 . . . . 0.0 110.188 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -56.68 98.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 110.244 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 61.09 26.11 65.32 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 206' ' ' HIS . 2.5 mtpt -143.16 158.97 43.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -1.156 . . . . 0.0 110.286 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -156.6 139.27 15.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.917 . . . . 0.0 110.153 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 212' ' ' GLU . 4.2 p -134.27 172.63 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.318 -0.863 . . . . 0.0 110.205 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.578 ' O ' HD21 ' A' ' 182' ' ' LEU . 1.5 tt0 -110.87 103.46 11.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.255 -0.903 . . . . 0.0 110.234 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.404 ' HA ' HD12 ' A' ' 213' ' ' LEU . 13.2 tp -95.22 171.69 8.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 110.087 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.956 ' O ' ' HB2' ' A' ' 218' ' ' ALA . 5.6 mt -91.12 166.17 13.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 110.141 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.466 ' HB2' ' HA ' ' A' ' 201' ' ' HIS . 6.0 t0 -89.9 -75.0 0.46 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 110.094 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.19 -22.34 60.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.929 . . . . 0.0 110.092 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.519 ' HB3' ' HB2' ' A' ' 214' ' ' LEU . 0.2 OUTLIER -90.04 -24.94 21.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.897 . . . . 0.0 110.272 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.956 ' HB2' ' O ' ' A' ' 214' ' ' LEU . . . -62.79 -33.03 74.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.204 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.97 ' CG ' HD11 ' A' ' 153' ' ' ILE . 0.3 OUTLIER -64.18 84.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 110.183 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 3.3 m -165.2 -46.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 110.577 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.871 HD11 ' HB ' ' A' ' 152' ' ' VAL . 0.3 OUTLIER -74.36 144.81 11.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.259 -0.9 . . . . 0.0 110.841 -179.566 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.535 ' O ' HG22 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -89.31 107.36 19.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.42 -0.8 . . . . 0.0 109.19 179.352 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 1.099 ' CG2' HG23 ' A' ' 165' ' ' ILE . 0.6 OUTLIER -119.87 163.98 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.316 -0.865 . . . . 0.0 110.84 -178.855 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.458 ' HG2' ' HA2' ' A' ' 149' ' ' GLY . 27.1 mt-10 -139.43 -177.77 5.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 0.0 110.27 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.586 ' HG3' HG12 ' A' ' 163' ' ' VAL . 3.6 mt-10 -95.02 70.18 3.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.878 . . . . 0.0 110.339 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 23.3 mt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.284 179.982 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo . . . . . 0 N--CA 1.483 0.903 0 N-CA-C 110.443 -0.637 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.439 ' HB ' ' HD2' ' A' ' 133' ' ' PRO . 10.0 pt -73.56 163.42 68.54 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 110.189 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 132' ' ' ILE . 46.2 Cg_endo -73.24 -17.01 24.75 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.973 1.512 . . . . 0.0 110.425 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 135' ' ' LEU . . . 107.46 -135.89 13.07 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.453 ' CB ' ' O ' ' A' ' 134' ' ' GLY . 0.3 OUTLIER 66.22 29.8 9.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -1.114 . . . . 0.0 110.259 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -151.96 87.99 1.37 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 110.298 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -71.83 61.68 0.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.935 . . . . 0.0 110.137 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.252 -0.905 . . . . 0.0 110.254 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.471 ' HA ' ' HG2' ' A' ' 222' ' ' ARG . 46.9 Cg_endo . . . . . 0 N--CA 1.483 0.857 0 N-CA-C 110.548 -0.597 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 148' ' ' PRO . . . 43.69 -111.46 0.43 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.466 ' O ' HG22 ' A' ' 150' ' ' THR . 87.0 m -131.47 0.49 4.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -1.147 . . . . 0.0 110.288 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' A' ' 153' ' ' ILE . 1.8 mtm-85 61.03 131.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 110.138 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.842 HG13 ' O ' ' A' ' 152' ' ' VAL . 4.7 p -65.69 55.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.264 -0.897 . . . . 0.0 110.683 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 1.103 ' CG2' ' HB1' ' A' ' 218' ' ' ALA . 3.1 pt -156.23 -35.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.085 -1.009 . . . . 0.0 110.019 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 150' ' ' THR . 0.2 OUTLIER -69.81 -13.99 62.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 0.0 109.083 179.224 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.75 ' HB3' HD11 ' A' ' 195' ' ' ILE . . . -96.31 1.76 52.23 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.582 -0.699 . . . . 0.0 109.899 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 155' ' ' ALA . . . -57.69 -152.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 110.399 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 159' ' ' MET . 12.6 t -41.02 -34.53 0.43 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.38 -0.825 . . . . 0.0 110.269 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 157' ' ' THR . 10.1 t -43.39 -26.12 0.18 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.917 . . . . 0.0 109.688 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' MET . . . . . 0.52 ' HB3' ' HD2' ' A' ' 161' ' ' ARG . 0.1 OUTLIER -160.37 103.84 1.36 Allowed Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.434 -0.791 . . . . 0.0 109.602 179.702 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.23 106.35 1.73 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.938 1.494 . . . . 0.0 110.476 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.52 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 0.0 OUTLIER -171.42 175.27 4.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.358 -0.839 . . . . 0.0 110.28 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.616 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 1.0 OUTLIER -88.98 150.54 22.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.275 -0.891 . . . . 0.0 110.326 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 1.031 HG22 ' HA ' ' A' ' 194' ' ' GLU . 2.8 m -147.34 -155.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.168 -0.957 . . . . 0.0 110.851 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.646 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 4.8 ttt-85 178.71 150.99 0.28 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.026 -1.046 . . . . 0.0 110.107 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 1.04 HG23 HG22 ' A' ' 223' ' ' ILE . 0.0 OUTLIER -93.71 149.39 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.217 -0.927 . . . . 0.0 109.864 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 222' ' ' ARG . 18.2 m -130.8 0.98 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.096 -1.003 . . . . 0.0 110.472 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.468 ' HB2' ' HB2' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -167.02 123.37 1.17 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.115 -0.991 . . . . 0.0 110.253 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.457 HD12 HG21 ' A' ' 221' ' ' ILE . 1.3 tt -130.32 9.04 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 0.0 110.138 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 168' ' ' ILE . 15.0 m-20 -41.49 101.37 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -0.887 . . . . 0.0 110.181 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.41 ' O ' ' CD1' ' A' ' 172' ' ' PHE . 2.3 tp10 -146.86 116.32 7.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.207 -0.933 . . . . 0.0 110.329 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.52 ' O ' HD12 ' A' ' 171' ' ' ILE . 1.2 pp -84.25 20.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 110.17 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.454 ' C ' ' O ' ' A' ' 171' ' ' ILE . 55.8 p90 -39.96 145.11 0.16 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 0.0 110.437 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -149.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.915 . . . . 0.0 110.267 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 176' ' ' THR . 37.0 t -119.32 -15.58 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.216 -0.927 . . . . 0.0 110.294 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.32 88.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 0.0 110.128 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.563 ' CG2' ' HB3' ' A' ' 179' ' ' PHE . 0.3 OUTLIER -155.09 -36.83 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 0.0 110.356 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.481 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.4 OUTLIER 53.48 -85.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.414 -0.804 . . . . 0.0 110.465 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 176' ' ' THR . 13.5 tm0? -41.64 -26.74 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.264 -0.898 . . . . 0.0 110.433 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.939 ' CE2' HD23 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -89.14 -44.36 10.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.236 -0.915 . . . . 0.0 110.219 -179.91 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.519 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -44.37 -24.35 0.17 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.085 -1.009 . . . . 0.0 109.799 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -66.7 -67.68 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.37 -0.831 . . . . 0.0 110.155 179.799 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.802 HD12 ' N ' ' A' ' 183' ' ' LEU . 4.3 pp -60.97 -16.57 44.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.88 . . . . 0.0 109.747 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.939 HD23 ' CE2' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -81.79 -32.71 31.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 109.663 179.549 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.74 -18.62 60.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.432 -0.793 . . . . 0.0 109.851 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -87.16 16.81 4.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.371 -0.831 . . . . 0.0 110.206 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 51.38 68.32 0.81 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.12 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 187' ' ' ILE . 16.2 mm -107.14 88.63 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 110.389 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 190' ' ' GLY . 1.5 ptp180 -100.49 142.39 32.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.364 -0.835 . . . . 0.0 109.636 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 1.0 ' O ' ' N ' ' A' ' 191' ' ' SER . 5.9 m 33.77 34.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 121.288 -0.883 . . . . 0.0 110.628 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.701 ' N ' HD12 ' A' ' 165' ' ' ILE . . . 22.93 21.86 0.0 OUTLIER Glycine 0 N--CA 1.496 2.683 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' SER . . . . . 1.0 ' N ' ' O ' ' A' ' 189' ' ' VAL . 1.3 t 36.48 -148.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -1.148 . . . . 0.0 109.842 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.646 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 22.3 tt0 -83.46 118.3 23.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.614 -0.679 . . . . 0.0 109.383 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.631 ' CG2' HD21 ' A' ' 204' ' ' LEU . 34.2 m -158.67 -137.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.091 -1.005 . . . . 0.0 110.097 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 1.031 ' HA ' HG22 ' A' ' 163' ' ' VAL . 42.9 tt0 -174.3 158.77 3.0 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.207 -0.933 . . . . 0.0 110.54 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.75 HD11 ' HB3' ' A' ' 155' ' ' ALA . 0.4 OUTLIER -120.84 145.62 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.311 -0.868 . . . . 0.0 109.973 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.482 ' O ' ' O ' ' A' ' 197' ' ' ASP . 6.5 t -135.37 35.76 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.154 -0.966 . . . . 0.0 110.298 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 196' ' ' VAL . 0.4 OUTLIER 54.64 162.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.345 -0.847 . . . . 0.0 110.451 179.8 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.55 ' HB2' ' N ' ' A' ' 203' ' ' THR . 30.0 ttt-85 -143.54 160.04 41.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.219 -0.926 . . . . 0.0 110.172 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 198' ' ' ARG . 0.1 OUTLIER -43.97 103.92 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.403 -179.877 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 61.58 11.83 30.69 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.417 ' C ' ' HB3' ' A' ' 198' ' ' ARG . 1.2 t60 -150.17 -156.19 0.7 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.138 -1.213 . . . . 0.0 110.194 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.861 HD13 HG22 ' A' ' 153' ' ' ILE . 92.5 mt -129.16 134.28 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.208 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.55 ' N ' ' HB2' ' A' ' 198' ' ' ARG . 4.3 m -109.27 148.2 31.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 110.149 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.811 HD22 ' CE1' ' A' ' 206' ' ' HIS . 1.1 tt -119.71 135.2 54.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 110.161 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.525 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.5 OUTLIER -119.86 124.93 47.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.355 -0.84 . . . . 0.0 109.895 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.811 ' CE1' HD22 ' A' ' 204' ' ' LEU . 2.9 m-70 -106.06 -162.69 0.88 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.378 -0.826 . . . . 0.0 110.105 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -52.83 90.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 110.175 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 59.93 26.58 63.31 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 54.5 mttt -132.54 169.9 15.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.25 -1.147 . . . . 0.0 110.328 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.569 ' O ' HG23 ' A' ' 211' ' ' VAL . 7.9 t70 -156.02 145.61 21.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.354 -0.842 . . . . 0.0 110.068 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 210' ' ' ASP . 55.5 t -156.22 144.12 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.92 . . . . 0.0 110.252 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.451 ' OE1' ' NE2' ' A' ' 178' ' ' GLN . 6.4 tt0 -56.56 161.56 2.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 110.14 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.673 ' CD1' ' HB2' ' A' ' 218' ' ' ALA . 1.5 tm? -142.57 92.63 2.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 110.216 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.655 HD23 ' H ' ' A' ' 214' ' ' LEU . 1.4 pt? -46.83 174.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.333 -0.854 . . . . 0.0 110.148 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -90.17 -30.91 17.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.353 -0.842 . . . . 0.0 110.27 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.33 -44.89 95.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.939 . . . . 0.0 110.364 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.637 HD13 ' CD2' ' A' ' 179' ' ' PHE . 0.1 OUTLIER -84.24 -18.92 34.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.172 -0.955 . . . . 0.0 110.18 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 1.103 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -67.18 -58.68 4.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 110.412 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.496 ' HA ' HD11 ' A' ' 153' ' ' ILE . 1.8 t60 -85.87 79.32 9.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.189 -0.944 . . . . 0.0 110.471 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' THR . . . . . 0.792 HG23 HG23 ' A' ' 221' ' ' ILE . 2.8 t -176.5 -48.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 110.294 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.819 HD11 HG12 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -70.4 142.58 15.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.215 -0.928 . . . . 0.0 110.294 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.793 ' O ' HG22 ' A' ' 166' ' ' VAL . 10.0 mtt180 -89.51 114.7 26.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.237 -0.914 . . . . 0.0 109.497 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 1.04 HG22 HG23 ' A' ' 165' ' ' ILE . 0.7 OUTLIER -120.83 -176.53 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 110.725 -179.224 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 223' ' ' ILE . 46.0 mm-40 -149.57 174.52 12.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.484 -0.76 . . . . 0.0 110.03 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.515 ' HG3' HG12 ' A' ' 163' ' ' VAL . 0.4 OUTLIER -100.01 144.03 29.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 110.176 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.546 HD21 ' HG3' ' A' ' 192' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.221 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo . . . . . 0 N--CA 1.485 0.971 0 N-CA-C 110.531 -0.603 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 63.0 mt -115.28 106.56 50.84 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.187 -0.946 . . . . 0.0 110.253 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.516 ' HB2' HD23 ' A' ' 135' ' ' LEU . 46.7 Cg_endo -73.02 -49.11 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.016 1.535 . . . . 0.0 110.513 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 128.71 1.91 5.86 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 133' ' ' PRO . 1.3 pp -94.22 141.39 28.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -1.13 . . . . 0.0 110.286 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -109.12 27.82 9.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.328 -0.857 . . . . 0.0 110.152 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.63 69.91 0.85 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 0.0 110.179 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.243 -0.911 . . . . 0.0 110.222 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo . . . . . 0 N--CA 1.484 0.934 0 N-CA-C 110.392 -0.657 . . . . 0.0 110.392 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.481 ' HA3' ' HD3' ' A' ' 222' ' ' ARG . . . 164.26 83.92 0.05 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.538 ' O ' ' CG1' ' A' ' 223' ' ' ILE . 30.0 m -97.26 136.48 37.69 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -1.153 . . . . 0.0 110.276 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 154' ' ' ASP . 26.1 mtt-85 -64.87 128.77 37.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.096 -1.002 . . . . 0.0 109.888 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 1.025 HG23 HG21 ' A' ' 223' ' ' ILE . 1.3 t -43.6 -32.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.168 -0.957 . . . . 0.0 110.232 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.735 HG21 ' HB3' ' A' ' 218' ' ' ALA . 1.1 pp -83.55 -13.33 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.209 -0.932 . . . . 0.0 110.451 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 151' ' ' ARG . 0.3 OUTLIER -79.52 -14.71 58.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 109.794 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -116.56 -5.38 11.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.332 -0.855 . . . . 0.0 109.998 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.48 135.2 40.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.299 -0.875 . . . . 0.0 110.296 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 158' ' ' SER . 0.2 OUTLIER -139.67 171.82 13.69 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.204 -0.935 . . . . 0.0 110.192 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 157' ' ' THR . 0.1 OUTLIER -42.9 -60.84 1.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 110.053 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 2.2 mtt -78.54 162.98 63.8 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.179 -0.95 . . . . 0.0 110.068 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.446 ' HB3' HG22 ' A' ' 196' ' ' VAL . 45.8 Cg_endo -73.21 73.29 3.26 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.946 1.498 . . . . 0.0 110.467 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.13 130.8 23.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.326 -0.859 . . . . 0.0 110.197 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.28 103.13 4.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 110.203 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.638 ' O ' ' O ' ' A' ' 193' ' ' VAL . 17.6 m -128.72 -169.12 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.168 -0.957 . . . . 0.0 110.273 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.635 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 9.2 ptt-85 -166.25 147.32 6.52 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.711 -1.243 . . . . 0.0 110.836 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 1.092 HG23 ' CG2' ' A' ' 223' ' ' ILE . 0.8 OUTLIER -90.42 152.23 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.394 -0.816 . . . . 0.0 110.117 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 222' ' ' ARG . 17.9 m -138.59 -29.71 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.208 -0.933 . . . . 0.0 110.762 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.518 ' HB2' ' HB2' ' A' ' 222' ' ' ARG . 35.3 mt-30 -131.87 118.01 19.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.169 -0.957 . . . . 0.0 110.34 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.564 ' HB ' HG12 ' A' ' 189' ' ' VAL . 1.0 OUTLIER -84.44 -4.71 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.336 -0.853 . . . . 0.0 110.134 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.9 m120 51.16 -89.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.231 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 168' ' ' ILE . 77.6 tt0 -173.75 88.62 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 110.207 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.643 ' CG2' HD23 ' A' ' 217' ' ' LEU . 5.8 mt -76.98 2.83 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.278 -0.889 . . . . 0.0 110.21 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -58.54 108.0 0.58 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.244 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -130.45 -172.38 2.79 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.307 -0.871 . . . . 0.0 110.177 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.649 ' O ' HG12 ' A' ' 174' ' ' VAL . 61.2 t -109.59 20.1 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.203 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 177' ' ' ASP . 20.7 mm-40 -114.54 -32.95 5.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 110.21 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.541 ' O ' ' HB3' ' A' ' 179' ' ' PHE . 69.0 p 42.26 -92.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.387 -0.821 . . . . 0.0 110.288 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 176' ' ' THR . 0.7 OUTLIER 72.41 -154.68 0.08 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.262 -0.898 . . . . 0.0 110.172 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 181' ' ' GLN . 4.4 mm-40 -57.7 -23.68 52.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 110.507 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.919 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -47.48 -40.91 19.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.133 -0.98 . . . . 0.0 110.259 -179.851 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.51 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -46.93 -24.88 0.67 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.994 -1.066 . . . . 0.0 109.634 179.662 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 178' ' ' GLN . 11.7 tp60 -63.24 -66.18 0.58 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.43 -0.794 . . . . 0.0 110.42 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.682 ' C ' HD12 ' A' ' 182' ' ' LEU . 4.6 pp -63.91 -12.69 39.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.0 110.11 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.919 HD13 ' CZ ' ' A' ' 179' ' ' PHE . 0.8 OUTLIER -93.14 -30.64 15.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.314 -0.866 . . . . 0.0 109.731 179.631 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 180' ' ' THR . 9.8 t70 -73.41 -7.02 49.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.293 -0.879 . . . . 0.0 109.855 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.48 ' O ' HG12 ' A' ' 187' ' ' ILE . . . -87.58 32.32 0.72 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.323 -0.861 . . . . 0.0 110.175 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 185' ' ' ALA . 7.6 t70 43.41 55.84 4.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.194 -0.941 . . . . 0.0 109.976 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 185' ' ' ALA . 9.3 mm -110.64 163.94 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.873 . . . . 0.0 110.511 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.722 ' C ' HG13 ' A' ' 189' ' ' VAL . 0.1 OUTLIER -166.15 104.54 0.65 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.722 HG13 ' C ' ' A' ' 188' ' ' ARG . 1.5 m 50.86 103.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.763 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -42.69 -16.95 0.03 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 189' ' ' VAL . 6.3 t 64.98 -145.59 0.24 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.191 -1.182 . . . . 0.0 109.13 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.635 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 21.7 tt0 -61.02 100.64 0.12 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.215 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.674 HG21 HD21 ' A' ' 204' ' ' LEU . 17.7 m -156.28 -136.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.165 -0.959 . . . . 0.0 109.77 -179.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.642 ' N ' HG23 ' A' ' 193' ' ' VAL . 11.5 pt-20 -173.19 164.43 4.78 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.35 -0.844 . . . . 0.0 110.007 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 1.022 HG21 HG13 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -122.81 173.32 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.201 -0.937 . . . . 0.0 110.394 -179.764 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.446 HG22 ' HB3' ' A' ' 160' ' ' PRO . 99.4 t -141.49 83.86 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 0.0 110.096 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 196' ' ' VAL . 8.4 t70 -42.46 121.94 2.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.927 . . . . 0.0 110.205 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.402 ' HB3' ' HB3' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -119.02 171.36 8.31 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.178 -0.951 . . . . 0.0 110.307 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -56.0 99.98 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 110.331 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 62.87 22.75 64.84 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.403 ' C ' HG13 ' A' ' 202' ' ' ILE . 0.2 OUTLIER -148.08 158.01 43.83 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.281 -1.129 . . . . 0.0 110.083 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.684 HD13 HG22 ' A' ' 153' ' ' ILE . 57.8 mt -142.33 95.2 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 110.225 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 92.0 m -84.83 157.27 20.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 0.0 109.998 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.83 ' HG ' HG23 ' A' ' 195' ' ' ILE . 0.6 OUTLIER -119.91 141.57 49.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.206 -0.934 . . . . 0.0 110.367 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.608 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.0 OUTLIER -119.58 122.71 42.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.353 -0.842 . . . . 0.0 109.966 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.661 ' CE1' HD22 ' A' ' 204' ' ' LEU . 6.9 m-70 -98.97 167.86 10.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.45 -0.781 . . . . 0.0 110.309 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -44.07 106.95 0.08 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.338 -0.851 . . . . 0.0 110.24 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 57.57 24.34 52.37 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 206' ' ' HIS . 3.8 mtmt -150.76 175.46 11.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -1.13 . . . . 0.0 110.226 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 211' ' ' VAL . 5.6 t70 -171.18 161.9 6.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.216 -0.928 . . . . 0.0 110.148 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.479 ' N ' ' OD1' ' A' ' 210' ' ' ASP . 10.0 p -151.72 150.66 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.185 -0.947 . . . . 0.0 110.336 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.74 168.47 9.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 0.0 110.08 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 26.3 tp -172.75 149.65 2.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -0.886 . . . . 0.0 110.239 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.888 HD12 ' HB2' ' A' ' 216' ' ' ASP . 0.3 OUTLIER -114.46 124.32 51.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.267 -0.895 . . . . 0.0 110.171 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.581 ' HA ' ' HB3' ' A' ' 218' ' ' ALA . 13.5 p-10 -47.28 -22.65 0.43 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 110.23 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.888 ' HB2' HD12 ' A' ' 214' ' ' LEU . 1.4 m-20 -51.42 -66.3 0.41 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 0.0 110.328 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.643 HD23 ' CG2' ' A' ' 171' ' ' ILE . 0.3 OUTLIER -89.84 -18.02 27.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 110.348 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.735 ' HB3' HG21 ' A' ' 153' ' ' ILE . . . -47.44 -22.78 0.49 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.337 -0.852 . . . . 0.0 110.286 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 216' ' ' ASP . 0.0 OUTLIER -89.16 58.14 4.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 110.409 -179.882 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 220' ' ' THR . . . . . 0.48 HG23 ' ND1' ' A' ' 219' ' ' HIS . 18.0 p -142.83 -41.72 0.32 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -0.918 . . . . 0.0 110.262 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.65 HD13 ' N ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -69.41 137.27 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.39 -0.819 . . . . 0.0 110.305 -179.931 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.518 ' HB2' ' HB2' ' A' ' 167' ' ' GLN . 30.3 mtt180 -89.99 115.45 27.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.53 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 1.092 ' CG2' HG23 ' A' ' 165' ' ' ILE . 1.0 OUTLIER -129.37 -178.07 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 110.816 -179.125 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.42 -179.65 7.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.349 -0.844 . . . . 0.0 110.208 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.459 ' HG3' HG12 ' A' ' 163' ' ' VAL . 10.6 tt0 -99.7 100.82 11.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.222 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.495 ' O ' ' NH1' ' A' ' 164' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.206 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 20.7 p30 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.794 0.331 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.05 -49.37 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.992 1.522 . . . . 0.0 110.413 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 pt -56.85 156.1 13.6 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 0.0 110.216 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.99 -168.2 0.4 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.059 1.558 . . . . 0.0 110.329 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -119.5 165.94 13.31 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.503 HD23 ' H ' ' A' ' 135' ' ' LEU . 0.6 OUTLIER -79.45 178.49 8.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -1.16 . . . . 0.0 110.231 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -151.86 46.43 0.78 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.329 -0.857 . . . . 0.0 110.25 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -102.91 29.25 5.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -0.905 . . . . 0.0 110.248 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.44 138.1 32.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.459 ' O ' ' HB ' ' A' ' 140' ' ' VAL . . . -124.84 154.92 18.32 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.459 ' HB ' ' O ' ' A' ' 139' ' ' GLY . 41.2 t 55.12 100.92 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -1.125 . . . . 0.0 110.219 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -114.82 -51.41 0.45 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.6 m120 51.33 -169.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.158 -1.201 . . . . 0.0 110.246 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.6 t -120.27 123.79 44.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.0 110.187 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 58.38 -167.74 0.14 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.211 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 45.0 84.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 110.199 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -118.32 -2.57 11.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.283 -0.886 . . . . 0.0 110.132 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -167.73 149.58 5.19 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 110.154 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.1 81.04 1.75 Allowed 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.07 1.563 . . . . 0.0 110.491 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.563 ' CA ' ' HG3' ' A' ' 222' ' ' ARG . . . 154.11 128.52 1.23 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 151' ' ' ARG . 26.1 m -142.29 5.2 1.64 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -1.14 . . . . 0.0 110.431 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 0.0 OUTLIER 58.41 135.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.882 . . . . 0.0 110.319 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.841 HG13 ' O ' ' A' ' 152' ' ' VAL . 4.2 p -65.84 56.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.162 -0.961 . . . . 0.0 110.391 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.891 ' CG2' ' HB1' ' A' ' 218' ' ' ALA . 5.1 pt -158.92 -37.1 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.104 -0.998 . . . . 0.0 110.156 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.494 ' HB3' HG22 ' A' ' 150' ' ' THR . 0.3 OUTLIER -74.64 -16.25 60.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.372 -0.83 . . . . 0.0 109.736 179.637 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 1.043 ' HB1' HG11 ' A' ' 163' ' ' VAL . . . -88.68 -20.12 25.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.489 -0.757 . . . . 0.0 109.971 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.569 ' HB1' ' H ' ' A' ' 197' ' ' ASP . . . -70.01 124.86 25.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.352 -0.842 . . . . 0.0 110.166 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.576 ' CB ' ' HD2' ' A' ' 161' ' ' ARG . 77.1 m -123.21 171.78 9.09 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.17 -0.956 . . . . 0.0 110.356 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.557 ' N ' HG22 ' A' ' 157' ' ' THR . 36.4 t -38.62 -39.62 0.5 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.344 -0.847 . . . . 0.0 109.603 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' MET . . . . . 0.465 ' O ' ' HD3' ' A' ' 161' ' ' ARG . 2.6 ptt? -104.05 146.52 32.7 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 121.496 -0.753 . . . . 0.0 109.566 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.718 ' HB3' HG22 ' A' ' 196' ' ' VAL . 44.1 Cg_endo -71.14 81.04 1.21 Allowed 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.898 1.472 . . . . 0.0 110.577 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.888 HH21 HG13 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -63.37 -135.19 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.175 -0.953 . . . . 0.0 109.902 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.58 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 12.7 tttt -154.65 107.46 2.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.309 -0.869 . . . . 0.0 109.9 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 1.043 HG11 ' HB1' ' A' ' 155' ' ' ALA . 23.3 m -123.74 -150.43 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 110.845 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.666 ' HG2' ' N ' ' A' ' 165' ' ' ILE . 0.7 OUTLIER 179.48 155.41 0.52 Allowed 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.152 -0.967 . . . . 0.0 109.876 -179.201 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 1.019 HG23 HG22 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -97.48 144.89 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.225 -0.922 . . . . 0.0 109.83 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 222' ' ' ARG . 21.6 m -123.32 7.16 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.068 -1.02 . . . . 0.0 110.455 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.423 ' O ' ' N ' ' A' ' 222' ' ' ARG . 2.4 mt-30 -177.04 114.06 0.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.911 . . . . 0.0 110.412 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.997 HG21 ' HG2' ' A' ' 188' ' ' ARG . 0.7 OUTLIER -103.59 20.93 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.35 -0.844 . . . . 0.0 109.945 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' ' 168' ' ' ILE . 1.8 t-20 -44.86 172.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 110.292 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.411 ' OE2' ' HB3' ' A' ' 175' ' ' GLU . 0.4 OUTLIER -166.68 92.04 0.44 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.176 -0.952 . . . . 0.0 110.261 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.3 pp -83.61 13.88 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.197 -0.939 . . . . 0.0 110.311 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.549 ' CD1' ' OE1' ' A' ' 175' ' ' GLU . 1.6 m-85 -62.56 135.54 57.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 110.209 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.463 ' O ' ' HB ' ' A' ' 174' ' ' VAL . 11.1 mm-40 -59.67 -21.08 60.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.184 -0.948 . . . . 0.0 110.225 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 174' ' ' VAL . 4.5 p 179.76 90.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -0.937 . . . . 0.0 110.159 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.549 ' OE1' ' CD1' ' A' ' 172' ' ' PHE . 4.7 tt0 -143.52 105.18 4.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 110.252 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.523 ' O ' ' CB ' ' A' ' 177' ' ' ASP . 0.1 OUTLIER -138.07 -82.93 0.32 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 110.147 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.523 ' CB ' ' O ' ' A' ' 176' ' ' THR . 0.8 OUTLIER 70.96 -159.36 0.13 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.301 -0.875 . . . . 0.0 110.438 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -59.27 -18.9 41.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.354 -0.841 . . . . 0.0 110.583 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.819 ' HA ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -53.29 -36.03 60.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.169 -0.957 . . . . 0.0 110.129 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.48 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.7 OUTLIER -40.63 -27.92 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 0.0 109.892 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 179' ' ' PHE . 19.7 tt0 -63.2 -41.55 99.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.854 . . . . 0.0 109.823 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.819 HD12 ' HA ' ' A' ' 179' ' ' PHE . 1.7 mt -58.25 -46.48 85.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.419 -0.801 . . . . 0.0 109.766 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.62 ' O ' HD13 ' A' ' 183' ' ' LEU . 0.2 OUTLIER -67.34 -32.75 73.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.551 -0.718 . . . . 0.0 110.164 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -83.15 0.62 44.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.389 -0.819 . . . . 0.0 110.278 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.472 ' O ' HG13 ' A' ' 187' ' ' ILE . . . -81.71 8.29 10.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 110.219 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 23.4 t0 59.98 49.9 7.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.254 -0.904 . . . . 0.0 110.152 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.551 ' O ' ' CB ' ' A' ' 188' ' ' ARG . 88.8 mt -138.6 -72.99 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 110.242 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.997 ' HG2' HG21 ' A' ' 168' ' ' ILE . 3.4 ttp180 72.46 157.17 0.18 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.435 -0.791 . . . . 0.0 109.839 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.947 ' O ' ' N ' ' A' ' 191' ' ' SER . 3.7 m 33.17 36.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 O-C-N 121.352 -0.842 . . . . 0.0 110.731 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.743 ' N ' HD12 ' A' ' 165' ' ' ILE . . . 27.74 19.26 0.0 OUTLIER Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.947 ' N ' ' O ' ' A' ' 189' ' ' VAL . 30.6 t 38.29 -144.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.233 -1.157 . . . . 0.0 109.801 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.644 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -90.74 113.2 25.25 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.256 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.64 HG13 ' C ' ' A' ' 192' ' ' GLU . 33.6 m -159.27 -137.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.288 -0.882 . . . . 0.0 109.996 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.934 ' HA ' HG22 ' A' ' 163' ' ' VAL . 5.4 pt-20 -170.54 167.37 8.07 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.214 -0.929 . . . . 0.0 110.086 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.687 HG21 HG22 ' A' ' 152' ' ' VAL . 0.4 OUTLIER -124.75 173.68 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.116 -0.99 . . . . 0.0 110.401 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.718 HG22 ' HB3' ' A' ' 160' ' ' PRO . 46.1 t -145.25 85.74 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.318 -0.864 . . . . 0.0 110.055 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.569 ' H ' ' HB1' ' A' ' 156' ' ' ALA . 18.9 p-10 -40.65 133.81 1.93 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.0 110.436 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.443 ' O ' ' C ' ' A' ' 199' ' ' ASP . 12.9 mmt85 -123.66 67.11 1.02 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.268 -0.895 . . . . 0.0 110.184 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 198' ' ' ARG . 2.7 t0 40.72 81.67 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.395 -0.815 . . . . 0.0 110.158 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 88.27 -37.9 3.23 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 198' ' ' ARG . 0.0 OUTLIER -94.62 164.61 12.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.223 -1.163 . . . . 0.0 110.166 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.881 ' CD1' HG22 ' A' ' 153' ' ' ILE . 4.1 mt -145.83 118.29 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.921 . . . . 0.0 110.24 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.1 m -104.85 163.14 12.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 109.961 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 1.001 HD22 ' NE2' ' A' ' 206' ' ' HIS . 0.5 OUTLIER -119.83 138.19 53.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.152 -0.967 . . . . 0.0 110.213 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.565 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.5 OUTLIER -119.72 117.08 27.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.36 -0.837 . . . . 0.0 109.97 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 1.001 ' NE2' HD22 ' A' ' 204' ' ' LEU . 3.9 m170 -105.46 162.13 13.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.384 -0.822 . . . . 0.0 110.14 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -59.63 77.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.312 -0.867 . . . . 0.0 110.473 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 102.86 24.68 7.97 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.56 ' O ' ' CG ' ' A' ' 206' ' ' HIS . 3.1 mtpt -174.06 124.64 0.34 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -1.226 . . . . 0.0 110.462 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.46 150.86 40.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.266 -0.896 . . . . 0.0 110.149 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.76 HG12 ' HB3' ' A' ' 204' ' ' LEU . 8.4 p -137.72 165.48 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.172 -0.955 . . . . 0.0 110.252 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.88 88.99 3.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 110.202 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.816 HD12 ' N ' ' A' ' 214' ' ' LEU . 3.4 pp -76.93 -160.01 0.15 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.21 -0.931 . . . . 0.0 110.216 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.816 ' N ' HD12 ' A' ' 213' ' ' LEU . 0.5 OUTLIER -130.01 132.91 46.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -0.892 . . . . 0.0 110.217 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.453 ' OD2' HG13 ' A' ' 202' ' ' ILE . 0.7 OUTLIER -51.8 -23.58 4.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 110.222 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.86 -54.29 44.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 110.242 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.512 HD22 ' CD2' ' A' ' 179' ' ' PHE . 0.1 OUTLIER -89.6 -19.1 25.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.188 -0.945 . . . . 0.0 110.345 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.891 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -53.33 -18.36 2.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -0.877 . . . . 0.0 110.19 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.587 ' HA ' HD11 ' A' ' 153' ' ' ILE . 14.0 t-80 -103.5 49.99 0.81 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.931 . . . . 0.0 110.136 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 1.3 m -133.74 -61.59 0.8 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.327 -0.858 . . . . 0.0 110.225 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.718 HD11 HG12 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -60.55 145.15 12.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.419 -0.8 . . . . 0.0 110.379 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.709 ' O ' HG22 ' A' ' 166' ' ' VAL . 1.0 OUTLIER -89.82 116.48 27.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 109.611 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 1.019 HG22 HG23 ' A' ' 165' ' ' ILE . 0.5 OUTLIER -124.64 170.07 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.077 -1.015 . . . . 0.0 110.636 -179.419 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.657 ' HG2' HG11 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -150.11 -168.89 3.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.449 -0.782 . . . . 0.0 110.07 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 22.3 mt-10 -90.18 149.17 22.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.176 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.532 ' CD1' ' HB2' ' A' ' 192' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.924 -1.036 . . . . 0.0 110.199 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.619 ' OD1' HG22 ' A' ' 132' ' ' ILE . 14.1 p30 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 120.747 0.308 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.11 62.97 4.18 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.061 1.559 . . . . 0.0 110.472 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.729 HG23 ' O ' ' A' ' 132' ' ' ILE . 7.3 tp -124.05 63.61 31.97 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 110.233 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.08 -164.52 0.2 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.059 1.557 . . . . 0.0 110.444 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -139.4 81.45 0.26 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 47.56 56.32 7.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -1.159 . . . . 0.0 110.249 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -89.62 42.25 1.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.942 . . . . 0.0 110.196 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.19 8.61 6.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.226 -0.921 . . . . 0.0 110.232 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.07 75.49 1.62 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 110.268 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 173.17 -177.9 45.39 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.716 HG13 ' N ' ' A' ' 141' ' ' GLY . 1.4 p -117.96 -156.63 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -1.141 . . . . 0.0 110.095 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.716 ' N ' HG13 ' A' ' 140' ' ' VAL . . . -47.7 -96.25 0.01 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.06 116.31 4.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -1.12 . . . . 0.0 110.235 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.502 ' OG ' ' N ' ' A' ' 144' ' ' ASP . 30.5 t -166.25 -142.3 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.255 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.502 ' N ' ' OG ' ' A' ' 143' ' ' SER . 5.7 m-20 54.16 -163.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 110.217 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.81 114.65 12.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 110.204 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.593 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -126.83 84.09 2.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.228 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . 62.76 158.35 0.12 Allowed Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.259 -0.901 . . . . 0.0 110.093 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.75 65.86 3.92 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.051 1.553 . . . . 0.0 110.368 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 140.19 153.17 5.97 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.576 HG22 ' HB3' ' A' ' 154' ' ' ASP . 3.7 m -131.5 2.46 4.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -1.138 . . . . 0.0 110.265 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.506 ' O ' ' HB2' ' A' ' 154' ' ' ASP . 6.1 mtm-85 61.0 118.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.266 -0.897 . . . . 0.0 110.276 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 1.077 HG13 HG23 ' A' ' 153' ' ' ILE . 5.9 p -42.82 165.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.183 -0.948 . . . . 0.0 110.218 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 1.077 HG23 HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER 72.17 -20.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.759 -0.588 . . . . 0.0 110.282 -179.439 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.576 ' HB3' HG22 ' A' ' 150' ' ' THR . 0.4 OUTLIER -91.4 -18.98 23.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 0.0 108.71 178.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.422 ' O ' ' HG3' ' A' ' 161' ' ' ARG . . . -108.33 -15.04 14.56 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.563 0.697 . . . . 0.0 109.45 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.611 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -67.83 152.12 46.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.437 -0.79 . . . . 0.0 110.157 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -161.94 174.59 12.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 110.227 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 157' ' ' THR . 0.2 OUTLIER -41.97 -48.32 4.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 110.166 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' MET . . . . . 0.448 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 4.0 mmm -82.32 166.66 35.39 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 110.201 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 46.5 Cg_endo -73.35 84.06 1.41 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.019 1.536 . . . . 0.0 110.437 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -70.72 111.48 6.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 0.0 110.241 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.597 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 0.2 OUTLIER -71.99 117.26 13.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.896 . . . . 0.0 110.286 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.819 HG12 ' C ' ' A' ' 224' ' ' GLU . 0.0 OUTLIER -133.88 -165.4 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.213 -0.929 . . . . 0.0 110.431 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.566 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 20.1 ttp180 -173.54 147.61 1.46 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.847 -1.158 . . . . 0.0 109.829 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.92 HG23 HG22 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -95.03 143.55 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.162 -0.961 . . . . 0.0 110.181 -179.457 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 222' ' ' ARG . 28.8 m -123.9 -8.21 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 110.175 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -158.66 124.04 4.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 0.0 110.188 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.776 HG21 ' HG2' ' A' ' 188' ' ' ARG . 5.1 tt -117.58 6.65 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.279 -0.888 . . . . 0.0 110.169 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.446 ' O ' ' CB ' ' A' ' 170' ' ' GLU . 27.1 t-20 -41.88 113.35 0.42 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.303 -0.873 . . . . 0.0 110.114 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.604 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 0.1 OUTLIER 172.68 123.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 110.321 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.6 ' O ' HG22 ' A' ' 171' ' ' ILE . 63.2 mt -84.89 17.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 109.91 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.604 ' CE1' ' HB3' ' A' ' 170' ' ' GLU . 0.5 OUTLIER 25.06 -138.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.686 -0.634 . . . . 0.0 110.954 179.736 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.04 -145.94 0.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 0.0 110.213 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 32.8 m -114.71 6.46 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 110.355 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.71 174.09 7.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 110.245 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' A' ' 177' ' ' ASP . 12.1 p -148.29 -84.48 0.1 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -0.889 . . . . 0.0 110.165 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 176' ' ' THR . 7.0 t0 70.09 -139.16 0.06 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.345 -0.847 . . . . 0.0 110.218 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.496 ' O ' ' HB3' ' A' ' 181' ' ' GLN . 0.0 OUTLIER -64.07 -28.34 69.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.114 -0.991 . . . . 0.0 110.256 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.639 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.3 OUTLIER -50.03 -51.8 39.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 110.076 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -49.97 -21.38 1.18 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.065 -1.022 . . . . 0.0 109.822 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.496 ' HB3' ' O ' ' A' ' 178' ' ' GLN . 20.8 tt0 -69.49 -59.95 2.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.291 -0.881 . . . . 0.0 110.422 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.877 HD12 ' N ' ' A' ' 183' ' ' LEU . 3.9 pp -66.62 -15.64 63.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.831 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.877 ' N ' HD12 ' A' ' 182' ' ' LEU . 0.3 OUTLIER -85.97 -28.81 24.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.36 -0.838 . . . . 0.0 109.668 179.619 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -81.12 6.85 12.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.346 -0.846 . . . . 0.0 109.821 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.755 ' HB3' HG22 ' A' ' 187' ' ' ILE . . . -81.05 12.46 3.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.353 -0.842 . . . . 0.0 110.232 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 185' ' ' ALA . 23.1 t70 43.48 41.15 3.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.156 -0.965 . . . . 0.0 109.326 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.755 HG22 ' HB3' ' A' ' 185' ' ' ALA . 0.4 OUTLIER -117.19 -43.63 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.451 -0.781 . . . . 0.0 110.379 -179.448 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.776 ' HG2' HG21 ' A' ' 168' ' ' ILE . 3.9 ttp-105 53.22 168.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.341 -0.849 . . . . 0.0 109.882 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.956 ' O ' ' N ' ' A' ' 191' ' ' SER . 2.7 m 31.46 37.67 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 121.369 -0.832 . . . . 0.0 110.809 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.741 ' N ' HD12 ' A' ' 165' ' ' ILE . . . 28.41 19.14 0.0 OUTLIER Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.956 ' N ' ' O ' ' A' ' 189' ' ' VAL . 18.1 t 41.52 -153.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.167 -1.196 . . . . 0.0 109.766 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.647 ' C ' HG13 ' A' ' 193' ' ' VAL . 1.8 pt-20 -89.11 115.81 26.91 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.582 -0.699 . . . . 0.0 109.115 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.668 ' O ' ' O ' ' A' ' 163' ' ' VAL . 35.4 m -159.8 -131.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.939 . . . . 0.0 109.942 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.68 ' O ' HD23 ' A' ' 204' ' ' LEU . 8.1 pt-20 -176.8 169.34 2.48 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.241 -0.912 . . . . 0.0 110.387 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 1.035 HD13 HG23 ' A' ' 152' ' ' VAL . 0.5 OUTLIER -125.46 170.78 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.221 -0.924 . . . . 0.0 110.51 -179.552 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.462 ' O ' ' C ' ' A' ' 197' ' ' ASP . 65.7 t -148.13 80.7 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.367 -0.833 . . . . 0.0 109.892 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 197' ' ' ASP . 11.5 p30 -39.39 123.28 1.42 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.394 -0.816 . . . . 0.0 110.448 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.511 ' HB3' ' HB2' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -107.12 78.1 1.2 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.271 -0.893 . . . . 0.0 110.135 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 198' ' ' ARG . 27.7 t0 41.78 79.43 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.295 -0.878 . . . . 0.0 110.212 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 87.68 -37.27 3.25 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 198' ' ' ARG . 45.0 m170 -90.99 168.37 11.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.239 -1.153 . . . . 0.0 110.202 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.559 ' CD1' ' HB ' ' A' ' 153' ' ' ILE . 7.7 mt -141.09 121.6 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.221 -0.924 . . . . 0.0 110.166 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 195' ' ' ILE . 58.0 m -109.12 160.18 16.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.332 -0.855 . . . . 0.0 109.863 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 1.05 HD12 HD22 ' A' ' 213' ' ' LEU . 0.6 OUTLIER -119.74 132.46 55.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.158 -0.964 . . . . 0.0 110.217 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.568 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 1.4 m -119.82 128.12 53.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.878 . . . . 0.0 109.941 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.653 ' HB3' HG12 ' A' ' 193' ' ' VAL . 2.4 m-70 -105.48 173.98 6.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.366 -0.834 . . . . 0.0 109.958 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -58.35 96.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 0.0 110.229 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 76.14 29.72 58.23 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.68 165.41 32.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.117 -1.225 . . . . 0.0 110.26 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -161.12 143.37 12.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.224 -0.922 . . . . 0.0 110.177 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.746 HG13 ' N ' ' A' ' 212' ' ' GLU . 1.6 p -142.74 -154.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.176 -0.952 . . . . 0.0 110.228 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.746 ' N ' HG13 ' A' ' 211' ' ' VAL . 1.3 tt0 -115.23 169.49 9.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 110.323 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 1.05 HD22 HD12 ' A' ' 204' ' ' LEU . 11.6 tp -168.27 89.68 0.26 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.355 -0.841 . . . . 0.0 110.149 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.934 HD11 ' HB2' ' A' ' 217' ' ' LEU . 2.5 pt? -41.62 152.78 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 110.292 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -83.01 -22.39 33.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 110.195 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.98 -61.93 2.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.241 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.934 ' HB2' HD11 ' A' ' 214' ' ' LEU . 0.2 OUTLIER -75.63 -14.86 60.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -0.872 . . . . 0.0 110.197 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.799 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -50.29 -51.16 47.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 110.16 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.538 ' HB2' ' CD1' ' A' ' 153' ' ' ILE . 9.6 t60 -74.02 72.98 1.67 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.211 -0.93 . . . . 0.0 110.22 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' THR . . . . . 0.413 HG21 ' HD1' ' A' ' 172' ' ' PHE . 31.5 m -156.39 -53.82 0.08 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.154 -0.967 . . . . 0.0 110.425 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.668 HD11 HG12 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -66.07 174.82 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.397 -0.815 . . . . 0.0 110.409 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.446 ' O ' HG22 ' A' ' 166' ' ' VAL . 1.2 mtm180 -122.62 99.67 6.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.417 -0.802 . . . . 0.0 109.734 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.92 HG22 HG23 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -119.36 167.45 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.97 . . . . 0.0 110.173 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.819 ' C ' HG12 ' A' ' 163' ' ' VAL . 15.1 pt-20 -150.3 174.35 12.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.245 -0.909 . . . . 0.0 110.135 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.427 ' OE1' ' OXT' ' A' ' 226' ' ' LEU . 0.7 OUTLIER -43.96 143.04 1.2 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.47 -0.769 . . . . 0.0 110.23 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.427 ' OXT' ' OE1' ' A' ' 225' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.196 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.447 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 24.5 p30 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 120.784 0.326 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 130' ' ' ASN . 46.1 Cg_endo -72.98 -89.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.95 1.5 . . . . 0.0 110.496 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.96 135.56 94.71 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.234 -0.916 . . . . 0.0 110.147 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.09 -90.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.986 1.519 . . . . 0.0 110.444 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 139.53 -116.17 1.19 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.6 mm? 59.11 166.12 0.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -1.143 . . . . 0.0 110.2 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -80.96 86.05 6.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.188 -0.945 . . . . 0.0 110.274 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -142.28 57.25 1.46 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.295 -0.878 . . . . 0.0 110.239 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.38 142.6 32.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 0.0 110.215 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 122.81 -82.25 0.35 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 140' ' ' VAL . 7.1 p -83.72 48.68 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.236 -1.155 . . . . 0.0 110.258 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -157.97 90.43 0.11 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -70.68 78.1 0.6 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -1.174 . . . . 0.0 110.186 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.2 t -164.6 -169.38 1.73 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 110.223 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 144' ' ' ASP . 1.2 p30 -139.7 117.88 11.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.887 . . . . 0.0 110.208 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.647 ' O ' ' HB2' ' A' ' 146' ' ' ALA . . . -78.82 74.49 5.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.203 -0.936 . . . . 0.0 110.167 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 145' ' ' ALA . . . 172.97 -160.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.251 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . 65.71 137.66 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 110.23 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.442 ' HB2' ' OE2' ' A' ' 224' ' ' GLU . 46.8 Cg_endo -72.99 57.59 3.26 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.041 1.548 . . . . 0.0 110.435 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.552 ' HA3' ' HB2' ' A' ' 222' ' ' ARG . . . -133.18 159.16 23.48 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.538 ' O ' ' HB3' ' A' ' 154' ' ' ASP . 0.6 OUTLIER -158.15 17.63 0.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -1.153 . . . . 0.0 110.471 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.634 ' C ' HD12 ' A' ' 223' ' ' ILE . 0.5 OUTLIER 56.11 117.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.146 -0.971 . . . . 0.0 110.375 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 1.031 HG13 HG21 ' A' ' 223' ' ' ILE . 0.0 OUTLIER -41.39 -80.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.193 -0.942 . . . . 0.0 111.247 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 1.108 ' CG2' ' HB1' ' A' ' 218' ' ' ALA . 0.2 OUTLIER -47.44 -18.82 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.429 -0.795 . . . . 0.0 111.631 -178.628 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.616 ' HB2' ' CB ' ' A' ' 151' ' ' ARG . 0.3 OUTLIER -71.9 -13.49 61.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.798 -1.189 . . . . 0.0 109.094 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -125.63 2.08 7.55 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.653 -0.655 . . . . 0.0 109.624 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.74 ' O ' HG22 ' A' ' 157' ' ' THR . . . -81.04 -177.5 6.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.42 -0.8 . . . . 0.0 110.486 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.74 HG22 ' O ' ' A' ' 156' ' ' ALA . 7.2 t 40.11 -168.53 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.548 -0.72 . . . . 0.0 110.55 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.53 ' C ' ' O ' ' A' ' 157' ' ' THR . 25.0 p 34.64 76.58 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.327 -0.858 . . . . 0.0 110.16 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' MET . . . . . 0.479 ' N ' ' CD ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER 58.33 54.28 5.73 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.92 . . . . 0.0 109.586 -179.445 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.575 ' HB3' ' N ' ' A' ' 157' ' ' THR . 43.8 Cg_endo -71.2 -159.09 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.091 1.574 . . . . 0.0 110.682 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.514 ' CB ' ' O ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER 168.2 -153.94 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.317 -0.865 . . . . 0.0 110.301 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.533 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 0.1 OUTLIER -90.73 116.7 28.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -0.919 . . . . 0.0 110.539 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.69 HG12 ' O ' ' A' ' 224' ' ' GLU . 0.0 OUTLIER -112.26 -171.44 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.271 -0.893 . . . . 0.0 110.112 179.555 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.7 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -170.61 131.43 0.89 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.888 -1.133 . . . . 0.0 110.056 -179.592 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.949 HG23 HG22 ' A' ' 223' ' ' ILE . 0.5 OUTLIER -88.97 152.03 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.333 -0.854 . . . . 0.0 110.656 -179.197 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 222' ' ' ARG . 9.2 m -133.61 -1.67 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 110.184 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.573 ' CB ' ' HD2' ' A' ' 222' ' ' ARG . 0.1 OUTLIER -171.59 125.24 0.59 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 110.169 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.85 HD11 HG13 ' A' ' 171' ' ' ILE . 8.5 tt -90.21 -3.12 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.854 . . . . 0.0 110.235 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 168' ' ' ILE . 5.3 t-20 62.71 -141.26 0.4 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 110.243 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.87 109.0 18.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 110.306 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.85 HG13 HD11 ' A' ' 168' ' ' ILE . 41.9 mm -87.84 23.19 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 110.178 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -54.93 86.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.285 -0.884 . . . . 0.0 110.234 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.504 ' N ' ' O ' ' A' ' 171' ' ' ILE . 0.7 OUTLIER -142.99 -172.07 3.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 110.181 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.415 ' O ' HG22 ' A' ' 174' ' ' VAL . 9.2 p -122.41 -4.78 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 110.262 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.426 ' C ' HG22 ' A' ' 176' ' ' THR . 77.0 mt-10 -71.48 167.0 20.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.178 -0.951 . . . . 0.0 110.204 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -173.7 -95.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.191 -0.943 . . . . 0.0 110.229 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 176' ' ' THR . 4.2 t0 72.35 -140.21 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.283 -0.886 . . . . 0.0 110.273 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -58.42 -16.2 13.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.276 -0.89 . . . . 0.0 110.43 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 1.0 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -60.5 -22.84 64.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.081 -1.012 . . . . 0.0 110.135 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.503 HG23 ' OG1' ' A' ' 176' ' ' THR . 0.6 OUTLIER -54.55 -26.91 34.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.144 -0.973 . . . . 0.0 109.864 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.489 ' HB3' ' OE2' ' A' ' 212' ' ' GLU . 3.2 tt0 -69.26 -65.75 0.67 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.365 -0.834 . . . . 0.0 110.218 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.651 ' C ' HD12 ' A' ' 182' ' ' LEU . 4.5 pp -58.99 -15.07 11.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.884 . . . . 0.0 110.268 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 1.0 HD13 ' CZ ' ' A' ' 179' ' ' PHE . 0.7 OUTLIER -86.45 -31.18 21.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 109.998 179.8 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.15 -8.03 35.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.359 -0.838 . . . . 0.0 110.07 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -88.86 10.06 22.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.865 . . . . 0.0 110.176 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 185' ' ' ALA . 31.8 t0 41.69 66.66 0.66 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.907 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.3 tt -121.3 -173.56 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 110.54 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.701 ' C ' HG13 ' A' ' 189' ' ' VAL . 0.1 OUTLIER -171.81 122.53 0.5 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.701 HG13 ' C ' ' A' ' 188' ' ' ARG . 1.4 m 50.27 105.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.204 -0.935 . . . . 0.0 108.947 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.74 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -45.14 -12.99 0.03 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.631 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 4.1 t 65.84 -143.26 0.19 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.012 -1.287 . . . . 0.0 109.42 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.7 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 1.9 tt0 -71.31 102.86 2.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.572 -0.705 . . . . 0.0 109.487 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.607 HG13 ' C ' ' A' ' 192' ' ' GLU . 16.9 m -156.65 -140.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.097 -1.002 . . . . 0.0 109.967 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.645 ' HA ' HG23 ' A' ' 163' ' ' VAL . 8.3 pt-20 -176.88 138.1 0.26 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 110.728 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.692 ' C ' HD13 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -132.26 161.21 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.293 -0.88 . . . . 0.0 109.99 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.553 ' N ' HG12 ' A' ' 195' ' ' ILE . 37.5 t -154.75 150.3 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.421 -0.799 . . . . 0.0 110.165 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -58.92 119.53 7.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -0.943 . . . . 0.0 110.133 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 199' ' ' ASP . 0.0 OUTLIER -119.32 106.95 12.81 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.232 -0.917 . . . . 0.0 110.396 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 198' ' ' ARG . 15.9 m-20 40.75 79.71 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.254 -0.904 . . . . 0.0 110.372 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 44.84 25.12 0.85 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.414 ' O ' ' CB ' ' A' ' 198' ' ' ARG . 0.0 OUTLIER -150.18 106.83 3.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.214 -1.168 . . . . 0.0 110.132 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.728 HD13 HG22 ' A' ' 153' ' ' ILE . 49.8 mt -64.27 139.46 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 110.336 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 195' ' ' ILE . 3.7 m -119.16 150.32 40.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.338 -0.851 . . . . 0.0 109.935 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.56 ' HG ' ' HB ' ' A' ' 195' ' ' ILE . 0.5 OUTLIER -119.8 130.34 54.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 0.0 110.284 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.556 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 3.2 t -119.79 126.86 52.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.393 -0.817 . . . . 0.0 110.014 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.514 ' HB3' HG12 ' A' ' 193' ' ' VAL . 0.0 OUTLIER -114.19 106.64 14.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.451 -0.781 . . . . 0.0 109.836 180.0 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.493 ' HB3' ' O ' ' A' ' 206' ' ' HIS . 21.4 t30 61.01 17.4 7.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 110.243 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 114.04 -20.01 17.35 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -81.35 101.37 9.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -1.155 . . . . 0.0 110.277 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 210' ' ' ASP . 30.5 p30 -83.93 147.84 27.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.912 . . . . 0.0 110.292 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.409 ' CG1' ' CE1' ' A' ' 206' ' ' HIS . 4.3 p -155.12 151.66 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.319 -0.863 . . . . 0.0 110.167 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.489 ' OE2' ' HB3' ' A' ' 181' ' ' GLN . 15.4 pt-20 -57.28 148.05 23.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 0.0 110.165 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.48 ' HG ' ' HB2' ' A' ' 204' ' ' LEU . 0.4 OUTLIER -113.86 -149.33 0.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 110.2 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.723 HD13 ' CB ' ' A' ' 217' ' ' LEU . 0.4 OUTLIER -152.16 108.89 3.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 110.223 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -59.8 -38.67 82.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 110.304 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.417 ' OD2' ' OE1' ' A' ' 175' ' ' GLU . 0.2 OUTLIER -65.7 -44.71 85.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.911 . . . . 0.0 110.267 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.848 ' O ' HG22 ' A' ' 220' ' ' THR . 0.2 OUTLIER -85.83 -22.91 27.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.267 -0.896 . . . . 0.0 110.254 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 1.108 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -40.63 -44.84 2.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.334 -0.853 . . . . 0.0 110.288 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.455 ' CD2' ' HG2' ' A' ' 151' ' ' ARG . 39.8 t-80 -90.69 49.73 1.71 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.155 -0.966 . . . . 0.0 110.509 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' THR . . . . . 0.848 HG22 ' O ' ' A' ' 217' ' ' LEU . 3.0 t -137.52 -27.16 0.95 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.126 -0.984 . . . . 0.0 110.486 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.762 HG13 HD13 ' A' ' 165' ' ' ILE . 0.1 OUTLIER -95.23 144.5 9.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 120.998 -1.064 . . . . 0.0 110.362 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.573 ' HD2' ' CB ' ' A' ' 167' ' ' GLN . 3.7 ptp85 -95.06 106.72 18.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.146 -0.971 . . . . 0.0 109.405 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 1.031 HG21 HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -119.78 174.03 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.183 -0.948 . . . . 0.0 110.253 -179.132 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.69 ' O ' HG12 ' A' ' 163' ' ' VAL . 1.2 tt0 -124.65 171.95 9.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.096 -1.003 . . . . 0.0 110.583 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 6.8 tp10 -113.52 110.99 21.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.374 -0.829 . . . . 0.0 110.182 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 162' ' ' LYS . 7.6 mp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.984 -1.007 . . . . 0.0 110.16 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.733 0.302 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.16 -45.66 0.43 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.023 1.539 . . . . 0.0 110.38 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 9.9 tt -63.79 140.63 97.86 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.25 -0.906 . . . . 0.0 110.223 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.09 -166.86 0.32 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.962 1.506 . . . . 0.0 110.384 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.12 -119.6 2.01 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.4 tp -130.44 138.36 50.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.198 -1.178 . . . . 0.0 110.187 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 138' ' ' LEU . 0.5 OUTLIER 52.93 33.27 14.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.305 -0.872 . . . . 0.0 110.158 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 59.83 -85.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.314 -0.866 . . . . 0.0 110.21 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -63.04 127.73 32.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.283 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.14 -40.68 95.08 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.1 t -76.48 120.21 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -1.145 . . . . 0.0 110.224 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -68.14 -35.01 82.48 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -80.79 85.64 6.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.274 -1.133 . . . . 0.0 110.26 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 36.4 t -173.8 -46.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.259 -0.901 . . . . 0.0 110.244 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.26 -157.09 0.4 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 0.0 110.211 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.67 146.97 53.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.271 -0.893 . . . . 0.0 110.252 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.666 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -173.47 161.38 4.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.882 . . . . 0.0 110.207 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.666 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . 66.17 169.5 0.11 Allowed Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.21 -0.931 . . . . 0.0 110.173 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.642 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 45.8 Cg_endo -72.98 76.35 2.55 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.122 1.59 . . . . 0.0 110.358 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 151' ' ' ARG . . . -114.83 35.01 4.6 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.539 ' O ' ' CG1' ' A' ' 223' ' ' ILE . 23.8 m -42.07 93.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.37 -1.076 . . . . 0.0 110.236 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.568 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 7.2 ptp85 -42.02 142.75 0.66 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.219 -0.926 . . . . 0.0 110.112 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 1.01 ' CG1' HG23 ' A' ' 153' ' ' ILE . 0.8 OUTLIER -57.57 -153.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.176 -0.953 . . . . 0.0 110.039 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 1.096 HG21 ' CB ' ' A' ' 218' ' ' ALA . 11.8 pt 39.29 25.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.321 -0.862 . . . . 0.0 110.436 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER -135.55 -36.35 0.78 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.312 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -88.76 -9.94 50.06 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.667 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -74.7 107.42 6.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.546 -0.721 . . . . 0.0 110.234 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 158' ' ' SER . 5.7 t -174.11 169.62 3.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.272 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 159' ' ' MET . 0.6 OUTLIER 41.77 74.17 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.327 -0.858 . . . . 0.0 110.124 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 159' ' ' MET . . . . . 0.513 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 0.0 OUTLIER 63.51 165.9 0.11 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.144 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 44.6 Cg_endo -72.24 88.01 0.87 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.999 1.526 . . . . 0.0 110.435 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.2 ttt85 -65.61 -140.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 110.21 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -145.29 93.15 2.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.234 -0.916 . . . . 0.0 110.254 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.675 ' O ' ' O ' ' A' ' 193' ' ' VAL . 21.5 m -111.52 -172.94 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.0 110.224 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.643 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 12.8 ptt-85 -162.39 147.17 12.3 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.725 -1.234 . . . . 0.0 110.872 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 1.042 HG23 ' CG2' ' A' ' 223' ' ' ILE . 1.2 mt -98.71 165.84 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.493 -0.755 . . . . 0.0 110.273 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 222' ' ' ARG . 19.1 m -142.54 -31.8 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.158 -0.964 . . . . 0.0 110.484 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 222' ' ' ARG . 0.7 OUTLIER -140.34 123.91 17.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 110.282 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.67 HG13 HG22 ' A' ' 221' ' ' ILE . 7.4 tt -99.61 -5.95 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 110.117 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 168' ' ' ILE . 17.4 m120 55.05 164.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.315 -0.866 . . . . 0.0 110.204 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 169' ' ' ASN . 28.5 mt-10 -144.51 49.57 1.32 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.14 -0.975 . . . . 0.0 110.204 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.0 mm -100.23 -3.08 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.211 -0.931 . . . . 0.0 110.234 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -123.01 154.47 38.42 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.142 -0.974 . . . . 0.0 110.214 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 174' ' ' VAL . 0.0 OUTLIER -79.43 -26.99 41.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.226 -0.921 . . . . 0.0 110.187 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.661 HG11 HD12 ' A' ' 217' ' ' LEU . 41.6 t 43.91 74.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 110.344 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -103.88 116.96 33.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.289 -0.882 . . . . 0.0 110.107 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.638 HG22 ' HB3' ' A' ' 179' ' ' PHE . 2.9 m -155.42 134.56 12.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.901 . . . . 0.0 110.18 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 179' ' ' PHE . 1.1 p-10 -48.73 -101.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.316 -0.865 . . . . 0.0 111.248 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.484 ' C ' ' O ' ' A' ' 177' ' ' ASP . 5.1 pt20 -34.04 -30.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.258 -0.901 . . . . 0.0 111.082 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.638 ' HB3' HG22 ' A' ' 176' ' ' THR . 7.4 t80 -60.48 -59.59 5.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.944 . . . . 0.0 110.487 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.547 ' HA ' ' HB3' ' A' ' 183' ' ' LEU . 0.9 OUTLIER -37.98 -29.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.359 -0.838 . . . . 0.0 110.33 -179.706 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.504 ' N ' ' O ' ' A' ' 179' ' ' PHE . 24.4 tt0 -57.45 -56.69 18.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.202 -0.937 . . . . 0.0 110.019 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.573 ' C ' HD12 ' A' ' 182' ' ' LEU . 2.6 pp -70.03 -14.04 62.5 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.286 -0.884 . . . . 0.0 109.686 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.547 ' HB3' ' HA ' ' A' ' 180' ' ' THR . 0.4 OUTLIER -89.8 -32.13 17.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.393 -0.817 . . . . 0.0 109.775 179.676 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -69.4 -4.8 19.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.309 -0.869 . . . . 0.0 109.806 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -83.74 14.33 4.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.428 -0.795 . . . . 0.0 110.114 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 185' ' ' ALA . 0.7 OUTLIER 42.82 62.74 1.67 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.156 -0.965 . . . . 0.0 109.896 -179.793 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.8 tt -119.35 -173.78 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 110.52 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.719 ' C ' HG13 ' A' ' 189' ' ' VAL . 0.1 OUTLIER -174.53 115.56 0.18 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.362 -0.836 . . . . 0.0 108.748 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.719 HG13 ' C ' ' A' ' 188' ' ' ARG . 1.3 m 51.57 108.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.298 -0.876 . . . . 0.0 109.073 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.794 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -46.12 -13.96 0.08 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.568 ' O ' ' HB2' ' A' ' 164' ' ' ARG . 7.7 t 63.93 -146.87 0.3 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -1.148 . . . . 0.0 109.483 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.643 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.2 OUTLIER -63.4 99.63 0.21 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.618 -0.676 . . . . 0.0 109.576 179.336 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.675 ' O ' ' O ' ' A' ' 163' ' ' VAL . 26.2 m -157.28 -135.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -0.93 . . . . 0.0 109.603 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.599 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.3 OUTLIER -175.04 160.47 2.78 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.124 179.297 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.797 HD13 ' CG2' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -119.97 176.62 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.074 -1.016 . . . . 0.0 110.227 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.463 HG23 ' C ' ' A' ' 195' ' ' ILE . 7.4 t -148.7 86.7 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.291 -0.881 . . . . 0.0 110.183 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 197' ' ' ASP . 15.8 p-10 -43.8 127.33 5.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 110.245 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.499 ' O ' ' C ' ' A' ' 199' ' ' ASP . 21.9 mtt180 -99.76 71.58 1.7 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -0.889 . . . . 0.0 110.37 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 198' ' ' ARG . 3.9 p-10 36.18 39.74 0.09 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.366 -0.833 . . . . 0.0 110.413 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 140.75 -48.77 0.81 Allowed Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.453 ' O ' ' CG1' ' A' ' 202' ' ' ILE . 0.1 OUTLIER -89.9 -158.12 0.51 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -1.11 . . . . 0.0 109.801 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.906 ' CD1' HG22 ' A' ' 153' ' ' ILE . 8.1 mt -155.63 159.53 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.073 -1.017 . . . . 0.0 110.571 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.613 ' O ' HG22 ' A' ' 195' ' ' ILE . 43.2 m -144.32 151.97 40.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.534 -0.729 . . . . 0.0 109.464 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 1.093 HD22 ' CE1' ' A' ' 206' ' ' HIS . 0.5 OUTLIER -119.91 129.09 54.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.166 -0.959 . . . . 0.0 110.536 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.59 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.5 OUTLIER -119.98 119.8 34.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.424 -0.797 . . . . 0.0 109.826 179.77 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 1.093 ' CE1' HD22 ' A' ' 204' ' ' LEU . 2.1 m-70 -107.31 152.35 24.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.498 -0.751 . . . . 0.0 109.931 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -49.04 -20.54 0.55 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.15 -0.969 . . . . 0.0 110.059 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 209' ' ' LYS . . . -91.2 -31.81 9.42 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 208' ' ' GLY . 10.4 pttt 174.02 -173.95 0.06 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.211 -1.17 . . . . 0.0 110.173 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 4.6 p30 -112.17 161.59 16.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.893 . . . . 0.0 110.413 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 39.1 t -147.04 147.14 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 0.0 110.127 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.0 160.74 30.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.0 110.283 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.704 ' C ' HD23 ' A' ' 214' ' ' LEU . 2.9 mt -131.83 -160.11 1.02 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.203 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.711 HD23 ' N ' ' A' ' 214' ' ' LEU . 0.9 OUTLIER -173.15 169.18 4.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.19 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -75.81 -26.17 56.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 110.183 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.537 ' CB ' HD12 ' A' ' 214' ' ' LEU . 1.0 OUTLIER -63.21 -57.02 11.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 110.125 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.661 HD12 HG11 ' A' ' 174' ' ' VAL . 0.2 OUTLIER -78.35 -28.0 47.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 110.112 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 1.096 ' CB ' HG21 ' A' ' 153' ' ' ILE . . . -40.05 -63.8 0.57 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.369 -0.832 . . . . 0.0 110.487 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.415 ' HB2' HD11 ' A' ' 153' ' ' ILE . 3.5 t-160 -91.77 77.59 5.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.879 . . . . 0.0 110.306 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 4.9 m -166.74 -48.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 0.0 110.44 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.67 HG22 HG13 ' A' ' 168' ' ' ILE . 0.1 OUTLIER -73.98 136.75 24.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.361 -0.837 . . . . 0.0 110.786 -179.66 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.718 ' O ' HG22 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -89.39 112.91 24.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.212 -0.93 . . . . 0.0 109.256 179.275 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 1.042 ' CG2' HG23 ' A' ' 165' ' ' ILE . 0.7 OUTLIER -119.97 -169.48 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.158 -0.964 . . . . 0.0 110.808 -179.053 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 148' ' ' PRO . 30.8 mt-10 -150.25 156.57 41.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.449 -0.782 . . . . 0.0 110.051 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -107.48 99.2 8.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 110.254 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.233 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.478 ' ND2' ' HB3' ' A' ' 133' ' ' PRO . 6.9 t30 . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.522 ' O ' ' HD3' ' A' ' 133' ' ' PRO . 44.3 Cg_endo -72.59 -85.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.05 1.553 . . . . 0.0 110.58 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 30.3 mt -106.12 85.96 1.83 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 110.134 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 131' ' ' PRO . 45.9 Cg_endo -72.6 -53.95 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.992 1.522 . . . . 0.0 110.453 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.43 42.48 2.01 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.54 HD12 HG21 ' A' ' 140' ' ' VAL . 1.4 tp -124.28 26.16 7.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.293 -1.122 . . . . 0.0 110.254 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -103.62 -88.22 0.42 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.898 . . . . 0.0 110.085 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -109.6 -17.98 13.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.284 -0.885 . . . . 0.0 110.208 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.72 -43.72 92.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.253 -0.904 . . . . 0.0 110.189 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 99.48 165.47 29.61 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.54 HG21 HD12 ' A' ' 135' ' ' LEU . 25.5 t -115.23 -19.04 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.247 -1.149 . . . . 0.0 110.16 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 140' ' ' VAL . . . 44.08 -151.08 0.63 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.649 ' OD1' ' HB3' ' A' ' 145' ' ' ALA . 0.5 OUTLIER 47.02 30.37 1.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -1.135 . . . . 0.0 110.223 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.54 -60.22 2.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 110.216 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -123.12 66.53 0.98 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.288 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.649 ' HB3' ' OD1' ' A' ' 142' ' ' ASN . . . -137.93 -166.95 2.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 110.113 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -124.91 -90.6 0.55 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.153 -0.967 . . . . 0.0 110.394 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -83.95 134.62 43.64 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.917 . . . . 0.0 110.394 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.8 89.12 1.01 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.989 1.521 . . . . 0.0 110.344 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.476 ' O ' ' HG2' ' A' ' 222' ' ' ARG . . . -48.21 123.41 9.62 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.821 HG22 ' N ' ' A' ' 151' ' ' ARG . 2.2 m -47.39 -89.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -1.142 . . . . 0.0 110.088 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.821 ' N ' HG22 ' A' ' 150' ' ' THR . 0.0 OUTLIER 169.07 135.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.89 . . . . 0.0 110.01 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.918 HG11 HD11 ' A' ' 221' ' ' ILE . 1.2 m -37.85 -92.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.346 -0.846 . . . . 0.0 111.302 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 1.02 HD12 ' N ' ' A' ' 154' ' ' ASP . 1.9 pp -41.04 -23.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.151 -0.968 . . . . 0.0 111.032 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 1.02 ' N ' HD12 ' A' ' 153' ' ' ILE . 1.2 m-20 -75.12 -16.79 60.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.107 -0.996 . . . . 0.0 110.001 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -109.9 -16.21 13.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.398 -0.814 . . . . 0.0 110.178 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.425 ' O ' ' OG1' ' A' ' 157' ' ' THR . . . -82.7 99.72 9.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.342 -0.849 . . . . 0.0 110.303 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 156' ' ' ALA . 3.2 m -169.8 152.11 4.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.261 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 159' ' ' MET . 6.4 t 55.41 88.29 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.897 . . . . 0.0 110.27 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' MET . . . . . 0.426 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 27.4 mtm 55.83 169.5 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 110.183 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.459 ' HB3' HG22 ' A' ' 196' ' ' VAL . 45.9 Cg_endo -72.87 91.29 0.82 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.047 1.551 . . . . 0.0 110.417 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -82.32 129.05 34.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 0.0 110.073 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.487 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 2.4 mmtp -68.91 125.5 26.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.898 . . . . 0.0 110.427 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.738 HG12 ' HA ' ' A' ' 225' ' ' GLU . 29.2 m -141.63 -153.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.229 -0.92 . . . . 0.0 110.234 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.618 ' HG2' ' N ' ' A' ' 165' ' ' ILE . 0.0 OUTLIER -176.21 153.94 1.32 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.901 -1.124 . . . . 0.0 110.213 -179.452 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 1.073 HG21 ' HB ' ' A' ' 189' ' ' VAL . 20.1 mt -102.36 176.21 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.159 -0.963 . . . . 0.0 111.291 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.91 HG22 ' O ' ' A' ' 222' ' ' ARG . 2.7 m -126.36 -28.2 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.664 -0.648 . . . . 0.0 109.561 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.622 ' HA ' ' CG2' ' A' ' 189' ' ' VAL . 0.5 OUTLIER 162.22 147.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.558 -0.714 . . . . 0.0 110.515 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.855 ' HA ' HG22 ' A' ' 221' ' ' ILE . 2.7 mt -66.0 -7.29 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.484 -0.76 . . . . 0.0 109.088 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.484 ' O ' ' HB2' ' A' ' 170' ' ' GLU . 0.1 OUTLIER 53.45 108.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.593 -0.692 . . . . 0.0 110.305 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 169' ' ' ASN . 1.0 OUTLIER 61.78 76.88 0.35 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -0.885 . . . . 0.0 110.278 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.505 HG22 ' HB ' ' A' ' 168' ' ' ILE . 1.7 pp -80.05 6.18 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.894 . . . . 0.0 110.181 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -49.06 -25.53 2.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 110.306 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -71.86 163.61 27.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.937 . . . . 0.0 110.335 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.774 ' O ' HG22 ' A' ' 174' ' ' VAL . 7.0 p -169.95 39.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.248 -0.908 . . . . 0.0 110.264 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.606 ' O ' ' C ' ' A' ' 176' ' ' THR . 18.6 pt-20 -72.73 -152.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.127 -0.983 . . . . 0.0 110.348 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.764 HG23 ' O ' ' A' ' 176' ' ' THR . 9.7 t 21.9 94.39 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.747 -0.595 . . . . 0.0 111.091 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.486 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.1 OUTLIER -60.49 -12.05 8.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.178 -0.951 . . . . 0.0 110.235 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -76.47 -6.9 53.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.118 -0.989 . . . . 0.0 110.251 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.757 ' HB3' HG23 ' A' ' 176' ' ' THR . 0.0 OUTLIER -87.02 -31.61 20.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.169 -0.957 . . . . 0.0 110.112 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.502 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 1.1 p -42.69 -31.62 0.49 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 109.808 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -60.6 -22.84 64.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.357 -0.839 . . . . 0.0 109.608 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.69 HD22 ' CG1' ' A' ' 211' ' ' VAL . 13.6 mt -83.17 -39.8 20.55 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.343 -0.848 . . . . 0.0 109.089 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.422 HD13 ' HZ ' ' A' ' 179' ' ' PHE . 0.5 OUTLIER -74.75 -29.13 61.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.61 -0.681 . . . . 0.0 109.778 179.633 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -72.73 -2.62 21.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 109.882 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.581 ' HB3' HG22 ' A' ' 187' ' ' ILE . . . -88.53 14.86 8.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.316 -0.865 . . . . 0.0 110.205 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 185' ' ' ALA . 0.2 OUTLIER 42.37 30.97 0.24 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 109.209 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.581 HG22 ' HB3' ' A' ' 185' ' ' ALA . 4.5 tt -116.29 164.34 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.602 -0.687 . . . . 0.0 110.48 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.424 ' N ' HG12 ' A' ' 187' ' ' ILE . 1.8 ttp180 -134.05 161.28 35.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.308 -0.87 . . . . 0.0 109.116 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 1.1 HG11 HG21 ' A' ' 221' ' ' ILE . 14.0 m -79.53 -37.39 18.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.871 -1.143 . . . . 0.0 109.099 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.642 ' HA2' ' CA ' ' A' ' 166' ' ' VAL . . . -56.07 50.54 0.01 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.768 ' N ' ' O ' ' A' ' 189' ' ' VAL . 1.8 t -140.66 167.36 22.35 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.372 -1.075 . . . . 0.0 109.228 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.61 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 1.4 mt-10 -65.46 122.45 17.21 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.794 -0.763 . . . . 0.0 109.036 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.683 ' HA ' ' O ' ' A' ' 205' ' ' SER . 0.4 OUTLIER -160.44 144.79 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.042 -1.036 . . . . 0.0 110.254 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.673 ' HA ' HG22 ' A' ' 163' ' ' VAL . 1.4 pt-20 -112.18 159.84 18.17 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.346 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 1.07 HG23 ' HG ' ' A' ' 204' ' ' LEU . 1.2 mt -119.53 153.93 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.069 -1.019 . . . . 0.0 110.532 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.459 HG22 ' HB3' ' A' ' 160' ' ' PRO . 42.3 t -127.63 107.57 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.482 -0.761 . . . . 0.0 109.991 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -75.17 111.74 10.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.928 . . . . 0.0 110.286 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.476 ' O ' ' C ' ' A' ' 199' ' ' ASP . 0.0 OUTLIER -102.89 67.03 0.95 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.217 -0.927 . . . . 0.0 110.299 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 198' ' ' ARG . 25.4 m-20 38.97 37.55 0.22 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.349 -0.844 . . . . 0.0 110.213 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 141.1 -43.16 1.12 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.451 ' O ' ' N ' ' A' ' 198' ' ' ARG . 0.1 OUTLIER -90.12 123.55 34.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -1.122 . . . . 0.0 110.139 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.946 HD13 HG22 ' A' ' 153' ' ' ILE . 10.4 mt -126.36 99.54 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.112 -0.993 . . . . 0.0 110.348 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.663 HG23 ' O ' ' A' ' 211' ' ' VAL . 89.9 m -106.86 157.45 17.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.318 -0.864 . . . . 0.0 109.878 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 1.07 ' HG ' HG23 ' A' ' 195' ' ' ILE . 2.0 mp -120.05 150.31 40.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.458 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.683 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 16.4 t -119.42 110.48 16.98 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.458 -0.776 . . . . 0.0 109.228 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.681 ' ND1' HG11 ' A' ' 193' ' ' VAL . 22.5 m-70 -92.45 153.58 19.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.597 -0.689 . . . . 0.0 110.129 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.464 ' N ' ' OD1' ' A' ' 207' ' ' ASN . 26.6 p-10 -51.77 93.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 110.286 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 136.91 -32.45 2.44 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 208' ' ' GLY . 0.0 OUTLIER 176.56 160.15 0.35 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -1.151 . . . . 0.0 110.285 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.537 ' O ' HG23 ' A' ' 211' ' ' VAL . 1.9 p-10 -109.68 174.78 5.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.33 -0.856 . . . . 0.0 110.117 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.69 ' CG1' HD22 ' A' ' 182' ' ' LEU . 45.6 t -154.6 140.98 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.378 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -73.48 74.37 1.43 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.4 -0.812 . . . . 0.0 110.219 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.616 ' CB ' ' CD1' ' A' ' 204' ' ' LEU . 30.6 tp -57.89 162.62 3.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.917 . . . . 0.0 110.273 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.574 ' O ' ' HB2' ' A' ' 218' ' ' ALA . 3.2 mm? -51.37 146.74 6.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 0.0 110.189 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 218' ' ' ALA . 2.1 m-20 -83.17 -102.39 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.942 . . . . 0.0 109.906 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.97 -24.48 1.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.0 -1.062 . . . . 0.0 109.742 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.671 ' HA ' ' CE1' ' A' ' 219' ' ' HIS . 0.1 OUTLIER -90.15 -14.25 33.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.319 -0.863 . . . . 0.0 110.211 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.73 ' CB ' HG23 ' A' ' 153' ' ' ILE . . . -29.98 -49.07 0.1 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.506 -0.746 . . . . 0.0 110.723 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.671 ' CE1' ' HA ' ' A' ' 217' ' ' LEU . 38.5 p-80 -51.37 78.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.364 -0.835 . . . . 0.0 110.404 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' THR . . . . . 0.659 ' N ' ' O ' ' A' ' 218' ' ' ALA . 1.2 p -136.56 -28.76 0.98 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 110.365 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 1.1 HG21 HG11 ' A' ' 189' ' ' VAL . 0.1 OUTLIER -109.98 154.74 11.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 O-C-N 121.196 -0.94 . . . . 0.0 110.584 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.91 ' O ' HG22 ' A' ' 166' ' ' VAL . 0.6 OUTLIER -89.03 94.41 9.94 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 178.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 1.029 ' CG2' HG23 ' A' ' 165' ' ' ILE . 0.4 OUTLIER -119.38 149.43 21.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.322 -0.861 . . . . 0.0 110.712 -178.202 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.83 ' N ' HD12 ' A' ' 223' ' ' ILE . 13.9 pt-20 -132.02 178.51 6.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.417 -0.802 . . . . 0.0 110.096 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.738 ' HA ' HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -85.93 173.97 9.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 110.349 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.411 ' HA ' HD22 ' A' ' 226' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.203 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 120.823 0.344 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.25 -90.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.006 1.529 . . . . 0.0 110.417 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 17.0 mm -96.63 122.44 57.12 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 110.141 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.43 -53.66 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.917 1.483 . . . . 0.0 110.372 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -156.74 -89.55 0.07 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.2 mt -104.29 -166.51 1.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.291 -1.123 . . . . 0.0 110.162 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 46.0 t0 -106.83 -20.96 13.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 110.209 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -63.97 85.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.315 -0.866 . . . . 0.0 110.208 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.534 ' HA ' HD13 ' A' ' 138' ' ' LEU . 0.4 OUTLIER -65.12 -61.76 1.95 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 0.0 110.206 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -85.92 -139.77 5.33 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.565 ' O ' HG13 ' A' ' 140' ' ' VAL . 7.3 p -170.02 69.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -1.17 . . . . 0.0 110.214 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.52 25.03 40.51 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 9.3 m120 52.05 89.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -1.114 . . . . 0.0 110.227 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.4 m -92.47 170.43 9.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 0.0 110.17 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.71 154.06 23.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.294 -0.879 . . . . 0.0 110.172 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.16 178.81 7.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.302 -0.874 . . . . 0.0 110.225 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.564 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -161.58 84.03 0.62 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.928 . . . . 0.0 110.201 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . 60.96 156.89 0.11 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.899 . . . . 0.0 110.309 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.43 57.97 3.64 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.968 1.51 . . . . 0.0 110.383 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.453 ' CA ' ' HB3' ' A' ' 222' ' ' ARG . . . -160.44 152.41 23.15 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.672 ' O ' HG22 ' A' ' 150' ' ' THR . 58.1 m -147.23 18.0 1.21 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -1.137 . . . . 0.0 110.242 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.968 ' HG3' HD11 ' A' ' 153' ' ' ILE . 1.9 mpp_? 63.15 127.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.964 . . . . 0.0 110.184 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.795 HG13 ' O ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER -78.6 36.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.121 -0.987 . . . . 0.0 111.155 -179.648 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.968 HD11 ' HG3' ' A' ' 151' ' ' ARG . 0.1 OUTLIER -138.84 -32.27 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.865 -1.147 . . . . 0.0 110.226 179.45 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.94 -12.67 61.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.454 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.519 ' O ' ' CB ' ' A' ' 161' ' ' ARG . . . -103.64 -14.03 16.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.516 -0.74 . . . . 0.0 109.966 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.913 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -81.8 72.64 8.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 110.273 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.451 ' OG1' ' HD3' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -73.54 -171.64 1.05 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.251 -0.906 . . . . 0.0 110.111 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.487 ' OG ' ' N ' ' A' ' 159' ' ' MET . 0.9 OUTLIER -42.41 -57.65 2.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 0.0 110.132 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' MET . . . . . 0.487 ' N ' ' OG ' ' A' ' 158' ' ' SER . 3.0 mmt -75.68 165.19 55.38 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.891 . . . . 0.0 110.081 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 44.4 Cg_endo -72.14 73.21 2.64 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.976 1.514 . . . . 0.0 110.444 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 155' ' ' ALA . 1.8 tpt180 -51.64 127.38 20.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -0.951 . . . . 0.0 110.197 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -74.8 125.4 28.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.873 . . . . 0.0 110.36 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.669 HG23 ' HA ' ' A' ' 194' ' ' GLU . 0.1 OUTLIER -144.86 -166.16 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 110.112 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.667 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -169.19 136.66 1.83 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.824 -1.172 . . . . 0.0 110.101 -179.601 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.945 HG23 HG22 ' A' ' 223' ' ' ILE . 0.9 OUTLIER -92.52 153.08 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.294 -0.879 . . . . 0.0 110.489 -179.434 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.476 ' CG1' ' NE ' ' A' ' 164' ' ' ARG . 11.1 m -145.43 11.22 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 110.204 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -170.91 123.92 0.63 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.229 -0.92 . . . . 0.0 110.195 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.52 HG13 HG22 ' A' ' 221' ' ' ILE . 19.2 tt -131.3 4.99 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.326 -0.858 . . . . 0.0 110.15 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.432 ' O ' ' CB ' ' A' ' 170' ' ' GLU . 4.4 p30 -52.58 169.05 0.09 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 110.163 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.432 ' CB ' ' O ' ' A' ' 169' ' ' ASN . 0.3 OUTLIER 64.86 44.8 3.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.182 -0.949 . . . . 0.0 110.134 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.512 HD12 ' C ' ' A' ' 171' ' ' ILE . 1.3 pp -119.61 31.95 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.27 -0.894 . . . . 0.0 110.22 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.27 89.7 1.21 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 110.215 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -106.06 165.38 11.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.274 -0.891 . . . . 0.0 110.205 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.5 m -106.72 11.45 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.161 -0.962 . . . . 0.0 110.27 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.78 139.74 37.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.896 . . . . 0.0 110.18 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.957 HG23 HG23 ' A' ' 180' ' ' THR . 54.4 m -118.88 -92.81 0.53 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 110.245 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.526 ' N ' HG22 ' A' ' 176' ' ' THR . 0.4 OUTLIER 66.3 -165.62 0.22 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.212 -0.93 . . . . 0.0 110.28 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -55.2 -20.64 11.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.261 -0.899 . . . . 0.0 110.294 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.98 ' CE2' HD13 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -49.17 -26.29 2.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.195 -0.941 . . . . 0.0 109.983 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.957 HG23 HG23 ' A' ' 176' ' ' THR . 0.2 OUTLIER -55.15 -26.42 38.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.884 . . . . 0.0 109.949 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -69.29 -63.36 1.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.321 -0.862 . . . . 0.0 110.114 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.8 HD12 ' N ' ' A' ' 183' ' ' LEU . 4.4 pp -61.6 -15.91 43.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.379 -0.826 . . . . 0.0 110.114 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.98 HD13 ' CE2' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -91.1 -28.55 17.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.162 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 180' ' ' THR . 18.9 t70 -79.99 4.25 17.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 110.183 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -85.12 16.66 3.38 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.862 . . . . 0.0 110.188 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 185' ' ' ALA . 3.8 t0 41.66 43.17 2.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.248 -0.907 . . . . 0.0 109.92 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.6 tt -102.9 -178.5 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.874 . . . . 0.0 110.367 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.717 ' C ' HG13 ' A' ' 189' ' ' VAL . 9.4 ptt180 -170.52 117.48 0.51 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.717 HG13 ' C ' ' A' ' 188' ' ' ARG . 1.3 m 51.3 108.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.199 -0.938 . . . . 0.0 109.154 -178.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.816 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -45.63 -13.65 0.06 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 3.7 t 66.05 -144.14 0.19 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.071 -1.253 . . . . 0.0 109.421 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.667 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -65.21 101.93 0.6 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.474 -0.766 . . . . 0.0 109.267 179.221 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.623 ' O ' ' O ' ' A' ' 163' ' ' VAL . 23.0 m -156.9 -138.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -0.948 . . . . 0.0 110.033 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.669 ' HA ' HG23 ' A' ' 163' ' ' VAL . 1.1 pp20? -175.48 160.85 2.61 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.293 -0.88 . . . . 0.0 110.142 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.913 HD12 ' HB2' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -120.86 169.81 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.159 -0.963 . . . . 0.0 110.335 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 196' ' ' VAL . 4.7 p -149.67 77.38 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.883 . . . . 0.0 110.032 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 202' ' ' ILE . 11.8 t70 -40.78 142.22 0.49 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 110.336 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.475 ' O ' ' N ' ' A' ' 200' ' ' GLY . 1.9 ttp180 -139.77 -174.6 3.95 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.205 -0.935 . . . . 0.0 110.315 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -42.28 96.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.258 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 198' ' ' ARG . . . 44.01 29.48 1.51 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -150.26 113.72 4.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.252 -1.146 . . . . 0.0 110.215 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.619 HD13 HG22 ' A' ' 153' ' ' ILE . 70.3 mt -94.24 144.99 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 0.0 110.167 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.529 ' HB ' ' CG1' ' A' ' 196' ' ' VAL . 1.2 m -126.32 156.09 40.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.056 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.949 HD22 ' CE1' ' A' ' 206' ' ' HIS . 1.0 OUTLIER -119.82 131.98 55.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -0.956 . . . . 0.0 110.232 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.538 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 20.1 t -119.75 124.6 46.58 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.3 -0.875 . . . . 0.0 109.781 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.949 ' CE1' HD22 ' A' ' 204' ' ' LEU . 3.1 m-70 -106.02 158.95 16.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.417 -0.802 . . . . 0.0 109.999 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -62.0 72.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 110.155 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 153.63 -21.07 0.71 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 208' ' ' GLY . 0.3 OUTLIER 169.93 149.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.161 -1.199 . . . . 0.0 110.218 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 1.2 p30 -97.08 -171.99 2.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.92 . . . . 0.0 110.13 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 8.7 p -158.69 165.36 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -0.917 . . . . 0.0 110.226 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -69.49 141.04 54.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 110.239 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.798 HD13 ' N ' ' A' ' 214' ' ' LEU . 0.3 OUTLIER -148.15 145.04 28.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.932 . . . . 0.0 110.173 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.798 ' N ' HD13 ' A' ' 213' ' ' LEU . 0.6 OUTLIER -133.61 143.49 48.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.268 -0.895 . . . . 0.0 110.21 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.617 ' HA ' ' HB3' ' A' ' 218' ' ' ALA . 0.3 OUTLIER -50.2 -51.56 43.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.197 -0.94 . . . . 0.0 110.185 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.771 ' HB2' HD12 ' A' ' 214' ' ' LEU . 0.5 OUTLIER -43.38 -49.18 7.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.932 . . . . 0.0 110.262 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.59 ' HB2' HD11 ' A' ' 214' ' ' LEU . 0.4 OUTLIER -89.12 -26.77 21.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.891 . . . . 0.0 110.14 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.758 ' HB2' ' CD1' ' A' ' 213' ' ' LEU . . . -64.83 -17.68 64.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.257 -0.902 . . . . 0.0 110.091 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.658 ' O ' HG23 ' A' ' 220' ' ' THR . 0.2 OUTLIER -89.2 56.56 3.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.135 -0.978 . . . . 0.0 110.217 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 220' ' ' THR . . . . . 0.658 HG23 ' O ' ' A' ' 219' ' ' HIS . 17.6 p -158.12 -47.22 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 0.0 110.372 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.7 HD13 ' N ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -63.17 130.93 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.29 -0.881 . . . . 0.0 110.52 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.453 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . 37.0 mtt85 -91.67 104.09 16.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.345 -0.847 . . . . 0.0 109.618 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.945 HG22 HG23 ' A' ' 165' ' ' ILE . 0.1 OUTLIER -119.51 171.53 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.144 -0.973 . . . . 0.0 110.023 -179.566 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.589 ' C ' HG12 ' A' ' 163' ' ' VAL . 6.6 mm-40 -140.13 167.58 21.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.163 -0.961 . . . . 0.0 110.415 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 8.1 pt-20 -91.53 38.85 0.99 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.381 -0.824 . . . . 0.0 110.247 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.175 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.559 ' CB ' ' CD ' ' A' ' 131' ' ' PRO . 1.5 m-80 . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.559 ' CD ' ' CB ' ' A' ' 130' ' ' ASN . 46.9 Cg_endo -73.01 53.67 2.49 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.975 1.513 . . . . 0.0 110.494 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 5.9 pt -104.27 161.04 24.07 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.199 -0.938 . . . . 0.0 110.262 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.0 -12.4 25.94 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.0 1.526 . . . . 0.0 110.464 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 135' ' ' LEU . . . 118.51 -77.32 0.3 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.448 ' CB ' ' O ' ' A' ' 134' ' ' GLY . 0.2 OUTLIER 65.29 138.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.294 -1.121 . . . . 0.0 110.241 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 17.7 p30 -61.98 96.63 0.07 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 110.22 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.2 89.12 4.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.933 . . . . 0.0 110.232 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.538 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -48.95 168.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.297 -0.877 . . . . 0.0 110.223 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -164.22 68.53 0.21 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.714 ' O ' HG13 ' A' ' 140' ' ' VAL . 8.2 p -171.32 91.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.279 -1.13 . . . . 0.0 110.228 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.13 -172.83 54.86 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.452 ' O ' ' O ' ' A' ' 143' ' ' SER . 8.9 t30 -137.62 -59.94 0.66 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -1.132 . . . . 0.0 110.16 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.452 ' O ' ' O ' ' A' ' 142' ' ' ASN . 1.5 p -50.01 -178.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 110.226 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 15.9 t0 60.57 104.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.213 -0.929 . . . . 0.0 110.2 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -110.22 -16.58 13.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.316 -0.865 . . . . 0.0 110.176 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -161.08 129.28 4.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.186 -0.946 . . . . 0.0 110.11 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . 58.71 156.12 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.342 -0.849 . . . . 0.0 110.161 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.51 52.67 2.48 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.967 1.509 . . . . 0.0 110.44 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 222' ' ' ARG . . . 131.84 157.5 8.72 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.544 ' O ' ' CG1' ' A' ' 223' ' ' ILE . 54.2 m -123.31 143.56 50.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.308 -1.113 . . . . 0.0 110.163 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 154' ' ' ASP . 0.1 OUTLIER -50.16 127.69 17.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.123 -0.986 . . . . 0.0 110.055 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.795 HG12 ' O ' ' A' ' 218' ' ' ALA . 2.5 p -43.88 -25.49 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.103 -0.998 . . . . 0.0 110.378 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.71 HG22 HD13 ' A' ' 202' ' ' ILE . 1.3 pt -95.22 -14.04 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 110.325 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.539 ' HB3' ' CG2' ' A' ' 150' ' ' THR . 2.0 m-20 -77.35 -19.28 56.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.994 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -97.36 -13.0 22.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.371 -0.831 . . . . 0.0 110.016 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 157' ' ' THR . . . -51.06 166.07 0.1 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.875 . . . . 0.0 110.262 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.533 ' O ' ' CB ' ' A' ' 158' ' ' SER . 14.7 m 51.93 167.37 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.315 -0.866 . . . . 0.0 110.398 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 157' ' ' THR . 0.1 OUTLIER 70.89 -52.14 0.68 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.24 -0.913 . . . . 0.0 110.309 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -100.72 139.17 20.36 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.175 -0.953 . . . . 0.0 110.147 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.552 ' O ' ' C ' ' A' ' 161' ' ' ARG . 45.4 Cg_endo -72.92 71.85 3.35 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.962 1.506 . . . . 0.0 110.426 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.781 ' HB3' HG22 ' A' ' 196' ' ' VAL . 7.7 ptt180 27.12 99.8 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.505 0.669 . . . . 0.0 111.282 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -170.72 56.41 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.175 -0.953 . . . . 0.0 109.995 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.669 ' O ' ' O ' ' A' ' 193' ' ' VAL . 34.9 m -141.83 -151.83 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.925 0.869 . . . . 0.0 110.503 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.671 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 16.4 ptt180 -175.46 169.03 3.21 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.86 -1.15 . . . . 0.0 110.433 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 1.068 HG23 HG22 ' A' ' 223' ' ' ILE . 0.1 OUTLIER -99.78 162.98 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.302 -0.874 . . . . 0.0 109.848 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.817 HG22 ' O ' ' A' ' 222' ' ' ARG . 27.0 m -137.28 -24.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.177 -0.952 . . . . 0.0 110.759 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.551 ' HB2' ' CD ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -152.45 127.89 9.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.038 -1.039 . . . . 0.0 110.458 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.771 HG13 HG22 ' A' ' 221' ' ' ILE . 1.2 tt -96.69 -1.68 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.983 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 168' ' ' ILE . 38.1 m-80 56.6 -95.17 0.05 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 110.231 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.554 ' HG3' ' CZ ' ' A' ' 172' ' ' PHE . 4.3 pt-20 -168.2 83.1 0.18 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.066 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.911 HD13 ' CD2' ' A' ' 217' ' ' LEU . 2.4 pp -86.57 25.78 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.329 -0.857 . . . . 0.0 110.377 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.6 ' C ' ' O ' ' A' ' 171' ' ' ILE . 0.9 OUTLIER 22.83 -136.26 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.583 -0.698 . . . . 0.0 111.024 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.659 ' C ' HG23 ' A' ' 176' ' ' THR . 60.8 mt-30 -107.66 -90.55 0.44 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.193 -0.942 . . . . 0.0 110.258 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.581 ' O ' ' N ' ' A' ' 176' ' ' THR . 6.7 t 59.64 90.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.891 . . . . 0.0 110.291 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.565 ' HB3' ' O ' ' A' ' 174' ' ' VAL . 3.7 tt0 63.63 -56.69 0.2 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.489 -0.757 . . . . 0.0 110.822 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.659 HG23 ' C ' ' A' ' 173' ' ' GLN . 8.9 p 45.54 -91.72 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.301 -0.874 . . . . 0.0 110.215 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 178' ' ' GLN . 12.5 t0 43.72 -93.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 110.129 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.528 ' N ' ' O ' ' A' ' 176' ' ' THR . 1.4 mt-30 -48.38 -25.11 1.46 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.179 -0.951 . . . . 0.0 110.015 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.985 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 3.0 t80 -82.97 -52.77 6.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.99 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 177' ' ' ASP . 0.3 OUTLIER -43.65 -25.15 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.172 -0.955 . . . . 0.0 109.889 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -69.17 -64.59 0.84 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.305 -0.872 . . . . 0.0 110.19 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.576 ' HB3' HG11 ' A' ' 211' ' ' VAL . 3.5 pp -63.92 -13.6 46.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.357 -0.839 . . . . 0.0 109.848 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.985 HD13 ' CZ ' ' A' ' 179' ' ' PHE . 1.7 tp -87.81 -30.42 20.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.387 -0.821 . . . . 0.0 109.861 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -72.18 -15.04 61.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.828 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -89.44 20.03 4.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -0.829 . . . . 0.0 110.136 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 47.31 85.21 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.892 . . . . 0.0 110.093 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.556 ' O ' ' CB ' ' A' ' 188' ' ' ARG . 57.6 mt -146.04 -82.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 0.0 110.374 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.556 ' CB ' ' O ' ' A' ' 187' ' ' ILE . 0.1 OUTLIER 72.79 161.38 0.24 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.453 -0.779 . . . . 0.0 109.683 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.971 ' O ' ' N ' ' A' ' 191' ' ' SER . 3.9 m 33.87 37.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 O-C-N 121.334 -0.853 . . . . 0.0 110.613 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.763 ' N ' HD12 ' A' ' 165' ' ' ILE . . . 25.68 19.73 0.0 OUTLIER Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.971 ' N ' ' O ' ' A' ' 189' ' ' VAL . 13.6 t 36.88 -146.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -1.149 . . . . 0.0 109.868 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.671 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.9 OUTLIER -89.95 115.26 27.11 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.026 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.669 ' O ' ' O ' ' A' ' 163' ' ' VAL . 34.1 m -159.69 -133.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.096 -1.003 . . . . 0.0 109.985 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.552 ' CG ' ' HB2' ' A' ' 205' ' ' SER . 1.7 pt-20 -158.47 168.82 25.92 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.266 -0.896 . . . . 0.0 110.094 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.919 HG23 ' HG ' ' A' ' 204' ' ' LEU . 0.0 OUTLIER -136.36 146.61 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.163 -0.96 . . . . 0.0 110.353 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.781 HG22 ' HB3' ' A' ' 161' ' ' ARG . 94.8 t -139.05 108.14 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.249 -0.907 . . . . 0.0 110.105 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 202' ' ' ILE . 4.6 t0 -50.77 113.73 0.98 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.211 -0.931 . . . . 0.0 110.135 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 201' ' ' HIS . 1.0 OUTLIER -110.1 93.61 4.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.224 -0.923 . . . . 0.0 110.294 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 198' ' ' ARG . 43.7 t0 41.81 53.96 3.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.222 -0.924 . . . . 0.0 110.126 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 88.89 -27.34 7.41 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.465 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 11.6 m170 -92.08 91.34 7.76 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.26 -1.141 . . . . 0.0 110.273 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.71 HD13 HG22 ' A' ' 153' ' ' ILE . 2.7 mt -59.66 91.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.904 . . . . 0.0 110.18 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 85.6 m -67.95 148.38 51.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.276 -0.89 . . . . 0.0 110.153 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.919 ' HG ' HG23 ' A' ' 195' ' ' ILE . 0.1 OUTLIER -120.23 132.89 55.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.241 -0.912 . . . . 0.0 110.282 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.582 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.7 OUTLIER -119.79 125.93 49.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.332 -0.855 . . . . 0.0 109.898 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.528 ' HA ' HG12 ' A' ' 193' ' ' VAL . 2.6 m-70 -104.55 74.08 1.14 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.385 -0.822 . . . . 0.0 110.366 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.52 ' C ' ' O ' ' A' ' 206' ' ' HIS . 3.7 p-10 32.14 51.51 0.21 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.484 -0.76 . . . . 0.0 110.793 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 135.58 -39.9 1.61 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.515 ' HB2' ' HB2' ' A' ' 206' ' ' HIS . 6.7 mtmt -102.58 162.91 12.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.296 -1.12 . . . . 0.0 110.138 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 204' ' ' LEU . 14.7 t0 -150.17 144.44 25.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 110.319 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.576 HG11 ' HB3' ' A' ' 182' ' ' LEU . 24.5 t -134.76 159.1 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.285 -0.884 . . . . 0.0 110.032 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -98.67 63.49 1.44 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 0.0 110.304 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.617 HD22 ' CD1' ' A' ' 204' ' ' LEU . 12.8 tp -56.12 160.12 3.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -0.919 . . . . 0.0 110.113 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.538 HD23 ' N ' ' A' ' 214' ' ' LEU . 0.6 OUTLIER -122.56 144.75 48.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 0.0 110.199 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -52.67 -40.72 63.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.265 -0.897 . . . . 0.0 110.168 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.518 ' CB ' HD12 ' A' ' 214' ' ' LEU . 0.2 OUTLIER -52.24 -56.66 13.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.894 . . . . 0.0 110.193 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.911 ' CD2' HD13 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -84.55 -27.15 27.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.201 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.795 ' O ' HG12 ' A' ' 152' ' ' VAL . . . -74.51 -11.05 60.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.0 110.186 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.686 ' O ' HG23 ' A' ' 220' ' ' THR . 0.3 OUTLIER -100.96 77.98 1.89 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.933 . . . . 0.0 110.244 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 220' ' ' THR . . . . . 0.686 HG23 ' O ' ' A' ' 219' ' ' HIS . 0.0 OUTLIER -178.3 -43.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -0.943 . . . . 0.0 110.468 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.771 HG22 HG13 ' A' ' 168' ' ' ILE . 0.1 OUTLIER -73.29 143.04 14.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.293 -0.88 . . . . 0.0 110.657 -179.738 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.817 ' O ' HG22 ' A' ' 166' ' ' VAL . 4.8 ptp85 -89.45 127.18 35.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.074 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 1.068 HG22 HG23 ' A' ' 165' ' ' ILE . 0.7 OUTLIER -125.5 170.91 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.192 -0.943 . . . . 0.0 110.821 -178.84 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.422 ' CG ' ' HA2' ' A' ' 149' ' ' GLY . 38.8 mt-10 -149.95 172.64 14.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -0.872 . . . . 0.0 110.12 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.431 ' OE1' ' OXT' ' A' ' 226' ' ' LEU . 0.0 OUTLIER -81.55 169.38 17.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.9 . . . . 0.0 110.156 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.441 ' O ' ' HG ' ' A' ' 226' ' ' LEU . 39.2 tp . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.167 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.641 ' N ' HD21 ' A' ' 130' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.75 0.31 . . . . 0.0 110.213 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 132' ' ' ILE . 46.1 Cg_endo -72.76 -57.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.036 1.545 . . . . 0.0 110.451 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.602 HD12 ' C ' ' A' ' 130' ' ' ASN . 1.7 mp 41.26 75.47 0.61 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.285 -0.884 . . . . 0.0 110.271 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.03 -28.37 13.02 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.983 1.517 . . . . 0.0 110.342 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -46.07 167.57 0.05 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.4 -154.63 0.48 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.305 -1.115 . . . . 0.0 110.229 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -102.13 52.3 0.81 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 110.23 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -124.61 55.98 1.31 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.292 -0.88 . . . . 0.0 110.252 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.28 -41.92 2.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 110.213 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 163.35 -25.98 0.21 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.501 HG12 ' N ' ' A' ' 141' ' ' GLY . 70.8 t -45.41 -89.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -1.129 . . . . 0.0 110.255 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.501 ' N ' HG12 ' A' ' 140' ' ' VAL . . . 159.05 -152.48 23.53 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.14 -67.46 0.54 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.306 -1.114 . . . . 0.0 110.233 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 54.95 35.98 25.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.911 . . . . 0.0 110.221 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -89.33 79.57 7.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.316 -0.865 . . . . 0.0 110.237 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.35 167.37 11.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 0.0 110.284 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.61 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -165.81 167.7 16.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.208 -0.932 . . . . 0.0 110.251 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . 63.0 152.32 0.11 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.137 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.486 ' HA ' ' OE1' ' A' ' 224' ' ' GLU . 45.9 Cg_endo -73.14 80.77 1.81 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.052 1.553 . . . . 0.0 110.456 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -164.35 106.18 0.27 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.513 ' O ' HG22 ' A' ' 150' ' ' THR . 99.7 m -134.53 2.2 3.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -1.115 . . . . 0.0 110.256 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 153' ' ' ILE . 32.9 mtt180 59.83 123.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 110.121 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.885 ' CG2' HG21 ' A' ' 223' ' ' ILE . 40.5 t -66.21 60.14 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.203 -0.936 . . . . 0.0 110.339 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.721 HG23 ' O ' ' A' ' 152' ' ' VAL . 0.8 OUTLIER -159.33 -34.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.306 -0.871 . . . . 0.0 110.145 179.802 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.33 -13.07 61.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.861 . . . . 0.0 109.44 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.712 ' CB ' HG11 ' A' ' 163' ' ' VAL . . . -88.17 -28.01 21.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.485 -0.759 . . . . 0.0 109.976 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -75.62 120.48 21.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.895 . . . . 0.0 110.238 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 14.6 m -162.6 109.0 1.23 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 110.267 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' A' ' 159' ' ' MET . 1.3 t 62.59 10.36 4.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 0.0 110.256 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' MET . . . . . 0.45 ' HB3' ' O ' ' A' ' 158' ' ' SER . 0.0 OUTLIER 173.12 158.42 0.27 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.286 -0.884 . . . . 0.0 110.2 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 46.2 Cg_endo -73.12 63.81 4.22 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.049 1.552 . . . . 0.0 110.299 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.585 ' O ' HG13 ' A' ' 163' ' ' VAL . 7.9 mtt180 -42.18 119.22 1.31 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 0.0 110.248 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.492 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 6.1 ttmt -58.33 124.98 21.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.291 -0.881 . . . . 0.0 110.258 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.856 HG22 ' HA ' ' A' ' 194' ' ' GLU . 30.6 m -139.67 -159.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.881 . . . . 0.0 110.122 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.645 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -175.09 139.11 0.46 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.822 -1.174 . . . . 0.0 110.486 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 1.033 HG23 HG22 ' A' ' 223' ' ' ILE . 2.1 mt -91.38 153.87 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.45 -0.781 . . . . 0.0 110.893 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.478 ' CG1' ' HD3' ' A' ' 164' ' ' ARG . 3.4 m -138.85 -29.62 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.486 -0.759 . . . . 0.0 110.448 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -136.57 118.88 15.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.117 -0.989 . . . . 0.0 110.217 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.585 ' HB ' HG12 ' A' ' 189' ' ' VAL . 1.3 tt -116.32 -3.12 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.201 -0.937 . . . . 0.0 110.254 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 57.26 170.73 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.222 -0.924 . . . . 0.0 110.298 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 172' ' ' PHE . 7.7 pt-20 -155.66 160.75 40.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.151 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.427 ' C ' ' O ' ' A' ' 170' ' ' GLU . 23.1 mt 41.3 27.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.919 . . . . 0.0 110.248 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 170' ' ' GLU . 2.6 t80 -172.29 57.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.255 -0.903 . . . . 0.0 110.245 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.512 ' HB3' HG12 ' A' ' 174' ' ' VAL . 1.9 mt-30 -112.5 -61.23 1.76 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -0.925 . . . . 0.0 110.169 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.846 HG22 ' N ' ' A' ' 175' ' ' GLU . 0.5 OUTLIER -164.22 -86.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.385 -0.822 . . . . 0.0 110.185 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.846 ' N ' HG22 ' A' ' 174' ' ' VAL . 2.6 mt-10 -141.89 11.89 2.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.059 -1.025 . . . . 0.0 110.228 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.984 HG22 HG23 ' A' ' 180' ' ' THR . 0.2 OUTLIER 66.28 -58.44 0.35 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.286 -0.883 . . . . 0.0 110.259 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 178' ' ' GLN . 3.3 p30 36.93 -145.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.377 -0.827 . . . . 0.0 110.776 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.512 ' N ' ' OD1' ' A' ' 177' ' ' ASP . 0.2 OUTLIER -63.46 -27.47 69.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.312 -0.867 . . . . 0.0 110.567 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.819 ' HA ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -44.08 -35.34 2.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.001 . . . . 0.0 109.771 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.984 HG23 HG22 ' A' ' 176' ' ' THR . 0.7 OUTLIER -42.8 -27.85 0.21 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.144 -0.973 . . . . 0.0 109.456 179.693 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 179' ' ' PHE . 23.5 tp60 -59.84 -36.01 75.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.542 -0.724 . . . . 0.0 109.609 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.819 HD12 ' HA ' ' A' ' 179' ' ' PHE . 1.2 mt -69.11 -43.62 74.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.38 -0.825 . . . . 0.0 109.433 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -37.64 88.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.613 -0.679 . . . . 0.0 109.888 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -59.16 -14.74 11.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.462 -0.774 . . . . 0.0 109.845 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -84.69 16.93 2.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.423 -0.798 . . . . 0.0 110.189 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 185' ' ' ALA . 27.4 t70 43.6 57.56 3.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -0.921 . . . . 0.0 109.764 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.6 tt -129.93 175.24 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.322 -0.861 . . . . 0.0 110.339 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.694 ' C ' HG13 ' A' ' 189' ' ' VAL . 0.1 OUTLIER -163.11 105.73 1.02 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.743 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.694 HG13 ' C ' ' A' ' 188' ' ' ARG . 1.3 m 50.63 105.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.332 -0.855 . . . . 0.0 108.813 -178.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.921 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -43.28 -15.74 0.03 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.604 ' N ' ' O ' ' A' ' 189' ' ' VAL . 6.1 t 65.57 -142.1 0.2 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.18 -1.188 . . . . 0.0 109.388 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.645 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -64.11 100.24 0.32 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.569 -0.707 . . . . 0.0 109.265 179.294 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.623 ' O ' ' O ' ' A' ' 163' ' ' VAL . 17.0 m -156.73 -141.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.158 -0.964 . . . . 0.0 110.222 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.856 ' HA ' HG22 ' A' ' 163' ' ' VAL . 4.2 pt-20 -173.26 169.08 4.59 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.345 -0.847 . . . . 0.0 110.11 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.872 HG21 HG12 ' A' ' 152' ' ' VAL . 0.6 OUTLIER -121.3 169.17 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.169 -0.957 . . . . 0.0 110.288 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 18.8 t -128.7 98.4 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.34 -0.85 . . . . 0.0 110.178 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -49.35 117.86 2.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.9 . . . . 0.0 110.201 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.546 ' HB3' ' CB ' ' A' ' 201' ' ' HIS . 0.1 OUTLIER -109.05 146.39 34.04 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.212 -0.93 . . . . 0.0 110.213 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.45 94.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.908 . . . . 0.0 110.12 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 198' ' ' ARG . . . 75.64 14.55 81.96 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.546 ' CB ' ' HB3' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -150.25 160.92 43.34 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.249 -1.148 . . . . 0.0 110.095 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 10.6 mt -136.02 159.73 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 110.251 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.545 ' O ' HG22 ' A' ' 195' ' ' ILE . 2.1 m -151.0 163.26 39.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -0.877 . . . . 0.0 109.96 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.854 HD11 HD11 ' A' ' 165' ' ' ILE . 0.6 OUTLIER -119.8 137.28 54.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.058 -1.026 . . . . 0.0 110.345 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.554 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 1.2 t -119.73 120.47 36.67 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.404 -0.81 . . . . 0.0 109.583 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.561 ' HA ' ' CG1' ' A' ' 193' ' ' VAL . 7.4 m170 -89.24 165.86 14.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.429 -0.795 . . . . 0.0 110.205 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.503 ' C ' ' O ' ' A' ' 206' ' ' HIS . 4.6 m-20 -32.85 -34.35 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.566 -0.709 . . . . 0.0 110.952 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -153.83 32.7 0.74 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 206' ' ' HIS . 20.8 mttt -154.29 179.38 9.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -1.124 . . . . 0.0 110.51 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 204' ' ' LEU . 12.8 t0 -155.56 158.46 38.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 110.053 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.487 HG12 ' HB3' ' A' ' 204' ' ' LEU . 7.3 p -146.49 140.81 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -0.953 . . . . 0.0 110.329 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -68.78 83.73 0.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.286 -0.884 . . . . 0.0 110.231 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.66 121.1 17.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.184 -0.948 . . . . 0.0 110.243 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 1.019 HD23 ' HB2' ' A' ' 217' ' ' LEU . 29.6 tp -57.63 158.82 5.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 0.0 110.222 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.596 ' H ' HD12 ' A' ' 214' ' ' LEU . 11.2 t0 -89.57 -49.65 6.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.346 -0.846 . . . . 0.0 110.274 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.544 ' O ' ' NE2' ' A' ' 219' ' ' HIS . 0.4 OUTLIER -55.35 -48.52 74.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -0.921 . . . . 0.0 110.202 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 1.019 ' HB2' HD23 ' A' ' 214' ' ' LEU . 0.5 OUTLIER -85.85 -11.93 52.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 110.113 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.699 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -35.62 -41.77 0.21 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.55 -0.718 . . . . 0.0 110.669 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.563 ' HB3' ' CD1' ' A' ' 153' ' ' ILE . 24.7 p80 -93.98 73.47 4.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 110.434 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' THR . . . . . 0.771 HG23 HG23 ' A' ' 221' ' ' ILE . 8.9 t -137.25 -44.86 0.56 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.941 . . . . 0.0 110.092 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.895 HD13 ' H ' ' A' ' 221' ' ' ILE . 0.3 OUTLIER -73.74 146.54 10.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.326 -0.859 . . . . 0.0 110.363 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.459 ' O ' HG22 ' A' ' 166' ' ' VAL . 8.1 mtt180 -89.89 114.39 26.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 0.0 109.28 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 1.033 HG22 HG23 ' A' ' 165' ' ' ILE . 0.8 OUTLIER -141.58 -172.6 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.131 -0.981 . . . . 0.0 110.894 -179.036 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.486 ' OE1' ' HA ' ' A' ' 148' ' ' PRO . 0.5 OUTLIER -144.18 166.81 23.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.355 -0.84 . . . . 0.0 110.178 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.829 ' HA ' HG12 ' A' ' 163' ' ' VAL . 0.3 OUTLIER -111.92 124.01 51.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.366 -0.834 . . . . 0.0 110.26 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.419 ' OXT' ' HB3' ' A' ' 162' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.19 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.523 ' N ' ' HD2' ' A' ' 131' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 130' ' ' ASN . 47.5 Cg_endo -73.95 57.31 3.84 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.962 1.506 . . . . 0.0 110.434 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.642 HG23 ' O ' ' A' ' 132' ' ' ILE . 10.8 tt -62.57 114.63 12.63 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.194 -0.941 . . . . 0.0 110.233 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.36 -166.05 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.959 1.505 . . . . 0.0 110.458 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 136' ' ' ASP . . . -173.0 -116.71 0.42 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.54 HD12 ' N ' ' A' ' 135' ' ' LEU . 6.8 mp 56.25 -83.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -1.151 . . . . 0.0 110.319 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 134' ' ' GLY . 6.7 t70 -41.79 -27.04 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.306 -0.871 . . . . 0.0 110.278 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 135' ' ' LEU . 0.5 OUTLIER 42.37 35.23 0.6 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 110.319 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 53.9 tp -45.36 112.54 0.46 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.235 -0.916 . . . . 0.0 110.167 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 174.7 -38.96 0.12 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.434 ' H ' HG23 ' A' ' 140' ' ' VAL . 48.3 t -48.55 -23.15 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -1.158 . . . . 0.0 110.204 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 100.26 28.13 7.37 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -78.9 126.0 30.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -1.164 . . . . 0.0 110.314 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 144' ' ' ASP . 2.7 p -156.65 -76.62 0.09 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.885 . . . . 0.0 110.22 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.632 ' O ' ' HB2' ' A' ' 145' ' ' ALA . 0.2 OUTLIER 66.64 121.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.241 -0.912 . . . . 0.0 110.153 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 144' ' ' ASP . . . 174.26 -94.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.159 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -125.01 85.59 2.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.141 -0.974 . . . . 0.0 110.172 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . 57.71 154.69 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.284 -0.885 . . . . 0.0 110.198 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 149' ' ' GLY . 46.5 Cg_endo -73.73 50.73 2.13 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.954 1.502 . . . . 0.0 110.54 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 148' ' ' PRO . . . 55.88 162.14 0.02 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.564 HG22 ' H ' ' A' ' 151' ' ' ARG . 1.6 m -73.75 -177.01 2.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.219 -1.165 . . . . 0.0 109.969 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.564 ' H ' HG22 ' A' ' 150' ' ' THR . 96.7 mtt180 -141.58 143.8 33.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.281 -0.887 . . . . 0.0 109.944 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.842 HG12 HG23 ' A' ' 153' ' ' ILE . 69.6 t -50.05 -177.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 109.413 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.977 HG21 ' HB3' ' A' ' 218' ' ' ALA . 8.2 pt 43.94 25.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.004 -1.06 . . . . 0.0 110.011 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.8 OUTLIER -147.47 -35.47 0.23 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.483 -0.761 . . . . 0.0 109.673 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -96.12 -15.64 22.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.492 -0.755 . . . . 0.0 109.812 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.691 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -57.22 172.98 0.26 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.293 -0.879 . . . . 0.0 110.268 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.535 ' CG2' ' HG2' ' A' ' 161' ' ' ARG . 7.2 t -174.36 167.44 4.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.192 -0.943 . . . . 0.0 110.104 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 157' ' ' THR . 96.9 p -42.7 -49.81 5.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.33 -0.856 . . . . 0.0 110.166 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.67 161.07 75.5 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.214 -0.929 . . . . 0.0 110.119 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.73 68.73 3.71 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.959 1.505 . . . . 0.0 110.481 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.665 ' O ' HG13 ' A' ' 163' ' ' VAL . 3.0 mmt85 -60.89 107.66 0.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.195 -0.941 . . . . 0.0 110.167 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.552 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -65.46 96.71 0.26 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.909 . . . . 0.0 110.311 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 1.091 HG22 ' HA ' ' A' ' 194' ' ' GLU . 8.5 m -104.7 -164.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.967 . . . . 0.0 110.254 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.672 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -179.67 149.03 0.35 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.843 -1.161 . . . . 0.0 110.169 -179.394 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 1.173 HG23 ' CG2' ' A' ' 223' ' ' ILE . 0.3 OUTLIER -89.82 150.03 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.302 -0.874 . . . . 0.0 110.233 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 222' ' ' ARG . 21.4 m -124.07 -20.3 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.151 -0.968 . . . . 0.0 110.289 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.87 120.61 2.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.18 -0.95 . . . . 0.0 110.251 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.761 HG13 HG22 ' A' ' 221' ' ' ILE . 5.3 tt -122.33 7.05 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.198 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.448 ' O ' ' HB3' ' A' ' 170' ' ' GLU . 52.9 t30 -62.32 89.28 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.2 -0.937 . . . . 0.0 110.214 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' A' ' 169' ' ' ASN . 10.3 pt-20 177.2 47.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.927 . . . . 0.0 110.253 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' ' 171' ' ' ILE . 9.8 mt -82.28 44.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.893 . . . . 0.0 110.336 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.429 ' O ' ' C ' ' A' ' 173' ' ' GLN . 2.9 m-85 -46.6 -64.09 0.85 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 110.188 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.429 ' C ' ' O ' ' A' ' 172' ' ' PHE . 0.4 OUTLIER -42.42 159.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.357 -0.839 . . . . 0.0 110.197 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.453 ' O ' HG12 ' A' ' 174' ' ' VAL . 55.6 t -111.01 -5.81 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.885 . . . . 0.0 110.237 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.634 ' O ' HG23 ' A' ' 176' ' ' THR . 0.2 OUTLIER -96.72 104.78 16.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.869 . . . . 0.0 110.267 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 175' ' ' GLU . 0.1 OUTLIER -165.74 33.24 0.05 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.145 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -52.83 -44.48 66.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.927 . . . . 0.0 110.215 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -68.21 -31.31 70.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.298 -0.876 . . . . 0.0 110.241 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 1.007 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -70.15 -39.75 75.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.367 -0.833 . . . . 0.0 109.995 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.506 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -55.58 -18.79 8.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.148 -0.97 . . . . 0.0 109.912 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -72.17 -58.02 3.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.35 -0.843 . . . . 0.0 110.234 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.782 ' C ' HD12 ' A' ' 182' ' ' LEU . 4.5 pp -69.54 -7.68 40.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 0.0 109.983 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 1.007 HD13 ' CZ ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -97.57 -27.13 14.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.359 -0.838 . . . . 0.0 109.924 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 180' ' ' THR . 4.6 t70 -81.37 -3.16 51.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.349 -0.844 . . . . 0.0 109.957 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -87.24 26.88 1.13 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.332 -0.855 . . . . 0.0 110.151 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 11.5 t0 56.01 63.06 2.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 0.0 110.137 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.56 ' O ' ' CB ' ' A' ' 188' ' ' ARG . 34.8 mt -130.86 -82.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.213 -0.929 . . . . 0.0 110.42 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.56 ' CB ' ' O ' ' A' ' 187' ' ' ILE . 0.1 OUTLIER 73.89 151.74 0.12 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.515 -0.741 . . . . 0.0 109.681 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.939 ' O ' ' N ' ' A' ' 191' ' ' SER . 4.4 m 33.86 38.52 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 O-C-N 121.315 -0.866 . . . . 0.0 110.443 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.829 ' N ' HD12 ' A' ' 165' ' ' ILE . . . 28.16 19.81 0.0 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.939 ' N ' ' O ' ' A' ' 189' ' ' VAL . 21.2 t 39.5 -145.12 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.346 -1.091 . . . . 0.0 109.608 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.672 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 1.8 tt0 -96.26 117.62 31.16 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.63 HG13 ' C ' ' A' ' 192' ' ' GLU . 33.0 m -157.71 -137.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.209 -0.932 . . . . 0.0 110.097 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 1.091 ' HA ' HG22 ' A' ' 163' ' ' VAL . 1.9 pt-20 -173.75 159.51 3.49 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 110.091 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.834 HD13 HG13 ' A' ' 152' ' ' VAL . 1.0 OUTLIER -120.46 165.13 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.07 -1.019 . . . . 0.0 110.452 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 197' ' ' ASP . 40.2 t -138.64 86.09 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.329 -0.857 . . . . 0.0 110.128 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 196' ' ' VAL . 48.5 t0 -42.31 129.92 3.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -0.893 . . . . 0.0 110.369 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.543 ' CB ' ' O ' ' A' ' 201' ' ' HIS . 8.7 ttp180 -115.16 72.66 0.8 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.223 -0.923 . . . . 0.0 110.161 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 198' ' ' ARG . 1.3 m-20 41.27 58.32 2.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 0.0 110.395 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 109.81 -44.82 1.42 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.543 ' O ' ' CB ' ' A' ' 198' ' ' ARG . 0.3 OUTLIER -93.74 114.86 27.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.187 -1.184 . . . . 0.0 110.266 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.688 HD13 ' HA ' ' A' ' 153' ' ' ILE . 11.9 mt -95.45 127.72 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.925 . . . . 0.0 110.411 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.424 ' O ' HG22 ' A' ' 195' ' ' ILE . 40.4 m -110.83 163.67 13.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 0.0 109.97 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 1.04 HD22 ' CD2' ' A' ' 206' ' ' HIS . 0.7 OUTLIER -119.64 133.76 55.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 110.293 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.548 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 1.4 t -119.84 120.02 35.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.342 -0.849 . . . . 0.0 109.865 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 1.04 ' CD2' HD22 ' A' ' 204' ' ' LEU . 2.8 m170 -106.53 -163.83 0.95 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.341 -0.849 . . . . 0.0 110.111 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -52.69 91.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 110.063 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 59.83 20.95 54.4 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -130.53 168.7 16.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -1.141 . . . . 0.0 110.181 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' A' ' 204' ' ' LEU . 0.2 OUTLIER -157.84 152.18 24.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.218 -0.926 . . . . 0.0 110.235 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 212' ' ' GLU . 40.5 t -146.87 167.55 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.891 . . . . 0.0 110.145 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.508 ' N ' HG12 ' A' ' 211' ' ' VAL . 2.7 tt0 -98.62 69.92 1.9 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.29 -0.881 . . . . 0.0 110.333 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.51 ' HG ' ' N ' ' A' ' 214' ' ' LEU . 6.5 tp -63.25 155.28 28.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.289 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.86 ' O ' ' HB2' ' A' ' 218' ' ' ALA . 27.8 mt -59.37 150.82 25.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.22 -0.925 . . . . 0.0 109.94 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' A' ' 218' ' ' ALA . 2.9 p-10 -90.91 -109.18 0.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.028 -1.045 . . . . 0.0 110.238 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 215' ' ' ASP . 0.3 OUTLIER -42.87 -25.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.029 -1.044 . . . . 0.0 109.911 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 215' ' ' ASP . 1.1 mp -81.46 -21.6 38.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.299 -0.876 . . . . 0.0 110.488 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.977 ' HB3' HG21 ' A' ' 153' ' ' ILE . . . -75.67 48.12 0.44 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.076 -1.015 . . . . 0.0 110.461 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.712 ' CB ' HD11 ' A' ' 153' ' ' ILE . 4.3 t60 -118.76 29.05 7.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.137 -0.977 . . . . 0.0 110.173 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' THR . . . . . 0.407 ' O ' ' CD ' ' A' ' 170' ' ' GLU . 0.2 OUTLIER -113.69 -34.23 5.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 110.165 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.777 HG12 HG23 ' A' ' 223' ' ' ILE . 0.1 OUTLIER -70.52 134.01 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.307 -0.87 . . . . 0.0 110.347 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.867 ' O ' HG22 ' A' ' 166' ' ' VAL . 4.4 mtt180 -89.87 101.39 14.09 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.216 -0.927 . . . . 0.0 109.642 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 1.173 ' CG2' HG23 ' A' ' 165' ' ' ILE . 1.0 OUTLIER -119.56 -176.78 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 110.659 -179.484 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.474 ' OE1' HG11 ' A' ' 166' ' ' VAL . 11.5 pt-20 -150.6 178.48 9.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.468 -0.77 . . . . 0.0 110.204 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 3.8 tm-20 -106.48 120.15 41.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.303 -0.873 . . . . 0.0 110.068 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.421 HD23 ' HD2' ' A' ' 162' ' ' LYS . 39.1 tp . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.222 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.533 ' CB ' ' CD ' ' A' ' 131' ' ' PRO . 2.0 m120 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 120.734 0.302 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 130' ' ' ASN . 45.7 Cg_endo -72.92 60.53 3.71 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.976 1.514 . . . . 0.0 110.468 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 24.6 mm -71.19 117.95 61.29 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 0.0 110.226 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.85 90.07 0.85 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.985 1.519 . . . . 0.0 110.373 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -84.3 99.67 2.28 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 137' ' ' GLU . 1.2 tp -69.79 -16.7 63.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -1.13 . . . . 0.0 110.14 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 137' ' ' GLU . 0.5 OUTLIER 60.76 -81.31 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.266 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 135' ' ' LEU . 7.5 mt-10 57.64 29.21 16.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.378 -0.826 . . . . 0.0 110.165 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.93 171.09 8.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 110.271 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -139.71 -93.46 0.25 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.3 m -123.33 -176.83 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.307 -1.114 . . . . 0.0 110.219 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -127.1 -95.01 0.89 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 47.11 62.62 2.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.259 -1.142 . . . . 0.0 110.276 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 144' ' ' ASP . 7.4 p -130.58 128.69 41.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.229 -0.92 . . . . 0.0 110.221 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 143' ' ' SER . 25.4 t0 43.19 55.62 4.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.235 -0.915 . . . . 0.0 110.213 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -170.83 -142.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 0.0 110.304 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.56 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -168.71 26.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.234 -0.916 . . . . 0.0 109.933 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.608 ' N ' ' CD ' ' A' ' 148' ' ' PRO . . . 61.5 45.86 0.92 Allowed Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.331 -0.856 . . . . 0.0 110.32 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 147' ' ' ALA . 49.9 Cg_endo -73.89 35.48 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.915 1.482 . . . . 0.0 110.631 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 147' ' ' ALA . . . -154.24 -172.48 22.23 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.631 ' O ' HG22 ' A' ' 150' ' ' THR . 53.7 m -147.28 10.76 1.0 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.296 -1.12 . . . . 0.0 110.375 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.533 ' HB2' ' HB2' ' A' ' 154' ' ' ASP . 13.5 mmt180 59.7 136.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -0.9 . . . . 0.0 110.226 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.992 HG13 HG21 ' A' ' 195' ' ' ILE . 1.4 t -64.97 -0.58 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.219 -0.926 . . . . 0.0 110.966 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.828 HG21 ' HB3' ' A' ' 218' ' ' ALA . 1.0 OUTLIER -115.53 -4.62 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.911 -1.118 . . . . 0.0 110.652 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.533 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 0.7 OUTLIER -103.19 -28.6 11.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.125 -0.985 . . . . 0.0 109.949 179.673 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.492 ' HB2' ' CG2' ' A' ' 150' ' ' THR . . . -84.09 -15.4 47.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 110.05 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.726 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -71.97 -161.8 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.326 -0.859 . . . . 0.0 110.197 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 156' ' ' ALA . 0.4 OUTLIER 55.88 160.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.33 -0.856 . . . . 0.0 110.12 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 157' ' ' THR . 5.6 p 42.86 30.84 0.27 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 110.212 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.73 134.15 1.74 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.323 -0.86 . . . . 0.0 110.065 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.608 ' O ' ' O ' ' A' ' 161' ' ' ARG . 45.9 Cg_endo -73.36 74.61 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.935 1.492 . . . . 0.0 110.542 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.667 ' HB3' HG22 ' A' ' 196' ' ' VAL . 2.1 ptt85 27.44 104.32 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.492 0.663 . . . . 0.0 111.393 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.51 ' C ' HG13 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -168.76 68.75 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.99 -1.069 . . . . 0.0 110.287 179.534 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.655 ' O ' ' O ' ' A' ' 193' ' ' VAL . 16.6 m -150.62 -155.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.886 . . . . 0.0 110.329 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.669 ' CB ' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -177.56 167.72 2.22 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.783 -1.198 . . . . 0.0 110.518 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 1.088 HG23 ' CG2' ' A' ' 223' ' ' ILE . 0.3 OUTLIER -98.83 159.52 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.224 -0.922 . . . . 0.0 110.268 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 222' ' ' ARG . 31.5 m -131.13 -28.62 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.892 . . . . 0.0 110.222 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -144.92 93.59 2.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.197 -0.939 . . . . 0.0 110.124 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.762 ' H ' HG12 ' A' ' 189' ' ' VAL . 0.3 OUTLIER -54.07 -32.23 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.219 -0.925 . . . . 0.0 110.124 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 168' ' ' ILE . 0.2 OUTLIER 42.56 71.25 0.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 0.0 110.252 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 170' ' ' GLU . 33.6 tt0 -151.28 72.29 1.04 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.259 -0.9 . . . . 0.0 110.211 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 32.4 mm -84.2 -6.63 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 110.281 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -75.32 166.37 23.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.427 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -115.66 -17.38 11.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -0.918 . . . . 0.0 110.2 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 86.6 t -69.66 -21.33 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.19 -0.944 . . . . 0.0 110.224 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -89.82 90.27 8.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.252 -0.905 . . . . 0.0 110.177 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' THR . . . . . 1.055 HG23 HG23 ' A' ' 180' ' ' THR . 21.2 m -124.36 -90.06 0.57 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.885 . . . . 0.0 110.197 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.589 ' N ' HG22 ' A' ' 176' ' ' THR . 3.0 t0 68.37 -158.0 0.19 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.214 -0.929 . . . . 0.0 110.319 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.443 ' OE1' ' OE1' ' A' ' 212' ' ' GLU . 1.2 mt-30 -59.14 -23.33 62.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.895 . . . . 0.0 110.411 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 1.025 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -47.96 -23.51 0.8 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.181 -0.949 . . . . 0.0 110.133 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 180' ' ' THR . . . . . 1.055 HG23 HG23 ' A' ' 176' ' ' THR . 0.5 OUTLIER -58.58 -25.75 62.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 109.949 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -71.46 -62.85 1.26 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.301 -0.874 . . . . 0.0 110.167 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.837 HD22 HD12 ' A' ' 213' ' ' LEU . 3.3 pp -61.06 -13.89 19.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.341 -0.85 . . . . 0.0 110.101 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 1.025 HD13 ' CZ ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -85.22 -30.14 24.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.903 . . . . 0.0 110.058 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -69.59 -14.28 62.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.416 -0.802 . . . . 0.0 110.039 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.453 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -91.45 24.82 2.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -0.858 . . . . 0.0 110.174 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 185' ' ' ALA . 30.5 t0 40.84 83.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 110.171 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.647 HD12 ' O ' ' A' ' 182' ' ' LEU . 87.7 mt -133.85 -75.78 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.0 110.448 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.548 ' CB ' ' O ' ' A' ' 187' ' ' ILE . 5.6 ttp85 71.48 154.65 0.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.374 -0.829 . . . . 0.0 109.716 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.956 ' O ' ' N ' ' A' ' 191' ' ' SER . 4.2 m 32.9 38.35 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 121.235 -0.916 . . . . 0.0 110.558 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.872 ' N ' HD12 ' A' ' 165' ' ' ILE . . . 26.83 19.58 0.0 OUTLIER Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.956 ' N ' ' O ' ' A' ' 189' ' ' VAL . 39.5 t 37.06 -146.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.322 -1.105 . . . . 0.0 109.868 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.669 ' HA ' ' CB ' ' A' ' 164' ' ' ARG . 18.9 mt-10 -92.12 115.99 28.55 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.655 ' O ' ' O ' ' A' ' 163' ' ' VAL . 34.3 m -159.25 -132.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.098 -1.001 . . . . 0.0 109.59 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.604 ' O ' HD23 ' A' ' 204' ' ' LEU . 1.5 pm0 -167.29 159.0 12.29 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.544 -0.862 . . . . 0.0 110.239 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.992 HG21 HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -119.98 163.95 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.28 -0.887 . . . . 0.0 110.154 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.667 HG22 ' HB3' ' A' ' 161' ' ' ARG . 54.8 t -140.83 90.01 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.208 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.48 ' OD1' ' CB ' ' A' ' 156' ' ' ALA . 15.4 m-20 -52.66 118.74 3.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.883 . . . . 0.0 110.332 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.474 ' HB3' ' HB3' ' A' ' 201' ' ' HIS . 0.6 OUTLIER -105.02 73.13 1.04 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.224 -0.922 . . . . 0.0 110.246 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 198' ' ' ARG . 1.6 m-20 42.55 53.87 4.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 110.21 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 110.62 -41.36 2.26 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 198' ' ' ARG . 0.1 OUTLIER -89.79 95.29 10.18 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.279 -1.13 . . . . 0.0 110.162 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.502 HD13 ' HA ' ' A' ' 153' ' ' ILE . 20.4 mt -80.71 114.45 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 110.322 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 211' ' ' VAL . 3.9 m -102.56 163.33 12.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 0.0 109.916 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.923 HD22 ' CD2' ' A' ' 206' ' ' HIS . 0.7 OUTLIER -119.81 136.84 54.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.097 -1.002 . . . . 0.0 110.308 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.626 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.4 OUTLIER -119.88 123.31 43.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 0.0 109.92 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.923 ' CD2' HD22 ' A' ' 204' ' ' LEU . 2.7 m80 -112.08 -171.59 1.88 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.296 -0.877 . . . . 0.0 110.07 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -48.94 91.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.215 -0.928 . . . . 0.0 110.175 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 54.98 23.84 32.71 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.511 ' O ' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -138.5 94.81 2.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -1.144 . . . . 0.0 110.259 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -100.44 148.44 24.75 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.254 -0.904 . . . . 0.0 110.246 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 212' ' ' GLU . 14.3 t -141.18 171.56 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.932 . . . . 0.0 110.225 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 213' ' ' LEU . 2.7 tt0 -95.72 84.89 4.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 110.181 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.904 ' O ' HD23 ' A' ' 214' ' ' LEU . 6.8 tp -60.03 -138.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -0.926 . . . . 0.0 110.296 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.904 HD23 ' O ' ' A' ' 213' ' ' LEU . 14.8 mt -139.62 157.71 45.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.248 -0.907 . . . . 0.0 110.087 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 216' ' ' ASP . 4.6 p30 -90.52 -106.76 0.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.207 -0.933 . . . . 0.0 110.263 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 215' ' ' ASP . 0.1 OUTLIER -41.73 -25.38 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.092 -1.005 . . . . 0.0 110.121 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 215' ' ' ASP . 0.3 OUTLIER -80.79 -26.76 36.97 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.259 -0.901 . . . . 0.0 110.329 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.842 ' HB2' ' O ' ' A' ' 214' ' ' LEU . . . -71.94 -3.88 25.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.053 -1.03 . . . . 0.0 110.018 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.499 ' O ' ' NH1' ' A' ' 151' ' ' ARG . 32.7 t60 -83.56 55.34 3.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 110.143 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.1 -49.72 0.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -0.913 . . . . 0.0 110.322 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.661 HD13 ' N ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -67.22 137.46 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.291 -0.881 . . . . 0.0 110.352 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.708 ' O ' HG22 ' A' ' 166' ' ' VAL . 0.6 OUTLIER -89.53 110.73 21.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 109.333 179.52 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 1.088 ' CG2' HG23 ' A' ' 165' ' ' ILE . 0.5 OUTLIER -119.82 175.46 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.165 -0.959 . . . . 0.0 110.636 -179.111 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.465 ' O ' ' HB ' ' A' ' 163' ' ' VAL . 5.9 mt-10 -143.61 167.32 22.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.336 -0.852 . . . . 0.0 110.12 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.51 ' HA ' HG12 ' A' ' 163' ' ' VAL . 4.7 pt-20 -101.57 48.51 0.88 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.312 -0.867 . . . . 0.0 110.253 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.519 HD13 ' NH2' ' A' ' 164' ' ' ARG . 2.4 tp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.118 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.5 m120 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 120.804 0.335 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.475 ' HB2' HD12 ' A' ' 132' ' ' ILE . 45.6 Cg_endo -72.28 -38.34 3.74 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.049 1.552 . . . . 0.0 110.41 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.475 HD12 ' HB2' ' A' ' 131' ' ' PRO . 1.8 mp -141.7 129.09 11.64 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.231 -0.918 . . . . 0.0 110.177 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.98 -19.61 22.97 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.955 1.503 . . . . 0.0 110.47 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.83 -97.41 1.85 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.43 ' O ' ' HG3' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -125.37 -6.34 7.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -1.12 . . . . 0.0 110.21 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.4 t70 52.11 54.13 11.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.27 -0.894 . . . . 0.0 110.216 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 135' ' ' LEU . 43.2 mt-10 -135.55 27.61 3.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 110.292 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 138' ' ' LEU . 0.5 OUTLIER -75.6 -28.04 58.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 110.223 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 115.73 -173.68 14.87 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 38.1 t -68.0 -20.78 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.229 -1.159 . . . . 0.0 110.203 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 99.71 -129.66 9.97 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -127.34 -163.18 1.23 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -1.133 . . . . 0.0 110.231 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.8 t -80.86 -27.92 36.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 110.236 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 145' ' ' ALA . 27.3 p-10 -46.6 -28.32 1.41 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.196 -0.94 . . . . 0.0 110.214 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.449 ' N ' ' OD1' ' A' ' 144' ' ' ASP . . . 47.19 26.75 0.72 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 110.211 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.561 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -139.07 47.57 1.91 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.298 -0.876 . . . . 0.0 110.259 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . 60.8 145.92 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 110.235 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.1 64.55 4.23 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.005 1.529 . . . . 0.0 110.415 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.502 ' HA3' ' HB3' ' A' ' 222' ' ' ARG . . . 113.61 126.18 4.38 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.58 HG22 ' CB ' ' A' ' 154' ' ' ASP . 98.0 m -141.39 151.97 43.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -1.101 . . . . 0.0 110.1 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.5 ' HG2' ' HA ' ' A' ' 219' ' ' HIS . 0.0 OUTLIER -43.15 125.06 3.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.142 -0.974 . . . . 0.0 110.259 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 1.096 HG22 HD13 ' A' ' 195' ' ' ILE . 5.9 p -44.75 -26.8 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.239 -0.913 . . . . 0.0 110.174 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.92 HG22 HD13 ' A' ' 202' ' ' ILE . 9.9 pt -92.33 -15.7 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.204 -0.935 . . . . 0.0 110.248 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.58 ' CB ' HG22 ' A' ' 150' ' ' THR . 0.8 OUTLIER -77.35 -21.97 52.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.396 179.558 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.411 ' HB3' HD11 ' A' ' 223' ' ' ILE . . . -106.9 -9.78 16.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.562 -0.711 . . . . 0.0 109.756 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.53 ' HA ' ' HB3' ' A' ' 160' ' ' PRO . . . -66.13 -174.11 0.23 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 110.216 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.766 HG22 ' H ' ' A' ' 158' ' ' SER . 4.0 m 43.64 -170.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 110.182 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.766 ' H ' HG22 ' A' ' 157' ' ' THR . 2.2 t 50.45 30.35 4.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.173 -0.954 . . . . 0.0 110.058 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' MET . . . . . 0.521 ' CB ' ' O ' ' A' ' 158' ' ' SER . 0.5 OUTLIER 69.88 64.8 0.49 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 110.135 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.588 ' O ' ' CG ' ' A' ' 161' ' ' ARG . 45.9 Cg_endo -74.11 -61.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.0 1.526 . . . . 0.0 110.22 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.764 ' O ' HG22 ' A' ' 163' ' ' VAL . 0.0 OUTLIER 74.07 179.63 0.2 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.455 -0.778 . . . . 0.0 110.238 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.59 ' N ' ' CD ' ' A' ' 161' ' ' ARG . 14.0 tptt -40.03 126.3 2.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.834 . . . . 0.0 110.84 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 1.063 HG23 ' HA ' ' A' ' 194' ' ' GLU . 0.1 OUTLIER -134.11 -160.88 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.411 -0.805 . . . . 0.0 109.436 179.175 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.654 ' HA ' ' O ' ' A' ' 191' ' ' SER . 0.1 OUTLIER -177.21 144.4 0.42 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.831 -1.168 . . . . 0.0 110.39 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.927 HG23 HG22 ' A' ' 223' ' ' ILE . 1.1 mt -103.66 151.03 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.39 -0.819 . . . . 0.0 110.442 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.508 HG13 ' C ' ' A' ' 165' ' ' ILE . 22.9 m -150.72 17.87 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.165 -0.959 . . . . 0.0 110.295 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.432 ' OE1' HG23 ' A' ' 166' ' ' VAL . 0.1 OUTLIER -155.03 119.86 4.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.213 -0.929 . . . . 0.0 110.196 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 168' ' ' ILE . 0.9 OUTLIER -111.31 11.18 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.187 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 168' ' ' ILE . 5.4 m-20 -42.06 122.29 2.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.21 -0.932 . . . . 0.0 110.086 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 171' ' ' ILE . 5.1 pt-20 -144.79 55.88 1.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 110.189 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 170' ' ' GLU . 28.1 mt -41.91 -33.32 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.291 -0.881 . . . . 0.0 110.022 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.58 ' HE1' HG22 ' A' ' 220' ' ' THR . 3.4 p90 -98.93 158.71 15.46 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.349 -0.845 . . . . 0.0 110.191 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.453 ' O ' ' HB ' ' A' ' 174' ' ' VAL . 0.0 OUTLIER -178.0 152.54 0.74 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 110.187 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 173' ' ' GLN . 2.5 p 178.33 -30.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 110.134 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.433 ' OE2' ' OD2' ' A' ' 216' ' ' ASP . 35.0 tt0 -85.29 151.39 24.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -0.891 . . . . 0.0 110.123 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.74 HG23 ' HD2' ' A' ' 179' ' ' PHE . 36.4 m -164.68 -96.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 110.037 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.62 ' N ' HG22 ' A' ' 176' ' ' THR . 2.6 m-20 69.17 -136.7 0.08 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.148 -0.97 . . . . 0.0 110.307 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -56.55 -28.94 61.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.207 -0.933 . . . . 0.0 110.52 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.74 ' HD2' HG23 ' A' ' 176' ' ' THR . 0.1 OUTLIER -42.95 -39.82 2.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 110.263 -179.812 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.694 HG23 ' CG2' ' A' ' 176' ' ' THR . 0.7 OUTLIER -39.26 -28.3 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.905 . . . . 0.0 110.089 -179.781 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 179' ' ' PHE . 28.0 tt0 -60.2 -36.02 76.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.268 -0.895 . . . . 0.0 109.576 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.607 HD12 ' HA ' ' A' ' 179' ' ' PHE . 1.0 OUTLIER -69.77 -41.32 75.31 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.389 -0.82 . . . . 0.0 109.431 179.345 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.57 HD23 ' CZ ' ' A' ' 179' ' ' PHE . 0.1 OUTLIER -66.87 -39.17 87.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.41 -0.806 . . . . 0.0 109.812 179.641 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -61.73 -17.78 57.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.429 -0.794 . . . . 0.0 109.703 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -90.66 18.87 5.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.385 -0.822 . . . . 0.0 110.033 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 185' ' ' ALA . 2.8 m-20 42.48 68.02 0.53 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 109.669 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.522 HG22 ' N ' ' A' ' 188' ' ' ARG . 10.6 mm -115.24 167.47 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.302 -0.874 . . . . 0.0 110.882 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.636 ' O ' ' O ' ' A' ' 189' ' ' VAL . 0.2 OUTLIER -173.31 113.26 0.22 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.691 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 0.6 OUTLIER 43.74 101.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.272 -0.893 . . . . 0.0 108.693 -178.149 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.894 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -39.02 -19.05 0.01 OUTLIER Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.654 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 3.7 t 67.04 -145.18 0.15 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.969 -1.312 . . . . 0.0 108.979 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.581 ' C ' HG13 ' A' ' 193' ' ' VAL . 7.8 mt-10 -62.68 98.33 0.12 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 109.25 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.612 HG23 ' N ' ' A' ' 194' ' ' GLU . 10.0 m -154.1 -142.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.062 -1.024 . . . . 0.0 110.356 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 1.063 ' HA ' HG23 ' A' ' 163' ' ' VAL . 24.3 tt0 -169.64 157.71 7.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.88 . . . . 0.0 110.394 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 1.096 HD13 HG22 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -131.54 161.92 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.147 -0.97 . . . . 0.0 110.215 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.465 ' O ' ' HG2' ' A' ' 198' ' ' ARG . 97.1 t -144.97 86.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.266 -0.897 . . . . 0.0 110.067 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.549 ' CB ' ' OG1' ' A' ' 157' ' ' THR . 53.1 t0 -55.7 124.29 16.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.305 -0.872 . . . . 0.0 110.404 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.515 ' NH2' ' HB3' ' A' ' 198' ' ' ARG . 6.5 mmm180 -107.12 80.98 1.48 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.351 -0.843 . . . . 0.0 110.19 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.489 ' C ' ' O ' ' A' ' 198' ' ' ARG . 2.7 p30 36.23 38.19 0.06 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.452 -0.78 . . . . 0.0 110.565 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 137.57 -50.47 0.82 Allowed Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 198' ' ' ARG . 1.6 t-160 -90.04 114.75 26.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.344 -1.092 . . . . 0.0 110.42 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.92 HD13 HG22 ' A' ' 153' ' ' ILE . 35.6 mt -100.98 116.93 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 110.171 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.469 HG22 ' OD2' ' A' ' 210' ' ' ASP . 6.9 m -97.1 152.57 18.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 110.364 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 1.086 HD22 ' CD2' ' A' ' 206' ' ' HIS . 0.7 OUTLIER -119.84 131.95 55.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.361 -0.837 . . . . 0.0 110.086 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.568 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 5.0 t -119.72 115.69 24.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.276 -0.89 . . . . 0.0 110.137 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 1.086 ' CD2' HD22 ' A' ' 204' ' ' LEU . 1.9 m80 -103.45 153.59 20.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.605 -0.684 . . . . 0.0 109.832 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -51.02 -19.2 0.98 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.214 -0.929 . . . . 0.0 110.094 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' A' ' 209' ' ' LYS . . . -95.86 -27.42 10.36 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 208' ' ' GLY . 1.4 ptmt 171.63 -179.36 0.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.261 -1.141 . . . . 0.0 110.281 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.469 ' OD2' HG22 ' A' ' 203' ' ' THR . 0.8 OUTLIER -124.36 149.71 46.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -0.848 . . . . 0.0 110.131 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 6.1 p -129.68 164.7 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.244 -0.91 . . . . 0.0 110.075 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -86.97 70.34 10.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.374 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.996 HD22 HD12 ' A' ' 204' ' ' LEU . 1.8 tp -63.08 163.37 10.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.975 . . . . 0.0 110.099 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.614 HD11 HD23 ' A' ' 217' ' ' LEU . 0.6 OUTLIER -130.2 145.43 51.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.911 . . . . 0.0 110.307 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.454 ' HA ' HG21 ' A' ' 153' ' ' ILE . 3.5 p30 -55.08 -37.1 66.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 110.271 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.575 ' HB2' HD12 ' A' ' 214' ' ' LEU . 0.6 OUTLIER -55.79 -50.37 70.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.193 -0.942 . . . . 0.0 110.245 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.614 HD23 HD11 ' A' ' 214' ' ' LEU . 2.2 mm? -89.41 -28.18 19.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 110.218 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.651 ' HB1' HG23 ' A' ' 153' ' ' ILE . . . -67.1 -9.28 37.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 109.969 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.8 ' O ' HG23 ' A' ' 220' ' ' THR . 2.4 t-80 -91.09 69.24 6.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.169 -0.957 . . . . 0.0 110.181 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' THR . . . . . 0.8 HG23 ' O ' ' A' ' 219' ' ' HIS . 0.6 OUTLIER -166.54 -58.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.177 -0.952 . . . . 0.0 110.4 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.675 ' N ' HD13 ' A' ' 221' ' ' ILE . 0.1 OUTLIER -65.53 136.43 26.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.304 -0.872 . . . . 0.0 110.319 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.502 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 47.1 mtt180 -95.67 116.59 29.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 110.058 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.927 HG22 HG23 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -119.78 177.37 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 110.168 -179.759 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.546 ' HB2' ' NH2' ' A' ' 164' ' ' ARG . 2.3 mt-10 -150.04 179.69 7.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.933 . . . . 0.0 110.295 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 1.5 mt-10 -90.15 69.89 7.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.384 -0.822 . . . . 0.0 110.214 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.463 ' OXT' ' O ' ' A' ' 225' ' ' GLU . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.214 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.572 ' CB ' ' CD ' ' A' ' 131' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 120.677 0.275 . . . . 0.0 110.274 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.572 ' CD ' ' CB ' ' A' ' 130' ' ' ASN . 46.2 Cg_endo -72.94 -9.34 23.52 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.93 1.49 . . . . 0.0 110.413 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.3 mp -113.91 112.08 47.82 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.312 -0.868 . . . . 0.0 110.149 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.65 159.42 48.77 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.035 1.545 . . . . 0.0 110.567 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 149.51 -43.57 0.76 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.59 -21.18 62.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.284 -1.127 . . . . 0.0 110.188 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.0 t70 50.97 89.48 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.282 -0.886 . . . . 0.0 110.252 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -138.38 21.42 2.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 110.194 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.692 ' N ' HD23 ' A' ' 138' ' ' LEU . 2.7 pt? -49.55 -21.94 1.12 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.195 -0.941 . . . . 0.0 110.171 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 141' ' ' GLY . . . -94.48 65.08 1.54 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.559 HG12 ' N ' ' A' ' 141' ' ' GLY . 97.7 t 46.53 -97.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.216 -1.167 . . . . 0.0 110.249 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.559 ' N ' HG12 ' A' ' 140' ' ' VAL . . . 152.94 -87.75 0.13 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' A' ' 143' ' ' SER . 1.6 t-20 -80.79 140.25 35.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.28 -1.129 . . . . 0.0 110.284 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 142' ' ' ASN . 34.7 t -178.94 109.6 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.184 -0.947 . . . . 0.0 110.278 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.402 ' CB ' ' O ' ' A' ' 143' ' ' SER . 0.3 OUTLIER 63.69 32.24 13.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.227 -0.921 . . . . 0.0 110.296 179.892 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.77 -145.3 0.11 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.161 -0.962 . . . . 0.0 110.228 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -157.95 -36.55 0.07 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 110.287 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.02 147.66 48.73 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.356 -0.84 . . . . 0.0 110.175 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.69 86.74 1.02 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.976 1.514 . . . . 0.0 110.439 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -178.95 153.17 12.03 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.53 ' HB ' ' O ' ' A' ' 223' ' ' ILE . 7.7 m -123.46 -1.82 8.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.159 -1.201 . . . . 0.0 110.216 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.507 ' CB ' ' HB2' ' A' ' 154' ' ' ASP . 2.5 mpt_? 57.21 110.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.879 . . . . 0.0 109.851 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 1.025 HG13 HD13 ' A' ' 195' ' ' ILE . 4.9 t -40.46 -68.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.358 -0.839 . . . . 0.0 110.278 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.782 HD13 ' N ' ' A' ' 153' ' ' ILE . 0.2 OUTLIER -43.8 -28.13 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.21 -0.932 . . . . 0.0 110.594 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 150' ' ' THR . 0.5 OUTLIER -81.05 -19.78 43.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.11 -0.994 . . . . 0.0 110.209 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 152' ' ' VAL . . . -100.44 -6.01 26.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.169 -0.957 . . . . 0.0 110.181 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.498 ' O ' HG22 ' A' ' 157' ' ' THR . . . -75.78 166.98 22.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.93 . . . . 0.0 110.174 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.697 HG23 ' N ' ' A' ' 158' ' ' SER . 0.4 OUTLIER 45.71 -175.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.165 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.697 ' N ' HG23 ' A' ' 157' ' ' THR . 1.7 t 69.85 -54.59 0.61 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 109.987 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' MET . . . . . 0.487 ' CB ' ' O ' ' A' ' 158' ' ' SER . 0.0 OUTLIER 169.65 59.59 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.362 -0.836 . . . . 0.0 110.129 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.545 ' O ' ' CB ' ' A' ' 161' ' ' ARG . 44.6 Cg_endo -73.2 -72.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.019 1.536 . . . . 0.0 110.414 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.545 ' CB ' ' O ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER 71.45 -66.44 0.3 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.28 -0.888 . . . . 0.0 110.255 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.609 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 4.9 tttp -162.24 120.08 2.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 0.0 110.755 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.815 HG22 ' HA ' ' A' ' 194' ' ' GLU . 31.3 m -139.89 -151.53 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.889 . . . . 0.0 110.016 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.616 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 11.1 ttp180 -179.89 155.5 0.62 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.676 -1.265 . . . . 0.0 110.556 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 1.102 HG23 ' CG2' ' A' ' 223' ' ' ILE . 0.3 OUTLIER -89.66 151.28 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.163 -0.961 . . . . 0.0 109.896 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.953 HG22 ' O ' ' A' ' 222' ' ' ARG . 20.0 m -122.48 -18.46 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.176 -0.952 . . . . 0.0 110.588 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -167.88 123.94 1.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.165 -0.96 . . . . 0.0 110.519 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.492 HG12 ' HB ' ' A' ' 221' ' ' ILE . 6.5 mt -99.83 -13.38 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.359 -0.838 . . . . 0.0 109.894 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 170' ' ' GLU . 9.8 p30 38.83 -161.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.521 -0.737 . . . . 0.0 110.39 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.529 ' O ' ' CG ' ' A' ' 170' ' ' GLU . 8.5 tt0 179.1 45.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.886 . . . . 0.0 110.278 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.428 ' C ' ' O ' ' A' ' 170' ' ' GLU . 5.3 mt -42.36 -42.32 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.144 -0.973 . . . . 0.0 110.049 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -85.16 151.32 24.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 110.041 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.661 ' O ' HG12 ' A' ' 174' ' ' VAL . 0.2 OUTLIER -127.18 -169.03 1.97 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.217 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.661 HG12 ' O ' ' A' ' 173' ' ' GLN . 9.7 p 37.42 35.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.404 -0.81 . . . . 0.0 110.514 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' A' ' 177' ' ' ASP . 1.9 tm-20 -107.71 -68.06 0.92 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.892 . . . . 0.0 110.168 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.582 HG22 ' CG2' ' A' ' 180' ' ' THR . 0.0 OUTLIER 45.17 -89.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.467 -0.77 . . . . 0.0 110.475 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 175' ' ' GLU . 0.6 OUTLIER 68.01 -170.29 0.19 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 0.0 110.101 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 11.3 tm0? -44.63 -24.01 0.16 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.217 -0.927 . . . . 0.0 110.482 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.597 ' CA ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -58.69 -34.01 70.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.185 -0.947 . . . . 0.0 110.328 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.582 ' CG2' HG22 ' A' ' 176' ' ' THR . 0.8 OUTLIER -40.31 -29.02 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 110.046 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 179' ' ' PHE . 5.9 tt0 -62.6 -34.13 76.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.385 -0.822 . . . . 0.0 110.038 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.597 HD12 ' CA ' ' A' ' 179' ' ' PHE . 1.6 mt -69.53 -45.41 68.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.346 -0.847 . . . . 0.0 109.738 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 2.0 tt -63.3 -29.32 70.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.448 -0.783 . . . . 0.0 110.051 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.58 -1.68 17.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 110.058 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.421 ' O ' HG13 ' A' ' 187' ' ' ILE . . . -103.04 11.11 37.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.888 . . . . 0.0 110.266 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 185' ' ' ALA . 0.4 OUTLIER 44.69 86.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 109.912 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.643 ' O ' ' CB ' ' A' ' 188' ' ' ARG . 16.1 mt -147.58 -79.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.216 -0.928 . . . . 0.0 110.631 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.643 ' CB ' ' O ' ' A' ' 187' ' ' ILE . 34.1 ttt-85 81.02 149.84 0.1 Allowed 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.92 ' O ' ' N ' ' A' ' 191' ' ' SER . 2.7 m 33.28 35.95 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.37 -0.831 . . . . 0.0 110.329 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.749 ' N ' HD12 ' A' ' 165' ' ' ILE . . . 30.28 17.41 0.0 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.92 ' N ' ' O ' ' A' ' 189' ' ' VAL . 9.5 t 43.37 -147.19 0.06 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.117 -1.225 . . . . 0.0 109.343 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.699 ' HG2' HD21 ' A' ' 226' ' ' LEU . 3.4 mt-10 -77.82 116.16 18.13 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.593 ' O ' ' O ' ' A' ' 163' ' ' VAL . 0.2 OUTLIER -161.66 162.98 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.117 -0.99 . . . . 0.0 109.886 -179.485 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.815 ' HA ' HG22 ' A' ' 163' ' ' VAL . 4.0 pt-20 -119.87 169.01 10.54 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 119.225 -0.99 . . . . 0.0 110.27 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 1.025 HD13 HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -123.31 142.25 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.931 . . . . 0.0 110.463 -179.483 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.474 ' O ' ' C ' ' A' ' 197' ' ' ASP . 56.5 t -133.9 98.97 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.442 -0.786 . . . . 0.0 109.878 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' A' ' 196' ' ' VAL . 1.1 t0 -38.58 106.58 0.05 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.262 -0.899 . . . . 0.0 110.484 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 200' ' ' GLY . 0.0 OUTLIER -90.55 -172.48 3.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.234 -0.916 . . . . 0.0 110.349 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -53.02 86.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 110.286 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 198' ' ' ARG . . . 65.59 18.37 65.76 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.449 ' O ' ' N ' ' A' ' 198' ' ' ARG . 0.3 OUTLIER -139.64 -176.13 4.45 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.284 -1.127 . . . . 0.0 110.123 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.706 ' CG2' HG22 ' A' ' 195' ' ' ILE . 47.6 mt -137.76 100.8 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 110.336 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.477 ' OG1' ' HG3' ' A' ' 198' ' ' ARG . 6.0 m -86.68 143.51 27.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.147 -0.971 . . . . 0.0 110.121 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.869 ' HG ' HG23 ' A' ' 195' ' ' ILE . 2.7 mp -120.89 146.23 46.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 0.0 110.148 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.518 ' O ' HG23 ' A' ' 193' ' ' VAL . 45.1 m -129.85 130.98 45.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.295 -0.878 . . . . 0.0 110.447 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.663 ' CE1' HG23 ' A' ' 211' ' ' VAL . 0.0 OUTLIER -116.13 -157.21 0.64 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.297 -0.877 . . . . 0.0 109.996 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -44.72 91.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.209 -0.932 . . . . 0.0 110.349 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 45.34 31.64 3.42 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.555 ' O ' ' CE1' ' A' ' 206' ' ' HIS . 0.4 OUTLIER -140.89 118.17 11.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -1.173 . . . . 0.0 110.328 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 2.3 p-10 -104.72 150.59 24.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 110.341 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.663 HG23 ' CE1' ' A' ' 206' ' ' HIS . 32.6 t -142.12 149.84 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.89 . . . . 0.0 110.18 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -82.5 67.25 8.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.284 -0.885 . . . . 0.0 110.297 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.863 ' CB ' HD13 ' A' ' 204' ' ' LEU . 3.4 tm? -51.54 125.56 14.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 0.0 110.056 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.786 HD11 ' HB2' ' A' ' 216' ' ' ASP . 22.1 tp -65.33 106.65 1.41 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 110.251 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.666 ' HB2' HD12 ' A' ' 202' ' ' ILE . 4.4 p30 -59.74 -41.57 91.25 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.306 -0.871 . . . . 0.0 110.358 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.786 ' HB2' HD11 ' A' ' 214' ' ' LEU . 0.3 OUTLIER -41.65 -69.66 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.316 -179.798 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.518 ' HA ' HD13 ' A' ' 217' ' ' LEU . 0.2 OUTLIER -79.58 -13.62 59.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -0.904 . . . . 0.0 110.501 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.643 ' HB3' HG21 ' A' ' 153' ' ' ILE . . . -40.44 -27.69 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.272 -0.893 . . . . 0.0 110.269 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.552 ' ND1' HG21 ' A' ' 153' ' ' ILE . 0.6 OUTLIER -72.09 67.56 0.66 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.893 . . . . 0.0 110.09 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 220' ' ' THR . . . . . 0.629 HG23 HG23 ' A' ' 221' ' ' ILE . 7.1 t -158.41 -42.31 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.973 . . . . 0.0 110.702 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.629 HG23 HG23 ' A' ' 220' ' ' THR . 0.1 OUTLIER -74.53 132.61 33.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.2 -0.938 . . . . 0.0 110.566 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.953 ' O ' HG22 ' A' ' 166' ' ' VAL . 19.3 mtm180 -89.48 110.68 21.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.23 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 1.102 ' CG2' HG23 ' A' ' 165' ' ' ILE . 0.8 OUTLIER -119.89 171.78 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 110.806 -179.092 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.477 ' O ' ' HB ' ' A' ' 163' ' ' VAL . 0.8 OUTLIER -150.2 -165.73 2.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.402 -0.811 . . . . 0.0 109.936 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.482 ' CG ' HG12 ' A' ' 163' ' ' VAL . 17.3 mt-10 -99.61 155.58 17.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 110.33 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.699 HD21 ' HG2' ' A' ' 192' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.241 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.4 m120 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 120.796 0.331 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.37 -47.35 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.039 1.547 . . . . 0.0 110.574 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.1 mt -100.83 118.57 60.37 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 110.359 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.28 155.48 46.46 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.917 1.483 . . . . 0.0 110.362 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -82.96 -107.34 0.48 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 28.7 tp -108.4 -36.22 6.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.118 -1.225 . . . . 0.0 110.203 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 10.2 t70 175.18 -93.98 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.408 -0.807 . . . . 0.0 110.093 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.448 ' N ' ' OD2' ' A' ' 136' ' ' ASP . 0.7 OUTLIER -73.0 62.69 0.63 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.183 -0.948 . . . . 0.0 110.26 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.413 ' HA ' HD12 ' A' ' 138' ' ' LEU . 25.7 tp -104.09 67.5 0.86 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.2 -0.938 . . . . 0.0 110.232 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -71.55 164.62 53.95 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 140' ' ' VAL . 44.5 t 51.51 89.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.23 -1.159 . . . . 0.0 110.182 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.68 67.26 0.4 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -130.0 68.02 1.45 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -1.14 . . . . 0.0 110.19 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 37.8 m -160.61 56.11 0.32 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.204 -0.935 . . . . 0.0 110.167 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 14.2 t0 51.99 38.84 24.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 110.268 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' A' ' 147' ' ' ALA . . . -74.3 55.87 0.62 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.0 110.123 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.614 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -63.96 76.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.333 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . 63.09 164.77 0.11 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.214 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.49 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 46.4 Cg_endo -73.45 77.15 2.59 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.02 1.537 . . . . 0.0 110.415 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -178.22 117.5 0.58 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.624 ' O ' HD13 ' A' ' 223' ' ' ILE . 8.3 m -159.82 146.15 16.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -1.155 . . . . 0.0 110.275 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.522 ' O ' ' CD1' ' A' ' 223' ' ' ILE . 11.4 ptp180 -53.61 171.09 0.09 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.282 -0.886 . . . . 0.0 110.178 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.934 HG22 HG21 ' A' ' 195' ' ' ILE . 12.5 p -104.1 36.82 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.209 -0.932 . . . . 0.0 110.612 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.873 HG22 HD13 ' A' ' 202' ' ' ILE . 9.0 pt -135.82 -34.29 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.946 . . . . 0.0 110.078 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.92 -14.11 61.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.286 -0.884 . . . . 0.0 109.457 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -97.52 -21.15 17.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.578 -0.701 . . . . 0.0 109.896 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.511 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -73.5 90.58 1.74 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 110.17 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 157' ' ' THR . 5.2 t -91.77 179.12 5.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.929 . . . . 0.0 110.252 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.4 t -44.77 -46.68 10.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.267 -0.895 . . . . 0.0 110.027 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' MET . . . . . 0.493 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 5.5 mmt -75.56 164.81 58.32 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 110.116 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 45.1 Cg_endo -71.94 73.86 2.44 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.947 1.498 . . . . 0.0 110.327 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.403 ' O ' HG22 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -63.31 110.19 1.82 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.855 . . . . 0.0 110.234 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.403 ' C ' HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.78 138.09 48.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.407 -0.808 . . . . 0.0 110.26 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.658 HG12 ' C ' ' A' ' 224' ' ' GLU . 0.1 OUTLIER -149.98 -174.13 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.348 -0.845 . . . . 0.0 110.071 179.932 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.723 ' NH2' HG12 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -163.22 134.93 5.01 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.856 -1.153 . . . . 0.0 110.244 -179.619 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 1.049 HG23 HG23 ' A' ' 221' ' ' ILE . 0.5 OUTLIER -76.05 151.34 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.171 -0.955 . . . . 0.0 110.145 -179.415 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.723 HG12 ' NH2' ' A' ' 164' ' ' ARG . 28.9 m -149.26 15.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.305 -0.872 . . . . 0.0 109.993 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -179.12 110.37 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.354 -0.841 . . . . 0.0 110.065 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.856 HG21 ' HD3' ' A' ' 188' ' ' ARG . 0.6 OUTLIER -95.9 24.27 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 110.121 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 170' ' ' GLU . 2.2 t-20 -42.43 165.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 110.041 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 169' ' ' ASN . 0.7 OUTLIER 57.84 72.66 0.51 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.143 -0.973 . . . . 0.0 110.009 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.485 ' CD1' HG12 ' A' ' 168' ' ' ILE . 25.8 mm -88.03 -13.35 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 0.0 110.349 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.558 ' CG ' ' O ' ' A' ' 172' ' ' PHE . 1.5 p90 -47.6 123.53 5.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.217 -0.927 . . . . 0.0 110.158 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.24 177.28 6.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.167 -0.958 . . . . 0.0 110.388 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.49 ' O ' HG22 ' A' ' 174' ' ' VAL . 8.7 p -160.28 39.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 110.127 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.539 ' O ' ' CB ' ' A' ' 176' ' ' THR . 0.2 OUTLIER -127.27 -73.6 0.61 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -0.891 . . . . 0.0 110.166 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.634 ' HA ' ' CD1' ' A' ' 179' ' ' PHE . 0.3 OUTLIER 72.0 -147.39 0.06 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.474 -0.766 . . . . 0.0 110.299 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 176' ' ' THR . 0.8 OUTLIER 65.52 -150.1 0.24 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.38 -0.825 . . . . 0.0 110.413 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 177' ' ' ASP . 1.6 tp60 -38.98 -37.1 0.33 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.279 -0.888 . . . . 0.0 110.738 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.811 ' HA ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -48.0 -33.96 8.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.941 . . . . 0.0 110.057 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.543 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 1.3 p -39.33 -31.15 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.43 -0.793 . . . . 0.0 110.193 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 179' ' ' PHE . 23.5 tt0 -59.38 -36.35 75.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.309 -0.87 . . . . 0.0 109.824 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.811 HD12 ' HA ' ' A' ' 179' ' ' PHE . 1.2 mt -68.99 -46.61 67.62 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.371 -0.831 . . . . 0.0 109.733 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.615 ' O ' HD13 ' A' ' 183' ' ' LEU . 0.2 OUTLIER -68.52 -32.62 72.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.489 -0.757 . . . . 0.0 110.11 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 180' ' ' THR . 0.9 OUTLIER -73.05 -4.51 32.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.84 . . . . 0.0 109.957 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.444 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -89.17 9.48 25.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.369 -0.832 . . . . 0.0 110.165 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 185' ' ' ALA . 23.1 t0 41.98 82.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.176 -0.953 . . . . 0.0 109.766 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.7 tt -141.22 173.3 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 110.49 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.856 ' HD3' HG21 ' A' ' 168' ' ' ILE . 0.0 OUTLIER -167.13 114.29 0.79 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.747 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.743 ' CG2' ' O ' ' A' ' 189' ' ' VAL . 1.7 m 49.92 96.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 120.986 -1.071 . . . . 0.0 108.188 -178.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.563 ' N ' HG13 ' A' ' 165' ' ' ILE . . . -42.0 -16.26 0.02 OUTLIER Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 189' ' ' VAL . 9.2 t 62.82 -143.35 0.38 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.128 -1.219 . . . . 0.0 109.825 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.701 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 1.0 OUTLIER -59.54 104.36 0.27 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.512 -0.743 . . . . 0.0 109.751 179.626 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.636 HG23 ' N ' ' A' ' 194' ' ' GLU . 11.0 m -154.78 -139.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.072 -1.018 . . . . 0.0 110.182 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.7 ' O ' HD23 ' A' ' 204' ' ' LEU . 54.7 tt0 -176.32 167.17 2.84 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 109.926 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.934 HG21 HG22 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -129.45 167.46 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.114 -0.992 . . . . 0.0 110.342 -179.831 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.465 HG23 ' C ' ' A' ' 195' ' ' ILE . 71.5 t -151.36 88.62 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.364 -0.835 . . . . 0.0 110.007 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 196' ' ' VAL . 17.8 t0 -41.24 110.23 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.319 -0.863 . . . . 0.0 110.104 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.479 ' HB3' ' HB3' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -109.01 88.18 2.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.24 -0.913 . . . . 0.0 110.364 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 198' ' ' ARG . 0.5 OUTLIER 40.93 58.2 2.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 110.213 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 89.17 -28.04 7.05 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 198' ' ' ARG . 1.4 t60 -90.64 87.42 6.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -1.154 . . . . 0.0 110.182 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.873 HD13 HG22 ' A' ' 153' ' ' ILE . 66.2 mt -70.48 87.72 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.347 -0.846 . . . . 0.0 110.299 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.7 m -71.79 157.46 37.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.948 . . . . 0.0 110.007 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 1.007 HD22 ' CD2' ' A' ' 206' ' ' HIS . 0.9 OUTLIER -119.64 141.26 49.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -0.937 . . . . 0.0 110.204 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.503 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 1.6 t -119.77 115.48 23.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.869 . . . . 0.0 109.99 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 1.007 ' CD2' HD22 ' A' ' 204' ' ' LEU . 3.2 m80 -105.42 -165.78 1.15 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.314 -0.866 . . . . 0.0 109.942 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.457 ' O ' ' OD1' ' A' ' 207' ' ' ASN . 11.5 p30 -46.45 91.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.863 . . . . 0.0 110.142 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 49.43 24.92 5.74 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.518 ' O ' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -136.89 102.59 4.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.237 -1.155 . . . . 0.0 110.283 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 18.4 p30 -99.77 153.81 18.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 110.241 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 52.7 t -140.98 147.66 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.179 -0.95 . . . . 0.0 110.208 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -74.97 77.58 2.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 110.176 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.627 ' CD2' HD12 ' A' ' 204' ' ' LEU . 19.6 tp -74.6 169.51 17.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -0.951 . . . . 0.0 110.238 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.647 HD23 ' N ' ' A' ' 214' ' ' LEU . 0.5 OUTLIER -123.53 142.96 50.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.252 -0.905 . . . . 0.0 110.21 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.401 ' HA ' ' CB ' ' A' ' 218' ' ' ALA . 38.8 t0 -56.7 -44.95 82.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 110.198 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.42 -49.61 13.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 110.204 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.507 ' HB2' ' CD1' ' A' ' 214' ' ' LEU . 1.9 mp -87.21 -17.6 32.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.0 110.225 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.825 ' O ' HG12 ' A' ' 152' ' ' VAL . . . -55.01 -19.03 5.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 110.152 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.415 ' O ' ' C ' ' A' ' 220' ' ' THR . 61.4 t60 -68.96 -52.85 24.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.209 -0.932 . . . . 0.0 110.146 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' THR . . . . . 0.495 ' O ' ' C ' ' A' ' 221' ' ' ILE . 68.9 p -43.0 -78.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.197 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 1.049 HG23 HG23 ' A' ' 165' ' ' ILE . 1.6 mp -31.54 117.71 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.55 -0.719 . . . . 0.0 111.935 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 2.4 ttm-85 -100.77 103.7 14.93 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 1.0 HG22 HG23 ' A' ' 165' ' ' ILE . 0.1 OUTLIER -119.47 -179.8 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.145 -0.972 . . . . 0.0 111.262 -178.351 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.658 ' C ' HG12 ' A' ' 163' ' ' VAL . 2.5 mm-40 -150.74 168.42 24.45 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -71.97 140.91 49.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.904 . . . . 0.0 110.251 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.588 HD11 ' HG3' ' A' ' 192' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.187 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.743 0.306 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.0 -28.2 13.26 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.06 1.558 . . . . 0.0 110.426 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 80.7 mt -119.06 122.6 29.49 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.237 -0.914 . . . . 0.0 110.204 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.48 -87.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.024 1.539 . . . . 0.0 110.419 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 135' ' ' LEU . . . 137.29 -6.52 3.64 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 13.5 mt 57.66 47.15 16.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -1.19 . . . . 0.0 110.184 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 137' ' ' GLU . 9.5 t70 179.48 -85.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.255 -0.903 . . . . 0.0 110.231 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER 59.89 48.79 8.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.313 -0.867 . . . . 0.0 110.224 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.9 -26.08 53.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.314 -0.866 . . . . 0.0 110.208 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 168.63 -98.44 0.14 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.552 HG12 ' H ' ' A' ' 142' ' ' ASN . 98.0 t -133.59 152.1 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -1.149 . . . . 0.0 110.15 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -80.5 -31.82 36.02 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.552 ' H ' HG12 ' A' ' 140' ' ' VAL . 1.2 m-20 -140.31 106.59 5.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.262 -1.14 . . . . 0.0 110.212 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.5 t -130.95 177.07 7.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.911 . . . . 0.0 110.15 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 144' ' ' ASP . 40.9 p-10 -119.4 76.44 1.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 110.256 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.33 35.23 3.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.258 -0.901 . . . . 0.0 110.203 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.585 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -152.63 111.6 3.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.902 . . . . 0.0 110.212 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . 62.03 144.22 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.333 -0.855 . . . . 0.0 110.176 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.14 115.47 4.36 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.017 1.535 . . . . 0.0 110.403 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.549 ' CA ' ' HG2' ' A' ' 222' ' ' ARG . . . 167.34 132.31 1.38 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.569 ' O ' HG22 ' A' ' 150' ' ' THR . 56.6 m -136.85 4.5 2.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -1.166 . . . . 0.0 110.197 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.536 ' HB2' ' HB2' ' A' ' 154' ' ' ASP . 0.3 OUTLIER 59.53 127.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 0.0 110.049 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.969 ' HB ' HG21 ' A' ' 223' ' ' ILE . 2.1 p -77.72 12.52 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.252 -0.905 . . . . 0.0 110.79 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 1.054 ' CG2' ' HB1' ' A' ' 218' ' ' ALA . 18.2 pt -124.58 -24.6 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.011 -1.055 . . . . 0.0 110.421 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.536 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 0.6 OUTLIER -71.53 -21.59 61.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.131 -0.981 . . . . 0.0 109.259 179.414 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.81 -16.85 29.3 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.605 -0.684 . . . . 0.0 109.805 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.813 ' HB2' ' CD1' ' A' ' 195' ' ' ILE . . . -64.03 92.55 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.836 . . . . 0.0 110.203 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.581 HG23 ' OG ' ' A' ' 158' ' ' SER . 6.4 t -177.36 171.7 1.95 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.937 . . . . 0.0 110.343 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.581 ' OG ' HG23 ' A' ' 157' ' ' THR . 3.7 p 42.35 73.1 0.14 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.345 -0.847 . . . . 0.0 110.118 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' MET . . . . . 0.523 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 1.6 mtp 68.62 167.45 0.12 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.281 -0.887 . . . . 0.0 110.117 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.523 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 45.7 Cg_endo -72.51 101.81 1.32 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.014 1.534 . . . . 0.0 110.381 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.594 ' O ' HG13 ' A' ' 163' ' ' VAL . 0.4 OUTLIER -85.41 120.14 26.54 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.291 -0.881 . . . . 0.0 110.207 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.566 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 13.7 mtmt -62.24 87.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 110.205 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.87 HG22 ' HA ' ' A' ' 194' ' ' GLU . 33.8 m -91.96 -166.36 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 110.352 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.669 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -172.61 136.74 0.76 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.841 -1.162 . . . . 0.0 110.41 -179.744 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 1.065 HG23 ' CG2' ' A' ' 223' ' ' ILE . 1.1 mt -93.6 162.36 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.374 -0.829 . . . . 0.0 110.544 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 222' ' ' ARG . 6.6 m -136.74 -32.62 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 110.736 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.576 ' CG ' ' HB2' ' A' ' 222' ' ' ARG . 6.3 pt20 -147.04 119.46 8.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.073 -1.017 . . . . 0.0 110.652 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.938 HG13 HG22 ' A' ' 221' ' ' ILE . 11.6 tt -110.76 17.82 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 0.0 109.869 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 168' ' ' ILE . 67.0 m-20 -37.84 105.52 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.466 -0.771 . . . . 0.0 110.606 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.441 ' CD ' ' HB2' ' A' ' 172' ' ' PHE . 0.4 OUTLIER -131.02 107.33 9.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 109.954 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 2.0 pp -81.49 11.33 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -0.889 . . . . 0.0 110.525 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.441 ' HB2' ' CD ' ' A' ' 170' ' ' GLU . 1.1 m-85 -64.7 176.37 1.18 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 0.0 110.18 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -77.29 -165.35 0.57 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.276 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.442 ' O ' HG22 ' A' ' 174' ' ' VAL . 10.0 p -117.92 32.37 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -0.89 . . . . 0.0 110.212 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' A' ' 176' ' ' THR . 4.6 tp10 -64.13 -143.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.293 -0.88 . . . . 0.0 110.301 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.566 ' OG1' ' CD1' ' A' ' 179' ' ' PHE . 75.2 p 42.64 92.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.281 -0.887 . . . . 0.0 110.139 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.408 ' HA ' ' OG1' ' A' ' 180' ' ' THR . 0.8 OUTLIER -62.53 -31.25 71.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 110.209 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -72.32 -25.21 61.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.862 . . . . 0.0 110.289 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.998 ' CE2' HD13 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -85.49 -29.1 24.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.237 -0.914 . . . . 0.0 110.072 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.551 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -58.81 -16.99 19.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.179 -0.951 . . . . 0.0 109.73 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.21 -60.19 2.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.346 -0.846 . . . . 0.0 110.254 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.76 ' C ' HD12 ' A' ' 182' ' ' LEU . 4.4 pp -64.59 -10.53 26.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.88 . . . . 0.0 110.133 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.998 HD13 ' CE2' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -92.57 -32.4 14.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 109.916 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -67.93 -7.27 27.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 0.0 109.883 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -83.54 13.79 4.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.343 -0.848 . . . . 0.0 110.23 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 185' ' ' ALA . 8.9 m-20 42.98 62.98 1.62 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.211 -0.931 . . . . 0.0 110.007 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.3 tt -118.5 -174.57 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.331 -0.856 . . . . 0.0 110.348 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.706 ' C ' HG13 ' A' ' 189' ' ' VAL . 0.4 OUTLIER -171.41 112.08 0.34 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.346 -0.846 . . . . 0.0 108.908 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.706 HG13 ' C ' ' A' ' 188' ' ' ARG . 1.1 m 51.35 109.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.381 -0.824 . . . . 0.0 109.202 -178.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.856 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -44.19 -15.68 0.05 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.594 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 3.3 t 68.3 -145.06 0.12 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.179 -1.189 . . . . 0.0 109.534 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.669 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 3.8 mm-40 -66.39 102.93 0.93 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.496 -0.752 . . . . 0.0 109.331 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.619 ' O ' ' O ' ' A' ' 163' ' ' VAL . 20.6 m -156.46 -140.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 110.323 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.87 ' HA ' HG22 ' A' ' 163' ' ' VAL . 3.1 pt-20 -177.3 139.77 0.27 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.334 -0.854 . . . . 0.0 110.029 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.958 HG21 HG22 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -130.39 161.19 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.104 -0.998 . . . . 0.0 110.452 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.543 ' N ' HG12 ' A' ' 195' ' ' ILE . 18.2 t -129.71 130.66 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.46 -0.775 . . . . 0.0 110.012 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.479 ' HA ' HG12 ' A' ' 202' ' ' ILE . 7.1 t70 -83.5 137.62 33.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -0.941 . . . . 0.0 110.321 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -130.23 71.34 1.45 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.28 -0.888 . . . . 0.0 110.201 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 198' ' ' ARG . 47.5 t0 42.73 71.39 0.23 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 110.149 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 88.84 -35.81 3.58 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.501 ' O ' ' N ' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -89.87 108.29 19.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.263 -1.139 . . . . 0.0 110.195 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.479 HG12 ' HA ' ' A' ' 197' ' ' ASP . 7.8 mt -112.82 138.63 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 110.296 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.549 ' O ' HG12 ' A' ' 195' ' ' ILE . 31.4 m -126.74 146.06 50.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.346 -0.846 . . . . 0.0 109.832 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.756 HD22 ' CD2' ' A' ' 206' ' ' HIS . 0.2 OUTLIER -119.48 133.16 55.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.086 -1.008 . . . . 0.0 110.387 -179.796 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.592 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 1.2 m -119.96 124.12 45.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.412 -0.805 . . . . 0.0 109.768 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.756 ' CD2' HD22 ' A' ' 204' ' ' LEU . 2.5 m170 -107.83 100.1 9.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.413 -0.805 . . . . 0.0 110.207 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 207' ' ' ASN . 1.2 p-10 39.02 29.77 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.352 -0.843 . . . . 0.0 110.78 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 123.6 -33.3 3.99 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.585 ' O ' ' CG ' ' A' ' 206' ' ' HIS . 3.6 mmtt -91.86 110.69 22.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.225 -1.162 . . . . 0.0 109.972 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.532 ' HA ' ' O ' ' A' ' 204' ' ' LEU . 4.1 p30 -109.23 169.7 8.52 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.118 -0.989 . . . . 0.0 110.484 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 210' ' ' ASP . 37.8 t -151.41 146.24 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.326 -0.859 . . . . 0.0 110.128 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 213' ' ' LEU . 2.3 tt0 -75.25 72.61 2.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.285 -0.884 . . . . 0.0 110.221 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.449 HD22 HD12 ' A' ' 204' ' ' LEU . 1.1 mp -55.19 -165.86 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.891 . . . . 0.0 110.23 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.714 HD12 ' HB3' ' A' ' 216' ' ' ASP . 0.5 OUTLIER -157.93 136.95 11.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 110.188 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 214' ' ' LEU . 21.7 t0 -41.88 -48.14 4.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -0.901 . . . . 0.0 110.428 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.714 ' HB3' HD12 ' A' ' 214' ' ' LEU . 7.4 t0 -47.84 -52.05 20.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.181 -0.95 . . . . 0.0 110.336 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.734 ' O ' HG23 ' A' ' 221' ' ' ILE . 0.4 OUTLIER -88.46 -32.29 18.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.272 -0.892 . . . . 0.0 110.297 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 1.054 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -62.99 -26.75 69.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.03 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.628 ' CG ' HD11 ' A' ' 153' ' ' ILE . 1.1 t60 -99.1 29.88 3.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.935 . . . . 0.0 110.11 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 50.6 m -138.41 -33.47 0.67 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.257 -0.902 . . . . 0.0 110.451 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.938 HG22 HG13 ' A' ' 168' ' ' ILE . 0.2 OUTLIER -67.35 140.21 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 110.445 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.576 ' HB2' ' CG ' ' A' ' 167' ' ' GLN . 1.4 mtt180 -91.94 113.5 25.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 109.383 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 1.065 ' CG2' HG23 ' A' ' 165' ' ' ILE . 0.7 OUTLIER -127.12 -169.26 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.126 -0.983 . . . . 0.0 110.954 -179.126 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.443 ' HG3' ' N ' ' A' ' 225' ' ' GLU . 3.0 tp10 -148.85 156.92 43.0 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.468 -0.77 . . . . 0.0 109.98 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 1.1 tt0 -104.95 122.68 46.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.296 -0.878 . . . . 0.0 110.221 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.1 tp . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.222 179.935 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.54 ' CB ' ' CD ' ' A' ' 131' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 120.698 0.285 . . . . 0.0 110.271 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.54 ' CD ' ' CB ' ' A' ' 130' ' ' ASN . 46.6 Cg_endo -73.37 -51.18 0.17 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.049 1.552 . . . . 0.0 110.473 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.401 ' HA ' ' HD2' ' A' ' 133' ' ' PRO . 2.1 mt -136.54 106.52 9.18 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.889 . . . . 0.0 110.255 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 132' ' ' ILE . 46.4 Cg_endo -73.23 -0.98 9.91 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.999 1.526 . . . . 0.0 110.461 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -85.43 -170.91 47.67 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.25 -35.03 0.18 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -1.117 . . . . 0.0 110.305 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.45 124.98 36.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 110.312 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -138.2 49.66 1.92 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -0.905 . . . . 0.0 110.197 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.406 ' HG ' ' N ' ' A' ' 139' ' ' GLY . 26.6 tp -100.14 -85.44 0.4 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 110.322 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.406 ' N ' ' HG ' ' A' ' 138' ' ' LEU . . . -75.1 66.91 2.15 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.7 t -71.99 -8.98 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -1.141 . . . . 0.0 110.14 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 142' ' ' ASN . . . -103.64 -31.81 4.73 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 141' ' ' GLY . 0.4 OUTLIER 43.05 45.97 4.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -1.133 . . . . 0.0 110.246 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.3 m -148.07 -164.44 2.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 110.2 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 144' ' ' ASP . 1.8 m-20 -53.38 -65.61 0.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.311 -0.868 . . . . 0.0 110.156 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.57 -175.68 2.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 110.176 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.595 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -151.34 80.54 1.3 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.181 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . 63.1 158.29 0.12 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.953 . . . . 0.0 110.17 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.54 123.11 8.83 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.073 1.565 . . . . 0.0 110.464 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 145.52 92.68 0.13 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.487 ' O ' ' O ' ' A' ' 151' ' ' ARG . 91.0 m -81.22 -20.91 40.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -1.152 . . . . 0.0 110.202 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.512 ' O ' ' O ' ' A' ' 152' ' ' VAL . 11.4 mtt85 59.92 132.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.34 -0.85 . . . . 0.0 110.043 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.775 HG12 ' H ' ' A' ' 153' ' ' ILE . 37.6 t -51.35 -174.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.239 -0.913 . . . . 0.0 109.369 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.799 HG21 ' HB3' ' A' ' 218' ' ' ALA . 1.0 OUTLIER 52.44 15.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.143 -0.973 . . . . 0.0 110.209 -179.589 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 151' ' ' ARG . 1.2 t0 -130.4 -31.21 1.85 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.357 -0.839 . . . . 0.0 109.419 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.67 ' CB ' HG11 ' A' ' 163' ' ' VAL . . . -84.64 -18.85 34.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.514 -0.741 . . . . 0.0 109.814 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.34 136.02 56.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.343 -0.848 . . . . 0.0 110.039 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 157' ' ' THR . 7.9 m -160.88 87.16 0.73 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.112 -0.992 . . . . 0.0 110.359 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 157' ' ' THR . 2.1 t 70.11 -53.17 0.63 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.305 -0.872 . . . . 0.0 110.058 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' MET . . . . . 0.455 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 59.0 mtp -108.98 168.01 8.33 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 121.327 -0.858 . . . . 0.0 110.056 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.488 ' HB2' ' OE2' ' A' ' 194' ' ' GLU . 46.2 Cg_endo -72.63 65.86 3.83 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.952 1.501 . . . . 0.0 110.427 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -44.0 109.66 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 110.234 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.496 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 5.6 tttm -58.1 132.15 52.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.905 . . . . 0.0 110.255 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.67 HG11 ' CB ' ' A' ' 155' ' ' ALA . 16.0 m -150.24 -159.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 110.498 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.64 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.1 OUTLIER -173.81 150.86 1.73 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.936 -1.103 . . . . 0.0 110.347 -179.633 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.993 HG23 HG22 ' A' ' 223' ' ' ILE . 2.0 mm -88.92 148.42 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.34 -0.85 . . . . 0.0 110.297 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.757 HG22 ' O ' ' A' ' 222' ' ' ARG . 22.6 m -136.47 5.34 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.888 . . . . 0.0 109.814 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.513 ' HB3' ' HB3' ' A' ' 222' ' ' ARG . 1.7 tm0? -171.77 121.17 0.48 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.898 . . . . 0.0 109.867 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.539 ' HB ' ' CG1' ' A' ' 189' ' ' VAL . 0.3 OUTLIER -93.74 -2.31 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.0 110.33 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 49.78 -137.07 1.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.168 -0.958 . . . . 0.0 110.022 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -117.87 108.23 15.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.956 . . . . 0.0 110.198 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 172' ' ' PHE . 1.0 OUTLIER -60.49 -13.84 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.164 -0.96 . . . . 0.0 110.105 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.439 ' N ' HG13 ' A' ' 171' ' ' ILE . 0.5 OUTLIER -75.69 82.93 2.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 110.127 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -110.58 -89.63 0.49 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 110.198 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.737 HG12 ' N ' ' A' ' 175' ' ' GLU . 37.5 t -128.47 -91.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.906 . . . . 0.0 110.233 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.737 ' N ' HG12 ' A' ' 174' ' ' VAL . 2.8 mt-10 -94.1 -172.14 2.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 0.0 110.198 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' THR . . . . . 1.058 HG23 ' CD2' ' A' ' 179' ' ' PHE . 20.0 m -136.04 -65.36 0.58 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.287 -0.883 . . . . 0.0 110.217 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 176' ' ' THR . 5.6 m-20 70.57 -153.43 0.11 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.455 -0.778 . . . . 0.0 110.359 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' A' ' 181' ' ' GLN . 18.6 tt0 -45.42 -25.68 0.45 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.278 -0.889 . . . . 0.0 110.607 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 1.058 ' CD2' HG23 ' A' ' 176' ' ' THR . 0.3 OUTLIER -42.39 -54.64 3.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.208 -0.932 . . . . 0.0 110.026 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 180' ' ' THR . . . . . 1.034 HG23 HG21 ' A' ' 176' ' ' THR . 0.0 OUTLIER -47.84 -23.42 0.74 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.054 -1.029 . . . . 0.0 109.836 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 178' ' ' GLN . 34.5 tt0 -71.98 -62.0 1.58 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 110.199 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.656 ' C ' HD12 ' A' ' 182' ' ' LEU . 4.6 pp -65.33 -9.3 23.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.346 -0.846 . . . . 0.0 109.892 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.903 ' O ' HD13 ' A' ' 183' ' ' LEU . 3.4 tm? -92.25 -31.67 15.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.876 . . . . 0.0 109.851 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -70.25 -5.81 30.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.42 -0.8 . . . . 0.0 110.008 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -88.11 29.35 0.95 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -0.906 . . . . 0.0 110.235 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 186' ' ' ASP . 1.8 m-20 52.48 36.23 19.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.214 -0.929 . . . . 0.0 110.208 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 16.3 mm -93.47 156.6 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 110.185 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.609 ' C ' HG22 ' A' ' 189' ' ' VAL . 2.5 ptm180 -170.83 130.32 0.81 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.863 ' O ' ' N ' ' A' ' 191' ' ' SER . 34.3 m 33.75 69.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.212 -0.93 . . . . 0.0 109.008 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 189' ' ' VAL . . . -20.93 -32.2 0.0 OUTLIER Glycine 0 N--CA 1.498 2.785 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.863 ' N ' ' O ' ' A' ' 189' ' ' VAL . 3.4 t 70.86 -143.54 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -1.142 . . . . 0.0 109.831 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.64 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.8 OUTLIER -61.36 102.48 0.23 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.416 -0.803 . . . . 0.0 109.796 179.741 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.74 ' CG2' HD21 ' A' ' 204' ' ' LEU . 20.3 m -156.32 -142.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.126 -0.984 . . . . 0.0 110.246 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.626 ' HA ' HG22 ' A' ' 163' ' ' VAL . 21.6 tt0 -175.95 161.21 2.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 110.218 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.753 HD13 HG13 ' A' ' 152' ' ' VAL . 0.7 OUTLIER -123.48 172.15 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.128 -0.983 . . . . 0.0 110.279 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.759 HG13 ' O ' ' A' ' 196' ' ' VAL . 14.8 p -146.59 102.13 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 110.158 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 197' ' ' ASP . 5.1 p-10 -42.35 113.94 0.51 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.266 -0.896 . . . . 0.0 110.193 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -100.55 160.6 14.22 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.252 -0.905 . . . . 0.0 110.304 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -55.73 91.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.253 -0.904 . . . . 0.0 110.064 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 198' ' ' ARG . . . 76.76 12.4 84.53 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.462 ' O ' ' N ' ' A' ' 198' ' ' ARG . 0.0 OUTLIER -150.13 179.88 7.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.169 -1.195 . . . . 0.0 110.179 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.542 HD12 ' CG ' ' A' ' 215' ' ' ASP . 42.5 mt -144.79 133.68 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.921 . . . . 0.0 110.308 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.53 ' HB ' HG12 ' A' ' 196' ' ' VAL . 0.2 OUTLIER -113.83 152.86 30.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 110.026 179.794 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.778 HD22 ' CE1' ' A' ' 206' ' ' HIS . 1.1 tt -119.72 137.25 54.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 110.294 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.539 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 3.0 t -119.78 128.14 53.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.356 -0.84 . . . . 0.0 109.865 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.778 ' CE1' HD22 ' A' ' 204' ' ' LEU . 3.1 m-70 -112.72 125.68 54.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.387 -0.82 . . . . 0.0 110.013 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 206' ' ' HIS . 14.1 t30 42.82 -93.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.216 -0.927 . . . . 0.0 110.224 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -126.28 19.1 6.42 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.13 129.27 39.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -1.138 . . . . 0.0 110.258 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 7.9 t70 -117.94 156.78 27.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.296 -0.878 . . . . 0.0 110.22 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.421 ' N ' ' OD1' ' A' ' 210' ' ' ASP . 5.5 p -149.43 162.23 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.251 -0.905 . . . . 0.0 110.201 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -65.01 156.4 31.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 110.126 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.574 HD13 HD12 ' A' ' 204' ' ' LEU . 0.7 OUTLIER -156.48 88.76 1.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.232 -0.917 . . . . 0.0 110.202 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.713 ' O ' ' HB2' ' A' ' 218' ' ' ALA . 14.5 tp -41.34 113.74 0.43 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.235 -0.916 . . . . 0.0 110.244 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.542 ' CG ' HD12 ' A' ' 202' ' ' ILE . 8.2 t0 -60.18 -43.17 96.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.325 -0.859 . . . . 0.0 110.428 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 215' ' ' ASP . 55.9 t0 -43.07 -67.37 0.28 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.131 -0.981 . . . . 0.0 110.177 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.527 ' HB2' HD23 ' A' ' 214' ' ' LEU . 0.5 OUTLIER -82.28 -13.54 56.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.259 -0.901 . . . . 0.0 110.531 -179.831 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.799 ' HB3' HG21 ' A' ' 153' ' ' ILE . . . -45.01 -26.43 0.43 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.148 -0.97 . . . . 0.0 110.1 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.767 ' CG ' HD11 ' A' ' 153' ' ' ILE . 0.7 OUTLIER -78.95 64.63 3.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.268 -0.895 . . . . 0.0 110.182 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 220' ' ' THR . . . . . 0.472 HG23 HG23 ' A' ' 221' ' ' ILE . 0.5 OUTLIER -129.25 -22.89 3.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -0.973 . . . . 0.0 110.467 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.75 HD13 ' H ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -99.78 145.95 9.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.09 -1.006 . . . . 0.0 110.57 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.757 ' O ' HG22 ' A' ' 166' ' ' VAL . 0.3 OUTLIER -88.81 96.35 10.65 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.323 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.993 HG22 HG23 ' A' ' 165' ' ' ILE . 0.5 OUTLIER -119.64 173.16 5.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.304 -0.873 . . . . 0.0 111.419 -177.492 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.485 ' HG3' ' OG1' ' A' ' 150' ' ' THR . 0.6 OUTLIER -145.9 -172.87 4.01 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.5 -0.75 . . . . 0.0 110.181 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 8.4 tt0 -112.08 127.14 55.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.377 -0.827 . . . . 0.0 110.201 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.231 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.2 t30 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 120.796 0.331 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.54 -15.84 24.45 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.977 1.514 . . . . 0.0 110.465 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 28.2 mm -72.96 124.07 90.3 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 110.218 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.11 96.02 0.86 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.917 1.483 . . . . 0.0 110.431 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -178.31 85.72 0.07 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -166.66 95.97 0.54 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.326 -1.102 . . . . 0.0 110.144 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -88.88 60.21 5.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 0.0 110.21 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 40.4 mt-10 63.08 -71.17 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.0 110.4 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 136' ' ' ASP . 14.8 tp -95.05 100.52 12.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.319 -0.863 . . . . 0.0 110.238 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 136.1 166.09 10.82 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 28.2 m -139.47 8.22 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -1.124 . . . . 0.0 110.242 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -165.72 163.7 36.86 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -129.7 150.49 50.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -1.136 . . . . 0.0 110.221 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 144' ' ' ASP . 1.0 OUTLIER 50.48 -164.16 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.922 . . . . 0.0 110.159 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 143' ' ' SER . 7.7 t0 59.85 145.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -0.893 . . . . 0.0 110.219 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 44.96 -141.79 0.26 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.349 -0.844 . . . . 0.0 110.261 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -154.99 82.21 1.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 110.237 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.621 ' HB1' ' OG1' ' A' ' 150' ' ' THR . . . 59.68 121.37 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.204 -0.935 . . . . 0.0 110.11 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.5 90.98 0.89 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.989 1.52 . . . . 0.0 110.694 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.58 ' O ' ' HB ' ' A' ' 150' ' ' THR . . . 95.23 -74.26 0.91 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.621 ' OG1' ' HB1' ' A' ' 147' ' ' ALA . 22.2 m 65.89 -121.54 0.34 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.345 -1.091 . . . . 0.0 109.889 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.529 ' CD ' ' O ' ' A' ' 150' ' ' THR . 1.5 mmt180 -143.41 157.62 44.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.961 -1.087 . . . . 0.0 109.989 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.877 HG22 HD13 ' A' ' 195' ' ' ILE . 0.6 OUTLIER -69.3 -3.94 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.157 -0.964 . . . . 0.0 110.479 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.884 ' CG2' ' HB1' ' A' ' 218' ' ' ALA . 1.6 pp -117.65 -30.9 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.098 -1.001 . . . . 0.0 110.335 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.52 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -74.88 -13.25 60.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -0.967 . . . . 0.0 109.214 179.346 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -113.04 -7.34 13.68 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.562 -0.711 . . . . 0.0 109.72 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 1.023 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -85.0 177.21 8.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.335 -0.853 . . . . 0.0 110.194 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.527 ' O ' ' CB ' ' A' ' 158' ' ' SER . 0.4 OUTLIER 56.88 153.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.347 -0.846 . . . . 0.0 110.185 179.839 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 157' ' ' THR . 0.7 OUTLIER 70.69 -51.5 0.67 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.181 -0.95 . . . . 0.0 110.157 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 159' ' ' MET . . . . . 0.454 ' N ' ' CD ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER -161.86 55.3 0.57 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.851 . . . . 0.0 109.883 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.582 ' HB3' ' HA ' ' A' ' 156' ' ' ALA . 43.6 Cg_endo -72.66 -67.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.092 1.575 . . . . 0.0 110.565 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.415 ' CB ' ' O ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER 64.23 -153.97 0.3 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.908 . . . . 0.0 110.228 179.833 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.467 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -86.92 90.37 8.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.21 -0.931 . . . . 0.0 110.553 -179.775 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.598 HG23 ' HA ' ' A' ' 194' ' ' GLU . 0.1 OUTLIER -92.46 -169.44 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.226 -0.921 . . . . 0.0 109.909 179.542 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.716 ' HD3' HG12 ' A' ' 166' ' ' VAL . 0.3 OUTLIER -167.07 137.96 3.13 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.712 -1.243 . . . . 0.0 110.286 -179.578 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 1.018 HG23 HG22 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -85.37 133.46 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.318 -0.864 . . . . 0.0 110.284 -179.59 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.716 HG12 ' HD3' ' A' ' 164' ' ' ARG . 15.5 m -119.92 -23.09 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.235 -0.916 . . . . 0.0 110.7 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -148.97 125.6 11.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.032 -1.043 . . . . 0.0 110.531 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 221' ' ' ILE . 5.1 tt -108.62 6.78 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.348 -0.845 . . . . 0.0 110.03 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 168' ' ' ILE . 3.0 t-20 -43.35 98.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.348 -0.845 . . . . 0.0 110.347 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.502 ' CG ' ' HB2' ' A' ' 172' ' ' PHE . 1.0 OUTLIER -157.9 116.06 3.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -0.929 . . . . 0.0 110.185 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 172' ' ' PHE . 1.6 pp -83.26 10.33 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.341 -0.85 . . . . 0.0 110.196 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.502 ' HB2' ' CG ' ' A' ' 170' ' ' GLU . 0.1 OUTLIER -60.09 -148.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.285 -0.885 . . . . 0.0 110.147 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.461 ' OE1' HD21 ' A' ' 217' ' ' LEU . 11.7 tt0 53.86 174.37 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 110.07 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 173' ' ' GLN . 1.6 p 175.44 -26.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 110.249 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' A' ' 176' ' ' THR . 0.0 OUTLIER -172.58 129.54 0.54 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.908 . . . . 0.0 110.329 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 176' ' ' THR . 1.7 t 177.36 99.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.337 -0.852 . . . . 0.0 110.172 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.55 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.5 OUTLIER -75.8 -28.25 58.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.291 -0.88 . . . . 0.0 110.307 -179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -17.51 64.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.105 -0.997 . . . . 0.0 109.972 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 1.052 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -90.28 -39.39 12.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 110.683 -179.827 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.55 ' OG1' ' O ' ' A' ' 177' ' ' ASP . 0.2 OUTLIER -41.19 -26.09 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.13 -0.981 . . . . 0.0 110.05 -179.568 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.499 ' N ' ' O ' ' A' ' 179' ' ' PHE . 6.6 tm0? -53.4 -45.09 69.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.183 -0.948 . . . . 0.0 109.515 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 1.052 HD12 ' O ' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -69.84 -34.76 74.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.403 -0.811 . . . . 0.0 108.973 179.083 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.672 ' O ' HD13 ' A' ' 183' ' ' LEU . 0.2 OUTLIER -66.05 -33.73 76.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.592 -0.692 . . . . 0.0 109.786 179.609 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -57.87 -16.16 10.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.409 -0.807 . . . . 0.0 109.87 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -92.83 12.61 23.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.438 -0.789 . . . . 0.0 110.252 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 185' ' ' ALA . 22.0 t70 43.8 85.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.732 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.2 tt -135.56 177.1 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 110.824 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.606 ' C ' HG13 ' A' ' 189' ' ' VAL . 4.2 ttp180 -174.64 114.41 0.17 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.719 ' CG2' ' O ' ' A' ' 189' ' ' VAL . 1.1 m 46.66 98.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.174 -0.954 . . . . 0.0 108.546 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.684 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -40.44 -18.19 0.01 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.627 ' N ' ' O ' ' A' ' 189' ' ' VAL . 5.7 t 64.65 -141.95 0.25 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.037 -1.272 . . . . 0.0 109.213 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.604 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 4.9 pm0 -61.57 99.69 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.507 -0.746 . . . . 0.0 109.3 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.661 HG21 HD21 ' A' ' 204' ' ' LEU . 13.1 m -155.07 -139.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.083 -1.01 . . . . 0.0 109.98 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.622 ' N ' HG23 ' A' ' 193' ' ' VAL . 3.4 pt-20 -173.26 158.69 3.65 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.3 -0.875 . . . . 0.0 110.564 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 1.023 HD12 ' HB2' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -131.09 162.97 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.28 -0.888 . . . . 0.0 110.275 -179.719 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 195' ' ' ILE . 77.7 t -157.28 100.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.249 -0.907 . . . . 0.0 110.12 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.524 ' CB ' ' OG1' ' A' ' 157' ' ' THR . 16.1 t0 -42.91 109.64 0.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.903 . . . . 0.0 110.258 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.521 ' CB ' ' O ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -97.11 81.17 3.02 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.307 -0.871 . . . . 0.0 110.129 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 49.3 57.73 6.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 110.101 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 89.26 -25.96 9.66 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.521 ' O ' ' CB ' ' A' ' 198' ' ' ARG . 2.7 t60 -98.72 95.0 6.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -1.143 . . . . 0.0 110.163 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.873 HD13 HG22 ' A' ' 153' ' ' ILE . 83.8 mt -64.56 115.85 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.341 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 195' ' ' ILE . 28.8 m -94.48 147.19 23.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.151 -0.968 . . . . 0.0 110.065 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.968 ' HB2' HD12 ' A' ' 213' ' ' LEU . 1.2 tt -119.71 129.34 54.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.227 -0.92 . . . . 0.0 110.128 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.561 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.0 OUTLIER -120.02 122.84 42.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.296 -0.877 . . . . 0.0 110.015 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.75 ' ND1' HD22 ' A' ' 204' ' ' LEU . 1.6 m-70 -106.91 154.5 20.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.534 -0.729 . . . . 0.0 109.89 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -50.66 -19.83 1.04 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.947 . . . . 0.0 109.955 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.457 ' O ' ' HD3' ' A' ' 209' ' ' LYS . . . -87.38 -32.76 12.88 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' A' ' 208' ' ' GLY . 0.0 OUTLIER 176.77 -152.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.159 -1.2 . . . . 0.0 110.29 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 204' ' ' LEU . 36.7 t70 -137.73 156.29 48.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.324 -0.86 . . . . 0.0 110.174 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.511 HG22 ' N ' ' A' ' 212' ' ' GLU . 7.6 p -149.92 173.39 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.218 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.511 ' N ' HG22 ' A' ' 211' ' ' VAL . 13.2 pt-20 -91.33 162.32 14.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 110.337 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.968 HD12 ' HB2' ' A' ' 204' ' ' LEU . 0.3 OUTLIER -147.88 153.21 38.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 110.177 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.726 HD12 ' HB3' ' A' ' 216' ' ' ASP . 0.4 OUTLIER -120.08 129.52 54.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.263 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.527 ' HA ' ' HB3' ' A' ' 218' ' ' ALA . 1.5 m-20 -43.31 -29.33 0.4 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 110.195 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.726 ' HB3' HD12 ' A' ' 214' ' ' LEU . 5.9 t0 -56.06 -59.17 5.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 110.119 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.62 ' CD2' ' CD1' ' A' ' 179' ' ' PHE . 1.0 OUTLIER -90.12 -24.68 21.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 110.314 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.884 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -52.19 -42.47 63.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.194 -0.941 . . . . 0.0 110.158 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.565 ' CG ' ' O ' ' A' ' 219' ' ' HIS . 69.2 t60 -84.03 58.84 4.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.893 . . . . 0.0 110.194 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 217' ' ' LEU . 30.6 p -145.02 -31.63 0.41 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 110.621 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.798 HG13 HD13 ' A' ' 165' ' ' ILE . 0.1 OUTLIER -90.97 141.05 14.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.175 -0.953 . . . . 0.0 110.456 -179.799 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.485 ' HG2' ' HA3' ' A' ' 149' ' ' GLY . 0.0 OUTLIER -92.6 111.33 22.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.379 -0.826 . . . . 0.0 109.793 179.778 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 1.018 HG22 HG23 ' A' ' 165' ' ' ILE . 0.1 OUTLIER -121.23 166.22 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.167 -0.958 . . . . 0.0 110.108 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.554 ' C ' HG12 ' A' ' 163' ' ' VAL . 1.2 tt0 -137.08 161.38 36.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.121 -0.987 . . . . 0.0 110.553 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 22.1 mm-40 -72.26 137.18 46.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.422 -0.799 . . . . 0.0 110.222 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.213 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.535 ' CB ' ' CD ' ' A' ' 131' ' ' PRO . 1.2 m-20 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 120.768 0.318 . . . . 0.0 110.226 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.535 ' CD ' ' CB ' ' A' ' 130' ' ' ASN . 47.2 Cg_endo -73.69 -39.45 1.89 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.982 1.517 . . . . 0.0 110.31 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.711 HG23 ' O ' ' A' ' 132' ' ' ILE . 16.9 tt -163.51 107.34 0.97 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.29 -0.881 . . . . 0.0 110.124 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.44 -26.62 16.82 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.009 1.531 . . . . 0.0 110.423 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.28 58.1 1.53 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.45 -76.71 0.55 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -1.153 . . . . 0.0 110.271 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.48 ' OD2' HD12 ' A' ' 138' ' ' LEU . 40.0 p-10 -87.06 33.98 0.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.347 -0.846 . . . . 0.0 110.323 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 136' ' ' ASP . 0.0 OUTLIER 42.87 54.03 4.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.912 . . . . 0.0 110.131 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.65 HD23 ' O ' ' A' ' 138' ' ' LEU . 1.6 tt -95.7 30.87 2.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 0.0 110.237 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 129.57 151.12 7.21 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.79 -25.66 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -1.152 . . . . 0.0 110.224 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.33 157.26 31.44 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.454 ' O ' ' OD1' ' A' ' 142' ' ' ASN . 8.7 p30 -120.79 46.19 2.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.324 -1.104 . . . . 0.0 110.2 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -134.05 165.81 24.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.0 110.253 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 144' ' ' ASP . 19.4 p30 -61.84 168.06 3.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.267 -0.896 . . . . 0.0 110.231 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 53.88 49.64 18.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 110.245 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.627 ' O ' ' HB2' ' A' ' 147' ' ' ALA . . . -163.08 26.87 0.09 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.287 -0.883 . . . . 0.0 110.149 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.627 ' HB2' ' O ' ' A' ' 146' ' ' ALA . . . 174.56 122.5 0.11 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 110.179 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.58 54.19 2.87 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.001 1.527 . . . . 0.0 110.441 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -170.91 167.79 40.94 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.743 ' O ' HD13 ' A' ' 223' ' ' ILE . 8.1 m -144.72 100.59 3.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -1.158 . . . . 0.0 109.978 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.721 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -37.09 150.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.873 . . . . 0.0 110.555 -179.8 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 1.064 HG23 HG23 ' A' ' 153' ' ' ILE . 17.7 m -54.88 -150.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.229 -0.919 . . . . 0.0 110.379 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 1.134 ' CG2' ' HB1' ' A' ' 218' ' ' ALA . 11.2 pt 40.22 27.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.23 -0.919 . . . . 0.0 110.042 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -144.0 -37.32 0.33 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.522 -0.736 . . . . 0.0 109.383 179.639 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.524 ' HB3' HG11 ' A' ' 163' ' ' VAL . . . -98.27 -9.67 25.16 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.541 -0.724 . . . . 0.0 109.741 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.414 ' O ' ' HB ' ' A' ' 157' ' ' THR . . . -74.05 175.37 7.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.328 -0.857 . . . . 0.0 110.201 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.617 HG22 ' HB2' ' A' ' 161' ' ' ARG . 5.7 t -177.09 178.41 1.13 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.258 -0.901 . . . . 0.0 110.127 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 157' ' ' THR . 21.1 t -42.83 -61.1 1.35 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.901 . . . . 0.0 110.131 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' MET . . . . . 0.547 ' HG2' HG23 ' A' ' 157' ' ' THR . 0.0 OUTLIER -71.01 165.01 51.69 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.898 . . . . 0.0 110.034 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.49 ' HB2' ' OE2' ' A' ' 194' ' ' GLU . 45.7 Cg_endo -72.6 66.99 3.78 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.944 1.497 . . . . 0.0 110.353 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.617 ' HB2' HG22 ' A' ' 157' ' ' THR . 0.0 OUTLIER -47.86 125.64 9.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.254 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.48 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 1.2 tttp -77.3 100.37 5.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -0.909 . . . . 0.0 110.274 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.958 HG12 ' O ' ' A' ' 224' ' ' GLU . 0.1 OUTLIER -117.41 -164.01 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 0.0 110.301 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.69 ' O ' ' HB ' ' A' ' 223' ' ' ILE . 23.7 ttt180 -172.33 157.82 4.22 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.911 -1.118 . . . . 0.0 110.265 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.946 HG23 HG22 ' A' ' 223' ' ' ILE . 0.8 OUTLIER -110.49 151.36 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.651 -179.359 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.0 m -133.04 -5.05 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.299 -0.876 . . . . 0.0 110.775 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -174.06 131.13 0.4 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.914 -1.116 . . . . 0.0 110.96 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.881 ' CD1' HG22 ' A' ' 221' ' ' ILE . 9.0 tt -126.23 10.03 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.451 -0.781 . . . . 0.0 109.598 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.459 ' O ' ' HB3' ' A' ' 170' ' ' GLU . 1.5 t-20 -56.09 83.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.373 -0.829 . . . . 0.0 110.356 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.519 ' O ' ' C ' ' A' ' 171' ' ' ILE . 0.7 OUTLIER -179.98 -173.76 0.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.363 -0.836 . . . . 0.0 109.934 179.84 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.554 HG22 ' O ' ' A' ' 171' ' ' ILE . 2.1 mm 33.15 36.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.409 -0.807 . . . . 0.0 110.408 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' A' ' 170' ' ' GLU . 0.2 OUTLIER -67.09 -38.9 86.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.914 . . . . 0.0 110.41 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.712 ' C ' HG23 ' A' ' 174' ' ' VAL . 0.0 OUTLIER -78.76 -156.62 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.878 . . . . 0.0 110.353 -179.741 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.712 HG23 ' C ' ' A' ' 173' ' ' GLN . 2.9 t 76.58 -29.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.601 -0.687 . . . . 0.0 110.876 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.481 ' O ' ' O ' ' A' ' 174' ' ' VAL . 46.2 tt0 55.19 161.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.041 -1.037 . . . . 0.0 110.278 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.587 ' CG2' ' HB3' ' A' ' 179' ' ' PHE . 1.9 m -166.37 113.43 0.86 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.193 -0.942 . . . . 0.0 110.257 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.541 ' O ' ' OG1' ' A' ' 180' ' ' THR . 12.3 m-20 -76.86 -30.39 56.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.124 -0.985 . . . . 0.0 110.443 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.81 -17.53 55.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.097 -1.002 . . . . 0.0 110.449 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 1.035 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -90.29 -15.23 31.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.14 -0.975 . . . . 0.0 110.392 -179.667 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.541 ' OG1' ' O ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -61.73 -20.63 63.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.002 -1.061 . . . . 0.0 109.891 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -71.41 -63.05 1.19 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.857 . . . . 0.0 109.899 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.696 HD21 ' HA ' ' A' ' 179' ' ' PHE . 0.7 OUTLIER -61.71 -14.31 30.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.659 179.643 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 1.035 HD13 ' CZ ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -83.13 -29.94 28.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.868 . . . . 0.0 109.878 179.653 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.97 -12.06 34.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 110.018 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.816 ' HB3' HG22 ' A' ' 187' ' ' ILE . . . -85.88 19.09 2.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 0.0 110.199 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 185' ' ' ALA . 0.2 OUTLIER 41.69 29.6 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.0 109.516 -179.61 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.816 HG22 ' HB3' ' A' ' 185' ' ' ALA . 1.5 tt -116.4 149.33 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.505 -0.747 . . . . 0.0 110.409 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.757 ' O ' ' O ' ' A' ' 189' ' ' VAL . 0.0 OUTLIER 164.91 108.91 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.757 ' O ' ' O ' ' A' ' 188' ' ' ARG . 6.1 p 38.45 175.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 121.589 0.709 . . . . 0.0 110.93 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.662 ' N ' HG22 ' A' ' 189' ' ' VAL . . . 107.41 -7.06 36.66 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.3 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.586 ' O ' ' HG3' ' A' ' 164' ' ' ARG . 0.5 OUTLIER -159.62 -177.35 6.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.859 -1.377 . . . . 0.0 111.74 -179.515 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.625 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 38.8 tt0 -67.39 137.87 56.28 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.753 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.709 HG11 ' CD2' ' A' ' 206' ' ' HIS . 2.0 m -161.16 134.62 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.291 -0.881 . . . . 0.0 109.467 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.641 ' HA ' HG23 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -102.68 156.84 17.36 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.309 179.51 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.677 HG12 HD23 ' A' ' 204' ' ' LEU . 1.2 mt -118.74 153.1 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.936 -1.102 . . . . 0.0 110.683 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 196' ' ' VAL . 55.8 t -132.16 91.47 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.513 -0.742 . . . . 0.0 110.31 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.476 ' HA ' HG12 ' A' ' 202' ' ' ILE . 33.3 m-20 -43.45 137.07 2.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.22 -0.925 . . . . 0.0 110.125 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.481 ' HB2' ' HB3' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -128.25 71.87 1.4 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.261 -0.899 . . . . 0.0 110.265 -180.0 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 198' ' ' ARG . 0.3 OUTLIER 42.07 75.05 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.251 -0.905 . . . . 0.0 110.223 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 87.92 -36.81 3.32 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -90.55 165.58 13.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.178 -1.19 . . . . 0.0 110.17 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.758 HD12 HG22 ' A' ' 153' ' ' ILE . 9.1 mt -153.77 149.61 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.205 -0.935 . . . . 0.0 110.395 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.821 HG23 ' O ' ' A' ' 211' ' ' VAL . 85.8 m -146.2 159.44 43.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.398 -0.813 . . . . 0.0 109.541 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.958 HD11 ' CD1' ' A' ' 213' ' ' LEU . 0.7 OUTLIER -119.37 157.33 28.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.934 . . . . 0.0 110.602 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.577 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 0.1 OUTLIER -124.54 95.07 4.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.528 -0.732 . . . . 0.0 109.429 179.429 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.709 ' CD2' HG11 ' A' ' 193' ' ' VAL . 40.6 m80 -76.36 74.11 3.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.448 -0.782 . . . . 0.0 110.382 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 206' ' ' HIS . 7.1 t-20 42.54 67.52 0.59 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -0.95 . . . . 0.0 110.278 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 99.17 -38.5 3.07 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.491 ' O ' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -95.71 97.11 9.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.287 -1.125 . . . . 0.0 110.23 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 204' ' ' LEU . 0.5 OUTLIER -102.07 153.62 19.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 110.295 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.821 ' O ' HG23 ' A' ' 203' ' ' THR . 1.0 OUTLIER -143.52 149.98 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.309 -0.869 . . . . 0.0 109.881 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -58.44 -174.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 110.199 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.958 ' CD1' HD11 ' A' ' 204' ' ' LEU . 0.3 OUTLIER -174.47 -28.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.253 -0.905 . . . . 0.0 110.271 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 1.061 ' O ' ' HB2' ' A' ' 218' ' ' ALA . 0.5 OUTLIER 33.04 -151.05 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.477 -0.764 . . . . 0.0 110.728 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 3.1 m-20 -90.49 -61.28 1.71 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.362 -0.836 . . . . 0.0 110.497 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.561 ' HB2' HD11 ' A' ' 214' ' ' LEU . 0.1 OUTLIER -41.48 -52.65 3.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 110.505 -179.686 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.823 ' HB3' HD23 ' A' ' 213' ' ' LEU . 0.5 OUTLIER -79.36 -27.76 41.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.18 -0.95 . . . . 0.0 110.261 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 1.134 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -43.36 -77.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 110.498 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.545 ' HB2' HD13 ' A' ' 153' ' ' ILE . 47.4 t-80 -65.88 89.7 0.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.347 -0.846 . . . . 0.0 110.386 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' THR . . . . . 0.453 ' O ' ' OE2' ' A' ' 170' ' ' GLU . 8.1 m -161.23 -63.85 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.825 . . . . 0.0 110.096 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.881 HG22 ' CD1' ' A' ' 168' ' ' ILE . 0.2 OUTLIER -76.18 139.66 18.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.513 -0.742 . . . . 0.0 110.781 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.514 ' HA ' ' HA ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -90.03 106.55 18.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.385 -0.822 . . . . 0.0 109.29 179.202 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.946 HG22 HG23 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -121.48 173.35 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.135 -0.978 . . . . 0.0 110.698 -178.894 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.958 ' O ' HG12 ' A' ' 163' ' ' VAL . 3.5 mt-10 -150.28 -170.25 3.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.355 -0.841 . . . . 0.0 110.165 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 10.0 tm-20 -104.98 112.27 25.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.261 -0.899 . . . . 0.0 110.18 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 19.9 tp . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.209 179.961 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 27.9 t30 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 120.777 0.322 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 132' ' ' ILE . 45.3 Cg_endo -72.04 60.94 3.14 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.046 1.551 . . . . 0.0 110.529 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' A' ' 131' ' ' PRO . 14.7 mt 41.31 94.64 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.337 -0.852 . . . . 0.0 110.388 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.61 -21.88 21.57 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.074 1.565 . . . . 0.0 110.466 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 135.47 -103.22 0.45 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 135' ' ' LEU . 1.8 mm? 49.02 -163.52 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -1.136 . . . . 0.0 110.29 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -118.67 76.5 1.1 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 110.236 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.422 ' OE2' HG23 ' A' ' 132' ' ' ILE . 2.8 pt-20 -126.49 90.03 3.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.919 . . . . 0.0 110.199 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mt -65.28 128.49 36.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.2 -0.938 . . . . 0.0 110.165 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -178.73 99.67 0.13 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 140' ' ' VAL . 4.8 p -66.84 98.0 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -1.097 . . . . 0.0 110.224 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 112.22 -158.3 14.4 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.469 ' N ' ' OD1' ' A' ' 142' ' ' ASN . 30.9 p-10 -176.16 111.23 0.1 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -1.112 . . . . 0.0 110.229 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -118.38 113.55 21.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 110.24 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -48.1 100.24 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 110.161 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.34 -89.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.893 . . . . 0.0 110.227 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -129.39 -90.72 0.48 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.268 -0.895 . . . . 0.0 110.209 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.533 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . -108.19 166.07 11.58 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.947 . . . . 0.0 110.249 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.533 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 46.2 Cg_endo -73.14 98.94 1.05 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.019 1.536 . . . . 0.0 110.608 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 148' ' ' PRO . . . 58.57 149.26 0.01 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.572 ' N ' ' O ' ' A' ' 223' ' ' ILE . 58.6 m -97.97 140.0 32.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.252 -1.146 . . . . 0.0 109.95 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 0.7 OUTLIER -76.53 131.57 39.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.902 -1.123 . . . . 0.0 110.058 179.84 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 1.026 ' CG2' HG21 ' A' ' 223' ' ' ILE . 32.8 t -40.87 161.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.271 -0.893 . . . . 0.0 109.974 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.97 HD11 ' CG ' ' A' ' 219' ' ' HIS . 0.1 OUTLIER 75.01 -15.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.583 -0.698 . . . . 0.0 110.292 -179.025 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 151' ' ' ARG . 0.3 OUTLIER -103.44 -15.0 16.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.104 -0.998 . . . . 0.0 109.265 179.24 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -111.99 -11.98 13.79 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.522 -0.736 . . . . 0.0 109.879 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.776 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -76.27 128.51 35.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 110.259 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.492 HG21 ' NH1' ' A' ' 161' ' ' ARG . 0.2 OUTLIER -102.32 176.81 5.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.15 -0.969 . . . . 0.0 110.259 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.54 -59.82 2.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.925 . . . . 0.0 110.21 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -75.11 166.3 46.62 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.898 . . . . 0.0 110.193 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 161' ' ' ARG . 45.8 Cg_endo -72.78 78.6 2.07 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.055 1.555 . . . . 0.0 110.437 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.492 ' NH1' HG21 ' A' ' 157' ' ' THR . 0.4 OUTLIER -60.35 -141.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 110.202 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.86 87.45 1.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.21 -0.931 . . . . 0.0 110.322 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.623 ' O ' ' O ' ' A' ' 193' ' ' VAL . 12.3 m -112.7 -162.43 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.311 -0.868 . . . . 0.0 110.221 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.861 HH11 HG12 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -169.79 151.81 4.32 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.808 -1.183 . . . . 0.0 110.985 -179.315 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 1.099 HG23 ' CG2' ' A' ' 223' ' ' ILE . 2.1 mt -100.65 154.0 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.361 -0.837 . . . . 0.0 109.97 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.861 HG12 HH11 ' A' ' 164' ' ' ARG . 31.4 m -133.91 -30.1 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.048 -1.033 . . . . 0.0 111.12 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' A' ' 222' ' ' ARG . 2.0 mt-30 -149.45 128.91 13.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.09 -1.006 . . . . 0.0 110.704 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.69 HG23 HG22 ' A' ' 221' ' ' ILE . 10.5 mt -83.36 -10.05 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.384 -0.822 . . . . 0.0 109.686 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.563 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 0.2 OUTLIER 70.36 2.38 4.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.375 -0.828 . . . . 0.0 110.342 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 44.09 62.53 1.94 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 110.394 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.563 ' CG1' ' HB3' ' A' ' 169' ' ' ASN . 13.9 mm -102.15 17.9 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 0.0 110.075 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.435 ' C ' ' O ' ' A' ' 171' ' ' ILE . 56.7 t80 -41.76 113.31 0.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.345 -0.847 . . . . 0.0 110.29 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -141.82 -32.58 0.52 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.312 -0.867 . . . . 0.0 110.378 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.457 ' O ' ' C ' ' A' ' 175' ' ' GLU . 48.7 t -127.6 75.73 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 110.101 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 174' ' ' VAL . 43.3 tt0 -39.3 157.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.429 -0.795 . . . . 0.0 110.429 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.637 ' OG1' ' CD1' ' A' ' 179' ' ' PHE . 1.0 OUTLIER -136.36 135.91 39.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.313 -0.867 . . . . 0.0 110.145 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.591 ' O ' ' OG1' ' A' ' 180' ' ' THR . 11.5 t70 -72.13 -45.91 58.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.234 -0.917 . . . . 0.0 110.871 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -21.38 63.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.056 -1.027 . . . . 0.0 110.42 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.669 ' HB2' HD11 ' A' ' 214' ' ' LEU . 0.0 OUTLIER -90.78 -31.42 16.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 110.667 -179.782 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.599 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.5 OUTLIER -43.88 -25.97 0.23 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.953 -1.092 . . . . 0.0 109.683 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 179' ' ' PHE . 35.5 tt0 -61.62 -35.04 76.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.85 . . . . 0.0 109.578 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.578 HD21 ' O ' ' A' ' 212' ' ' GLU . 0.8 OUTLIER -72.12 -39.85 68.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.398 -0.813 . . . . 0.0 109.546 179.454 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.61 -33.7 75.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.517 -0.739 . . . . 0.0 109.928 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -63.19 -14.75 52.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 0.0 109.735 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -86.89 16.66 4.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.375 -0.828 . . . . 0.0 110.034 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 186' ' ' ASP . 5.8 m-20 42.26 48.64 4.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 109.368 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.3 tt -128.96 169.56 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.517 -0.739 . . . . 0.0 110.554 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.483 ' O ' ' C ' ' A' ' 189' ' ' VAL . 0.0 OUTLIER -150.87 -133.29 0.05 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.365 -0.835 . . . . 0.0 108.784 179.506 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 189' ' ' VAL . 4.3 m -42.47 120.37 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 120.965 -1.084 . . . . 0.0 109.076 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.84 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -50.31 -7.7 0.14 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.607 ' O ' ' HB2' ' A' ' 164' ' ' ARG . 28.3 t 58.77 -150.53 0.44 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.163 -1.198 . . . . 0.0 109.675 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.682 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 95.5 mt-10 -64.35 101.86 0.47 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.693 -0.63 . . . . 0.0 109.826 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.623 ' O ' ' O ' ' A' ' 163' ' ' VAL . 30.8 m -158.16 -135.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.913 . . . . 0.0 109.742 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.537 ' N ' HG23 ' A' ' 193' ' ' VAL . 0.0 OUTLIER -169.05 158.74 8.73 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.293 -0.879 . . . . 0.0 110.117 179.407 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.776 HD12 ' HB2' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -120.04 156.81 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 0.0 110.088 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.449 ' N ' ' O ' ' A' ' 203' ' ' THR . 11.4 t -125.24 92.38 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 110.165 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.498 ' HA ' HG12 ' A' ' 202' ' ' ILE . 8.5 t0 -41.73 134.1 2.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.292 -0.88 . . . . 0.0 110.205 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.523 ' CB ' ' O ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -132.92 154.98 49.89 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.233 -0.917 . . . . 0.0 110.137 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -59.26 90.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.237 -0.914 . . . . 0.0 110.362 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 89.88 1.56 76.49 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.523 ' O ' ' CB ' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -150.14 170.79 18.1 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -1.182 . . . . 0.0 110.326 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.498 HG12 ' HA ' ' A' ' 197' ' ' ASP . 7.5 mt -146.62 99.96 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.0 110.202 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 196' ' ' VAL . 55.1 m -72.61 150.78 42.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -0.909 . . . . 0.0 110.004 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.718 ' HG ' HG23 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -119.9 137.9 53.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.129 -0.982 . . . . 0.0 110.288 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.56 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.6 OUTLIER -119.66 124.05 45.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.36 -0.837 . . . . 0.0 109.964 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.519 ' HA ' ' CB ' ' A' ' 193' ' ' VAL . 3.0 m80 -110.09 -171.95 1.94 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.458 -0.776 . . . . 0.0 110.188 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -56.68 98.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 110.244 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 61.09 26.11 65.32 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 206' ' ' HIS . 2.5 mtpt -143.16 158.97 43.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -1.156 . . . . 0.0 110.286 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -156.6 139.27 15.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.917 . . . . 0.0 110.153 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 212' ' ' GLU . 4.2 p -134.27 172.63 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.318 -0.863 . . . . 0.0 110.205 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.578 ' O ' HD21 ' A' ' 182' ' ' LEU . 1.5 tt0 -110.87 103.46 11.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.255 -0.903 . . . . 0.0 110.234 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.404 ' HA ' HD12 ' A' ' 213' ' ' LEU . 13.2 tp -95.22 171.69 8.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 110.087 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.956 ' O ' ' HB2' ' A' ' 218' ' ' ALA . 5.6 mt -91.12 166.17 13.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 110.141 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.466 ' HB2' ' HA ' ' A' ' 201' ' ' HIS . 6.0 t0 -89.9 -75.0 0.46 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 110.094 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.19 -22.34 60.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.929 . . . . 0.0 110.092 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.519 ' HB3' ' HB2' ' A' ' 214' ' ' LEU . 0.2 OUTLIER -90.04 -24.94 21.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.897 . . . . 0.0 110.272 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.956 ' HB2' ' O ' ' A' ' 214' ' ' LEU . . . -62.79 -33.03 74.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.204 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.97 ' CG ' HD11 ' A' ' 153' ' ' ILE . 0.3 OUTLIER -64.18 84.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 110.183 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 3.3 m -165.2 -46.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 110.577 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.871 HD11 ' HB ' ' A' ' 152' ' ' VAL . 0.3 OUTLIER -74.36 144.81 11.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.259 -0.9 . . . . 0.0 110.841 -179.566 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.535 ' O ' HG22 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -89.31 107.36 19.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.42 -0.8 . . . . 0.0 109.19 179.352 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 1.099 ' CG2' HG23 ' A' ' 165' ' ' ILE . 0.6 OUTLIER -119.87 163.98 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.316 -0.865 . . . . 0.0 110.84 -178.855 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.458 ' HG2' ' HA2' ' A' ' 149' ' ' GLY . 27.1 mt-10 -139.43 -177.77 5.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 0.0 110.27 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.586 ' HG3' HG12 ' A' ' 163' ' ' VAL . 3.6 mt-10 -95.02 70.18 3.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.878 . . . . 0.0 110.339 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 23.3 mt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.284 179.982 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 9.1 t30 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 120.832 0.349 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.07 -45.22 0.47 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.058 1.557 . . . . 0.0 110.443 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.439 ' HB ' ' HD2' ' A' ' 133' ' ' PRO . 10.0 pt -73.56 163.42 68.54 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 110.189 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 132' ' ' ILE . 46.2 Cg_endo -73.24 -17.01 24.75 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.973 1.512 . . . . 0.0 110.425 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 135' ' ' LEU . . . 107.46 -135.89 13.07 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.453 ' CB ' ' O ' ' A' ' 134' ' ' GLY . 0.3 OUTLIER 66.22 29.8 9.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -1.114 . . . . 0.0 110.259 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -151.96 87.99 1.37 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 110.298 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -71.83 61.68 0.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.935 . . . . 0.0 110.137 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.34 152.29 20.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.252 -0.905 . . . . 0.0 110.254 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.35 -168.07 13.41 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 58.9 t -80.09 96.42 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -1.156 . . . . 0.0 110.236 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -88.43 8.7 78.11 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -130.01 171.1 13.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.269 -1.136 . . . . 0.0 110.209 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 31.1 t -119.44 124.6 46.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.332 -0.855 . . . . 0.0 110.156 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.605 ' O ' ' HB3' ' A' ' 145' ' ' ALA . 2.6 m-20 -140.48 155.88 46.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 110.189 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 144' ' ' ASP . . . 62.73 178.91 0.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.237 -0.914 . . . . 0.0 110.232 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -122.91 -27.02 4.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.203 -0.936 . . . . 0.0 110.228 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -166.54 142.93 3.96 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 110.198 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.471 ' HA ' ' HG2' ' A' ' 222' ' ' ARG . 46.9 Cg_endo -73.89 60.51 4.52 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.968 1.51 . . . . 0.0 110.548 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 148' ' ' PRO . . . 43.69 -111.46 0.43 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.466 ' O ' HG22 ' A' ' 150' ' ' THR . 87.0 m -131.47 0.49 4.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -1.147 . . . . 0.0 110.288 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' A' ' 153' ' ' ILE . 1.8 mtm-85 61.03 131.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 110.138 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.842 HG13 ' O ' ' A' ' 152' ' ' VAL . 4.7 p -65.69 55.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.264 -0.897 . . . . 0.0 110.683 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 1.103 ' CG2' ' HB1' ' A' ' 218' ' ' ALA . 3.1 pt -156.23 -35.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.085 -1.009 . . . . 0.0 110.019 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 150' ' ' THR . 0.2 OUTLIER -69.81 -13.99 62.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 0.0 109.083 179.224 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.75 ' HB3' HD11 ' A' ' 195' ' ' ILE . . . -96.31 1.76 52.23 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.582 -0.699 . . . . 0.0 109.899 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 155' ' ' ALA . . . -57.69 -152.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 110.399 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 159' ' ' MET . 12.6 t -41.02 -34.53 0.43 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.38 -0.825 . . . . 0.0 110.269 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 157' ' ' THR . 10.1 t -43.39 -26.12 0.18 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.917 . . . . 0.0 109.688 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' MET . . . . . 0.52 ' HB3' ' HD2' ' A' ' 161' ' ' ARG . 0.1 OUTLIER -160.37 103.84 1.36 Allowed Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.434 -0.791 . . . . 0.0 109.602 179.702 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.23 106.35 1.73 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.938 1.494 . . . . 0.0 110.476 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.52 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 0.0 OUTLIER -171.42 175.27 4.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.358 -0.839 . . . . 0.0 110.28 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.616 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 1.0 OUTLIER -88.98 150.54 22.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.275 -0.891 . . . . 0.0 110.326 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 1.031 HG22 ' HA ' ' A' ' 194' ' ' GLU . 2.8 m -147.34 -155.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.168 -0.957 . . . . 0.0 110.851 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.646 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 4.8 ttt-85 178.71 150.99 0.28 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.026 -1.046 . . . . 0.0 110.107 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 1.04 HG23 HG22 ' A' ' 223' ' ' ILE . 0.0 OUTLIER -93.71 149.39 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.217 -0.927 . . . . 0.0 109.864 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 222' ' ' ARG . 18.2 m -130.8 0.98 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.096 -1.003 . . . . 0.0 110.472 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.468 ' HB2' ' HB2' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -167.02 123.37 1.17 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.115 -0.991 . . . . 0.0 110.253 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.457 HD12 HG21 ' A' ' 221' ' ' ILE . 1.3 tt -130.32 9.04 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 0.0 110.138 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 168' ' ' ILE . 15.0 m-20 -41.49 101.37 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -0.887 . . . . 0.0 110.181 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.41 ' O ' ' CD1' ' A' ' 172' ' ' PHE . 2.3 tp10 -146.86 116.32 7.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.207 -0.933 . . . . 0.0 110.329 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.52 ' O ' HD12 ' A' ' 171' ' ' ILE . 1.2 pp -84.25 20.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 110.17 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.454 ' C ' ' O ' ' A' ' 171' ' ' ILE . 55.8 p90 -39.96 145.11 0.16 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 0.0 110.437 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -149.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.915 . . . . 0.0 110.267 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 176' ' ' THR . 37.0 t -119.32 -15.58 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.216 -0.927 . . . . 0.0 110.294 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.32 88.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 0.0 110.128 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.563 ' CG2' ' HB3' ' A' ' 179' ' ' PHE . 0.3 OUTLIER -155.09 -36.83 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 0.0 110.356 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.481 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.4 OUTLIER 53.48 -85.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.414 -0.804 . . . . 0.0 110.465 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 176' ' ' THR . 13.5 tm0? -41.64 -26.74 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.264 -0.898 . . . . 0.0 110.433 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.939 ' CE2' HD23 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -89.14 -44.36 10.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.236 -0.915 . . . . 0.0 110.219 -179.91 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.519 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -44.37 -24.35 0.17 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.085 -1.009 . . . . 0.0 109.799 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -66.7 -67.68 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.37 -0.831 . . . . 0.0 110.155 179.799 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.802 HD12 ' N ' ' A' ' 183' ' ' LEU . 4.3 pp -60.97 -16.57 44.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.88 . . . . 0.0 109.747 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.939 HD23 ' CE2' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -81.79 -32.71 31.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 109.663 179.549 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.74 -18.62 60.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.432 -0.793 . . . . 0.0 109.851 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -87.16 16.81 4.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.371 -0.831 . . . . 0.0 110.206 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 51.38 68.32 0.81 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.12 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 187' ' ' ILE . 16.2 mm -107.14 88.63 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 110.389 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 190' ' ' GLY . 1.5 ptp180 -100.49 142.39 32.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.364 -0.835 . . . . 0.0 109.636 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 1.0 ' O ' ' N ' ' A' ' 191' ' ' SER . 5.9 m 33.77 34.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 121.288 -0.883 . . . . 0.0 110.628 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.701 ' N ' HD12 ' A' ' 165' ' ' ILE . . . 22.93 21.86 0.0 OUTLIER Glycine 0 N--CA 1.496 2.683 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' SER . . . . . 1.0 ' N ' ' O ' ' A' ' 189' ' ' VAL . 1.3 t 36.48 -148.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -1.148 . . . . 0.0 109.842 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.646 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 22.3 tt0 -83.46 118.3 23.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.614 -0.679 . . . . 0.0 109.383 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.631 ' CG2' HD21 ' A' ' 204' ' ' LEU . 34.2 m -158.67 -137.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.091 -1.005 . . . . 0.0 110.097 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 1.031 ' HA ' HG22 ' A' ' 163' ' ' VAL . 42.9 tt0 -174.3 158.77 3.0 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.207 -0.933 . . . . 0.0 110.54 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.75 HD11 ' HB3' ' A' ' 155' ' ' ALA . 0.4 OUTLIER -120.84 145.62 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.311 -0.868 . . . . 0.0 109.973 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.482 ' O ' ' O ' ' A' ' 197' ' ' ASP . 6.5 t -135.37 35.76 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.154 -0.966 . . . . 0.0 110.298 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 196' ' ' VAL . 0.4 OUTLIER 54.64 162.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.345 -0.847 . . . . 0.0 110.451 179.8 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.55 ' HB2' ' N ' ' A' ' 203' ' ' THR . 30.0 ttt-85 -143.54 160.04 41.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.219 -0.926 . . . . 0.0 110.172 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 198' ' ' ARG . 0.1 OUTLIER -43.97 103.92 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.403 -179.877 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 61.58 11.83 30.69 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.417 ' C ' ' HB3' ' A' ' 198' ' ' ARG . 1.2 t60 -150.17 -156.19 0.7 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.138 -1.213 . . . . 0.0 110.194 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.861 HD13 HG22 ' A' ' 153' ' ' ILE . 92.5 mt -129.16 134.28 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.208 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.55 ' N ' ' HB2' ' A' ' 198' ' ' ARG . 4.3 m -109.27 148.2 31.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 110.149 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.811 HD22 ' CE1' ' A' ' 206' ' ' HIS . 1.1 tt -119.71 135.2 54.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 110.161 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.525 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.5 OUTLIER -119.86 124.93 47.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.355 -0.84 . . . . 0.0 109.895 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.811 ' CE1' HD22 ' A' ' 204' ' ' LEU . 2.9 m-70 -106.06 -162.69 0.88 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.378 -0.826 . . . . 0.0 110.105 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -52.83 90.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 110.175 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 59.93 26.58 63.31 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 54.5 mttt -132.54 169.9 15.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.25 -1.147 . . . . 0.0 110.328 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.569 ' O ' HG23 ' A' ' 211' ' ' VAL . 7.9 t70 -156.02 145.61 21.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.354 -0.842 . . . . 0.0 110.068 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 210' ' ' ASP . 55.5 t -156.22 144.12 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.92 . . . . 0.0 110.252 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.451 ' OE1' ' NE2' ' A' ' 178' ' ' GLN . 6.4 tt0 -56.56 161.56 2.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 110.14 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.673 ' CD1' ' HB2' ' A' ' 218' ' ' ALA . 1.5 tm? -142.57 92.63 2.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 110.216 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.655 HD23 ' H ' ' A' ' 214' ' ' LEU . 1.4 pt? -46.83 174.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.333 -0.854 . . . . 0.0 110.148 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -90.17 -30.91 17.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.353 -0.842 . . . . 0.0 110.27 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.33 -44.89 95.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.939 . . . . 0.0 110.364 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.637 HD13 ' CD2' ' A' ' 179' ' ' PHE . 0.1 OUTLIER -84.24 -18.92 34.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.172 -0.955 . . . . 0.0 110.18 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 1.103 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -67.18 -58.68 4.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 110.412 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.496 ' HA ' HD11 ' A' ' 153' ' ' ILE . 1.8 t60 -85.87 79.32 9.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.189 -0.944 . . . . 0.0 110.471 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' THR . . . . . 0.792 HG23 HG23 ' A' ' 221' ' ' ILE . 2.8 t -176.5 -48.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 110.294 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.819 HD11 HG12 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -70.4 142.58 15.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.215 -0.928 . . . . 0.0 110.294 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.793 ' O ' HG22 ' A' ' 166' ' ' VAL . 10.0 mtt180 -89.51 114.7 26.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.237 -0.914 . . . . 0.0 109.497 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 1.04 HG22 HG23 ' A' ' 165' ' ' ILE . 0.7 OUTLIER -120.83 -176.53 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 110.725 -179.224 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 223' ' ' ILE . 46.0 mm-40 -149.57 174.52 12.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.484 -0.76 . . . . 0.0 110.03 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.515 ' HG3' HG12 ' A' ' 163' ' ' VAL . 0.4 OUTLIER -100.01 144.03 29.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 110.176 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.546 HD21 ' HG3' ' A' ' 192' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.221 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 120.738 0.304 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.72 -27.38 15.08 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.008 1.53 . . . . 0.0 110.531 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 63.0 mt -115.28 106.56 50.84 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.187 -0.946 . . . . 0.0 110.253 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.516 ' HB2' HD23 ' A' ' 135' ' ' LEU . 46.7 Cg_endo -73.02 -49.11 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.016 1.535 . . . . 0.0 110.513 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 128.71 1.91 5.86 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 133' ' ' PRO . 1.3 pp -94.22 141.39 28.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -1.13 . . . . 0.0 110.286 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -109.12 27.82 9.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.328 -0.857 . . . . 0.0 110.152 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.63 69.91 0.85 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 0.0 110.179 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.23 71.57 1.7 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.243 -0.911 . . . . 0.0 110.222 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.89 57.29 6.96 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.403 HG23 ' N ' ' A' ' 141' ' ' GLY . 19.9 m -73.43 -146.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -1.166 . . . . 0.0 110.165 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.403 ' N ' HG23 ' A' ' 140' ' ' VAL . . . 113.44 -10.84 23.95 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -112.35 135.56 52.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -1.158 . . . . 0.0 110.203 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.1 t 47.51 77.58 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 110.149 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.8 -4.28 16.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 110.296 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.543 ' O ' ' HB3' ' A' ' 146' ' ' ALA . . . -62.92 -148.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 110.209 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 145' ' ' ALA . . . 60.1 54.34 4.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.276 -0.89 . . . . 0.0 110.217 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.65 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . -177.77 169.71 0.97 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.283 -0.886 . . . . 0.0 110.197 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.65 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 45.5 Cg_endo -73.1 53.77 2.55 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.977 1.514 . . . . 0.0 110.392 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.481 ' HA3' ' HD3' ' A' ' 222' ' ' ARG . . . 164.26 83.92 0.05 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.538 ' O ' ' CG1' ' A' ' 223' ' ' ILE . 30.0 m -97.26 136.48 37.69 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -1.153 . . . . 0.0 110.276 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 154' ' ' ASP . 26.1 mtt-85 -64.87 128.77 37.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.096 -1.002 . . . . 0.0 109.888 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 1.025 HG23 HG21 ' A' ' 223' ' ' ILE . 1.3 t -43.6 -32.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.168 -0.957 . . . . 0.0 110.232 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.735 HG21 ' HB3' ' A' ' 218' ' ' ALA . 1.1 pp -83.55 -13.33 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.209 -0.932 . . . . 0.0 110.451 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 151' ' ' ARG . 0.3 OUTLIER -79.52 -14.71 58.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 109.794 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -116.56 -5.38 11.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.332 -0.855 . . . . 0.0 109.998 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.48 135.2 40.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.299 -0.875 . . . . 0.0 110.296 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 158' ' ' SER . 0.2 OUTLIER -139.67 171.82 13.69 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.204 -0.935 . . . . 0.0 110.192 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 157' ' ' THR . 0.1 OUTLIER -42.9 -60.84 1.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 110.053 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 2.2 mtt -78.54 162.98 63.8 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.179 -0.95 . . . . 0.0 110.068 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.446 ' HB3' HG22 ' A' ' 196' ' ' VAL . 45.8 Cg_endo -73.21 73.29 3.26 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.946 1.498 . . . . 0.0 110.467 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.13 130.8 23.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.326 -0.859 . . . . 0.0 110.197 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.28 103.13 4.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 110.203 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.638 ' O ' ' O ' ' A' ' 193' ' ' VAL . 17.6 m -128.72 -169.12 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.168 -0.957 . . . . 0.0 110.273 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.635 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 9.2 ptt-85 -166.25 147.32 6.52 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.711 -1.243 . . . . 0.0 110.836 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 1.092 HG23 ' CG2' ' A' ' 223' ' ' ILE . 0.8 OUTLIER -90.42 152.23 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.394 -0.816 . . . . 0.0 110.117 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 222' ' ' ARG . 17.9 m -138.59 -29.71 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.208 -0.933 . . . . 0.0 110.762 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.518 ' HB2' ' HB2' ' A' ' 222' ' ' ARG . 35.3 mt-30 -131.87 118.01 19.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.169 -0.957 . . . . 0.0 110.34 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.564 ' HB ' HG12 ' A' ' 189' ' ' VAL . 1.0 OUTLIER -84.44 -4.71 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.336 -0.853 . . . . 0.0 110.134 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.9 m120 51.16 -89.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.231 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 168' ' ' ILE . 77.6 tt0 -173.75 88.62 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 110.207 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.643 ' CG2' HD23 ' A' ' 217' ' ' LEU . 5.8 mt -76.98 2.83 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.278 -0.889 . . . . 0.0 110.21 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -58.54 108.0 0.58 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.244 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -130.45 -172.38 2.79 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.307 -0.871 . . . . 0.0 110.177 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.649 ' O ' HG12 ' A' ' 174' ' ' VAL . 61.2 t -109.59 20.1 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.203 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 177' ' ' ASP . 20.7 mm-40 -114.54 -32.95 5.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 110.21 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.541 ' O ' ' HB3' ' A' ' 179' ' ' PHE . 69.0 p 42.26 -92.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.387 -0.821 . . . . 0.0 110.288 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 176' ' ' THR . 0.7 OUTLIER 72.41 -154.68 0.08 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.262 -0.898 . . . . 0.0 110.172 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 181' ' ' GLN . 4.4 mm-40 -57.7 -23.68 52.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 110.507 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.919 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -47.48 -40.91 19.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.133 -0.98 . . . . 0.0 110.259 -179.851 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.51 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -46.93 -24.88 0.67 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.994 -1.066 . . . . 0.0 109.634 179.662 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 178' ' ' GLN . 11.7 tp60 -63.24 -66.18 0.58 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.43 -0.794 . . . . 0.0 110.42 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.682 ' C ' HD12 ' A' ' 182' ' ' LEU . 4.6 pp -63.91 -12.69 39.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.0 110.11 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.919 HD13 ' CZ ' ' A' ' 179' ' ' PHE . 0.8 OUTLIER -93.14 -30.64 15.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.314 -0.866 . . . . 0.0 109.731 179.631 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 180' ' ' THR . 9.8 t70 -73.41 -7.02 49.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.293 -0.879 . . . . 0.0 109.855 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.48 ' O ' HG12 ' A' ' 187' ' ' ILE . . . -87.58 32.32 0.72 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.323 -0.861 . . . . 0.0 110.175 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 185' ' ' ALA . 7.6 t70 43.41 55.84 4.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.194 -0.941 . . . . 0.0 109.976 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 185' ' ' ALA . 9.3 mm -110.64 163.94 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.873 . . . . 0.0 110.511 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.722 ' C ' HG13 ' A' ' 189' ' ' VAL . 0.1 OUTLIER -166.15 104.54 0.65 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.722 HG13 ' C ' ' A' ' 188' ' ' ARG . 1.5 m 50.86 103.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.763 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -42.69 -16.95 0.03 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 189' ' ' VAL . 6.3 t 64.98 -145.59 0.24 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.191 -1.182 . . . . 0.0 109.13 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.635 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 21.7 tt0 -61.02 100.64 0.12 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.215 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.674 HG21 HD21 ' A' ' 204' ' ' LEU . 17.7 m -156.28 -136.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.165 -0.959 . . . . 0.0 109.77 -179.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.642 ' N ' HG23 ' A' ' 193' ' ' VAL . 11.5 pt-20 -173.19 164.43 4.78 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.35 -0.844 . . . . 0.0 110.007 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 1.022 HG21 HG13 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -122.81 173.32 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.201 -0.937 . . . . 0.0 110.394 -179.764 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.446 HG22 ' HB3' ' A' ' 160' ' ' PRO . 99.4 t -141.49 83.86 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 0.0 110.096 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 196' ' ' VAL . 8.4 t70 -42.46 121.94 2.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.927 . . . . 0.0 110.205 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.402 ' HB3' ' HB3' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -119.02 171.36 8.31 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.178 -0.951 . . . . 0.0 110.307 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -56.0 99.98 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 110.331 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 62.87 22.75 64.84 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.403 ' C ' HG13 ' A' ' 202' ' ' ILE . 0.2 OUTLIER -148.08 158.01 43.83 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.281 -1.129 . . . . 0.0 110.083 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.684 HD13 HG22 ' A' ' 153' ' ' ILE . 57.8 mt -142.33 95.2 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 110.225 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 92.0 m -84.83 157.27 20.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 0.0 109.998 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.83 ' HG ' HG23 ' A' ' 195' ' ' ILE . 0.6 OUTLIER -119.91 141.57 49.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.206 -0.934 . . . . 0.0 110.367 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.608 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.0 OUTLIER -119.58 122.71 42.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.353 -0.842 . . . . 0.0 109.966 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.661 ' CE1' HD22 ' A' ' 204' ' ' LEU . 6.9 m-70 -98.97 167.86 10.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.45 -0.781 . . . . 0.0 110.309 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -44.07 106.95 0.08 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.338 -0.851 . . . . 0.0 110.24 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 57.57 24.34 52.37 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 206' ' ' HIS . 3.8 mtmt -150.76 175.46 11.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -1.13 . . . . 0.0 110.226 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 211' ' ' VAL . 5.6 t70 -171.18 161.9 6.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.216 -0.928 . . . . 0.0 110.148 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.479 ' N ' ' OD1' ' A' ' 210' ' ' ASP . 10.0 p -151.72 150.66 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.185 -0.947 . . . . 0.0 110.336 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.74 168.47 9.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 0.0 110.08 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 26.3 tp -172.75 149.65 2.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -0.886 . . . . 0.0 110.239 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.888 HD12 ' HB2' ' A' ' 216' ' ' ASP . 0.3 OUTLIER -114.46 124.32 51.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.267 -0.895 . . . . 0.0 110.171 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.581 ' HA ' ' HB3' ' A' ' 218' ' ' ALA . 13.5 p-10 -47.28 -22.65 0.43 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 110.23 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.888 ' HB2' HD12 ' A' ' 214' ' ' LEU . 1.4 m-20 -51.42 -66.3 0.41 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 0.0 110.328 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.643 HD23 ' CG2' ' A' ' 171' ' ' ILE . 0.3 OUTLIER -89.84 -18.02 27.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 110.348 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.735 ' HB3' HG21 ' A' ' 153' ' ' ILE . . . -47.44 -22.78 0.49 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.337 -0.852 . . . . 0.0 110.286 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 216' ' ' ASP . 0.0 OUTLIER -89.16 58.14 4.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 110.409 -179.882 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 220' ' ' THR . . . . . 0.48 HG23 ' ND1' ' A' ' 219' ' ' HIS . 18.0 p -142.83 -41.72 0.32 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -0.918 . . . . 0.0 110.262 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.65 HD13 ' N ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -69.41 137.27 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.39 -0.819 . . . . 0.0 110.305 -179.931 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.518 ' HB2' ' HB2' ' A' ' 167' ' ' GLN . 30.3 mtt180 -89.99 115.45 27.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.53 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 1.092 ' CG2' HG23 ' A' ' 165' ' ' ILE . 1.0 OUTLIER -129.37 -178.07 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 110.816 -179.125 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.42 -179.65 7.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.349 -0.844 . . . . 0.0 110.208 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.459 ' HG3' HG12 ' A' ' 163' ' ' VAL . 10.6 tt0 -99.7 100.82 11.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.222 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.495 ' O ' ' NH1' ' A' ' 164' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.206 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo . . . . . 0 N--CA 1.484 0.945 0 N-CA-C 110.413 -0.649 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 pt -56.85 156.1 13.6 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 0.0 110.216 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.99 -168.2 0.4 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.059 1.558 . . . . 0.0 110.329 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -119.5 165.94 13.31 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.503 HD23 ' H ' ' A' ' 135' ' ' LEU . 0.6 OUTLIER -79.45 178.49 8.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -1.16 . . . . 0.0 110.231 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -151.86 46.43 0.78 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.329 -0.857 . . . . 0.0 110.25 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -102.91 29.25 5.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -0.905 . . . . 0.0 110.248 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo . . . . . 0 N--CA 1.484 0.96 0 N-CA-C 110.491 -0.619 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.563 ' CA ' ' HG3' ' A' ' 222' ' ' ARG . . . 154.11 128.52 1.23 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 151' ' ' ARG . 26.1 m -142.29 5.2 1.64 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -1.14 . . . . 0.0 110.431 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 0.0 OUTLIER 58.41 135.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.882 . . . . 0.0 110.319 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.841 HG13 ' O ' ' A' ' 152' ' ' VAL . 4.2 p -65.84 56.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.162 -0.961 . . . . 0.0 110.391 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.891 ' CG2' ' HB1' ' A' ' 218' ' ' ALA . 5.1 pt -158.92 -37.1 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.104 -0.998 . . . . 0.0 110.156 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.494 ' HB3' HG22 ' A' ' 150' ' ' THR . 0.3 OUTLIER -74.64 -16.25 60.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.372 -0.83 . . . . 0.0 109.736 179.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 1.043 ' HB1' HG11 ' A' ' 163' ' ' VAL . . . -88.68 -20.12 25.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.489 -0.757 . . . . 0.0 109.971 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.569 ' HB1' ' H ' ' A' ' 197' ' ' ASP . . . -70.01 124.86 25.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.352 -0.842 . . . . 0.0 110.166 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.576 ' CB ' ' HD2' ' A' ' 161' ' ' ARG . 77.1 m -123.21 171.78 9.09 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.17 -0.956 . . . . 0.0 110.356 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.557 ' N ' HG22 ' A' ' 157' ' ' THR . 36.4 t -38.62 -39.62 0.5 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.344 -0.847 . . . . 0.0 109.603 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . 0.465 ' O ' ' HD3' ' A' ' 161' ' ' ARG . 2.6 ptt? -104.05 146.52 32.7 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 121.496 -0.753 . . . . 0.0 109.566 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.718 ' HB3' HG22 ' A' ' 196' ' ' VAL . 44.1 Cg_endo -71.14 81.04 1.21 Allowed 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.898 1.472 . . . . 0.0 110.577 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.888 HH21 HG13 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -63.37 -135.19 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.175 -0.953 . . . . 0.0 109.902 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.58 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 12.7 tttt -154.65 107.46 2.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.309 -0.869 . . . . 0.0 109.9 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 1.043 HG11 ' HB1' ' A' ' 155' ' ' ALA . 23.3 m -123.74 -150.43 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 110.845 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.666 ' HG2' ' N ' ' A' ' 165' ' ' ILE . 0.7 OUTLIER 179.48 155.41 0.52 Allowed 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.152 -0.967 . . . . 0.0 109.876 -179.201 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 1.019 HG23 HG22 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -97.48 144.89 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.225 -0.922 . . . . 0.0 109.83 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 222' ' ' ARG . 21.6 m -123.32 7.16 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.068 -1.02 . . . . 0.0 110.455 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.423 ' O ' ' N ' ' A' ' 222' ' ' ARG . 2.4 mt-30 -177.04 114.06 0.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.911 . . . . 0.0 110.412 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.997 HG21 ' HG2' ' A' ' 188' ' ' ARG . 0.7 OUTLIER -103.59 20.93 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.35 -0.844 . . . . 0.0 109.945 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' ' 168' ' ' ILE . 1.8 t-20 -44.86 172.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 110.292 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.411 ' OE2' ' HB3' ' A' ' 175' ' ' GLU . 0.4 OUTLIER -166.68 92.04 0.44 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.176 -0.952 . . . . 0.0 110.261 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.3 pp -83.61 13.88 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.197 -0.939 . . . . 0.0 110.311 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.549 ' CD1' ' OE1' ' A' ' 175' ' ' GLU . 1.6 m-85 -62.56 135.54 57.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 110.209 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.463 ' O ' ' HB ' ' A' ' 174' ' ' VAL . 11.1 mm-40 -59.67 -21.08 60.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.184 -0.948 . . . . 0.0 110.225 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 174' ' ' VAL . 4.5 p 179.76 90.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -0.937 . . . . 0.0 110.159 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.549 ' OE1' ' CD1' ' A' ' 172' ' ' PHE . 4.7 tt0 -143.52 105.18 4.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 110.252 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.523 ' O ' ' CB ' ' A' ' 177' ' ' ASP . 0.1 OUTLIER -138.07 -82.93 0.32 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 110.147 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.523 ' CB ' ' O ' ' A' ' 176' ' ' THR . 0.8 OUTLIER 70.96 -159.36 0.13 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.301 -0.875 . . . . 0.0 110.438 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -59.27 -18.9 41.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.354 -0.841 . . . . 0.0 110.583 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.819 ' HA ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -53.29 -36.03 60.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.169 -0.957 . . . . 0.0 110.129 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.48 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.7 OUTLIER -40.63 -27.92 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 0.0 109.892 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 179' ' ' PHE . 19.7 tt0 -63.2 -41.55 99.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.854 . . . . 0.0 109.823 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.819 HD12 ' HA ' ' A' ' 179' ' ' PHE . 1.7 mt -58.25 -46.48 85.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.419 -0.801 . . . . 0.0 109.766 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.62 ' O ' HD13 ' A' ' 183' ' ' LEU . 0.2 OUTLIER -67.34 -32.75 73.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.551 -0.718 . . . . 0.0 110.164 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -83.15 0.62 44.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.389 -0.819 . . . . 0.0 110.278 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.472 ' O ' HG13 ' A' ' 187' ' ' ILE . . . -81.71 8.29 10.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 110.219 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 23.4 t0 59.98 49.9 7.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.254 -0.904 . . . . 0.0 110.152 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.551 ' O ' ' CB ' ' A' ' 188' ' ' ARG . 88.8 mt -138.6 -72.99 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 110.242 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.997 ' HG2' HG21 ' A' ' 168' ' ' ILE . 3.4 ttp180 72.46 157.17 0.18 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.435 -0.791 . . . . 0.0 109.839 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.947 ' O ' ' N ' ' A' ' 191' ' ' SER . 3.7 m 33.17 36.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 O-C-N 121.352 -0.842 . . . . 0.0 110.731 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.743 ' N ' HD12 ' A' ' 165' ' ' ILE . . . 27.74 19.26 0.0 OUTLIER Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.947 ' N ' ' O ' ' A' ' 189' ' ' VAL . 30.6 t 38.29 -144.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.233 -1.157 . . . . 0.0 109.801 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.644 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -90.74 113.2 25.25 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.256 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.64 HG13 ' C ' ' A' ' 192' ' ' GLU . 33.6 m -159.27 -137.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.288 -0.882 . . . . 0.0 109.996 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.934 ' HA ' HG22 ' A' ' 163' ' ' VAL . 5.4 pt-20 -170.54 167.37 8.07 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.214 -0.929 . . . . 0.0 110.086 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.687 HG21 HG22 ' A' ' 152' ' ' VAL . 0.4 OUTLIER -124.75 173.68 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.116 -0.99 . . . . 0.0 110.401 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.718 HG22 ' HB3' ' A' ' 160' ' ' PRO . 46.1 t -145.25 85.74 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.318 -0.864 . . . . 0.0 110.055 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.569 ' H ' ' HB1' ' A' ' 156' ' ' ALA . 18.9 p-10 -40.65 133.81 1.93 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.0 110.436 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.443 ' O ' ' C ' ' A' ' 199' ' ' ASP . 12.9 mmt85 -123.66 67.11 1.02 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.268 -0.895 . . . . 0.0 110.184 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 198' ' ' ARG . 2.7 t0 40.72 81.67 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.395 -0.815 . . . . 0.0 110.158 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 88.27 -37.9 3.23 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 198' ' ' ARG . 0.0 OUTLIER -94.62 164.61 12.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.223 -1.163 . . . . 0.0 110.166 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.881 ' CD1' HG22 ' A' ' 153' ' ' ILE . 4.1 mt -145.83 118.29 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.921 . . . . 0.0 110.24 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.1 m -104.85 163.14 12.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 109.961 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 1.001 HD22 ' NE2' ' A' ' 206' ' ' HIS . 0.5 OUTLIER -119.83 138.19 53.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.152 -0.967 . . . . 0.0 110.213 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.565 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.5 OUTLIER -119.72 117.08 27.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.36 -0.837 . . . . 0.0 109.97 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 1.001 ' NE2' HD22 ' A' ' 204' ' ' LEU . 3.9 m170 -105.46 162.13 13.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.384 -0.822 . . . . 0.0 110.14 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -59.63 77.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.312 -0.867 . . . . 0.0 110.473 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 102.86 24.68 7.97 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.56 ' O ' ' CG ' ' A' ' 206' ' ' HIS . 3.1 mtpt -174.06 124.64 0.34 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -1.226 . . . . 0.0 110.462 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.46 150.86 40.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.266 -0.896 . . . . 0.0 110.149 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.76 HG12 ' HB3' ' A' ' 204' ' ' LEU . 8.4 p -137.72 165.48 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.172 -0.955 . . . . 0.0 110.252 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.88 88.99 3.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 110.202 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.816 HD12 ' N ' ' A' ' 214' ' ' LEU . 3.4 pp -76.93 -160.01 0.15 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.21 -0.931 . . . . 0.0 110.216 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.816 ' N ' HD12 ' A' ' 213' ' ' LEU . 0.5 OUTLIER -130.01 132.91 46.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -0.892 . . . . 0.0 110.217 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.453 ' OD2' HG13 ' A' ' 202' ' ' ILE . 0.7 OUTLIER -51.8 -23.58 4.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 110.222 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.86 -54.29 44.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 110.242 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.512 HD22 ' CD2' ' A' ' 179' ' ' PHE . 0.1 OUTLIER -89.6 -19.1 25.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.188 -0.945 . . . . 0.0 110.345 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.891 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -53.33 -18.36 2.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -0.877 . . . . 0.0 110.19 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.587 ' HA ' HD11 ' A' ' 153' ' ' ILE . 14.0 t-80 -103.5 49.99 0.81 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.931 . . . . 0.0 110.136 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 1.3 m -133.74 -61.59 0.8 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.327 -0.858 . . . . 0.0 110.225 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.718 HD11 HG12 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -60.55 145.15 12.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.419 -0.8 . . . . 0.0 110.379 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.709 ' O ' HG22 ' A' ' 166' ' ' VAL . 1.0 OUTLIER -89.82 116.48 27.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 109.611 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 1.019 HG22 HG23 ' A' ' 165' ' ' ILE . 0.5 OUTLIER -124.64 170.07 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.077 -1.015 . . . . 0.0 110.636 -179.419 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.657 ' HG2' HG11 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -150.11 -168.89 3.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.449 -0.782 . . . . 0.0 110.07 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 22.3 mt-10 -90.18 149.17 22.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.176 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.532 ' CD1' ' HB2' ' A' ' 192' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.924 -1.036 . . . . 0.0 110.199 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 N--CA 1.484 0.932 0 N-CA-C 110.472 -0.626 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.729 HG23 ' O ' ' A' ' 132' ' ' ILE . 7.3 tp -124.05 63.61 31.97 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 110.233 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.08 -164.52 0.2 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.059 1.557 . . . . 0.0 110.444 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -139.4 81.45 0.26 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 47.56 56.32 7.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -1.159 . . . . 0.0 110.249 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -89.62 42.25 1.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.942 . . . . 0.0 110.196 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.19 8.61 6.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.226 -0.921 . . . . 0.0 110.232 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 110.268 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo . . . . . 0 N--CA 1.483 0.911 0 N-CA-C 110.368 -0.666 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 140.19 153.17 5.97 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.576 HG22 ' HB3' ' A' ' 154' ' ' ASP . 3.7 m -131.5 2.46 4.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -1.138 . . . . 0.0 110.265 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.506 ' O ' ' HB2' ' A' ' 154' ' ' ASP . 6.1 mtm-85 61.0 118.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.266 -0.897 . . . . 0.0 110.276 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 1.077 HG13 HG23 ' A' ' 153' ' ' ILE . 5.9 p -42.82 165.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.183 -0.948 . . . . 0.0 110.218 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 1.077 HG23 HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER 72.17 -20.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.759 -0.588 . . . . 0.0 110.282 -179.439 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.576 ' HB3' HG22 ' A' ' 150' ' ' THR . 0.4 OUTLIER -91.4 -18.98 23.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 0.0 108.71 178.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.422 ' O ' ' HG3' ' A' ' 161' ' ' ARG . . . -108.33 -15.04 14.56 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.563 0.697 . . . . 0.0 109.45 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.611 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -67.83 152.12 46.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.437 -0.79 . . . . 0.0 110.157 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -161.94 174.59 12.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 110.227 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 157' ' ' THR . 0.2 OUTLIER -41.97 -48.32 4.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 110.166 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . 0.448 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 4.0 mmm -82.32 166.66 35.39 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 110.201 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 46.5 Cg_endo -73.35 84.06 1.41 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.019 1.536 . . . . 0.0 110.437 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -70.72 111.48 6.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 0.0 110.241 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.597 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 0.2 OUTLIER -71.99 117.26 13.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.896 . . . . 0.0 110.286 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.819 HG12 ' C ' ' A' ' 224' ' ' GLU . 0.0 OUTLIER -133.88 -165.4 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.213 -0.929 . . . . 0.0 110.431 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.566 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 20.1 ttp180 -173.54 147.61 1.46 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.847 -1.158 . . . . 0.0 109.829 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.92 HG23 HG22 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -95.03 143.55 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.162 -0.961 . . . . 0.0 110.181 -179.457 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 222' ' ' ARG . 28.8 m -123.9 -8.21 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 110.175 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -158.66 124.04 4.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 0.0 110.188 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.776 HG21 ' HG2' ' A' ' 188' ' ' ARG . 5.1 tt -117.58 6.65 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.279 -0.888 . . . . 0.0 110.169 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.446 ' O ' ' CB ' ' A' ' 170' ' ' GLU . 27.1 t-20 -41.88 113.35 0.42 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.303 -0.873 . . . . 0.0 110.114 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.604 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 0.1 OUTLIER 172.68 123.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 110.321 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.6 ' O ' HG22 ' A' ' 171' ' ' ILE . 63.2 mt -84.89 17.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 109.91 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.604 ' CE1' ' HB3' ' A' ' 170' ' ' GLU . 0.5 OUTLIER 25.06 -138.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.686 -0.634 . . . . 0.0 110.954 179.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.04 -145.94 0.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 0.0 110.213 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 32.8 m -114.71 6.46 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 110.355 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.71 174.09 7.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 110.245 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' A' ' 177' ' ' ASP . 12.1 p -148.29 -84.48 0.1 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -0.889 . . . . 0.0 110.165 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 176' ' ' THR . 7.0 t0 70.09 -139.16 0.06 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.345 -0.847 . . . . 0.0 110.218 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.496 ' O ' ' HB3' ' A' ' 181' ' ' GLN . 0.0 OUTLIER -64.07 -28.34 69.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.114 -0.991 . . . . 0.0 110.256 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.639 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.3 OUTLIER -50.03 -51.8 39.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 110.076 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -49.97 -21.38 1.18 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.065 -1.022 . . . . 0.0 109.822 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.496 ' HB3' ' O ' ' A' ' 178' ' ' GLN . 20.8 tt0 -69.49 -59.95 2.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.291 -0.881 . . . . 0.0 110.422 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.877 HD12 ' N ' ' A' ' 183' ' ' LEU . 3.9 pp -66.62 -15.64 63.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.831 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.877 ' N ' HD12 ' A' ' 182' ' ' LEU . 0.3 OUTLIER -85.97 -28.81 24.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.36 -0.838 . . . . 0.0 109.668 179.619 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -81.12 6.85 12.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.346 -0.846 . . . . 0.0 109.821 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.755 ' HB3' HG22 ' A' ' 187' ' ' ILE . . . -81.05 12.46 3.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.353 -0.842 . . . . 0.0 110.232 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 185' ' ' ALA . 23.1 t70 43.48 41.15 3.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.156 -0.965 . . . . 0.0 109.326 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.755 HG22 ' HB3' ' A' ' 185' ' ' ALA . 0.4 OUTLIER -117.19 -43.63 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.451 -0.781 . . . . 0.0 110.379 -179.448 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.776 ' HG2' HG21 ' A' ' 168' ' ' ILE . 3.9 ttp-105 53.22 168.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.341 -0.849 . . . . 0.0 109.882 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.956 ' O ' ' N ' ' A' ' 191' ' ' SER . 2.7 m 31.46 37.67 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 121.369 -0.832 . . . . 0.0 110.809 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.741 ' N ' HD12 ' A' ' 165' ' ' ILE . . . 28.41 19.14 0.0 OUTLIER Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.956 ' N ' ' O ' ' A' ' 189' ' ' VAL . 18.1 t 41.52 -153.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.167 -1.196 . . . . 0.0 109.766 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.647 ' C ' HG13 ' A' ' 193' ' ' VAL . 1.8 pt-20 -89.11 115.81 26.91 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.582 -0.699 . . . . 0.0 109.115 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.668 ' O ' ' O ' ' A' ' 163' ' ' VAL . 35.4 m -159.8 -131.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.939 . . . . 0.0 109.942 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.68 ' O ' HD23 ' A' ' 204' ' ' LEU . 8.1 pt-20 -176.8 169.34 2.48 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.241 -0.912 . . . . 0.0 110.387 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 1.035 HD13 HG23 ' A' ' 152' ' ' VAL . 0.5 OUTLIER -125.46 170.78 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.221 -0.924 . . . . 0.0 110.51 -179.552 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.462 ' O ' ' C ' ' A' ' 197' ' ' ASP . 65.7 t -148.13 80.7 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.367 -0.833 . . . . 0.0 109.892 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 197' ' ' ASP . 11.5 p30 -39.39 123.28 1.42 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.394 -0.816 . . . . 0.0 110.448 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.511 ' HB3' ' HB2' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -107.12 78.1 1.2 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.271 -0.893 . . . . 0.0 110.135 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 198' ' ' ARG . 27.7 t0 41.78 79.43 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.295 -0.878 . . . . 0.0 110.212 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 87.68 -37.27 3.25 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 198' ' ' ARG . 45.0 m170 -90.99 168.37 11.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.239 -1.153 . . . . 0.0 110.202 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.559 ' CD1' ' HB ' ' A' ' 153' ' ' ILE . 7.7 mt -141.09 121.6 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.221 -0.924 . . . . 0.0 110.166 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 195' ' ' ILE . 58.0 m -109.12 160.18 16.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.332 -0.855 . . . . 0.0 109.863 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 1.05 HD12 HD22 ' A' ' 213' ' ' LEU . 0.6 OUTLIER -119.74 132.46 55.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.158 -0.964 . . . . 0.0 110.217 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.568 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 1.4 m -119.82 128.12 53.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.878 . . . . 0.0 109.941 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.653 ' HB3' HG12 ' A' ' 193' ' ' VAL . 1.8 m170 -105.48 173.98 6.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.366 -0.834 . . . . 0.0 109.958 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -58.35 96.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 0.0 110.229 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 76.14 29.72 58.23 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.68 165.41 32.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.117 -1.225 . . . . 0.0 110.26 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -161.12 143.37 12.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.224 -0.922 . . . . 0.0 110.177 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.746 HG13 ' N ' ' A' ' 212' ' ' GLU . 1.6 p -142.74 -154.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.176 -0.952 . . . . 0.0 110.228 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.746 ' N ' HG13 ' A' ' 211' ' ' VAL . 1.3 tt0 -115.23 169.49 9.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 110.323 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 1.05 HD22 HD12 ' A' ' 204' ' ' LEU . 11.6 tp -168.27 89.68 0.26 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.355 -0.841 . . . . 0.0 110.149 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.934 HD11 ' HB2' ' A' ' 217' ' ' LEU . 2.5 pt? -41.62 152.78 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 110.292 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -83.01 -22.39 33.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 110.195 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.98 -61.93 2.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.241 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.934 ' HB2' HD11 ' A' ' 214' ' ' LEU . 0.2 OUTLIER -75.63 -14.86 60.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -0.872 . . . . 0.0 110.197 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.799 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -50.29 -51.16 47.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 110.16 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.538 ' HB2' ' CD1' ' A' ' 153' ' ' ILE . 9.6 t60 -74.02 72.98 1.67 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.211 -0.93 . . . . 0.0 110.22 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . 0.413 HG21 ' HD1' ' A' ' 172' ' ' PHE . 31.5 m -156.39 -53.82 0.08 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.154 -0.967 . . . . 0.0 110.425 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.668 HD11 HG12 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -66.07 174.82 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.397 -0.815 . . . . 0.0 110.409 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.446 ' O ' HG22 ' A' ' 166' ' ' VAL . 1.2 mtm180 -122.62 99.67 6.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.417 -0.802 . . . . 0.0 109.734 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.92 HG22 HG23 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -119.36 167.45 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.97 . . . . 0.0 110.173 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.819 ' C ' HG12 ' A' ' 163' ' ' VAL . 15.1 pt-20 -150.3 174.35 12.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.245 -0.909 . . . . 0.0 110.135 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.427 ' OE1' ' OXT' ' A' ' 226' ' ' LEU . 0.7 OUTLIER -43.96 143.04 1.2 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.47 -0.769 . . . . 0.0 110.23 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.427 ' OXT' ' OE1' ' A' ' 225' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.196 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo . . . . . 0 N--CA 1.483 0.877 0 N-CA-C 110.496 -0.617 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.96 135.56 94.71 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.234 -0.916 . . . . 0.0 110.147 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.09 -90.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.986 1.519 . . . . 0.0 110.444 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 139.53 -116.17 1.19 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.6 mm? 59.11 166.12 0.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -1.143 . . . . 0.0 110.2 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -80.96 86.05 6.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.188 -0.945 . . . . 0.0 110.274 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -142.28 57.25 1.46 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.295 -0.878 . . . . 0.0 110.239 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 0.0 110.215 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.442 ' HB2' ' OE2' ' A' ' 224' ' ' GLU . 46.8 Cg_endo . . . . . 0 N--CA 1.484 0.955 0 N-CA-C 110.435 -0.641 . . . . 0.0 110.435 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.552 ' HA3' ' HB2' ' A' ' 222' ' ' ARG . . . -133.18 159.16 23.48 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.538 ' O ' ' HB3' ' A' ' 154' ' ' ASP . 0.6 OUTLIER -158.15 17.63 0.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -1.153 . . . . 0.0 110.471 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.634 ' C ' HD12 ' A' ' 223' ' ' ILE . 0.5 OUTLIER 56.11 117.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.146 -0.971 . . . . 0.0 110.375 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 1.031 HG13 HG21 ' A' ' 223' ' ' ILE . 0.0 OUTLIER -41.39 -80.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.193 -0.942 . . . . 0.0 111.247 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 1.108 ' CG2' ' HB1' ' A' ' 218' ' ' ALA . 0.2 OUTLIER -47.44 -18.82 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.429 -0.795 . . . . 0.0 111.631 -178.628 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.616 ' HB2' ' CB ' ' A' ' 151' ' ' ARG . 0.3 OUTLIER -71.9 -13.49 61.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.798 -1.189 . . . . 0.0 109.094 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -125.63 2.08 7.55 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.653 -0.655 . . . . 0.0 109.624 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.74 ' O ' HG22 ' A' ' 157' ' ' THR . . . -81.04 -177.5 6.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.42 -0.8 . . . . 0.0 110.486 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.74 HG22 ' O ' ' A' ' 156' ' ' ALA . 7.2 t 40.11 -168.53 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.548 -0.72 . . . . 0.0 110.55 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.53 ' C ' ' O ' ' A' ' 157' ' ' THR . 25.0 p 34.64 76.58 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.327 -0.858 . . . . 0.0 110.16 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . 0.479 ' N ' ' CD ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER 58.33 54.28 5.73 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.92 . . . . 0.0 109.586 -179.445 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.575 ' HB3' ' N ' ' A' ' 157' ' ' THR . 43.8 Cg_endo -71.2 -159.09 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.091 1.574 . . . . 0.0 110.682 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.514 ' CB ' ' O ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER 168.2 -153.94 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.317 -0.865 . . . . 0.0 110.301 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.533 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 0.1 OUTLIER -90.73 116.7 28.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -0.919 . . . . 0.0 110.539 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.69 HG12 ' O ' ' A' ' 224' ' ' GLU . 0.0 OUTLIER -112.26 -171.44 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.271 -0.893 . . . . 0.0 110.112 179.555 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.7 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -170.61 131.43 0.89 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.888 -1.133 . . . . 0.0 110.056 -179.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.949 HG23 HG22 ' A' ' 223' ' ' ILE . 0.5 OUTLIER -88.97 152.03 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.333 -0.854 . . . . 0.0 110.656 -179.197 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 222' ' ' ARG . 9.2 m -133.61 -1.67 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 110.184 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.573 ' CB ' ' HD2' ' A' ' 222' ' ' ARG . 0.1 OUTLIER -171.59 125.24 0.59 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 110.169 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.85 HD11 HG13 ' A' ' 171' ' ' ILE . 8.5 tt -90.21 -3.12 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.854 . . . . 0.0 110.235 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 168' ' ' ILE . 0.2 OUTLIER 62.71 -141.26 0.4 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 110.243 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.87 109.0 18.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 110.306 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.85 HG13 HD11 ' A' ' 168' ' ' ILE . 41.9 mm -87.84 23.19 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 110.178 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -54.93 86.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.285 -0.884 . . . . 0.0 110.234 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.504 ' N ' ' O ' ' A' ' 171' ' ' ILE . 0.7 OUTLIER -142.99 -172.07 3.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 110.181 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.415 ' O ' HG22 ' A' ' 174' ' ' VAL . 9.2 p -122.41 -4.78 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 110.262 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.426 ' C ' HG22 ' A' ' 176' ' ' THR . 77.0 mt-10 -71.48 167.0 20.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.178 -0.951 . . . . 0.0 110.204 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -173.7 -95.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.191 -0.943 . . . . 0.0 110.229 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 176' ' ' THR . 4.2 t0 72.35 -140.21 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.283 -0.886 . . . . 0.0 110.273 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -58.42 -16.2 13.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.276 -0.89 . . . . 0.0 110.43 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 1.0 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -60.5 -22.84 64.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.081 -1.012 . . . . 0.0 110.135 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.503 HG23 ' OG1' ' A' ' 176' ' ' THR . 0.6 OUTLIER -54.55 -26.91 34.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.144 -0.973 . . . . 0.0 109.864 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.489 ' HB3' ' OE2' ' A' ' 212' ' ' GLU . 3.2 tt0 -69.26 -65.75 0.67 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.365 -0.834 . . . . 0.0 110.218 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.651 ' C ' HD12 ' A' ' 182' ' ' LEU . 4.5 pp -58.99 -15.07 11.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.884 . . . . 0.0 110.268 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 1.0 HD13 ' CZ ' ' A' ' 179' ' ' PHE . 0.7 OUTLIER -86.45 -31.18 21.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 109.998 179.8 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.15 -8.03 35.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.359 -0.838 . . . . 0.0 110.07 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -88.86 10.06 22.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.865 . . . . 0.0 110.176 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 185' ' ' ALA . 31.8 t0 41.69 66.66 0.66 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.907 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.3 tt -121.3 -173.56 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 110.54 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.701 ' C ' HG13 ' A' ' 189' ' ' VAL . 0.1 OUTLIER -171.81 122.53 0.5 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.701 HG13 ' C ' ' A' ' 188' ' ' ARG . 1.4 m 50.27 105.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.204 -0.935 . . . . 0.0 108.947 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.74 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -45.14 -12.99 0.03 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.631 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 4.1 t 65.84 -143.26 0.19 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.012 -1.287 . . . . 0.0 109.42 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.7 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 1.9 tt0 -71.31 102.86 2.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.572 -0.705 . . . . 0.0 109.487 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.607 HG13 ' C ' ' A' ' 192' ' ' GLU . 16.9 m -156.65 -140.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.097 -1.002 . . . . 0.0 109.967 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.645 ' HA ' HG23 ' A' ' 163' ' ' VAL . 8.3 pt-20 -176.88 138.1 0.26 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 110.728 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.692 ' C ' HD13 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -132.26 161.21 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.293 -0.88 . . . . 0.0 109.99 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.553 ' N ' HG12 ' A' ' 195' ' ' ILE . 37.5 t -154.75 150.3 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.421 -0.799 . . . . 0.0 110.165 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -58.92 119.53 7.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -0.943 . . . . 0.0 110.133 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 199' ' ' ASP . 0.0 OUTLIER -119.32 106.95 12.81 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.232 -0.917 . . . . 0.0 110.396 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 198' ' ' ARG . 15.9 m-20 40.75 79.71 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.254 -0.904 . . . . 0.0 110.372 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 44.84 25.12 0.85 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.414 ' O ' ' CB ' ' A' ' 198' ' ' ARG . 0.0 OUTLIER -150.18 106.83 3.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.214 -1.168 . . . . 0.0 110.132 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.728 HD13 HG22 ' A' ' 153' ' ' ILE . 49.8 mt -64.27 139.46 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 110.336 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 195' ' ' ILE . 3.7 m -119.16 150.32 40.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.338 -0.851 . . . . 0.0 109.935 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.56 ' HG ' ' HB ' ' A' ' 195' ' ' ILE . 0.5 OUTLIER -119.8 130.34 54.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 0.0 110.284 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.556 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 3.2 t -119.79 126.86 52.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.393 -0.817 . . . . 0.0 110.014 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.514 ' HB3' HG12 ' A' ' 193' ' ' VAL . 0.0 OUTLIER -114.19 106.64 14.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.451 -0.781 . . . . 0.0 109.836 180.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.493 ' HB3' ' O ' ' A' ' 206' ' ' HIS . 21.4 t30 61.01 17.4 7.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 110.243 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 114.04 -20.01 17.35 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -81.35 101.37 9.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -1.155 . . . . 0.0 110.277 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 210' ' ' ASP . 30.5 p30 -83.93 147.84 27.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.912 . . . . 0.0 110.292 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.409 ' CG1' ' CE1' ' A' ' 206' ' ' HIS . 4.3 p -155.12 151.66 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.319 -0.863 . . . . 0.0 110.167 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.489 ' OE2' ' HB3' ' A' ' 181' ' ' GLN . 15.4 pt-20 -57.28 148.05 23.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 0.0 110.165 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.48 ' HG ' ' HB2' ' A' ' 204' ' ' LEU . 0.4 OUTLIER -113.86 -149.33 0.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 110.2 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.723 HD13 ' CB ' ' A' ' 217' ' ' LEU . 0.4 OUTLIER -152.16 108.89 3.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 110.223 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -59.8 -38.67 82.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 110.304 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.417 ' OD2' ' OE1' ' A' ' 175' ' ' GLU . 0.2 OUTLIER -65.7 -44.71 85.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.911 . . . . 0.0 110.267 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.848 ' O ' HG22 ' A' ' 220' ' ' THR . 0.2 OUTLIER -85.83 -22.91 27.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.267 -0.896 . . . . 0.0 110.254 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 1.108 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -40.63 -44.84 2.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.334 -0.853 . . . . 0.0 110.288 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.455 ' CD2' ' HG2' ' A' ' 151' ' ' ARG . 39.8 t-80 -90.69 49.73 1.71 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.155 -0.966 . . . . 0.0 110.509 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . 0.848 HG22 ' O ' ' A' ' 217' ' ' LEU . 3.0 t -137.52 -27.16 0.95 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.126 -0.984 . . . . 0.0 110.486 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.762 HG13 HD13 ' A' ' 165' ' ' ILE . 0.1 OUTLIER -95.23 144.5 9.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 120.998 -1.064 . . . . 0.0 110.362 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.573 ' HD2' ' CB ' ' A' ' 167' ' ' GLN . 3.7 ptp85 -95.06 106.72 18.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.146 -0.971 . . . . 0.0 109.405 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 1.031 HG21 HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -119.78 174.03 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.183 -0.948 . . . . 0.0 110.253 -179.132 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.69 ' O ' HG12 ' A' ' 163' ' ' VAL . 1.2 tt0 -124.65 171.95 9.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.096 -1.003 . . . . 0.0 110.583 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 6.8 tp10 -113.52 110.99 21.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.374 -0.829 . . . . 0.0 110.182 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 162' ' ' LYS . 7.6 mp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.984 -1.007 . . . . 0.0 110.16 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 N--CA 1.484 0.949 0 N-CA-C 110.38 -0.662 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 9.9 tt -63.79 140.63 97.86 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.25 -0.906 . . . . 0.0 110.223 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.09 -166.86 0.32 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.962 1.506 . . . . 0.0 110.384 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.12 -119.6 2.01 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.4 tp -130.44 138.36 50.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.198 -1.178 . . . . 0.0 110.187 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 138' ' ' LEU . 0.5 OUTLIER 52.93 33.27 14.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.305 -0.872 . . . . 0.0 110.158 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 59.83 -85.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.314 -0.866 . . . . 0.0 110.21 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 136' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.283 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.473 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 45.8 Cg_endo . . . . . 0 N--CA 1.484 0.927 0 N-CA-C 110.358 -0.67 . . . . 0.0 110.358 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 151' ' ' ARG . . . -114.83 35.01 4.6 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.539 ' O ' ' CG1' ' A' ' 223' ' ' ILE . 23.8 m -42.07 93.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.37 -1.076 . . . . 0.0 110.236 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.568 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 7.2 ptp85 -42.02 142.75 0.66 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.219 -0.926 . . . . 0.0 110.112 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 1.01 ' CG1' HG23 ' A' ' 153' ' ' ILE . 0.8 OUTLIER -57.57 -153.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.176 -0.953 . . . . 0.0 110.039 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 1.096 HG21 ' CB ' ' A' ' 218' ' ' ALA . 11.8 pt 39.29 25.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.321 -0.862 . . . . 0.0 110.436 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER -135.55 -36.35 0.78 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.312 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -88.76 -9.94 50.06 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.667 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -74.7 107.42 6.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.546 -0.721 . . . . 0.0 110.234 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 158' ' ' SER . 5.7 t -174.11 169.62 3.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.272 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 159' ' ' MET . 0.6 OUTLIER 41.77 74.17 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.327 -0.858 . . . . 0.0 110.124 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . 0.513 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 0.0 OUTLIER 63.51 165.9 0.11 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.144 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 44.6 Cg_endo -72.24 88.01 0.87 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.999 1.526 . . . . 0.0 110.435 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.2 ttt85 -65.61 -140.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 110.21 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -145.29 93.15 2.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.234 -0.916 . . . . 0.0 110.254 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.675 ' O ' ' O ' ' A' ' 193' ' ' VAL . 21.5 m -111.52 -172.94 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.0 110.224 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.643 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 12.8 ptt-85 -162.39 147.17 12.3 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.725 -1.234 . . . . 0.0 110.872 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 1.042 HG23 ' CG2' ' A' ' 223' ' ' ILE . 1.2 mt -98.71 165.84 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.493 -0.755 . . . . 0.0 110.273 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 222' ' ' ARG . 19.1 m -142.54 -31.8 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.158 -0.964 . . . . 0.0 110.484 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 222' ' ' ARG . 0.7 OUTLIER -140.34 123.91 17.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 110.282 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.67 HG13 HG22 ' A' ' 221' ' ' ILE . 7.4 tt -99.61 -5.95 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 110.117 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 168' ' ' ILE . 17.4 m120 55.05 164.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.315 -0.866 . . . . 0.0 110.204 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 169' ' ' ASN . 28.5 mt-10 -144.51 49.57 1.32 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.14 -0.975 . . . . 0.0 110.204 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.0 mm -100.23 -3.08 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.211 -0.931 . . . . 0.0 110.234 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -123.01 154.47 38.42 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.142 -0.974 . . . . 0.0 110.214 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 174' ' ' VAL . 0.0 OUTLIER -79.43 -26.99 41.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.226 -0.921 . . . . 0.0 110.187 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.661 HG11 HD12 ' A' ' 217' ' ' LEU . 41.6 t 43.91 74.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 110.344 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -103.88 116.96 33.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.289 -0.882 . . . . 0.0 110.107 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.638 HG22 ' HB3' ' A' ' 179' ' ' PHE . 2.9 m -155.42 134.56 12.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.901 . . . . 0.0 110.18 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 179' ' ' PHE . 1.1 p-10 -48.73 -101.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.316 -0.865 . . . . 0.0 111.248 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.484 ' C ' ' O ' ' A' ' 177' ' ' ASP . 5.1 pt20 -34.04 -30.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.258 -0.901 . . . . 0.0 111.082 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.638 ' HB3' HG22 ' A' ' 176' ' ' THR . 7.4 t80 -60.48 -59.59 5.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.944 . . . . 0.0 110.487 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.547 ' HA ' ' HB3' ' A' ' 183' ' ' LEU . 0.9 OUTLIER -37.98 -29.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.359 -0.838 . . . . 0.0 110.33 -179.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.504 ' N ' ' O ' ' A' ' 179' ' ' PHE . 24.4 tt0 -57.45 -56.69 18.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.202 -0.937 . . . . 0.0 110.019 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.573 ' C ' HD12 ' A' ' 182' ' ' LEU . 2.6 pp -70.03 -14.04 62.5 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.286 -0.884 . . . . 0.0 109.686 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.547 ' HB3' ' HA ' ' A' ' 180' ' ' THR . 0.4 OUTLIER -89.8 -32.13 17.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.393 -0.817 . . . . 0.0 109.775 179.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -69.4 -4.8 19.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.309 -0.869 . . . . 0.0 109.806 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -83.74 14.33 4.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.428 -0.795 . . . . 0.0 110.114 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 185' ' ' ALA . 0.7 OUTLIER 42.82 62.74 1.67 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.156 -0.965 . . . . 0.0 109.896 -179.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.8 tt -119.35 -173.78 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 110.52 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.719 ' C ' HG13 ' A' ' 189' ' ' VAL . 0.1 OUTLIER -174.53 115.56 0.18 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.362 -0.836 . . . . 0.0 108.748 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.719 HG13 ' C ' ' A' ' 188' ' ' ARG . 1.3 m 51.57 108.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.298 -0.876 . . . . 0.0 109.073 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.794 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -46.12 -13.96 0.08 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.568 ' O ' ' HB2' ' A' ' 164' ' ' ARG . 7.7 t 63.93 -146.87 0.3 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -1.148 . . . . 0.0 109.483 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.643 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.2 OUTLIER -63.4 99.63 0.21 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.618 -0.676 . . . . 0.0 109.576 179.336 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.675 ' O ' ' O ' ' A' ' 163' ' ' VAL . 26.2 m -157.28 -135.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -0.93 . . . . 0.0 109.603 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.599 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.3 OUTLIER -175.04 160.47 2.78 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.124 179.297 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.797 HD13 ' CG2' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -119.97 176.62 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.074 -1.016 . . . . 0.0 110.227 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.463 HG23 ' C ' ' A' ' 195' ' ' ILE . 7.4 t -148.7 86.7 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.291 -0.881 . . . . 0.0 110.183 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 197' ' ' ASP . 15.8 p-10 -43.8 127.33 5.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 110.245 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.499 ' O ' ' C ' ' A' ' 199' ' ' ASP . 21.9 mtt180 -99.76 71.58 1.7 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -0.889 . . . . 0.0 110.37 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 198' ' ' ARG . 3.9 p-10 36.18 39.74 0.09 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.366 -0.833 . . . . 0.0 110.413 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 140.75 -48.77 0.81 Allowed Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.453 ' O ' ' CG1' ' A' ' 202' ' ' ILE . 0.1 OUTLIER -89.9 -158.12 0.51 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -1.11 . . . . 0.0 109.801 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.906 ' CD1' HG22 ' A' ' 153' ' ' ILE . 8.1 mt -155.63 159.53 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.073 -1.017 . . . . 0.0 110.571 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.613 ' O ' HG22 ' A' ' 195' ' ' ILE . 43.2 m -144.32 151.97 40.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.534 -0.729 . . . . 0.0 109.464 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.903 HD22 ' CD2' ' A' ' 206' ' ' HIS . 0.5 OUTLIER -119.91 129.09 54.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.166 -0.959 . . . . 0.0 110.536 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.59 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.5 OUTLIER -119.98 119.8 34.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.424 -0.797 . . . . 0.0 109.826 179.77 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.903 ' CD2' HD22 ' A' ' 204' ' ' LEU . 1.5 m170 -107.31 152.35 24.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.498 -0.751 . . . . 0.0 109.931 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -49.04 -20.54 0.55 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.15 -0.969 . . . . 0.0 110.059 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 209' ' ' LYS . . . -91.2 -31.81 9.42 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 208' ' ' GLY . 10.4 pttt 174.02 -173.95 0.06 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.211 -1.17 . . . . 0.0 110.173 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 4.6 p30 -112.17 161.59 16.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.893 . . . . 0.0 110.413 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 39.1 t -147.04 147.14 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 0.0 110.127 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.0 160.74 30.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.0 110.283 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.704 ' C ' HD23 ' A' ' 214' ' ' LEU . 2.9 mt -131.83 -160.11 1.02 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.203 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.711 HD23 ' N ' ' A' ' 214' ' ' LEU . 0.9 OUTLIER -173.15 169.18 4.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.19 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -75.81 -26.17 56.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 110.183 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.537 ' CB ' HD12 ' A' ' 214' ' ' LEU . 1.0 OUTLIER -63.21 -57.02 11.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 110.125 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.661 HD12 HG11 ' A' ' 174' ' ' VAL . 0.2 OUTLIER -78.35 -28.0 47.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 110.112 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 1.096 ' CB ' HG21 ' A' ' 153' ' ' ILE . . . -40.05 -63.8 0.57 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.369 -0.832 . . . . 0.0 110.487 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.415 ' HB2' HD11 ' A' ' 153' ' ' ILE . 3.5 t-160 -91.77 77.59 5.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.879 . . . . 0.0 110.306 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 4.9 m -166.74 -48.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 0.0 110.44 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.67 HG22 HG13 ' A' ' 168' ' ' ILE . 0.1 OUTLIER -73.98 136.75 24.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.361 -0.837 . . . . 0.0 110.786 -179.66 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.718 ' O ' HG22 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -89.39 112.91 24.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.212 -0.93 . . . . 0.0 109.256 179.275 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 1.042 ' CG2' HG23 ' A' ' 165' ' ' ILE . 0.7 OUTLIER -119.97 -169.48 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.158 -0.964 . . . . 0.0 110.808 -179.053 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 148' ' ' PRO . 30.8 mt-10 -150.25 156.57 41.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.449 -0.782 . . . . 0.0 110.051 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -107.48 99.2 8.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 110.254 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.233 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.522 ' O ' ' HD3' ' A' ' 133' ' ' PRO . 44.3 Cg_endo . . . . . 0 N--CA 1.486 1.034 0 N-CA-C 110.58 -0.585 . . . . 0.0 110.58 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 30.3 mt -106.12 85.96 1.83 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 110.134 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 131' ' ' PRO . 45.9 Cg_endo -72.6 -53.95 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.992 1.522 . . . . 0.0 110.453 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.43 42.48 2.01 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.4 tp -124.28 26.16 7.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.293 -1.122 . . . . 0.0 110.254 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -103.62 -88.22 0.42 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.898 . . . . 0.0 110.085 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -109.6 -17.98 13.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.284 -0.885 . . . . 0.0 110.208 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.253 -0.904 . . . . 0.0 110.189 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 N--CA 1.484 0.913 0 N-CA-C 110.344 -0.675 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.476 ' O ' ' HG2' ' A' ' 222' ' ' ARG . . . -48.21 123.41 9.62 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.821 HG22 ' N ' ' A' ' 151' ' ' ARG . 2.2 m -47.39 -89.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -1.142 . . . . 0.0 110.088 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.821 ' N ' HG22 ' A' ' 150' ' ' THR . 0.0 OUTLIER 169.07 135.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.89 . . . . 0.0 110.01 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.918 HG11 HD11 ' A' ' 221' ' ' ILE . 1.2 m -37.85 -92.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.346 -0.846 . . . . 0.0 111.302 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 1.02 HD12 ' N ' ' A' ' 154' ' ' ASP . 1.9 pp -41.04 -23.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.151 -0.968 . . . . 0.0 111.032 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 1.02 ' N ' HD12 ' A' ' 153' ' ' ILE . 1.2 m-20 -75.12 -16.79 60.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.107 -0.996 . . . . 0.0 110.001 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -109.9 -16.21 13.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.398 -0.814 . . . . 0.0 110.178 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.425 ' O ' ' OG1' ' A' ' 157' ' ' THR . . . -82.7 99.72 9.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.342 -0.849 . . . . 0.0 110.303 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 156' ' ' ALA . 3.2 m -169.8 152.11 4.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.261 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 159' ' ' MET . 6.4 t 55.41 88.29 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.897 . . . . 0.0 110.27 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . 0.426 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 27.4 mtm 55.83 169.5 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 110.183 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.459 ' HB3' HG22 ' A' ' 196' ' ' VAL . 45.9 Cg_endo -72.87 91.29 0.82 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.047 1.551 . . . . 0.0 110.417 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -82.32 129.05 34.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 0.0 110.073 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.487 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 2.4 mmtp -68.91 125.5 26.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.898 . . . . 0.0 110.427 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.738 HG12 ' HA ' ' A' ' 225' ' ' GLU . 29.2 m -141.63 -153.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.229 -0.92 . . . . 0.0 110.234 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.618 ' HG2' ' N ' ' A' ' 165' ' ' ILE . 0.0 OUTLIER -176.21 153.94 1.32 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.901 -1.124 . . . . 0.0 110.213 -179.452 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 1.073 HG21 ' HB ' ' A' ' 189' ' ' VAL . 20.1 mt -102.36 176.21 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.159 -0.963 . . . . 0.0 111.291 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.91 HG22 ' O ' ' A' ' 222' ' ' ARG . 2.7 m -126.36 -28.2 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.664 -0.648 . . . . 0.0 109.561 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.622 ' HA ' ' CG2' ' A' ' 189' ' ' VAL . 0.5 OUTLIER 162.22 147.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.558 -0.714 . . . . 0.0 110.515 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.855 ' HA ' HG22 ' A' ' 221' ' ' ILE . 2.7 mt -66.0 -7.29 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.484 -0.76 . . . . 0.0 109.088 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.484 ' O ' ' HB2' ' A' ' 170' ' ' GLU . 0.1 OUTLIER 53.45 108.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.593 -0.692 . . . . 0.0 110.305 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 169' ' ' ASN . 1.0 OUTLIER 61.78 76.88 0.35 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -0.885 . . . . 0.0 110.278 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.505 HG22 ' HB ' ' A' ' 168' ' ' ILE . 1.7 pp -80.05 6.18 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.894 . . . . 0.0 110.181 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -49.06 -25.53 2.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 110.306 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -71.86 163.61 27.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.937 . . . . 0.0 110.335 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.774 ' O ' HG22 ' A' ' 174' ' ' VAL . 7.0 p -169.95 39.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.248 -0.908 . . . . 0.0 110.264 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.606 ' O ' ' C ' ' A' ' 176' ' ' THR . 18.6 pt-20 -72.73 -152.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.127 -0.983 . . . . 0.0 110.348 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.764 HG23 ' O ' ' A' ' 176' ' ' THR . 9.7 t 21.9 94.39 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.747 -0.595 . . . . 0.0 111.091 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.486 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.1 OUTLIER -60.49 -12.05 8.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.178 -0.951 . . . . 0.0 110.235 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -76.47 -6.9 53.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.118 -0.989 . . . . 0.0 110.251 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.757 ' HB3' HG23 ' A' ' 176' ' ' THR . 0.0 OUTLIER -87.02 -31.61 20.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.169 -0.957 . . . . 0.0 110.112 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.502 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 1.1 p -42.69 -31.62 0.49 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 109.808 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -60.6 -22.84 64.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.357 -0.839 . . . . 0.0 109.608 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.69 HD22 ' CG1' ' A' ' 211' ' ' VAL . 13.6 mt -83.17 -39.8 20.55 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.343 -0.848 . . . . 0.0 109.089 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.422 HD13 ' HZ ' ' A' ' 179' ' ' PHE . 0.5 OUTLIER -74.75 -29.13 61.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.61 -0.681 . . . . 0.0 109.778 179.633 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -72.73 -2.62 21.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 109.882 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.581 ' HB3' HG22 ' A' ' 187' ' ' ILE . . . -88.53 14.86 8.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.316 -0.865 . . . . 0.0 110.205 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 185' ' ' ALA . 0.2 OUTLIER 42.37 30.97 0.24 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 109.209 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.581 HG22 ' HB3' ' A' ' 185' ' ' ALA . 4.5 tt -116.29 164.34 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.602 -0.687 . . . . 0.0 110.48 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.424 ' N ' HG12 ' A' ' 187' ' ' ILE . 1.8 ttp180 -134.05 161.28 35.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.308 -0.87 . . . . 0.0 109.116 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 1.1 HG11 HG21 ' A' ' 221' ' ' ILE . 14.0 m -79.53 -37.39 18.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.871 -1.143 . . . . 0.0 109.099 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.642 ' HA2' ' CA ' ' A' ' 166' ' ' VAL . . . -56.07 50.54 0.01 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.768 ' N ' ' O ' ' A' ' 189' ' ' VAL . 1.8 t -140.66 167.36 22.35 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.372 -1.075 . . . . 0.0 109.228 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.61 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 1.4 mt-10 -65.46 122.45 17.21 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.794 -0.763 . . . . 0.0 109.036 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.881 HG11 ' CD2' ' A' ' 206' ' ' HIS . 0.4 OUTLIER -160.44 144.79 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.042 -1.036 . . . . 0.0 110.254 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.673 ' HA ' HG22 ' A' ' 163' ' ' VAL . 1.4 pt-20 -112.18 159.84 18.17 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.346 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 1.07 HG23 ' HG ' ' A' ' 204' ' ' LEU . 1.2 mt -119.53 153.93 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.069 -1.019 . . . . 0.0 110.532 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.459 HG22 ' HB3' ' A' ' 160' ' ' PRO . 42.3 t -127.63 107.57 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.482 -0.761 . . . . 0.0 109.991 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -75.17 111.74 10.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.928 . . . . 0.0 110.286 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.476 ' O ' ' C ' ' A' ' 199' ' ' ASP . 0.0 OUTLIER -102.89 67.03 0.95 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.217 -0.927 . . . . 0.0 110.299 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 198' ' ' ARG . 25.4 m-20 38.97 37.55 0.22 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.349 -0.844 . . . . 0.0 110.213 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 141.1 -43.16 1.12 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.451 ' O ' ' N ' ' A' ' 198' ' ' ARG . 0.1 OUTLIER -90.12 123.55 34.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -1.122 . . . . 0.0 110.139 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.946 HD13 HG22 ' A' ' 153' ' ' ILE . 10.4 mt -126.36 99.54 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.112 -0.993 . . . . 0.0 110.348 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.663 HG23 ' O ' ' A' ' 211' ' ' VAL . 89.9 m -106.86 157.45 17.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.318 -0.864 . . . . 0.0 109.878 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 1.07 ' HG ' HG23 ' A' ' 195' ' ' ILE . 2.0 mp -120.05 150.31 40.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.458 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.683 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 16.4 t -119.42 110.48 16.98 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.458 -0.776 . . . . 0.0 109.228 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.881 ' CD2' HG11 ' A' ' 193' ' ' VAL . 23.6 m80 -92.45 153.58 19.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.597 -0.689 . . . . 0.0 110.129 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.464 ' N ' ' OD1' ' A' ' 207' ' ' ASN . 26.6 p-10 -51.77 93.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 110.286 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 136.91 -32.45 2.44 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 208' ' ' GLY . 0.0 OUTLIER 176.56 160.15 0.35 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -1.151 . . . . 0.0 110.285 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.537 ' O ' HG23 ' A' ' 211' ' ' VAL . 1.9 p-10 -109.68 174.78 5.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.33 -0.856 . . . . 0.0 110.117 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.69 ' CG1' HD22 ' A' ' 182' ' ' LEU . 45.6 t -154.6 140.98 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.378 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -73.48 74.37 1.43 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.4 -0.812 . . . . 0.0 110.219 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.616 ' CB ' ' CD1' ' A' ' 204' ' ' LEU . 30.6 tp -57.89 162.62 3.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.917 . . . . 0.0 110.273 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.574 ' O ' ' HB2' ' A' ' 218' ' ' ALA . 3.2 mm? -51.37 146.74 6.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 0.0 110.189 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 218' ' ' ALA . 2.1 m-20 -83.17 -102.39 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.942 . . . . 0.0 109.906 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.97 -24.48 1.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.0 -1.062 . . . . 0.0 109.742 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.542 ' O ' ' C ' ' A' ' 218' ' ' ALA . 0.1 OUTLIER -90.15 -14.25 33.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.319 -0.863 . . . . 0.0 110.211 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.73 ' CB ' HG23 ' A' ' 153' ' ' ILE . . . -29.98 -49.07 0.1 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.506 -0.746 . . . . 0.0 110.723 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.568 ' CG ' ' O ' ' A' ' 219' ' ' HIS . 7.8 p80 -51.37 78.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.364 -0.835 . . . . 0.0 110.404 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . 0.659 ' N ' ' O ' ' A' ' 218' ' ' ALA . 1.2 p -136.56 -28.76 0.98 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 110.365 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 1.1 HG21 HG11 ' A' ' 189' ' ' VAL . 0.1 OUTLIER -109.98 154.74 11.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 O-C-N 121.196 -0.94 . . . . 0.0 110.584 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.91 ' O ' HG22 ' A' ' 166' ' ' VAL . 0.6 OUTLIER -89.03 94.41 9.94 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 178.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 1.029 ' CG2' HG23 ' A' ' 165' ' ' ILE . 0.4 OUTLIER -119.38 149.43 21.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.322 -0.861 . . . . 0.0 110.712 -178.202 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.83 ' N ' HD12 ' A' ' 223' ' ' ILE . 13.9 pt-20 -132.02 178.51 6.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.417 -0.802 . . . . 0.0 110.096 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.738 ' HA ' HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -85.93 173.97 9.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 110.349 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.411 ' HA ' HD22 ' A' ' 226' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.203 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo . . . . . 0 N--CA 1.484 0.932 0 N-CA-C 110.417 -0.647 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 17.0 mm -96.63 122.44 57.12 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 110.141 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.43 -53.66 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.917 1.483 . . . . 0.0 110.372 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -156.74 -89.55 0.07 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.2 mt -104.29 -166.51 1.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.291 -1.123 . . . . 0.0 110.162 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 46.0 t0 -106.83 -20.96 13.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 110.209 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -63.97 85.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.315 -0.866 . . . . 0.0 110.208 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.534 ' HA ' HD13 ' A' ' 138' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 0.0 110.206 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo . . . . . 0 N--CA 1.483 0.865 0 N-CA-C 110.383 -0.66 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.453 ' CA ' ' HB3' ' A' ' 222' ' ' ARG . . . -160.44 152.41 23.15 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.672 ' O ' HG22 ' A' ' 150' ' ' THR . 58.1 m -147.23 18.0 1.21 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -1.137 . . . . 0.0 110.242 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.968 ' HG3' HD11 ' A' ' 153' ' ' ILE . 1.9 mpp_? 63.15 127.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.964 . . . . 0.0 110.184 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.795 HG13 ' O ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER -78.6 36.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.121 -0.987 . . . . 0.0 111.155 -179.648 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.968 HD11 ' HG3' ' A' ' 151' ' ' ARG . 0.1 OUTLIER -138.84 -32.27 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.865 -1.147 . . . . 0.0 110.226 179.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.94 -12.67 61.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.454 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.519 ' O ' ' CB ' ' A' ' 161' ' ' ARG . . . -103.64 -14.03 16.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.516 -0.74 . . . . 0.0 109.966 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.913 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -81.8 72.64 8.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 110.273 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.451 ' OG1' ' HD3' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -73.54 -171.64 1.05 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.251 -0.906 . . . . 0.0 110.111 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.487 ' OG ' ' N ' ' A' ' 159' ' ' MET . 0.9 OUTLIER -42.41 -57.65 2.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 0.0 110.132 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . 0.487 ' N ' ' OG ' ' A' ' 158' ' ' SER . 3.0 mmt -75.68 165.19 55.38 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.891 . . . . 0.0 110.081 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 44.4 Cg_endo -72.14 73.21 2.64 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.976 1.514 . . . . 0.0 110.444 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 155' ' ' ALA . 1.8 tpt180 -51.64 127.38 20.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -0.951 . . . . 0.0 110.197 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -74.8 125.4 28.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.873 . . . . 0.0 110.36 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.669 HG23 ' HA ' ' A' ' 194' ' ' GLU . 0.1 OUTLIER -144.86 -166.16 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 110.112 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.667 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -169.19 136.66 1.83 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.824 -1.172 . . . . 0.0 110.101 -179.601 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.945 HG23 HG22 ' A' ' 223' ' ' ILE . 0.9 OUTLIER -92.52 153.08 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.294 -0.879 . . . . 0.0 110.489 -179.434 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.476 ' CG1' ' NE ' ' A' ' 164' ' ' ARG . 11.1 m -145.43 11.22 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 110.204 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -170.91 123.92 0.63 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.229 -0.92 . . . . 0.0 110.195 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.52 HG13 HG22 ' A' ' 221' ' ' ILE . 19.2 tt -131.3 4.99 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.326 -0.858 . . . . 0.0 110.15 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.432 ' O ' ' CB ' ' A' ' 170' ' ' GLU . 4.4 p30 -52.58 169.05 0.09 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 110.163 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.432 ' CB ' ' O ' ' A' ' 169' ' ' ASN . 0.3 OUTLIER 64.86 44.8 3.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.182 -0.949 . . . . 0.0 110.134 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.512 HD12 ' C ' ' A' ' 171' ' ' ILE . 1.3 pp -119.61 31.95 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.27 -0.894 . . . . 0.0 110.22 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.27 89.7 1.21 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 110.215 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -106.06 165.38 11.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.274 -0.891 . . . . 0.0 110.205 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.5 m -106.72 11.45 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.161 -0.962 . . . . 0.0 110.27 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.78 139.74 37.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.896 . . . . 0.0 110.18 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.957 HG23 HG23 ' A' ' 180' ' ' THR . 54.4 m -118.88 -92.81 0.53 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 110.245 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.526 ' N ' HG22 ' A' ' 176' ' ' THR . 0.4 OUTLIER 66.3 -165.62 0.22 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.212 -0.93 . . . . 0.0 110.28 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -55.2 -20.64 11.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.261 -0.899 . . . . 0.0 110.294 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.98 ' CE2' HD13 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -49.17 -26.29 2.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.195 -0.941 . . . . 0.0 109.983 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.957 HG23 HG23 ' A' ' 176' ' ' THR . 0.2 OUTLIER -55.15 -26.42 38.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.884 . . . . 0.0 109.949 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -69.29 -63.36 1.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.321 -0.862 . . . . 0.0 110.114 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.8 HD12 ' N ' ' A' ' 183' ' ' LEU . 4.4 pp -61.6 -15.91 43.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.379 -0.826 . . . . 0.0 110.114 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.98 HD13 ' CE2' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -91.1 -28.55 17.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.162 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 180' ' ' THR . 18.9 t70 -79.99 4.25 17.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 110.183 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -85.12 16.66 3.38 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.862 . . . . 0.0 110.188 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 185' ' ' ALA . 3.8 t0 41.66 43.17 2.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.248 -0.907 . . . . 0.0 109.92 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.6 tt -102.9 -178.5 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.874 . . . . 0.0 110.367 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.717 ' C ' HG13 ' A' ' 189' ' ' VAL . 9.4 ptt180 -170.52 117.48 0.51 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.717 HG13 ' C ' ' A' ' 188' ' ' ARG . 1.3 m 51.3 108.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.199 -0.938 . . . . 0.0 109.154 -178.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.816 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -45.63 -13.65 0.06 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 3.7 t 66.05 -144.14 0.19 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.071 -1.253 . . . . 0.0 109.421 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.667 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -65.21 101.93 0.6 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.474 -0.766 . . . . 0.0 109.267 179.221 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.623 ' O ' ' O ' ' A' ' 163' ' ' VAL . 23.0 m -156.9 -138.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -0.948 . . . . 0.0 110.033 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.669 ' HA ' HG23 ' A' ' 163' ' ' VAL . 1.1 pp20? -175.48 160.85 2.61 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.293 -0.88 . . . . 0.0 110.142 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.913 HD12 ' HB2' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -120.86 169.81 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.159 -0.963 . . . . 0.0 110.335 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 196' ' ' VAL . 4.7 p -149.67 77.38 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.883 . . . . 0.0 110.032 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 202' ' ' ILE . 11.8 t70 -40.78 142.22 0.49 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 110.336 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.475 ' O ' ' N ' ' A' ' 200' ' ' GLY . 1.9 ttp180 -139.77 -174.6 3.95 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.205 -0.935 . . . . 0.0 110.315 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -42.28 96.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.258 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 198' ' ' ARG . . . 44.01 29.48 1.51 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -150.26 113.72 4.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.252 -1.146 . . . . 0.0 110.215 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.619 HD13 HG22 ' A' ' 153' ' ' ILE . 70.3 mt -94.24 144.99 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 0.0 110.167 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.529 ' HB ' ' CG1' ' A' ' 196' ' ' VAL . 1.2 m -126.32 156.09 40.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.056 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.912 HD22 ' CD2' ' A' ' 206' ' ' HIS . 1.0 OUTLIER -119.82 131.98 55.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -0.956 . . . . 0.0 110.232 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.538 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 20.1 t -119.75 124.6 46.58 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.3 -0.875 . . . . 0.0 109.781 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.912 ' CD2' HD22 ' A' ' 204' ' ' LEU . 2.4 m170 -106.02 158.95 16.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.417 -0.802 . . . . 0.0 109.999 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.0 72.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 110.155 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 153.63 -21.07 0.71 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 208' ' ' GLY . 0.3 OUTLIER 169.93 149.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.161 -1.199 . . . . 0.0 110.218 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 1.2 p30 -97.08 -171.99 2.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.92 . . . . 0.0 110.13 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 8.7 p -158.69 165.36 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -0.917 . . . . 0.0 110.226 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -69.49 141.04 54.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 110.239 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.798 HD13 ' N ' ' A' ' 214' ' ' LEU . 0.3 OUTLIER -148.15 145.04 28.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.932 . . . . 0.0 110.173 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.798 ' N ' HD13 ' A' ' 213' ' ' LEU . 0.6 OUTLIER -133.61 143.49 48.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.268 -0.895 . . . . 0.0 110.21 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.617 ' HA ' ' HB3' ' A' ' 218' ' ' ALA . 0.3 OUTLIER -50.2 -51.56 43.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.197 -0.94 . . . . 0.0 110.185 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.771 ' HB2' HD12 ' A' ' 214' ' ' LEU . 0.5 OUTLIER -43.38 -49.18 7.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.932 . . . . 0.0 110.262 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.59 ' HB2' HD11 ' A' ' 214' ' ' LEU . 0.4 OUTLIER -89.12 -26.77 21.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.891 . . . . 0.0 110.14 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.758 ' HB2' ' CD1' ' A' ' 213' ' ' LEU . . . -64.83 -17.68 64.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.257 -0.902 . . . . 0.0 110.091 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.658 ' O ' HG23 ' A' ' 220' ' ' THR . 0.2 OUTLIER -89.2 56.56 3.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.135 -0.978 . . . . 0.0 110.217 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . 0.658 HG23 ' O ' ' A' ' 219' ' ' HIS . 17.6 p -158.12 -47.22 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 0.0 110.372 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.7 HD13 ' N ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -63.17 130.93 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.29 -0.881 . . . . 0.0 110.52 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.453 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . 37.0 mtt85 -91.67 104.09 16.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.345 -0.847 . . . . 0.0 109.618 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.945 HG22 HG23 ' A' ' 165' ' ' ILE . 0.1 OUTLIER -119.51 171.53 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.144 -0.973 . . . . 0.0 110.023 -179.566 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.589 ' C ' HG12 ' A' ' 163' ' ' VAL . 6.6 mm-40 -140.13 167.58 21.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.163 -0.961 . . . . 0.0 110.415 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 8.1 pt-20 -91.53 38.85 0.99 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.381 -0.824 . . . . 0.0 110.247 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.175 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 N--CA 1.483 0.889 0 N-CA-C 110.494 -0.618 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 5.9 pt -104.27 161.04 24.07 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.199 -0.938 . . . . 0.0 110.262 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.0 -12.4 25.94 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.0 1.526 . . . . 0.0 110.464 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 135' ' ' LEU . . . 118.51 -77.32 0.3 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.448 ' CB ' ' O ' ' A' ' 134' ' ' GLY . 0.2 OUTLIER 65.29 138.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.294 -1.121 . . . . 0.0 110.241 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 17.7 p30 -61.98 96.63 0.07 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 110.22 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.2 89.12 4.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.933 . . . . 0.0 110.232 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.538 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.297 -0.877 . . . . 0.0 110.223 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 N--CA 1.484 0.943 0 N-CA-C 110.44 -0.639 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 222' ' ' ARG . . . 131.84 157.5 8.72 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.544 ' O ' ' CG1' ' A' ' 223' ' ' ILE . 54.2 m -123.31 143.56 50.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.308 -1.113 . . . . 0.0 110.163 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 154' ' ' ASP . 0.1 OUTLIER -50.16 127.69 17.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.123 -0.986 . . . . 0.0 110.055 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.795 HG12 ' O ' ' A' ' 218' ' ' ALA . 2.5 p -43.88 -25.49 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.103 -0.998 . . . . 0.0 110.378 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.71 HG22 HD13 ' A' ' 202' ' ' ILE . 1.3 pt -95.22 -14.04 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 110.325 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.539 ' HB3' ' CG2' ' A' ' 150' ' ' THR . 2.0 m-20 -77.35 -19.28 56.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.994 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -97.36 -13.0 22.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.371 -0.831 . . . . 0.0 110.016 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 157' ' ' THR . . . -51.06 166.07 0.1 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.875 . . . . 0.0 110.262 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.533 ' O ' ' CB ' ' A' ' 158' ' ' SER . 14.7 m 51.93 167.37 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.315 -0.866 . . . . 0.0 110.398 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 157' ' ' THR . 0.1 OUTLIER 70.89 -52.14 0.68 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.24 -0.913 . . . . 0.0 110.309 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -100.72 139.17 20.36 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.175 -0.953 . . . . 0.0 110.147 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.552 ' O ' ' C ' ' A' ' 161' ' ' ARG . 45.4 Cg_endo -72.92 71.85 3.35 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.962 1.506 . . . . 0.0 110.426 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.781 ' HB3' HG22 ' A' ' 196' ' ' VAL . 7.7 ptt180 27.12 99.8 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.505 0.669 . . . . 0.0 111.282 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -170.72 56.41 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.175 -0.953 . . . . 0.0 109.995 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.669 ' O ' ' O ' ' A' ' 193' ' ' VAL . 34.9 m -141.83 -151.83 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.925 0.869 . . . . 0.0 110.503 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.671 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 16.4 ptt180 -175.46 169.03 3.21 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.86 -1.15 . . . . 0.0 110.433 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 1.068 HG23 HG22 ' A' ' 223' ' ' ILE . 0.1 OUTLIER -99.78 162.98 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.302 -0.874 . . . . 0.0 109.848 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.817 HG22 ' O ' ' A' ' 222' ' ' ARG . 27.0 m -137.28 -24.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.177 -0.952 . . . . 0.0 110.759 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.551 ' HB2' ' CD ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -152.45 127.89 9.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.038 -1.039 . . . . 0.0 110.458 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.771 HG13 HG22 ' A' ' 221' ' ' ILE . 1.2 tt -96.69 -1.68 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.983 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 168' ' ' ILE . 38.1 m-80 56.6 -95.17 0.05 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 110.231 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.554 ' HG3' ' CZ ' ' A' ' 172' ' ' PHE . 4.3 pt-20 -168.2 83.1 0.18 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.066 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.911 HD13 ' CD2' ' A' ' 217' ' ' LEU . 2.4 pp -86.57 25.78 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.329 -0.857 . . . . 0.0 110.377 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.6 ' C ' ' O ' ' A' ' 171' ' ' ILE . 0.9 OUTLIER 22.83 -136.26 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.583 -0.698 . . . . 0.0 111.024 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.659 ' C ' HG23 ' A' ' 176' ' ' THR . 14.9 mt-30 -107.66 -90.55 0.44 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.193 -0.942 . . . . 0.0 110.258 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.581 ' O ' ' N ' ' A' ' 176' ' ' THR . 6.7 t 59.64 90.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.891 . . . . 0.0 110.291 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.565 ' HB3' ' O ' ' A' ' 174' ' ' VAL . 3.7 tt0 63.63 -56.69 0.2 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.489 -0.757 . . . . 0.0 110.822 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.659 HG23 ' C ' ' A' ' 173' ' ' GLN . 8.9 p 45.54 -91.72 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.301 -0.874 . . . . 0.0 110.215 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 178' ' ' GLN . 12.5 t0 43.72 -93.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 110.129 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.528 ' N ' ' O ' ' A' ' 176' ' ' THR . 1.4 mt-30 -48.38 -25.11 1.46 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.179 -0.951 . . . . 0.0 110.015 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.985 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 3.0 t80 -82.97 -52.77 6.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.99 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 177' ' ' ASP . 0.3 OUTLIER -43.65 -25.15 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.172 -0.955 . . . . 0.0 109.889 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -69.17 -64.59 0.84 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.305 -0.872 . . . . 0.0 110.19 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.576 ' HB3' HG11 ' A' ' 211' ' ' VAL . 3.5 pp -63.92 -13.6 46.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.357 -0.839 . . . . 0.0 109.848 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.985 HD13 ' CZ ' ' A' ' 179' ' ' PHE . 1.7 tp -87.81 -30.42 20.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.387 -0.821 . . . . 0.0 109.861 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -72.18 -15.04 61.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.828 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -89.44 20.03 4.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -0.829 . . . . 0.0 110.136 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 47.31 85.21 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.892 . . . . 0.0 110.093 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.556 ' O ' ' CB ' ' A' ' 188' ' ' ARG . 57.6 mt -146.04 -82.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 0.0 110.374 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.556 ' CB ' ' O ' ' A' ' 187' ' ' ILE . 0.1 OUTLIER 72.79 161.38 0.24 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.453 -0.779 . . . . 0.0 109.683 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.971 ' O ' ' N ' ' A' ' 191' ' ' SER . 3.9 m 33.87 37.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 O-C-N 121.334 -0.853 . . . . 0.0 110.613 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.763 ' N ' HD12 ' A' ' 165' ' ' ILE . . . 25.68 19.73 0.0 OUTLIER Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.971 ' N ' ' O ' ' A' ' 189' ' ' VAL . 13.6 t 36.88 -146.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -1.149 . . . . 0.0 109.868 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.671 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.9 OUTLIER -89.95 115.26 27.11 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.026 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.669 ' O ' ' O ' ' A' ' 163' ' ' VAL . 34.1 m -159.69 -133.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.096 -1.003 . . . . 0.0 109.985 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.552 ' CG ' ' HB2' ' A' ' 205' ' ' SER . 1.7 pt-20 -158.47 168.82 25.92 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.266 -0.896 . . . . 0.0 110.094 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.919 HG23 ' HG ' ' A' ' 204' ' ' LEU . 0.0 OUTLIER -136.36 146.61 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.163 -0.96 . . . . 0.0 110.353 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.781 HG22 ' HB3' ' A' ' 161' ' ' ARG . 94.8 t -139.05 108.14 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.249 -0.907 . . . . 0.0 110.105 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 202' ' ' ILE . 4.6 t0 -50.77 113.73 0.98 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.211 -0.931 . . . . 0.0 110.135 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 201' ' ' HIS . 1.0 OUTLIER -110.1 93.61 4.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.224 -0.923 . . . . 0.0 110.294 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 198' ' ' ARG . 43.7 t0 41.81 53.96 3.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.222 -0.924 . . . . 0.0 110.126 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 88.89 -27.34 7.41 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.465 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 11.6 m170 -92.08 91.34 7.76 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.26 -1.141 . . . . 0.0 110.273 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.71 HD13 HG22 ' A' ' 153' ' ' ILE . 2.7 mt -59.66 91.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.904 . . . . 0.0 110.18 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 85.6 m -67.95 148.38 51.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.276 -0.89 . . . . 0.0 110.153 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.919 ' HG ' HG23 ' A' ' 195' ' ' ILE . 0.1 OUTLIER -120.23 132.89 55.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.241 -0.912 . . . . 0.0 110.282 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.582 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.7 OUTLIER -119.79 125.93 49.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.332 -0.855 . . . . 0.0 109.898 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.528 ' HA ' HG12 ' A' ' 193' ' ' VAL . 1.9 m170 -104.55 74.08 1.14 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.385 -0.822 . . . . 0.0 110.366 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.52 ' C ' ' O ' ' A' ' 206' ' ' HIS . 3.7 p-10 32.14 51.51 0.21 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.484 -0.76 . . . . 0.0 110.793 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 135.58 -39.9 1.61 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.515 ' HB2' ' HB2' ' A' ' 206' ' ' HIS . 6.7 mtmt -102.58 162.91 12.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.296 -1.12 . . . . 0.0 110.138 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 204' ' ' LEU . 14.7 t0 -150.17 144.44 25.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 110.319 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.576 HG11 ' HB3' ' A' ' 182' ' ' LEU . 24.5 t -134.76 159.1 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.285 -0.884 . . . . 0.0 110.032 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -98.67 63.49 1.44 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 0.0 110.304 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.617 HD22 ' CD1' ' A' ' 204' ' ' LEU . 12.8 tp -56.12 160.12 3.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -0.919 . . . . 0.0 110.113 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.538 HD23 ' N ' ' A' ' 214' ' ' LEU . 0.6 OUTLIER -122.56 144.75 48.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 0.0 110.199 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -52.67 -40.72 63.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.265 -0.897 . . . . 0.0 110.168 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.518 ' CB ' HD12 ' A' ' 214' ' ' LEU . 0.2 OUTLIER -52.24 -56.66 13.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.894 . . . . 0.0 110.193 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.911 ' CD2' HD13 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -84.55 -27.15 27.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.201 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.795 ' O ' HG12 ' A' ' 152' ' ' VAL . . . -74.51 -11.05 60.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.0 110.186 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.686 ' O ' HG23 ' A' ' 220' ' ' THR . 12.2 t-160 -100.96 77.98 1.89 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.933 . . . . 0.0 110.244 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . 0.686 HG23 ' O ' ' A' ' 219' ' ' HIS . 0.0 OUTLIER -178.3 -43.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -0.943 . . . . 0.0 110.468 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.771 HG22 HG13 ' A' ' 168' ' ' ILE . 0.1 OUTLIER -73.29 143.04 14.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.293 -0.88 . . . . 0.0 110.657 -179.738 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.817 ' O ' HG22 ' A' ' 166' ' ' VAL . 4.8 ptp85 -89.45 127.18 35.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.074 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 1.068 HG22 HG23 ' A' ' 165' ' ' ILE . 0.7 OUTLIER -125.5 170.91 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.192 -0.943 . . . . 0.0 110.821 -178.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.422 ' CG ' ' HA2' ' A' ' 149' ' ' GLY . 38.8 mt-10 -149.95 172.64 14.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -0.872 . . . . 0.0 110.12 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.431 ' OE1' ' OXT' ' A' ' 226' ' ' LEU . 0.0 OUTLIER -81.55 169.38 17.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.9 . . . . 0.0 110.156 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.441 ' O ' ' HG ' ' A' ' 226' ' ' LEU . 39.2 tp . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.167 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 132' ' ' ILE . 46.1 Cg_endo . . . . . 0 N--CA 1.483 0.881 0 N-CA-C 110.451 -0.634 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.441 ' C ' ' O ' ' A' ' 131' ' ' PRO . 1.7 mp 41.26 75.47 0.61 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.285 -0.884 . . . . 0.0 110.271 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.03 -28.37 13.02 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.983 1.517 . . . . 0.0 110.342 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -46.07 167.57 0.05 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.4 -154.63 0.48 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.305 -1.115 . . . . 0.0 110.229 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -102.13 52.3 0.81 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 110.23 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -124.61 55.98 1.31 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.292 -0.88 . . . . 0.0 110.252 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 110.213 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.486 ' HA ' ' OE1' ' A' ' 224' ' ' GLU . 45.9 Cg_endo . . . . . 0 N--CA 1.484 0.951 0 N-CA-C 110.456 -0.632 . . . . 0.0 110.456 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -164.35 106.18 0.27 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.513 ' O ' HG22 ' A' ' 150' ' ' THR . 99.7 m -134.53 2.2 3.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -1.115 . . . . 0.0 110.256 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 153' ' ' ILE . 32.9 mtt180 59.83 123.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 110.121 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.885 ' CG2' HG21 ' A' ' 223' ' ' ILE . 40.5 t -66.21 60.14 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.203 -0.936 . . . . 0.0 110.339 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.721 HG23 ' O ' ' A' ' 152' ' ' VAL . 0.8 OUTLIER -159.33 -34.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.306 -0.871 . . . . 0.0 110.145 179.802 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.33 -13.07 61.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.861 . . . . 0.0 109.44 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.712 ' CB ' HG11 ' A' ' 163' ' ' VAL . . . -88.17 -28.01 21.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.485 -0.759 . . . . 0.0 109.976 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -75.62 120.48 21.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.895 . . . . 0.0 110.238 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 14.6 m -162.6 109.0 1.23 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 110.267 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' A' ' 159' ' ' MET . 1.3 t 62.59 10.36 4.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 0.0 110.256 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . 0.45 ' HB3' ' O ' ' A' ' 158' ' ' SER . 0.0 OUTLIER 173.12 158.42 0.27 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.286 -0.884 . . . . 0.0 110.2 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 46.2 Cg_endo -73.12 63.81 4.22 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.049 1.552 . . . . 0.0 110.299 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.585 ' O ' HG13 ' A' ' 163' ' ' VAL . 7.9 mtt180 -42.18 119.22 1.31 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 0.0 110.248 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.492 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 6.1 ttmt -58.33 124.98 21.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.291 -0.881 . . . . 0.0 110.258 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.856 HG22 ' HA ' ' A' ' 194' ' ' GLU . 30.6 m -139.67 -159.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.881 . . . . 0.0 110.122 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.645 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -175.09 139.11 0.46 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.822 -1.174 . . . . 0.0 110.486 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 1.033 HG23 HG22 ' A' ' 223' ' ' ILE . 2.1 mt -91.38 153.87 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.45 -0.781 . . . . 0.0 110.893 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.478 ' CG1' ' HD3' ' A' ' 164' ' ' ARG . 3.4 m -138.85 -29.62 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.486 -0.759 . . . . 0.0 110.448 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -136.57 118.88 15.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.117 -0.989 . . . . 0.0 110.217 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.585 ' HB ' HG12 ' A' ' 189' ' ' VAL . 1.3 tt -116.32 -3.12 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.201 -0.937 . . . . 0.0 110.254 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 57.26 170.73 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.222 -0.924 . . . . 0.0 110.298 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 172' ' ' PHE . 7.7 pt-20 -155.66 160.75 40.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.151 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.427 ' C ' ' O ' ' A' ' 170' ' ' GLU . 23.1 mt 41.3 27.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.919 . . . . 0.0 110.248 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 170' ' ' GLU . 2.6 t80 -172.29 57.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.255 -0.903 . . . . 0.0 110.245 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.512 ' HB3' HG12 ' A' ' 174' ' ' VAL . 1.9 mt-30 -112.5 -61.23 1.76 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -0.925 . . . . 0.0 110.169 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.846 HG22 ' N ' ' A' ' 175' ' ' GLU . 0.5 OUTLIER -164.22 -86.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.385 -0.822 . . . . 0.0 110.185 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.846 ' N ' HG22 ' A' ' 174' ' ' VAL . 2.6 mt-10 -141.89 11.89 2.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.059 -1.025 . . . . 0.0 110.228 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.984 HG22 HG23 ' A' ' 180' ' ' THR . 0.2 OUTLIER 66.28 -58.44 0.35 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.286 -0.883 . . . . 0.0 110.259 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 178' ' ' GLN . 3.3 p30 36.93 -145.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.377 -0.827 . . . . 0.0 110.776 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.512 ' N ' ' OD1' ' A' ' 177' ' ' ASP . 0.2 OUTLIER -63.46 -27.47 69.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.312 -0.867 . . . . 0.0 110.567 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.819 ' HA ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -44.08 -35.34 2.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.001 . . . . 0.0 109.771 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.984 HG23 HG22 ' A' ' 176' ' ' THR . 0.7 OUTLIER -42.8 -27.85 0.21 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.144 -0.973 . . . . 0.0 109.456 179.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 179' ' ' PHE . 23.5 tp60 -59.84 -36.01 75.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.542 -0.724 . . . . 0.0 109.609 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.819 HD12 ' HA ' ' A' ' 179' ' ' PHE . 1.2 mt -69.11 -43.62 74.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.38 -0.825 . . . . 0.0 109.433 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -37.64 88.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.613 -0.679 . . . . 0.0 109.888 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -59.16 -14.74 11.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.462 -0.774 . . . . 0.0 109.845 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -84.69 16.93 2.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.423 -0.798 . . . . 0.0 110.189 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 185' ' ' ALA . 27.4 t70 43.6 57.56 3.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -0.921 . . . . 0.0 109.764 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.6 tt -129.93 175.24 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.322 -0.861 . . . . 0.0 110.339 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.694 ' C ' HG13 ' A' ' 189' ' ' VAL . 0.1 OUTLIER -163.11 105.73 1.02 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.743 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.694 HG13 ' C ' ' A' ' 188' ' ' ARG . 1.3 m 50.63 105.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.332 -0.855 . . . . 0.0 108.813 -178.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.921 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -43.28 -15.74 0.03 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.604 ' N ' ' O ' ' A' ' 189' ' ' VAL . 6.1 t 65.57 -142.1 0.2 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.18 -1.188 . . . . 0.0 109.388 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.645 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -64.11 100.24 0.32 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.569 -0.707 . . . . 0.0 109.265 179.294 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.623 ' O ' ' O ' ' A' ' 163' ' ' VAL . 17.0 m -156.73 -141.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.158 -0.964 . . . . 0.0 110.222 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.856 ' HA ' HG22 ' A' ' 163' ' ' VAL . 4.2 pt-20 -173.26 169.08 4.59 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.345 -0.847 . . . . 0.0 110.11 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.872 HG21 HG12 ' A' ' 152' ' ' VAL . 0.6 OUTLIER -121.3 169.17 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.169 -0.957 . . . . 0.0 110.288 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 18.8 t -128.7 98.4 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.34 -0.85 . . . . 0.0 110.178 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -49.35 117.86 2.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.9 . . . . 0.0 110.201 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.546 ' HB3' ' CB ' ' A' ' 201' ' ' HIS . 0.1 OUTLIER -109.05 146.39 34.04 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.212 -0.93 . . . . 0.0 110.213 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.45 94.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.908 . . . . 0.0 110.12 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 198' ' ' ARG . . . 75.64 14.55 81.96 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.546 ' CB ' ' HB3' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -150.25 160.92 43.34 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.249 -1.148 . . . . 0.0 110.095 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 10.6 mt -136.02 159.73 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 110.251 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.545 ' O ' HG22 ' A' ' 195' ' ' ILE . 2.1 m -151.0 163.26 39.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -0.877 . . . . 0.0 109.96 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.854 HD11 HD11 ' A' ' 165' ' ' ILE . 0.6 OUTLIER -119.8 137.28 54.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.058 -1.026 . . . . 0.0 110.345 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.554 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 1.2 t -119.73 120.47 36.67 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.404 -0.81 . . . . 0.0 109.583 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.561 ' HA ' ' CG1' ' A' ' 193' ' ' VAL . 7.4 m170 -89.24 165.86 14.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.429 -0.795 . . . . 0.0 110.205 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.503 ' C ' ' O ' ' A' ' 206' ' ' HIS . 4.6 m-20 -32.85 -34.35 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.566 -0.709 . . . . 0.0 110.952 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -153.83 32.7 0.74 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 206' ' ' HIS . 20.8 mttt -154.29 179.38 9.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -1.124 . . . . 0.0 110.51 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 204' ' ' LEU . 12.8 t0 -155.56 158.46 38.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 110.053 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.487 HG12 ' HB3' ' A' ' 204' ' ' LEU . 7.3 p -146.49 140.81 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -0.953 . . . . 0.0 110.329 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -68.78 83.73 0.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.286 -0.884 . . . . 0.0 110.231 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.66 121.1 17.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.184 -0.948 . . . . 0.0 110.243 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 1.019 HD23 ' HB2' ' A' ' 217' ' ' LEU . 29.6 tp -57.63 158.82 5.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 0.0 110.222 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.596 ' H ' HD12 ' A' ' 214' ' ' LEU . 11.2 t0 -89.57 -49.65 6.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.346 -0.846 . . . . 0.0 110.274 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.544 ' O ' ' NE2' ' A' ' 219' ' ' HIS . 0.4 OUTLIER -55.35 -48.52 74.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -0.921 . . . . 0.0 110.202 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 1.019 ' HB2' HD23 ' A' ' 214' ' ' LEU . 0.5 OUTLIER -85.85 -11.93 52.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 110.113 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.699 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -35.62 -41.77 0.21 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.55 -0.718 . . . . 0.0 110.669 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.563 ' HB3' ' CD1' ' A' ' 153' ' ' ILE . 24.7 p80 -93.98 73.47 4.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 110.434 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . 0.771 HG23 HG23 ' A' ' 221' ' ' ILE . 8.9 t -137.25 -44.86 0.56 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.941 . . . . 0.0 110.092 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.895 HD13 ' H ' ' A' ' 221' ' ' ILE . 0.3 OUTLIER -73.74 146.54 10.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.326 -0.859 . . . . 0.0 110.363 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.459 ' O ' HG22 ' A' ' 166' ' ' VAL . 8.1 mtt180 -89.89 114.39 26.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 0.0 109.28 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 1.033 HG22 HG23 ' A' ' 165' ' ' ILE . 0.8 OUTLIER -141.58 -172.6 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.131 -0.981 . . . . 0.0 110.894 -179.036 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.486 ' OE1' ' HA ' ' A' ' 148' ' ' PRO . 0.5 OUTLIER -144.18 166.81 23.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.355 -0.84 . . . . 0.0 110.178 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.829 ' HA ' HG12 ' A' ' 163' ' ' VAL . 0.3 OUTLIER -111.92 124.01 51.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.366 -0.834 . . . . 0.0 110.26 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.419 ' OXT' ' HB3' ' A' ' 162' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.19 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 N--CA 1.483 0.861 0 N-CA-C 110.434 -0.641 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.642 HG23 ' O ' ' A' ' 132' ' ' ILE . 10.8 tt -62.57 114.63 12.63 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.194 -0.941 . . . . 0.0 110.233 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.36 -166.05 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.959 1.505 . . . . 0.0 110.458 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 136' ' ' ASP . . . -173.0 -116.71 0.42 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.54 HD12 ' N ' ' A' ' 135' ' ' LEU . 6.8 mp 56.25 -83.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -1.151 . . . . 0.0 110.319 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 134' ' ' GLY . 6.7 t70 -41.79 -27.04 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.306 -0.871 . . . . 0.0 110.278 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 135' ' ' LEU . 0.5 OUTLIER 42.37 35.23 0.6 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 110.319 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 53.9 tp . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.235 -0.916 . . . . 0.0 110.167 -179.963 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 149' ' ' GLY . 46.5 Cg_endo . . . . . 0 N--CA 1.483 0.882 0 N-CA-C 110.54 -0.6 . . . . 0.0 110.54 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 148' ' ' PRO . . . 55.88 162.14 0.02 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.564 HG22 ' H ' ' A' ' 151' ' ' ARG . 1.6 m -73.75 -177.01 2.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.219 -1.165 . . . . 0.0 109.969 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.564 ' H ' HG22 ' A' ' 150' ' ' THR . 96.7 mtt180 -141.58 143.8 33.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.281 -0.887 . . . . 0.0 109.944 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.842 HG12 HG23 ' A' ' 153' ' ' ILE . 69.6 t -50.05 -177.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 109.413 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.977 HG21 ' HB3' ' A' ' 218' ' ' ALA . 8.2 pt 43.94 25.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.004 -1.06 . . . . 0.0 110.011 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.8 OUTLIER -147.47 -35.47 0.23 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.483 -0.761 . . . . 0.0 109.673 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -96.12 -15.64 22.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.492 -0.755 . . . . 0.0 109.812 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.691 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -57.22 172.98 0.26 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.293 -0.879 . . . . 0.0 110.268 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.535 ' CG2' ' HG2' ' A' ' 161' ' ' ARG . 7.2 t -174.36 167.44 4.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.192 -0.943 . . . . 0.0 110.104 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 157' ' ' THR . 96.9 p -42.7 -49.81 5.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.33 -0.856 . . . . 0.0 110.166 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.67 161.07 75.5 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.214 -0.929 . . . . 0.0 110.119 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.73 68.73 3.71 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.959 1.505 . . . . 0.0 110.481 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.665 ' O ' HG13 ' A' ' 163' ' ' VAL . 3.0 mmt85 -60.89 107.66 0.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.195 -0.941 . . . . 0.0 110.167 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.552 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -65.46 96.71 0.26 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.909 . . . . 0.0 110.311 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 1.091 HG22 ' HA ' ' A' ' 194' ' ' GLU . 8.5 m -104.7 -164.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.967 . . . . 0.0 110.254 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.672 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -179.67 149.03 0.35 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.843 -1.161 . . . . 0.0 110.169 -179.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 1.173 HG23 ' CG2' ' A' ' 223' ' ' ILE . 0.3 OUTLIER -89.82 150.03 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.302 -0.874 . . . . 0.0 110.233 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 222' ' ' ARG . 21.4 m -124.07 -20.3 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.151 -0.968 . . . . 0.0 110.289 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.87 120.61 2.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.18 -0.95 . . . . 0.0 110.251 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.761 HG13 HG22 ' A' ' 221' ' ' ILE . 5.3 tt -122.33 7.05 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.198 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.448 ' O ' ' HB3' ' A' ' 170' ' ' GLU . 52.9 t30 -62.32 89.28 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.2 -0.937 . . . . 0.0 110.214 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' A' ' 169' ' ' ASN . 10.3 pt-20 177.2 47.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.927 . . . . 0.0 110.253 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' ' 171' ' ' ILE . 9.8 mt -82.28 44.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.893 . . . . 0.0 110.336 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.429 ' O ' ' C ' ' A' ' 173' ' ' GLN . 2.9 m-85 -46.6 -64.09 0.85 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 110.188 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.429 ' C ' ' O ' ' A' ' 172' ' ' PHE . 0.4 OUTLIER -42.42 159.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.357 -0.839 . . . . 0.0 110.197 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.453 ' O ' HG12 ' A' ' 174' ' ' VAL . 55.6 t -111.01 -5.81 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.885 . . . . 0.0 110.237 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.634 ' O ' HG23 ' A' ' 176' ' ' THR . 0.2 OUTLIER -96.72 104.78 16.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.869 . . . . 0.0 110.267 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 175' ' ' GLU . 0.1 OUTLIER -165.74 33.24 0.05 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.145 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -52.83 -44.48 66.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.927 . . . . 0.0 110.215 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -68.21 -31.31 70.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.298 -0.876 . . . . 0.0 110.241 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 1.007 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -70.15 -39.75 75.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.367 -0.833 . . . . 0.0 109.995 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.506 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -55.58 -18.79 8.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.148 -0.97 . . . . 0.0 109.912 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -72.17 -58.02 3.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.35 -0.843 . . . . 0.0 110.234 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.782 ' C ' HD12 ' A' ' 182' ' ' LEU . 4.5 pp -69.54 -7.68 40.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 0.0 109.983 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 1.007 HD13 ' CZ ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -97.57 -27.13 14.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.359 -0.838 . . . . 0.0 109.924 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 180' ' ' THR . 4.6 t70 -81.37 -3.16 51.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.349 -0.844 . . . . 0.0 109.957 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -87.24 26.88 1.13 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.332 -0.855 . . . . 0.0 110.151 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 11.5 t0 56.01 63.06 2.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 0.0 110.137 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.56 ' O ' ' CB ' ' A' ' 188' ' ' ARG . 34.8 mt -130.86 -82.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.213 -0.929 . . . . 0.0 110.42 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.56 ' CB ' ' O ' ' A' ' 187' ' ' ILE . 0.1 OUTLIER 73.89 151.74 0.12 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.515 -0.741 . . . . 0.0 109.681 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.939 ' O ' ' N ' ' A' ' 191' ' ' SER . 4.4 m 33.86 38.52 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 O-C-N 121.315 -0.866 . . . . 0.0 110.443 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.829 ' N ' HD12 ' A' ' 165' ' ' ILE . . . 28.16 19.81 0.0 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.939 ' N ' ' O ' ' A' ' 189' ' ' VAL . 21.2 t 39.5 -145.12 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.346 -1.091 . . . . 0.0 109.608 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.672 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 1.8 tt0 -96.26 117.62 31.16 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.63 HG13 ' C ' ' A' ' 192' ' ' GLU . 33.0 m -157.71 -137.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.209 -0.932 . . . . 0.0 110.097 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 1.091 ' HA ' HG22 ' A' ' 163' ' ' VAL . 1.9 pt-20 -173.75 159.51 3.49 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 110.091 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.834 HD13 HG13 ' A' ' 152' ' ' VAL . 1.0 OUTLIER -120.46 165.13 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.07 -1.019 . . . . 0.0 110.452 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 197' ' ' ASP . 40.2 t -138.64 86.09 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.329 -0.857 . . . . 0.0 110.128 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 196' ' ' VAL . 48.5 t0 -42.31 129.92 3.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -0.893 . . . . 0.0 110.369 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.543 ' CB ' ' O ' ' A' ' 201' ' ' HIS . 8.7 ttp180 -115.16 72.66 0.8 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.223 -0.923 . . . . 0.0 110.161 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 198' ' ' ARG . 1.3 m-20 41.27 58.32 2.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 0.0 110.395 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 109.81 -44.82 1.42 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.543 ' O ' ' CB ' ' A' ' 198' ' ' ARG . 0.3 OUTLIER -93.74 114.86 27.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.187 -1.184 . . . . 0.0 110.266 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.688 HD13 ' HA ' ' A' ' 153' ' ' ILE . 11.9 mt -95.45 127.72 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.925 . . . . 0.0 110.411 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.424 ' O ' HG22 ' A' ' 195' ' ' ILE . 40.4 m -110.83 163.67 13.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 0.0 109.97 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 1.04 HD22 ' CD2' ' A' ' 206' ' ' HIS . 0.7 OUTLIER -119.64 133.76 55.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 110.293 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.548 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 1.4 t -119.84 120.02 35.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.342 -0.849 . . . . 0.0 109.865 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 1.04 ' CD2' HD22 ' A' ' 204' ' ' LEU . 2.8 m170 -106.53 -163.83 0.95 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.341 -0.849 . . . . 0.0 110.111 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -52.69 91.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 110.063 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 59.83 20.95 54.4 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -130.53 168.7 16.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -1.141 . . . . 0.0 110.181 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' A' ' 204' ' ' LEU . 0.2 OUTLIER -157.84 152.18 24.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.218 -0.926 . . . . 0.0 110.235 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 212' ' ' GLU . 40.5 t -146.87 167.55 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.891 . . . . 0.0 110.145 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.508 ' N ' HG12 ' A' ' 211' ' ' VAL . 2.7 tt0 -98.62 69.92 1.9 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.29 -0.881 . . . . 0.0 110.333 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.51 ' HG ' ' N ' ' A' ' 214' ' ' LEU . 6.5 tp -63.25 155.28 28.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.289 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.86 ' O ' ' HB2' ' A' ' 218' ' ' ALA . 27.8 mt -59.37 150.82 25.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.22 -0.925 . . . . 0.0 109.94 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' A' ' 218' ' ' ALA . 2.9 p-10 -90.91 -109.18 0.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.028 -1.045 . . . . 0.0 110.238 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 215' ' ' ASP . 0.3 OUTLIER -42.87 -25.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.029 -1.044 . . . . 0.0 109.911 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 215' ' ' ASP . 1.1 mp -81.46 -21.6 38.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.299 -0.876 . . . . 0.0 110.488 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.977 ' HB3' HG21 ' A' ' 153' ' ' ILE . . . -75.67 48.12 0.44 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.076 -1.015 . . . . 0.0 110.461 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.712 ' CB ' HD11 ' A' ' 153' ' ' ILE . 4.3 t60 -118.76 29.05 7.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.137 -0.977 . . . . 0.0 110.173 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . 0.407 ' O ' ' CD ' ' A' ' 170' ' ' GLU . 0.2 OUTLIER -113.69 -34.23 5.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 110.165 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.777 HG12 HG23 ' A' ' 223' ' ' ILE . 0.1 OUTLIER -70.52 134.01 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.307 -0.87 . . . . 0.0 110.347 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.867 ' O ' HG22 ' A' ' 166' ' ' VAL . 4.4 mtt180 -89.87 101.39 14.09 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.216 -0.927 . . . . 0.0 109.642 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 1.173 ' CG2' HG23 ' A' ' 165' ' ' ILE . 1.0 OUTLIER -119.56 -176.78 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 110.659 -179.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.474 ' OE1' HG11 ' A' ' 166' ' ' VAL . 11.5 pt-20 -150.6 178.48 9.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.468 -0.77 . . . . 0.0 110.204 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 3.8 tm-20 -106.48 120.15 41.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.303 -0.873 . . . . 0.0 110.068 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.421 HD23 ' HD2' ' A' ' 162' ' ' LYS . 39.1 tp . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.222 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 N--CA 1.484 0.916 0 N-CA-C 110.468 -0.628 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 24.6 mm -71.19 117.95 61.29 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 0.0 110.226 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.85 90.07 0.85 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.985 1.519 . . . . 0.0 110.373 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -84.3 99.67 2.28 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 137' ' ' GLU . 1.2 tp -69.79 -16.7 63.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -1.13 . . . . 0.0 110.14 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 137' ' ' GLU . 0.5 OUTLIER 60.76 -81.31 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.266 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 135' ' ' LEU . 7.5 mt-10 57.64 29.21 16.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.378 -0.826 . . . . 0.0 110.165 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 110.271 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.484 0.953 0 N-CA-C 110.631 -0.565 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -154.24 -172.48 22.23 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.631 ' O ' HG22 ' A' ' 150' ' ' THR . 53.7 m -147.28 10.76 1.0 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.296 -1.12 . . . . 0.0 110.375 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.533 ' HB2' ' HB2' ' A' ' 154' ' ' ASP . 13.5 mmt180 59.7 136.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -0.9 . . . . 0.0 110.226 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.992 HG13 HG21 ' A' ' 195' ' ' ILE . 1.4 t -64.97 -0.58 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.219 -0.926 . . . . 0.0 110.966 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.828 HG21 ' HB3' ' A' ' 218' ' ' ALA . 1.0 OUTLIER -115.53 -4.62 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.911 -1.118 . . . . 0.0 110.652 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.533 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 0.7 OUTLIER -103.19 -28.6 11.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.125 -0.985 . . . . 0.0 109.949 179.673 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.492 ' HB2' ' CG2' ' A' ' 150' ' ' THR . . . -84.09 -15.4 47.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 110.05 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.726 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -71.97 -161.8 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.326 -0.859 . . . . 0.0 110.197 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 156' ' ' ALA . 0.4 OUTLIER 55.88 160.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.33 -0.856 . . . . 0.0 110.12 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 157' ' ' THR . 5.6 p 42.86 30.84 0.27 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 110.212 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.73 134.15 1.74 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.323 -0.86 . . . . 0.0 110.065 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.608 ' O ' ' O ' ' A' ' 161' ' ' ARG . 45.9 Cg_endo -73.36 74.61 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.935 1.492 . . . . 0.0 110.542 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.667 ' HB3' HG22 ' A' ' 196' ' ' VAL . 2.1 ptt85 27.44 104.32 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.492 0.663 . . . . 0.0 111.393 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.51 ' C ' HG13 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -168.76 68.75 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.99 -1.069 . . . . 0.0 110.287 179.534 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.655 ' O ' ' O ' ' A' ' 193' ' ' VAL . 16.6 m -150.62 -155.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.886 . . . . 0.0 110.329 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.669 ' CB ' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -177.56 167.72 2.22 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.783 -1.198 . . . . 0.0 110.518 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 1.088 HG23 ' CG2' ' A' ' 223' ' ' ILE . 0.3 OUTLIER -98.83 159.52 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.224 -0.922 . . . . 0.0 110.268 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 222' ' ' ARG . 31.5 m -131.13 -28.62 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.892 . . . . 0.0 110.222 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -144.92 93.59 2.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.197 -0.939 . . . . 0.0 110.124 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.762 ' H ' HG12 ' A' ' 189' ' ' VAL . 0.3 OUTLIER -54.07 -32.23 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.219 -0.925 . . . . 0.0 110.124 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 168' ' ' ILE . 0.2 OUTLIER 42.56 71.25 0.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 0.0 110.252 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 170' ' ' GLU . 33.6 tt0 -151.28 72.29 1.04 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.259 -0.9 . . . . 0.0 110.211 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 32.4 mm -84.2 -6.63 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 110.281 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -75.32 166.37 23.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.427 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -115.66 -17.38 11.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -0.918 . . . . 0.0 110.2 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 86.6 t -69.66 -21.33 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.19 -0.944 . . . . 0.0 110.224 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -89.82 90.27 8.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.252 -0.905 . . . . 0.0 110.177 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 1.055 HG23 HG23 ' A' ' 180' ' ' THR . 21.2 m -124.36 -90.06 0.57 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.885 . . . . 0.0 110.197 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.589 ' N ' HG22 ' A' ' 176' ' ' THR . 3.0 t0 68.37 -158.0 0.19 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.214 -0.929 . . . . 0.0 110.319 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.443 ' OE1' ' OE1' ' A' ' 212' ' ' GLU . 1.2 mt-30 -59.14 -23.33 62.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.895 . . . . 0.0 110.411 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 1.025 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -47.96 -23.51 0.8 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.181 -0.949 . . . . 0.0 110.133 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 1.055 HG23 HG23 ' A' ' 176' ' ' THR . 0.5 OUTLIER -58.58 -25.75 62.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 109.949 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -71.46 -62.85 1.26 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.301 -0.874 . . . . 0.0 110.167 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.837 HD22 HD12 ' A' ' 213' ' ' LEU . 3.3 pp -61.06 -13.89 19.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.341 -0.85 . . . . 0.0 110.101 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 1.025 HD13 ' CZ ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -85.22 -30.14 24.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.903 . . . . 0.0 110.058 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -69.59 -14.28 62.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.416 -0.802 . . . . 0.0 110.039 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.453 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -91.45 24.82 2.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -0.858 . . . . 0.0 110.174 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 185' ' ' ALA . 30.5 t0 40.84 83.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 110.171 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.647 HD12 ' O ' ' A' ' 182' ' ' LEU . 87.7 mt -133.85 -75.78 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.0 110.448 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.548 ' CB ' ' O ' ' A' ' 187' ' ' ILE . 5.6 ttp85 71.48 154.65 0.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.374 -0.829 . . . . 0.0 109.716 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.956 ' O ' ' N ' ' A' ' 191' ' ' SER . 4.2 m 32.9 38.35 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 121.235 -0.916 . . . . 0.0 110.558 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.872 ' N ' HD12 ' A' ' 165' ' ' ILE . . . 26.83 19.58 0.0 OUTLIER Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.956 ' N ' ' O ' ' A' ' 189' ' ' VAL . 39.5 t 37.06 -146.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.322 -1.105 . . . . 0.0 109.868 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.669 ' HA ' ' CB ' ' A' ' 164' ' ' ARG . 18.9 mt-10 -92.12 115.99 28.55 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.655 ' O ' ' O ' ' A' ' 163' ' ' VAL . 34.3 m -159.25 -132.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.098 -1.001 . . . . 0.0 109.59 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.604 ' O ' HD23 ' A' ' 204' ' ' LEU . 1.5 pm0 -167.29 159.0 12.29 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.544 -0.862 . . . . 0.0 110.239 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.992 HG21 HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -119.98 163.95 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.28 -0.887 . . . . 0.0 110.154 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.667 HG22 ' HB3' ' A' ' 161' ' ' ARG . 54.8 t -140.83 90.01 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.208 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.48 ' OD1' ' CB ' ' A' ' 156' ' ' ALA . 15.4 m-20 -52.66 118.74 3.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.883 . . . . 0.0 110.332 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.474 ' HB3' ' HB3' ' A' ' 201' ' ' HIS . 0.6 OUTLIER -105.02 73.13 1.04 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.224 -0.922 . . . . 0.0 110.246 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 198' ' ' ARG . 1.6 m-20 42.55 53.87 4.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 110.21 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 110.62 -41.36 2.26 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 198' ' ' ARG . 0.1 OUTLIER -89.79 95.29 10.18 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.279 -1.13 . . . . 0.0 110.162 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.502 HD13 ' HA ' ' A' ' 153' ' ' ILE . 20.4 mt -80.71 114.45 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 110.322 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 211' ' ' VAL . 3.9 m -102.56 163.33 12.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 0.0 109.916 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.923 HD22 ' CD2' ' A' ' 206' ' ' HIS . 0.7 OUTLIER -119.81 136.84 54.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.097 -1.002 . . . . 0.0 110.308 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.626 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.4 OUTLIER -119.88 123.31 43.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 0.0 109.92 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.923 ' CD2' HD22 ' A' ' 204' ' ' LEU . 2.7 m80 -112.08 -171.59 1.88 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.296 -0.877 . . . . 0.0 110.07 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -48.94 91.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.215 -0.928 . . . . 0.0 110.175 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 54.98 23.84 32.71 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.511 ' O ' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -138.5 94.81 2.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -1.144 . . . . 0.0 110.259 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -100.44 148.44 24.75 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.254 -0.904 . . . . 0.0 110.246 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 212' ' ' GLU . 14.3 t -141.18 171.56 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.932 . . . . 0.0 110.225 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 213' ' ' LEU . 2.7 tt0 -95.72 84.89 4.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 110.181 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.904 ' O ' HD23 ' A' ' 214' ' ' LEU . 6.8 tp -60.03 -138.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -0.926 . . . . 0.0 110.296 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.904 HD23 ' O ' ' A' ' 213' ' ' LEU . 14.8 mt -139.62 157.71 45.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.248 -0.907 . . . . 0.0 110.087 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 216' ' ' ASP . 4.6 p30 -90.52 -106.76 0.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.207 -0.933 . . . . 0.0 110.263 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 215' ' ' ASP . 0.1 OUTLIER -41.73 -25.38 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.092 -1.005 . . . . 0.0 110.121 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 215' ' ' ASP . 0.3 OUTLIER -80.79 -26.76 36.97 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.259 -0.901 . . . . 0.0 110.329 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.842 ' HB2' ' O ' ' A' ' 214' ' ' LEU . . . -71.94 -3.88 25.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.053 -1.03 . . . . 0.0 110.018 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.499 ' O ' ' NH1' ' A' ' 151' ' ' ARG . 11.2 t-80 -83.56 55.34 3.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 110.143 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.1 -49.72 0.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -0.913 . . . . 0.0 110.322 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.661 HD13 ' N ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -67.22 137.46 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.291 -0.881 . . . . 0.0 110.352 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.708 ' O ' HG22 ' A' ' 166' ' ' VAL . 0.6 OUTLIER -89.53 110.73 21.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 109.333 179.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 1.088 ' CG2' HG23 ' A' ' 165' ' ' ILE . 0.5 OUTLIER -119.82 175.46 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.165 -0.959 . . . . 0.0 110.636 -179.111 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.465 ' O ' ' HB ' ' A' ' 163' ' ' VAL . 5.9 mt-10 -143.61 167.32 22.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.336 -0.852 . . . . 0.0 110.12 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.51 ' HA ' HG12 ' A' ' 163' ' ' VAL . 4.7 pt-20 -101.57 48.51 0.88 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.312 -0.867 . . . . 0.0 110.253 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.519 HD13 ' NH2' ' A' ' 164' ' ' ARG . 2.4 tp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.118 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.475 ' HB2' HD12 ' A' ' 132' ' ' ILE . 45.6 Cg_endo . . . . . 0 N--CA 1.484 0.939 0 N-CA-C 110.41 -0.65 . . . . 0.0 110.41 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.475 HD12 ' HB2' ' A' ' 131' ' ' PRO . 1.8 mp -141.7 129.09 11.64 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.231 -0.918 . . . . 0.0 110.177 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.98 -19.61 22.97 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.955 1.503 . . . . 0.0 110.47 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.83 -97.41 1.85 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.43 ' O ' ' HG3' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -125.37 -6.34 7.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -1.12 . . . . 0.0 110.21 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.4 t70 52.11 54.13 11.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.27 -0.894 . . . . 0.0 110.216 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 135' ' ' LEU . 43.2 mt-10 -135.55 27.61 3.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 110.292 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 138' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 110.223 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo . . . . . 0 N--CA 1.483 0.889 0 N-CA-C 110.415 -0.648 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.502 ' HA3' ' HB3' ' A' ' 222' ' ' ARG . . . 113.61 126.18 4.38 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.58 HG22 ' CB ' ' A' ' 154' ' ' ASP . 98.0 m -141.39 151.97 43.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -1.101 . . . . 0.0 110.1 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.5 ' HG2' ' HA ' ' A' ' 219' ' ' HIS . 0.0 OUTLIER -43.15 125.06 3.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.142 -0.974 . . . . 0.0 110.259 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 1.096 HG22 HD13 ' A' ' 195' ' ' ILE . 5.9 p -44.75 -26.8 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.239 -0.913 . . . . 0.0 110.174 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.92 HG22 HD13 ' A' ' 202' ' ' ILE . 9.9 pt -92.33 -15.7 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.204 -0.935 . . . . 0.0 110.248 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.58 ' CB ' HG22 ' A' ' 150' ' ' THR . 0.8 OUTLIER -77.35 -21.97 52.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.396 179.558 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.411 ' HB3' HD11 ' A' ' 223' ' ' ILE . . . -106.9 -9.78 16.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.562 -0.711 . . . . 0.0 109.756 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.53 ' HA ' ' HB3' ' A' ' 160' ' ' PRO . . . -66.13 -174.11 0.23 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 110.216 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.766 HG22 ' H ' ' A' ' 158' ' ' SER . 4.0 m 43.64 -170.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 110.182 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.766 ' H ' HG22 ' A' ' 157' ' ' THR . 2.2 t 50.45 30.35 4.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.173 -0.954 . . . . 0.0 110.058 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . 0.521 ' CB ' ' O ' ' A' ' 158' ' ' SER . 0.5 OUTLIER 69.88 64.8 0.49 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 110.135 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.588 ' O ' ' CG ' ' A' ' 161' ' ' ARG . 45.9 Cg_endo -74.11 -61.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.0 1.526 . . . . 0.0 110.22 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.764 ' O ' HG22 ' A' ' 163' ' ' VAL . 0.0 OUTLIER 74.07 179.63 0.2 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.455 -0.778 . . . . 0.0 110.238 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.59 ' N ' ' CD ' ' A' ' 161' ' ' ARG . 14.0 tptt -40.03 126.3 2.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.834 . . . . 0.0 110.84 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 1.063 HG23 ' HA ' ' A' ' 194' ' ' GLU . 0.1 OUTLIER -134.11 -160.88 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.411 -0.805 . . . . 0.0 109.436 179.175 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.654 ' HA ' ' O ' ' A' ' 191' ' ' SER . 0.1 OUTLIER -177.21 144.4 0.42 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.831 -1.168 . . . . 0.0 110.39 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.927 HG23 HG22 ' A' ' 223' ' ' ILE . 1.1 mt -103.66 151.03 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.39 -0.819 . . . . 0.0 110.442 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.508 HG13 ' C ' ' A' ' 165' ' ' ILE . 22.9 m -150.72 17.87 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.165 -0.959 . . . . 0.0 110.295 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.432 ' OE1' HG23 ' A' ' 166' ' ' VAL . 0.1 OUTLIER -155.03 119.86 4.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.213 -0.929 . . . . 0.0 110.196 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 168' ' ' ILE . 0.9 OUTLIER -111.31 11.18 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.187 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 168' ' ' ILE . 5.4 m-20 -42.06 122.29 2.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.21 -0.932 . . . . 0.0 110.086 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 171' ' ' ILE . 5.1 pt-20 -144.79 55.88 1.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 110.189 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 170' ' ' GLU . 28.1 mt -41.91 -33.32 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.291 -0.881 . . . . 0.0 110.022 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.58 ' HE1' HG22 ' A' ' 220' ' ' THR . 3.4 p90 -98.93 158.71 15.46 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.349 -0.845 . . . . 0.0 110.191 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.453 ' O ' ' HB ' ' A' ' 174' ' ' VAL . 0.0 OUTLIER -178.0 152.54 0.74 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 110.187 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 173' ' ' GLN . 2.5 p 178.33 -30.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 110.134 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.433 ' OE2' ' OD2' ' A' ' 216' ' ' ASP . 35.0 tt0 -85.29 151.39 24.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -0.891 . . . . 0.0 110.123 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.74 HG23 ' HD2' ' A' ' 179' ' ' PHE . 36.4 m -164.68 -96.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 110.037 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.62 ' N ' HG22 ' A' ' 176' ' ' THR . 2.6 m-20 69.17 -136.7 0.08 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.148 -0.97 . . . . 0.0 110.307 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -56.55 -28.94 61.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.207 -0.933 . . . . 0.0 110.52 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.74 ' HD2' HG23 ' A' ' 176' ' ' THR . 0.1 OUTLIER -42.95 -39.82 2.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 110.263 -179.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.694 HG23 ' CG2' ' A' ' 176' ' ' THR . 0.7 OUTLIER -39.26 -28.3 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.905 . . . . 0.0 110.089 -179.781 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 179' ' ' PHE . 5.9 tt0 -60.2 -36.02 76.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.268 -0.895 . . . . 0.0 109.576 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.607 HD12 ' HA ' ' A' ' 179' ' ' PHE . 1.0 OUTLIER -69.77 -41.32 75.31 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.389 -0.82 . . . . 0.0 109.431 179.345 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.57 HD23 ' CZ ' ' A' ' 179' ' ' PHE . 0.1 OUTLIER -66.87 -39.17 87.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.41 -0.806 . . . . 0.0 109.812 179.641 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -61.73 -17.78 57.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.429 -0.794 . . . . 0.0 109.703 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -90.66 18.87 5.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.385 -0.822 . . . . 0.0 110.033 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 185' ' ' ALA . 2.8 m-20 42.48 68.02 0.53 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 109.669 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.522 HG22 ' N ' ' A' ' 188' ' ' ARG . 10.6 mm -115.24 167.47 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.302 -0.874 . . . . 0.0 110.882 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.636 ' O ' ' O ' ' A' ' 189' ' ' VAL . 0.2 OUTLIER -173.31 113.26 0.22 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.691 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 0.6 OUTLIER 43.74 101.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.272 -0.893 . . . . 0.0 108.693 -178.149 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.894 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -39.02 -19.05 0.01 OUTLIER Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.654 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 3.7 t 67.04 -145.18 0.15 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.969 -1.312 . . . . 0.0 108.979 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.581 ' C ' HG13 ' A' ' 193' ' ' VAL . 7.8 mt-10 -62.68 98.33 0.12 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 109.25 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.612 HG23 ' N ' ' A' ' 194' ' ' GLU . 10.0 m -154.1 -142.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.062 -1.024 . . . . 0.0 110.356 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 1.063 ' HA ' HG23 ' A' ' 163' ' ' VAL . 24.3 tt0 -169.64 157.71 7.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.88 . . . . 0.0 110.394 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 1.096 HD13 HG22 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -131.54 161.92 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.147 -0.97 . . . . 0.0 110.215 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.465 ' O ' ' HG2' ' A' ' 198' ' ' ARG . 97.1 t -144.97 86.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.266 -0.897 . . . . 0.0 110.067 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.549 ' CB ' ' OG1' ' A' ' 157' ' ' THR . 53.1 t0 -55.7 124.29 16.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.305 -0.872 . . . . 0.0 110.404 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.515 ' NH2' ' HB3' ' A' ' 198' ' ' ARG . 6.5 mmm180 -107.12 80.98 1.48 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.351 -0.843 . . . . 0.0 110.19 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.489 ' C ' ' O ' ' A' ' 198' ' ' ARG . 2.7 p30 36.23 38.19 0.06 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.452 -0.78 . . . . 0.0 110.565 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 137.57 -50.47 0.82 Allowed Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 198' ' ' ARG . 1.6 t-160 -90.04 114.75 26.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.344 -1.092 . . . . 0.0 110.42 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.92 HD13 HG22 ' A' ' 153' ' ' ILE . 35.6 mt -100.98 116.93 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 110.171 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.469 HG22 ' OD2' ' A' ' 210' ' ' ASP . 6.9 m -97.1 152.57 18.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 110.364 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 1.086 HD22 ' CD2' ' A' ' 206' ' ' HIS . 0.7 OUTLIER -119.84 131.95 55.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.361 -0.837 . . . . 0.0 110.086 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.568 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 5.0 t -119.72 115.69 24.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.276 -0.89 . . . . 0.0 110.137 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 1.086 ' CD2' HD22 ' A' ' 204' ' ' LEU . 1.9 m80 -103.45 153.59 20.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.605 -0.684 . . . . 0.0 109.832 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -51.02 -19.2 0.98 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.214 -0.929 . . . . 0.0 110.094 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' A' ' 209' ' ' LYS . . . -95.86 -27.42 10.36 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 208' ' ' GLY . 1.4 ptmt 171.63 -179.36 0.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.261 -1.141 . . . . 0.0 110.281 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.469 ' OD2' HG22 ' A' ' 203' ' ' THR . 0.8 OUTLIER -124.36 149.71 46.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -0.848 . . . . 0.0 110.131 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 6.1 p -129.68 164.7 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.244 -0.91 . . . . 0.0 110.075 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -86.97 70.34 10.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.374 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.996 HD22 HD12 ' A' ' 204' ' ' LEU . 1.8 tp -63.08 163.37 10.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.975 . . . . 0.0 110.099 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.614 HD11 HD23 ' A' ' 217' ' ' LEU . 0.6 OUTLIER -130.2 145.43 51.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.911 . . . . 0.0 110.307 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.454 ' HA ' HG21 ' A' ' 153' ' ' ILE . 3.5 p30 -55.08 -37.1 66.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 110.271 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.575 ' HB2' HD12 ' A' ' 214' ' ' LEU . 0.6 OUTLIER -55.79 -50.37 70.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.193 -0.942 . . . . 0.0 110.245 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.614 HD23 HD11 ' A' ' 214' ' ' LEU . 2.2 mm? -89.41 -28.18 19.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 110.218 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.651 ' HB1' HG23 ' A' ' 153' ' ' ILE . . . -67.1 -9.28 37.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 109.969 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.8 ' O ' HG23 ' A' ' 220' ' ' THR . 3.0 t-160 -91.09 69.24 6.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.169 -0.957 . . . . 0.0 110.181 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . 0.8 HG23 ' O ' ' A' ' 219' ' ' HIS . 0.6 OUTLIER -166.54 -58.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.177 -0.952 . . . . 0.0 110.4 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.675 ' N ' HD13 ' A' ' 221' ' ' ILE . 0.1 OUTLIER -65.53 136.43 26.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.304 -0.872 . . . . 0.0 110.319 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.502 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 47.1 mtt180 -95.67 116.59 29.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 110.058 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.927 HG22 HG23 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -119.78 177.37 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 110.168 -179.759 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.546 ' HB2' ' NH2' ' A' ' 164' ' ' ARG . 2.3 mt-10 -150.04 179.69 7.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.933 . . . . 0.0 110.295 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 1.5 mt-10 -90.15 69.89 7.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.384 -0.822 . . . . 0.0 110.214 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.463 ' OXT' ' O ' ' A' ' 225' ' ' GLU . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.214 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo . . . . . 0 N--CA 1.483 0.876 0 N-CA-C 110.413 -0.649 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.3 mp -113.91 112.08 47.82 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.312 -0.868 . . . . 0.0 110.149 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.65 159.42 48.77 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.035 1.545 . . . . 0.0 110.567 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 149.51 -43.57 0.76 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.59 -21.18 62.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.284 -1.127 . . . . 0.0 110.188 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.0 t70 50.97 89.48 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.282 -0.886 . . . . 0.0 110.252 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -138.38 21.42 2.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 110.194 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.692 ' N ' HD23 ' A' ' 138' ' ' LEU . 2.7 pt? . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.195 -0.941 . . . . 0.0 110.171 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 N--CA 1.482 0.817 0 N-CA-C 110.439 -0.639 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -178.95 153.17 12.03 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.53 ' HB ' ' O ' ' A' ' 223' ' ' ILE . 7.7 m -123.46 -1.82 8.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.159 -1.201 . . . . 0.0 110.216 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.507 ' CB ' ' HB2' ' A' ' 154' ' ' ASP . 2.5 mpt_? 57.21 110.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.879 . . . . 0.0 109.851 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 1.025 HG13 HD13 ' A' ' 195' ' ' ILE . 4.9 t -40.46 -68.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.358 -0.839 . . . . 0.0 110.278 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.782 HD13 ' N ' ' A' ' 153' ' ' ILE . 0.2 OUTLIER -43.8 -28.13 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.21 -0.932 . . . . 0.0 110.594 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 150' ' ' THR . 0.5 OUTLIER -81.05 -19.78 43.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.11 -0.994 . . . . 0.0 110.209 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 152' ' ' VAL . . . -100.44 -6.01 26.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.169 -0.957 . . . . 0.0 110.181 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.498 ' O ' HG22 ' A' ' 157' ' ' THR . . . -75.78 166.98 22.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.93 . . . . 0.0 110.174 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.697 HG23 ' N ' ' A' ' 158' ' ' SER . 0.4 OUTLIER 45.71 -175.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.165 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.697 ' N ' HG23 ' A' ' 157' ' ' THR . 1.7 t 69.85 -54.59 0.61 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 109.987 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . 0.487 ' CB ' ' O ' ' A' ' 158' ' ' SER . 0.0 OUTLIER 169.65 59.59 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.362 -0.836 . . . . 0.0 110.129 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.545 ' O ' ' CB ' ' A' ' 161' ' ' ARG . 44.6 Cg_endo -73.2 -72.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.019 1.536 . . . . 0.0 110.414 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.545 ' CB ' ' O ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER 71.45 -66.44 0.3 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.28 -0.888 . . . . 0.0 110.255 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.609 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 4.9 tttp -162.24 120.08 2.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 0.0 110.755 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.815 HG22 ' HA ' ' A' ' 194' ' ' GLU . 31.3 m -139.89 -151.53 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.889 . . . . 0.0 110.016 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.616 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 11.1 ttp180 -179.89 155.5 0.62 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.676 -1.265 . . . . 0.0 110.556 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 1.102 HG23 ' CG2' ' A' ' 223' ' ' ILE . 0.3 OUTLIER -89.66 151.28 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.163 -0.961 . . . . 0.0 109.896 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.953 HG22 ' O ' ' A' ' 222' ' ' ARG . 20.0 m -122.48 -18.46 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.176 -0.952 . . . . 0.0 110.588 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -167.88 123.94 1.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.165 -0.96 . . . . 0.0 110.519 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.492 HG12 ' HB ' ' A' ' 221' ' ' ILE . 6.5 mt -99.83 -13.38 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.359 -0.838 . . . . 0.0 109.894 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 170' ' ' GLU . 9.8 p30 38.83 -161.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.521 -0.737 . . . . 0.0 110.39 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.529 ' O ' ' CG ' ' A' ' 170' ' ' GLU . 8.5 tt0 179.1 45.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.886 . . . . 0.0 110.278 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.428 ' C ' ' O ' ' A' ' 170' ' ' GLU . 5.3 mt -42.36 -42.32 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.144 -0.973 . . . . 0.0 110.049 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -85.16 151.32 24.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 110.041 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.661 ' O ' HG12 ' A' ' 174' ' ' VAL . 0.2 OUTLIER -127.18 -169.03 1.97 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.217 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.661 HG12 ' O ' ' A' ' 173' ' ' GLN . 9.7 p 37.42 35.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.404 -0.81 . . . . 0.0 110.514 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' A' ' 177' ' ' ASP . 1.9 tm-20 -107.71 -68.06 0.92 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.892 . . . . 0.0 110.168 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.582 HG22 ' CG2' ' A' ' 180' ' ' THR . 0.0 OUTLIER 45.17 -89.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.467 -0.77 . . . . 0.0 110.475 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 175' ' ' GLU . 0.6 OUTLIER 68.01 -170.29 0.19 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 0.0 110.101 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 11.3 tm0? -44.63 -24.01 0.16 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.217 -0.927 . . . . 0.0 110.482 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.597 ' CA ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -58.69 -34.01 70.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.185 -0.947 . . . . 0.0 110.328 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.582 ' CG2' HG22 ' A' ' 176' ' ' THR . 0.8 OUTLIER -40.31 -29.02 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 110.046 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 179' ' ' PHE . 5.9 tt0 -62.6 -34.13 76.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.385 -0.822 . . . . 0.0 110.038 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.597 HD12 ' CA ' ' A' ' 179' ' ' PHE . 1.6 mt -69.53 -45.41 68.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.346 -0.847 . . . . 0.0 109.738 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 2.0 tt -63.3 -29.32 70.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.448 -0.783 . . . . 0.0 110.051 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.58 -1.68 17.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 110.058 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.421 ' O ' HG13 ' A' ' 187' ' ' ILE . . . -103.04 11.11 37.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.888 . . . . 0.0 110.266 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 185' ' ' ALA . 0.4 OUTLIER 44.69 86.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 109.912 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.643 ' O ' ' CB ' ' A' ' 188' ' ' ARG . 16.1 mt -147.58 -79.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.216 -0.928 . . . . 0.0 110.631 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.643 ' CB ' ' O ' ' A' ' 187' ' ' ILE . 34.1 ttt-85 81.02 149.84 0.1 Allowed 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.92 ' O ' ' N ' ' A' ' 191' ' ' SER . 2.7 m 33.28 35.95 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.37 -0.831 . . . . 0.0 110.329 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.749 ' N ' HD12 ' A' ' 165' ' ' ILE . . . 30.28 17.41 0.0 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.92 ' N ' ' O ' ' A' ' 189' ' ' VAL . 9.5 t 43.37 -147.19 0.06 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.117 -1.225 . . . . 0.0 109.343 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.699 ' HG2' HD21 ' A' ' 226' ' ' LEU . 3.4 mt-10 -77.82 116.16 18.13 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.593 ' O ' ' O ' ' A' ' 163' ' ' VAL . 0.2 OUTLIER -161.66 162.98 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.117 -0.99 . . . . 0.0 109.886 -179.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.815 ' HA ' HG22 ' A' ' 163' ' ' VAL . 4.0 pt-20 -119.87 169.01 10.54 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 119.225 -0.99 . . . . 0.0 110.27 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 1.025 HD13 HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -123.31 142.25 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.931 . . . . 0.0 110.463 -179.483 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.474 ' O ' ' C ' ' A' ' 197' ' ' ASP . 56.5 t -133.9 98.97 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.442 -0.786 . . . . 0.0 109.878 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' A' ' 196' ' ' VAL . 1.1 t0 -38.58 106.58 0.05 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.262 -0.899 . . . . 0.0 110.484 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 200' ' ' GLY . 0.0 OUTLIER -90.55 -172.48 3.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.234 -0.916 . . . . 0.0 110.349 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -53.02 86.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 110.286 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 198' ' ' ARG . . . 65.59 18.37 65.76 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.449 ' O ' ' N ' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -139.64 -176.13 4.45 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.284 -1.127 . . . . 0.0 110.123 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.706 ' CG2' HG22 ' A' ' 195' ' ' ILE . 47.6 mt -137.76 100.8 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 110.336 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.477 ' OG1' ' HG3' ' A' ' 198' ' ' ARG . 6.0 m -86.68 143.51 27.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.147 -0.971 . . . . 0.0 110.121 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.869 ' HG ' HG23 ' A' ' 195' ' ' ILE . 2.7 mp -120.89 146.23 46.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 0.0 110.148 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.518 ' O ' HG23 ' A' ' 193' ' ' VAL . 45.1 m -129.85 130.98 45.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.295 -0.878 . . . . 0.0 110.447 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.663 ' CE1' HG23 ' A' ' 211' ' ' VAL . 0.0 OUTLIER -116.13 -157.21 0.64 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.297 -0.877 . . . . 0.0 109.996 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -44.72 91.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.209 -0.932 . . . . 0.0 110.349 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 45.34 31.64 3.42 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.555 ' O ' ' CE1' ' A' ' 206' ' ' HIS . 0.4 OUTLIER -140.89 118.17 11.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -1.173 . . . . 0.0 110.328 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 2.3 p-10 -104.72 150.59 24.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 110.341 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.663 HG23 ' CE1' ' A' ' 206' ' ' HIS . 32.6 t -142.12 149.84 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.89 . . . . 0.0 110.18 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -82.5 67.25 8.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.284 -0.885 . . . . 0.0 110.297 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.863 ' CB ' HD13 ' A' ' 204' ' ' LEU . 3.4 tm? -51.54 125.56 14.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 0.0 110.056 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.786 HD11 ' HB2' ' A' ' 216' ' ' ASP . 22.1 tp -65.33 106.65 1.41 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 110.251 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.666 ' HB2' HD12 ' A' ' 202' ' ' ILE . 4.4 p30 -59.74 -41.57 91.25 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.306 -0.871 . . . . 0.0 110.358 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.786 ' HB2' HD11 ' A' ' 214' ' ' LEU . 0.3 OUTLIER -41.65 -69.66 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.316 -179.798 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.518 ' HA ' HD13 ' A' ' 217' ' ' LEU . 0.2 OUTLIER -79.58 -13.62 59.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -0.904 . . . . 0.0 110.501 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.643 ' HB3' HG21 ' A' ' 153' ' ' ILE . . . -40.44 -27.69 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.272 -0.893 . . . . 0.0 110.269 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.779 ' HD2' HG21 ' A' ' 153' ' ' ILE . 6.3 m170 -72.09 67.56 0.66 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.893 . . . . 0.0 110.09 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . 0.629 HG23 HG23 ' A' ' 221' ' ' ILE . 7.1 t -158.41 -42.31 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.973 . . . . 0.0 110.702 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.629 HG23 HG23 ' A' ' 220' ' ' THR . 0.1 OUTLIER -74.53 132.61 33.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.2 -0.938 . . . . 0.0 110.566 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.953 ' O ' HG22 ' A' ' 166' ' ' VAL . 19.3 mtm180 -89.48 110.68 21.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.23 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 1.102 ' CG2' HG23 ' A' ' 165' ' ' ILE . 0.8 OUTLIER -119.89 171.78 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 110.806 -179.092 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.477 ' O ' ' HB ' ' A' ' 163' ' ' VAL . 0.8 OUTLIER -150.2 -165.73 2.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.402 -0.811 . . . . 0.0 109.936 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.482 ' CG ' HG12 ' A' ' 163' ' ' VAL . 17.3 mt-10 -99.61 155.58 17.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 110.33 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.699 HD21 ' HG2' ' A' ' 192' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.241 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 N--CA 1.483 0.902 0 N-CA-C 110.574 -0.587 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.1 mt -100.83 118.57 60.37 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 110.359 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.28 155.48 46.46 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.917 1.483 . . . . 0.0 110.362 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -82.96 -107.34 0.48 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 28.7 tp -108.4 -36.22 6.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.118 -1.225 . . . . 0.0 110.203 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 10.2 t70 175.18 -93.98 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.408 -0.807 . . . . 0.0 110.093 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.448 ' N ' ' OD2' ' A' ' 136' ' ' ASP . 0.7 OUTLIER -73.0 62.69 0.63 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.183 -0.948 . . . . 0.0 110.26 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.413 ' HA ' HD12 ' A' ' 138' ' ' LEU . 25.7 tp . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.2 -0.938 . . . . 0.0 110.232 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo . . . . . 0 N--CA 1.484 0.919 0 N-CA-C 110.415 -0.648 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -178.22 117.5 0.58 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.624 ' O ' HD13 ' A' ' 223' ' ' ILE . 8.3 m -159.82 146.15 16.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -1.155 . . . . 0.0 110.275 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.522 ' O ' ' CD1' ' A' ' 223' ' ' ILE . 11.4 ptp180 -53.61 171.09 0.09 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.282 -0.886 . . . . 0.0 110.178 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.934 HG22 HG21 ' A' ' 195' ' ' ILE . 12.5 p -104.1 36.82 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.209 -0.932 . . . . 0.0 110.612 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.873 HG22 HD13 ' A' ' 202' ' ' ILE . 9.0 pt -135.82 -34.29 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.946 . . . . 0.0 110.078 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.92 -14.11 61.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.286 -0.884 . . . . 0.0 109.457 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -97.52 -21.15 17.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.578 -0.701 . . . . 0.0 109.896 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.511 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -73.5 90.58 1.74 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 110.17 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 157' ' ' THR . 5.2 t -91.77 179.12 5.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.929 . . . . 0.0 110.252 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.4 t -44.77 -46.68 10.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.267 -0.895 . . . . 0.0 110.027 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . 0.493 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 5.5 mmt -75.56 164.81 58.32 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 110.116 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 45.1 Cg_endo -71.94 73.86 2.44 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.947 1.498 . . . . 0.0 110.327 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.403 ' O ' HG22 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -63.31 110.19 1.82 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.855 . . . . 0.0 110.234 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.403 ' C ' HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.78 138.09 48.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.407 -0.808 . . . . 0.0 110.26 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.658 HG12 ' C ' ' A' ' 224' ' ' GLU . 0.1 OUTLIER -149.98 -174.13 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.348 -0.845 . . . . 0.0 110.071 179.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.723 ' NH2' HG12 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -163.22 134.93 5.01 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.856 -1.153 . . . . 0.0 110.244 -179.619 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 1.049 HG23 HG23 ' A' ' 221' ' ' ILE . 0.5 OUTLIER -76.05 151.34 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.171 -0.955 . . . . 0.0 110.145 -179.415 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.723 HG12 ' NH2' ' A' ' 164' ' ' ARG . 28.9 m -149.26 15.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.305 -0.872 . . . . 0.0 109.993 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -179.12 110.37 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.354 -0.841 . . . . 0.0 110.065 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.856 HG21 ' HD3' ' A' ' 188' ' ' ARG . 0.6 OUTLIER -95.9 24.27 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 110.121 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 170' ' ' GLU . 2.2 t-20 -42.43 165.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 110.041 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 169' ' ' ASN . 0.7 OUTLIER 57.84 72.66 0.51 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.143 -0.973 . . . . 0.0 110.009 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.485 ' CD1' HG12 ' A' ' 168' ' ' ILE . 25.8 mm -88.03 -13.35 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 0.0 110.349 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.558 ' CG ' ' O ' ' A' ' 172' ' ' PHE . 1.5 p90 -47.6 123.53 5.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.217 -0.927 . . . . 0.0 110.158 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.24 177.28 6.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.167 -0.958 . . . . 0.0 110.388 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.49 ' O ' HG22 ' A' ' 174' ' ' VAL . 8.7 p -160.28 39.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 110.127 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.539 ' O ' ' CB ' ' A' ' 176' ' ' THR . 0.2 OUTLIER -127.27 -73.6 0.61 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -0.891 . . . . 0.0 110.166 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.634 ' HA ' ' CD1' ' A' ' 179' ' ' PHE . 0.3 OUTLIER 72.0 -147.39 0.06 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.474 -0.766 . . . . 0.0 110.299 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 176' ' ' THR . 0.8 OUTLIER 65.52 -150.1 0.24 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.38 -0.825 . . . . 0.0 110.413 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 177' ' ' ASP . 1.6 tp60 -38.98 -37.1 0.33 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.279 -0.888 . . . . 0.0 110.738 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.811 ' HA ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -48.0 -33.96 8.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.941 . . . . 0.0 110.057 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.543 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 1.3 p -39.33 -31.15 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.43 -0.793 . . . . 0.0 110.193 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 179' ' ' PHE . 23.5 tt0 -59.38 -36.35 75.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.309 -0.87 . . . . 0.0 109.824 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.811 HD12 ' HA ' ' A' ' 179' ' ' PHE . 1.2 mt -68.99 -46.61 67.62 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.371 -0.831 . . . . 0.0 109.733 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.615 ' O ' HD13 ' A' ' 183' ' ' LEU . 0.2 OUTLIER -68.52 -32.62 72.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.489 -0.757 . . . . 0.0 110.11 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 180' ' ' THR . 0.9 OUTLIER -73.05 -4.51 32.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.84 . . . . 0.0 109.957 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.444 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -89.17 9.48 25.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.369 -0.832 . . . . 0.0 110.165 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 185' ' ' ALA . 23.1 t0 41.98 82.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.176 -0.953 . . . . 0.0 109.766 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.7 tt -141.22 173.3 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 110.49 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.856 ' HD3' HG21 ' A' ' 168' ' ' ILE . 0.0 OUTLIER -167.13 114.29 0.79 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.743 ' CG2' ' O ' ' A' ' 189' ' ' VAL . 1.7 m 49.92 96.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 120.986 -1.071 . . . . 0.0 108.188 -178.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.563 ' N ' HG13 ' A' ' 165' ' ' ILE . . . -42.0 -16.26 0.02 OUTLIER Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 189' ' ' VAL . 9.2 t 62.82 -143.35 0.38 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.128 -1.219 . . . . 0.0 109.825 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.701 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 1.0 OUTLIER -59.54 104.36 0.27 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.512 -0.743 . . . . 0.0 109.751 179.626 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.636 HG23 ' N ' ' A' ' 194' ' ' GLU . 11.0 m -154.78 -139.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.072 -1.018 . . . . 0.0 110.182 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.7 ' O ' HD23 ' A' ' 204' ' ' LEU . 54.7 tt0 -176.32 167.17 2.84 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 109.926 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.934 HG21 HG22 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -129.45 167.46 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.114 -0.992 . . . . 0.0 110.342 -179.831 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.465 HG23 ' C ' ' A' ' 195' ' ' ILE . 71.5 t -151.36 88.62 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.364 -0.835 . . . . 0.0 110.007 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 196' ' ' VAL . 17.8 t0 -41.24 110.23 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.319 -0.863 . . . . 0.0 110.104 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.479 ' HB3' ' HB3' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -109.01 88.18 2.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.24 -0.913 . . . . 0.0 110.364 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 198' ' ' ARG . 0.5 OUTLIER 40.93 58.2 2.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 110.213 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 89.17 -28.04 7.05 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 198' ' ' ARG . 1.4 t60 -90.64 87.42 6.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -1.154 . . . . 0.0 110.182 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.873 HD13 HG22 ' A' ' 153' ' ' ILE . 66.2 mt -70.48 87.72 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.347 -0.846 . . . . 0.0 110.299 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.7 m -71.79 157.46 37.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.948 . . . . 0.0 110.007 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 1.007 HD22 ' CD2' ' A' ' 206' ' ' HIS . 0.9 OUTLIER -119.64 141.26 49.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -0.937 . . . . 0.0 110.204 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.503 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 1.6 t -119.77 115.48 23.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.869 . . . . 0.0 109.99 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 1.007 ' CD2' HD22 ' A' ' 204' ' ' LEU . 3.2 m80 -105.42 -165.78 1.15 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.314 -0.866 . . . . 0.0 109.942 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.457 ' O ' ' OD1' ' A' ' 207' ' ' ASN . 11.5 p30 -46.45 91.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.863 . . . . 0.0 110.142 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 49.43 24.92 5.74 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.518 ' O ' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -136.89 102.59 4.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.237 -1.155 . . . . 0.0 110.283 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 18.4 p30 -99.77 153.81 18.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 110.241 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 52.7 t -140.98 147.66 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.179 -0.95 . . . . 0.0 110.208 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -74.97 77.58 2.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 110.176 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.627 ' CD2' HD12 ' A' ' 204' ' ' LEU . 19.6 tp -74.6 169.51 17.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -0.951 . . . . 0.0 110.238 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.647 HD23 ' N ' ' A' ' 214' ' ' LEU . 0.5 OUTLIER -123.53 142.96 50.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.252 -0.905 . . . . 0.0 110.21 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.401 ' HA ' ' CB ' ' A' ' 218' ' ' ALA . 38.8 t0 -56.7 -44.95 82.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 110.198 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.42 -49.61 13.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 110.204 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.507 ' HB2' ' CD1' ' A' ' 214' ' ' LEU . 1.9 mp -87.21 -17.6 32.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.0 110.225 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.825 ' O ' HG12 ' A' ' 152' ' ' VAL . . . -55.01 -19.03 5.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 110.152 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.415 ' O ' ' C ' ' A' ' 220' ' ' THR . 61.4 t60 -68.96 -52.85 24.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.209 -0.932 . . . . 0.0 110.146 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . 0.495 ' O ' ' C ' ' A' ' 221' ' ' ILE . 68.9 p -43.0 -78.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.197 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 1.049 HG23 HG23 ' A' ' 165' ' ' ILE . 1.6 mp -31.54 117.71 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.55 -0.719 . . . . 0.0 111.935 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 2.4 ttm-85 -100.77 103.7 14.93 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 1.0 HG22 HG23 ' A' ' 165' ' ' ILE . 0.1 OUTLIER -119.47 -179.8 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.145 -0.972 . . . . 0.0 111.262 -178.351 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.658 ' C ' HG12 ' A' ' 163' ' ' VAL . 2.5 mm-40 -150.74 168.42 24.45 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -71.97 140.91 49.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.904 . . . . 0.0 110.251 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.588 HD11 ' HG3' ' A' ' 192' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.187 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 N--CA 1.483 0.905 0 N-CA-C 110.426 -0.644 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 80.7 mt -119.06 122.6 29.49 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.237 -0.914 . . . . 0.0 110.204 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.48 -87.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.024 1.539 . . . . 0.0 110.419 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 135' ' ' LEU . . . 137.29 -6.52 3.64 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 13.5 mt 57.66 47.15 16.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -1.19 . . . . 0.0 110.184 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 137' ' ' GLU . 9.5 t70 179.48 -85.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.255 -0.903 . . . . 0.0 110.231 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER 59.89 48.79 8.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.313 -0.867 . . . . 0.0 110.224 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.314 -0.866 . . . . 0.0 110.208 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 N--CA 1.483 0.898 0 N-CA-C 110.403 -0.653 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.549 ' CA ' ' HG2' ' A' ' 222' ' ' ARG . . . 167.34 132.31 1.38 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.569 ' O ' HG22 ' A' ' 150' ' ' THR . 56.6 m -136.85 4.5 2.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -1.166 . . . . 0.0 110.197 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.536 ' HB2' ' HB2' ' A' ' 154' ' ' ASP . 0.3 OUTLIER 59.53 127.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 0.0 110.049 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.969 ' HB ' HG21 ' A' ' 223' ' ' ILE . 2.1 p -77.72 12.52 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.252 -0.905 . . . . 0.0 110.79 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 1.054 ' CG2' ' HB1' ' A' ' 218' ' ' ALA . 18.2 pt -124.58 -24.6 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.011 -1.055 . . . . 0.0 110.421 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.536 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 0.6 OUTLIER -71.53 -21.59 61.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.131 -0.981 . . . . 0.0 109.259 179.414 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.81 -16.85 29.3 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.605 -0.684 . . . . 0.0 109.805 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.813 ' HB2' ' CD1' ' A' ' 195' ' ' ILE . . . -64.03 92.55 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.836 . . . . 0.0 110.203 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.581 HG23 ' OG ' ' A' ' 158' ' ' SER . 6.4 t -177.36 171.7 1.95 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.937 . . . . 0.0 110.343 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.581 ' OG ' HG23 ' A' ' 157' ' ' THR . 3.7 p 42.35 73.1 0.14 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.345 -0.847 . . . . 0.0 110.118 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . 0.523 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 1.6 mtp 68.62 167.45 0.12 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.281 -0.887 . . . . 0.0 110.117 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.523 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 45.7 Cg_endo -72.51 101.81 1.32 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.014 1.534 . . . . 0.0 110.381 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.594 ' O ' HG13 ' A' ' 163' ' ' VAL . 0.4 OUTLIER -85.41 120.14 26.54 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.291 -0.881 . . . . 0.0 110.207 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.566 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 13.7 mtmt -62.24 87.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 110.205 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.87 HG22 ' HA ' ' A' ' 194' ' ' GLU . 33.8 m -91.96 -166.36 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 110.352 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.669 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -172.61 136.74 0.76 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.841 -1.162 . . . . 0.0 110.41 -179.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 1.065 HG23 ' CG2' ' A' ' 223' ' ' ILE . 1.1 mt -93.6 162.36 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.374 -0.829 . . . . 0.0 110.544 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 222' ' ' ARG . 6.6 m -136.74 -32.62 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 110.736 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.576 ' CG ' ' HB2' ' A' ' 222' ' ' ARG . 6.3 pt20 -147.04 119.46 8.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.073 -1.017 . . . . 0.0 110.652 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.938 HG13 HG22 ' A' ' 221' ' ' ILE . 11.6 tt -110.76 17.82 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 0.0 109.869 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 168' ' ' ILE . 67.0 m-20 -37.84 105.52 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.466 -0.771 . . . . 0.0 110.606 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.441 ' CD ' ' HB2' ' A' ' 172' ' ' PHE . 0.4 OUTLIER -131.02 107.33 9.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 109.954 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 2.0 pp -81.49 11.33 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -0.889 . . . . 0.0 110.525 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.441 ' HB2' ' CD ' ' A' ' 170' ' ' GLU . 1.1 m-85 -64.7 176.37 1.18 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 0.0 110.18 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -77.29 -165.35 0.57 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.276 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.442 ' O ' HG22 ' A' ' 174' ' ' VAL . 10.0 p -117.92 32.37 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -0.89 . . . . 0.0 110.212 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' A' ' 176' ' ' THR . 4.6 tp10 -64.13 -143.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.293 -0.88 . . . . 0.0 110.301 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.566 ' OG1' ' CD1' ' A' ' 179' ' ' PHE . 75.2 p 42.64 92.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.281 -0.887 . . . . 0.0 110.139 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.408 ' HA ' ' OG1' ' A' ' 180' ' ' THR . 0.8 OUTLIER -62.53 -31.25 71.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 110.209 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -72.32 -25.21 61.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.862 . . . . 0.0 110.289 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.998 ' CE2' HD13 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -85.49 -29.1 24.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.237 -0.914 . . . . 0.0 110.072 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.551 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -58.81 -16.99 19.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.179 -0.951 . . . . 0.0 109.73 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.21 -60.19 2.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.346 -0.846 . . . . 0.0 110.254 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.76 ' C ' HD12 ' A' ' 182' ' ' LEU . 4.4 pp -64.59 -10.53 26.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.88 . . . . 0.0 110.133 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.998 HD13 ' CE2' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -92.57 -32.4 14.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 109.916 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -67.93 -7.27 27.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 0.0 109.883 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -83.54 13.79 4.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.343 -0.848 . . . . 0.0 110.23 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 185' ' ' ALA . 8.9 m-20 42.98 62.98 1.62 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.211 -0.931 . . . . 0.0 110.007 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.3 tt -118.5 -174.57 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.331 -0.856 . . . . 0.0 110.348 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.706 ' C ' HG13 ' A' ' 189' ' ' VAL . 0.4 OUTLIER -171.41 112.08 0.34 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.346 -0.846 . . . . 0.0 108.908 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.706 HG13 ' C ' ' A' ' 188' ' ' ARG . 1.1 m 51.35 109.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.381 -0.824 . . . . 0.0 109.202 -178.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.856 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -44.19 -15.68 0.05 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.594 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 3.3 t 68.3 -145.06 0.12 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.179 -1.189 . . . . 0.0 109.534 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.669 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 3.8 mm-40 -66.39 102.93 0.93 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.496 -0.752 . . . . 0.0 109.331 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.619 ' O ' ' O ' ' A' ' 163' ' ' VAL . 20.6 m -156.46 -140.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 110.323 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.87 ' HA ' HG22 ' A' ' 163' ' ' VAL . 3.1 pt-20 -177.3 139.77 0.27 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.334 -0.854 . . . . 0.0 110.029 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.958 HG21 HG22 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -130.39 161.19 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.104 -0.998 . . . . 0.0 110.452 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.543 ' N ' HG12 ' A' ' 195' ' ' ILE . 18.2 t -129.71 130.66 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.46 -0.775 . . . . 0.0 110.012 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.479 ' HA ' HG12 ' A' ' 202' ' ' ILE . 7.1 t70 -83.5 137.62 33.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -0.941 . . . . 0.0 110.321 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -130.23 71.34 1.45 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.28 -0.888 . . . . 0.0 110.201 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 198' ' ' ARG . 47.5 t0 42.73 71.39 0.23 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 110.149 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 88.84 -35.81 3.58 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.501 ' O ' ' N ' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -89.87 108.29 19.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.263 -1.139 . . . . 0.0 110.195 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.479 HG12 ' HA ' ' A' ' 197' ' ' ASP . 7.8 mt -112.82 138.63 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 110.296 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.549 ' O ' HG12 ' A' ' 195' ' ' ILE . 31.4 m -126.74 146.06 50.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.346 -0.846 . . . . 0.0 109.832 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.756 HD22 ' CD2' ' A' ' 206' ' ' HIS . 0.2 OUTLIER -119.48 133.16 55.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.086 -1.008 . . . . 0.0 110.387 -179.796 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.592 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 1.2 m -119.96 124.12 45.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.412 -0.805 . . . . 0.0 109.768 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.756 ' CD2' HD22 ' A' ' 204' ' ' LEU . 2.5 m170 -107.83 100.1 9.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.413 -0.805 . . . . 0.0 110.207 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 207' ' ' ASN . 1.2 p-10 39.02 29.77 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.352 -0.843 . . . . 0.0 110.78 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 123.6 -33.3 3.99 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.585 ' O ' ' CG ' ' A' ' 206' ' ' HIS . 3.6 mmtt -91.86 110.69 22.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.225 -1.162 . . . . 0.0 109.972 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.532 ' HA ' ' O ' ' A' ' 204' ' ' LEU . 4.1 p30 -109.23 169.7 8.52 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.118 -0.989 . . . . 0.0 110.484 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 210' ' ' ASP . 37.8 t -151.41 146.24 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.326 -0.859 . . . . 0.0 110.128 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 213' ' ' LEU . 2.3 tt0 -75.25 72.61 2.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.285 -0.884 . . . . 0.0 110.221 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.449 HD22 HD12 ' A' ' 204' ' ' LEU . 1.1 mp -55.19 -165.86 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.891 . . . . 0.0 110.23 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.714 HD12 ' HB3' ' A' ' 216' ' ' ASP . 0.5 OUTLIER -157.93 136.95 11.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 110.188 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 214' ' ' LEU . 21.7 t0 -41.88 -48.14 4.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -0.901 . . . . 0.0 110.428 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.714 ' HB3' HD12 ' A' ' 214' ' ' LEU . 7.4 t0 -47.84 -52.05 20.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.181 -0.95 . . . . 0.0 110.336 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.734 ' O ' HG23 ' A' ' 221' ' ' ILE . 0.4 OUTLIER -88.46 -32.29 18.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.272 -0.892 . . . . 0.0 110.297 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 1.054 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -62.99 -26.75 69.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.03 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.628 ' CG ' HD11 ' A' ' 153' ' ' ILE . 1.1 t60 -99.1 29.88 3.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.935 . . . . 0.0 110.11 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 50.6 m -138.41 -33.47 0.67 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.257 -0.902 . . . . 0.0 110.451 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.938 HG22 HG13 ' A' ' 168' ' ' ILE . 0.2 OUTLIER -67.35 140.21 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 110.445 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.576 ' HB2' ' CG ' ' A' ' 167' ' ' GLN . 1.4 mtt180 -91.94 113.5 25.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 109.383 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 1.065 ' CG2' HG23 ' A' ' 165' ' ' ILE . 0.7 OUTLIER -127.12 -169.26 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.126 -0.983 . . . . 0.0 110.954 -179.126 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.443 ' HG3' ' N ' ' A' ' 225' ' ' GLU . 3.0 tp10 -148.85 156.92 43.0 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.468 -0.77 . . . . 0.0 109.98 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 1.1 tt0 -104.95 122.68 46.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.296 -0.878 . . . . 0.0 110.221 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.1 tp . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.222 179.935 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo . . . . . 0 N--CA 1.484 0.918 0 N-CA-C 110.473 -0.626 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.401 ' HA ' ' HD2' ' A' ' 133' ' ' PRO . 2.1 mt -136.54 106.52 9.18 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.889 . . . . 0.0 110.255 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 132' ' ' ILE . 46.4 Cg_endo -73.23 -0.98 9.91 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.999 1.526 . . . . 0.0 110.461 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -85.43 -170.91 47.67 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.25 -35.03 0.18 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -1.117 . . . . 0.0 110.305 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.45 124.98 36.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 110.312 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -138.2 49.66 1.92 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -0.905 . . . . 0.0 110.197 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 26.6 tp . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 110.322 -179.903 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo . . . . . 0 N--CA 1.483 0.898 0 N-CA-C 110.464 -0.629 . . . . 0.0 110.464 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 145.52 92.68 0.13 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.487 ' O ' ' O ' ' A' ' 151' ' ' ARG . 91.0 m -81.22 -20.91 40.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -1.152 . . . . 0.0 110.202 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.512 ' O ' ' O ' ' A' ' 152' ' ' VAL . 11.4 mtt85 59.92 132.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.34 -0.85 . . . . 0.0 110.043 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.775 HG12 ' H ' ' A' ' 153' ' ' ILE . 37.6 t -51.35 -174.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.239 -0.913 . . . . 0.0 109.369 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.799 HG21 ' HB3' ' A' ' 218' ' ' ALA . 1.0 OUTLIER 52.44 15.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.143 -0.973 . . . . 0.0 110.209 -179.589 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 151' ' ' ARG . 1.2 t0 -130.4 -31.21 1.85 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.357 -0.839 . . . . 0.0 109.419 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.67 ' CB ' HG11 ' A' ' 163' ' ' VAL . . . -84.64 -18.85 34.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.514 -0.741 . . . . 0.0 109.814 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.34 136.02 56.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.343 -0.848 . . . . 0.0 110.039 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 157' ' ' THR . 7.9 m -160.88 87.16 0.73 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.112 -0.992 . . . . 0.0 110.359 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 157' ' ' THR . 2.1 t 70.11 -53.17 0.63 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.305 -0.872 . . . . 0.0 110.058 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . 0.455 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 59.0 mtp -108.98 168.01 8.33 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 121.327 -0.858 . . . . 0.0 110.056 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.488 ' HB2' ' OE2' ' A' ' 194' ' ' GLU . 46.2 Cg_endo -72.63 65.86 3.83 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.952 1.501 . . . . 0.0 110.427 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -44.0 109.66 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 110.234 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.496 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 5.6 tttm -58.1 132.15 52.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.905 . . . . 0.0 110.255 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.67 HG11 ' CB ' ' A' ' 155' ' ' ALA . 16.0 m -150.24 -159.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 110.498 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.64 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.1 OUTLIER -173.81 150.86 1.73 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.936 -1.103 . . . . 0.0 110.347 -179.633 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.993 HG23 HG22 ' A' ' 223' ' ' ILE . 2.0 mm -88.92 148.42 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.34 -0.85 . . . . 0.0 110.297 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.757 HG22 ' O ' ' A' ' 222' ' ' ARG . 22.6 m -136.47 5.34 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.888 . . . . 0.0 109.814 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.513 ' HB3' ' HB3' ' A' ' 222' ' ' ARG . 1.7 tm0? -171.77 121.17 0.48 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.898 . . . . 0.0 109.867 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.539 ' HB ' ' CG1' ' A' ' 189' ' ' VAL . 0.3 OUTLIER -93.74 -2.31 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.0 110.33 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 49.78 -137.07 1.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.168 -0.958 . . . . 0.0 110.022 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -117.87 108.23 15.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.956 . . . . 0.0 110.198 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 172' ' ' PHE . 1.0 OUTLIER -60.49 -13.84 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.164 -0.96 . . . . 0.0 110.105 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.439 ' N ' HG13 ' A' ' 171' ' ' ILE . 0.5 OUTLIER -75.69 82.93 2.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 110.127 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -110.58 -89.63 0.49 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 110.198 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.737 HG12 ' N ' ' A' ' 175' ' ' GLU . 37.5 t -128.47 -91.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.906 . . . . 0.0 110.233 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.737 ' N ' HG12 ' A' ' 174' ' ' VAL . 2.8 mt-10 -94.1 -172.14 2.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 0.0 110.198 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 1.058 HG23 ' CD2' ' A' ' 179' ' ' PHE . 20.0 m -136.04 -65.36 0.58 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.287 -0.883 . . . . 0.0 110.217 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 176' ' ' THR . 5.6 m-20 70.57 -153.43 0.11 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.455 -0.778 . . . . 0.0 110.359 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' A' ' 181' ' ' GLN . 18.6 tt0 -45.42 -25.68 0.45 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.278 -0.889 . . . . 0.0 110.607 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 1.058 ' CD2' HG23 ' A' ' 176' ' ' THR . 0.3 OUTLIER -42.39 -54.64 3.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.208 -0.932 . . . . 0.0 110.026 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 1.034 HG23 HG21 ' A' ' 176' ' ' THR . 0.0 OUTLIER -47.84 -23.42 0.74 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.054 -1.029 . . . . 0.0 109.836 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 178' ' ' GLN . 34.5 tt0 -71.98 -62.0 1.58 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 110.199 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.656 ' C ' HD12 ' A' ' 182' ' ' LEU . 4.6 pp -65.33 -9.3 23.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.346 -0.846 . . . . 0.0 109.892 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.903 ' O ' HD13 ' A' ' 183' ' ' LEU . 3.4 tm? -92.25 -31.67 15.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.876 . . . . 0.0 109.851 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -70.25 -5.81 30.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.42 -0.8 . . . . 0.0 110.008 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -88.11 29.35 0.95 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -0.906 . . . . 0.0 110.235 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 186' ' ' ASP . 1.8 m-20 52.48 36.23 19.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.214 -0.929 . . . . 0.0 110.208 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 16.3 mm -93.47 156.6 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 110.185 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.609 ' C ' HG22 ' A' ' 189' ' ' VAL . 2.5 ptm180 -170.83 130.32 0.81 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.863 ' O ' ' N ' ' A' ' 191' ' ' SER . 34.3 m 33.75 69.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.212 -0.93 . . . . 0.0 109.008 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 189' ' ' VAL . . . -20.93 -32.2 0.0 OUTLIER Glycine 0 N--CA 1.498 2.785 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.863 ' N ' ' O ' ' A' ' 189' ' ' VAL . 3.4 t 70.86 -143.54 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -1.142 . . . . 0.0 109.831 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.64 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.8 OUTLIER -61.36 102.48 0.23 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.416 -0.803 . . . . 0.0 109.796 179.741 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.74 ' CG2' HD21 ' A' ' 204' ' ' LEU . 20.3 m -156.32 -142.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.126 -0.984 . . . . 0.0 110.246 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.626 ' HA ' HG22 ' A' ' 163' ' ' VAL . 21.6 tt0 -175.95 161.21 2.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 110.218 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.753 HD13 HG13 ' A' ' 152' ' ' VAL . 0.7 OUTLIER -123.48 172.15 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.128 -0.983 . . . . 0.0 110.279 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.759 HG13 ' O ' ' A' ' 196' ' ' VAL . 14.8 p -146.59 102.13 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 110.158 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 197' ' ' ASP . 5.1 p-10 -42.35 113.94 0.51 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.266 -0.896 . . . . 0.0 110.193 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -100.55 160.6 14.22 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.252 -0.905 . . . . 0.0 110.304 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -55.73 91.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.253 -0.904 . . . . 0.0 110.064 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 198' ' ' ARG . . . 76.76 12.4 84.53 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.462 ' O ' ' N ' ' A' ' 198' ' ' ARG . 0.0 OUTLIER -150.13 179.88 7.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.169 -1.195 . . . . 0.0 110.179 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.542 HD12 ' CG ' ' A' ' 215' ' ' ASP . 42.5 mt -144.79 133.68 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.921 . . . . 0.0 110.308 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.53 ' HB ' HG12 ' A' ' 196' ' ' VAL . 0.2 OUTLIER -113.83 152.86 30.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 110.026 179.794 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.843 HD22 ' CD2' ' A' ' 206' ' ' HIS . 1.1 tt -119.72 137.25 54.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 110.294 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.539 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 3.0 t -119.78 128.14 53.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.356 -0.84 . . . . 0.0 109.865 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.843 ' CD2' HD22 ' A' ' 204' ' ' LEU . 1.3 m80 -112.72 125.68 54.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.387 -0.82 . . . . 0.0 110.013 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 206' ' ' HIS . 2.0 t-20 42.82 -93.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.216 -0.927 . . . . 0.0 110.224 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -126.28 19.1 6.42 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.13 129.27 39.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -1.138 . . . . 0.0 110.258 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 7.9 t70 -117.94 156.78 27.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.296 -0.878 . . . . 0.0 110.22 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.421 ' N ' ' OD1' ' A' ' 210' ' ' ASP . 5.5 p -149.43 162.23 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.251 -0.905 . . . . 0.0 110.201 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -65.01 156.4 31.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 110.126 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.574 HD13 HD12 ' A' ' 204' ' ' LEU . 0.7 OUTLIER -156.48 88.76 1.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.232 -0.917 . . . . 0.0 110.202 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.713 ' O ' ' HB2' ' A' ' 218' ' ' ALA . 14.5 tp -41.34 113.74 0.43 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.235 -0.916 . . . . 0.0 110.244 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.542 ' CG ' HD12 ' A' ' 202' ' ' ILE . 8.2 t0 -60.18 -43.17 96.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.325 -0.859 . . . . 0.0 110.428 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 215' ' ' ASP . 55.9 t0 -43.07 -67.37 0.28 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.131 -0.981 . . . . 0.0 110.177 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.527 ' HB2' HD23 ' A' ' 214' ' ' LEU . 0.5 OUTLIER -82.28 -13.54 56.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.259 -0.901 . . . . 0.0 110.531 -179.831 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.799 ' HB3' HG21 ' A' ' 153' ' ' ILE . . . -45.01 -26.43 0.43 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.148 -0.97 . . . . 0.0 110.1 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.767 ' CG ' HD11 ' A' ' 153' ' ' ILE . 0.7 OUTLIER -78.95 64.63 3.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.268 -0.895 . . . . 0.0 110.182 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . 0.472 HG23 HG23 ' A' ' 221' ' ' ILE . 0.5 OUTLIER -129.25 -22.89 3.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -0.973 . . . . 0.0 110.467 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.75 HD13 ' H ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -99.78 145.95 9.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.09 -1.006 . . . . 0.0 110.57 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.757 ' O ' HG22 ' A' ' 166' ' ' VAL . 0.3 OUTLIER -88.81 96.35 10.65 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.323 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.993 HG22 HG23 ' A' ' 165' ' ' ILE . 0.5 OUTLIER -119.64 173.16 5.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.304 -0.873 . . . . 0.0 111.419 -177.492 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.485 ' HG3' ' OG1' ' A' ' 150' ' ' THR . 0.6 OUTLIER -145.9 -172.87 4.01 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.5 -0.75 . . . . 0.0 110.181 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 8.4 tt0 -112.08 127.14 55.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.377 -0.827 . . . . 0.0 110.201 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.231 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 N--CA 1.483 0.904 0 N-CA-C 110.465 -0.629 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 28.2 mm -72.96 124.07 90.3 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 110.218 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.11 96.02 0.86 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.917 1.483 . . . . 0.0 110.431 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -178.31 85.72 0.07 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -166.66 95.97 0.54 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.326 -1.102 . . . . 0.0 110.144 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -88.88 60.21 5.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 0.0 110.21 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 40.4 mt-10 63.08 -71.17 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.0 110.4 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 136' ' ' ASP . 14.8 tp . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.319 -0.863 . . . . 0.0 110.238 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo . . . . . 0 N--CA 1.484 0.915 0 N-CA-C 110.694 -0.541 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.58 ' O ' ' HB ' ' A' ' 150' ' ' THR . . . 95.23 -74.26 0.91 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.58 ' HB ' ' O ' ' A' ' 149' ' ' GLY . 22.2 m 65.89 -121.54 0.34 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.345 -1.091 . . . . 0.0 109.889 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.529 ' CD ' ' O ' ' A' ' 150' ' ' THR . 1.5 mmt180 -143.41 157.62 44.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.961 -1.087 . . . . 0.0 109.989 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.877 HG22 HD13 ' A' ' 195' ' ' ILE . 0.6 OUTLIER -69.3 -3.94 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.157 -0.964 . . . . 0.0 110.479 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.884 ' CG2' ' HB1' ' A' ' 218' ' ' ALA . 1.6 pp -117.65 -30.9 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.098 -1.001 . . . . 0.0 110.335 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.52 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -74.88 -13.25 60.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -0.967 . . . . 0.0 109.214 179.346 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -113.04 -7.34 13.68 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.562 -0.711 . . . . 0.0 109.72 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 1.023 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -85.0 177.21 8.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.335 -0.853 . . . . 0.0 110.194 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.527 ' O ' ' CB ' ' A' ' 158' ' ' SER . 0.4 OUTLIER 56.88 153.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.347 -0.846 . . . . 0.0 110.185 179.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 157' ' ' THR . 0.7 OUTLIER 70.69 -51.5 0.67 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.181 -0.95 . . . . 0.0 110.157 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . 0.454 ' N ' ' CD ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER -161.86 55.3 0.57 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.851 . . . . 0.0 109.883 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.582 ' HB3' ' HA ' ' A' ' 156' ' ' ALA . 43.6 Cg_endo -72.66 -67.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.092 1.575 . . . . 0.0 110.565 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.415 ' CB ' ' O ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER 64.23 -153.97 0.3 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.908 . . . . 0.0 110.228 179.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.467 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -86.92 90.37 8.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.21 -0.931 . . . . 0.0 110.553 -179.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.598 HG23 ' HA ' ' A' ' 194' ' ' GLU . 0.1 OUTLIER -92.46 -169.44 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.226 -0.921 . . . . 0.0 109.909 179.542 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.716 ' HD3' HG12 ' A' ' 166' ' ' VAL . 0.3 OUTLIER -167.07 137.96 3.13 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.712 -1.243 . . . . 0.0 110.286 -179.578 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 1.018 HG23 HG22 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -85.37 133.46 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.318 -0.864 . . . . 0.0 110.284 -179.59 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.716 HG12 ' HD3' ' A' ' 164' ' ' ARG . 15.5 m -119.92 -23.09 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.235 -0.916 . . . . 0.0 110.7 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -148.97 125.6 11.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.032 -1.043 . . . . 0.0 110.531 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 221' ' ' ILE . 5.1 tt -108.62 6.78 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.348 -0.845 . . . . 0.0 110.03 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 168' ' ' ILE . 3.0 t-20 -43.35 98.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.348 -0.845 . . . . 0.0 110.347 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.502 ' CG ' ' HB2' ' A' ' 172' ' ' PHE . 1.0 OUTLIER -157.9 116.06 3.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -0.929 . . . . 0.0 110.185 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 172' ' ' PHE . 1.6 pp -83.26 10.33 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.341 -0.85 . . . . 0.0 110.196 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.502 ' HB2' ' CG ' ' A' ' 170' ' ' GLU . 0.1 OUTLIER -60.09 -148.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.285 -0.885 . . . . 0.0 110.147 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.461 ' OE1' HD21 ' A' ' 217' ' ' LEU . 11.7 tt0 53.86 174.37 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 110.07 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 173' ' ' GLN . 1.6 p 175.44 -26.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 110.249 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' A' ' 176' ' ' THR . 0.0 OUTLIER -172.58 129.54 0.54 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.908 . . . . 0.0 110.329 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 176' ' ' THR . 1.7 t 177.36 99.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.337 -0.852 . . . . 0.0 110.172 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.55 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.5 OUTLIER -75.8 -28.25 58.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.291 -0.88 . . . . 0.0 110.307 -179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -17.51 64.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.105 -0.997 . . . . 0.0 109.972 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 1.052 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -90.28 -39.39 12.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 110.683 -179.827 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.55 ' OG1' ' O ' ' A' ' 177' ' ' ASP . 0.2 OUTLIER -41.19 -26.09 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.13 -0.981 . . . . 0.0 110.05 -179.568 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.5 ' NE2' ' OE2' ' A' ' 212' ' ' GLU . 0.6 OUTLIER -53.4 -45.09 69.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.183 -0.948 . . . . 0.0 109.515 179.303 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 1.052 HD12 ' O ' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -69.84 -34.76 74.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.403 -0.811 . . . . 0.0 108.973 179.083 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.672 ' O ' HD13 ' A' ' 183' ' ' LEU . 0.2 OUTLIER -66.05 -33.73 76.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.592 -0.692 . . . . 0.0 109.786 179.609 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -57.87 -16.16 10.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.409 -0.807 . . . . 0.0 109.87 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -92.83 12.61 23.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.438 -0.789 . . . . 0.0 110.252 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 185' ' ' ALA . 22.0 t70 43.8 85.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.732 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.2 tt -135.56 177.1 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 110.824 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.606 ' C ' HG13 ' A' ' 189' ' ' VAL . 4.2 ttp180 -174.64 114.41 0.17 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.719 ' CG2' ' O ' ' A' ' 189' ' ' VAL . 1.1 m 46.66 98.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.174 -0.954 . . . . 0.0 108.546 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.684 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -40.44 -18.19 0.01 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.627 ' N ' ' O ' ' A' ' 189' ' ' VAL . 5.7 t 64.65 -141.95 0.25 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.037 -1.272 . . . . 0.0 109.213 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.604 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 4.9 pm0 -61.57 99.69 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.507 -0.746 . . . . 0.0 109.3 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.661 HG21 HD21 ' A' ' 204' ' ' LEU . 13.1 m -155.07 -139.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.083 -1.01 . . . . 0.0 109.98 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.622 ' N ' HG23 ' A' ' 193' ' ' VAL . 3.4 pt-20 -173.26 158.69 3.65 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.3 -0.875 . . . . 0.0 110.564 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 1.023 HD12 ' HB2' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -131.09 162.97 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.28 -0.888 . . . . 0.0 110.275 -179.719 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 195' ' ' ILE . 77.7 t -157.28 100.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.249 -0.907 . . . . 0.0 110.12 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.524 ' CB ' ' OG1' ' A' ' 157' ' ' THR . 16.1 t0 -42.91 109.64 0.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.903 . . . . 0.0 110.258 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.521 ' CB ' ' O ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -97.11 81.17 3.02 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.307 -0.871 . . . . 0.0 110.129 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 49.3 57.73 6.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 110.101 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 89.26 -25.96 9.66 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.521 ' O ' ' CB ' ' A' ' 198' ' ' ARG . 2.7 t60 -98.72 95.0 6.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -1.143 . . . . 0.0 110.163 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.873 HD13 HG22 ' A' ' 153' ' ' ILE . 83.8 mt -64.56 115.85 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.341 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 195' ' ' ILE . 28.8 m -94.48 147.19 23.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.151 -0.968 . . . . 0.0 110.065 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.968 ' HB2' HD12 ' A' ' 213' ' ' LEU . 1.2 tt -119.71 129.34 54.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.227 -0.92 . . . . 0.0 110.128 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.561 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.0 OUTLIER -120.02 122.84 42.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.296 -0.877 . . . . 0.0 110.015 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.95 ' CD2' HD22 ' A' ' 204' ' ' LEU . 0.1 OUTLIER -106.91 154.5 20.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.534 -0.729 . . . . 0.0 109.89 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -50.66 -19.83 1.04 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.947 . . . . 0.0 109.955 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.457 ' O ' ' HD3' ' A' ' 209' ' ' LYS . . . -87.38 -32.76 12.88 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' A' ' 208' ' ' GLY . 0.0 OUTLIER 176.77 -152.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.159 -1.2 . . . . 0.0 110.29 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 204' ' ' LEU . 36.7 t70 -137.73 156.29 48.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.324 -0.86 . . . . 0.0 110.174 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.511 HG22 ' N ' ' A' ' 212' ' ' GLU . 7.6 p -149.92 173.39 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.218 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.511 ' N ' HG22 ' A' ' 211' ' ' VAL . 13.2 pt-20 -91.33 162.32 14.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 110.337 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.968 HD12 ' HB2' ' A' ' 204' ' ' LEU . 0.3 OUTLIER -147.88 153.21 38.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 110.177 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.726 HD12 ' HB3' ' A' ' 216' ' ' ASP . 0.4 OUTLIER -120.08 129.52 54.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.263 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.527 ' HA ' ' HB3' ' A' ' 218' ' ' ALA . 1.5 m-20 -43.31 -29.33 0.4 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 110.195 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.726 ' HB3' HD12 ' A' ' 214' ' ' LEU . 5.9 t0 -56.06 -59.17 5.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 110.119 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.62 ' CD2' ' CD1' ' A' ' 179' ' ' PHE . 1.0 OUTLIER -90.12 -24.68 21.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 110.314 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.884 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -52.19 -42.47 63.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.194 -0.941 . . . . 0.0 110.158 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.565 ' CG ' ' O ' ' A' ' 219' ' ' HIS . 69.2 t60 -84.03 58.84 4.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.893 . . . . 0.0 110.194 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 217' ' ' LEU . 30.6 p -145.02 -31.63 0.41 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 110.621 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.798 HG13 HD13 ' A' ' 165' ' ' ILE . 0.1 OUTLIER -90.97 141.05 14.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.175 -0.953 . . . . 0.0 110.456 -179.799 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.485 ' HG2' ' HA3' ' A' ' 149' ' ' GLY . 0.0 OUTLIER -92.6 111.33 22.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.379 -0.826 . . . . 0.0 109.793 179.778 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 1.018 HG22 HG23 ' A' ' 165' ' ' ILE . 0.1 OUTLIER -121.23 166.22 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.167 -0.958 . . . . 0.0 110.108 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.554 ' C ' HG12 ' A' ' 163' ' ' VAL . 1.2 tt0 -137.08 161.38 36.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.121 -0.987 . . . . 0.0 110.553 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 22.1 mm-40 -72.26 137.18 46.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.422 -0.799 . . . . 0.0 110.222 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.213 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 N--CA 1.483 0.89 0 N-CA-C 110.31 -0.688 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.711 HG23 ' O ' ' A' ' 132' ' ' ILE . 16.9 tt -163.51 107.34 0.97 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.29 -0.881 . . . . 0.0 110.124 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.44 -26.62 16.82 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.009 1.531 . . . . 0.0 110.423 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.28 58.1 1.53 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.45 -76.71 0.55 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -1.153 . . . . 0.0 110.271 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.48 ' OD2' HD12 ' A' ' 138' ' ' LEU . 40.0 p-10 -87.06 33.98 0.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.347 -0.846 . . . . 0.0 110.323 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 136' ' ' ASP . 0.0 OUTLIER 42.87 54.03 4.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.912 . . . . 0.0 110.131 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.65 HD23 ' O ' ' A' ' 138' ' ' LEU . 1.6 tt . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 0.0 110.237 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 N--CA 1.484 0.964 0 N-CA-C 110.441 -0.638 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -170.91 167.79 40.94 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.743 ' O ' HD13 ' A' ' 223' ' ' ILE . 8.1 m -144.72 100.59 3.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -1.158 . . . . 0.0 109.978 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.721 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -37.09 150.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.873 . . . . 0.0 110.555 -179.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 1.064 HG23 HG23 ' A' ' 153' ' ' ILE . 17.7 m -54.88 -150.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.229 -0.919 . . . . 0.0 110.379 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 1.134 ' CG2' ' HB1' ' A' ' 218' ' ' ALA . 11.2 pt 40.22 27.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.23 -0.919 . . . . 0.0 110.042 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -144.0 -37.32 0.33 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.522 -0.736 . . . . 0.0 109.383 179.639 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.524 ' HB3' HG11 ' A' ' 163' ' ' VAL . . . -98.27 -9.67 25.16 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.541 -0.724 . . . . 0.0 109.741 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.414 ' O ' ' HB ' ' A' ' 157' ' ' THR . . . -74.05 175.37 7.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.328 -0.857 . . . . 0.0 110.201 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.617 HG22 ' HB2' ' A' ' 161' ' ' ARG . 5.7 t -177.09 178.41 1.13 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.258 -0.901 . . . . 0.0 110.127 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 157' ' ' THR . 21.1 t -42.83 -61.1 1.35 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.901 . . . . 0.0 110.131 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . 0.547 ' HG2' HG23 ' A' ' 157' ' ' THR . 0.0 OUTLIER -71.01 165.01 51.69 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.898 . . . . 0.0 110.034 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.49 ' HB2' ' OE2' ' A' ' 194' ' ' GLU . 45.7 Cg_endo -72.6 66.99 3.78 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.944 1.497 . . . . 0.0 110.353 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.617 ' HB2' HG22 ' A' ' 157' ' ' THR . 0.0 OUTLIER -47.86 125.64 9.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.254 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.48 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 1.2 tttp -77.3 100.37 5.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -0.909 . . . . 0.0 110.274 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.958 HG12 ' O ' ' A' ' 224' ' ' GLU . 0.1 OUTLIER -117.41 -164.01 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 0.0 110.301 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.69 ' O ' ' HB ' ' A' ' 223' ' ' ILE . 23.7 ttt180 -172.33 157.82 4.22 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.911 -1.118 . . . . 0.0 110.265 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.946 HG23 HG22 ' A' ' 223' ' ' ILE . 0.8 OUTLIER -110.49 151.36 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.651 -179.359 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.0 m -133.04 -5.05 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.299 -0.876 . . . . 0.0 110.775 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -174.06 131.13 0.4 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.914 -1.116 . . . . 0.0 110.96 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.881 ' CD1' HG22 ' A' ' 221' ' ' ILE . 9.0 tt -126.23 10.03 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.451 -0.781 . . . . 0.0 109.598 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.459 ' O ' ' HB3' ' A' ' 170' ' ' GLU . 1.5 t-20 -56.09 83.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.373 -0.829 . . . . 0.0 110.356 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.519 ' O ' ' C ' ' A' ' 171' ' ' ILE . 0.7 OUTLIER -179.98 -173.76 0.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.363 -0.836 . . . . 0.0 109.934 179.84 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.554 HG22 ' O ' ' A' ' 171' ' ' ILE . 2.1 mm 33.15 36.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.409 -0.807 . . . . 0.0 110.408 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' A' ' 170' ' ' GLU . 0.2 OUTLIER -67.09 -38.9 86.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.914 . . . . 0.0 110.41 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.712 ' C ' HG23 ' A' ' 174' ' ' VAL . 0.0 OUTLIER -78.76 -156.62 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.878 . . . . 0.0 110.353 -179.741 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.712 HG23 ' C ' ' A' ' 173' ' ' GLN . 2.9 t 76.58 -29.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.601 -0.687 . . . . 0.0 110.876 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.481 ' O ' ' O ' ' A' ' 174' ' ' VAL . 46.2 tt0 55.19 161.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.041 -1.037 . . . . 0.0 110.278 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.587 ' CG2' ' HB3' ' A' ' 179' ' ' PHE . 1.9 m -166.37 113.43 0.86 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.193 -0.942 . . . . 0.0 110.257 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.541 ' O ' ' OG1' ' A' ' 180' ' ' THR . 12.3 m-20 -76.86 -30.39 56.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.124 -0.985 . . . . 0.0 110.443 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.81 -17.53 55.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.097 -1.002 . . . . 0.0 110.449 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 1.035 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -90.29 -15.23 31.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.14 -0.975 . . . . 0.0 110.392 -179.667 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.541 ' OG1' ' O ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -61.73 -20.63 63.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.002 -1.061 . . . . 0.0 109.891 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -71.41 -63.05 1.19 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.857 . . . . 0.0 109.899 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.696 HD21 ' HA ' ' A' ' 179' ' ' PHE . 0.7 OUTLIER -61.71 -14.31 30.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.659 179.643 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 1.035 HD13 ' CZ ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -83.13 -29.94 28.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.868 . . . . 0.0 109.878 179.653 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.97 -12.06 34.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 110.018 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.816 ' HB3' HG22 ' A' ' 187' ' ' ILE . . . -85.88 19.09 2.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 0.0 110.199 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 185' ' ' ALA . 0.2 OUTLIER 41.69 29.6 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.0 109.516 -179.61 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.816 HG22 ' HB3' ' A' ' 185' ' ' ALA . 1.5 tt -116.4 149.33 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.505 -0.747 . . . . 0.0 110.409 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.757 ' O ' ' O ' ' A' ' 189' ' ' VAL . 0.0 OUTLIER 164.91 108.91 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.757 ' O ' ' O ' ' A' ' 188' ' ' ARG . 6.1 p 38.45 175.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 121.589 0.709 . . . . 0.0 110.93 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.662 ' N ' HG22 ' A' ' 189' ' ' VAL . . . 107.41 -7.06 36.66 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.3 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.586 ' O ' ' HG3' ' A' ' 164' ' ' ARG . 0.5 OUTLIER -159.62 -177.35 6.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.859 -1.377 . . . . 0.0 111.74 -179.515 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.625 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 38.8 tt0 -67.39 137.87 56.28 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.753 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.709 HG11 ' CD2' ' A' ' 206' ' ' HIS . 2.0 m -161.16 134.62 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.291 -0.881 . . . . 0.0 109.467 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.641 ' HA ' HG23 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -102.68 156.84 17.36 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.309 179.51 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.677 HG12 HD23 ' A' ' 204' ' ' LEU . 1.2 mt -118.74 153.1 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.936 -1.102 . . . . 0.0 110.683 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 196' ' ' VAL . 55.8 t -132.16 91.47 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.513 -0.742 . . . . 0.0 110.31 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.476 ' HA ' HG12 ' A' ' 202' ' ' ILE . 33.3 m-20 -43.45 137.07 2.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.22 -0.925 . . . . 0.0 110.125 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.481 ' HB2' ' HB3' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -128.25 71.87 1.4 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.261 -0.899 . . . . 0.0 110.265 -180.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 198' ' ' ARG . 0.3 OUTLIER 42.07 75.05 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.251 -0.905 . . . . 0.0 110.223 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 87.92 -36.81 3.32 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -90.55 165.58 13.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.178 -1.19 . . . . 0.0 110.17 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.758 HD12 HG22 ' A' ' 153' ' ' ILE . 9.1 mt -153.77 149.61 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.205 -0.935 . . . . 0.0 110.395 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.821 HG23 ' O ' ' A' ' 211' ' ' VAL . 85.8 m -146.2 159.44 43.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.398 -0.813 . . . . 0.0 109.541 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.958 HD11 ' CD1' ' A' ' 213' ' ' LEU . 0.7 OUTLIER -119.37 157.33 28.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.934 . . . . 0.0 110.602 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.577 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 0.1 OUTLIER -124.54 95.07 4.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.528 -0.732 . . . . 0.0 109.429 179.429 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.709 ' CD2' HG11 ' A' ' 193' ' ' VAL . 40.6 m80 -76.36 74.11 3.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.448 -0.782 . . . . 0.0 110.382 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 206' ' ' HIS . 7.1 t-20 42.54 67.52 0.59 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -0.95 . . . . 0.0 110.278 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 99.17 -38.5 3.07 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.491 ' O ' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -95.71 97.11 9.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.287 -1.125 . . . . 0.0 110.23 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 204' ' ' LEU . 0.5 OUTLIER -102.07 153.62 19.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 110.295 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.821 ' O ' HG23 ' A' ' 203' ' ' THR . 1.0 OUTLIER -143.52 149.98 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.309 -0.869 . . . . 0.0 109.881 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -58.44 -174.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 110.199 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.958 ' CD1' HD11 ' A' ' 204' ' ' LEU . 0.3 OUTLIER -174.47 -28.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.253 -0.905 . . . . 0.0 110.271 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 1.061 ' O ' ' HB2' ' A' ' 218' ' ' ALA . 0.5 OUTLIER 33.04 -151.05 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.477 -0.764 . . . . 0.0 110.728 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 3.1 m-20 -90.49 -61.28 1.71 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.362 -0.836 . . . . 0.0 110.497 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.561 ' HB2' HD11 ' A' ' 214' ' ' LEU . 0.1 OUTLIER -41.48 -52.65 3.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 110.505 -179.686 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.823 ' HB3' HD23 ' A' ' 213' ' ' LEU . 0.5 OUTLIER -79.36 -27.76 41.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.18 -0.95 . . . . 0.0 110.261 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 1.134 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -43.36 -77.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 110.498 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.545 ' HB2' HD13 ' A' ' 153' ' ' ILE . 47.4 t-80 -65.88 89.7 0.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.347 -0.846 . . . . 0.0 110.386 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . 0.453 ' O ' ' OE2' ' A' ' 170' ' ' GLU . 8.1 m -161.23 -63.85 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.825 . . . . 0.0 110.096 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.881 HG22 ' CD1' ' A' ' 168' ' ' ILE . 0.2 OUTLIER -76.18 139.66 18.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.513 -0.742 . . . . 0.0 110.781 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.514 ' HA ' ' HA ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -90.03 106.55 18.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.385 -0.822 . . . . 0.0 109.29 179.202 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.946 HG22 HG23 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -121.48 173.35 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.135 -0.978 . . . . 0.0 110.698 -178.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.958 ' O ' HG12 ' A' ' 163' ' ' VAL . 3.5 mt-10 -150.28 -170.25 3.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.355 -0.841 . . . . 0.0 110.165 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 10.0 tm-20 -104.98 112.27 25.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.261 -0.899 . . . . 0.0 110.18 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 19.9 tp . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.209 179.961 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 132' ' ' ILE . 45.3 Cg_endo . . . . . 0 N--CA 1.483 0.896 0 N-CA-C 110.529 -0.604 . . . . 0.0 110.529 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' A' ' 131' ' ' PRO . 14.7 mt 41.31 94.64 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.337 -0.852 . . . . 0.0 110.388 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.61 -21.88 21.57 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.074 1.565 . . . . 0.0 110.466 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 135.47 -103.22 0.45 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 135' ' ' LEU . 1.8 mm? 49.02 -163.52 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -1.136 . . . . 0.0 110.29 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -118.67 76.5 1.1 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 110.236 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.422 ' OE2' HG23 ' A' ' 132' ' ' ILE . 2.8 pt-20 -126.49 90.03 3.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.919 . . . . 0.0 110.199 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mt . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.2 -0.938 . . . . 0.0 110.165 179.998 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 149' ' ' GLY . 46.2 Cg_endo . . . . . 0 N--CA 1.483 0.896 0 N-CA-C 110.608 -0.574 . . . . 0.0 110.608 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 148' ' ' PRO . . . 58.57 149.26 0.01 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.572 ' N ' ' O ' ' A' ' 223' ' ' ILE . 58.6 m -97.97 140.0 32.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.252 -1.146 . . . . 0.0 109.95 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 0.7 OUTLIER -76.53 131.57 39.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.902 -1.123 . . . . 0.0 110.058 179.84 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 1.026 ' CG2' HG21 ' A' ' 223' ' ' ILE . 32.8 t -40.87 161.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.271 -0.893 . . . . 0.0 109.974 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.97 HD11 ' CG ' ' A' ' 219' ' ' HIS . 0.1 OUTLIER 75.01 -15.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.583 -0.698 . . . . 0.0 110.292 -179.025 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 151' ' ' ARG . 0.3 OUTLIER -103.44 -15.0 16.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.104 -0.998 . . . . 0.0 109.265 179.24 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -111.99 -11.98 13.79 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.522 -0.736 . . . . 0.0 109.879 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.776 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -76.27 128.51 35.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 110.259 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.492 HG21 ' NH1' ' A' ' 161' ' ' ARG . 0.2 OUTLIER -102.32 176.81 5.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.15 -0.969 . . . . 0.0 110.259 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.54 -59.82 2.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.925 . . . . 0.0 110.21 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -75.11 166.3 46.62 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.898 . . . . 0.0 110.193 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 161' ' ' ARG . 45.8 Cg_endo -72.78 78.6 2.07 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.055 1.555 . . . . 0.0 110.437 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.492 ' NH1' HG21 ' A' ' 157' ' ' THR . 0.4 OUTLIER -60.35 -141.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 110.202 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.86 87.45 1.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.21 -0.931 . . . . 0.0 110.322 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.623 ' O ' ' O ' ' A' ' 193' ' ' VAL . 12.3 m -112.7 -162.43 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.311 -0.868 . . . . 0.0 110.221 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.861 HH11 HG12 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -169.79 151.81 4.32 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.808 -1.183 . . . . 0.0 110.985 -179.315 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 1.099 HG23 ' CG2' ' A' ' 223' ' ' ILE . 2.1 mt -100.65 154.0 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.361 -0.837 . . . . 0.0 109.97 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.861 HG12 HH11 ' A' ' 164' ' ' ARG . 31.4 m -133.91 -30.1 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.048 -1.033 . . . . 0.0 111.12 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' A' ' 222' ' ' ARG . 2.0 mt-30 -149.45 128.91 13.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.09 -1.006 . . . . 0.0 110.704 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.69 HG23 HG22 ' A' ' 221' ' ' ILE . 10.5 mt -83.36 -10.05 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.384 -0.822 . . . . 0.0 109.686 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.563 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 1.6 t30 70.36 2.38 4.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.375 -0.828 . . . . 0.0 110.342 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 44.09 62.53 1.94 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 110.394 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.563 ' CG1' ' HB3' ' A' ' 169' ' ' ASN . 13.9 mm -102.15 17.9 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 0.0 110.075 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.435 ' C ' ' O ' ' A' ' 171' ' ' ILE . 56.7 t80 -41.76 113.31 0.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.345 -0.847 . . . . 0.0 110.29 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -141.82 -32.58 0.52 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.312 -0.867 . . . . 0.0 110.378 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.457 ' O ' ' C ' ' A' ' 175' ' ' GLU . 48.7 t -127.6 75.73 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 110.101 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 174' ' ' VAL . 43.3 tt0 -39.3 157.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.429 -0.795 . . . . 0.0 110.429 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.637 ' OG1' ' CD1' ' A' ' 179' ' ' PHE . 1.0 OUTLIER -136.36 135.91 39.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.313 -0.867 . . . . 0.0 110.145 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.591 ' O ' ' OG1' ' A' ' 180' ' ' THR . 11.5 t70 -72.13 -45.91 58.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.234 -0.917 . . . . 0.0 110.871 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -21.38 63.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.056 -1.027 . . . . 0.0 110.42 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.669 ' HB2' HD11 ' A' ' 214' ' ' LEU . 0.0 OUTLIER -90.78 -31.42 16.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 110.667 -179.782 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.599 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.5 OUTLIER -43.88 -25.97 0.23 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.953 -1.092 . . . . 0.0 109.683 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 179' ' ' PHE . 35.5 tt0 -61.62 -35.04 76.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.85 . . . . 0.0 109.578 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.578 HD21 ' O ' ' A' ' 212' ' ' GLU . 0.8 OUTLIER -72.12 -39.85 68.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.398 -0.813 . . . . 0.0 109.546 179.454 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.61 -33.7 75.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.517 -0.739 . . . . 0.0 109.928 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -63.19 -14.75 52.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 0.0 109.735 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -86.89 16.66 4.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.375 -0.828 . . . . 0.0 110.034 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 186' ' ' ASP . 5.8 m-20 42.26 48.64 4.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 109.368 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.3 tt -128.96 169.56 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.517 -0.739 . . . . 0.0 110.554 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.483 ' O ' ' C ' ' A' ' 189' ' ' VAL . 0.0 OUTLIER -150.87 -133.29 0.05 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.365 -0.835 . . . . 0.0 108.784 179.506 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 189' ' ' VAL . 4.3 m -42.47 120.37 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 120.965 -1.084 . . . . 0.0 109.076 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.84 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -50.31 -7.7 0.14 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.607 ' O ' ' HB2' ' A' ' 164' ' ' ARG . 28.3 t 58.77 -150.53 0.44 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.163 -1.198 . . . . 0.0 109.675 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.682 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 95.5 mt-10 -64.35 101.86 0.47 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.693 -0.63 . . . . 0.0 109.826 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.623 ' O ' ' O ' ' A' ' 163' ' ' VAL . 30.8 m -158.16 -135.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.913 . . . . 0.0 109.742 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.537 ' N ' HG23 ' A' ' 193' ' ' VAL . 0.0 OUTLIER -169.05 158.74 8.73 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.293 -0.879 . . . . 0.0 110.117 179.407 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.776 HD12 ' HB2' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -120.04 156.81 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 0.0 110.088 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.449 ' N ' ' O ' ' A' ' 203' ' ' THR . 11.4 t -125.24 92.38 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 110.165 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.498 ' HA ' HG12 ' A' ' 202' ' ' ILE . 8.5 t0 -41.73 134.1 2.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.292 -0.88 . . . . 0.0 110.205 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.523 ' CB ' ' O ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -132.92 154.98 49.89 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.233 -0.917 . . . . 0.0 110.137 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -59.26 90.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.237 -0.914 . . . . 0.0 110.362 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 89.88 1.56 76.49 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.523 ' O ' ' CB ' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -150.14 170.79 18.1 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -1.182 . . . . 0.0 110.326 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.498 HG12 ' HA ' ' A' ' 197' ' ' ASP . 7.5 mt -146.62 99.96 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.0 110.202 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 196' ' ' VAL . 55.1 m -72.61 150.78 42.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -0.909 . . . . 0.0 110.004 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.718 ' HG ' HG23 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -119.9 137.9 53.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.129 -0.982 . . . . 0.0 110.288 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.56 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.6 OUTLIER -119.66 124.05 45.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.36 -0.837 . . . . 0.0 109.964 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.519 ' HA ' ' CB ' ' A' ' 193' ' ' VAL . 3.0 m80 -110.09 -171.95 1.94 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.458 -0.776 . . . . 0.0 110.188 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -56.68 98.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 110.244 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 61.09 26.11 65.32 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 206' ' ' HIS . 2.5 mtpt -143.16 158.97 43.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -1.156 . . . . 0.0 110.286 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -156.6 139.27 15.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.917 . . . . 0.0 110.153 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 212' ' ' GLU . 4.2 p -134.27 172.63 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.318 -0.863 . . . . 0.0 110.205 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.578 ' O ' HD21 ' A' ' 182' ' ' LEU . 1.5 tt0 -110.87 103.46 11.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.255 -0.903 . . . . 0.0 110.234 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.404 ' HA ' HD12 ' A' ' 213' ' ' LEU . 13.2 tp -95.22 171.69 8.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 110.087 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.956 ' O ' ' HB2' ' A' ' 218' ' ' ALA . 5.6 mt -91.12 166.17 13.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 110.141 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.466 ' HB2' ' HA ' ' A' ' 201' ' ' HIS . 6.0 t0 -89.9 -75.0 0.46 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 110.094 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.19 -22.34 60.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.929 . . . . 0.0 110.092 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.519 ' HB3' ' HB2' ' A' ' 214' ' ' LEU . 0.2 OUTLIER -90.04 -24.94 21.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.897 . . . . 0.0 110.272 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.956 ' HB2' ' O ' ' A' ' 214' ' ' LEU . . . -62.79 -33.03 74.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.204 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.97 ' CG ' HD11 ' A' ' 153' ' ' ILE . 0.3 OUTLIER -64.18 84.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 110.183 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 3.3 m -165.2 -46.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 110.577 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.871 HD11 ' HB ' ' A' ' 152' ' ' VAL . 0.3 OUTLIER -74.36 144.81 11.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.259 -0.9 . . . . 0.0 110.841 -179.566 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.535 ' O ' HG22 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -89.31 107.36 19.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.42 -0.8 . . . . 0.0 109.19 179.352 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 1.099 ' CG2' HG23 ' A' ' 165' ' ' ILE . 0.6 OUTLIER -119.87 163.98 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.316 -0.865 . . . . 0.0 110.84 -178.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.458 ' HG2' ' HA2' ' A' ' 149' ' ' GLY . 27.1 mt-10 -139.43 -177.77 5.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 0.0 110.27 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.586 ' HG3' HG12 ' A' ' 163' ' ' VAL . 3.6 mt-10 -95.02 70.18 3.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.878 . . . . 0.0 110.339 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 23.3 mt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.284 179.982 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo . . . . . 0 N--CA 1.483 0.903 0 N-CA-C 110.443 -0.637 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.439 ' HB ' ' HD2' ' A' ' 133' ' ' PRO . 10.0 pt -73.56 163.42 68.54 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 110.189 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 132' ' ' ILE . 46.2 Cg_endo -73.24 -17.01 24.75 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.973 1.512 . . . . 0.0 110.425 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 135' ' ' LEU . . . 107.46 -135.89 13.07 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.453 ' CB ' ' O ' ' A' ' 134' ' ' GLY . 0.3 OUTLIER 66.22 29.8 9.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -1.114 . . . . 0.0 110.259 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -151.96 87.99 1.37 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 110.298 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -71.83 61.68 0.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.935 . . . . 0.0 110.137 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.252 -0.905 . . . . 0.0 110.254 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.471 ' HA ' ' HG2' ' A' ' 222' ' ' ARG . 46.9 Cg_endo . . . . . 0 N--CA 1.483 0.857 0 N-CA-C 110.548 -0.597 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 148' ' ' PRO . . . 43.69 -111.46 0.43 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.466 ' O ' HG22 ' A' ' 150' ' ' THR . 87.0 m -131.47 0.49 4.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -1.147 . . . . 0.0 110.288 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' A' ' 153' ' ' ILE . 1.8 mtm-85 61.03 131.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 110.138 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.842 HG13 ' O ' ' A' ' 152' ' ' VAL . 4.7 p -65.69 55.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.264 -0.897 . . . . 0.0 110.683 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 1.103 ' CG2' ' HB1' ' A' ' 218' ' ' ALA . 3.1 pt -156.23 -35.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.085 -1.009 . . . . 0.0 110.019 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 150' ' ' THR . 0.2 OUTLIER -69.81 -13.99 62.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 0.0 109.083 179.224 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.75 ' HB3' HD11 ' A' ' 195' ' ' ILE . . . -96.31 1.76 52.23 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.582 -0.699 . . . . 0.0 109.899 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 155' ' ' ALA . . . -57.69 -152.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 110.399 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 159' ' ' MET . 12.6 t -41.02 -34.53 0.43 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.38 -0.825 . . . . 0.0 110.269 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 157' ' ' THR . 10.1 t -43.39 -26.12 0.18 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.917 . . . . 0.0 109.688 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . 0.52 ' HB3' ' HD2' ' A' ' 161' ' ' ARG . 0.1 OUTLIER -160.37 103.84 1.36 Allowed Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.434 -0.791 . . . . 0.0 109.602 179.702 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.23 106.35 1.73 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.938 1.494 . . . . 0.0 110.476 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.52 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 0.0 OUTLIER -171.42 175.27 4.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.358 -0.839 . . . . 0.0 110.28 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.616 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 1.0 OUTLIER -88.98 150.54 22.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.275 -0.891 . . . . 0.0 110.326 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 1.031 HG22 ' HA ' ' A' ' 194' ' ' GLU . 2.8 m -147.34 -155.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.168 -0.957 . . . . 0.0 110.851 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.646 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 4.8 ttt-85 178.71 150.99 0.28 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.026 -1.046 . . . . 0.0 110.107 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 1.04 HG23 HG22 ' A' ' 223' ' ' ILE . 0.0 OUTLIER -93.71 149.39 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.217 -0.927 . . . . 0.0 109.864 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 222' ' ' ARG . 18.2 m -130.8 0.98 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.096 -1.003 . . . . 0.0 110.472 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.483 ' NE2' ' O ' ' A' ' 166' ' ' VAL . 0.9 OUTLIER -167.02 123.37 1.17 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.115 -0.991 . . . . 0.0 110.253 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.457 HD12 HG21 ' A' ' 221' ' ' ILE . 1.3 tt -130.32 9.04 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 0.0 110.138 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 168' ' ' ILE . 15.0 m-20 -41.49 101.37 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -0.887 . . . . 0.0 110.181 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.41 ' O ' ' CD1' ' A' ' 172' ' ' PHE . 2.3 tp10 -146.86 116.32 7.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.207 -0.933 . . . . 0.0 110.329 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.52 ' O ' HD12 ' A' ' 171' ' ' ILE . 1.2 pp -84.25 20.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 110.17 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.454 ' C ' ' O ' ' A' ' 171' ' ' ILE . 55.8 p90 -39.96 145.11 0.16 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 0.0 110.437 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -149.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.915 . . . . 0.0 110.267 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 176' ' ' THR . 37.0 t -119.32 -15.58 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.216 -0.927 . . . . 0.0 110.294 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.32 88.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 0.0 110.128 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.563 ' CG2' ' HB3' ' A' ' 179' ' ' PHE . 0.3 OUTLIER -155.09 -36.83 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 0.0 110.356 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.481 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.4 OUTLIER 53.48 -85.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.414 -0.804 . . . . 0.0 110.465 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 176' ' ' THR . 13.5 tm0? -41.64 -26.74 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.264 -0.898 . . . . 0.0 110.433 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.939 ' CE2' HD23 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -89.14 -44.36 10.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.236 -0.915 . . . . 0.0 110.219 -179.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.519 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -44.37 -24.35 0.17 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.085 -1.009 . . . . 0.0 109.799 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -66.7 -67.68 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.37 -0.831 . . . . 0.0 110.155 179.799 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.802 HD12 ' N ' ' A' ' 183' ' ' LEU . 4.3 pp -60.97 -16.57 44.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.88 . . . . 0.0 109.747 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.939 HD23 ' CE2' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -81.79 -32.71 31.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 109.663 179.549 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.74 -18.62 60.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.432 -0.793 . . . . 0.0 109.851 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -87.16 16.81 4.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.371 -0.831 . . . . 0.0 110.206 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 51.38 68.32 0.81 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.12 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 187' ' ' ILE . 16.2 mm -107.14 88.63 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 110.389 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 190' ' ' GLY . 1.5 ptp180 -100.49 142.39 32.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.364 -0.835 . . . . 0.0 109.636 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 1.0 ' O ' ' N ' ' A' ' 191' ' ' SER . 5.9 m 33.77 34.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 121.288 -0.883 . . . . 0.0 110.628 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.701 ' N ' HD12 ' A' ' 165' ' ' ILE . . . 22.93 21.86 0.0 OUTLIER Glycine 0 N--CA 1.496 2.683 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 1.0 ' N ' ' O ' ' A' ' 189' ' ' VAL . 1.3 t 36.48 -148.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -1.148 . . . . 0.0 109.842 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.646 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 22.3 tt0 -83.46 118.3 23.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.614 -0.679 . . . . 0.0 109.383 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.631 ' CG2' HD21 ' A' ' 204' ' ' LEU . 34.2 m -158.67 -137.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.091 -1.005 . . . . 0.0 110.097 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 1.031 ' HA ' HG22 ' A' ' 163' ' ' VAL . 42.9 tt0 -174.3 158.77 3.0 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.207 -0.933 . . . . 0.0 110.54 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.75 HD11 ' HB3' ' A' ' 155' ' ' ALA . 0.4 OUTLIER -120.84 145.62 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.311 -0.868 . . . . 0.0 109.973 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.482 ' O ' ' O ' ' A' ' 197' ' ' ASP . 6.5 t -135.37 35.76 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.154 -0.966 . . . . 0.0 110.298 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 196' ' ' VAL . 0.4 OUTLIER 54.64 162.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.345 -0.847 . . . . 0.0 110.451 179.8 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.55 ' HB2' ' N ' ' A' ' 203' ' ' THR . 30.0 ttt-85 -143.54 160.04 41.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.219 -0.926 . . . . 0.0 110.172 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 198' ' ' ARG . 0.1 OUTLIER -43.97 103.92 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.403 -179.877 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 61.58 11.83 30.69 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.417 ' C ' ' HB3' ' A' ' 198' ' ' ARG . 1.2 t60 -150.17 -156.19 0.7 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.138 -1.213 . . . . 0.0 110.194 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.861 HD13 HG22 ' A' ' 153' ' ' ILE . 92.5 mt -129.16 134.28 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.208 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.55 ' N ' ' HB2' ' A' ' 198' ' ' ARG . 4.3 m -109.27 148.2 31.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 110.149 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.839 HD22 ' CD2' ' A' ' 206' ' ' HIS . 1.1 tt -119.71 135.2 54.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 110.161 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.525 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.5 OUTLIER -119.86 124.93 47.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.355 -0.84 . . . . 0.0 109.895 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.839 ' CD2' HD22 ' A' ' 204' ' ' LEU . 2.2 m170 -106.06 -162.69 0.88 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.378 -0.826 . . . . 0.0 110.105 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -52.83 90.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 110.175 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 59.93 26.58 63.31 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 54.5 mttt -132.54 169.9 15.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.25 -1.147 . . . . 0.0 110.328 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.569 ' O ' HG23 ' A' ' 211' ' ' VAL . 7.9 t70 -156.02 145.61 21.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.354 -0.842 . . . . 0.0 110.068 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 210' ' ' ASP . 55.5 t -156.22 144.12 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.92 . . . . 0.0 110.252 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.451 ' OE1' ' NE2' ' A' ' 178' ' ' GLN . 6.4 tt0 -56.56 161.56 2.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 110.14 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.673 ' CD1' ' HB2' ' A' ' 218' ' ' ALA . 1.5 tm? -142.57 92.63 2.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 110.216 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.655 HD23 ' H ' ' A' ' 214' ' ' LEU . 1.4 pt? -46.83 174.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.333 -0.854 . . . . 0.0 110.148 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -90.17 -30.91 17.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.353 -0.842 . . . . 0.0 110.27 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.33 -44.89 95.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.939 . . . . 0.0 110.364 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.637 HD13 ' CD2' ' A' ' 179' ' ' PHE . 0.1 OUTLIER -84.24 -18.92 34.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.172 -0.955 . . . . 0.0 110.18 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 1.103 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -67.18 -58.68 4.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 110.412 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.634 ' CD2' ' CD1' ' A' ' 153' ' ' ILE . 13.0 t-80 -85.87 79.32 9.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.189 -0.944 . . . . 0.0 110.471 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . 0.792 HG23 HG23 ' A' ' 221' ' ' ILE . 2.8 t -176.5 -48.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 110.294 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.819 HD11 HG12 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -70.4 142.58 15.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.215 -0.928 . . . . 0.0 110.294 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.793 ' O ' HG22 ' A' ' 166' ' ' VAL . 10.0 mtt180 -89.51 114.7 26.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.237 -0.914 . . . . 0.0 109.497 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 1.04 HG22 HG23 ' A' ' 165' ' ' ILE . 0.7 OUTLIER -120.83 -176.53 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 110.725 -179.224 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 223' ' ' ILE . 46.0 mm-40 -149.57 174.52 12.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.484 -0.76 . . . . 0.0 110.03 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.515 ' HG3' HG12 ' A' ' 163' ' ' VAL . 0.4 OUTLIER -100.01 144.03 29.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 110.176 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.546 HD21 ' HG3' ' A' ' 192' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.221 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo . . . . . 0 N--CA 1.485 0.971 0 N-CA-C 110.531 -0.603 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 63.0 mt -115.28 106.56 50.84 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.187 -0.946 . . . . 0.0 110.253 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.516 ' HB2' HD23 ' A' ' 135' ' ' LEU . 46.7 Cg_endo -73.02 -49.11 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.016 1.535 . . . . 0.0 110.513 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 128.71 1.91 5.86 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 133' ' ' PRO . 1.3 pp -94.22 141.39 28.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -1.13 . . . . 0.0 110.286 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -109.12 27.82 9.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.328 -0.857 . . . . 0.0 110.152 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.63 69.91 0.85 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 0.0 110.179 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.243 -0.911 . . . . 0.0 110.222 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo . . . . . 0 N--CA 1.484 0.934 0 N-CA-C 110.392 -0.657 . . . . 0.0 110.392 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.481 ' HA3' ' HD3' ' A' ' 222' ' ' ARG . . . 164.26 83.92 0.05 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.538 ' O ' ' CG1' ' A' ' 223' ' ' ILE . 30.0 m -97.26 136.48 37.69 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -1.153 . . . . 0.0 110.276 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 154' ' ' ASP . 26.1 mtt-85 -64.87 128.77 37.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.096 -1.002 . . . . 0.0 109.888 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 1.025 HG23 HG21 ' A' ' 223' ' ' ILE . 1.3 t -43.6 -32.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.168 -0.957 . . . . 0.0 110.232 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.735 HG21 ' HB3' ' A' ' 218' ' ' ALA . 1.1 pp -83.55 -13.33 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.209 -0.932 . . . . 0.0 110.451 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 151' ' ' ARG . 0.3 OUTLIER -79.52 -14.71 58.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 109.794 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -116.56 -5.38 11.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.332 -0.855 . . . . 0.0 109.998 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.48 135.2 40.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.299 -0.875 . . . . 0.0 110.296 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 158' ' ' SER . 0.2 OUTLIER -139.67 171.82 13.69 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.204 -0.935 . . . . 0.0 110.192 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 157' ' ' THR . 0.1 OUTLIER -42.9 -60.84 1.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 110.053 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 2.2 mtt -78.54 162.98 63.8 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.179 -0.95 . . . . 0.0 110.068 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.446 ' HB3' HG22 ' A' ' 196' ' ' VAL . 45.8 Cg_endo -73.21 73.29 3.26 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.946 1.498 . . . . 0.0 110.467 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.13 130.8 23.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.326 -0.859 . . . . 0.0 110.197 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.28 103.13 4.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 110.203 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.638 ' O ' ' O ' ' A' ' 193' ' ' VAL . 17.6 m -128.72 -169.12 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.168 -0.957 . . . . 0.0 110.273 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.635 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 9.2 ptt-85 -166.25 147.32 6.52 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.711 -1.243 . . . . 0.0 110.836 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 1.092 HG23 ' CG2' ' A' ' 223' ' ' ILE . 0.8 OUTLIER -90.42 152.23 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.394 -0.816 . . . . 0.0 110.117 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 222' ' ' ARG . 17.9 m -138.59 -29.71 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.208 -0.933 . . . . 0.0 110.762 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.518 ' HB2' ' HB2' ' A' ' 222' ' ' ARG . 35.3 mt-30 -131.87 118.01 19.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.169 -0.957 . . . . 0.0 110.34 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.564 ' HB ' HG12 ' A' ' 189' ' ' VAL . 1.0 OUTLIER -84.44 -4.71 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.336 -0.853 . . . . 0.0 110.134 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.9 m120 51.16 -89.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.231 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 168' ' ' ILE . 77.6 tt0 -173.75 88.62 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 110.207 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.643 ' CG2' HD23 ' A' ' 217' ' ' LEU . 5.8 mt -76.98 2.83 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.278 -0.889 . . . . 0.0 110.21 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -58.54 108.0 0.58 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.244 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -130.45 -172.38 2.79 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.307 -0.871 . . . . 0.0 110.177 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.649 ' O ' HG12 ' A' ' 174' ' ' VAL . 61.2 t -109.59 20.1 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.203 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 177' ' ' ASP . 20.7 mm-40 -114.54 -32.95 5.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 110.21 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.541 ' O ' ' HB3' ' A' ' 179' ' ' PHE . 69.0 p 42.26 -92.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.387 -0.821 . . . . 0.0 110.288 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 176' ' ' THR . 0.7 OUTLIER 72.41 -154.68 0.08 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.262 -0.898 . . . . 0.0 110.172 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 181' ' ' GLN . 4.4 mm-40 -57.7 -23.68 52.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 110.507 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.919 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -47.48 -40.91 19.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.133 -0.98 . . . . 0.0 110.259 -179.851 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.51 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -46.93 -24.88 0.67 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.994 -1.066 . . . . 0.0 109.634 179.662 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 178' ' ' GLN . 11.7 tp60 -63.24 -66.18 0.58 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.43 -0.794 . . . . 0.0 110.42 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.682 ' C ' HD12 ' A' ' 182' ' ' LEU . 4.6 pp -63.91 -12.69 39.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.0 110.11 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.919 HD13 ' CZ ' ' A' ' 179' ' ' PHE . 0.8 OUTLIER -93.14 -30.64 15.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.314 -0.866 . . . . 0.0 109.731 179.631 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 180' ' ' THR . 9.8 t70 -73.41 -7.02 49.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.293 -0.879 . . . . 0.0 109.855 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.48 ' O ' HG12 ' A' ' 187' ' ' ILE . . . -87.58 32.32 0.72 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.323 -0.861 . . . . 0.0 110.175 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 185' ' ' ALA . 7.6 t70 43.41 55.84 4.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.194 -0.941 . . . . 0.0 109.976 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 185' ' ' ALA . 9.3 mm -110.64 163.94 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.873 . . . . 0.0 110.511 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.722 ' C ' HG13 ' A' ' 189' ' ' VAL . 0.1 OUTLIER -166.15 104.54 0.65 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.722 HG13 ' C ' ' A' ' 188' ' ' ARG . 1.5 m 50.86 103.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.763 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -42.69 -16.95 0.03 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 189' ' ' VAL . 6.3 t 64.98 -145.59 0.24 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.191 -1.182 . . . . 0.0 109.13 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.635 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 21.7 tt0 -61.02 100.64 0.12 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.215 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.674 HG21 HD21 ' A' ' 204' ' ' LEU . 17.7 m -156.28 -136.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.165 -0.959 . . . . 0.0 109.77 -179.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.642 ' N ' HG23 ' A' ' 193' ' ' VAL . 11.5 pt-20 -173.19 164.43 4.78 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.35 -0.844 . . . . 0.0 110.007 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 1.022 HG21 HG13 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -122.81 173.32 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.201 -0.937 . . . . 0.0 110.394 -179.764 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.446 HG22 ' HB3' ' A' ' 160' ' ' PRO . 99.4 t -141.49 83.86 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 0.0 110.096 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 196' ' ' VAL . 8.4 t70 -42.46 121.94 2.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.927 . . . . 0.0 110.205 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.402 ' HB3' ' HB3' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -119.02 171.36 8.31 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.178 -0.951 . . . . 0.0 110.307 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -56.0 99.98 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 110.331 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 62.87 22.75 64.84 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.403 ' C ' HG13 ' A' ' 202' ' ' ILE . 0.2 OUTLIER -148.08 158.01 43.83 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.281 -1.129 . . . . 0.0 110.083 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.684 HD13 HG22 ' A' ' 153' ' ' ILE . 57.8 mt -142.33 95.2 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 110.225 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 92.0 m -84.83 157.27 20.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 0.0 109.998 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.83 ' HG ' HG23 ' A' ' 195' ' ' ILE . 0.6 OUTLIER -119.91 141.57 49.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.206 -0.934 . . . . 0.0 110.367 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.608 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.0 OUTLIER -119.58 122.71 42.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.353 -0.842 . . . . 0.0 109.966 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.565 ' HA ' ' HB ' ' A' ' 193' ' ' VAL . 5.3 m170 -98.97 167.86 10.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.45 -0.781 . . . . 0.0 110.309 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -44.07 106.95 0.08 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.338 -0.851 . . . . 0.0 110.24 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 57.57 24.34 52.37 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 206' ' ' HIS . 3.8 mtmt -150.76 175.46 11.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -1.13 . . . . 0.0 110.226 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 211' ' ' VAL . 5.6 t70 -171.18 161.9 6.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.216 -0.928 . . . . 0.0 110.148 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.479 ' N ' ' OD1' ' A' ' 210' ' ' ASP . 10.0 p -151.72 150.66 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.185 -0.947 . . . . 0.0 110.336 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.74 168.47 9.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 0.0 110.08 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 26.3 tp -172.75 149.65 2.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -0.886 . . . . 0.0 110.239 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.888 HD12 ' HB2' ' A' ' 216' ' ' ASP . 0.3 OUTLIER -114.46 124.32 51.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.267 -0.895 . . . . 0.0 110.171 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.581 ' HA ' ' HB3' ' A' ' 218' ' ' ALA . 13.5 p-10 -47.28 -22.65 0.43 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 110.23 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.888 ' HB2' HD12 ' A' ' 214' ' ' LEU . 1.4 m-20 -51.42 -66.3 0.41 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 0.0 110.328 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.643 HD23 ' CG2' ' A' ' 171' ' ' ILE . 0.3 OUTLIER -89.84 -18.02 27.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 110.348 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.735 ' HB3' HG21 ' A' ' 153' ' ' ILE . . . -47.44 -22.78 0.49 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.337 -0.852 . . . . 0.0 110.286 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 216' ' ' ASP . 0.0 OUTLIER -89.16 58.14 4.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 110.409 -179.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . 0.48 HG23 ' ND1' ' A' ' 219' ' ' HIS . 18.0 p -142.83 -41.72 0.32 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -0.918 . . . . 0.0 110.262 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.65 HD13 ' N ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -69.41 137.27 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.39 -0.819 . . . . 0.0 110.305 -179.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.518 ' HB2' ' HB2' ' A' ' 167' ' ' GLN . 30.3 mtt180 -89.99 115.45 27.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.53 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 1.092 ' CG2' HG23 ' A' ' 165' ' ' ILE . 1.0 OUTLIER -129.37 -178.07 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 110.816 -179.125 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.42 -179.65 7.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.349 -0.844 . . . . 0.0 110.208 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.459 ' HG3' HG12 ' A' ' 163' ' ' VAL . 10.6 tt0 -99.7 100.82 11.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.222 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.495 ' O ' ' NH1' ' A' ' 164' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.206 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 20.7 p30 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.794 0.331 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.05 -49.37 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.992 1.522 . . . . 0.0 110.413 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 pt -56.85 156.1 13.6 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 0.0 110.216 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.99 -168.2 0.4 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.059 1.558 . . . . 0.0 110.329 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -119.5 165.94 13.31 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.503 HD23 ' H ' ' A' ' 135' ' ' LEU . 0.6 OUTLIER -79.45 178.49 8.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -1.16 . . . . 0.0 110.231 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -151.86 46.43 0.78 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.329 -0.857 . . . . 0.0 110.25 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -102.91 29.25 5.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -0.905 . . . . 0.0 110.248 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.44 138.1 32.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.459 ' O ' ' HB ' ' A' ' 140' ' ' VAL . . . -124.84 154.92 18.32 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.459 ' HB ' ' O ' ' A' ' 139' ' ' GLY . 41.2 t 55.12 100.92 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -1.125 . . . . 0.0 110.219 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -114.82 -51.41 0.45 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.6 m120 51.33 -169.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.158 -1.201 . . . . 0.0 110.246 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.6 t -120.27 123.79 44.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.0 110.187 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 58.38 -167.74 0.14 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.211 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 45.0 84.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 110.199 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -118.32 -2.57 11.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.283 -0.886 . . . . 0.0 110.132 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -167.73 149.58 5.19 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 110.154 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.1 81.04 1.75 Allowed 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.07 1.563 . . . . 0.0 110.491 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.563 ' CA ' ' HG3' ' A' ' 222' ' ' ARG . . . 154.11 128.52 1.23 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 151' ' ' ARG . 26.1 m -142.29 5.2 1.64 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -1.14 . . . . 0.0 110.431 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 0.0 OUTLIER 58.41 135.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.882 . . . . 0.0 110.319 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.841 HG13 ' O ' ' A' ' 152' ' ' VAL . 4.2 p -65.84 56.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.162 -0.961 . . . . 0.0 110.391 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.891 ' CG2' ' HB1' ' A' ' 218' ' ' ALA . 5.1 pt -158.92 -37.1 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.104 -0.998 . . . . 0.0 110.156 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.494 ' HB3' HG22 ' A' ' 150' ' ' THR . 0.3 OUTLIER -74.64 -16.25 60.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.372 -0.83 . . . . 0.0 109.736 179.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 1.043 ' HB1' HG11 ' A' ' 163' ' ' VAL . . . -88.68 -20.12 25.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.489 -0.757 . . . . 0.0 109.971 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.569 ' HB1' ' H ' ' A' ' 197' ' ' ASP . . . -70.01 124.86 25.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.352 -0.842 . . . . 0.0 110.166 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.576 ' CB ' ' HD2' ' A' ' 161' ' ' ARG . 77.1 m -123.21 171.78 9.09 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.17 -0.956 . . . . 0.0 110.356 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.557 ' N ' HG22 ' A' ' 157' ' ' THR . 36.4 t -38.62 -39.62 0.5 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.344 -0.847 . . . . 0.0 109.603 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . 0.465 ' O ' ' HD3' ' A' ' 161' ' ' ARG . 2.6 ptt? -104.05 146.52 32.7 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 121.496 -0.753 . . . . 0.0 109.566 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.718 ' HB3' HG22 ' A' ' 196' ' ' VAL . 44.1 Cg_endo -71.14 81.04 1.21 Allowed 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.898 1.472 . . . . 0.0 110.577 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.888 HH21 HG13 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -63.37 -135.19 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.175 -0.953 . . . . 0.0 109.902 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.58 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 12.7 tttt -154.65 107.46 2.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.309 -0.869 . . . . 0.0 109.9 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 1.043 HG11 ' HB1' ' A' ' 155' ' ' ALA . 23.3 m -123.74 -150.43 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 110.845 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.666 ' HG2' ' N ' ' A' ' 165' ' ' ILE . 0.7 OUTLIER 179.48 155.41 0.52 Allowed 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.152 -0.967 . . . . 0.0 109.876 -179.201 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 1.019 HG23 HG22 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -97.48 144.89 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.225 -0.922 . . . . 0.0 109.83 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 222' ' ' ARG . 21.6 m -123.32 7.16 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.068 -1.02 . . . . 0.0 110.455 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.423 ' O ' ' N ' ' A' ' 222' ' ' ARG . 2.4 mt-30 -177.04 114.06 0.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.911 . . . . 0.0 110.412 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.997 HG21 ' HG2' ' A' ' 188' ' ' ARG . 0.7 OUTLIER -103.59 20.93 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.35 -0.844 . . . . 0.0 109.945 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' ' 168' ' ' ILE . 1.8 t-20 -44.86 172.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 110.292 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.411 ' OE2' ' HB3' ' A' ' 175' ' ' GLU . 0.4 OUTLIER -166.68 92.04 0.44 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.176 -0.952 . . . . 0.0 110.261 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.3 pp -83.61 13.88 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.197 -0.939 . . . . 0.0 110.311 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.549 ' CD1' ' OE1' ' A' ' 175' ' ' GLU . 1.6 m-85 -62.56 135.54 57.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 110.209 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.463 ' O ' ' HB ' ' A' ' 174' ' ' VAL . 11.1 mm-40 -59.67 -21.08 60.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.184 -0.948 . . . . 0.0 110.225 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 174' ' ' VAL . 4.5 p 179.76 90.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -0.937 . . . . 0.0 110.159 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.549 ' OE1' ' CD1' ' A' ' 172' ' ' PHE . 4.7 tt0 -143.52 105.18 4.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 110.252 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.523 ' O ' ' CB ' ' A' ' 177' ' ' ASP . 0.1 OUTLIER -138.07 -82.93 0.32 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 110.147 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.523 ' CB ' ' O ' ' A' ' 176' ' ' THR . 0.8 OUTLIER 70.96 -159.36 0.13 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.301 -0.875 . . . . 0.0 110.438 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -59.27 -18.9 41.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.354 -0.841 . . . . 0.0 110.583 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.819 ' HA ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -53.29 -36.03 60.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.169 -0.957 . . . . 0.0 110.129 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.48 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.7 OUTLIER -40.63 -27.92 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 0.0 109.892 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 179' ' ' PHE . 19.7 tt0 -63.2 -41.55 99.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.854 . . . . 0.0 109.823 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.819 HD12 ' HA ' ' A' ' 179' ' ' PHE . 1.7 mt -58.25 -46.48 85.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.419 -0.801 . . . . 0.0 109.766 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.62 ' O ' HD13 ' A' ' 183' ' ' LEU . 0.2 OUTLIER -67.34 -32.75 73.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.551 -0.718 . . . . 0.0 110.164 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -83.15 0.62 44.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.389 -0.819 . . . . 0.0 110.278 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.472 ' O ' HG13 ' A' ' 187' ' ' ILE . . . -81.71 8.29 10.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 110.219 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 23.4 t0 59.98 49.9 7.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.254 -0.904 . . . . 0.0 110.152 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.551 ' O ' ' CB ' ' A' ' 188' ' ' ARG . 88.8 mt -138.6 -72.99 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 110.242 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.997 ' HG2' HG21 ' A' ' 168' ' ' ILE . 3.4 ttp180 72.46 157.17 0.18 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.435 -0.791 . . . . 0.0 109.839 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.947 ' O ' ' N ' ' A' ' 191' ' ' SER . 3.7 m 33.17 36.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 O-C-N 121.352 -0.842 . . . . 0.0 110.731 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.743 ' N ' HD12 ' A' ' 165' ' ' ILE . . . 27.74 19.26 0.0 OUTLIER Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.947 ' N ' ' O ' ' A' ' 189' ' ' VAL . 30.6 t 38.29 -144.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.233 -1.157 . . . . 0.0 109.801 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.644 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -90.74 113.2 25.25 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.256 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.64 HG13 ' C ' ' A' ' 192' ' ' GLU . 33.6 m -159.27 -137.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.288 -0.882 . . . . 0.0 109.996 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.934 ' HA ' HG22 ' A' ' 163' ' ' VAL . 5.4 pt-20 -170.54 167.37 8.07 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.214 -0.929 . . . . 0.0 110.086 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.687 HG21 HG22 ' A' ' 152' ' ' VAL . 0.4 OUTLIER -124.75 173.68 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.116 -0.99 . . . . 0.0 110.401 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.718 HG22 ' HB3' ' A' ' 160' ' ' PRO . 46.1 t -145.25 85.74 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.318 -0.864 . . . . 0.0 110.055 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.569 ' H ' ' HB1' ' A' ' 156' ' ' ALA . 18.9 p-10 -40.65 133.81 1.93 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.0 110.436 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.443 ' O ' ' C ' ' A' ' 199' ' ' ASP . 12.9 mmt85 -123.66 67.11 1.02 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.268 -0.895 . . . . 0.0 110.184 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 198' ' ' ARG . 2.7 t0 40.72 81.67 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.395 -0.815 . . . . 0.0 110.158 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 88.27 -37.9 3.23 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 198' ' ' ARG . 0.0 OUTLIER -94.62 164.61 12.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.223 -1.163 . . . . 0.0 110.166 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.881 ' CD1' HG22 ' A' ' 153' ' ' ILE . 4.1 mt -145.83 118.29 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.921 . . . . 0.0 110.24 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.1 m -104.85 163.14 12.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 109.961 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 1.001 HD22 ' NE2' ' A' ' 206' ' ' HIS . 0.5 OUTLIER -119.83 138.19 53.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.152 -0.967 . . . . 0.0 110.213 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.565 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.5 OUTLIER -119.72 117.08 27.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.36 -0.837 . . . . 0.0 109.97 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 1.001 ' NE2' HD22 ' A' ' 204' ' ' LEU . 3.9 m170 -105.46 162.13 13.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.384 -0.822 . . . . 0.0 110.14 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -59.63 77.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.312 -0.867 . . . . 0.0 110.473 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 102.86 24.68 7.97 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.56 ' O ' ' CG ' ' A' ' 206' ' ' HIS . 3.1 mtpt -174.06 124.64 0.34 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -1.226 . . . . 0.0 110.462 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.46 150.86 40.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.266 -0.896 . . . . 0.0 110.149 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.76 HG12 ' HB3' ' A' ' 204' ' ' LEU . 8.4 p -137.72 165.48 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.172 -0.955 . . . . 0.0 110.252 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.88 88.99 3.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 110.202 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.816 HD12 ' N ' ' A' ' 214' ' ' LEU . 3.4 pp -76.93 -160.01 0.15 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.21 -0.931 . . . . 0.0 110.216 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.816 ' N ' HD12 ' A' ' 213' ' ' LEU . 0.5 OUTLIER -130.01 132.91 46.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -0.892 . . . . 0.0 110.217 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.453 ' OD2' HG13 ' A' ' 202' ' ' ILE . 0.7 OUTLIER -51.8 -23.58 4.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 110.222 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.86 -54.29 44.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 110.242 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.512 HD22 ' CD2' ' A' ' 179' ' ' PHE . 0.1 OUTLIER -89.6 -19.1 25.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.188 -0.945 . . . . 0.0 110.345 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.891 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -53.33 -18.36 2.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -0.877 . . . . 0.0 110.19 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.587 ' HA ' HD11 ' A' ' 153' ' ' ILE . 14.0 t-80 -103.5 49.99 0.81 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.931 . . . . 0.0 110.136 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 1.3 m -133.74 -61.59 0.8 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.327 -0.858 . . . . 0.0 110.225 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.718 HD11 HG12 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -60.55 145.15 12.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.419 -0.8 . . . . 0.0 110.379 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.709 ' O ' HG22 ' A' ' 166' ' ' VAL . 1.0 OUTLIER -89.82 116.48 27.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 109.611 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 1.019 HG22 HG23 ' A' ' 165' ' ' ILE . 0.5 OUTLIER -124.64 170.07 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.077 -1.015 . . . . 0.0 110.636 -179.419 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.657 ' HG2' HG11 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -150.11 -168.89 3.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.449 -0.782 . . . . 0.0 110.07 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 22.3 mt-10 -90.18 149.17 22.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.176 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.532 ' CD1' ' HB2' ' A' ' 192' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.924 -1.036 . . . . 0.0 110.199 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.619 ' OD1' HG22 ' A' ' 132' ' ' ILE . 14.1 p30 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 120.747 0.308 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.11 62.97 4.18 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.061 1.559 . . . . 0.0 110.472 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.729 HG23 ' O ' ' A' ' 132' ' ' ILE . 7.3 tp -124.05 63.61 31.97 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 110.233 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.08 -164.52 0.2 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.059 1.557 . . . . 0.0 110.444 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -139.4 81.45 0.26 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 47.56 56.32 7.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -1.159 . . . . 0.0 110.249 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -89.62 42.25 1.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.942 . . . . 0.0 110.196 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.19 8.61 6.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.226 -0.921 . . . . 0.0 110.232 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.07 75.49 1.62 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 110.268 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 173.17 -177.9 45.39 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.716 HG13 ' N ' ' A' ' 141' ' ' GLY . 1.4 p -117.96 -156.63 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -1.141 . . . . 0.0 110.095 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.716 ' N ' HG13 ' A' ' 140' ' ' VAL . . . -47.7 -96.25 0.01 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.06 116.31 4.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -1.12 . . . . 0.0 110.235 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.502 ' OG ' ' N ' ' A' ' 144' ' ' ASP . 30.5 t -166.25 -142.3 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.255 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.502 ' N ' ' OG ' ' A' ' 143' ' ' SER . 5.7 m-20 54.16 -163.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 110.217 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.81 114.65 12.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 110.204 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.593 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -126.83 84.09 2.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.228 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . 62.76 158.35 0.12 Allowed Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.259 -0.901 . . . . 0.0 110.093 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.75 65.86 3.92 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.051 1.553 . . . . 0.0 110.368 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 140.19 153.17 5.97 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.576 HG22 ' HB3' ' A' ' 154' ' ' ASP . 3.7 m -131.5 2.46 4.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -1.138 . . . . 0.0 110.265 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.506 ' O ' ' HB2' ' A' ' 154' ' ' ASP . 6.1 mtm-85 61.0 118.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.266 -0.897 . . . . 0.0 110.276 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 1.077 HG13 HG23 ' A' ' 153' ' ' ILE . 5.9 p -42.82 165.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.183 -0.948 . . . . 0.0 110.218 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 1.077 HG23 HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER 72.17 -20.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.759 -0.588 . . . . 0.0 110.282 -179.439 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.576 ' HB3' HG22 ' A' ' 150' ' ' THR . 0.4 OUTLIER -91.4 -18.98 23.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 0.0 108.71 178.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.422 ' O ' ' HG3' ' A' ' 161' ' ' ARG . . . -108.33 -15.04 14.56 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.563 0.697 . . . . 0.0 109.45 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.611 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -67.83 152.12 46.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.437 -0.79 . . . . 0.0 110.157 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -161.94 174.59 12.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 110.227 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 157' ' ' THR . 0.2 OUTLIER -41.97 -48.32 4.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 110.166 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . 0.448 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 4.0 mmm -82.32 166.66 35.39 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 110.201 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 46.5 Cg_endo -73.35 84.06 1.41 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.019 1.536 . . . . 0.0 110.437 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -70.72 111.48 6.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 0.0 110.241 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.597 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 0.2 OUTLIER -71.99 117.26 13.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.896 . . . . 0.0 110.286 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.819 HG12 ' C ' ' A' ' 224' ' ' GLU . 0.0 OUTLIER -133.88 -165.4 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.213 -0.929 . . . . 0.0 110.431 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.566 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 20.1 ttp180 -173.54 147.61 1.46 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.847 -1.158 . . . . 0.0 109.829 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.92 HG23 HG22 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -95.03 143.55 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.162 -0.961 . . . . 0.0 110.181 -179.457 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 222' ' ' ARG . 28.8 m -123.9 -8.21 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 110.175 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -158.66 124.04 4.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 0.0 110.188 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.776 HG21 ' HG2' ' A' ' 188' ' ' ARG . 5.1 tt -117.58 6.65 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.279 -0.888 . . . . 0.0 110.169 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.446 ' O ' ' CB ' ' A' ' 170' ' ' GLU . 27.1 t-20 -41.88 113.35 0.42 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.303 -0.873 . . . . 0.0 110.114 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.604 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 0.1 OUTLIER 172.68 123.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 110.321 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.6 ' O ' HG22 ' A' ' 171' ' ' ILE . 63.2 mt -84.89 17.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 109.91 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.604 ' CE1' ' HB3' ' A' ' 170' ' ' GLU . 0.5 OUTLIER 25.06 -138.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.686 -0.634 . . . . 0.0 110.954 179.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.04 -145.94 0.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 0.0 110.213 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 32.8 m -114.71 6.46 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 110.355 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.71 174.09 7.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 110.245 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' A' ' 177' ' ' ASP . 12.1 p -148.29 -84.48 0.1 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -0.889 . . . . 0.0 110.165 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 176' ' ' THR . 7.0 t0 70.09 -139.16 0.06 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.345 -0.847 . . . . 0.0 110.218 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.496 ' O ' ' HB3' ' A' ' 181' ' ' GLN . 0.0 OUTLIER -64.07 -28.34 69.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.114 -0.991 . . . . 0.0 110.256 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.639 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.3 OUTLIER -50.03 -51.8 39.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 110.076 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -49.97 -21.38 1.18 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.065 -1.022 . . . . 0.0 109.822 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.496 ' HB3' ' O ' ' A' ' 178' ' ' GLN . 20.8 tt0 -69.49 -59.95 2.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.291 -0.881 . . . . 0.0 110.422 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.877 HD12 ' N ' ' A' ' 183' ' ' LEU . 3.9 pp -66.62 -15.64 63.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.831 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.877 ' N ' HD12 ' A' ' 182' ' ' LEU . 0.3 OUTLIER -85.97 -28.81 24.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.36 -0.838 . . . . 0.0 109.668 179.619 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -81.12 6.85 12.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.346 -0.846 . . . . 0.0 109.821 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.755 ' HB3' HG22 ' A' ' 187' ' ' ILE . . . -81.05 12.46 3.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.353 -0.842 . . . . 0.0 110.232 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 185' ' ' ALA . 23.1 t70 43.48 41.15 3.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.156 -0.965 . . . . 0.0 109.326 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.755 HG22 ' HB3' ' A' ' 185' ' ' ALA . 0.4 OUTLIER -117.19 -43.63 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.451 -0.781 . . . . 0.0 110.379 -179.448 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.776 ' HG2' HG21 ' A' ' 168' ' ' ILE . 3.9 ttp-105 53.22 168.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.341 -0.849 . . . . 0.0 109.882 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.956 ' O ' ' N ' ' A' ' 191' ' ' SER . 2.7 m 31.46 37.67 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 121.369 -0.832 . . . . 0.0 110.809 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.741 ' N ' HD12 ' A' ' 165' ' ' ILE . . . 28.41 19.14 0.0 OUTLIER Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.956 ' N ' ' O ' ' A' ' 189' ' ' VAL . 18.1 t 41.52 -153.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.167 -1.196 . . . . 0.0 109.766 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.647 ' C ' HG13 ' A' ' 193' ' ' VAL . 1.8 pt-20 -89.11 115.81 26.91 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.582 -0.699 . . . . 0.0 109.115 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.668 ' O ' ' O ' ' A' ' 163' ' ' VAL . 35.4 m -159.8 -131.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.939 . . . . 0.0 109.942 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.68 ' O ' HD23 ' A' ' 204' ' ' LEU . 8.1 pt-20 -176.8 169.34 2.48 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.241 -0.912 . . . . 0.0 110.387 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 1.035 HD13 HG23 ' A' ' 152' ' ' VAL . 0.5 OUTLIER -125.46 170.78 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.221 -0.924 . . . . 0.0 110.51 -179.552 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.462 ' O ' ' C ' ' A' ' 197' ' ' ASP . 65.7 t -148.13 80.7 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.367 -0.833 . . . . 0.0 109.892 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 197' ' ' ASP . 11.5 p30 -39.39 123.28 1.42 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.394 -0.816 . . . . 0.0 110.448 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.511 ' HB3' ' HB2' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -107.12 78.1 1.2 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.271 -0.893 . . . . 0.0 110.135 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 198' ' ' ARG . 27.7 t0 41.78 79.43 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.295 -0.878 . . . . 0.0 110.212 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 87.68 -37.27 3.25 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 198' ' ' ARG . 45.0 m170 -90.99 168.37 11.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.239 -1.153 . . . . 0.0 110.202 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.559 ' CD1' ' HB ' ' A' ' 153' ' ' ILE . 7.7 mt -141.09 121.6 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.221 -0.924 . . . . 0.0 110.166 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 195' ' ' ILE . 58.0 m -109.12 160.18 16.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.332 -0.855 . . . . 0.0 109.863 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 1.05 HD12 HD22 ' A' ' 213' ' ' LEU . 0.6 OUTLIER -119.74 132.46 55.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.158 -0.964 . . . . 0.0 110.217 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.568 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 1.4 m -119.82 128.12 53.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.878 . . . . 0.0 109.941 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.653 ' HB3' HG12 ' A' ' 193' ' ' VAL . 1.8 m170 -105.48 173.98 6.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.366 -0.834 . . . . 0.0 109.958 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -58.35 96.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 0.0 110.229 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 76.14 29.72 58.23 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.68 165.41 32.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.117 -1.225 . . . . 0.0 110.26 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -161.12 143.37 12.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.224 -0.922 . . . . 0.0 110.177 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.746 HG13 ' N ' ' A' ' 212' ' ' GLU . 1.6 p -142.74 -154.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.176 -0.952 . . . . 0.0 110.228 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.746 ' N ' HG13 ' A' ' 211' ' ' VAL . 1.3 tt0 -115.23 169.49 9.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 110.323 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 1.05 HD22 HD12 ' A' ' 204' ' ' LEU . 11.6 tp -168.27 89.68 0.26 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.355 -0.841 . . . . 0.0 110.149 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.934 HD11 ' HB2' ' A' ' 217' ' ' LEU . 2.5 pt? -41.62 152.78 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 110.292 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -83.01 -22.39 33.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 110.195 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.98 -61.93 2.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.241 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.934 ' HB2' HD11 ' A' ' 214' ' ' LEU . 0.2 OUTLIER -75.63 -14.86 60.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -0.872 . . . . 0.0 110.197 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.799 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -50.29 -51.16 47.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 110.16 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.538 ' HB2' ' CD1' ' A' ' 153' ' ' ILE . 9.6 t60 -74.02 72.98 1.67 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.211 -0.93 . . . . 0.0 110.22 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . 0.413 HG21 ' HD1' ' A' ' 172' ' ' PHE . 31.5 m -156.39 -53.82 0.08 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.154 -0.967 . . . . 0.0 110.425 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.668 HD11 HG12 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -66.07 174.82 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.397 -0.815 . . . . 0.0 110.409 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.446 ' O ' HG22 ' A' ' 166' ' ' VAL . 1.2 mtm180 -122.62 99.67 6.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.417 -0.802 . . . . 0.0 109.734 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.92 HG22 HG23 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -119.36 167.45 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.97 . . . . 0.0 110.173 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.819 ' C ' HG12 ' A' ' 163' ' ' VAL . 15.1 pt-20 -150.3 174.35 12.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.245 -0.909 . . . . 0.0 110.135 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.427 ' OE1' ' OXT' ' A' ' 226' ' ' LEU . 0.7 OUTLIER -43.96 143.04 1.2 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.47 -0.769 . . . . 0.0 110.23 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.427 ' OXT' ' OE1' ' A' ' 225' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.196 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.447 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 24.5 p30 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 120.784 0.326 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 130' ' ' ASN . 46.1 Cg_endo -72.98 -89.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.95 1.5 . . . . 0.0 110.496 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.96 135.56 94.71 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.234 -0.916 . . . . 0.0 110.147 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.09 -90.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.986 1.519 . . . . 0.0 110.444 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 139.53 -116.17 1.19 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.6 mm? 59.11 166.12 0.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -1.143 . . . . 0.0 110.2 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -80.96 86.05 6.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.188 -0.945 . . . . 0.0 110.274 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -142.28 57.25 1.46 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.295 -0.878 . . . . 0.0 110.239 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.38 142.6 32.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 0.0 110.215 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 122.81 -82.25 0.35 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 140' ' ' VAL . 7.1 p -83.72 48.68 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.236 -1.155 . . . . 0.0 110.258 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -157.97 90.43 0.11 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -70.68 78.1 0.6 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -1.174 . . . . 0.0 110.186 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.2 t -164.6 -169.38 1.73 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 110.223 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 144' ' ' ASP . 1.2 p30 -139.7 117.88 11.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.887 . . . . 0.0 110.208 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.647 ' O ' ' HB2' ' A' ' 146' ' ' ALA . . . -78.82 74.49 5.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.203 -0.936 . . . . 0.0 110.167 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 145' ' ' ALA . . . 172.97 -160.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.251 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . 65.71 137.66 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 110.23 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.442 ' HB2' ' OE2' ' A' ' 224' ' ' GLU . 46.8 Cg_endo -72.99 57.59 3.26 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.041 1.548 . . . . 0.0 110.435 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.552 ' HA3' ' HB2' ' A' ' 222' ' ' ARG . . . -133.18 159.16 23.48 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.538 ' O ' ' HB3' ' A' ' 154' ' ' ASP . 0.6 OUTLIER -158.15 17.63 0.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -1.153 . . . . 0.0 110.471 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.634 ' C ' HD12 ' A' ' 223' ' ' ILE . 0.5 OUTLIER 56.11 117.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.146 -0.971 . . . . 0.0 110.375 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 1.031 HG13 HG21 ' A' ' 223' ' ' ILE . 0.0 OUTLIER -41.39 -80.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.193 -0.942 . . . . 0.0 111.247 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 1.108 ' CG2' ' HB1' ' A' ' 218' ' ' ALA . 0.2 OUTLIER -47.44 -18.82 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.429 -0.795 . . . . 0.0 111.631 -178.628 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.616 ' HB2' ' CB ' ' A' ' 151' ' ' ARG . 0.3 OUTLIER -71.9 -13.49 61.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.798 -1.189 . . . . 0.0 109.094 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -125.63 2.08 7.55 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.653 -0.655 . . . . 0.0 109.624 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.74 ' O ' HG22 ' A' ' 157' ' ' THR . . . -81.04 -177.5 6.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.42 -0.8 . . . . 0.0 110.486 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.74 HG22 ' O ' ' A' ' 156' ' ' ALA . 7.2 t 40.11 -168.53 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.548 -0.72 . . . . 0.0 110.55 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.53 ' C ' ' O ' ' A' ' 157' ' ' THR . 25.0 p 34.64 76.58 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.327 -0.858 . . . . 0.0 110.16 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . 0.479 ' N ' ' CD ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER 58.33 54.28 5.73 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.92 . . . . 0.0 109.586 -179.445 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.575 ' HB3' ' N ' ' A' ' 157' ' ' THR . 43.8 Cg_endo -71.2 -159.09 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.091 1.574 . . . . 0.0 110.682 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.514 ' CB ' ' O ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER 168.2 -153.94 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.317 -0.865 . . . . 0.0 110.301 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.533 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 0.1 OUTLIER -90.73 116.7 28.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -0.919 . . . . 0.0 110.539 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.69 HG12 ' O ' ' A' ' 224' ' ' GLU . 0.0 OUTLIER -112.26 -171.44 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.271 -0.893 . . . . 0.0 110.112 179.555 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.7 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -170.61 131.43 0.89 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.888 -1.133 . . . . 0.0 110.056 -179.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.949 HG23 HG22 ' A' ' 223' ' ' ILE . 0.5 OUTLIER -88.97 152.03 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.333 -0.854 . . . . 0.0 110.656 -179.197 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 222' ' ' ARG . 9.2 m -133.61 -1.67 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 110.184 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.573 ' CB ' ' HD2' ' A' ' 222' ' ' ARG . 0.1 OUTLIER -171.59 125.24 0.59 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 110.169 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.85 HD11 HG13 ' A' ' 171' ' ' ILE . 8.5 tt -90.21 -3.12 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.854 . . . . 0.0 110.235 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 168' ' ' ILE . 0.2 OUTLIER 62.71 -141.26 0.4 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 110.243 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.87 109.0 18.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 110.306 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.85 HG13 HD11 ' A' ' 168' ' ' ILE . 41.9 mm -87.84 23.19 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 110.178 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -54.93 86.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.285 -0.884 . . . . 0.0 110.234 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.504 ' N ' ' O ' ' A' ' 171' ' ' ILE . 0.7 OUTLIER -142.99 -172.07 3.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 110.181 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.415 ' O ' HG22 ' A' ' 174' ' ' VAL . 9.2 p -122.41 -4.78 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 110.262 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.426 ' C ' HG22 ' A' ' 176' ' ' THR . 77.0 mt-10 -71.48 167.0 20.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.178 -0.951 . . . . 0.0 110.204 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -173.7 -95.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.191 -0.943 . . . . 0.0 110.229 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 176' ' ' THR . 4.2 t0 72.35 -140.21 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.283 -0.886 . . . . 0.0 110.273 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -58.42 -16.2 13.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.276 -0.89 . . . . 0.0 110.43 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 1.0 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -60.5 -22.84 64.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.081 -1.012 . . . . 0.0 110.135 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.503 HG23 ' OG1' ' A' ' 176' ' ' THR . 0.6 OUTLIER -54.55 -26.91 34.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.144 -0.973 . . . . 0.0 109.864 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.489 ' HB3' ' OE2' ' A' ' 212' ' ' GLU . 3.2 tt0 -69.26 -65.75 0.67 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.365 -0.834 . . . . 0.0 110.218 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.651 ' C ' HD12 ' A' ' 182' ' ' LEU . 4.5 pp -58.99 -15.07 11.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.884 . . . . 0.0 110.268 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 1.0 HD13 ' CZ ' ' A' ' 179' ' ' PHE . 0.7 OUTLIER -86.45 -31.18 21.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 109.998 179.8 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.15 -8.03 35.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.359 -0.838 . . . . 0.0 110.07 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -88.86 10.06 22.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.865 . . . . 0.0 110.176 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 185' ' ' ALA . 31.8 t0 41.69 66.66 0.66 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.907 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.3 tt -121.3 -173.56 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 110.54 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.701 ' C ' HG13 ' A' ' 189' ' ' VAL . 0.1 OUTLIER -171.81 122.53 0.5 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.701 HG13 ' C ' ' A' ' 188' ' ' ARG . 1.4 m 50.27 105.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.204 -0.935 . . . . 0.0 108.947 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.74 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -45.14 -12.99 0.03 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.631 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 4.1 t 65.84 -143.26 0.19 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.012 -1.287 . . . . 0.0 109.42 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.7 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 1.9 tt0 -71.31 102.86 2.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.572 -0.705 . . . . 0.0 109.487 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.607 HG13 ' C ' ' A' ' 192' ' ' GLU . 16.9 m -156.65 -140.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.097 -1.002 . . . . 0.0 109.967 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.645 ' HA ' HG23 ' A' ' 163' ' ' VAL . 8.3 pt-20 -176.88 138.1 0.26 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 110.728 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.692 ' C ' HD13 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -132.26 161.21 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.293 -0.88 . . . . 0.0 109.99 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.553 ' N ' HG12 ' A' ' 195' ' ' ILE . 37.5 t -154.75 150.3 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.421 -0.799 . . . . 0.0 110.165 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -58.92 119.53 7.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -0.943 . . . . 0.0 110.133 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 199' ' ' ASP . 0.0 OUTLIER -119.32 106.95 12.81 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.232 -0.917 . . . . 0.0 110.396 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 198' ' ' ARG . 15.9 m-20 40.75 79.71 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.254 -0.904 . . . . 0.0 110.372 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 44.84 25.12 0.85 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.414 ' O ' ' CB ' ' A' ' 198' ' ' ARG . 0.0 OUTLIER -150.18 106.83 3.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.214 -1.168 . . . . 0.0 110.132 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.728 HD13 HG22 ' A' ' 153' ' ' ILE . 49.8 mt -64.27 139.46 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 110.336 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 195' ' ' ILE . 3.7 m -119.16 150.32 40.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.338 -0.851 . . . . 0.0 109.935 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.56 ' HG ' ' HB ' ' A' ' 195' ' ' ILE . 0.5 OUTLIER -119.8 130.34 54.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 0.0 110.284 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.556 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 3.2 t -119.79 126.86 52.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.393 -0.817 . . . . 0.0 110.014 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.514 ' HB3' HG12 ' A' ' 193' ' ' VAL . 0.0 OUTLIER -114.19 106.64 14.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.451 -0.781 . . . . 0.0 109.836 180.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.493 ' HB3' ' O ' ' A' ' 206' ' ' HIS . 21.4 t30 61.01 17.4 7.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 110.243 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 114.04 -20.01 17.35 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -81.35 101.37 9.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -1.155 . . . . 0.0 110.277 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 210' ' ' ASP . 30.5 p30 -83.93 147.84 27.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.912 . . . . 0.0 110.292 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.409 ' CG1' ' CE1' ' A' ' 206' ' ' HIS . 4.3 p -155.12 151.66 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.319 -0.863 . . . . 0.0 110.167 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.489 ' OE2' ' HB3' ' A' ' 181' ' ' GLN . 15.4 pt-20 -57.28 148.05 23.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 0.0 110.165 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.48 ' HG ' ' HB2' ' A' ' 204' ' ' LEU . 0.4 OUTLIER -113.86 -149.33 0.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 110.2 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.723 HD13 ' CB ' ' A' ' 217' ' ' LEU . 0.4 OUTLIER -152.16 108.89 3.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 110.223 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -59.8 -38.67 82.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 110.304 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.417 ' OD2' ' OE1' ' A' ' 175' ' ' GLU . 0.2 OUTLIER -65.7 -44.71 85.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.911 . . . . 0.0 110.267 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.848 ' O ' HG22 ' A' ' 220' ' ' THR . 0.2 OUTLIER -85.83 -22.91 27.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.267 -0.896 . . . . 0.0 110.254 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 1.108 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -40.63 -44.84 2.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.334 -0.853 . . . . 0.0 110.288 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.455 ' CD2' ' HG2' ' A' ' 151' ' ' ARG . 39.8 t-80 -90.69 49.73 1.71 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.155 -0.966 . . . . 0.0 110.509 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . 0.848 HG22 ' O ' ' A' ' 217' ' ' LEU . 3.0 t -137.52 -27.16 0.95 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.126 -0.984 . . . . 0.0 110.486 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.762 HG13 HD13 ' A' ' 165' ' ' ILE . 0.1 OUTLIER -95.23 144.5 9.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 120.998 -1.064 . . . . 0.0 110.362 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.573 ' HD2' ' CB ' ' A' ' 167' ' ' GLN . 3.7 ptp85 -95.06 106.72 18.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.146 -0.971 . . . . 0.0 109.405 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 1.031 HG21 HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -119.78 174.03 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.183 -0.948 . . . . 0.0 110.253 -179.132 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.69 ' O ' HG12 ' A' ' 163' ' ' VAL . 1.2 tt0 -124.65 171.95 9.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.096 -1.003 . . . . 0.0 110.583 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 6.8 tp10 -113.52 110.99 21.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.374 -0.829 . . . . 0.0 110.182 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 162' ' ' LYS . 7.6 mp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.984 -1.007 . . . . 0.0 110.16 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.733 0.302 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.16 -45.66 0.43 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.023 1.539 . . . . 0.0 110.38 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 9.9 tt -63.79 140.63 97.86 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.25 -0.906 . . . . 0.0 110.223 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.09 -166.86 0.32 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.962 1.506 . . . . 0.0 110.384 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.12 -119.6 2.01 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.4 tp -130.44 138.36 50.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.198 -1.178 . . . . 0.0 110.187 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 138' ' ' LEU . 0.5 OUTLIER 52.93 33.27 14.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.305 -0.872 . . . . 0.0 110.158 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 59.83 -85.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.314 -0.866 . . . . 0.0 110.21 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -63.04 127.73 32.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.283 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.14 -40.68 95.08 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.1 t -76.48 120.21 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -1.145 . . . . 0.0 110.224 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -68.14 -35.01 82.48 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -80.79 85.64 6.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.274 -1.133 . . . . 0.0 110.26 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 36.4 t -173.8 -46.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.259 -0.901 . . . . 0.0 110.244 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.26 -157.09 0.4 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 0.0 110.211 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.67 146.97 53.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.271 -0.893 . . . . 0.0 110.252 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.666 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -173.47 161.38 4.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.882 . . . . 0.0 110.207 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.666 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . 66.17 169.5 0.11 Allowed Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.21 -0.931 . . . . 0.0 110.173 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.642 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 45.8 Cg_endo -72.98 76.35 2.55 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.122 1.59 . . . . 0.0 110.358 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 151' ' ' ARG . . . -114.83 35.01 4.6 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.539 ' O ' ' CG1' ' A' ' 223' ' ' ILE . 23.8 m -42.07 93.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.37 -1.076 . . . . 0.0 110.236 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.568 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 7.2 ptp85 -42.02 142.75 0.66 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.219 -0.926 . . . . 0.0 110.112 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 1.01 ' CG1' HG23 ' A' ' 153' ' ' ILE . 0.8 OUTLIER -57.57 -153.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.176 -0.953 . . . . 0.0 110.039 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 1.096 HG21 ' CB ' ' A' ' 218' ' ' ALA . 11.8 pt 39.29 25.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.321 -0.862 . . . . 0.0 110.436 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER -135.55 -36.35 0.78 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.312 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -88.76 -9.94 50.06 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.667 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -74.7 107.42 6.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.546 -0.721 . . . . 0.0 110.234 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 158' ' ' SER . 5.7 t -174.11 169.62 3.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.272 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 159' ' ' MET . 0.6 OUTLIER 41.77 74.17 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.327 -0.858 . . . . 0.0 110.124 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . 0.513 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 0.0 OUTLIER 63.51 165.9 0.11 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.144 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 44.6 Cg_endo -72.24 88.01 0.87 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.999 1.526 . . . . 0.0 110.435 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.2 ttt85 -65.61 -140.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 110.21 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -145.29 93.15 2.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.234 -0.916 . . . . 0.0 110.254 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.675 ' O ' ' O ' ' A' ' 193' ' ' VAL . 21.5 m -111.52 -172.94 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.0 110.224 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.643 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 12.8 ptt-85 -162.39 147.17 12.3 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.725 -1.234 . . . . 0.0 110.872 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 1.042 HG23 ' CG2' ' A' ' 223' ' ' ILE . 1.2 mt -98.71 165.84 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.493 -0.755 . . . . 0.0 110.273 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 222' ' ' ARG . 19.1 m -142.54 -31.8 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.158 -0.964 . . . . 0.0 110.484 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 222' ' ' ARG . 0.7 OUTLIER -140.34 123.91 17.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 110.282 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.67 HG13 HG22 ' A' ' 221' ' ' ILE . 7.4 tt -99.61 -5.95 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 110.117 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 168' ' ' ILE . 17.4 m120 55.05 164.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.315 -0.866 . . . . 0.0 110.204 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 169' ' ' ASN . 28.5 mt-10 -144.51 49.57 1.32 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.14 -0.975 . . . . 0.0 110.204 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.0 mm -100.23 -3.08 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.211 -0.931 . . . . 0.0 110.234 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -123.01 154.47 38.42 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.142 -0.974 . . . . 0.0 110.214 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 174' ' ' VAL . 0.0 OUTLIER -79.43 -26.99 41.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.226 -0.921 . . . . 0.0 110.187 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.661 HG11 HD12 ' A' ' 217' ' ' LEU . 41.6 t 43.91 74.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 110.344 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -103.88 116.96 33.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.289 -0.882 . . . . 0.0 110.107 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.638 HG22 ' HB3' ' A' ' 179' ' ' PHE . 2.9 m -155.42 134.56 12.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.901 . . . . 0.0 110.18 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 179' ' ' PHE . 1.1 p-10 -48.73 -101.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.316 -0.865 . . . . 0.0 111.248 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.484 ' C ' ' O ' ' A' ' 177' ' ' ASP . 5.1 pt20 -34.04 -30.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.258 -0.901 . . . . 0.0 111.082 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.638 ' HB3' HG22 ' A' ' 176' ' ' THR . 7.4 t80 -60.48 -59.59 5.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.944 . . . . 0.0 110.487 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.547 ' HA ' ' HB3' ' A' ' 183' ' ' LEU . 0.9 OUTLIER -37.98 -29.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.359 -0.838 . . . . 0.0 110.33 -179.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.504 ' N ' ' O ' ' A' ' 179' ' ' PHE . 24.4 tt0 -57.45 -56.69 18.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.202 -0.937 . . . . 0.0 110.019 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.573 ' C ' HD12 ' A' ' 182' ' ' LEU . 2.6 pp -70.03 -14.04 62.5 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.286 -0.884 . . . . 0.0 109.686 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.547 ' HB3' ' HA ' ' A' ' 180' ' ' THR . 0.4 OUTLIER -89.8 -32.13 17.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.393 -0.817 . . . . 0.0 109.775 179.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -69.4 -4.8 19.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.309 -0.869 . . . . 0.0 109.806 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -83.74 14.33 4.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.428 -0.795 . . . . 0.0 110.114 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 185' ' ' ALA . 0.7 OUTLIER 42.82 62.74 1.67 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.156 -0.965 . . . . 0.0 109.896 -179.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.8 tt -119.35 -173.78 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 110.52 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.719 ' C ' HG13 ' A' ' 189' ' ' VAL . 0.1 OUTLIER -174.53 115.56 0.18 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.362 -0.836 . . . . 0.0 108.748 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.719 HG13 ' C ' ' A' ' 188' ' ' ARG . 1.3 m 51.57 108.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.298 -0.876 . . . . 0.0 109.073 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.794 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -46.12 -13.96 0.08 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.568 ' O ' ' HB2' ' A' ' 164' ' ' ARG . 7.7 t 63.93 -146.87 0.3 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -1.148 . . . . 0.0 109.483 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.643 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.2 OUTLIER -63.4 99.63 0.21 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.618 -0.676 . . . . 0.0 109.576 179.336 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.675 ' O ' ' O ' ' A' ' 163' ' ' VAL . 26.2 m -157.28 -135.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -0.93 . . . . 0.0 109.603 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.599 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.3 OUTLIER -175.04 160.47 2.78 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.124 179.297 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.797 HD13 ' CG2' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -119.97 176.62 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.074 -1.016 . . . . 0.0 110.227 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.463 HG23 ' C ' ' A' ' 195' ' ' ILE . 7.4 t -148.7 86.7 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.291 -0.881 . . . . 0.0 110.183 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 197' ' ' ASP . 15.8 p-10 -43.8 127.33 5.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 110.245 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.499 ' O ' ' C ' ' A' ' 199' ' ' ASP . 21.9 mtt180 -99.76 71.58 1.7 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -0.889 . . . . 0.0 110.37 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 198' ' ' ARG . 3.9 p-10 36.18 39.74 0.09 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.366 -0.833 . . . . 0.0 110.413 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 140.75 -48.77 0.81 Allowed Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.453 ' O ' ' CG1' ' A' ' 202' ' ' ILE . 0.1 OUTLIER -89.9 -158.12 0.51 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -1.11 . . . . 0.0 109.801 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.906 ' CD1' HG22 ' A' ' 153' ' ' ILE . 8.1 mt -155.63 159.53 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.073 -1.017 . . . . 0.0 110.571 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.613 ' O ' HG22 ' A' ' 195' ' ' ILE . 43.2 m -144.32 151.97 40.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.534 -0.729 . . . . 0.0 109.464 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.903 HD22 ' CD2' ' A' ' 206' ' ' HIS . 0.5 OUTLIER -119.91 129.09 54.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.166 -0.959 . . . . 0.0 110.536 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.59 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.5 OUTLIER -119.98 119.8 34.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.424 -0.797 . . . . 0.0 109.826 179.77 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.903 ' CD2' HD22 ' A' ' 204' ' ' LEU . 1.5 m170 -107.31 152.35 24.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.498 -0.751 . . . . 0.0 109.931 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -49.04 -20.54 0.55 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.15 -0.969 . . . . 0.0 110.059 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 209' ' ' LYS . . . -91.2 -31.81 9.42 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 208' ' ' GLY . 10.4 pttt 174.02 -173.95 0.06 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.211 -1.17 . . . . 0.0 110.173 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 4.6 p30 -112.17 161.59 16.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.893 . . . . 0.0 110.413 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 39.1 t -147.04 147.14 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 0.0 110.127 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.0 160.74 30.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.0 110.283 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.704 ' C ' HD23 ' A' ' 214' ' ' LEU . 2.9 mt -131.83 -160.11 1.02 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.203 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.711 HD23 ' N ' ' A' ' 214' ' ' LEU . 0.9 OUTLIER -173.15 169.18 4.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.19 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -75.81 -26.17 56.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 110.183 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.537 ' CB ' HD12 ' A' ' 214' ' ' LEU . 1.0 OUTLIER -63.21 -57.02 11.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 110.125 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.661 HD12 HG11 ' A' ' 174' ' ' VAL . 0.2 OUTLIER -78.35 -28.0 47.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 110.112 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 1.096 ' CB ' HG21 ' A' ' 153' ' ' ILE . . . -40.05 -63.8 0.57 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.369 -0.832 . . . . 0.0 110.487 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.415 ' HB2' HD11 ' A' ' 153' ' ' ILE . 3.5 t-160 -91.77 77.59 5.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.879 . . . . 0.0 110.306 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 4.9 m -166.74 -48.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 0.0 110.44 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.67 HG22 HG13 ' A' ' 168' ' ' ILE . 0.1 OUTLIER -73.98 136.75 24.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.361 -0.837 . . . . 0.0 110.786 -179.66 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.718 ' O ' HG22 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -89.39 112.91 24.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.212 -0.93 . . . . 0.0 109.256 179.275 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 1.042 ' CG2' HG23 ' A' ' 165' ' ' ILE . 0.7 OUTLIER -119.97 -169.48 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.158 -0.964 . . . . 0.0 110.808 -179.053 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 148' ' ' PRO . 30.8 mt-10 -150.25 156.57 41.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.449 -0.782 . . . . 0.0 110.051 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -107.48 99.2 8.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 110.254 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.233 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.478 ' ND2' ' HB3' ' A' ' 133' ' ' PRO . 6.9 t30 . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.522 ' O ' ' HD3' ' A' ' 133' ' ' PRO . 44.3 Cg_endo -72.59 -85.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.05 1.553 . . . . 0.0 110.58 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 30.3 mt -106.12 85.96 1.83 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 110.134 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 131' ' ' PRO . 45.9 Cg_endo -72.6 -53.95 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.992 1.522 . . . . 0.0 110.453 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.43 42.48 2.01 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.54 HD12 HG21 ' A' ' 140' ' ' VAL . 1.4 tp -124.28 26.16 7.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.293 -1.122 . . . . 0.0 110.254 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -103.62 -88.22 0.42 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.898 . . . . 0.0 110.085 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -109.6 -17.98 13.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.284 -0.885 . . . . 0.0 110.208 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.72 -43.72 92.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.253 -0.904 . . . . 0.0 110.189 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 99.48 165.47 29.61 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.54 HG21 HD12 ' A' ' 135' ' ' LEU . 25.5 t -115.23 -19.04 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.247 -1.149 . . . . 0.0 110.16 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 140' ' ' VAL . . . 44.08 -151.08 0.63 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.649 ' OD1' ' HB3' ' A' ' 145' ' ' ALA . 0.5 OUTLIER 47.02 30.37 1.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -1.135 . . . . 0.0 110.223 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.54 -60.22 2.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 110.216 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -123.12 66.53 0.98 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.288 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.649 ' HB3' ' OD1' ' A' ' 142' ' ' ASN . . . -137.93 -166.95 2.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 110.113 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -124.91 -90.6 0.55 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.153 -0.967 . . . . 0.0 110.394 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -83.95 134.62 43.64 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.917 . . . . 0.0 110.394 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.8 89.12 1.01 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.989 1.521 . . . . 0.0 110.344 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.476 ' O ' ' HG2' ' A' ' 222' ' ' ARG . . . -48.21 123.41 9.62 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.821 HG22 ' N ' ' A' ' 151' ' ' ARG . 2.2 m -47.39 -89.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -1.142 . . . . 0.0 110.088 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.821 ' N ' HG22 ' A' ' 150' ' ' THR . 0.0 OUTLIER 169.07 135.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.89 . . . . 0.0 110.01 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.918 HG11 HD11 ' A' ' 221' ' ' ILE . 1.2 m -37.85 -92.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.346 -0.846 . . . . 0.0 111.302 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 1.02 HD12 ' N ' ' A' ' 154' ' ' ASP . 1.9 pp -41.04 -23.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.151 -0.968 . . . . 0.0 111.032 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 1.02 ' N ' HD12 ' A' ' 153' ' ' ILE . 1.2 m-20 -75.12 -16.79 60.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.107 -0.996 . . . . 0.0 110.001 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -109.9 -16.21 13.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.398 -0.814 . . . . 0.0 110.178 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.425 ' O ' ' OG1' ' A' ' 157' ' ' THR . . . -82.7 99.72 9.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.342 -0.849 . . . . 0.0 110.303 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 156' ' ' ALA . 3.2 m -169.8 152.11 4.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.261 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 159' ' ' MET . 6.4 t 55.41 88.29 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.897 . . . . 0.0 110.27 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . 0.426 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 27.4 mtm 55.83 169.5 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 110.183 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.459 ' HB3' HG22 ' A' ' 196' ' ' VAL . 45.9 Cg_endo -72.87 91.29 0.82 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.047 1.551 . . . . 0.0 110.417 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -82.32 129.05 34.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 0.0 110.073 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.487 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 2.4 mmtp -68.91 125.5 26.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.898 . . . . 0.0 110.427 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.738 HG12 ' HA ' ' A' ' 225' ' ' GLU . 29.2 m -141.63 -153.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.229 -0.92 . . . . 0.0 110.234 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.618 ' HG2' ' N ' ' A' ' 165' ' ' ILE . 0.0 OUTLIER -176.21 153.94 1.32 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.901 -1.124 . . . . 0.0 110.213 -179.452 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 1.073 HG21 ' HB ' ' A' ' 189' ' ' VAL . 20.1 mt -102.36 176.21 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.159 -0.963 . . . . 0.0 111.291 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.91 HG22 ' O ' ' A' ' 222' ' ' ARG . 2.7 m -126.36 -28.2 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.664 -0.648 . . . . 0.0 109.561 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.622 ' HA ' ' CG2' ' A' ' 189' ' ' VAL . 0.5 OUTLIER 162.22 147.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.558 -0.714 . . . . 0.0 110.515 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.855 ' HA ' HG22 ' A' ' 221' ' ' ILE . 2.7 mt -66.0 -7.29 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.484 -0.76 . . . . 0.0 109.088 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.484 ' O ' ' HB2' ' A' ' 170' ' ' GLU . 0.1 OUTLIER 53.45 108.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.593 -0.692 . . . . 0.0 110.305 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 169' ' ' ASN . 1.0 OUTLIER 61.78 76.88 0.35 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -0.885 . . . . 0.0 110.278 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.505 HG22 ' HB ' ' A' ' 168' ' ' ILE . 1.7 pp -80.05 6.18 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.894 . . . . 0.0 110.181 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -49.06 -25.53 2.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 110.306 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -71.86 163.61 27.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.937 . . . . 0.0 110.335 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.774 ' O ' HG22 ' A' ' 174' ' ' VAL . 7.0 p -169.95 39.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.248 -0.908 . . . . 0.0 110.264 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.606 ' O ' ' C ' ' A' ' 176' ' ' THR . 18.6 pt-20 -72.73 -152.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.127 -0.983 . . . . 0.0 110.348 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.764 HG23 ' O ' ' A' ' 176' ' ' THR . 9.7 t 21.9 94.39 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.747 -0.595 . . . . 0.0 111.091 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.486 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.1 OUTLIER -60.49 -12.05 8.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.178 -0.951 . . . . 0.0 110.235 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -76.47 -6.9 53.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.118 -0.989 . . . . 0.0 110.251 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.757 ' HB3' HG23 ' A' ' 176' ' ' THR . 0.0 OUTLIER -87.02 -31.61 20.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.169 -0.957 . . . . 0.0 110.112 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.502 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 1.1 p -42.69 -31.62 0.49 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 109.808 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -60.6 -22.84 64.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.357 -0.839 . . . . 0.0 109.608 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.69 HD22 ' CG1' ' A' ' 211' ' ' VAL . 13.6 mt -83.17 -39.8 20.55 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.343 -0.848 . . . . 0.0 109.089 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.422 HD13 ' HZ ' ' A' ' 179' ' ' PHE . 0.5 OUTLIER -74.75 -29.13 61.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.61 -0.681 . . . . 0.0 109.778 179.633 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -72.73 -2.62 21.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 109.882 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.581 ' HB3' HG22 ' A' ' 187' ' ' ILE . . . -88.53 14.86 8.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.316 -0.865 . . . . 0.0 110.205 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 185' ' ' ALA . 0.2 OUTLIER 42.37 30.97 0.24 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 109.209 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.581 HG22 ' HB3' ' A' ' 185' ' ' ALA . 4.5 tt -116.29 164.34 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.602 -0.687 . . . . 0.0 110.48 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.424 ' N ' HG12 ' A' ' 187' ' ' ILE . 1.8 ttp180 -134.05 161.28 35.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.308 -0.87 . . . . 0.0 109.116 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 1.1 HG11 HG21 ' A' ' 221' ' ' ILE . 14.0 m -79.53 -37.39 18.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.871 -1.143 . . . . 0.0 109.099 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.642 ' HA2' ' CA ' ' A' ' 166' ' ' VAL . . . -56.07 50.54 0.01 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.768 ' N ' ' O ' ' A' ' 189' ' ' VAL . 1.8 t -140.66 167.36 22.35 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.372 -1.075 . . . . 0.0 109.228 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.61 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 1.4 mt-10 -65.46 122.45 17.21 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.794 -0.763 . . . . 0.0 109.036 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.881 HG11 ' CD2' ' A' ' 206' ' ' HIS . 0.4 OUTLIER -160.44 144.79 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.042 -1.036 . . . . 0.0 110.254 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.673 ' HA ' HG22 ' A' ' 163' ' ' VAL . 1.4 pt-20 -112.18 159.84 18.17 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.346 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 1.07 HG23 ' HG ' ' A' ' 204' ' ' LEU . 1.2 mt -119.53 153.93 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.069 -1.019 . . . . 0.0 110.532 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.459 HG22 ' HB3' ' A' ' 160' ' ' PRO . 42.3 t -127.63 107.57 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.482 -0.761 . . . . 0.0 109.991 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -75.17 111.74 10.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.928 . . . . 0.0 110.286 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.476 ' O ' ' C ' ' A' ' 199' ' ' ASP . 0.0 OUTLIER -102.89 67.03 0.95 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.217 -0.927 . . . . 0.0 110.299 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 198' ' ' ARG . 25.4 m-20 38.97 37.55 0.22 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.349 -0.844 . . . . 0.0 110.213 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 141.1 -43.16 1.12 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.451 ' O ' ' N ' ' A' ' 198' ' ' ARG . 0.1 OUTLIER -90.12 123.55 34.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -1.122 . . . . 0.0 110.139 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.946 HD13 HG22 ' A' ' 153' ' ' ILE . 10.4 mt -126.36 99.54 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.112 -0.993 . . . . 0.0 110.348 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.663 HG23 ' O ' ' A' ' 211' ' ' VAL . 89.9 m -106.86 157.45 17.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.318 -0.864 . . . . 0.0 109.878 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 1.07 ' HG ' HG23 ' A' ' 195' ' ' ILE . 2.0 mp -120.05 150.31 40.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.458 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.683 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 16.4 t -119.42 110.48 16.98 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.458 -0.776 . . . . 0.0 109.228 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.881 ' CD2' HG11 ' A' ' 193' ' ' VAL . 23.6 m80 -92.45 153.58 19.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.597 -0.689 . . . . 0.0 110.129 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.464 ' N ' ' OD1' ' A' ' 207' ' ' ASN . 26.6 p-10 -51.77 93.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 110.286 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 136.91 -32.45 2.44 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 208' ' ' GLY . 0.0 OUTLIER 176.56 160.15 0.35 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -1.151 . . . . 0.0 110.285 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.537 ' O ' HG23 ' A' ' 211' ' ' VAL . 1.9 p-10 -109.68 174.78 5.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.33 -0.856 . . . . 0.0 110.117 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.69 ' CG1' HD22 ' A' ' 182' ' ' LEU . 45.6 t -154.6 140.98 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.378 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -73.48 74.37 1.43 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.4 -0.812 . . . . 0.0 110.219 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.616 ' CB ' ' CD1' ' A' ' 204' ' ' LEU . 30.6 tp -57.89 162.62 3.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.917 . . . . 0.0 110.273 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.574 ' O ' ' HB2' ' A' ' 218' ' ' ALA . 3.2 mm? -51.37 146.74 6.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 0.0 110.189 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 218' ' ' ALA . 2.1 m-20 -83.17 -102.39 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.942 . . . . 0.0 109.906 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.97 -24.48 1.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.0 -1.062 . . . . 0.0 109.742 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.542 ' O ' ' C ' ' A' ' 218' ' ' ALA . 0.1 OUTLIER -90.15 -14.25 33.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.319 -0.863 . . . . 0.0 110.211 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.73 ' CB ' HG23 ' A' ' 153' ' ' ILE . . . -29.98 -49.07 0.1 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.506 -0.746 . . . . 0.0 110.723 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.568 ' CG ' ' O ' ' A' ' 219' ' ' HIS . 7.8 p80 -51.37 78.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.364 -0.835 . . . . 0.0 110.404 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . 0.659 ' N ' ' O ' ' A' ' 218' ' ' ALA . 1.2 p -136.56 -28.76 0.98 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 110.365 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 1.1 HG21 HG11 ' A' ' 189' ' ' VAL . 0.1 OUTLIER -109.98 154.74 11.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 O-C-N 121.196 -0.94 . . . . 0.0 110.584 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.91 ' O ' HG22 ' A' ' 166' ' ' VAL . 0.6 OUTLIER -89.03 94.41 9.94 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 178.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 1.029 ' CG2' HG23 ' A' ' 165' ' ' ILE . 0.4 OUTLIER -119.38 149.43 21.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.322 -0.861 . . . . 0.0 110.712 -178.202 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.83 ' N ' HD12 ' A' ' 223' ' ' ILE . 13.9 pt-20 -132.02 178.51 6.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.417 -0.802 . . . . 0.0 110.096 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.738 ' HA ' HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -85.93 173.97 9.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 110.349 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.411 ' HA ' HD22 ' A' ' 226' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.203 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 120.823 0.344 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.25 -90.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.006 1.529 . . . . 0.0 110.417 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 17.0 mm -96.63 122.44 57.12 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 110.141 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.43 -53.66 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.917 1.483 . . . . 0.0 110.372 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -156.74 -89.55 0.07 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.2 mt -104.29 -166.51 1.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.291 -1.123 . . . . 0.0 110.162 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 46.0 t0 -106.83 -20.96 13.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 110.209 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -63.97 85.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.315 -0.866 . . . . 0.0 110.208 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.534 ' HA ' HD13 ' A' ' 138' ' ' LEU . 0.4 OUTLIER -65.12 -61.76 1.95 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 0.0 110.206 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -85.92 -139.77 5.33 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.565 ' O ' HG13 ' A' ' 140' ' ' VAL . 7.3 p -170.02 69.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -1.17 . . . . 0.0 110.214 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.52 25.03 40.51 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 9.3 m120 52.05 89.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -1.114 . . . . 0.0 110.227 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.4 m -92.47 170.43 9.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 0.0 110.17 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.71 154.06 23.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.294 -0.879 . . . . 0.0 110.172 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.16 178.81 7.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.302 -0.874 . . . . 0.0 110.225 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.564 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -161.58 84.03 0.62 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.928 . . . . 0.0 110.201 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . 60.96 156.89 0.11 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.899 . . . . 0.0 110.309 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.43 57.97 3.64 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.968 1.51 . . . . 0.0 110.383 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.453 ' CA ' ' HB3' ' A' ' 222' ' ' ARG . . . -160.44 152.41 23.15 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.672 ' O ' HG22 ' A' ' 150' ' ' THR . 58.1 m -147.23 18.0 1.21 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -1.137 . . . . 0.0 110.242 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.968 ' HG3' HD11 ' A' ' 153' ' ' ILE . 1.9 mpp_? 63.15 127.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.964 . . . . 0.0 110.184 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.795 HG13 ' O ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER -78.6 36.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.121 -0.987 . . . . 0.0 111.155 -179.648 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.968 HD11 ' HG3' ' A' ' 151' ' ' ARG . 0.1 OUTLIER -138.84 -32.27 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.865 -1.147 . . . . 0.0 110.226 179.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.94 -12.67 61.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.454 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.519 ' O ' ' CB ' ' A' ' 161' ' ' ARG . . . -103.64 -14.03 16.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.516 -0.74 . . . . 0.0 109.966 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.913 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -81.8 72.64 8.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 110.273 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.451 ' OG1' ' HD3' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -73.54 -171.64 1.05 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.251 -0.906 . . . . 0.0 110.111 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.487 ' OG ' ' N ' ' A' ' 159' ' ' MET . 0.9 OUTLIER -42.41 -57.65 2.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 0.0 110.132 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . 0.487 ' N ' ' OG ' ' A' ' 158' ' ' SER . 3.0 mmt -75.68 165.19 55.38 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.891 . . . . 0.0 110.081 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 44.4 Cg_endo -72.14 73.21 2.64 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.976 1.514 . . . . 0.0 110.444 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 155' ' ' ALA . 1.8 tpt180 -51.64 127.38 20.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -0.951 . . . . 0.0 110.197 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -74.8 125.4 28.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.873 . . . . 0.0 110.36 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.669 HG23 ' HA ' ' A' ' 194' ' ' GLU . 0.1 OUTLIER -144.86 -166.16 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 110.112 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.667 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -169.19 136.66 1.83 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.824 -1.172 . . . . 0.0 110.101 -179.601 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.945 HG23 HG22 ' A' ' 223' ' ' ILE . 0.9 OUTLIER -92.52 153.08 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.294 -0.879 . . . . 0.0 110.489 -179.434 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.476 ' CG1' ' NE ' ' A' ' 164' ' ' ARG . 11.1 m -145.43 11.22 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 110.204 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -170.91 123.92 0.63 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.229 -0.92 . . . . 0.0 110.195 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.52 HG13 HG22 ' A' ' 221' ' ' ILE . 19.2 tt -131.3 4.99 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.326 -0.858 . . . . 0.0 110.15 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.432 ' O ' ' CB ' ' A' ' 170' ' ' GLU . 4.4 p30 -52.58 169.05 0.09 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 110.163 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.432 ' CB ' ' O ' ' A' ' 169' ' ' ASN . 0.3 OUTLIER 64.86 44.8 3.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.182 -0.949 . . . . 0.0 110.134 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.512 HD12 ' C ' ' A' ' 171' ' ' ILE . 1.3 pp -119.61 31.95 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.27 -0.894 . . . . 0.0 110.22 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.27 89.7 1.21 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 110.215 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -106.06 165.38 11.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.274 -0.891 . . . . 0.0 110.205 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.5 m -106.72 11.45 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.161 -0.962 . . . . 0.0 110.27 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.78 139.74 37.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.896 . . . . 0.0 110.18 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.957 HG23 HG23 ' A' ' 180' ' ' THR . 54.4 m -118.88 -92.81 0.53 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 110.245 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.526 ' N ' HG22 ' A' ' 176' ' ' THR . 0.4 OUTLIER 66.3 -165.62 0.22 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.212 -0.93 . . . . 0.0 110.28 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -55.2 -20.64 11.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.261 -0.899 . . . . 0.0 110.294 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.98 ' CE2' HD13 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -49.17 -26.29 2.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.195 -0.941 . . . . 0.0 109.983 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.957 HG23 HG23 ' A' ' 176' ' ' THR . 0.2 OUTLIER -55.15 -26.42 38.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.884 . . . . 0.0 109.949 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -69.29 -63.36 1.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.321 -0.862 . . . . 0.0 110.114 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.8 HD12 ' N ' ' A' ' 183' ' ' LEU . 4.4 pp -61.6 -15.91 43.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.379 -0.826 . . . . 0.0 110.114 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.98 HD13 ' CE2' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -91.1 -28.55 17.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.162 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 180' ' ' THR . 18.9 t70 -79.99 4.25 17.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 110.183 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -85.12 16.66 3.38 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.862 . . . . 0.0 110.188 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 185' ' ' ALA . 3.8 t0 41.66 43.17 2.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.248 -0.907 . . . . 0.0 109.92 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.6 tt -102.9 -178.5 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.874 . . . . 0.0 110.367 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.717 ' C ' HG13 ' A' ' 189' ' ' VAL . 9.4 ptt180 -170.52 117.48 0.51 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.717 HG13 ' C ' ' A' ' 188' ' ' ARG . 1.3 m 51.3 108.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.199 -0.938 . . . . 0.0 109.154 -178.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.816 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -45.63 -13.65 0.06 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 3.7 t 66.05 -144.14 0.19 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.071 -1.253 . . . . 0.0 109.421 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.667 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -65.21 101.93 0.6 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.474 -0.766 . . . . 0.0 109.267 179.221 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.623 ' O ' ' O ' ' A' ' 163' ' ' VAL . 23.0 m -156.9 -138.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -0.948 . . . . 0.0 110.033 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.669 ' HA ' HG23 ' A' ' 163' ' ' VAL . 1.1 pp20? -175.48 160.85 2.61 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.293 -0.88 . . . . 0.0 110.142 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.913 HD12 ' HB2' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -120.86 169.81 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.159 -0.963 . . . . 0.0 110.335 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 196' ' ' VAL . 4.7 p -149.67 77.38 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.883 . . . . 0.0 110.032 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 202' ' ' ILE . 11.8 t70 -40.78 142.22 0.49 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 110.336 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.475 ' O ' ' N ' ' A' ' 200' ' ' GLY . 1.9 ttp180 -139.77 -174.6 3.95 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.205 -0.935 . . . . 0.0 110.315 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -42.28 96.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.258 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 198' ' ' ARG . . . 44.01 29.48 1.51 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -150.26 113.72 4.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.252 -1.146 . . . . 0.0 110.215 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.619 HD13 HG22 ' A' ' 153' ' ' ILE . 70.3 mt -94.24 144.99 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 0.0 110.167 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.529 ' HB ' ' CG1' ' A' ' 196' ' ' VAL . 1.2 m -126.32 156.09 40.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.056 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.912 HD22 ' CD2' ' A' ' 206' ' ' HIS . 1.0 OUTLIER -119.82 131.98 55.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -0.956 . . . . 0.0 110.232 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.538 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 20.1 t -119.75 124.6 46.58 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.3 -0.875 . . . . 0.0 109.781 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.912 ' CD2' HD22 ' A' ' 204' ' ' LEU . 2.4 m170 -106.02 158.95 16.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.417 -0.802 . . . . 0.0 109.999 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.0 72.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 110.155 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 153.63 -21.07 0.71 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 208' ' ' GLY . 0.3 OUTLIER 169.93 149.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.161 -1.199 . . . . 0.0 110.218 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 1.2 p30 -97.08 -171.99 2.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.92 . . . . 0.0 110.13 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 8.7 p -158.69 165.36 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -0.917 . . . . 0.0 110.226 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -69.49 141.04 54.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 110.239 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.798 HD13 ' N ' ' A' ' 214' ' ' LEU . 0.3 OUTLIER -148.15 145.04 28.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.932 . . . . 0.0 110.173 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.798 ' N ' HD13 ' A' ' 213' ' ' LEU . 0.6 OUTLIER -133.61 143.49 48.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.268 -0.895 . . . . 0.0 110.21 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.617 ' HA ' ' HB3' ' A' ' 218' ' ' ALA . 0.3 OUTLIER -50.2 -51.56 43.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.197 -0.94 . . . . 0.0 110.185 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.771 ' HB2' HD12 ' A' ' 214' ' ' LEU . 0.5 OUTLIER -43.38 -49.18 7.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.932 . . . . 0.0 110.262 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.59 ' HB2' HD11 ' A' ' 214' ' ' LEU . 0.4 OUTLIER -89.12 -26.77 21.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.891 . . . . 0.0 110.14 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.758 ' HB2' ' CD1' ' A' ' 213' ' ' LEU . . . -64.83 -17.68 64.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.257 -0.902 . . . . 0.0 110.091 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.658 ' O ' HG23 ' A' ' 220' ' ' THR . 0.2 OUTLIER -89.2 56.56 3.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.135 -0.978 . . . . 0.0 110.217 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . 0.658 HG23 ' O ' ' A' ' 219' ' ' HIS . 17.6 p -158.12 -47.22 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 0.0 110.372 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.7 HD13 ' N ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -63.17 130.93 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.29 -0.881 . . . . 0.0 110.52 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.453 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . 37.0 mtt85 -91.67 104.09 16.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.345 -0.847 . . . . 0.0 109.618 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.945 HG22 HG23 ' A' ' 165' ' ' ILE . 0.1 OUTLIER -119.51 171.53 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.144 -0.973 . . . . 0.0 110.023 -179.566 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.589 ' C ' HG12 ' A' ' 163' ' ' VAL . 6.6 mm-40 -140.13 167.58 21.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.163 -0.961 . . . . 0.0 110.415 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 8.1 pt-20 -91.53 38.85 0.99 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.381 -0.824 . . . . 0.0 110.247 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.175 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.559 ' CB ' ' CD ' ' A' ' 131' ' ' PRO . 1.5 m-80 . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.559 ' CD ' ' CB ' ' A' ' 130' ' ' ASN . 46.9 Cg_endo -73.01 53.67 2.49 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.975 1.513 . . . . 0.0 110.494 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 5.9 pt -104.27 161.04 24.07 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.199 -0.938 . . . . 0.0 110.262 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.0 -12.4 25.94 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.0 1.526 . . . . 0.0 110.464 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 135' ' ' LEU . . . 118.51 -77.32 0.3 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.448 ' CB ' ' O ' ' A' ' 134' ' ' GLY . 0.2 OUTLIER 65.29 138.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.294 -1.121 . . . . 0.0 110.241 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 17.7 p30 -61.98 96.63 0.07 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 110.22 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.2 89.12 4.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.933 . . . . 0.0 110.232 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.538 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -48.95 168.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.297 -0.877 . . . . 0.0 110.223 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -164.22 68.53 0.21 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.714 ' O ' HG13 ' A' ' 140' ' ' VAL . 8.2 p -171.32 91.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.279 -1.13 . . . . 0.0 110.228 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.13 -172.83 54.86 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.452 ' O ' ' O ' ' A' ' 143' ' ' SER . 8.9 t30 -137.62 -59.94 0.66 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -1.132 . . . . 0.0 110.16 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.452 ' O ' ' O ' ' A' ' 142' ' ' ASN . 1.5 p -50.01 -178.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 110.226 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 15.9 t0 60.57 104.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.213 -0.929 . . . . 0.0 110.2 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -110.22 -16.58 13.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.316 -0.865 . . . . 0.0 110.176 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -161.08 129.28 4.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.186 -0.946 . . . . 0.0 110.11 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . 58.71 156.12 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.342 -0.849 . . . . 0.0 110.161 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.51 52.67 2.48 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.967 1.509 . . . . 0.0 110.44 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 222' ' ' ARG . . . 131.84 157.5 8.72 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.544 ' O ' ' CG1' ' A' ' 223' ' ' ILE . 54.2 m -123.31 143.56 50.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.308 -1.113 . . . . 0.0 110.163 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 154' ' ' ASP . 0.1 OUTLIER -50.16 127.69 17.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.123 -0.986 . . . . 0.0 110.055 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.795 HG12 ' O ' ' A' ' 218' ' ' ALA . 2.5 p -43.88 -25.49 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.103 -0.998 . . . . 0.0 110.378 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.71 HG22 HD13 ' A' ' 202' ' ' ILE . 1.3 pt -95.22 -14.04 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 110.325 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.539 ' HB3' ' CG2' ' A' ' 150' ' ' THR . 2.0 m-20 -77.35 -19.28 56.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.994 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -97.36 -13.0 22.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.371 -0.831 . . . . 0.0 110.016 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 157' ' ' THR . . . -51.06 166.07 0.1 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.875 . . . . 0.0 110.262 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.533 ' O ' ' CB ' ' A' ' 158' ' ' SER . 14.7 m 51.93 167.37 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.315 -0.866 . . . . 0.0 110.398 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 157' ' ' THR . 0.1 OUTLIER 70.89 -52.14 0.68 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.24 -0.913 . . . . 0.0 110.309 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -100.72 139.17 20.36 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.175 -0.953 . . . . 0.0 110.147 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.552 ' O ' ' C ' ' A' ' 161' ' ' ARG . 45.4 Cg_endo -72.92 71.85 3.35 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.962 1.506 . . . . 0.0 110.426 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.781 ' HB3' HG22 ' A' ' 196' ' ' VAL . 7.7 ptt180 27.12 99.8 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.505 0.669 . . . . 0.0 111.282 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -170.72 56.41 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.175 -0.953 . . . . 0.0 109.995 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.669 ' O ' ' O ' ' A' ' 193' ' ' VAL . 34.9 m -141.83 -151.83 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.925 0.869 . . . . 0.0 110.503 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.671 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 16.4 ptt180 -175.46 169.03 3.21 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.86 -1.15 . . . . 0.0 110.433 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 1.068 HG23 HG22 ' A' ' 223' ' ' ILE . 0.1 OUTLIER -99.78 162.98 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.302 -0.874 . . . . 0.0 109.848 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.817 HG22 ' O ' ' A' ' 222' ' ' ARG . 27.0 m -137.28 -24.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.177 -0.952 . . . . 0.0 110.759 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.551 ' HB2' ' CD ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -152.45 127.89 9.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.038 -1.039 . . . . 0.0 110.458 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.771 HG13 HG22 ' A' ' 221' ' ' ILE . 1.2 tt -96.69 -1.68 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.983 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 168' ' ' ILE . 38.1 m-80 56.6 -95.17 0.05 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 110.231 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.554 ' HG3' ' CZ ' ' A' ' 172' ' ' PHE . 4.3 pt-20 -168.2 83.1 0.18 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.066 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.911 HD13 ' CD2' ' A' ' 217' ' ' LEU . 2.4 pp -86.57 25.78 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.329 -0.857 . . . . 0.0 110.377 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.6 ' C ' ' O ' ' A' ' 171' ' ' ILE . 0.9 OUTLIER 22.83 -136.26 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.583 -0.698 . . . . 0.0 111.024 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.659 ' C ' HG23 ' A' ' 176' ' ' THR . 14.9 mt-30 -107.66 -90.55 0.44 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.193 -0.942 . . . . 0.0 110.258 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.581 ' O ' ' N ' ' A' ' 176' ' ' THR . 6.7 t 59.64 90.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.891 . . . . 0.0 110.291 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.565 ' HB3' ' O ' ' A' ' 174' ' ' VAL . 3.7 tt0 63.63 -56.69 0.2 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.489 -0.757 . . . . 0.0 110.822 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.659 HG23 ' C ' ' A' ' 173' ' ' GLN . 8.9 p 45.54 -91.72 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.301 -0.874 . . . . 0.0 110.215 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 178' ' ' GLN . 12.5 t0 43.72 -93.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 110.129 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.528 ' N ' ' O ' ' A' ' 176' ' ' THR . 1.4 mt-30 -48.38 -25.11 1.46 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.179 -0.951 . . . . 0.0 110.015 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.985 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 3.0 t80 -82.97 -52.77 6.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.99 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 177' ' ' ASP . 0.3 OUTLIER -43.65 -25.15 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.172 -0.955 . . . . 0.0 109.889 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -69.17 -64.59 0.84 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.305 -0.872 . . . . 0.0 110.19 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.576 ' HB3' HG11 ' A' ' 211' ' ' VAL . 3.5 pp -63.92 -13.6 46.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.357 -0.839 . . . . 0.0 109.848 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.985 HD13 ' CZ ' ' A' ' 179' ' ' PHE . 1.7 tp -87.81 -30.42 20.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.387 -0.821 . . . . 0.0 109.861 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -72.18 -15.04 61.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.828 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -89.44 20.03 4.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -0.829 . . . . 0.0 110.136 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 47.31 85.21 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.892 . . . . 0.0 110.093 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.556 ' O ' ' CB ' ' A' ' 188' ' ' ARG . 57.6 mt -146.04 -82.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 0.0 110.374 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.556 ' CB ' ' O ' ' A' ' 187' ' ' ILE . 0.1 OUTLIER 72.79 161.38 0.24 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.453 -0.779 . . . . 0.0 109.683 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.971 ' O ' ' N ' ' A' ' 191' ' ' SER . 3.9 m 33.87 37.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 O-C-N 121.334 -0.853 . . . . 0.0 110.613 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.763 ' N ' HD12 ' A' ' 165' ' ' ILE . . . 25.68 19.73 0.0 OUTLIER Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.971 ' N ' ' O ' ' A' ' 189' ' ' VAL . 13.6 t 36.88 -146.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -1.149 . . . . 0.0 109.868 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.671 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.9 OUTLIER -89.95 115.26 27.11 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.026 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.669 ' O ' ' O ' ' A' ' 163' ' ' VAL . 34.1 m -159.69 -133.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.096 -1.003 . . . . 0.0 109.985 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.552 ' CG ' ' HB2' ' A' ' 205' ' ' SER . 1.7 pt-20 -158.47 168.82 25.92 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.266 -0.896 . . . . 0.0 110.094 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.919 HG23 ' HG ' ' A' ' 204' ' ' LEU . 0.0 OUTLIER -136.36 146.61 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.163 -0.96 . . . . 0.0 110.353 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.781 HG22 ' HB3' ' A' ' 161' ' ' ARG . 94.8 t -139.05 108.14 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.249 -0.907 . . . . 0.0 110.105 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 202' ' ' ILE . 4.6 t0 -50.77 113.73 0.98 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.211 -0.931 . . . . 0.0 110.135 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 201' ' ' HIS . 1.0 OUTLIER -110.1 93.61 4.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.224 -0.923 . . . . 0.0 110.294 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 198' ' ' ARG . 43.7 t0 41.81 53.96 3.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.222 -0.924 . . . . 0.0 110.126 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 88.89 -27.34 7.41 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.465 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 11.6 m170 -92.08 91.34 7.76 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.26 -1.141 . . . . 0.0 110.273 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.71 HD13 HG22 ' A' ' 153' ' ' ILE . 2.7 mt -59.66 91.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.904 . . . . 0.0 110.18 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 85.6 m -67.95 148.38 51.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.276 -0.89 . . . . 0.0 110.153 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.919 ' HG ' HG23 ' A' ' 195' ' ' ILE . 0.1 OUTLIER -120.23 132.89 55.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.241 -0.912 . . . . 0.0 110.282 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.582 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.7 OUTLIER -119.79 125.93 49.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.332 -0.855 . . . . 0.0 109.898 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.528 ' HA ' HG12 ' A' ' 193' ' ' VAL . 1.9 m170 -104.55 74.08 1.14 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.385 -0.822 . . . . 0.0 110.366 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.52 ' C ' ' O ' ' A' ' 206' ' ' HIS . 3.7 p-10 32.14 51.51 0.21 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.484 -0.76 . . . . 0.0 110.793 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 135.58 -39.9 1.61 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.515 ' HB2' ' HB2' ' A' ' 206' ' ' HIS . 6.7 mtmt -102.58 162.91 12.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.296 -1.12 . . . . 0.0 110.138 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 204' ' ' LEU . 14.7 t0 -150.17 144.44 25.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 110.319 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.576 HG11 ' HB3' ' A' ' 182' ' ' LEU . 24.5 t -134.76 159.1 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.285 -0.884 . . . . 0.0 110.032 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -98.67 63.49 1.44 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 0.0 110.304 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.617 HD22 ' CD1' ' A' ' 204' ' ' LEU . 12.8 tp -56.12 160.12 3.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -0.919 . . . . 0.0 110.113 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.538 HD23 ' N ' ' A' ' 214' ' ' LEU . 0.6 OUTLIER -122.56 144.75 48.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 0.0 110.199 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -52.67 -40.72 63.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.265 -0.897 . . . . 0.0 110.168 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.518 ' CB ' HD12 ' A' ' 214' ' ' LEU . 0.2 OUTLIER -52.24 -56.66 13.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.894 . . . . 0.0 110.193 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.911 ' CD2' HD13 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -84.55 -27.15 27.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.201 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.795 ' O ' HG12 ' A' ' 152' ' ' VAL . . . -74.51 -11.05 60.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.0 110.186 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.686 ' O ' HG23 ' A' ' 220' ' ' THR . 12.2 t-160 -100.96 77.98 1.89 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.933 . . . . 0.0 110.244 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . 0.686 HG23 ' O ' ' A' ' 219' ' ' HIS . 0.0 OUTLIER -178.3 -43.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -0.943 . . . . 0.0 110.468 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.771 HG22 HG13 ' A' ' 168' ' ' ILE . 0.1 OUTLIER -73.29 143.04 14.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.293 -0.88 . . . . 0.0 110.657 -179.738 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.817 ' O ' HG22 ' A' ' 166' ' ' VAL . 4.8 ptp85 -89.45 127.18 35.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.074 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 1.068 HG22 HG23 ' A' ' 165' ' ' ILE . 0.7 OUTLIER -125.5 170.91 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.192 -0.943 . . . . 0.0 110.821 -178.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.422 ' CG ' ' HA2' ' A' ' 149' ' ' GLY . 38.8 mt-10 -149.95 172.64 14.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -0.872 . . . . 0.0 110.12 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.431 ' OE1' ' OXT' ' A' ' 226' ' ' LEU . 0.0 OUTLIER -81.55 169.38 17.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.9 . . . . 0.0 110.156 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.441 ' O ' ' HG ' ' A' ' 226' ' ' LEU . 39.2 tp . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.167 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.602 ' C ' HD12 ' A' ' 132' ' ' ILE . 8.8 p-10 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.75 0.31 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 132' ' ' ILE . 46.1 Cg_endo -72.76 -57.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.036 1.545 . . . . 0.0 110.451 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.602 HD12 ' C ' ' A' ' 130' ' ' ASN . 1.7 mp 41.26 75.47 0.61 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.285 -0.884 . . . . 0.0 110.271 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.03 -28.37 13.02 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.983 1.517 . . . . 0.0 110.342 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -46.07 167.57 0.05 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.4 -154.63 0.48 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.305 -1.115 . . . . 0.0 110.229 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -102.13 52.3 0.81 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 110.23 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -124.61 55.98 1.31 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.292 -0.88 . . . . 0.0 110.252 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.28 -41.92 2.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 110.213 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 163.35 -25.98 0.21 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.501 HG12 ' N ' ' A' ' 141' ' ' GLY . 70.8 t -45.41 -89.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -1.129 . . . . 0.0 110.255 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.501 ' N ' HG12 ' A' ' 140' ' ' VAL . . . 159.05 -152.48 23.53 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.14 -67.46 0.54 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.306 -1.114 . . . . 0.0 110.233 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 54.95 35.98 25.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.911 . . . . 0.0 110.221 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -89.33 79.57 7.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.316 -0.865 . . . . 0.0 110.237 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.35 167.37 11.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 0.0 110.284 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.61 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -165.81 167.7 16.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.208 -0.932 . . . . 0.0 110.251 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . 63.0 152.32 0.11 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.137 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.486 ' HA ' ' OE1' ' A' ' 224' ' ' GLU . 45.9 Cg_endo -73.14 80.77 1.81 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.052 1.553 . . . . 0.0 110.456 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -164.35 106.18 0.27 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.513 ' O ' HG22 ' A' ' 150' ' ' THR . 99.7 m -134.53 2.2 3.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -1.115 . . . . 0.0 110.256 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 153' ' ' ILE . 32.9 mtt180 59.83 123.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 110.121 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.885 ' CG2' HG21 ' A' ' 223' ' ' ILE . 40.5 t -66.21 60.14 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.203 -0.936 . . . . 0.0 110.339 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.721 HG23 ' O ' ' A' ' 152' ' ' VAL . 0.8 OUTLIER -159.33 -34.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.306 -0.871 . . . . 0.0 110.145 179.802 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.33 -13.07 61.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.861 . . . . 0.0 109.44 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.712 ' CB ' HG11 ' A' ' 163' ' ' VAL . . . -88.17 -28.01 21.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.485 -0.759 . . . . 0.0 109.976 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -75.62 120.48 21.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.895 . . . . 0.0 110.238 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 14.6 m -162.6 109.0 1.23 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 110.267 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' A' ' 159' ' ' MET . 1.3 t 62.59 10.36 4.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 0.0 110.256 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . 0.45 ' HB3' ' O ' ' A' ' 158' ' ' SER . 0.0 OUTLIER 173.12 158.42 0.27 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.286 -0.884 . . . . 0.0 110.2 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 46.2 Cg_endo -73.12 63.81 4.22 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.049 1.552 . . . . 0.0 110.299 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.585 ' O ' HG13 ' A' ' 163' ' ' VAL . 7.9 mtt180 -42.18 119.22 1.31 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 0.0 110.248 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.492 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 6.1 ttmt -58.33 124.98 21.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.291 -0.881 . . . . 0.0 110.258 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.856 HG22 ' HA ' ' A' ' 194' ' ' GLU . 30.6 m -139.67 -159.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.881 . . . . 0.0 110.122 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.645 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -175.09 139.11 0.46 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.822 -1.174 . . . . 0.0 110.486 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 1.033 HG23 HG22 ' A' ' 223' ' ' ILE . 2.1 mt -91.38 153.87 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.45 -0.781 . . . . 0.0 110.893 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.478 ' CG1' ' HD3' ' A' ' 164' ' ' ARG . 3.4 m -138.85 -29.62 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.486 -0.759 . . . . 0.0 110.448 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -136.57 118.88 15.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.117 -0.989 . . . . 0.0 110.217 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.585 ' HB ' HG12 ' A' ' 189' ' ' VAL . 1.3 tt -116.32 -3.12 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.201 -0.937 . . . . 0.0 110.254 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 57.26 170.73 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.222 -0.924 . . . . 0.0 110.298 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 172' ' ' PHE . 7.7 pt-20 -155.66 160.75 40.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.151 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.427 ' C ' ' O ' ' A' ' 170' ' ' GLU . 23.1 mt 41.3 27.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.919 . . . . 0.0 110.248 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 170' ' ' GLU . 2.6 t80 -172.29 57.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.255 -0.903 . . . . 0.0 110.245 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.512 ' HB3' HG12 ' A' ' 174' ' ' VAL . 1.9 mt-30 -112.5 -61.23 1.76 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -0.925 . . . . 0.0 110.169 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.846 HG22 ' N ' ' A' ' 175' ' ' GLU . 0.5 OUTLIER -164.22 -86.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.385 -0.822 . . . . 0.0 110.185 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.846 ' N ' HG22 ' A' ' 174' ' ' VAL . 2.6 mt-10 -141.89 11.89 2.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.059 -1.025 . . . . 0.0 110.228 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.984 HG22 HG23 ' A' ' 180' ' ' THR . 0.2 OUTLIER 66.28 -58.44 0.35 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.286 -0.883 . . . . 0.0 110.259 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 178' ' ' GLN . 3.3 p30 36.93 -145.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.377 -0.827 . . . . 0.0 110.776 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.512 ' N ' ' OD1' ' A' ' 177' ' ' ASP . 0.2 OUTLIER -63.46 -27.47 69.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.312 -0.867 . . . . 0.0 110.567 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.819 ' HA ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -44.08 -35.34 2.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.001 . . . . 0.0 109.771 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.984 HG23 HG22 ' A' ' 176' ' ' THR . 0.7 OUTLIER -42.8 -27.85 0.21 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.144 -0.973 . . . . 0.0 109.456 179.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 179' ' ' PHE . 23.5 tp60 -59.84 -36.01 75.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.542 -0.724 . . . . 0.0 109.609 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.819 HD12 ' HA ' ' A' ' 179' ' ' PHE . 1.2 mt -69.11 -43.62 74.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.38 -0.825 . . . . 0.0 109.433 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -37.64 88.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.613 -0.679 . . . . 0.0 109.888 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -59.16 -14.74 11.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.462 -0.774 . . . . 0.0 109.845 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -84.69 16.93 2.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.423 -0.798 . . . . 0.0 110.189 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 185' ' ' ALA . 27.4 t70 43.6 57.56 3.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -0.921 . . . . 0.0 109.764 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.6 tt -129.93 175.24 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.322 -0.861 . . . . 0.0 110.339 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.694 ' C ' HG13 ' A' ' 189' ' ' VAL . 0.1 OUTLIER -163.11 105.73 1.02 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.743 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.694 HG13 ' C ' ' A' ' 188' ' ' ARG . 1.3 m 50.63 105.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.332 -0.855 . . . . 0.0 108.813 -178.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.921 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -43.28 -15.74 0.03 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.604 ' N ' ' O ' ' A' ' 189' ' ' VAL . 6.1 t 65.57 -142.1 0.2 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.18 -1.188 . . . . 0.0 109.388 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.645 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -64.11 100.24 0.32 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.569 -0.707 . . . . 0.0 109.265 179.294 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.623 ' O ' ' O ' ' A' ' 163' ' ' VAL . 17.0 m -156.73 -141.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.158 -0.964 . . . . 0.0 110.222 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.856 ' HA ' HG22 ' A' ' 163' ' ' VAL . 4.2 pt-20 -173.26 169.08 4.59 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.345 -0.847 . . . . 0.0 110.11 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.872 HG21 HG12 ' A' ' 152' ' ' VAL . 0.6 OUTLIER -121.3 169.17 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.169 -0.957 . . . . 0.0 110.288 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 18.8 t -128.7 98.4 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.34 -0.85 . . . . 0.0 110.178 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -49.35 117.86 2.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.9 . . . . 0.0 110.201 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.546 ' HB3' ' CB ' ' A' ' 201' ' ' HIS . 0.1 OUTLIER -109.05 146.39 34.04 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.212 -0.93 . . . . 0.0 110.213 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.45 94.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.908 . . . . 0.0 110.12 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 198' ' ' ARG . . . 75.64 14.55 81.96 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.546 ' CB ' ' HB3' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -150.25 160.92 43.34 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.249 -1.148 . . . . 0.0 110.095 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 10.6 mt -136.02 159.73 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 110.251 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.545 ' O ' HG22 ' A' ' 195' ' ' ILE . 2.1 m -151.0 163.26 39.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -0.877 . . . . 0.0 109.96 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.854 HD11 HD11 ' A' ' 165' ' ' ILE . 0.6 OUTLIER -119.8 137.28 54.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.058 -1.026 . . . . 0.0 110.345 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.554 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 1.2 t -119.73 120.47 36.67 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.404 -0.81 . . . . 0.0 109.583 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.561 ' HA ' ' CG1' ' A' ' 193' ' ' VAL . 7.4 m170 -89.24 165.86 14.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.429 -0.795 . . . . 0.0 110.205 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.503 ' C ' ' O ' ' A' ' 206' ' ' HIS . 4.6 m-20 -32.85 -34.35 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.566 -0.709 . . . . 0.0 110.952 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -153.83 32.7 0.74 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 206' ' ' HIS . 20.8 mttt -154.29 179.38 9.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -1.124 . . . . 0.0 110.51 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 204' ' ' LEU . 12.8 t0 -155.56 158.46 38.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 110.053 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.487 HG12 ' HB3' ' A' ' 204' ' ' LEU . 7.3 p -146.49 140.81 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -0.953 . . . . 0.0 110.329 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -68.78 83.73 0.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.286 -0.884 . . . . 0.0 110.231 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.66 121.1 17.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.184 -0.948 . . . . 0.0 110.243 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 1.019 HD23 ' HB2' ' A' ' 217' ' ' LEU . 29.6 tp -57.63 158.82 5.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 0.0 110.222 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.596 ' H ' HD12 ' A' ' 214' ' ' LEU . 11.2 t0 -89.57 -49.65 6.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.346 -0.846 . . . . 0.0 110.274 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.544 ' O ' ' NE2' ' A' ' 219' ' ' HIS . 0.4 OUTLIER -55.35 -48.52 74.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -0.921 . . . . 0.0 110.202 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 1.019 ' HB2' HD23 ' A' ' 214' ' ' LEU . 0.5 OUTLIER -85.85 -11.93 52.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 110.113 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.699 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -35.62 -41.77 0.21 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.55 -0.718 . . . . 0.0 110.669 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.563 ' HB3' ' CD1' ' A' ' 153' ' ' ILE . 24.7 p80 -93.98 73.47 4.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 110.434 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . 0.771 HG23 HG23 ' A' ' 221' ' ' ILE . 8.9 t -137.25 -44.86 0.56 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.941 . . . . 0.0 110.092 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.895 HD13 ' H ' ' A' ' 221' ' ' ILE . 0.3 OUTLIER -73.74 146.54 10.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.326 -0.859 . . . . 0.0 110.363 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.459 ' O ' HG22 ' A' ' 166' ' ' VAL . 8.1 mtt180 -89.89 114.39 26.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 0.0 109.28 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 1.033 HG22 HG23 ' A' ' 165' ' ' ILE . 0.8 OUTLIER -141.58 -172.6 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.131 -0.981 . . . . 0.0 110.894 -179.036 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.486 ' OE1' ' HA ' ' A' ' 148' ' ' PRO . 0.5 OUTLIER -144.18 166.81 23.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.355 -0.84 . . . . 0.0 110.178 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.829 ' HA ' HG12 ' A' ' 163' ' ' VAL . 0.3 OUTLIER -111.92 124.01 51.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.366 -0.834 . . . . 0.0 110.26 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.419 ' OXT' ' HB3' ' A' ' 162' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.19 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.523 ' N ' ' HD2' ' A' ' 131' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 130' ' ' ASN . 47.5 Cg_endo -73.95 57.31 3.84 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.962 1.506 . . . . 0.0 110.434 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.642 HG23 ' O ' ' A' ' 132' ' ' ILE . 10.8 tt -62.57 114.63 12.63 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.194 -0.941 . . . . 0.0 110.233 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.36 -166.05 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.959 1.505 . . . . 0.0 110.458 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 136' ' ' ASP . . . -173.0 -116.71 0.42 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.54 HD12 ' N ' ' A' ' 135' ' ' LEU . 6.8 mp 56.25 -83.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -1.151 . . . . 0.0 110.319 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 134' ' ' GLY . 6.7 t70 -41.79 -27.04 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.306 -0.871 . . . . 0.0 110.278 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 135' ' ' LEU . 0.5 OUTLIER 42.37 35.23 0.6 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 110.319 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 53.9 tp -45.36 112.54 0.46 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.235 -0.916 . . . . 0.0 110.167 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 174.7 -38.96 0.12 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.434 ' H ' HG23 ' A' ' 140' ' ' VAL . 48.3 t -48.55 -23.15 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -1.158 . . . . 0.0 110.204 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 100.26 28.13 7.37 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -78.9 126.0 30.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -1.164 . . . . 0.0 110.314 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 144' ' ' ASP . 2.7 p -156.65 -76.62 0.09 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.885 . . . . 0.0 110.22 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.632 ' O ' ' HB2' ' A' ' 145' ' ' ALA . 0.2 OUTLIER 66.64 121.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.241 -0.912 . . . . 0.0 110.153 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 144' ' ' ASP . . . 174.26 -94.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.159 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -125.01 85.59 2.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.141 -0.974 . . . . 0.0 110.172 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . 57.71 154.69 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.284 -0.885 . . . . 0.0 110.198 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 149' ' ' GLY . 46.5 Cg_endo -73.73 50.73 2.13 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.954 1.502 . . . . 0.0 110.54 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 148' ' ' PRO . . . 55.88 162.14 0.02 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.564 HG22 ' H ' ' A' ' 151' ' ' ARG . 1.6 m -73.75 -177.01 2.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.219 -1.165 . . . . 0.0 109.969 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.564 ' H ' HG22 ' A' ' 150' ' ' THR . 96.7 mtt180 -141.58 143.8 33.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.281 -0.887 . . . . 0.0 109.944 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.842 HG12 HG23 ' A' ' 153' ' ' ILE . 69.6 t -50.05 -177.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 109.413 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.977 HG21 ' HB3' ' A' ' 218' ' ' ALA . 8.2 pt 43.94 25.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.004 -1.06 . . . . 0.0 110.011 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.8 OUTLIER -147.47 -35.47 0.23 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.483 -0.761 . . . . 0.0 109.673 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -96.12 -15.64 22.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.492 -0.755 . . . . 0.0 109.812 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.691 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -57.22 172.98 0.26 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.293 -0.879 . . . . 0.0 110.268 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.535 ' CG2' ' HG2' ' A' ' 161' ' ' ARG . 7.2 t -174.36 167.44 4.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.192 -0.943 . . . . 0.0 110.104 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 157' ' ' THR . 96.9 p -42.7 -49.81 5.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.33 -0.856 . . . . 0.0 110.166 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.67 161.07 75.5 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.214 -0.929 . . . . 0.0 110.119 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.73 68.73 3.71 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.959 1.505 . . . . 0.0 110.481 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.665 ' O ' HG13 ' A' ' 163' ' ' VAL . 3.0 mmt85 -60.89 107.66 0.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.195 -0.941 . . . . 0.0 110.167 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.552 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -65.46 96.71 0.26 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.909 . . . . 0.0 110.311 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 1.091 HG22 ' HA ' ' A' ' 194' ' ' GLU . 8.5 m -104.7 -164.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.967 . . . . 0.0 110.254 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.672 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -179.67 149.03 0.35 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.843 -1.161 . . . . 0.0 110.169 -179.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 1.173 HG23 ' CG2' ' A' ' 223' ' ' ILE . 0.3 OUTLIER -89.82 150.03 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.302 -0.874 . . . . 0.0 110.233 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 222' ' ' ARG . 21.4 m -124.07 -20.3 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.151 -0.968 . . . . 0.0 110.289 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.87 120.61 2.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.18 -0.95 . . . . 0.0 110.251 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.761 HG13 HG22 ' A' ' 221' ' ' ILE . 5.3 tt -122.33 7.05 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.198 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.448 ' O ' ' HB3' ' A' ' 170' ' ' GLU . 52.9 t30 -62.32 89.28 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.2 -0.937 . . . . 0.0 110.214 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' A' ' 169' ' ' ASN . 10.3 pt-20 177.2 47.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.927 . . . . 0.0 110.253 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' ' 171' ' ' ILE . 9.8 mt -82.28 44.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.893 . . . . 0.0 110.336 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.429 ' O ' ' C ' ' A' ' 173' ' ' GLN . 2.9 m-85 -46.6 -64.09 0.85 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 110.188 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.429 ' C ' ' O ' ' A' ' 172' ' ' PHE . 0.4 OUTLIER -42.42 159.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.357 -0.839 . . . . 0.0 110.197 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.453 ' O ' HG12 ' A' ' 174' ' ' VAL . 55.6 t -111.01 -5.81 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.885 . . . . 0.0 110.237 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.634 ' O ' HG23 ' A' ' 176' ' ' THR . 0.2 OUTLIER -96.72 104.78 16.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.869 . . . . 0.0 110.267 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 175' ' ' GLU . 0.1 OUTLIER -165.74 33.24 0.05 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.145 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -52.83 -44.48 66.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.927 . . . . 0.0 110.215 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -68.21 -31.31 70.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.298 -0.876 . . . . 0.0 110.241 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 1.007 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -70.15 -39.75 75.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.367 -0.833 . . . . 0.0 109.995 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.506 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -55.58 -18.79 8.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.148 -0.97 . . . . 0.0 109.912 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -72.17 -58.02 3.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.35 -0.843 . . . . 0.0 110.234 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.782 ' C ' HD12 ' A' ' 182' ' ' LEU . 4.5 pp -69.54 -7.68 40.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 0.0 109.983 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 1.007 HD13 ' CZ ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -97.57 -27.13 14.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.359 -0.838 . . . . 0.0 109.924 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 180' ' ' THR . 4.6 t70 -81.37 -3.16 51.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.349 -0.844 . . . . 0.0 109.957 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -87.24 26.88 1.13 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.332 -0.855 . . . . 0.0 110.151 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 11.5 t0 56.01 63.06 2.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 0.0 110.137 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.56 ' O ' ' CB ' ' A' ' 188' ' ' ARG . 34.8 mt -130.86 -82.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.213 -0.929 . . . . 0.0 110.42 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.56 ' CB ' ' O ' ' A' ' 187' ' ' ILE . 0.1 OUTLIER 73.89 151.74 0.12 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.515 -0.741 . . . . 0.0 109.681 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.939 ' O ' ' N ' ' A' ' 191' ' ' SER . 4.4 m 33.86 38.52 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 O-C-N 121.315 -0.866 . . . . 0.0 110.443 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.829 ' N ' HD12 ' A' ' 165' ' ' ILE . . . 28.16 19.81 0.0 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.939 ' N ' ' O ' ' A' ' 189' ' ' VAL . 21.2 t 39.5 -145.12 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.346 -1.091 . . . . 0.0 109.608 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.672 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 1.8 tt0 -96.26 117.62 31.16 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.63 HG13 ' C ' ' A' ' 192' ' ' GLU . 33.0 m -157.71 -137.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.209 -0.932 . . . . 0.0 110.097 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 1.091 ' HA ' HG22 ' A' ' 163' ' ' VAL . 1.9 pt-20 -173.75 159.51 3.49 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 110.091 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.834 HD13 HG13 ' A' ' 152' ' ' VAL . 1.0 OUTLIER -120.46 165.13 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.07 -1.019 . . . . 0.0 110.452 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 197' ' ' ASP . 40.2 t -138.64 86.09 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.329 -0.857 . . . . 0.0 110.128 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 196' ' ' VAL . 48.5 t0 -42.31 129.92 3.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -0.893 . . . . 0.0 110.369 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.543 ' CB ' ' O ' ' A' ' 201' ' ' HIS . 8.7 ttp180 -115.16 72.66 0.8 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.223 -0.923 . . . . 0.0 110.161 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 198' ' ' ARG . 1.3 m-20 41.27 58.32 2.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 0.0 110.395 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 109.81 -44.82 1.42 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.543 ' O ' ' CB ' ' A' ' 198' ' ' ARG . 0.3 OUTLIER -93.74 114.86 27.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.187 -1.184 . . . . 0.0 110.266 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.688 HD13 ' HA ' ' A' ' 153' ' ' ILE . 11.9 mt -95.45 127.72 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.925 . . . . 0.0 110.411 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.424 ' O ' HG22 ' A' ' 195' ' ' ILE . 40.4 m -110.83 163.67 13.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 0.0 109.97 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 1.04 HD22 ' CD2' ' A' ' 206' ' ' HIS . 0.7 OUTLIER -119.64 133.76 55.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 110.293 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.548 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 1.4 t -119.84 120.02 35.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.342 -0.849 . . . . 0.0 109.865 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 1.04 ' CD2' HD22 ' A' ' 204' ' ' LEU . 2.8 m170 -106.53 -163.83 0.95 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.341 -0.849 . . . . 0.0 110.111 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -52.69 91.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 110.063 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 59.83 20.95 54.4 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -130.53 168.7 16.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -1.141 . . . . 0.0 110.181 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' A' ' 204' ' ' LEU . 0.2 OUTLIER -157.84 152.18 24.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.218 -0.926 . . . . 0.0 110.235 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 212' ' ' GLU . 40.5 t -146.87 167.55 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.891 . . . . 0.0 110.145 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.508 ' N ' HG12 ' A' ' 211' ' ' VAL . 2.7 tt0 -98.62 69.92 1.9 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.29 -0.881 . . . . 0.0 110.333 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.51 ' HG ' ' N ' ' A' ' 214' ' ' LEU . 6.5 tp -63.25 155.28 28.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.289 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.86 ' O ' ' HB2' ' A' ' 218' ' ' ALA . 27.8 mt -59.37 150.82 25.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.22 -0.925 . . . . 0.0 109.94 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' A' ' 218' ' ' ALA . 2.9 p-10 -90.91 -109.18 0.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.028 -1.045 . . . . 0.0 110.238 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 215' ' ' ASP . 0.3 OUTLIER -42.87 -25.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.029 -1.044 . . . . 0.0 109.911 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 215' ' ' ASP . 1.1 mp -81.46 -21.6 38.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.299 -0.876 . . . . 0.0 110.488 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.977 ' HB3' HG21 ' A' ' 153' ' ' ILE . . . -75.67 48.12 0.44 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.076 -1.015 . . . . 0.0 110.461 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.712 ' CB ' HD11 ' A' ' 153' ' ' ILE . 4.3 t60 -118.76 29.05 7.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.137 -0.977 . . . . 0.0 110.173 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . 0.407 ' O ' ' CD ' ' A' ' 170' ' ' GLU . 0.2 OUTLIER -113.69 -34.23 5.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 110.165 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.777 HG12 HG23 ' A' ' 223' ' ' ILE . 0.1 OUTLIER -70.52 134.01 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.307 -0.87 . . . . 0.0 110.347 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.867 ' O ' HG22 ' A' ' 166' ' ' VAL . 4.4 mtt180 -89.87 101.39 14.09 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.216 -0.927 . . . . 0.0 109.642 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 1.173 ' CG2' HG23 ' A' ' 165' ' ' ILE . 1.0 OUTLIER -119.56 -176.78 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 110.659 -179.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.474 ' OE1' HG11 ' A' ' 166' ' ' VAL . 11.5 pt-20 -150.6 178.48 9.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.468 -0.77 . . . . 0.0 110.204 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 3.8 tm-20 -106.48 120.15 41.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.303 -0.873 . . . . 0.0 110.068 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.421 HD23 ' HD2' ' A' ' 162' ' ' LYS . 39.1 tp . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.222 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.533 ' CB ' ' CD ' ' A' ' 131' ' ' PRO . 2.0 m120 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 120.734 0.302 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 130' ' ' ASN . 45.7 Cg_endo -72.92 60.53 3.71 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.976 1.514 . . . . 0.0 110.468 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 24.6 mm -71.19 117.95 61.29 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 0.0 110.226 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.85 90.07 0.85 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.985 1.519 . . . . 0.0 110.373 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -84.3 99.67 2.28 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 137' ' ' GLU . 1.2 tp -69.79 -16.7 63.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -1.13 . . . . 0.0 110.14 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 137' ' ' GLU . 0.5 OUTLIER 60.76 -81.31 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.266 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 135' ' ' LEU . 7.5 mt-10 57.64 29.21 16.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.378 -0.826 . . . . 0.0 110.165 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.93 171.09 8.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 110.271 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -139.71 -93.46 0.25 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.3 m -123.33 -176.83 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.307 -1.114 . . . . 0.0 110.219 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -127.1 -95.01 0.89 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 47.11 62.62 2.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.259 -1.142 . . . . 0.0 110.276 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 144' ' ' ASP . 7.4 p -130.58 128.69 41.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.229 -0.92 . . . . 0.0 110.221 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 143' ' ' SER . 25.4 t0 43.19 55.62 4.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.235 -0.915 . . . . 0.0 110.213 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -170.83 -142.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 0.0 110.304 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.56 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -168.71 26.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.234 -0.916 . . . . 0.0 109.933 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.608 ' N ' ' CD ' ' A' ' 148' ' ' PRO . . . 61.5 45.86 0.92 Allowed Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.331 -0.856 . . . . 0.0 110.32 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 147' ' ' ALA . 49.9 Cg_endo -73.89 35.48 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.915 1.482 . . . . 0.0 110.631 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 147' ' ' ALA . . . -154.24 -172.48 22.23 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.631 ' O ' HG22 ' A' ' 150' ' ' THR . 53.7 m -147.28 10.76 1.0 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.296 -1.12 . . . . 0.0 110.375 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.533 ' HB2' ' HB2' ' A' ' 154' ' ' ASP . 13.5 mmt180 59.7 136.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -0.9 . . . . 0.0 110.226 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.992 HG13 HG21 ' A' ' 195' ' ' ILE . 1.4 t -64.97 -0.58 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.219 -0.926 . . . . 0.0 110.966 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.828 HG21 ' HB3' ' A' ' 218' ' ' ALA . 1.0 OUTLIER -115.53 -4.62 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.911 -1.118 . . . . 0.0 110.652 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.533 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 0.7 OUTLIER -103.19 -28.6 11.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.125 -0.985 . . . . 0.0 109.949 179.673 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.492 ' HB2' ' CG2' ' A' ' 150' ' ' THR . . . -84.09 -15.4 47.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 110.05 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.726 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -71.97 -161.8 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.326 -0.859 . . . . 0.0 110.197 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 156' ' ' ALA . 0.4 OUTLIER 55.88 160.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.33 -0.856 . . . . 0.0 110.12 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 157' ' ' THR . 5.6 p 42.86 30.84 0.27 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 110.212 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.73 134.15 1.74 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.323 -0.86 . . . . 0.0 110.065 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.608 ' O ' ' O ' ' A' ' 161' ' ' ARG . 45.9 Cg_endo -73.36 74.61 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.935 1.492 . . . . 0.0 110.542 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.667 ' HB3' HG22 ' A' ' 196' ' ' VAL . 2.1 ptt85 27.44 104.32 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.492 0.663 . . . . 0.0 111.393 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.51 ' C ' HG13 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -168.76 68.75 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.99 -1.069 . . . . 0.0 110.287 179.534 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.655 ' O ' ' O ' ' A' ' 193' ' ' VAL . 16.6 m -150.62 -155.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.886 . . . . 0.0 110.329 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.669 ' CB ' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -177.56 167.72 2.22 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.783 -1.198 . . . . 0.0 110.518 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 1.088 HG23 ' CG2' ' A' ' 223' ' ' ILE . 0.3 OUTLIER -98.83 159.52 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.224 -0.922 . . . . 0.0 110.268 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 222' ' ' ARG . 31.5 m -131.13 -28.62 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.892 . . . . 0.0 110.222 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -144.92 93.59 2.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.197 -0.939 . . . . 0.0 110.124 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.762 ' H ' HG12 ' A' ' 189' ' ' VAL . 0.3 OUTLIER -54.07 -32.23 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.219 -0.925 . . . . 0.0 110.124 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 168' ' ' ILE . 0.2 OUTLIER 42.56 71.25 0.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 0.0 110.252 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 170' ' ' GLU . 33.6 tt0 -151.28 72.29 1.04 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.259 -0.9 . . . . 0.0 110.211 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 32.4 mm -84.2 -6.63 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 110.281 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -75.32 166.37 23.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.427 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -115.66 -17.38 11.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -0.918 . . . . 0.0 110.2 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 86.6 t -69.66 -21.33 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.19 -0.944 . . . . 0.0 110.224 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -89.82 90.27 8.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.252 -0.905 . . . . 0.0 110.177 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 1.055 HG23 HG23 ' A' ' 180' ' ' THR . 21.2 m -124.36 -90.06 0.57 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.885 . . . . 0.0 110.197 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.589 ' N ' HG22 ' A' ' 176' ' ' THR . 3.0 t0 68.37 -158.0 0.19 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.214 -0.929 . . . . 0.0 110.319 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.443 ' OE1' ' OE1' ' A' ' 212' ' ' GLU . 1.2 mt-30 -59.14 -23.33 62.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.895 . . . . 0.0 110.411 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 1.025 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -47.96 -23.51 0.8 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.181 -0.949 . . . . 0.0 110.133 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 1.055 HG23 HG23 ' A' ' 176' ' ' THR . 0.5 OUTLIER -58.58 -25.75 62.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 109.949 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -71.46 -62.85 1.26 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.301 -0.874 . . . . 0.0 110.167 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.837 HD22 HD12 ' A' ' 213' ' ' LEU . 3.3 pp -61.06 -13.89 19.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.341 -0.85 . . . . 0.0 110.101 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 1.025 HD13 ' CZ ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -85.22 -30.14 24.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.903 . . . . 0.0 110.058 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -69.59 -14.28 62.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.416 -0.802 . . . . 0.0 110.039 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.453 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -91.45 24.82 2.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -0.858 . . . . 0.0 110.174 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 185' ' ' ALA . 30.5 t0 40.84 83.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 110.171 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.647 HD12 ' O ' ' A' ' 182' ' ' LEU . 87.7 mt -133.85 -75.78 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.0 110.448 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.548 ' CB ' ' O ' ' A' ' 187' ' ' ILE . 5.6 ttp85 71.48 154.65 0.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.374 -0.829 . . . . 0.0 109.716 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.956 ' O ' ' N ' ' A' ' 191' ' ' SER . 4.2 m 32.9 38.35 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 121.235 -0.916 . . . . 0.0 110.558 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.872 ' N ' HD12 ' A' ' 165' ' ' ILE . . . 26.83 19.58 0.0 OUTLIER Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.956 ' N ' ' O ' ' A' ' 189' ' ' VAL . 39.5 t 37.06 -146.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.322 -1.105 . . . . 0.0 109.868 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.669 ' HA ' ' CB ' ' A' ' 164' ' ' ARG . 18.9 mt-10 -92.12 115.99 28.55 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.655 ' O ' ' O ' ' A' ' 163' ' ' VAL . 34.3 m -159.25 -132.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.098 -1.001 . . . . 0.0 109.59 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.604 ' O ' HD23 ' A' ' 204' ' ' LEU . 1.5 pm0 -167.29 159.0 12.29 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.544 -0.862 . . . . 0.0 110.239 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.992 HG21 HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -119.98 163.95 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.28 -0.887 . . . . 0.0 110.154 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.667 HG22 ' HB3' ' A' ' 161' ' ' ARG . 54.8 t -140.83 90.01 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.208 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.48 ' OD1' ' CB ' ' A' ' 156' ' ' ALA . 15.4 m-20 -52.66 118.74 3.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.883 . . . . 0.0 110.332 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.474 ' HB3' ' HB3' ' A' ' 201' ' ' HIS . 0.6 OUTLIER -105.02 73.13 1.04 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.224 -0.922 . . . . 0.0 110.246 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 198' ' ' ARG . 1.6 m-20 42.55 53.87 4.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 110.21 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 110.62 -41.36 2.26 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 198' ' ' ARG . 0.1 OUTLIER -89.79 95.29 10.18 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.279 -1.13 . . . . 0.0 110.162 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.502 HD13 ' HA ' ' A' ' 153' ' ' ILE . 20.4 mt -80.71 114.45 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 110.322 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 211' ' ' VAL . 3.9 m -102.56 163.33 12.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 0.0 109.916 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.923 HD22 ' CD2' ' A' ' 206' ' ' HIS . 0.7 OUTLIER -119.81 136.84 54.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.097 -1.002 . . . . 0.0 110.308 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.626 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.4 OUTLIER -119.88 123.31 43.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 0.0 109.92 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.923 ' CD2' HD22 ' A' ' 204' ' ' LEU . 2.7 m80 -112.08 -171.59 1.88 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.296 -0.877 . . . . 0.0 110.07 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -48.94 91.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.215 -0.928 . . . . 0.0 110.175 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 54.98 23.84 32.71 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.511 ' O ' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -138.5 94.81 2.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -1.144 . . . . 0.0 110.259 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -100.44 148.44 24.75 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.254 -0.904 . . . . 0.0 110.246 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 212' ' ' GLU . 14.3 t -141.18 171.56 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.932 . . . . 0.0 110.225 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 213' ' ' LEU . 2.7 tt0 -95.72 84.89 4.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 110.181 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.904 ' O ' HD23 ' A' ' 214' ' ' LEU . 6.8 tp -60.03 -138.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -0.926 . . . . 0.0 110.296 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.904 HD23 ' O ' ' A' ' 213' ' ' LEU . 14.8 mt -139.62 157.71 45.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.248 -0.907 . . . . 0.0 110.087 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 216' ' ' ASP . 4.6 p30 -90.52 -106.76 0.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.207 -0.933 . . . . 0.0 110.263 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 215' ' ' ASP . 0.1 OUTLIER -41.73 -25.38 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.092 -1.005 . . . . 0.0 110.121 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 215' ' ' ASP . 0.3 OUTLIER -80.79 -26.76 36.97 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.259 -0.901 . . . . 0.0 110.329 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.842 ' HB2' ' O ' ' A' ' 214' ' ' LEU . . . -71.94 -3.88 25.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.053 -1.03 . . . . 0.0 110.018 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.499 ' O ' ' NH1' ' A' ' 151' ' ' ARG . 11.2 t-80 -83.56 55.34 3.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 110.143 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.1 -49.72 0.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -0.913 . . . . 0.0 110.322 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.661 HD13 ' N ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -67.22 137.46 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.291 -0.881 . . . . 0.0 110.352 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.708 ' O ' HG22 ' A' ' 166' ' ' VAL . 0.6 OUTLIER -89.53 110.73 21.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 109.333 179.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 1.088 ' CG2' HG23 ' A' ' 165' ' ' ILE . 0.5 OUTLIER -119.82 175.46 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.165 -0.959 . . . . 0.0 110.636 -179.111 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.465 ' O ' ' HB ' ' A' ' 163' ' ' VAL . 5.9 mt-10 -143.61 167.32 22.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.336 -0.852 . . . . 0.0 110.12 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.51 ' HA ' HG12 ' A' ' 163' ' ' VAL . 4.7 pt-20 -101.57 48.51 0.88 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.312 -0.867 . . . . 0.0 110.253 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.519 HD13 ' NH2' ' A' ' 164' ' ' ARG . 2.4 tp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.118 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.5 m120 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 120.804 0.335 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.475 ' HB2' HD12 ' A' ' 132' ' ' ILE . 45.6 Cg_endo -72.28 -38.34 3.74 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.049 1.552 . . . . 0.0 110.41 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.475 HD12 ' HB2' ' A' ' 131' ' ' PRO . 1.8 mp -141.7 129.09 11.64 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.231 -0.918 . . . . 0.0 110.177 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.98 -19.61 22.97 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.955 1.503 . . . . 0.0 110.47 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.83 -97.41 1.85 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.43 ' O ' ' HG3' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -125.37 -6.34 7.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -1.12 . . . . 0.0 110.21 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.4 t70 52.11 54.13 11.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.27 -0.894 . . . . 0.0 110.216 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 135' ' ' LEU . 43.2 mt-10 -135.55 27.61 3.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 110.292 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 138' ' ' LEU . 0.5 OUTLIER -75.6 -28.04 58.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 110.223 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 115.73 -173.68 14.87 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 38.1 t -68.0 -20.78 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.229 -1.159 . . . . 0.0 110.203 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 99.71 -129.66 9.97 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -127.34 -163.18 1.23 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -1.133 . . . . 0.0 110.231 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.8 t -80.86 -27.92 36.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 110.236 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 145' ' ' ALA . 27.3 p-10 -46.6 -28.32 1.41 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.196 -0.94 . . . . 0.0 110.214 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.449 ' N ' ' OD1' ' A' ' 144' ' ' ASP . . . 47.19 26.75 0.72 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 110.211 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.561 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -139.07 47.57 1.91 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.298 -0.876 . . . . 0.0 110.259 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . 60.8 145.92 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 110.235 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.1 64.55 4.23 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.005 1.529 . . . . 0.0 110.415 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.502 ' HA3' ' HB3' ' A' ' 222' ' ' ARG . . . 113.61 126.18 4.38 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.58 HG22 ' CB ' ' A' ' 154' ' ' ASP . 98.0 m -141.39 151.97 43.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -1.101 . . . . 0.0 110.1 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.5 ' HG2' ' HA ' ' A' ' 219' ' ' HIS . 0.0 OUTLIER -43.15 125.06 3.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.142 -0.974 . . . . 0.0 110.259 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 1.096 HG22 HD13 ' A' ' 195' ' ' ILE . 5.9 p -44.75 -26.8 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.239 -0.913 . . . . 0.0 110.174 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.92 HG22 HD13 ' A' ' 202' ' ' ILE . 9.9 pt -92.33 -15.7 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.204 -0.935 . . . . 0.0 110.248 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.58 ' CB ' HG22 ' A' ' 150' ' ' THR . 0.8 OUTLIER -77.35 -21.97 52.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.396 179.558 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.411 ' HB3' HD11 ' A' ' 223' ' ' ILE . . . -106.9 -9.78 16.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.562 -0.711 . . . . 0.0 109.756 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.53 ' HA ' ' HB3' ' A' ' 160' ' ' PRO . . . -66.13 -174.11 0.23 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 110.216 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.766 HG22 ' H ' ' A' ' 158' ' ' SER . 4.0 m 43.64 -170.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 110.182 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.766 ' H ' HG22 ' A' ' 157' ' ' THR . 2.2 t 50.45 30.35 4.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.173 -0.954 . . . . 0.0 110.058 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . 0.521 ' CB ' ' O ' ' A' ' 158' ' ' SER . 0.5 OUTLIER 69.88 64.8 0.49 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 110.135 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.588 ' O ' ' CG ' ' A' ' 161' ' ' ARG . 45.9 Cg_endo -74.11 -61.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.0 1.526 . . . . 0.0 110.22 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.764 ' O ' HG22 ' A' ' 163' ' ' VAL . 0.0 OUTLIER 74.07 179.63 0.2 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.455 -0.778 . . . . 0.0 110.238 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.59 ' N ' ' CD ' ' A' ' 161' ' ' ARG . 14.0 tptt -40.03 126.3 2.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.834 . . . . 0.0 110.84 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 1.063 HG23 ' HA ' ' A' ' 194' ' ' GLU . 0.1 OUTLIER -134.11 -160.88 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.411 -0.805 . . . . 0.0 109.436 179.175 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.654 ' HA ' ' O ' ' A' ' 191' ' ' SER . 0.1 OUTLIER -177.21 144.4 0.42 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.831 -1.168 . . . . 0.0 110.39 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.927 HG23 HG22 ' A' ' 223' ' ' ILE . 1.1 mt -103.66 151.03 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.39 -0.819 . . . . 0.0 110.442 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.508 HG13 ' C ' ' A' ' 165' ' ' ILE . 22.9 m -150.72 17.87 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.165 -0.959 . . . . 0.0 110.295 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.432 ' OE1' HG23 ' A' ' 166' ' ' VAL . 0.1 OUTLIER -155.03 119.86 4.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.213 -0.929 . . . . 0.0 110.196 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 168' ' ' ILE . 0.9 OUTLIER -111.31 11.18 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.187 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 168' ' ' ILE . 5.4 m-20 -42.06 122.29 2.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.21 -0.932 . . . . 0.0 110.086 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 171' ' ' ILE . 5.1 pt-20 -144.79 55.88 1.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 110.189 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 170' ' ' GLU . 28.1 mt -41.91 -33.32 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.291 -0.881 . . . . 0.0 110.022 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.58 ' HE1' HG22 ' A' ' 220' ' ' THR . 3.4 p90 -98.93 158.71 15.46 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.349 -0.845 . . . . 0.0 110.191 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.453 ' O ' ' HB ' ' A' ' 174' ' ' VAL . 0.0 OUTLIER -178.0 152.54 0.74 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 110.187 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 173' ' ' GLN . 2.5 p 178.33 -30.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 110.134 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.433 ' OE2' ' OD2' ' A' ' 216' ' ' ASP . 35.0 tt0 -85.29 151.39 24.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -0.891 . . . . 0.0 110.123 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.74 HG23 ' HD2' ' A' ' 179' ' ' PHE . 36.4 m -164.68 -96.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 110.037 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.62 ' N ' HG22 ' A' ' 176' ' ' THR . 2.6 m-20 69.17 -136.7 0.08 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.148 -0.97 . . . . 0.0 110.307 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -56.55 -28.94 61.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.207 -0.933 . . . . 0.0 110.52 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.74 ' HD2' HG23 ' A' ' 176' ' ' THR . 0.1 OUTLIER -42.95 -39.82 2.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 110.263 -179.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.694 HG23 ' CG2' ' A' ' 176' ' ' THR . 0.7 OUTLIER -39.26 -28.3 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.905 . . . . 0.0 110.089 -179.781 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 179' ' ' PHE . 5.9 tt0 -60.2 -36.02 76.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.268 -0.895 . . . . 0.0 109.576 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.607 HD12 ' HA ' ' A' ' 179' ' ' PHE . 1.0 OUTLIER -69.77 -41.32 75.31 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.389 -0.82 . . . . 0.0 109.431 179.345 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.57 HD23 ' CZ ' ' A' ' 179' ' ' PHE . 0.1 OUTLIER -66.87 -39.17 87.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.41 -0.806 . . . . 0.0 109.812 179.641 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -61.73 -17.78 57.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.429 -0.794 . . . . 0.0 109.703 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -90.66 18.87 5.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.385 -0.822 . . . . 0.0 110.033 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 185' ' ' ALA . 2.8 m-20 42.48 68.02 0.53 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 109.669 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.522 HG22 ' N ' ' A' ' 188' ' ' ARG . 10.6 mm -115.24 167.47 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.302 -0.874 . . . . 0.0 110.882 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.636 ' O ' ' O ' ' A' ' 189' ' ' VAL . 0.2 OUTLIER -173.31 113.26 0.22 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.691 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 0.6 OUTLIER 43.74 101.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.272 -0.893 . . . . 0.0 108.693 -178.149 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.894 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -39.02 -19.05 0.01 OUTLIER Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.654 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 3.7 t 67.04 -145.18 0.15 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.969 -1.312 . . . . 0.0 108.979 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.581 ' C ' HG13 ' A' ' 193' ' ' VAL . 7.8 mt-10 -62.68 98.33 0.12 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 109.25 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.612 HG23 ' N ' ' A' ' 194' ' ' GLU . 10.0 m -154.1 -142.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.062 -1.024 . . . . 0.0 110.356 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 1.063 ' HA ' HG23 ' A' ' 163' ' ' VAL . 24.3 tt0 -169.64 157.71 7.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.88 . . . . 0.0 110.394 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 1.096 HD13 HG22 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -131.54 161.92 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.147 -0.97 . . . . 0.0 110.215 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.465 ' O ' ' HG2' ' A' ' 198' ' ' ARG . 97.1 t -144.97 86.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.266 -0.897 . . . . 0.0 110.067 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.549 ' CB ' ' OG1' ' A' ' 157' ' ' THR . 53.1 t0 -55.7 124.29 16.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.305 -0.872 . . . . 0.0 110.404 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.515 ' NH2' ' HB3' ' A' ' 198' ' ' ARG . 6.5 mmm180 -107.12 80.98 1.48 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.351 -0.843 . . . . 0.0 110.19 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.489 ' C ' ' O ' ' A' ' 198' ' ' ARG . 2.7 p30 36.23 38.19 0.06 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.452 -0.78 . . . . 0.0 110.565 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 137.57 -50.47 0.82 Allowed Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 198' ' ' ARG . 1.6 t-160 -90.04 114.75 26.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.344 -1.092 . . . . 0.0 110.42 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.92 HD13 HG22 ' A' ' 153' ' ' ILE . 35.6 mt -100.98 116.93 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 110.171 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.469 HG22 ' OD2' ' A' ' 210' ' ' ASP . 6.9 m -97.1 152.57 18.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 110.364 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 1.086 HD22 ' CD2' ' A' ' 206' ' ' HIS . 0.7 OUTLIER -119.84 131.95 55.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.361 -0.837 . . . . 0.0 110.086 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.568 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 5.0 t -119.72 115.69 24.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.276 -0.89 . . . . 0.0 110.137 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 1.086 ' CD2' HD22 ' A' ' 204' ' ' LEU . 1.9 m80 -103.45 153.59 20.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.605 -0.684 . . . . 0.0 109.832 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -51.02 -19.2 0.98 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.214 -0.929 . . . . 0.0 110.094 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' A' ' 209' ' ' LYS . . . -95.86 -27.42 10.36 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 208' ' ' GLY . 1.4 ptmt 171.63 -179.36 0.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.261 -1.141 . . . . 0.0 110.281 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.469 ' OD2' HG22 ' A' ' 203' ' ' THR . 0.8 OUTLIER -124.36 149.71 46.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -0.848 . . . . 0.0 110.131 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 6.1 p -129.68 164.7 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.244 -0.91 . . . . 0.0 110.075 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -86.97 70.34 10.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.374 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.996 HD22 HD12 ' A' ' 204' ' ' LEU . 1.8 tp -63.08 163.37 10.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.975 . . . . 0.0 110.099 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.614 HD11 HD23 ' A' ' 217' ' ' LEU . 0.6 OUTLIER -130.2 145.43 51.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.911 . . . . 0.0 110.307 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.454 ' HA ' HG21 ' A' ' 153' ' ' ILE . 3.5 p30 -55.08 -37.1 66.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 110.271 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.575 ' HB2' HD12 ' A' ' 214' ' ' LEU . 0.6 OUTLIER -55.79 -50.37 70.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.193 -0.942 . . . . 0.0 110.245 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.614 HD23 HD11 ' A' ' 214' ' ' LEU . 2.2 mm? -89.41 -28.18 19.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 110.218 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.651 ' HB1' HG23 ' A' ' 153' ' ' ILE . . . -67.1 -9.28 37.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 109.969 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.8 ' O ' HG23 ' A' ' 220' ' ' THR . 3.0 t-160 -91.09 69.24 6.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.169 -0.957 . . . . 0.0 110.181 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . 0.8 HG23 ' O ' ' A' ' 219' ' ' HIS . 0.6 OUTLIER -166.54 -58.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.177 -0.952 . . . . 0.0 110.4 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.675 ' N ' HD13 ' A' ' 221' ' ' ILE . 0.1 OUTLIER -65.53 136.43 26.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.304 -0.872 . . . . 0.0 110.319 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.502 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 47.1 mtt180 -95.67 116.59 29.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 110.058 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.927 HG22 HG23 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -119.78 177.37 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 110.168 -179.759 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.546 ' HB2' ' NH2' ' A' ' 164' ' ' ARG . 2.3 mt-10 -150.04 179.69 7.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.933 . . . . 0.0 110.295 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 1.5 mt-10 -90.15 69.89 7.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.384 -0.822 . . . . 0.0 110.214 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.463 ' OXT' ' O ' ' A' ' 225' ' ' GLU . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.214 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.572 ' CB ' ' CD ' ' A' ' 131' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 120.677 0.275 . . . . 0.0 110.274 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.572 ' CD ' ' CB ' ' A' ' 130' ' ' ASN . 46.2 Cg_endo -72.94 -9.34 23.52 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.93 1.49 . . . . 0.0 110.413 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.3 mp -113.91 112.08 47.82 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.312 -0.868 . . . . 0.0 110.149 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.65 159.42 48.77 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.035 1.545 . . . . 0.0 110.567 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 149.51 -43.57 0.76 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.59 -21.18 62.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.284 -1.127 . . . . 0.0 110.188 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.0 t70 50.97 89.48 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.282 -0.886 . . . . 0.0 110.252 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -138.38 21.42 2.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 110.194 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.692 ' N ' HD23 ' A' ' 138' ' ' LEU . 2.7 pt? -49.55 -21.94 1.12 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.195 -0.941 . . . . 0.0 110.171 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 141' ' ' GLY . . . -94.48 65.08 1.54 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.559 HG12 ' N ' ' A' ' 141' ' ' GLY . 97.7 t 46.53 -97.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.216 -1.167 . . . . 0.0 110.249 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.559 ' N ' HG12 ' A' ' 140' ' ' VAL . . . 152.94 -87.75 0.13 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' A' ' 143' ' ' SER . 1.6 t-20 -80.79 140.25 35.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.28 -1.129 . . . . 0.0 110.284 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 142' ' ' ASN . 34.7 t -178.94 109.6 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.184 -0.947 . . . . 0.0 110.278 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.402 ' CB ' ' O ' ' A' ' 143' ' ' SER . 0.3 OUTLIER 63.69 32.24 13.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.227 -0.921 . . . . 0.0 110.296 179.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.77 -145.3 0.11 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.161 -0.962 . . . . 0.0 110.228 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -157.95 -36.55 0.07 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 110.287 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.02 147.66 48.73 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.356 -0.84 . . . . 0.0 110.175 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.69 86.74 1.02 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.976 1.514 . . . . 0.0 110.439 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -178.95 153.17 12.03 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.53 ' HB ' ' O ' ' A' ' 223' ' ' ILE . 7.7 m -123.46 -1.82 8.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.159 -1.201 . . . . 0.0 110.216 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.507 ' CB ' ' HB2' ' A' ' 154' ' ' ASP . 2.5 mpt_? 57.21 110.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.879 . . . . 0.0 109.851 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 1.025 HG13 HD13 ' A' ' 195' ' ' ILE . 4.9 t -40.46 -68.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.358 -0.839 . . . . 0.0 110.278 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.782 HD13 ' N ' ' A' ' 153' ' ' ILE . 0.2 OUTLIER -43.8 -28.13 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.21 -0.932 . . . . 0.0 110.594 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 150' ' ' THR . 0.5 OUTLIER -81.05 -19.78 43.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.11 -0.994 . . . . 0.0 110.209 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 152' ' ' VAL . . . -100.44 -6.01 26.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.169 -0.957 . . . . 0.0 110.181 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.498 ' O ' HG22 ' A' ' 157' ' ' THR . . . -75.78 166.98 22.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.93 . . . . 0.0 110.174 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.697 HG23 ' N ' ' A' ' 158' ' ' SER . 0.4 OUTLIER 45.71 -175.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.165 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.697 ' N ' HG23 ' A' ' 157' ' ' THR . 1.7 t 69.85 -54.59 0.61 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 109.987 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . 0.487 ' CB ' ' O ' ' A' ' 158' ' ' SER . 0.0 OUTLIER 169.65 59.59 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.362 -0.836 . . . . 0.0 110.129 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.545 ' O ' ' CB ' ' A' ' 161' ' ' ARG . 44.6 Cg_endo -73.2 -72.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.019 1.536 . . . . 0.0 110.414 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.545 ' CB ' ' O ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER 71.45 -66.44 0.3 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.28 -0.888 . . . . 0.0 110.255 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.609 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 4.9 tttp -162.24 120.08 2.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 0.0 110.755 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.815 HG22 ' HA ' ' A' ' 194' ' ' GLU . 31.3 m -139.89 -151.53 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.889 . . . . 0.0 110.016 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.616 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 11.1 ttp180 -179.89 155.5 0.62 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.676 -1.265 . . . . 0.0 110.556 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 1.102 HG23 ' CG2' ' A' ' 223' ' ' ILE . 0.3 OUTLIER -89.66 151.28 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.163 -0.961 . . . . 0.0 109.896 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.953 HG22 ' O ' ' A' ' 222' ' ' ARG . 20.0 m -122.48 -18.46 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.176 -0.952 . . . . 0.0 110.588 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -167.88 123.94 1.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.165 -0.96 . . . . 0.0 110.519 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.492 HG12 ' HB ' ' A' ' 221' ' ' ILE . 6.5 mt -99.83 -13.38 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.359 -0.838 . . . . 0.0 109.894 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 170' ' ' GLU . 9.8 p30 38.83 -161.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.521 -0.737 . . . . 0.0 110.39 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.529 ' O ' ' CG ' ' A' ' 170' ' ' GLU . 8.5 tt0 179.1 45.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.886 . . . . 0.0 110.278 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.428 ' C ' ' O ' ' A' ' 170' ' ' GLU . 5.3 mt -42.36 -42.32 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.144 -0.973 . . . . 0.0 110.049 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -85.16 151.32 24.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 110.041 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.661 ' O ' HG12 ' A' ' 174' ' ' VAL . 0.2 OUTLIER -127.18 -169.03 1.97 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.217 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.661 HG12 ' O ' ' A' ' 173' ' ' GLN . 9.7 p 37.42 35.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.404 -0.81 . . . . 0.0 110.514 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' A' ' 177' ' ' ASP . 1.9 tm-20 -107.71 -68.06 0.92 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.892 . . . . 0.0 110.168 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.582 HG22 ' CG2' ' A' ' 180' ' ' THR . 0.0 OUTLIER 45.17 -89.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.467 -0.77 . . . . 0.0 110.475 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 175' ' ' GLU . 0.6 OUTLIER 68.01 -170.29 0.19 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 0.0 110.101 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 11.3 tm0? -44.63 -24.01 0.16 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.217 -0.927 . . . . 0.0 110.482 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.597 ' CA ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -58.69 -34.01 70.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.185 -0.947 . . . . 0.0 110.328 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.582 ' CG2' HG22 ' A' ' 176' ' ' THR . 0.8 OUTLIER -40.31 -29.02 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 110.046 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 179' ' ' PHE . 5.9 tt0 -62.6 -34.13 76.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.385 -0.822 . . . . 0.0 110.038 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.597 HD12 ' CA ' ' A' ' 179' ' ' PHE . 1.6 mt -69.53 -45.41 68.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.346 -0.847 . . . . 0.0 109.738 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 2.0 tt -63.3 -29.32 70.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.448 -0.783 . . . . 0.0 110.051 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.58 -1.68 17.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 110.058 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.421 ' O ' HG13 ' A' ' 187' ' ' ILE . . . -103.04 11.11 37.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.888 . . . . 0.0 110.266 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 185' ' ' ALA . 0.4 OUTLIER 44.69 86.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 109.912 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.643 ' O ' ' CB ' ' A' ' 188' ' ' ARG . 16.1 mt -147.58 -79.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.216 -0.928 . . . . 0.0 110.631 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.643 ' CB ' ' O ' ' A' ' 187' ' ' ILE . 34.1 ttt-85 81.02 149.84 0.1 Allowed 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.92 ' O ' ' N ' ' A' ' 191' ' ' SER . 2.7 m 33.28 35.95 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.37 -0.831 . . . . 0.0 110.329 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.749 ' N ' HD12 ' A' ' 165' ' ' ILE . . . 30.28 17.41 0.0 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.92 ' N ' ' O ' ' A' ' 189' ' ' VAL . 9.5 t 43.37 -147.19 0.06 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.117 -1.225 . . . . 0.0 109.343 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.699 ' HG2' HD21 ' A' ' 226' ' ' LEU . 3.4 mt-10 -77.82 116.16 18.13 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.593 ' O ' ' O ' ' A' ' 163' ' ' VAL . 0.2 OUTLIER -161.66 162.98 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.117 -0.99 . . . . 0.0 109.886 -179.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.815 ' HA ' HG22 ' A' ' 163' ' ' VAL . 4.0 pt-20 -119.87 169.01 10.54 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 119.225 -0.99 . . . . 0.0 110.27 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 1.025 HD13 HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -123.31 142.25 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.931 . . . . 0.0 110.463 -179.483 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.474 ' O ' ' C ' ' A' ' 197' ' ' ASP . 56.5 t -133.9 98.97 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.442 -0.786 . . . . 0.0 109.878 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' A' ' 196' ' ' VAL . 1.1 t0 -38.58 106.58 0.05 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.262 -0.899 . . . . 0.0 110.484 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 200' ' ' GLY . 0.0 OUTLIER -90.55 -172.48 3.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.234 -0.916 . . . . 0.0 110.349 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -53.02 86.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 110.286 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 198' ' ' ARG . . . 65.59 18.37 65.76 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.449 ' O ' ' N ' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -139.64 -176.13 4.45 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.284 -1.127 . . . . 0.0 110.123 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.706 ' CG2' HG22 ' A' ' 195' ' ' ILE . 47.6 mt -137.76 100.8 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 110.336 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.477 ' OG1' ' HG3' ' A' ' 198' ' ' ARG . 6.0 m -86.68 143.51 27.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.147 -0.971 . . . . 0.0 110.121 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.869 ' HG ' HG23 ' A' ' 195' ' ' ILE . 2.7 mp -120.89 146.23 46.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 0.0 110.148 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.518 ' O ' HG23 ' A' ' 193' ' ' VAL . 45.1 m -129.85 130.98 45.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.295 -0.878 . . . . 0.0 110.447 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.663 ' CE1' HG23 ' A' ' 211' ' ' VAL . 0.0 OUTLIER -116.13 -157.21 0.64 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.297 -0.877 . . . . 0.0 109.996 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -44.72 91.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.209 -0.932 . . . . 0.0 110.349 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 45.34 31.64 3.42 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.555 ' O ' ' CE1' ' A' ' 206' ' ' HIS . 0.4 OUTLIER -140.89 118.17 11.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -1.173 . . . . 0.0 110.328 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 2.3 p-10 -104.72 150.59 24.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 110.341 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.663 HG23 ' CE1' ' A' ' 206' ' ' HIS . 32.6 t -142.12 149.84 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.89 . . . . 0.0 110.18 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -82.5 67.25 8.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.284 -0.885 . . . . 0.0 110.297 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.863 ' CB ' HD13 ' A' ' 204' ' ' LEU . 3.4 tm? -51.54 125.56 14.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 0.0 110.056 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.786 HD11 ' HB2' ' A' ' 216' ' ' ASP . 22.1 tp -65.33 106.65 1.41 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 110.251 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.666 ' HB2' HD12 ' A' ' 202' ' ' ILE . 4.4 p30 -59.74 -41.57 91.25 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.306 -0.871 . . . . 0.0 110.358 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.786 ' HB2' HD11 ' A' ' 214' ' ' LEU . 0.3 OUTLIER -41.65 -69.66 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.316 -179.798 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.518 ' HA ' HD13 ' A' ' 217' ' ' LEU . 0.2 OUTLIER -79.58 -13.62 59.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -0.904 . . . . 0.0 110.501 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.643 ' HB3' HG21 ' A' ' 153' ' ' ILE . . . -40.44 -27.69 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.272 -0.893 . . . . 0.0 110.269 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.779 ' HD2' HG21 ' A' ' 153' ' ' ILE . 6.3 m170 -72.09 67.56 0.66 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.893 . . . . 0.0 110.09 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . 0.629 HG23 HG23 ' A' ' 221' ' ' ILE . 7.1 t -158.41 -42.31 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.973 . . . . 0.0 110.702 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.629 HG23 HG23 ' A' ' 220' ' ' THR . 0.1 OUTLIER -74.53 132.61 33.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.2 -0.938 . . . . 0.0 110.566 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.953 ' O ' HG22 ' A' ' 166' ' ' VAL . 19.3 mtm180 -89.48 110.68 21.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.23 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 1.102 ' CG2' HG23 ' A' ' 165' ' ' ILE . 0.8 OUTLIER -119.89 171.78 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 110.806 -179.092 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.477 ' O ' ' HB ' ' A' ' 163' ' ' VAL . 0.8 OUTLIER -150.2 -165.73 2.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.402 -0.811 . . . . 0.0 109.936 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.482 ' CG ' HG12 ' A' ' 163' ' ' VAL . 17.3 mt-10 -99.61 155.58 17.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 110.33 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.699 HD21 ' HG2' ' A' ' 192' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.241 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.4 m120 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 120.796 0.331 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.37 -47.35 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.039 1.547 . . . . 0.0 110.574 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.1 mt -100.83 118.57 60.37 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 110.359 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.28 155.48 46.46 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.917 1.483 . . . . 0.0 110.362 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -82.96 -107.34 0.48 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 28.7 tp -108.4 -36.22 6.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.118 -1.225 . . . . 0.0 110.203 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 10.2 t70 175.18 -93.98 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.408 -0.807 . . . . 0.0 110.093 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.448 ' N ' ' OD2' ' A' ' 136' ' ' ASP . 0.7 OUTLIER -73.0 62.69 0.63 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.183 -0.948 . . . . 0.0 110.26 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.413 ' HA ' HD12 ' A' ' 138' ' ' LEU . 25.7 tp -104.09 67.5 0.86 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.2 -0.938 . . . . 0.0 110.232 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -71.55 164.62 53.95 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 140' ' ' VAL . 44.5 t 51.51 89.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.23 -1.159 . . . . 0.0 110.182 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.68 67.26 0.4 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -130.0 68.02 1.45 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -1.14 . . . . 0.0 110.19 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 37.8 m -160.61 56.11 0.32 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.204 -0.935 . . . . 0.0 110.167 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 14.2 t0 51.99 38.84 24.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 110.268 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' A' ' 147' ' ' ALA . . . -74.3 55.87 0.62 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.0 110.123 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.614 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -63.96 76.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.333 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . 63.09 164.77 0.11 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.214 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.49 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 46.4 Cg_endo -73.45 77.15 2.59 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.02 1.537 . . . . 0.0 110.415 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -178.22 117.5 0.58 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.624 ' O ' HD13 ' A' ' 223' ' ' ILE . 8.3 m -159.82 146.15 16.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -1.155 . . . . 0.0 110.275 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.522 ' O ' ' CD1' ' A' ' 223' ' ' ILE . 11.4 ptp180 -53.61 171.09 0.09 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.282 -0.886 . . . . 0.0 110.178 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.934 HG22 HG21 ' A' ' 195' ' ' ILE . 12.5 p -104.1 36.82 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.209 -0.932 . . . . 0.0 110.612 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.873 HG22 HD13 ' A' ' 202' ' ' ILE . 9.0 pt -135.82 -34.29 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.946 . . . . 0.0 110.078 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.92 -14.11 61.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.286 -0.884 . . . . 0.0 109.457 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -97.52 -21.15 17.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.578 -0.701 . . . . 0.0 109.896 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.511 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -73.5 90.58 1.74 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 110.17 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 157' ' ' THR . 5.2 t -91.77 179.12 5.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.929 . . . . 0.0 110.252 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.4 t -44.77 -46.68 10.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.267 -0.895 . . . . 0.0 110.027 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . 0.493 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 5.5 mmt -75.56 164.81 58.32 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 110.116 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 45.1 Cg_endo -71.94 73.86 2.44 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.947 1.498 . . . . 0.0 110.327 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.403 ' O ' HG22 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -63.31 110.19 1.82 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.855 . . . . 0.0 110.234 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.403 ' C ' HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.78 138.09 48.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.407 -0.808 . . . . 0.0 110.26 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.658 HG12 ' C ' ' A' ' 224' ' ' GLU . 0.1 OUTLIER -149.98 -174.13 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.348 -0.845 . . . . 0.0 110.071 179.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.723 ' NH2' HG12 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -163.22 134.93 5.01 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.856 -1.153 . . . . 0.0 110.244 -179.619 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 1.049 HG23 HG23 ' A' ' 221' ' ' ILE . 0.5 OUTLIER -76.05 151.34 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.171 -0.955 . . . . 0.0 110.145 -179.415 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.723 HG12 ' NH2' ' A' ' 164' ' ' ARG . 28.9 m -149.26 15.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.305 -0.872 . . . . 0.0 109.993 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -179.12 110.37 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.354 -0.841 . . . . 0.0 110.065 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.856 HG21 ' HD3' ' A' ' 188' ' ' ARG . 0.6 OUTLIER -95.9 24.27 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 110.121 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 170' ' ' GLU . 2.2 t-20 -42.43 165.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 110.041 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 169' ' ' ASN . 0.7 OUTLIER 57.84 72.66 0.51 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.143 -0.973 . . . . 0.0 110.009 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.485 ' CD1' HG12 ' A' ' 168' ' ' ILE . 25.8 mm -88.03 -13.35 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 0.0 110.349 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.558 ' CG ' ' O ' ' A' ' 172' ' ' PHE . 1.5 p90 -47.6 123.53 5.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.217 -0.927 . . . . 0.0 110.158 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.24 177.28 6.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.167 -0.958 . . . . 0.0 110.388 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.49 ' O ' HG22 ' A' ' 174' ' ' VAL . 8.7 p -160.28 39.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 110.127 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.539 ' O ' ' CB ' ' A' ' 176' ' ' THR . 0.2 OUTLIER -127.27 -73.6 0.61 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -0.891 . . . . 0.0 110.166 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.634 ' HA ' ' CD1' ' A' ' 179' ' ' PHE . 0.3 OUTLIER 72.0 -147.39 0.06 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.474 -0.766 . . . . 0.0 110.299 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 176' ' ' THR . 0.8 OUTLIER 65.52 -150.1 0.24 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.38 -0.825 . . . . 0.0 110.413 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 177' ' ' ASP . 1.6 tp60 -38.98 -37.1 0.33 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.279 -0.888 . . . . 0.0 110.738 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.811 ' HA ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -48.0 -33.96 8.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.941 . . . . 0.0 110.057 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.543 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 1.3 p -39.33 -31.15 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.43 -0.793 . . . . 0.0 110.193 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 179' ' ' PHE . 23.5 tt0 -59.38 -36.35 75.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.309 -0.87 . . . . 0.0 109.824 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.811 HD12 ' HA ' ' A' ' 179' ' ' PHE . 1.2 mt -68.99 -46.61 67.62 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.371 -0.831 . . . . 0.0 109.733 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.615 ' O ' HD13 ' A' ' 183' ' ' LEU . 0.2 OUTLIER -68.52 -32.62 72.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.489 -0.757 . . . . 0.0 110.11 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 180' ' ' THR . 0.9 OUTLIER -73.05 -4.51 32.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.84 . . . . 0.0 109.957 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.444 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -89.17 9.48 25.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.369 -0.832 . . . . 0.0 110.165 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 185' ' ' ALA . 23.1 t0 41.98 82.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.176 -0.953 . . . . 0.0 109.766 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.7 tt -141.22 173.3 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 110.49 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.856 ' HD3' HG21 ' A' ' 168' ' ' ILE . 0.0 OUTLIER -167.13 114.29 0.79 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.743 ' CG2' ' O ' ' A' ' 189' ' ' VAL . 1.7 m 49.92 96.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 120.986 -1.071 . . . . 0.0 108.188 -178.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.563 ' N ' HG13 ' A' ' 165' ' ' ILE . . . -42.0 -16.26 0.02 OUTLIER Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 189' ' ' VAL . 9.2 t 62.82 -143.35 0.38 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.128 -1.219 . . . . 0.0 109.825 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.701 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 1.0 OUTLIER -59.54 104.36 0.27 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.512 -0.743 . . . . 0.0 109.751 179.626 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.636 HG23 ' N ' ' A' ' 194' ' ' GLU . 11.0 m -154.78 -139.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.072 -1.018 . . . . 0.0 110.182 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.7 ' O ' HD23 ' A' ' 204' ' ' LEU . 54.7 tt0 -176.32 167.17 2.84 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 109.926 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.934 HG21 HG22 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -129.45 167.46 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.114 -0.992 . . . . 0.0 110.342 -179.831 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.465 HG23 ' C ' ' A' ' 195' ' ' ILE . 71.5 t -151.36 88.62 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.364 -0.835 . . . . 0.0 110.007 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 196' ' ' VAL . 17.8 t0 -41.24 110.23 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.319 -0.863 . . . . 0.0 110.104 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.479 ' HB3' ' HB3' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -109.01 88.18 2.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.24 -0.913 . . . . 0.0 110.364 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 198' ' ' ARG . 0.5 OUTLIER 40.93 58.2 2.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 110.213 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 89.17 -28.04 7.05 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 198' ' ' ARG . 1.4 t60 -90.64 87.42 6.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -1.154 . . . . 0.0 110.182 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.873 HD13 HG22 ' A' ' 153' ' ' ILE . 66.2 mt -70.48 87.72 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.347 -0.846 . . . . 0.0 110.299 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.7 m -71.79 157.46 37.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.948 . . . . 0.0 110.007 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 1.007 HD22 ' CD2' ' A' ' 206' ' ' HIS . 0.9 OUTLIER -119.64 141.26 49.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -0.937 . . . . 0.0 110.204 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.503 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 1.6 t -119.77 115.48 23.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.869 . . . . 0.0 109.99 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 1.007 ' CD2' HD22 ' A' ' 204' ' ' LEU . 3.2 m80 -105.42 -165.78 1.15 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.314 -0.866 . . . . 0.0 109.942 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.457 ' O ' ' OD1' ' A' ' 207' ' ' ASN . 11.5 p30 -46.45 91.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.863 . . . . 0.0 110.142 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 49.43 24.92 5.74 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.518 ' O ' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -136.89 102.59 4.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.237 -1.155 . . . . 0.0 110.283 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 18.4 p30 -99.77 153.81 18.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 110.241 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 52.7 t -140.98 147.66 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.179 -0.95 . . . . 0.0 110.208 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -74.97 77.58 2.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 110.176 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.627 ' CD2' HD12 ' A' ' 204' ' ' LEU . 19.6 tp -74.6 169.51 17.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -0.951 . . . . 0.0 110.238 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.647 HD23 ' N ' ' A' ' 214' ' ' LEU . 0.5 OUTLIER -123.53 142.96 50.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.252 -0.905 . . . . 0.0 110.21 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.401 ' HA ' ' CB ' ' A' ' 218' ' ' ALA . 38.8 t0 -56.7 -44.95 82.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 110.198 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.42 -49.61 13.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 110.204 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.507 ' HB2' ' CD1' ' A' ' 214' ' ' LEU . 1.9 mp -87.21 -17.6 32.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.0 110.225 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.825 ' O ' HG12 ' A' ' 152' ' ' VAL . . . -55.01 -19.03 5.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 110.152 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.415 ' O ' ' C ' ' A' ' 220' ' ' THR . 61.4 t60 -68.96 -52.85 24.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.209 -0.932 . . . . 0.0 110.146 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . 0.495 ' O ' ' C ' ' A' ' 221' ' ' ILE . 68.9 p -43.0 -78.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.197 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 1.049 HG23 HG23 ' A' ' 165' ' ' ILE . 1.6 mp -31.54 117.71 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.55 -0.719 . . . . 0.0 111.935 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 2.4 ttm-85 -100.77 103.7 14.93 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 1.0 HG22 HG23 ' A' ' 165' ' ' ILE . 0.1 OUTLIER -119.47 -179.8 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.145 -0.972 . . . . 0.0 111.262 -178.351 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.658 ' C ' HG12 ' A' ' 163' ' ' VAL . 2.5 mm-40 -150.74 168.42 24.45 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -71.97 140.91 49.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.904 . . . . 0.0 110.251 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.588 HD11 ' HG3' ' A' ' 192' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.187 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.743 0.306 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.0 -28.2 13.26 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.06 1.558 . . . . 0.0 110.426 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 80.7 mt -119.06 122.6 29.49 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.237 -0.914 . . . . 0.0 110.204 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.48 -87.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.024 1.539 . . . . 0.0 110.419 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 135' ' ' LEU . . . 137.29 -6.52 3.64 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 13.5 mt 57.66 47.15 16.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -1.19 . . . . 0.0 110.184 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 137' ' ' GLU . 9.5 t70 179.48 -85.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.255 -0.903 . . . . 0.0 110.231 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER 59.89 48.79 8.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.313 -0.867 . . . . 0.0 110.224 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.9 -26.08 53.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.314 -0.866 . . . . 0.0 110.208 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 168.63 -98.44 0.14 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.552 HG12 ' H ' ' A' ' 142' ' ' ASN . 98.0 t -133.59 152.1 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -1.149 . . . . 0.0 110.15 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -80.5 -31.82 36.02 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.552 ' H ' HG12 ' A' ' 140' ' ' VAL . 1.2 m-20 -140.31 106.59 5.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.262 -1.14 . . . . 0.0 110.212 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.5 t -130.95 177.07 7.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.911 . . . . 0.0 110.15 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 144' ' ' ASP . 40.9 p-10 -119.4 76.44 1.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 110.256 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.33 35.23 3.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.258 -0.901 . . . . 0.0 110.203 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.585 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -152.63 111.6 3.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.902 . . . . 0.0 110.212 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . 62.03 144.22 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.333 -0.855 . . . . 0.0 110.176 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.14 115.47 4.36 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.017 1.535 . . . . 0.0 110.403 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.549 ' CA ' ' HG2' ' A' ' 222' ' ' ARG . . . 167.34 132.31 1.38 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.569 ' O ' HG22 ' A' ' 150' ' ' THR . 56.6 m -136.85 4.5 2.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -1.166 . . . . 0.0 110.197 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.536 ' HB2' ' HB2' ' A' ' 154' ' ' ASP . 0.3 OUTLIER 59.53 127.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 0.0 110.049 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.969 ' HB ' HG21 ' A' ' 223' ' ' ILE . 2.1 p -77.72 12.52 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.252 -0.905 . . . . 0.0 110.79 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 1.054 ' CG2' ' HB1' ' A' ' 218' ' ' ALA . 18.2 pt -124.58 -24.6 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.011 -1.055 . . . . 0.0 110.421 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.536 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 0.6 OUTLIER -71.53 -21.59 61.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.131 -0.981 . . . . 0.0 109.259 179.414 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.81 -16.85 29.3 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.605 -0.684 . . . . 0.0 109.805 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.813 ' HB2' ' CD1' ' A' ' 195' ' ' ILE . . . -64.03 92.55 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.836 . . . . 0.0 110.203 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.581 HG23 ' OG ' ' A' ' 158' ' ' SER . 6.4 t -177.36 171.7 1.95 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.937 . . . . 0.0 110.343 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.581 ' OG ' HG23 ' A' ' 157' ' ' THR . 3.7 p 42.35 73.1 0.14 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.345 -0.847 . . . . 0.0 110.118 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . 0.523 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 1.6 mtp 68.62 167.45 0.12 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.281 -0.887 . . . . 0.0 110.117 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.523 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 45.7 Cg_endo -72.51 101.81 1.32 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.014 1.534 . . . . 0.0 110.381 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.594 ' O ' HG13 ' A' ' 163' ' ' VAL . 0.4 OUTLIER -85.41 120.14 26.54 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.291 -0.881 . . . . 0.0 110.207 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.566 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 13.7 mtmt -62.24 87.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 110.205 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.87 HG22 ' HA ' ' A' ' 194' ' ' GLU . 33.8 m -91.96 -166.36 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 110.352 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.669 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -172.61 136.74 0.76 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.841 -1.162 . . . . 0.0 110.41 -179.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 1.065 HG23 ' CG2' ' A' ' 223' ' ' ILE . 1.1 mt -93.6 162.36 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.374 -0.829 . . . . 0.0 110.544 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 222' ' ' ARG . 6.6 m -136.74 -32.62 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 110.736 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.576 ' CG ' ' HB2' ' A' ' 222' ' ' ARG . 6.3 pt20 -147.04 119.46 8.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.073 -1.017 . . . . 0.0 110.652 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.938 HG13 HG22 ' A' ' 221' ' ' ILE . 11.6 tt -110.76 17.82 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 0.0 109.869 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 168' ' ' ILE . 67.0 m-20 -37.84 105.52 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.466 -0.771 . . . . 0.0 110.606 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.441 ' CD ' ' HB2' ' A' ' 172' ' ' PHE . 0.4 OUTLIER -131.02 107.33 9.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 109.954 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 2.0 pp -81.49 11.33 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -0.889 . . . . 0.0 110.525 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.441 ' HB2' ' CD ' ' A' ' 170' ' ' GLU . 1.1 m-85 -64.7 176.37 1.18 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 0.0 110.18 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -77.29 -165.35 0.57 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.276 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.442 ' O ' HG22 ' A' ' 174' ' ' VAL . 10.0 p -117.92 32.37 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -0.89 . . . . 0.0 110.212 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' A' ' 176' ' ' THR . 4.6 tp10 -64.13 -143.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.293 -0.88 . . . . 0.0 110.301 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.566 ' OG1' ' CD1' ' A' ' 179' ' ' PHE . 75.2 p 42.64 92.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.281 -0.887 . . . . 0.0 110.139 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.408 ' HA ' ' OG1' ' A' ' 180' ' ' THR . 0.8 OUTLIER -62.53 -31.25 71.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 110.209 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -72.32 -25.21 61.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.862 . . . . 0.0 110.289 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.998 ' CE2' HD13 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -85.49 -29.1 24.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.237 -0.914 . . . . 0.0 110.072 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.551 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -58.81 -16.99 19.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.179 -0.951 . . . . 0.0 109.73 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.21 -60.19 2.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.346 -0.846 . . . . 0.0 110.254 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.76 ' C ' HD12 ' A' ' 182' ' ' LEU . 4.4 pp -64.59 -10.53 26.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.88 . . . . 0.0 110.133 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.998 HD13 ' CE2' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -92.57 -32.4 14.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 109.916 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -67.93 -7.27 27.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 0.0 109.883 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -83.54 13.79 4.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.343 -0.848 . . . . 0.0 110.23 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 185' ' ' ALA . 8.9 m-20 42.98 62.98 1.62 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.211 -0.931 . . . . 0.0 110.007 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.3 tt -118.5 -174.57 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.331 -0.856 . . . . 0.0 110.348 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.706 ' C ' HG13 ' A' ' 189' ' ' VAL . 0.4 OUTLIER -171.41 112.08 0.34 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.346 -0.846 . . . . 0.0 108.908 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.706 HG13 ' C ' ' A' ' 188' ' ' ARG . 1.1 m 51.35 109.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.381 -0.824 . . . . 0.0 109.202 -178.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.856 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -44.19 -15.68 0.05 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.594 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 3.3 t 68.3 -145.06 0.12 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.179 -1.189 . . . . 0.0 109.534 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.669 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 3.8 mm-40 -66.39 102.93 0.93 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.496 -0.752 . . . . 0.0 109.331 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.619 ' O ' ' O ' ' A' ' 163' ' ' VAL . 20.6 m -156.46 -140.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 110.323 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.87 ' HA ' HG22 ' A' ' 163' ' ' VAL . 3.1 pt-20 -177.3 139.77 0.27 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.334 -0.854 . . . . 0.0 110.029 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.958 HG21 HG22 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -130.39 161.19 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.104 -0.998 . . . . 0.0 110.452 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.543 ' N ' HG12 ' A' ' 195' ' ' ILE . 18.2 t -129.71 130.66 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.46 -0.775 . . . . 0.0 110.012 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.479 ' HA ' HG12 ' A' ' 202' ' ' ILE . 7.1 t70 -83.5 137.62 33.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -0.941 . . . . 0.0 110.321 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -130.23 71.34 1.45 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.28 -0.888 . . . . 0.0 110.201 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 198' ' ' ARG . 47.5 t0 42.73 71.39 0.23 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 110.149 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 88.84 -35.81 3.58 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.501 ' O ' ' N ' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -89.87 108.29 19.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.263 -1.139 . . . . 0.0 110.195 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.479 HG12 ' HA ' ' A' ' 197' ' ' ASP . 7.8 mt -112.82 138.63 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 110.296 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.549 ' O ' HG12 ' A' ' 195' ' ' ILE . 31.4 m -126.74 146.06 50.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.346 -0.846 . . . . 0.0 109.832 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.756 HD22 ' CD2' ' A' ' 206' ' ' HIS . 0.2 OUTLIER -119.48 133.16 55.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.086 -1.008 . . . . 0.0 110.387 -179.796 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.592 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 1.2 m -119.96 124.12 45.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.412 -0.805 . . . . 0.0 109.768 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.756 ' CD2' HD22 ' A' ' 204' ' ' LEU . 2.5 m170 -107.83 100.1 9.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.413 -0.805 . . . . 0.0 110.207 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 207' ' ' ASN . 1.2 p-10 39.02 29.77 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.352 -0.843 . . . . 0.0 110.78 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 123.6 -33.3 3.99 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.585 ' O ' ' CG ' ' A' ' 206' ' ' HIS . 3.6 mmtt -91.86 110.69 22.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.225 -1.162 . . . . 0.0 109.972 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.532 ' HA ' ' O ' ' A' ' 204' ' ' LEU . 4.1 p30 -109.23 169.7 8.52 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.118 -0.989 . . . . 0.0 110.484 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 210' ' ' ASP . 37.8 t -151.41 146.24 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.326 -0.859 . . . . 0.0 110.128 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 213' ' ' LEU . 2.3 tt0 -75.25 72.61 2.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.285 -0.884 . . . . 0.0 110.221 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.449 HD22 HD12 ' A' ' 204' ' ' LEU . 1.1 mp -55.19 -165.86 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.891 . . . . 0.0 110.23 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.714 HD12 ' HB3' ' A' ' 216' ' ' ASP . 0.5 OUTLIER -157.93 136.95 11.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 110.188 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 214' ' ' LEU . 21.7 t0 -41.88 -48.14 4.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -0.901 . . . . 0.0 110.428 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.714 ' HB3' HD12 ' A' ' 214' ' ' LEU . 7.4 t0 -47.84 -52.05 20.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.181 -0.95 . . . . 0.0 110.336 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.734 ' O ' HG23 ' A' ' 221' ' ' ILE . 0.4 OUTLIER -88.46 -32.29 18.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.272 -0.892 . . . . 0.0 110.297 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 1.054 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -62.99 -26.75 69.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.03 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.628 ' CG ' HD11 ' A' ' 153' ' ' ILE . 1.1 t60 -99.1 29.88 3.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.935 . . . . 0.0 110.11 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 50.6 m -138.41 -33.47 0.67 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.257 -0.902 . . . . 0.0 110.451 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.938 HG22 HG13 ' A' ' 168' ' ' ILE . 0.2 OUTLIER -67.35 140.21 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 110.445 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.576 ' HB2' ' CG ' ' A' ' 167' ' ' GLN . 1.4 mtt180 -91.94 113.5 25.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 109.383 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 1.065 ' CG2' HG23 ' A' ' 165' ' ' ILE . 0.7 OUTLIER -127.12 -169.26 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.126 -0.983 . . . . 0.0 110.954 -179.126 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.443 ' HG3' ' N ' ' A' ' 225' ' ' GLU . 3.0 tp10 -148.85 156.92 43.0 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.468 -0.77 . . . . 0.0 109.98 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 1.1 tt0 -104.95 122.68 46.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.296 -0.878 . . . . 0.0 110.221 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.1 tp . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.222 179.935 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.54 ' CB ' ' CD ' ' A' ' 131' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 120.698 0.285 . . . . 0.0 110.271 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.54 ' CD ' ' CB ' ' A' ' 130' ' ' ASN . 46.6 Cg_endo -73.37 -51.18 0.17 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.049 1.552 . . . . 0.0 110.473 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.401 ' HA ' ' HD2' ' A' ' 133' ' ' PRO . 2.1 mt -136.54 106.52 9.18 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.889 . . . . 0.0 110.255 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 132' ' ' ILE . 46.4 Cg_endo -73.23 -0.98 9.91 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.999 1.526 . . . . 0.0 110.461 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -85.43 -170.91 47.67 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.25 -35.03 0.18 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -1.117 . . . . 0.0 110.305 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.45 124.98 36.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 110.312 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -138.2 49.66 1.92 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -0.905 . . . . 0.0 110.197 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.406 ' HG ' ' N ' ' A' ' 139' ' ' GLY . 26.6 tp -100.14 -85.44 0.4 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 110.322 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.406 ' N ' ' HG ' ' A' ' 138' ' ' LEU . . . -75.1 66.91 2.15 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.7 t -71.99 -8.98 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -1.141 . . . . 0.0 110.14 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 142' ' ' ASN . . . -103.64 -31.81 4.73 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 141' ' ' GLY . 0.4 OUTLIER 43.05 45.97 4.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -1.133 . . . . 0.0 110.246 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.3 m -148.07 -164.44 2.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 110.2 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 144' ' ' ASP . 1.8 m-20 -53.38 -65.61 0.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.311 -0.868 . . . . 0.0 110.156 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.57 -175.68 2.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 110.176 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.595 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -151.34 80.54 1.3 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.181 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . 63.1 158.29 0.12 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.953 . . . . 0.0 110.17 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.54 123.11 8.83 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.073 1.565 . . . . 0.0 110.464 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 145.52 92.68 0.13 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.487 ' O ' ' O ' ' A' ' 151' ' ' ARG . 91.0 m -81.22 -20.91 40.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -1.152 . . . . 0.0 110.202 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.512 ' O ' ' O ' ' A' ' 152' ' ' VAL . 11.4 mtt85 59.92 132.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.34 -0.85 . . . . 0.0 110.043 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.775 HG12 ' H ' ' A' ' 153' ' ' ILE . 37.6 t -51.35 -174.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.239 -0.913 . . . . 0.0 109.369 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.799 HG21 ' HB3' ' A' ' 218' ' ' ALA . 1.0 OUTLIER 52.44 15.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.143 -0.973 . . . . 0.0 110.209 -179.589 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 151' ' ' ARG . 1.2 t0 -130.4 -31.21 1.85 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.357 -0.839 . . . . 0.0 109.419 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.67 ' CB ' HG11 ' A' ' 163' ' ' VAL . . . -84.64 -18.85 34.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.514 -0.741 . . . . 0.0 109.814 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.34 136.02 56.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.343 -0.848 . . . . 0.0 110.039 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 157' ' ' THR . 7.9 m -160.88 87.16 0.73 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.112 -0.992 . . . . 0.0 110.359 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 157' ' ' THR . 2.1 t 70.11 -53.17 0.63 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.305 -0.872 . . . . 0.0 110.058 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . 0.455 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 59.0 mtp -108.98 168.01 8.33 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 121.327 -0.858 . . . . 0.0 110.056 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.488 ' HB2' ' OE2' ' A' ' 194' ' ' GLU . 46.2 Cg_endo -72.63 65.86 3.83 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.952 1.501 . . . . 0.0 110.427 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -44.0 109.66 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 110.234 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.496 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 5.6 tttm -58.1 132.15 52.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.905 . . . . 0.0 110.255 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.67 HG11 ' CB ' ' A' ' 155' ' ' ALA . 16.0 m -150.24 -159.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 110.498 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.64 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 0.1 OUTLIER -173.81 150.86 1.73 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.936 -1.103 . . . . 0.0 110.347 -179.633 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.993 HG23 HG22 ' A' ' 223' ' ' ILE . 2.0 mm -88.92 148.42 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.34 -0.85 . . . . 0.0 110.297 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.757 HG22 ' O ' ' A' ' 222' ' ' ARG . 22.6 m -136.47 5.34 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.888 . . . . 0.0 109.814 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.513 ' HB3' ' HB3' ' A' ' 222' ' ' ARG . 1.7 tm0? -171.77 121.17 0.48 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.898 . . . . 0.0 109.867 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.539 ' HB ' ' CG1' ' A' ' 189' ' ' VAL . 0.3 OUTLIER -93.74 -2.31 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.0 110.33 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 49.78 -137.07 1.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.168 -0.958 . . . . 0.0 110.022 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -117.87 108.23 15.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.956 . . . . 0.0 110.198 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 172' ' ' PHE . 1.0 OUTLIER -60.49 -13.84 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.164 -0.96 . . . . 0.0 110.105 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.439 ' N ' HG13 ' A' ' 171' ' ' ILE . 0.5 OUTLIER -75.69 82.93 2.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 110.127 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -110.58 -89.63 0.49 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 110.198 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.737 HG12 ' N ' ' A' ' 175' ' ' GLU . 37.5 t -128.47 -91.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.906 . . . . 0.0 110.233 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.737 ' N ' HG12 ' A' ' 174' ' ' VAL . 2.8 mt-10 -94.1 -172.14 2.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 0.0 110.198 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 1.058 HG23 ' CD2' ' A' ' 179' ' ' PHE . 20.0 m -136.04 -65.36 0.58 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.287 -0.883 . . . . 0.0 110.217 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 176' ' ' THR . 5.6 m-20 70.57 -153.43 0.11 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.455 -0.778 . . . . 0.0 110.359 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' A' ' 181' ' ' GLN . 18.6 tt0 -45.42 -25.68 0.45 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.278 -0.889 . . . . 0.0 110.607 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 1.058 ' CD2' HG23 ' A' ' 176' ' ' THR . 0.3 OUTLIER -42.39 -54.64 3.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.208 -0.932 . . . . 0.0 110.026 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 1.034 HG23 HG21 ' A' ' 176' ' ' THR . 0.0 OUTLIER -47.84 -23.42 0.74 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.054 -1.029 . . . . 0.0 109.836 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 178' ' ' GLN . 34.5 tt0 -71.98 -62.0 1.58 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 110.199 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.656 ' C ' HD12 ' A' ' 182' ' ' LEU . 4.6 pp -65.33 -9.3 23.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.346 -0.846 . . . . 0.0 109.892 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.903 ' O ' HD13 ' A' ' 183' ' ' LEU . 3.4 tm? -92.25 -31.67 15.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.876 . . . . 0.0 109.851 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -70.25 -5.81 30.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.42 -0.8 . . . . 0.0 110.008 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -88.11 29.35 0.95 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -0.906 . . . . 0.0 110.235 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 186' ' ' ASP . 1.8 m-20 52.48 36.23 19.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.214 -0.929 . . . . 0.0 110.208 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 16.3 mm -93.47 156.6 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 110.185 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.609 ' C ' HG22 ' A' ' 189' ' ' VAL . 2.5 ptm180 -170.83 130.32 0.81 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.863 ' O ' ' N ' ' A' ' 191' ' ' SER . 34.3 m 33.75 69.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.212 -0.93 . . . . 0.0 109.008 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 189' ' ' VAL . . . -20.93 -32.2 0.0 OUTLIER Glycine 0 N--CA 1.498 2.785 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.863 ' N ' ' O ' ' A' ' 189' ' ' VAL . 3.4 t 70.86 -143.54 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -1.142 . . . . 0.0 109.831 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.64 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 0.8 OUTLIER -61.36 102.48 0.23 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.416 -0.803 . . . . 0.0 109.796 179.741 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.74 ' CG2' HD21 ' A' ' 204' ' ' LEU . 20.3 m -156.32 -142.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.126 -0.984 . . . . 0.0 110.246 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.626 ' HA ' HG22 ' A' ' 163' ' ' VAL . 21.6 tt0 -175.95 161.21 2.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 110.218 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.753 HD13 HG13 ' A' ' 152' ' ' VAL . 0.7 OUTLIER -123.48 172.15 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.128 -0.983 . . . . 0.0 110.279 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.759 HG13 ' O ' ' A' ' 196' ' ' VAL . 14.8 p -146.59 102.13 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 110.158 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 197' ' ' ASP . 5.1 p-10 -42.35 113.94 0.51 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.266 -0.896 . . . . 0.0 110.193 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -100.55 160.6 14.22 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.252 -0.905 . . . . 0.0 110.304 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -55.73 91.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.253 -0.904 . . . . 0.0 110.064 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 198' ' ' ARG . . . 76.76 12.4 84.53 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.462 ' O ' ' N ' ' A' ' 198' ' ' ARG . 0.0 OUTLIER -150.13 179.88 7.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.169 -1.195 . . . . 0.0 110.179 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.542 HD12 ' CG ' ' A' ' 215' ' ' ASP . 42.5 mt -144.79 133.68 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.921 . . . . 0.0 110.308 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.53 ' HB ' HG12 ' A' ' 196' ' ' VAL . 0.2 OUTLIER -113.83 152.86 30.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 110.026 179.794 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.843 HD22 ' CD2' ' A' ' 206' ' ' HIS . 1.1 tt -119.72 137.25 54.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 110.294 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.539 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 3.0 t -119.78 128.14 53.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.356 -0.84 . . . . 0.0 109.865 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.843 ' CD2' HD22 ' A' ' 204' ' ' LEU . 1.3 m80 -112.72 125.68 54.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.387 -0.82 . . . . 0.0 110.013 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 206' ' ' HIS . 2.0 t-20 42.82 -93.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.216 -0.927 . . . . 0.0 110.224 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -126.28 19.1 6.42 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.13 129.27 39.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -1.138 . . . . 0.0 110.258 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 7.9 t70 -117.94 156.78 27.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.296 -0.878 . . . . 0.0 110.22 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.421 ' N ' ' OD1' ' A' ' 210' ' ' ASP . 5.5 p -149.43 162.23 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.251 -0.905 . . . . 0.0 110.201 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -65.01 156.4 31.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 110.126 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.574 HD13 HD12 ' A' ' 204' ' ' LEU . 0.7 OUTLIER -156.48 88.76 1.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.232 -0.917 . . . . 0.0 110.202 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.713 ' O ' ' HB2' ' A' ' 218' ' ' ALA . 14.5 tp -41.34 113.74 0.43 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.235 -0.916 . . . . 0.0 110.244 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.542 ' CG ' HD12 ' A' ' 202' ' ' ILE . 8.2 t0 -60.18 -43.17 96.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.325 -0.859 . . . . 0.0 110.428 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 215' ' ' ASP . 55.9 t0 -43.07 -67.37 0.28 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.131 -0.981 . . . . 0.0 110.177 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.527 ' HB2' HD23 ' A' ' 214' ' ' LEU . 0.5 OUTLIER -82.28 -13.54 56.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.259 -0.901 . . . . 0.0 110.531 -179.831 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.799 ' HB3' HG21 ' A' ' 153' ' ' ILE . . . -45.01 -26.43 0.43 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.148 -0.97 . . . . 0.0 110.1 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.767 ' CG ' HD11 ' A' ' 153' ' ' ILE . 0.7 OUTLIER -78.95 64.63 3.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.268 -0.895 . . . . 0.0 110.182 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . 0.472 HG23 HG23 ' A' ' 221' ' ' ILE . 0.5 OUTLIER -129.25 -22.89 3.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -0.973 . . . . 0.0 110.467 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.75 HD13 ' H ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -99.78 145.95 9.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.09 -1.006 . . . . 0.0 110.57 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.757 ' O ' HG22 ' A' ' 166' ' ' VAL . 0.3 OUTLIER -88.81 96.35 10.65 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.323 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.993 HG22 HG23 ' A' ' 165' ' ' ILE . 0.5 OUTLIER -119.64 173.16 5.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.304 -0.873 . . . . 0.0 111.419 -177.492 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.485 ' HG3' ' OG1' ' A' ' 150' ' ' THR . 0.6 OUTLIER -145.9 -172.87 4.01 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.5 -0.75 . . . . 0.0 110.181 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 8.4 tt0 -112.08 127.14 55.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.377 -0.827 . . . . 0.0 110.201 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.231 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.2 t30 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 120.796 0.331 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.54 -15.84 24.45 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.977 1.514 . . . . 0.0 110.465 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 28.2 mm -72.96 124.07 90.3 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 110.218 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.11 96.02 0.86 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.917 1.483 . . . . 0.0 110.431 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -178.31 85.72 0.07 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -166.66 95.97 0.54 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.326 -1.102 . . . . 0.0 110.144 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -88.88 60.21 5.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 0.0 110.21 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 40.4 mt-10 63.08 -71.17 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.0 110.4 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 136' ' ' ASP . 14.8 tp -95.05 100.52 12.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.319 -0.863 . . . . 0.0 110.238 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 136.1 166.09 10.82 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 28.2 m -139.47 8.22 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -1.124 . . . . 0.0 110.242 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -165.72 163.7 36.86 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -129.7 150.49 50.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -1.136 . . . . 0.0 110.221 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 144' ' ' ASP . 1.0 OUTLIER 50.48 -164.16 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.922 . . . . 0.0 110.159 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 143' ' ' SER . 7.7 t0 59.85 145.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -0.893 . . . . 0.0 110.219 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 44.96 -141.79 0.26 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.349 -0.844 . . . . 0.0 110.261 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -154.99 82.21 1.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 110.237 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.621 ' HB1' ' OG1' ' A' ' 150' ' ' THR . . . 59.68 121.37 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.204 -0.935 . . . . 0.0 110.11 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.5 90.98 0.89 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.989 1.52 . . . . 0.0 110.694 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.58 ' O ' ' HB ' ' A' ' 150' ' ' THR . . . 95.23 -74.26 0.91 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.621 ' OG1' ' HB1' ' A' ' 147' ' ' ALA . 22.2 m 65.89 -121.54 0.34 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.345 -1.091 . . . . 0.0 109.889 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.529 ' CD ' ' O ' ' A' ' 150' ' ' THR . 1.5 mmt180 -143.41 157.62 44.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.961 -1.087 . . . . 0.0 109.989 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.877 HG22 HD13 ' A' ' 195' ' ' ILE . 0.6 OUTLIER -69.3 -3.94 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.157 -0.964 . . . . 0.0 110.479 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.884 ' CG2' ' HB1' ' A' ' 218' ' ' ALA . 1.6 pp -117.65 -30.9 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.098 -1.001 . . . . 0.0 110.335 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.52 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -74.88 -13.25 60.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -0.967 . . . . 0.0 109.214 179.346 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -113.04 -7.34 13.68 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.562 -0.711 . . . . 0.0 109.72 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 1.023 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -85.0 177.21 8.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.335 -0.853 . . . . 0.0 110.194 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.527 ' O ' ' CB ' ' A' ' 158' ' ' SER . 0.4 OUTLIER 56.88 153.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.347 -0.846 . . . . 0.0 110.185 179.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 157' ' ' THR . 0.7 OUTLIER 70.69 -51.5 0.67 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.181 -0.95 . . . . 0.0 110.157 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . 0.454 ' N ' ' CD ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER -161.86 55.3 0.57 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.851 . . . . 0.0 109.883 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.582 ' HB3' ' HA ' ' A' ' 156' ' ' ALA . 43.6 Cg_endo -72.66 -67.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.092 1.575 . . . . 0.0 110.565 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.415 ' CB ' ' O ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER 64.23 -153.97 0.3 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.908 . . . . 0.0 110.228 179.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.467 ' HA ' ' CB ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -86.92 90.37 8.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.21 -0.931 . . . . 0.0 110.553 -179.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.598 HG23 ' HA ' ' A' ' 194' ' ' GLU . 0.1 OUTLIER -92.46 -169.44 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.226 -0.921 . . . . 0.0 109.909 179.542 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.716 ' HD3' HG12 ' A' ' 166' ' ' VAL . 0.3 OUTLIER -167.07 137.96 3.13 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.712 -1.243 . . . . 0.0 110.286 -179.578 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 1.018 HG23 HG22 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -85.37 133.46 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.318 -0.864 . . . . 0.0 110.284 -179.59 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.716 HG12 ' HD3' ' A' ' 164' ' ' ARG . 15.5 m -119.92 -23.09 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.235 -0.916 . . . . 0.0 110.7 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -148.97 125.6 11.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.032 -1.043 . . . . 0.0 110.531 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 221' ' ' ILE . 5.1 tt -108.62 6.78 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.348 -0.845 . . . . 0.0 110.03 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 168' ' ' ILE . 3.0 t-20 -43.35 98.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.348 -0.845 . . . . 0.0 110.347 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.502 ' CG ' ' HB2' ' A' ' 172' ' ' PHE . 1.0 OUTLIER -157.9 116.06 3.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -0.929 . . . . 0.0 110.185 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 172' ' ' PHE . 1.6 pp -83.26 10.33 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.341 -0.85 . . . . 0.0 110.196 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.502 ' HB2' ' CG ' ' A' ' 170' ' ' GLU . 0.1 OUTLIER -60.09 -148.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.285 -0.885 . . . . 0.0 110.147 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.461 ' O ' ' HB ' ' A' ' 174' ' ' VAL . 11.7 tt0 53.86 174.37 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 110.07 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 173' ' ' GLN . 1.6 p 175.44 -26.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 110.249 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' A' ' 176' ' ' THR . 0.0 OUTLIER -172.58 129.54 0.54 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.908 . . . . 0.0 110.329 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.506 ' O ' HG23 ' A' ' 176' ' ' THR . 1.7 t 177.36 99.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.337 -0.852 . . . . 0.0 110.172 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.55 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.5 OUTLIER -75.8 -28.25 58.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.291 -0.88 . . . . 0.0 110.307 -179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -17.51 64.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.105 -0.997 . . . . 0.0 109.972 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 1.052 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -90.28 -39.39 12.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 110.683 -179.827 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.55 ' OG1' ' O ' ' A' ' 177' ' ' ASP . 0.2 OUTLIER -41.19 -26.09 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.13 -0.981 . . . . 0.0 110.05 -179.568 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.5 ' NE2' ' OE2' ' A' ' 212' ' ' GLU . 0.6 OUTLIER -53.4 -45.09 69.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.183 -0.948 . . . . 0.0 109.515 179.303 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 1.052 HD12 ' O ' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -69.84 -34.76 74.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.403 -0.811 . . . . 0.0 108.973 179.083 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.672 ' O ' HD13 ' A' ' 183' ' ' LEU . 0.2 OUTLIER -66.05 -33.73 76.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.592 -0.692 . . . . 0.0 109.786 179.609 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -57.87 -16.16 10.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.409 -0.807 . . . . 0.0 109.87 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -92.83 12.61 23.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.438 -0.789 . . . . 0.0 110.252 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 185' ' ' ALA . 22.0 t70 43.8 85.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.732 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.2 tt -135.56 177.1 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 110.824 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.606 ' C ' HG13 ' A' ' 189' ' ' VAL . 4.2 ttp180 -174.64 114.41 0.17 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.719 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 1.1 m 46.66 98.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.174 -0.954 . . . . 0.0 108.546 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.684 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -40.44 -18.19 0.01 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.627 ' N ' ' O ' ' A' ' 189' ' ' VAL . 5.7 t 64.65 -141.95 0.25 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.037 -1.272 . . . . 0.0 109.213 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.604 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 4.9 pm0 -61.57 99.69 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.507 -0.746 . . . . 0.0 109.3 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.661 HG21 HD21 ' A' ' 204' ' ' LEU . 13.1 m -155.07 -139.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.083 -1.01 . . . . 0.0 109.98 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.622 ' N ' HG23 ' A' ' 193' ' ' VAL . 3.4 pt-20 -173.26 158.69 3.65 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.3 -0.875 . . . . 0.0 110.564 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 1.023 HD12 ' HB2' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -131.09 162.97 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.28 -0.888 . . . . 0.0 110.275 -179.719 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 195' ' ' ILE . 77.7 t -157.28 100.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.249 -0.907 . . . . 0.0 110.12 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.524 ' CB ' ' OG1' ' A' ' 157' ' ' THR . 16.1 t0 -42.91 109.64 0.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.903 . . . . 0.0 110.258 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.521 ' CB ' ' O ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -97.11 81.17 3.02 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.307 -0.871 . . . . 0.0 110.129 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 49.3 57.73 6.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 110.101 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 89.26 -25.96 9.66 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.521 ' O ' ' CB ' ' A' ' 198' ' ' ARG . 2.7 t60 -98.72 95.0 6.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -1.143 . . . . 0.0 110.163 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.873 HD13 HG22 ' A' ' 153' ' ' ILE . 83.8 mt -64.56 115.85 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.341 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 195' ' ' ILE . 28.8 m -94.48 147.19 23.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.151 -0.968 . . . . 0.0 110.065 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.968 ' HB2' HD12 ' A' ' 213' ' ' LEU . 1.2 tt -119.71 129.34 54.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.227 -0.92 . . . . 0.0 110.128 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.561 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.0 OUTLIER -120.02 122.84 42.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.296 -0.877 . . . . 0.0 110.015 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.95 ' CD2' HD22 ' A' ' 204' ' ' LEU . 0.1 OUTLIER -106.91 154.5 20.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.534 -0.729 . . . . 0.0 109.89 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -50.66 -19.83 1.04 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.947 . . . . 0.0 109.955 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.457 ' O ' ' HD3' ' A' ' 209' ' ' LYS . . . -87.38 -32.76 12.88 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' A' ' 208' ' ' GLY . 0.0 OUTLIER 176.77 -152.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.159 -1.2 . . . . 0.0 110.29 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 204' ' ' LEU . 36.7 t70 -137.73 156.29 48.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.324 -0.86 . . . . 0.0 110.174 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.511 HG22 ' N ' ' A' ' 212' ' ' GLU . 7.6 p -149.92 173.39 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.218 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.511 ' N ' HG22 ' A' ' 211' ' ' VAL . 13.2 pt-20 -91.33 162.32 14.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 110.337 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.968 HD12 ' HB2' ' A' ' 204' ' ' LEU . 0.3 OUTLIER -147.88 153.21 38.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 110.177 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.726 HD12 ' HB3' ' A' ' 216' ' ' ASP . 0.4 OUTLIER -120.08 129.52 54.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.263 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.527 ' HA ' ' HB3' ' A' ' 218' ' ' ALA . 1.5 m-20 -43.31 -29.33 0.4 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 110.195 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.726 ' HB3' HD12 ' A' ' 214' ' ' LEU . 5.9 t0 -56.06 -59.17 5.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 110.119 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.62 ' CD2' ' CD1' ' A' ' 179' ' ' PHE . 1.0 OUTLIER -90.12 -24.68 21.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 110.314 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.884 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -52.19 -42.47 63.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.194 -0.941 . . . . 0.0 110.158 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.565 ' O ' ' CG ' ' A' ' 219' ' ' HIS . 69.2 t60 -84.03 58.84 4.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.893 . . . . 0.0 110.194 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 217' ' ' LEU . 30.6 p -145.02 -31.63 0.41 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 110.621 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.798 HG13 HD13 ' A' ' 165' ' ' ILE . 0.1 OUTLIER -90.97 141.05 14.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.175 -0.953 . . . . 0.0 110.456 -179.799 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.485 ' HG2' ' HA3' ' A' ' 149' ' ' GLY . 0.0 OUTLIER -92.6 111.33 22.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.379 -0.826 . . . . 0.0 109.793 179.778 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 1.018 HG22 HG23 ' A' ' 165' ' ' ILE . 0.1 OUTLIER -121.23 166.22 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.167 -0.958 . . . . 0.0 110.108 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.554 ' C ' HG12 ' A' ' 163' ' ' VAL . 1.2 tt0 -137.08 161.38 36.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.121 -0.987 . . . . 0.0 110.553 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 22.1 mm-40 -72.26 137.18 46.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.422 -0.799 . . . . 0.0 110.222 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.213 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.535 ' CB ' ' CD ' ' A' ' 131' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 120.768 0.318 . . . . 0.0 110.226 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.535 ' CD ' ' CB ' ' A' ' 130' ' ' ASN . 47.2 Cg_endo -73.69 -39.45 1.89 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.982 1.517 . . . . 0.0 110.31 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.711 HG23 ' O ' ' A' ' 132' ' ' ILE . 16.9 tt -163.51 107.34 0.97 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.29 -0.881 . . . . 0.0 110.124 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.44 -26.62 16.82 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.009 1.531 . . . . 0.0 110.423 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.28 58.1 1.53 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.45 -76.71 0.55 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -1.153 . . . . 0.0 110.271 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.48 ' OD2' HD12 ' A' ' 138' ' ' LEU . 40.0 p-10 -87.06 33.98 0.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.347 -0.846 . . . . 0.0 110.323 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 136' ' ' ASP . 0.0 OUTLIER 42.87 54.03 4.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.912 . . . . 0.0 110.131 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.65 HD23 ' O ' ' A' ' 138' ' ' LEU . 1.6 tt -95.7 30.87 2.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 0.0 110.237 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 129.57 151.12 7.21 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.79 -25.66 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -1.152 . . . . 0.0 110.224 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.33 157.26 31.44 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.454 ' O ' ' OD1' ' A' ' 142' ' ' ASN . 8.7 p30 -120.79 46.19 2.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.324 -1.104 . . . . 0.0 110.2 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -134.05 165.81 24.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.0 110.253 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 144' ' ' ASP . 19.4 p30 -61.84 168.06 3.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.267 -0.896 . . . . 0.0 110.231 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 53.88 49.64 18.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 110.245 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.627 ' O ' ' HB2' ' A' ' 147' ' ' ALA . . . -163.08 26.87 0.09 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.287 -0.883 . . . . 0.0 110.149 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.627 ' HB2' ' O ' ' A' ' 146' ' ' ALA . . . 174.56 122.5 0.11 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 110.179 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.58 54.19 2.87 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.001 1.527 . . . . 0.0 110.441 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -170.91 167.79 40.94 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.743 ' O ' HD13 ' A' ' 223' ' ' ILE . 8.1 m -144.72 100.59 3.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -1.158 . . . . 0.0 109.978 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.721 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -37.09 150.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.873 . . . . 0.0 110.555 -179.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 1.064 HG23 HG23 ' A' ' 153' ' ' ILE . 17.7 m -54.88 -150.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.229 -0.919 . . . . 0.0 110.379 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 1.134 ' CG2' ' HB1' ' A' ' 218' ' ' ALA . 11.2 pt 40.22 27.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.23 -0.919 . . . . 0.0 110.042 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -144.0 -37.32 0.33 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.522 -0.736 . . . . 0.0 109.383 179.639 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.524 ' HB3' HG11 ' A' ' 163' ' ' VAL . . . -98.27 -9.67 25.16 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.541 -0.724 . . . . 0.0 109.741 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.414 ' O ' ' HB ' ' A' ' 157' ' ' THR . . . -74.05 175.37 7.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.328 -0.857 . . . . 0.0 110.201 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.617 HG22 ' HB2' ' A' ' 161' ' ' ARG . 5.7 t -177.09 178.41 1.13 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.258 -0.901 . . . . 0.0 110.127 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 157' ' ' THR . 21.1 t -42.83 -61.1 1.35 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.901 . . . . 0.0 110.131 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . 0.547 ' HG2' HG23 ' A' ' 157' ' ' THR . 0.0 OUTLIER -71.01 165.01 51.69 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.898 . . . . 0.0 110.034 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.49 ' HB2' ' OE2' ' A' ' 194' ' ' GLU . 45.7 Cg_endo -72.6 66.99 3.78 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.944 1.497 . . . . 0.0 110.353 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.617 ' HB2' HG22 ' A' ' 157' ' ' THR . 0.0 OUTLIER -47.86 125.64 9.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.254 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.48 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 1.2 tttp -77.3 100.37 5.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -0.909 . . . . 0.0 110.274 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.958 HG12 ' O ' ' A' ' 224' ' ' GLU . 0.1 OUTLIER -117.41 -164.01 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 0.0 110.301 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.69 ' O ' ' HB ' ' A' ' 223' ' ' ILE . 23.7 ttt180 -172.33 157.82 4.22 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.911 -1.118 . . . . 0.0 110.265 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.946 HG23 HG22 ' A' ' 223' ' ' ILE . 0.8 OUTLIER -110.49 151.36 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.651 -179.359 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.0 m -133.04 -5.05 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.299 -0.876 . . . . 0.0 110.775 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -174.06 131.13 0.4 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.914 -1.116 . . . . 0.0 110.96 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.881 ' CD1' HG22 ' A' ' 221' ' ' ILE . 9.0 tt -126.23 10.03 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.451 -0.781 . . . . 0.0 109.598 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.459 ' O ' ' HB3' ' A' ' 170' ' ' GLU . 1.5 t-20 -56.09 83.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.373 -0.829 . . . . 0.0 110.356 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.519 ' O ' ' C ' ' A' ' 171' ' ' ILE . 0.7 OUTLIER -179.98 -173.76 0.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.363 -0.836 . . . . 0.0 109.934 179.84 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.554 HG22 ' O ' ' A' ' 171' ' ' ILE . 2.1 mm 33.15 36.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.409 -0.807 . . . . 0.0 110.408 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' A' ' 170' ' ' GLU . 0.2 OUTLIER -67.09 -38.9 86.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.914 . . . . 0.0 110.41 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.712 ' C ' HG23 ' A' ' 174' ' ' VAL . 0.0 OUTLIER -78.76 -156.62 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.878 . . . . 0.0 110.353 -179.741 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.712 HG23 ' C ' ' A' ' 173' ' ' GLN . 2.9 t 76.58 -29.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.601 -0.687 . . . . 0.0 110.876 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.481 ' O ' ' O ' ' A' ' 174' ' ' VAL . 46.2 tt0 55.19 161.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.041 -1.037 . . . . 0.0 110.278 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.587 ' CG2' ' HB3' ' A' ' 179' ' ' PHE . 1.9 m -166.37 113.43 0.86 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.193 -0.942 . . . . 0.0 110.257 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.541 ' O ' ' OG1' ' A' ' 180' ' ' THR . 12.3 m-20 -76.86 -30.39 56.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.124 -0.985 . . . . 0.0 110.443 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.81 -17.53 55.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.097 -1.002 . . . . 0.0 110.449 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 1.035 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -90.29 -15.23 31.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.14 -0.975 . . . . 0.0 110.392 -179.667 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.541 ' OG1' ' O ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -61.73 -20.63 63.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.002 -1.061 . . . . 0.0 109.891 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -71.41 -63.05 1.19 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.857 . . . . 0.0 109.899 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.696 HD21 ' HA ' ' A' ' 179' ' ' PHE . 0.7 OUTLIER -61.71 -14.31 30.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.659 179.643 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 1.035 HD13 ' CZ ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -83.13 -29.94 28.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.868 . . . . 0.0 109.878 179.653 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.97 -12.06 34.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 110.018 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.816 ' HB3' HG22 ' A' ' 187' ' ' ILE . . . -85.88 19.09 2.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 0.0 110.199 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 185' ' ' ALA . 0.2 OUTLIER 41.69 29.6 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.0 109.516 -179.61 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.816 HG22 ' HB3' ' A' ' 185' ' ' ALA . 1.5 tt -116.4 149.33 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.505 -0.747 . . . . 0.0 110.409 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.757 ' O ' ' O ' ' A' ' 189' ' ' VAL . 0.0 OUTLIER 164.91 108.91 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.757 ' O ' ' O ' ' A' ' 188' ' ' ARG . 6.1 p 38.45 175.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 121.589 0.709 . . . . 0.0 110.93 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.662 ' N ' HG22 ' A' ' 189' ' ' VAL . . . 107.41 -7.06 36.66 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.3 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.586 ' O ' ' HG3' ' A' ' 164' ' ' ARG . 0.5 OUTLIER -159.62 -177.35 6.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.859 -1.377 . . . . 0.0 111.74 -179.515 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.625 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 38.8 tt0 -67.39 137.87 56.28 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.753 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.709 HG11 ' CD2' ' A' ' 206' ' ' HIS . 2.0 m -161.16 134.62 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.291 -0.881 . . . . 0.0 109.467 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.641 ' HA ' HG23 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -102.68 156.84 17.36 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.309 179.51 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.677 HG12 HD23 ' A' ' 204' ' ' LEU . 1.2 mt -118.74 153.1 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.936 -1.102 . . . . 0.0 110.683 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 196' ' ' VAL . 55.8 t -132.16 91.47 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.513 -0.742 . . . . 0.0 110.31 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.476 ' HA ' HG12 ' A' ' 202' ' ' ILE . 33.3 m-20 -43.45 137.07 2.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.22 -0.925 . . . . 0.0 110.125 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.481 ' HB2' ' HB3' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -128.25 71.87 1.4 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.261 -0.899 . . . . 0.0 110.265 -180.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 198' ' ' ARG . 0.3 OUTLIER 42.07 75.05 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.251 -0.905 . . . . 0.0 110.223 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 87.92 -36.81 3.32 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -90.55 165.58 13.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.178 -1.19 . . . . 0.0 110.17 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.758 HD12 HG22 ' A' ' 153' ' ' ILE . 9.1 mt -153.77 149.61 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.205 -0.935 . . . . 0.0 110.395 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.821 HG23 ' O ' ' A' ' 211' ' ' VAL . 85.8 m -146.2 159.44 43.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.398 -0.813 . . . . 0.0 109.541 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.958 HD11 ' CD1' ' A' ' 213' ' ' LEU . 0.7 OUTLIER -119.37 157.33 28.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.934 . . . . 0.0 110.602 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.577 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 0.1 OUTLIER -124.54 95.07 4.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.528 -0.732 . . . . 0.0 109.429 179.429 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.709 ' CD2' HG11 ' A' ' 193' ' ' VAL . 40.6 m80 -76.36 74.11 3.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.448 -0.782 . . . . 0.0 110.382 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 206' ' ' HIS . 7.1 t-20 42.54 67.52 0.59 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -0.95 . . . . 0.0 110.278 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 99.17 -38.5 3.07 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.491 ' O ' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -95.71 97.11 9.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.287 -1.125 . . . . 0.0 110.23 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 204' ' ' LEU . 0.5 OUTLIER -102.07 153.62 19.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 110.295 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.821 ' O ' HG23 ' A' ' 203' ' ' THR . 1.0 OUTLIER -143.52 149.98 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.309 -0.869 . . . . 0.0 109.881 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -58.44 -174.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 110.199 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.958 ' CD1' HD11 ' A' ' 204' ' ' LEU . 0.3 OUTLIER -174.47 -28.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.253 -0.905 . . . . 0.0 110.271 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 1.061 ' O ' ' HB2' ' A' ' 218' ' ' ALA . 0.5 OUTLIER 33.04 -151.05 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.477 -0.764 . . . . 0.0 110.728 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 3.1 m-20 -90.49 -61.28 1.71 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.362 -0.836 . . . . 0.0 110.497 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.561 ' HB2' HD11 ' A' ' 214' ' ' LEU . 0.1 OUTLIER -41.48 -52.65 3.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 110.505 -179.686 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.823 ' HB3' HD23 ' A' ' 213' ' ' LEU . 0.5 OUTLIER -79.36 -27.76 41.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.18 -0.95 . . . . 0.0 110.261 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 1.134 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -43.36 -77.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 110.498 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.545 ' HB2' HD13 ' A' ' 153' ' ' ILE . 47.4 t-80 -65.88 89.7 0.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.347 -0.846 . . . . 0.0 110.386 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . 0.453 ' O ' ' OE2' ' A' ' 170' ' ' GLU . 8.1 m -161.23 -63.85 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.825 . . . . 0.0 110.096 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.881 HG22 ' CD1' ' A' ' 168' ' ' ILE . 0.2 OUTLIER -76.18 139.66 18.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.513 -0.742 . . . . 0.0 110.781 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.514 ' HA ' ' HA ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -90.03 106.55 18.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.385 -0.822 . . . . 0.0 109.29 179.202 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.946 HG22 HG23 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -121.48 173.35 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.135 -0.978 . . . . 0.0 110.698 -178.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.958 ' O ' HG12 ' A' ' 163' ' ' VAL . 3.5 mt-10 -150.28 -170.25 3.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.355 -0.841 . . . . 0.0 110.165 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 163' ' ' VAL . 10.0 tm-20 -104.98 112.27 25.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.261 -0.899 . . . . 0.0 110.18 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 19.9 tp . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.209 179.961 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 27.9 t30 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 120.777 0.322 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 132' ' ' ILE . 45.3 Cg_endo -72.04 60.94 3.14 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.046 1.551 . . . . 0.0 110.529 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' A' ' 131' ' ' PRO . 14.7 mt 41.31 94.64 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.337 -0.852 . . . . 0.0 110.388 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.61 -21.88 21.57 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.074 1.565 . . . . 0.0 110.466 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 135.47 -103.22 0.45 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 135' ' ' LEU . 1.8 mm? 49.02 -163.52 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -1.136 . . . . 0.0 110.29 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -118.67 76.5 1.1 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 110.236 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.422 ' OE2' HG23 ' A' ' 132' ' ' ILE . 2.8 pt-20 -126.49 90.03 3.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.919 . . . . 0.0 110.199 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mt -65.28 128.49 36.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.2 -0.938 . . . . 0.0 110.165 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -178.73 99.67 0.13 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 140' ' ' VAL . 4.8 p -66.84 98.0 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -1.097 . . . . 0.0 110.224 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 112.22 -158.3 14.4 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.469 ' N ' ' OD1' ' A' ' 142' ' ' ASN . 30.9 p-10 -176.16 111.23 0.1 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -1.112 . . . . 0.0 110.229 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -118.38 113.55 21.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 110.24 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -48.1 100.24 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 110.161 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.34 -89.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.893 . . . . 0.0 110.227 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -129.39 -90.72 0.48 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.268 -0.895 . . . . 0.0 110.209 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.533 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . -108.19 166.07 11.58 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.947 . . . . 0.0 110.249 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.533 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 46.2 Cg_endo -73.14 98.94 1.05 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.019 1.536 . . . . 0.0 110.608 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 148' ' ' PRO . . . 58.57 149.26 0.01 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.572 ' N ' ' O ' ' A' ' 223' ' ' ILE . 58.6 m -97.97 140.0 32.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.252 -1.146 . . . . 0.0 109.95 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 0.7 OUTLIER -76.53 131.57 39.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.902 -1.123 . . . . 0.0 110.058 179.84 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 1.026 ' CG2' HG21 ' A' ' 223' ' ' ILE . 32.8 t -40.87 161.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.271 -0.893 . . . . 0.0 109.974 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.97 HD11 ' CG ' ' A' ' 219' ' ' HIS . 0.1 OUTLIER 75.01 -15.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.583 -0.698 . . . . 0.0 110.292 -179.025 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 151' ' ' ARG . 0.3 OUTLIER -103.44 -15.0 16.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.104 -0.998 . . . . 0.0 109.265 179.24 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -111.99 -11.98 13.79 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.522 -0.736 . . . . 0.0 109.879 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.776 ' HB2' HD12 ' A' ' 195' ' ' ILE . . . -76.27 128.51 35.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 110.259 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.492 HG21 ' NH1' ' A' ' 161' ' ' ARG . 0.2 OUTLIER -102.32 176.81 5.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.15 -0.969 . . . . 0.0 110.259 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.54 -59.82 2.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.925 . . . . 0.0 110.21 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -75.11 166.3 46.62 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.898 . . . . 0.0 110.193 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 161' ' ' ARG . 45.8 Cg_endo -72.78 78.6 2.07 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.055 1.555 . . . . 0.0 110.437 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.492 ' NH1' HG21 ' A' ' 157' ' ' THR . 0.4 OUTLIER -60.35 -141.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 110.202 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.86 87.45 1.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.21 -0.931 . . . . 0.0 110.322 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.623 ' O ' ' O ' ' A' ' 193' ' ' VAL . 12.3 m -112.7 -162.43 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.311 -0.868 . . . . 0.0 110.221 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.861 HH11 HG12 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -169.79 151.81 4.32 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.808 -1.183 . . . . 0.0 110.985 -179.315 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 1.099 HG23 ' CG2' ' A' ' 223' ' ' ILE . 2.1 mt -100.65 154.0 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.361 -0.837 . . . . 0.0 109.97 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.861 HG12 HH11 ' A' ' 164' ' ' ARG . 31.4 m -133.91 -30.1 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.048 -1.033 . . . . 0.0 111.12 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' A' ' 222' ' ' ARG . 2.0 mt-30 -149.45 128.91 13.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.09 -1.006 . . . . 0.0 110.704 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.69 HG23 HG22 ' A' ' 221' ' ' ILE . 10.5 mt -83.36 -10.05 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.384 -0.822 . . . . 0.0 109.686 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.563 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 1.6 t30 70.36 2.38 4.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.375 -0.828 . . . . 0.0 110.342 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 44.09 62.53 1.94 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 110.394 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.563 ' CG1' ' HB3' ' A' ' 169' ' ' ASN . 13.9 mm -102.15 17.9 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 0.0 110.075 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.435 ' C ' ' O ' ' A' ' 171' ' ' ILE . 56.7 t80 -41.76 113.31 0.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.345 -0.847 . . . . 0.0 110.29 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -141.82 -32.58 0.52 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.312 -0.867 . . . . 0.0 110.378 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.457 ' O ' ' C ' ' A' ' 175' ' ' GLU . 48.7 t -127.6 75.73 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 110.101 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 174' ' ' VAL . 43.3 tt0 -39.3 157.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.429 -0.795 . . . . 0.0 110.429 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.637 ' OG1' ' CD1' ' A' ' 179' ' ' PHE . 1.0 OUTLIER -136.36 135.91 39.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.313 -0.867 . . . . 0.0 110.145 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.591 ' O ' ' OG1' ' A' ' 180' ' ' THR . 11.5 t70 -72.13 -45.91 58.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.234 -0.917 . . . . 0.0 110.871 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -21.38 63.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.056 -1.027 . . . . 0.0 110.42 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.669 ' HB2' HD11 ' A' ' 214' ' ' LEU . 0.0 OUTLIER -90.78 -31.42 16.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 110.667 -179.782 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.599 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.5 OUTLIER -43.88 -25.97 0.23 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.953 -1.092 . . . . 0.0 109.683 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 179' ' ' PHE . 35.5 tt0 -61.62 -35.04 76.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.85 . . . . 0.0 109.578 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.578 HD21 ' O ' ' A' ' 212' ' ' GLU . 0.8 OUTLIER -72.12 -39.85 68.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.398 -0.813 . . . . 0.0 109.546 179.454 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.61 -33.7 75.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.517 -0.739 . . . . 0.0 109.928 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -63.19 -14.75 52.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 0.0 109.735 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 186' ' ' ASP . . . -86.89 16.66 4.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.375 -0.828 . . . . 0.0 110.034 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 186' ' ' ASP . 5.8 m-20 42.26 48.64 4.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 109.368 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.3 tt -128.96 169.56 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.517 -0.739 . . . . 0.0 110.554 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.483 ' O ' ' C ' ' A' ' 189' ' ' VAL . 0.0 OUTLIER -150.87 -133.29 0.05 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.365 -0.835 . . . . 0.0 108.784 179.506 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 189' ' ' VAL . 4.3 m -42.47 120.37 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 120.965 -1.084 . . . . 0.0 109.076 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.84 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -50.31 -7.7 0.14 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.607 ' O ' ' HB2' ' A' ' 164' ' ' ARG . 28.3 t 58.77 -150.53 0.44 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.163 -1.198 . . . . 0.0 109.675 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.682 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 95.5 mt-10 -64.35 101.86 0.47 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.693 -0.63 . . . . 0.0 109.826 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.623 ' O ' ' O ' ' A' ' 163' ' ' VAL . 30.8 m -158.16 -135.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.913 . . . . 0.0 109.742 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.537 ' N ' HG23 ' A' ' 193' ' ' VAL . 0.0 OUTLIER -169.05 158.74 8.73 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.293 -0.879 . . . . 0.0 110.117 179.407 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.776 HD12 ' HB2' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -120.04 156.81 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 0.0 110.088 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.449 ' N ' ' O ' ' A' ' 203' ' ' THR . 11.4 t -125.24 92.38 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 110.165 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.498 ' HA ' HG12 ' A' ' 202' ' ' ILE . 8.5 t0 -41.73 134.1 2.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.292 -0.88 . . . . 0.0 110.205 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.523 ' CB ' ' O ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -132.92 154.98 49.89 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.233 -0.917 . . . . 0.0 110.137 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -59.26 90.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.237 -0.914 . . . . 0.0 110.362 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 89.88 1.56 76.49 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.523 ' O ' ' CB ' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -150.14 170.79 18.1 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -1.182 . . . . 0.0 110.326 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.498 HG12 ' HA ' ' A' ' 197' ' ' ASP . 7.5 mt -146.62 99.96 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.0 110.202 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 196' ' ' VAL . 55.1 m -72.61 150.78 42.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -0.909 . . . . 0.0 110.004 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.718 ' HG ' HG23 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -119.9 137.9 53.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.129 -0.982 . . . . 0.0 110.288 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.56 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.6 OUTLIER -119.66 124.05 45.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.36 -0.837 . . . . 0.0 109.964 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.519 ' HA ' ' CB ' ' A' ' 193' ' ' VAL . 3.0 m80 -110.09 -171.95 1.94 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.458 -0.776 . . . . 0.0 110.188 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -56.68 98.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 110.244 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 61.09 26.11 65.32 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 206' ' ' HIS . 2.5 mtpt -143.16 158.97 43.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -1.156 . . . . 0.0 110.286 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -156.6 139.27 15.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.917 . . . . 0.0 110.153 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 212' ' ' GLU . 4.2 p -134.27 172.63 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.318 -0.863 . . . . 0.0 110.205 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.578 ' O ' HD21 ' A' ' 182' ' ' LEU . 1.5 tt0 -110.87 103.46 11.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.255 -0.903 . . . . 0.0 110.234 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.404 ' HA ' HD12 ' A' ' 213' ' ' LEU . 13.2 tp -95.22 171.69 8.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 110.087 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.956 ' O ' ' HB2' ' A' ' 218' ' ' ALA . 5.6 mt -91.12 166.17 13.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 110.141 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.466 ' HB2' ' HA ' ' A' ' 201' ' ' HIS . 6.0 t0 -89.9 -75.0 0.46 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 110.094 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.19 -22.34 60.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.929 . . . . 0.0 110.092 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.519 ' HB3' ' HB2' ' A' ' 214' ' ' LEU . 0.2 OUTLIER -90.04 -24.94 21.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.897 . . . . 0.0 110.272 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.956 ' HB2' ' O ' ' A' ' 214' ' ' LEU . . . -62.79 -33.03 74.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.204 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.97 ' CG ' HD11 ' A' ' 153' ' ' ILE . 0.3 OUTLIER -64.18 84.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 110.183 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 3.3 m -165.2 -46.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 110.577 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.871 HD11 ' HB ' ' A' ' 152' ' ' VAL . 0.3 OUTLIER -74.36 144.81 11.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.259 -0.9 . . . . 0.0 110.841 -179.566 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.535 ' O ' HG22 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -89.31 107.36 19.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.42 -0.8 . . . . 0.0 109.19 179.352 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 1.099 ' CG2' HG23 ' A' ' 165' ' ' ILE . 0.6 OUTLIER -119.87 163.98 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.316 -0.865 . . . . 0.0 110.84 -178.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.458 ' HG2' ' HA2' ' A' ' 149' ' ' GLY . 27.1 mt-10 -139.43 -177.77 5.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 0.0 110.27 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.586 ' HG3' HG12 ' A' ' 163' ' ' VAL . 3.6 mt-10 -95.02 70.18 3.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.878 . . . . 0.0 110.339 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 23.3 mt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.284 179.982 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 9.1 t30 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 120.832 0.349 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.07 -45.22 0.47 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.058 1.557 . . . . 0.0 110.443 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.439 ' HB ' ' HD2' ' A' ' 133' ' ' PRO . 10.0 pt -73.56 163.42 68.54 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 110.189 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 132' ' ' ILE . 46.2 Cg_endo -73.24 -17.01 24.75 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.973 1.512 . . . . 0.0 110.425 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 135' ' ' LEU . . . 107.46 -135.89 13.07 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.453 ' CB ' ' O ' ' A' ' 134' ' ' GLY . 0.3 OUTLIER 66.22 29.8 9.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -1.114 . . . . 0.0 110.259 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -151.96 87.99 1.37 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 110.298 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -71.83 61.68 0.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.935 . . . . 0.0 110.137 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.34 152.29 20.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.252 -0.905 . . . . 0.0 110.254 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.35 -168.07 13.41 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 58.9 t -80.09 96.42 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -1.156 . . . . 0.0 110.236 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -88.43 8.7 78.11 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -130.01 171.1 13.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.269 -1.136 . . . . 0.0 110.209 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 31.1 t -119.44 124.6 46.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.332 -0.855 . . . . 0.0 110.156 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.605 ' O ' ' HB3' ' A' ' 145' ' ' ALA . 2.6 m-20 -140.48 155.88 46.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 110.189 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 144' ' ' ASP . . . 62.73 178.91 0.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.237 -0.914 . . . . 0.0 110.232 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -122.91 -27.02 4.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.203 -0.936 . . . . 0.0 110.228 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -166.54 142.93 3.96 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 110.198 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.471 ' HA ' ' HG2' ' A' ' 222' ' ' ARG . 46.9 Cg_endo -73.89 60.51 4.52 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.968 1.51 . . . . 0.0 110.548 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 148' ' ' PRO . . . 43.69 -111.46 0.43 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.466 ' O ' HG22 ' A' ' 150' ' ' THR . 87.0 m -131.47 0.49 4.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -1.147 . . . . 0.0 110.288 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' A' ' 153' ' ' ILE . 1.8 mtm-85 61.03 131.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 110.138 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.842 HG13 ' O ' ' A' ' 152' ' ' VAL . 4.7 p -65.69 55.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.264 -0.897 . . . . 0.0 110.683 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 1.103 ' CG2' ' HB1' ' A' ' 218' ' ' ALA . 3.1 pt -156.23 -35.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.085 -1.009 . . . . 0.0 110.019 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 150' ' ' THR . 0.2 OUTLIER -69.81 -13.99 62.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 0.0 109.083 179.224 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.75 ' HB3' HD11 ' A' ' 195' ' ' ILE . . . -96.31 1.76 52.23 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.582 -0.699 . . . . 0.0 109.899 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 155' ' ' ALA . . . -57.69 -152.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 110.399 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 159' ' ' MET . 12.6 t -41.02 -34.53 0.43 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.38 -0.825 . . . . 0.0 110.269 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 157' ' ' THR . 10.1 t -43.39 -26.12 0.18 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.917 . . . . 0.0 109.688 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . 0.52 ' HB3' ' HD2' ' A' ' 161' ' ' ARG . 0.1 OUTLIER -160.37 103.84 1.36 Allowed Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.434 -0.791 . . . . 0.0 109.602 179.702 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.23 106.35 1.73 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.938 1.494 . . . . 0.0 110.476 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.52 ' HD2' ' HB3' ' A' ' 159' ' ' MET . 0.0 OUTLIER -171.42 175.27 4.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.358 -0.839 . . . . 0.0 110.28 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.616 ' HA ' ' HB2' ' A' ' 194' ' ' GLU . 1.0 OUTLIER -88.98 150.54 22.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.275 -0.891 . . . . 0.0 110.326 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 1.031 HG22 ' HA ' ' A' ' 194' ' ' GLU . 2.8 m -147.34 -155.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.168 -0.957 . . . . 0.0 110.851 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.646 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 4.8 ttt-85 178.71 150.99 0.28 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.026 -1.046 . . . . 0.0 110.107 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 1.04 HG23 HG22 ' A' ' 223' ' ' ILE . 0.0 OUTLIER -93.71 149.39 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.217 -0.927 . . . . 0.0 109.864 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 222' ' ' ARG . 18.2 m -130.8 0.98 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.096 -1.003 . . . . 0.0 110.472 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.483 ' NE2' ' O ' ' A' ' 166' ' ' VAL . 0.9 OUTLIER -167.02 123.37 1.17 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.115 -0.991 . . . . 0.0 110.253 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.457 HD12 HG21 ' A' ' 221' ' ' ILE . 1.3 tt -130.32 9.04 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 0.0 110.138 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 168' ' ' ILE . 15.0 m-20 -41.49 101.37 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -0.887 . . . . 0.0 110.181 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.41 ' O ' ' CD1' ' A' ' 172' ' ' PHE . 2.3 tp10 -146.86 116.32 7.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.207 -0.933 . . . . 0.0 110.329 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.52 ' O ' HD12 ' A' ' 171' ' ' ILE . 1.2 pp -84.25 20.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 110.17 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.454 ' C ' ' O ' ' A' ' 171' ' ' ILE . 55.8 p90 -39.96 145.11 0.16 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 0.0 110.437 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -149.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.915 . . . . 0.0 110.267 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 176' ' ' THR . 37.0 t -119.32 -15.58 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.216 -0.927 . . . . 0.0 110.294 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.32 88.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 0.0 110.128 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.563 ' CG2' ' HB3' ' A' ' 179' ' ' PHE . 0.3 OUTLIER -155.09 -36.83 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 0.0 110.356 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.481 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.4 OUTLIER 53.48 -85.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.414 -0.804 . . . . 0.0 110.465 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 176' ' ' THR . 13.5 tm0? -41.64 -26.74 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.264 -0.898 . . . . 0.0 110.433 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.939 ' CE2' HD23 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -89.14 -44.36 10.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.236 -0.915 . . . . 0.0 110.219 -179.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.519 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -44.37 -24.35 0.17 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.085 -1.009 . . . . 0.0 109.799 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -66.7 -67.68 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.37 -0.831 . . . . 0.0 110.155 179.799 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.802 HD12 ' N ' ' A' ' 183' ' ' LEU . 4.3 pp -60.97 -16.57 44.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.88 . . . . 0.0 109.747 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.939 HD23 ' CE2' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -81.79 -32.71 31.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 109.663 179.549 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.74 -18.62 60.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.432 -0.793 . . . . 0.0 109.851 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -87.16 16.81 4.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.371 -0.831 . . . . 0.0 110.206 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 51.38 68.32 0.81 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.12 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 187' ' ' ILE . 16.2 mm -107.14 88.63 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 110.389 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 190' ' ' GLY . 1.5 ptp180 -100.49 142.39 32.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.364 -0.835 . . . . 0.0 109.636 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 1.0 ' O ' ' N ' ' A' ' 191' ' ' SER . 5.9 m 33.77 34.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 121.288 -0.883 . . . . 0.0 110.628 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.701 ' N ' HD12 ' A' ' 165' ' ' ILE . . . 22.93 21.86 0.0 OUTLIER Glycine 0 N--CA 1.496 2.683 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 1.0 ' N ' ' O ' ' A' ' 189' ' ' VAL . 1.3 t 36.48 -148.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -1.148 . . . . 0.0 109.842 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.646 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 22.3 tt0 -83.46 118.3 23.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.614 -0.679 . . . . 0.0 109.383 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.631 ' CG2' HD21 ' A' ' 204' ' ' LEU . 34.2 m -158.67 -137.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.091 -1.005 . . . . 0.0 110.097 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 1.031 ' HA ' HG22 ' A' ' 163' ' ' VAL . 42.9 tt0 -174.3 158.77 3.0 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.207 -0.933 . . . . 0.0 110.54 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.75 HD11 ' HB3' ' A' ' 155' ' ' ALA . 0.4 OUTLIER -120.84 145.62 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.311 -0.868 . . . . 0.0 109.973 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.482 ' O ' ' O ' ' A' ' 197' ' ' ASP . 6.5 t -135.37 35.76 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.154 -0.966 . . . . 0.0 110.298 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 196' ' ' VAL . 0.4 OUTLIER 54.64 162.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.345 -0.847 . . . . 0.0 110.451 179.8 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.55 ' HB2' ' N ' ' A' ' 203' ' ' THR . 30.0 ttt-85 -143.54 160.04 41.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.219 -0.926 . . . . 0.0 110.172 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 198' ' ' ARG . 0.1 OUTLIER -43.97 103.92 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.403 -179.877 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 61.58 11.83 30.69 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.417 ' C ' ' HB3' ' A' ' 198' ' ' ARG . 1.2 t60 -150.17 -156.19 0.7 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.138 -1.213 . . . . 0.0 110.194 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.861 HD13 HG22 ' A' ' 153' ' ' ILE . 92.5 mt -129.16 134.28 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.208 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.55 ' N ' ' HB2' ' A' ' 198' ' ' ARG . 4.3 m -109.27 148.2 31.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 110.149 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.839 HD22 ' CD2' ' A' ' 206' ' ' HIS . 1.1 tt -119.71 135.2 54.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 110.161 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.525 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.5 OUTLIER -119.86 124.93 47.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.355 -0.84 . . . . 0.0 109.895 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.839 ' CD2' HD22 ' A' ' 204' ' ' LEU . 2.2 m170 -106.06 -162.69 0.88 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.378 -0.826 . . . . 0.0 110.105 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -52.83 90.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 110.175 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . 59.93 26.58 63.31 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 54.5 mttt -132.54 169.9 15.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.25 -1.147 . . . . 0.0 110.328 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.569 ' O ' HG23 ' A' ' 211' ' ' VAL . 7.9 t70 -156.02 145.61 21.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.354 -0.842 . . . . 0.0 110.068 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 210' ' ' ASP . 55.5 t -156.22 144.12 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.92 . . . . 0.0 110.252 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.451 ' OE1' ' NE2' ' A' ' 178' ' ' GLN . 6.4 tt0 -56.56 161.56 2.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 110.14 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.673 ' CD1' ' HB2' ' A' ' 218' ' ' ALA . 1.5 tm? -142.57 92.63 2.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 110.216 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.655 HD23 ' H ' ' A' ' 214' ' ' LEU . 1.4 pt? -46.83 174.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.333 -0.854 . . . . 0.0 110.148 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -90.17 -30.91 17.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.353 -0.842 . . . . 0.0 110.27 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.33 -44.89 95.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.939 . . . . 0.0 110.364 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.637 HD13 ' CD2' ' A' ' 179' ' ' PHE . 0.1 OUTLIER -84.24 -18.92 34.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.172 -0.955 . . . . 0.0 110.18 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 1.103 ' HB1' ' CG2' ' A' ' 153' ' ' ILE . . . -67.18 -58.68 4.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 110.412 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.634 ' CD2' ' CD1' ' A' ' 153' ' ' ILE . 13.0 t-80 -85.87 79.32 9.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.189 -0.944 . . . . 0.0 110.471 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . 0.792 HG23 HG23 ' A' ' 221' ' ' ILE . 2.8 t -176.5 -48.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 110.294 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.819 HD11 HG12 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -70.4 142.58 15.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.215 -0.928 . . . . 0.0 110.294 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.793 ' O ' HG22 ' A' ' 166' ' ' VAL . 10.0 mtt180 -89.51 114.7 26.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.237 -0.914 . . . . 0.0 109.497 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 1.04 HG22 HG23 ' A' ' 165' ' ' ILE . 0.7 OUTLIER -120.83 -176.53 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 110.725 -179.224 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 223' ' ' ILE . 46.0 mm-40 -149.57 174.52 12.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.484 -0.76 . . . . 0.0 110.03 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.515 ' HG3' HG12 ' A' ' 163' ' ' VAL . 0.4 OUTLIER -100.01 144.03 29.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 110.176 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.546 HD21 ' HG3' ' A' ' 192' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.221 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 120.738 0.304 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.72 -27.38 15.08 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.008 1.53 . . . . 0.0 110.531 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 63.0 mt -115.28 106.56 50.84 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.187 -0.946 . . . . 0.0 110.253 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.516 ' HB2' HD23 ' A' ' 135' ' ' LEU . 46.7 Cg_endo -73.02 -49.11 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.016 1.535 . . . . 0.0 110.513 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 128.71 1.91 5.86 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 133' ' ' PRO . 1.3 pp -94.22 141.39 28.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -1.13 . . . . 0.0 110.286 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -109.12 27.82 9.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.328 -0.857 . . . . 0.0 110.152 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.63 69.91 0.85 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 0.0 110.179 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.23 71.57 1.7 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.243 -0.911 . . . . 0.0 110.222 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.89 57.29 6.96 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.403 HG23 ' N ' ' A' ' 141' ' ' GLY . 19.9 m -73.43 -146.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -1.166 . . . . 0.0 110.165 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.403 ' N ' HG23 ' A' ' 140' ' ' VAL . . . 113.44 -10.84 23.95 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -112.35 135.56 52.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -1.158 . . . . 0.0 110.203 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.1 t 47.51 77.58 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 110.149 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.8 -4.28 16.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 110.296 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.543 ' O ' ' HB3' ' A' ' 146' ' ' ALA . . . -62.92 -148.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 110.209 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 145' ' ' ALA . . . 60.1 54.34 4.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.276 -0.89 . . . . 0.0 110.217 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.65 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . -177.77 169.71 0.97 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.283 -0.886 . . . . 0.0 110.197 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.65 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 45.5 Cg_endo -73.1 53.77 2.55 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.977 1.514 . . . . 0.0 110.392 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.481 ' HA3' ' HD3' ' A' ' 222' ' ' ARG . . . 164.26 83.92 0.05 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.538 ' O ' ' CG1' ' A' ' 223' ' ' ILE . 30.0 m -97.26 136.48 37.69 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -1.153 . . . . 0.0 110.276 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 154' ' ' ASP . 26.1 mtt-85 -64.87 128.77 37.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.096 -1.002 . . . . 0.0 109.888 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 1.025 HG23 HG21 ' A' ' 223' ' ' ILE . 1.3 t -43.6 -32.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.168 -0.957 . . . . 0.0 110.232 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.735 HG21 ' HB3' ' A' ' 218' ' ' ALA . 1.1 pp -83.55 -13.33 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.209 -0.932 . . . . 0.0 110.451 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 151' ' ' ARG . 0.3 OUTLIER -79.52 -14.71 58.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 109.794 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -116.56 -5.38 11.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.332 -0.855 . . . . 0.0 109.998 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.48 135.2 40.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.299 -0.875 . . . . 0.0 110.296 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 158' ' ' SER . 0.2 OUTLIER -139.67 171.82 13.69 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.204 -0.935 . . . . 0.0 110.192 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 157' ' ' THR . 0.1 OUTLIER -42.9 -60.84 1.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 110.053 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 2.2 mtt -78.54 162.98 63.8 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.179 -0.95 . . . . 0.0 110.068 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.446 ' HB3' HG22 ' A' ' 196' ' ' VAL . 45.8 Cg_endo -73.21 73.29 3.26 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.946 1.498 . . . . 0.0 110.467 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.13 130.8 23.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.326 -0.859 . . . . 0.0 110.197 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.28 103.13 4.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 110.203 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.638 ' O ' ' O ' ' A' ' 193' ' ' VAL . 17.6 m -128.72 -169.12 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.168 -0.957 . . . . 0.0 110.273 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.635 ' HB2' ' HA ' ' A' ' 192' ' ' GLU . 9.2 ptt-85 -166.25 147.32 6.52 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.711 -1.243 . . . . 0.0 110.836 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 1.092 HG23 ' CG2' ' A' ' 223' ' ' ILE . 0.8 OUTLIER -90.42 152.23 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.394 -0.816 . . . . 0.0 110.117 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 222' ' ' ARG . 17.9 m -138.59 -29.71 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.208 -0.933 . . . . 0.0 110.762 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.518 ' HB2' ' HB2' ' A' ' 222' ' ' ARG . 35.3 mt-30 -131.87 118.01 19.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.169 -0.957 . . . . 0.0 110.34 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.564 ' HB ' HG12 ' A' ' 189' ' ' VAL . 1.0 OUTLIER -84.44 -4.71 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.336 -0.853 . . . . 0.0 110.134 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.9 m120 51.16 -89.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.231 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 168' ' ' ILE . 77.6 tt0 -173.75 88.62 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 110.207 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.643 ' CG2' HD23 ' A' ' 217' ' ' LEU . 5.8 mt -76.98 2.83 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.278 -0.889 . . . . 0.0 110.21 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -58.54 108.0 0.58 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.244 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -130.45 -172.38 2.79 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.307 -0.871 . . . . 0.0 110.177 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.649 ' O ' HG12 ' A' ' 174' ' ' VAL . 61.2 t -109.59 20.1 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.203 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 177' ' ' ASP . 20.7 mm-40 -114.54 -32.95 5.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 110.21 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.541 ' O ' ' HB3' ' A' ' 179' ' ' PHE . 69.0 p 42.26 -92.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.387 -0.821 . . . . 0.0 110.288 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 176' ' ' THR . 0.7 OUTLIER 72.41 -154.68 0.08 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.262 -0.898 . . . . 0.0 110.172 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 181' ' ' GLN . 4.4 mm-40 -57.7 -23.68 52.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 110.507 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.919 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -47.48 -40.91 19.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.133 -0.98 . . . . 0.0 110.259 -179.851 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.51 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -46.93 -24.88 0.67 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.994 -1.066 . . . . 0.0 109.634 179.662 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 178' ' ' GLN . 11.7 tp60 -63.24 -66.18 0.58 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.43 -0.794 . . . . 0.0 110.42 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.682 ' C ' HD12 ' A' ' 182' ' ' LEU . 4.6 pp -63.91 -12.69 39.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.0 110.11 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.919 HD13 ' CZ ' ' A' ' 179' ' ' PHE . 0.8 OUTLIER -93.14 -30.64 15.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.314 -0.866 . . . . 0.0 109.731 179.631 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 180' ' ' THR . 9.8 t70 -73.41 -7.02 49.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.293 -0.879 . . . . 0.0 109.855 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.48 ' O ' HG12 ' A' ' 187' ' ' ILE . . . -87.58 32.32 0.72 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.323 -0.861 . . . . 0.0 110.175 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 185' ' ' ALA . 7.6 t70 43.41 55.84 4.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.194 -0.941 . . . . 0.0 109.976 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 185' ' ' ALA . 9.3 mm -110.64 163.94 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.873 . . . . 0.0 110.511 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.722 ' C ' HG13 ' A' ' 189' ' ' VAL . 0.1 OUTLIER -166.15 104.54 0.65 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.722 HG13 ' C ' ' A' ' 188' ' ' ARG . 1.5 m 50.86 103.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.763 ' H ' HD12 ' A' ' 165' ' ' ILE . . . -42.69 -16.95 0.03 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 189' ' ' VAL . 6.3 t 64.98 -145.59 0.24 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.191 -1.182 . . . . 0.0 109.13 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.635 ' HA ' ' HB2' ' A' ' 164' ' ' ARG . 21.7 tt0 -61.02 100.64 0.12 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.215 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.674 HG21 HD21 ' A' ' 204' ' ' LEU . 17.7 m -156.28 -136.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.165 -0.959 . . . . 0.0 109.77 -179.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.642 ' N ' HG23 ' A' ' 193' ' ' VAL . 11.5 pt-20 -173.19 164.43 4.78 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.35 -0.844 . . . . 0.0 110.007 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 1.022 HG21 HG13 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -122.81 173.32 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.201 -0.937 . . . . 0.0 110.394 -179.764 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.446 HG22 ' HB3' ' A' ' 160' ' ' PRO . 99.4 t -141.49 83.86 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 0.0 110.096 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 196' ' ' VAL . 8.4 t70 -42.46 121.94 2.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.927 . . . . 0.0 110.205 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.402 ' HB3' ' HB3' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -119.02 171.36 8.31 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.178 -0.951 . . . . 0.0 110.307 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -56.0 99.98 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 110.331 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 62.87 22.75 64.84 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.403 ' C ' HG13 ' A' ' 202' ' ' ILE . 0.2 OUTLIER -148.08 158.01 43.83 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.281 -1.129 . . . . 0.0 110.083 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.684 HD13 HG22 ' A' ' 153' ' ' ILE . 57.8 mt -142.33 95.2 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 110.225 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 92.0 m -84.83 157.27 20.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 0.0 109.998 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.83 ' HG ' HG23 ' A' ' 195' ' ' ILE . 0.6 OUTLIER -119.91 141.57 49.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.206 -0.934 . . . . 0.0 110.367 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.608 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 0.0 OUTLIER -119.58 122.71 42.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.353 -0.842 . . . . 0.0 109.966 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.565 ' HA ' ' HB ' ' A' ' 193' ' ' VAL . 5.3 m170 -98.97 167.86 10.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.45 -0.781 . . . . 0.0 110.309 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -44.07 106.95 0.08 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.338 -0.851 . . . . 0.0 110.24 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 57.57 24.34 52.37 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 206' ' ' HIS . 3.8 mtmt -150.76 175.46 11.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -1.13 . . . . 0.0 110.226 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 211' ' ' VAL . 5.6 t70 -171.18 161.9 6.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.216 -0.928 . . . . 0.0 110.148 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.479 ' N ' ' OD1' ' A' ' 210' ' ' ASP . 10.0 p -151.72 150.66 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.185 -0.947 . . . . 0.0 110.336 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.74 168.47 9.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 0.0 110.08 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 26.3 tp -172.75 149.65 2.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -0.886 . . . . 0.0 110.239 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.888 HD12 ' HB2' ' A' ' 216' ' ' ASP . 0.3 OUTLIER -114.46 124.32 51.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.267 -0.895 . . . . 0.0 110.171 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.581 ' HA ' ' HB3' ' A' ' 218' ' ' ALA . 13.5 p-10 -47.28 -22.65 0.43 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 110.23 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.888 ' HB2' HD12 ' A' ' 214' ' ' LEU . 1.4 m-20 -51.42 -66.3 0.41 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 0.0 110.328 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.643 HD23 ' CG2' ' A' ' 171' ' ' ILE . 0.3 OUTLIER -89.84 -18.02 27.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 110.348 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.735 ' HB3' HG21 ' A' ' 153' ' ' ILE . . . -47.44 -22.78 0.49 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.337 -0.852 . . . . 0.0 110.286 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 216' ' ' ASP . 0.0 OUTLIER -89.16 58.14 4.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 110.409 -179.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . 0.48 HG23 ' ND1' ' A' ' 219' ' ' HIS . 18.0 p -142.83 -41.72 0.32 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -0.918 . . . . 0.0 110.262 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.65 HD13 ' N ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -69.41 137.27 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.39 -0.819 . . . . 0.0 110.305 -179.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.518 ' HB2' ' HB2' ' A' ' 167' ' ' GLN . 30.3 mtt180 -89.99 115.45 27.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.53 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 1.092 ' CG2' HG23 ' A' ' 165' ' ' ILE . 1.0 OUTLIER -129.37 -178.07 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 110.816 -179.125 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.42 -179.65 7.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.349 -0.844 . . . . 0.0 110.208 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.459 ' HG3' HG12 ' A' ' 163' ' ' VAL . 10.6 tt0 -99.7 100.82 11.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.222 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.495 ' O ' ' NH1' ' A' ' 164' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.206 -179.987 . . . . . . . . 2 2 . 1 stop_ save_